PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hodgkin, PD; Dowling, MR; Duffy, KR				Hodgkin, Philip D.; Dowling, Mark R.; Duffy, Ken R.			Why the immune system takes its chances with randomness	NATURE REVIEWS IMMUNOLOGY			English	Letter							T-CELL DIFFERENTIATION; FATES; COMPETITION; EXPRESSION		[Hodgkin, Philip D.; Dowling, Mark R.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [Hodgkin, Philip D.; Dowling, Mark R.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia; [Duffy, Ken R.] Natl Univ Ireland, Hamilton Inst, Maynooth, Kildare, Ireland	Walter & Eliza Hall Institute; University of Melbourne; Maynooth University	Hodgkin, PD (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia.	hodgkin@wehi.edu.au	Duffy, Ken/D-7955-2011	Duffy, Ken/0000-0001-5587-9356; Hodgkin, Philip/0000-0002-8604-1940; Dowling, Mark/0000-0002-8056-5348				Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; Duffy KR, 2012, TRENDS CELL BIOL, V22, P457, DOI 10.1016/j.tcb.2012.05.004; Duffy KR, 2012, SCIENCE, V335, P338, DOI 10.1126/science.1213230; Duffy KR, 2009, J MATH BIOL, V59, P255, DOI 10.1007/s00285-008-0231-x; Gerlach C, 2013, SCIENCE, V340, P635, DOI 10.1126/science.1235487; Guo LY, 2005, IMMUNITY, V23, P89, DOI 10.1016/j.immuni.2005.05.008; Hasbold J, 2004, NAT IMMUNOL, V5, P55, DOI 10.1038/ni1016; Hawkins ED, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2796; Hodgkin PD, 2007, IMMUNOL CELL BIOL, V85, P295, DOI 10.1038/sj.icb.7100061; KELSO A, 1995, EUR J IMMUNOL, V25, P1168, DOI 10.1002/eji.1830250506; Raulet DH, 1997, IMMUNOL REV, V155, P41, DOI 10.1111/j.1600-065X.1997.tb00938.x; Reiner SL, 2014, NAT REV IMMUNOL, V14, P699, DOI 10.1038/nri3734; Rohr JC, 2014, TRENDS IMMUNOL, V35, P170, DOI 10.1016/j.it.2014.02.006; Subramanian VG, 2008, J MATH BIOL, V56, P861, DOI 10.1007/s00285-007-0142-2	15	13	13	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2014	14	10								10.1038/nri3734-cl	http://dx.doi.org/10.1038/nri3734-cl			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AZ6KT	25212742				2022-12-18	WOS:000348329500001
J	Kugelberg, E				Kugelberg, Elisabeth			PATTERN RECOGNITION RECEPTORS Curbing gut inflammation	NATURE REVIEWS IMMUNOLOGY			English	News Item														Kugelberg, Elisabeth/0000-0002-8302-3595				Ramanan D., 2014, IMMUNITY	1	13	13	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2014	14	9					583	583		10.1038/nri3735	http://dx.doi.org/10.1038/nri3735			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO5KL	25132096				2022-12-18	WOS:000341383600007
J	Shin, JI; Bayry, J				Shin, Jae Il; Bayry, Jagadeesh			A role for IL-17 in age-related macular degeneration	NATURE REVIEWS IMMUNOLOGY			English	Letter							T-CELLS		[Shin, Jae Il] Yonsei Univ, Coll Med, Dept Pediat, Seoul 120752, South Korea; [Bayry, Jagadeesh] INSERM, U872, F-75006 Paris, France; [Bayry, Jagadeesh] Univ Paris 06, Ctr Rech Cordeliers, Equipe Immunopathol & Therapeut Immunointervent 1, F-75006 Paris, France; [Bayry, Jagadeesh] Univ Paris 05, UMR S 872, F-75006 Paris, France	Yonsei University; Yonsei University Health System; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Shin, JI (corresponding author), Yonsei Univ, Coll Med, Dept Pediat, Seoul 120752, South Korea.	pedshin2000@yahoo.co.kr; jagadeesh.bayry@crc.jussieu.fr	SHIN, JAE IL/J-6922-2017; SHIN, JAE IL/ABD-9660-2021; Bayry, Jagadeesh/A-6589-2011	SHIN, JAE IL/0000-0003-2326-1820; SHIN, JAE IL/0000-0003-2326-1820; Bayry, Jagadeesh/0000-0003-0498-9808				Ambati J, 2013, NAT REV IMMUNOL, V13, P438, DOI 10.1038/nri3459; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Hasegawa E, 2013, J IMMUNOL, V190, P1778, DOI 10.4049/jimmunol.1202495; Liu BY, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-111; Takahashi H, 2005, IMMUNOL LETT, V98, P189, DOI 10.1016/j.imlet.2004.11.012; Tuo JS, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-59	6	13	14	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2013	13	9								10.1038/nri3459-c1	http://dx.doi.org/10.1038/nri3459-c1			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	208BA	23969738	Bronze			2022-12-18	WOS:000323648900014
J	Kekalainen, E; Miettinen, A; Arstila, TP				Kekalainen, Eliisa; Miettinen, Aaro; Arstila, T. Petteri			Does the deficiency of Aire in mice really resemble human APECED?	NATURE REVIEWS IMMUNOLOGY			English	Letter							CANDIDIASIS-ECTODERMAL DYSTROPHY; T-CELLS; AUTOANTIBODIES; PHENOTYPE; DEVELOP; THYMUS		Univ Helsinki, Dept Immunol, Haartman Inst, FIN-00014 Helsinki, Finland; Univ Helsinki, HUSLAB, Helsinki, Finland	University of Helsinki; University of Helsinki	Arstila, TP (corresponding author), Univ Helsinki, Dept Immunol, Haartman Inst, FIN-00014 Helsinki, Finland.	petteri.arstila@helsinki.fi	, eliisa.kekalainen@helsinki.fi/G-6140-2010	, eliisa.kekalainen@helsinki.fi/0000-0001-6045-108X				Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Gylling M, 2003, J CLIN ENDOCR METAB, V88, P4602, DOI 10.1210/jc.2003-030700; Gylling M, 2000, J CLIN ENDOCR METAB, V85, P4434, DOI 10.1210/jc.85.12.4434; Halonen M, 2002, J CLIN ENDOCR METAB, V87, P2568, DOI 10.1210/jc.87.6.2568; Jiang WY, 2005, J EXP MED, V202, P805, DOI 10.1084/jem.20050693; Kekalainen E, 2007, J IMMUNOL, V178, P1208, DOI 10.4049/jimmunol.178.2.1208; Lacroix-Desmazes S, 1998, J IMMUNOL METHODS, V216, P117, DOI 10.1016/S0022-1759(98)00074-X; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Mathis D, 2007, NAT REV IMMUNOL, V7, P645, DOI 10.1038/nri2136; Pisetsky DS, 2000, CURR OPIN RHEUMATOL, V12, P364, DOI 10.1097/00002281-200009000-00002; Pontynen N, 2006, J AUTOIMMUN, V27, P96, DOI 10.1016/j.jaut.2006.06.001; Ramsey C, 2002, HUM MOL GENET, V11, P397, DOI 10.1093/hmg/11.4.397; Soderbergh A, 2004, J CLIN ENDOCR METAB, V89, P557, DOI 10.1210/jc.2003-030279; Watanabe N, 2005, NATURE, V436, P1181, DOI 10.1038/nature03886; 2006, J CLIN ENDOCRINOL ME, V91, P2843	15	13	14	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2007	7	11								10.1038/nri2136-c1	http://dx.doi.org/10.1038/nri2136-c1			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	224KA	17932495	Bronze			2022-12-18	WOS:000250444700018
J	Martin, MP				Martin, MP			Epistatic interaction between KIRDS1 and HLA-B delays the progression to AIDS	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	13	13	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2002	2	8					545	545		10.1038/ng934	http://dx.doi.org/10.1038/ng934			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	636DH		Bronze			2022-12-18	WOS:000180438900018
J	Attfield, KE; Jensen, LT; Kaufmann, M; Friese, MA; Fugger, L				Attfield, Kathrine E.; Jensen, Lise Torp; Kaufmann, Max; Friese, Manuel A.; Fugger, Lars			The immunology of multiple sclerosis	NATURE REVIEWS IMMUNOLOGY			English	Review							CENTRAL-NERVOUS-SYSTEM; CD8(+) T-CELLS; PLASMACYTOID DENDRITIC CELLS; INTERFERON-BETA THERAPY; NATURAL-KILLER-CELLS; CEREBROSPINAL-FLUID; PERIPHERAL-BLOOD; GENETIC RISK; MAIT CELLS; TH17 CELLS	Our incomplete understanding of the causes and pathways involved in the onset and progression of multiple sclerosis (MS) limits our ability to effectively treat this complex neurological disease. Recent studies explore the role of immune cells at different stages of MS and how they interact with cells of the central nervous system (CNS). The findings presented here begin to question the exclusivity of an antigen-specific cause and highlight how seemingly distinct immune cell types can share common functions that drive disease. Innovative techniques further expose new disease-associated immune cell populations and reinforce how environmental context is critical to their phenotype and subsequent role in disease. Importantly, the differentiation of immune cells into a pathogenic state is potentially reversible through therapeutic manipulation. As such, understanding the mechanisms that provide plasticity to causal cell types is likely key to uncoupling these disease processes and may identify novel therapeutic targets that replace the need for cell ablation. This Review explores the complex roles of immune cells in the onset and progression of multiple sclerosis, describing the influence of environmental and genetic factors on immune cell phenotype and function. The authors highlight that teasing out the precise roles of different immune cell subsets at different stages of the disease will be key to effective treatment strategies.	[Attfield, Kathrine E.; Fugger, Lars] Univ Oxford, Oxford Univ Hosp, Oxford Ctr Neuroinflammat, Nuffield Dept Clin Neurosci, Oxford, England; [Jensen, Lise Torp] Aarhus Univ Hosp, Dept Clin Med, Aarhus, Denmark; [Kaufmann, Max; Friese, Manuel A.] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol Hamburg, Inst Neuroimmunol & Multiple Sklerose, Hamburg, Germany; [Fugger, Lars] Univ Oxford, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England	University of Oxford; Aarhus University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Oxford	Fugger, L (corresponding author), Univ Oxford, Oxford Univ Hosp, Oxford Ctr Neuroinflammat, Nuffield Dept Clin Neurosci, Oxford, England.; Fugger, L (corresponding author), Univ Oxford, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England.	lars.fugger@ndcn.ox.ac.uk		Kaufmann, Max/0000-0002-1954-4425; Friese, Manuel A./0000-0001-6380-2420				Abrahamsson SV, 2013, BRAIN, V136, P2888, DOI 10.1093/brain/awt182; Absinta M, 2019, JAMA NEUROL, V76, P1474, DOI 10.1001/jamaneurol.2019.2399; Absinta M, 2017, ELIFE, V6, DOI 10.7554/eLife.29738; Afrasiabi A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22062927; Afrasiabi A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-55850-z; Akaishi T, 2018, J NEUROIMMUNOL, V319, P37, DOI 10.1016/j.jneuroim.2018.03.016; Aksoy S, 2007, LEUKEMIA LYMPHOMA, V48, P1307, DOI 10.1080/10428190701411441; Alfredsson L, 2019, CSH PERSPECT MED, V9, DOI 10.1101/cshperspect.a028944; Ammitzboll C, 2020, J NEUROIMMUNOL, V339, DOI 10.1016/j.jneuroim.2019.577117; Ammitzboll C, 2017, J LEUKOCYTE BIOL, V101, P1211, DOI 10.1189/jlb.3A0616-267R; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Astier AL, 2007, J NEUROIMMUNOL, V191, P70, DOI 10.1016/j.jneuroim.2007.09.018; Babbe H, 2000, J EXP MED, V192, P393, DOI 10.1084/jem.192.3.393; Balashov KE, 2010, ANN NEUROL, V68, P899, DOI 10.1002/ana.22136; Barcellos LF, 2000, IMMUNOGENETICS, V51, P281, DOI 10.1007/s002510050621; Baughman EJ, 2011, J AUTOIMMUN, V36, P115, DOI 10.1016/j.jaut.2010.12.003; Benton ML, 2021, NAT REV GENET, V22, P269, DOI 10.1038/s41576-020-00305-9; Berer K, 2017, P NATL ACAD SCI USA, V114, P10719, DOI 10.1073/pnas.1711233114; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Bevan RJ, 2018, ANN NEUROL, V84, P829, DOI 10.1002/ana.25365; Bjornevik K, 2022, SCIENCE, V375, P296, DOI 10.1126/science.abj8222; Bjornevik K, 2020, JAMA NEUROL, V77, P58, DOI 10.1001/jamaneurol.2019.3238; Blecher-Gonen R, 2019, CELL SYST, V8, P109, DOI 10.1016/j.cels.2019.01.001; Bosch-Queralt M, 2021, NAT METAB, V3, P211, DOI 10.1038/s42255-021-00341-7; Brandle SM, 2016, P NATL ACAD SCI USA, V113, P7864, DOI 10.1073/pnas.1522730113; Briggs FBS, 2011, GENES IMMUN, V12, P615, DOI 10.1038/gene.2011.34; Brioschi S, 2021, SCIENCE, V373, P408, DOI 10.1126/science.abf9277; Brown JWL, 2019, JAMA-J AM MED ASSOC, V321, P175, DOI 10.1001/jama.2018.20588; Cano-Gamez E, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15543-y; Carassiti D, 2018, NEUROPATH APPL NEURO, V44, P377, DOI 10.1111/nan.12405; Contentti EC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02690; Caruana P, 2017, MULT SCLER J, V23, P1479, DOI 10.1177/1352458516679267; Cencioni MT, 2021, NAT REV NEUROL, V17, P399, DOI 10.1038/s41582-021-00498-5; Cermelli C, 2003, J INFECT DIS, V187, P1377, DOI 10.1086/368166; Choi SR, 2012, BRAIN, V135, P2925, DOI 10.1093/brain/aws189; Cignarella F, 2018, CELL METAB, V27, P1222, DOI 10.1016/j.cmet.2018.05.006; Clark IC, 2021, SCIENCE, V372, P360, DOI 10.1126/science.abf1230; Colpitts SL, 2017, GUT MICROBES, V8, P561, DOI 10.1080/19490976.2017.1353843; Constantinescu CS, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000117; Croxford JL, 2006, NAT IMMUNOL, V7, P987, DOI 10.1038/ni1370; Cruciani C, 2021, NEUROL-NEUROIMMUNOL, V8, DOI 10.1212/NXI.0000000000001075; Cugurra A, 2021, SCIENCE, V373, P409, DOI 10.1126/science.abf7844; Cui Y, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00245; Cunnusamy K, 2014, CLIN IMMUNOL, V152, P115, DOI 10.1016/j.clim.2014.03.005; Dankers W, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01504; Darlington PJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00834; De Biasi S, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00555; Dendrou CA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1974; Dias J, 2017, P NATL ACAD SCI USA, V114, pE5434, DOI 10.1073/pnas.1705759114; Diaz GM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26519-w; Dominguez-Villar, 2021, CONTROL REGULATORY T; Dominguez-Villar M, 2011, NAT MED, V17, P673, DOI 10.1038/nm.2389; Duscha A, 2020, CELL, V180, P1067, DOI 10.1016/j.cell.2020.02.035; Eken A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00217; Elliott C, 2019, BRAIN, V142, P2787, DOI 10.1093/brain/awz212; Endriz J, 2017, NEUROL-NEUROIMMUNOL, V4, DOI 10.1212/NXI.0000000000000308; Engdahl E, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02715; Eshaghi A, 2018, BRAIN, V141, P1665, DOI 10.1093/brain/awy088; Farez MF, 2015, CELL, V162, P1338, DOI 10.1016/j.cell.2015.08.025; Fiedler SE, 2021, IMMUNOL CELL BIOL, V99, P107, DOI 10.1111/imcb.12392; Filippi M, 2019, BRAIN, V142, P1858, DOI 10.1093/brain/awz144; Florou D, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10100758; Fransen NL, 2020, BRAIN, V143, P1714, DOI 10.1093/brain/awaa117; FREEDMAN MS, 1992, J NEUROIMMUNOL, V41, P231, DOI 10.1016/0165-5728(92)90074-U; Friese MA, 2014, NAT REV NEUROL, V10, P225, DOI 10.1038/nrneurol.2014.37; Gade-Andavolu R, 2004, GENET MED, V6, P126, DOI 10.1097/01.GIM.0000127274.45301.54; Galli E, 2019, NAT MED, V25, P1290, DOI 10.1038/s41591-019-0521-4; Gigli G, 2007, IMMUNOLOGY, V122, P409, DOI 10.1111/j.1365-2567.2007.02655.x; Giladi A, 2020, NAT IMMUNOL, V21, P525, DOI 10.1038/s41590-020-0661-1; Giles DA, 2018, J CLIN INVEST, V128, P5322, DOI 10.1172/JCI123708; Gregory AP, 2012, NATURE, V488, P508, DOI 10.1038/nature11307; Gresle MM, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.202000650; Grigg JB, 2021, NATURE, V600, P707, DOI 10.1038/s41586-021-04136-4; Gross CC, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000289; Gross CC, 2016, P NATL ACAD SCI USA, V113, pE2973, DOI 10.1073/pnas.1524924113; Guilliams M, 2018, IMMUNITY, V49, P595, DOI 10.1016/j.immuni.2018.10.005; Guo J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00944; Haas J, 2016, J NEUROIMMUNOL, V301, P53, DOI 10.1016/j.jneuroim.2016.10.007; Han S, 2014, J IMMUNOL, V192, P2551, DOI 10.4049/jimmunol.1302884; Handel AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012496; He A, 2020, LANCET NEUROL, V19, P307, DOI 10.1016/S1474-4422(20)30067-3; Hedstrom AK, 2012, MULT SCLER J, V18, P1334, DOI 10.1177/1352458512436596; Held K, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000107; Hiltensperger M, 2021, NAT IMMUNOL, V22, P880, DOI 10.1038/s41590-021-00948-8; Hirose S, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101549; Huang YB, 2018, NAT NEUROSCI, V21, P530, DOI 10.1038/s41593-018-0090-8; Huseby ES, 2001, J EXP MED, V194, P669, DOI 10.1084/jem.194.5.669; HVAS J, 1993, J NEUROIMMUNOL, V46, P225, DOI 10.1016/0165-5728(93)90253-U; Illes Z, 2000, J IMMUNOL, V164, P4375, DOI 10.4049/jimmunol.164.8.4375; Illes Z, 2004, INT IMMUNOL, V16, P223, DOI 10.1093/intimm/dxh018; Jacobs BM, 2020, MULT SCLER J, V26, P1281, DOI 10.1177/1352458520907901; Jacobs BM, 2021, NEUROL-NEUROIMMUNOL, V8, DOI 10.1212/NXI.0000000000001007; Jensen SN, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abd4595; Ji QY, 2013, NAT IMMUNOL, V14, P254, DOI 10.1038/ni.2513; JIANG H, 1992, SCIENCE, V256, P1213, DOI 10.1126/science.256.5060.1213; Karandikar NJ, 2002, J CLIN INVEST, V109, P641, DOI 10.1172/JCI200214380; Karni A, 2006, J IMMUNOL, V177, P4196, DOI 10.4049/jimmunol.177.6.4196; Kaufmann M, 2021, MED-CAMBRIDGE, V2, P296, DOI 10.1016/j.medj.2021.01.006; Kaufmann T, 2019, NAT NEUROSCI, V22, P1617, DOI 10.1038/s41593-019-0471-7; Kaur G, 2013, BRAIN, V136, P2657, DOI 10.1093/brain/aws159; Khalil M, 2018, NAT REV NEUROL, V14, P577, DOI 10.1038/s41582-018-0058-z; Kiner E, 2021, NAT IMMUNOL, V22, P216, DOI 10.1038/s41590-020-00836-7; King EA, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008489; King IL, 2009, BLOOD, V113, P3190, DOI 10.1182/blood-2008-07-168575; Ko HJ, 2014, J IMMUNOL, V192, P2202, DOI 10.4049/jimmunol.1302040; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Kouwenhoven M, 2001, J NEUROIMMUNOL, V112, P197, DOI 10.1016/S0165-5728(00)00396-9; Krogsgaard M, 2000, J EXP MED, V191, P1395, DOI 10.1084/jem.191.8.1395; Krumbholz M, 2007, J NEUROIMMUNOL, V190, P72, DOI 10.1016/j.jneuroim.2007.07.024; Kuenz B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002559; Kuhlmann T, 2017, ACTA NEUROPATHOL, V133, P13, DOI 10.1007/s00401-016-1653-y; Kunkl M, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020482; Kwong B, 2017, NAT IMMUNOL, V18, P1117, DOI 10.1038/ni.3816; Lanz Tobias V, 2022, Nature, V603, P321, DOI 10.1038/s41586-022-04432-7; Lassmann H, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a028936; Lee KMC, 2020, IMMUNOTARGETS THER, V9, P225, DOI 10.2147/ITT.S262566; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lisak RP, 2017, J NEUROIMMUNOL, V309, P88, DOI 10.1016/j.jneuroim.2017.05.004; Lisak RP, 2012, J NEUROIMMUNOL, V246, P85, DOI 10.1016/j.jneuroim.2012.02.015; Locatelli G, 2018, NAT NEUROSCI, V21, P1196, DOI 10.1038/s41593-018-0212-3; Lodygin D, 2019, NATURE, V566, P503, DOI 10.1038/s41586-019-0964-2; Lotfi N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58131-2; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lucca LE, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124427; Lunemann JD, 2010, ANN NEUROL, V67, P159, DOI 10.1002/ana.21886; Machado-Santos J, 2018, BRAIN, V141, P2066, DOI 10.1093/brain/awy151; Madireddy L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09773-y; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Magliozzi R, 2010, ANN NEUROL, V68, P477, DOI 10.1002/ana.22230; Mahad D, 2008, BRAIN, V131, P1722, DOI 10.1093/brain/awn105; Makhlouf K, 2001, J NEUROIMMUNOL, V119, P145, DOI 10.1016/S0165-5728(01)00371-X; Malik S, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00014; Mancuso R, 2014, MULT SCLER J, V20, P1900, DOI 10.1177/1352458514538111; Martinez-Rodriguez JE, 2011, CLIN IMMUNOL, V141, P348, DOI 10.1016/j.clim.2011.09.006; Mascanfroni ID, 2015, NAT MED, V21, P638, DOI 10.1038/nm.3868; Masuda T, 2019, NATURE, V566, P388, DOI 10.1038/s41586-019-0924-x; Matthias J, 2020, J CLIN INVEST, V130, P4587, DOI 10.1172/JCI137786; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; McKenzie DR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15632; MEDAWAR PB, 1948, BRIT J EXP PATHOL, V29, P58; Medina S, 2018, MULT SCLER J, V24, P1317, DOI 10.1177/1352458517717088; Mexhitaj I, 2019, BRAIN, V142, P617, DOI 10.1093/brain/awz017; Mishra MK, 2012, AM J PATHOL, V181, P642, DOI 10.1016/j.ajpath.2012.05.011; Mitsdoerffer M, 2021, BRAIN, V144, P1697, DOI 10.1093/brain/awab093; Mitsdoerffer M, 2009, ANN NEUROL, V65, P487, DOI 10.1002/ana.21722; Mondal S, 2020, P NATL ACAD SCI USA, V117, P21557, DOI 10.1073/pnas.2000653117; Morandi F, 2013, J NEUROIMMUNE PHARM, V8, P944, DOI 10.1007/s11481-013-9459-3; Moutsianas L, 2015, NAT GENET, V47, P1107, DOI 10.1038/ng.3395; Mundt S, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau8380; Murphy AC, 2010, BRAIN BEHAV IMMUN, V24, P641, DOI 10.1016/j.bbi.2010.01.014; Na SY, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2025944118; Najafian N, 2003, J CLIN INVEST, V112, P1037, DOI 10.1172/JCI200317935; Nielsen N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031959; Nutt SL, 2020, IMMUNITY, V52, P942, DOI 10.1016/j.immuni.2020.05.005; O'Keeffe J, 2008, J NEUROL SCI, V275, P22, DOI 10.1016/j.jns.2008.07.007; Ochoa-Reparaz J, 2009, J IMMUNOL, V183, P6041, DOI 10.4049/jimmunol.0900747; Ontaneda D, 2017, LANCET, V389, P1357, DOI 10.1016/S0140-6736(16)31320-4; Page N, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21109-3; Palanichamy A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008930; Pannemans K, 2014, MULT SCLER J, V20, P790, DOI 10.1177/1352458513509703; Papp K, 2018, NEW ENGL J MED, V379, P1313, DOI 10.1056/NEJMoa1806382; Parks NE, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004192.pub4; Patsopoulos NA, 2019, SCIENCE, V365, P1417, DOI 10.1126/science.aav7188; Pender MP, 2017, CLIN TRANSL IMMUNOL, V6, DOI 10.1038/cti.2016.87; Pender MP, 2014, MULT SCLER J, V20, P1825, DOI 10.1177/1352458514536252; Peng C, 2020, NAT REV NEUROL, V16, P199, DOI 10.1038/s41582-020-0333-7; Perlejewski K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240601; Pitzalis C, 2014, NAT REV IMMUNOL, V14, P447, DOI 10.1038/nri3700; Plantone D, 2013, J NEUROIMMUNOL, V265, P124, DOI 10.1016/j.jneuroim.2013.10.004; Plastini MJ, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00269; Prineas JW, 2012, ANN NEUROL, V72, P18, DOI 10.1002/ana.23634; Prinz M, 2019, CELL, V179, P292, DOI 10.1016/j.cell.2019.08.053; Quinn JL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00382; Ramien C, 2016, NEUROSCI BIOBEHAV R, V67, P137, DOI 10.1016/j.neubiorev.2015.12.015; Reay WR, 2021, NAT REV GENET, V22, P658, DOI 10.1038/s41576-021-00387-z; Ricigliano VAG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119605; Rinaldi L, 2006, BRAIN, V129, P1993, DOI 10.1093/brain/awl179; Rizzo F, 2016, IMMUNOL CELL BIOL, V94, P886, DOI 10.1038/icb.2016.55; Rodriguez-Martin E, 2015, CLIN EXP IMMUNOL, V180, P243, DOI 10.1111/cei.12580; Rojas OL, 2019, CELL, V176, P610, DOI 10.1016/j.cell.2018.11.035; Rothhammer V, 2018, NATURE, V557, P724, DOI 10.1038/s41586-018-0119-x; Rothhammer V, 2016, NAT MED, V22, P586, DOI 10.1038/nm.4106; Russi AE, 2018, P NATL ACAD SCI USA, V115, pE1520, DOI 10.1073/pnas.1710401115; Ryu JK, 2018, NAT IMMUNOL, V19, P1212, DOI 10.1038/s41590-018-0232-x; Sabolek MK, 2019, ANN CLIN TRANSL NEUR, V6, P1151, DOI 10.1002/acn3.783; Sage PT, 2018, J IMMUNOL, V200, P2592, DOI 10.4049/jimmunol.1701231; Saligrama N, 2019, NATURE, V572, P481, DOI 10.1038/s41586-019-1467-x; Salou M, 2016, CLIN IMMUNOL, V166, P1, DOI 10.1016/j.clim.2016.03.014; Sanmarco LM, 2021, J EXP MED, V218, DOI 10.1084/jem.20202715; Saraste M, 2007, NEUROL SCI, V28, P121, DOI 10.1007/s10072-007-0803-3; Scalfari A, 2018, NEUROLOGY, V90, pE2107, DOI 10.1212/WNL.0000000000005685; Schafflick D, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14118-w; Schattling B, 2019, NAT NEUROSCI, V22, P887, DOI 10.1038/s41593-019-0385-4; Schirmer L, 2019, NATURE, V573, P75, DOI 10.1038/s41586-019-1404-z; Schirmer L, 2013, JAMA NEUROL, V70, P345, DOI 10.1001/2013.jamaneurol.409; Schlager C, 2016, NATURE, V530, P349, DOI 10.1038/nature16939; Schwab N, 2010, J IMMUNOL, V184, P5368, DOI 10.4049/jimmunol.0903662; Segal BM, 2008, LANCET NEUROL, V7, P796, DOI 10.1016/S1474-4422(08)70173-X; Serafini B, 2004, BRAIN PATHOL, V14, P164, DOI 10.1111/j.1750-3639.2004.tb00049.x; Serafini B, 2007, J EXP MED, V204, P2899, DOI 10.1084/jem.20071030; Seyedmirzaei H, 2021, EXPERT REV CLIN IMMU, V17, P1323, DOI 10.1080/1744666X.2022.2011720; SHIMONKEVITZ R, 1993, P NATL ACAD SCI USA, V90, P923, DOI 10.1073/pnas.90.3.923; Sie C, 2017, SEMIN IMMUNOPATHOL, V39, P99, DOI 10.1007/s00281-016-0608-7; Singh AK, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00260; Skarica M, 2011, J NEUROIMMUNOL, V235, P70, DOI 10.1016/j.jneuroim.2011.02.010; Smith BC, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01861-x; Smolders J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07053-9; Spain R, 2017, NEUROL-NEUROIMMUNOL, V4, DOI 10.1212/NXI.0000000000000374; Spath S, 2017, IMMUNITY, V46, P245, DOI 10.1016/j.immuni.2017.01.007; Spelman T, 2021, JAMA NEUROL, V78, P1197, DOI 10.1001/jamaneurol.2021.2738; Stasiolek M, 2006, BRAIN, V129, P1293, DOI 10.1093/brain/awl043; Steinbach K, 2016, J EXP MED, V213, P1571, DOI 10.1084/jem.20151916; Stern JNH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008879; STINISSEN P, 1995, J IMMUNOL, V154, P4883; Sumida T, 2018, NAT IMMUNOL, V19, P1391, DOI 10.1038/s41590-018-0236-6; Tahmasebinia F, 2017, PROG NEURO-PSYCHOPH, V79, P408, DOI 10.1016/j.pnpbp.2017.07.023; Tennakoon DK, 2006, J IMMUNOL, V176, P7119, DOI 10.4049/jimmunol.176.11.7119; Thewissen K, 2014, MULT SCLER J, V20, P548, DOI 10.1177/1352458513505352; Tozaki-Saitoh H, 2019, GLIA, V67, P729, DOI 10.1002/glia.23570; Tuzlak S, 2021, NAT IMMUNOL, V22, P1210, DOI 10.1038/s41590-021-01009-w; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Urban SL, 2020, NAT IMMUNOL, V21, P938, DOI 10.1038/s41590-020-0711-8; van Nierop GP, 2017, ACTA NEUROPATHOL, V134, P383, DOI 10.1007/s00401-017-1744-4; vanOosten BW, 1997, NEUROLOGY, V49, P351, DOI 10.1212/WNL.49.2.351; Venken K, 2008, IMMUNOLOGY, V123, P79, DOI 10.1111/j.1365-2567.2007.02690.x; Verma ND, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-88448-5; Veroni C, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-017-1049-5; Villar LM, 2014, ANN NEUROL, V76, P231, DOI 10.1002/ana.24190; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; von Budingen HC, 2012, J CLIN INVEST, V122, P4533, DOI 10.1172/JCI63842; Wagner CA, 2020, J EXP MED, V217, DOI 10.1084/jem.20190460; Wang A, 2021, IMMUNOL REV, V299, P45, DOI 10.1111/imr.12929; Wang J, 2020, CELL, V183, P1264, DOI 10.1016/j.cell.2020.09.054; WEKERLE H, 1994, ANN NEUROL, V36, pS47, DOI 10.1002/ana.410360714; Werneburg S, 2020, IMMUNITY, V52, P167, DOI 10.1016/j.immuni.2019.12.004; Wesnes K, 2015, MULT SCLER J, V21, P388, DOI 10.1177/1352458514546785; Wheeler MA, 2020, NATURE, V578, P593, DOI 10.1038/s41586-020-1999-0; White MPJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18543-z; Wilck N, 2017, NATURE, V551, P585, DOI 10.1038/nature24628; Willing A, 2018, J IMMUNOL, V200, P974, DOI 10.4049/jimmunol.1701213; Willing A, 2014, EUR J IMMUNOL, V44, P3119, DOI 10.1002/eji.201344160; Wolf Y, 2018, EUR J IMMUNOL, V48, P1308, DOI 10.1002/eji.201847540; Woo MS, 2021, J EXP MED, V218, DOI 10.1084/jem.20201290; Yates RL, 2017, ANN NEUROL, V82, P259, DOI 10.1002/ana.24997; Yu N, 2012, INFLAMMATION, V35, P1773, DOI 10.1007/s10753-012-9496-8; Zeine R, 1998, J NEUROIMMUNOL, V87, P49, DOI 10.1016/S0165-5728(98)00047-2; Zhan JS, 2021, IMMUNOLOGY, V164, P450, DOI 10.1111/imm.13395; Zhang DF, 2019, IMMUNITY, V51, P671, DOI 10.1016/j.immuni.2019.08.001; Zhao H, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01578	249	12	12	6	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2022	22	12					734	750		10.1038/s41577-022-00718-z	http://dx.doi.org/10.1038/s41577-022-00718-z		MAY 2022	17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6M3AE	35508809				2022-12-18	WOS:000790616200001
J	Pishesha, N; Harmand, TJ; Ploegh, HL				Pishesha, Novalia; Harmand, Thibault J.; Ploegh, Hidde L.			A guide to antigen processing and presentation	NATURE REVIEWS IMMUNOLOGY			English	Review							MHC CLASS-I; NATURAL-KILLER-CELLS; CROSS-PRESENTATION; PEPTIDE BINDING; HUMAN CYTOMEGALOVIRUS; EXOGENOUS ANTIGENS; CRYSTAL-STRUCTURE; HLA-E; MOLECULES; COMPLEX	This 'guide to' article provides an overview of the antigen processing and presentation pathways, which lead to the loading of antigenic peptides on major histocompatibility complex (MHC) molecules for detection by T cells. Antigen processing and presentation are the cornerstones of adaptive immunity. B cells cannot generate high-affinity antibodies without T cell help. CD4(+) T cells, which provide such help, use antigen-specific receptors that recognize major histocompatibility complex (MHC) molecules in complex with peptide cargo. Similarly, eradication of virus-infected cells often depends on cytotoxic CD8(+) T cells, which rely on the recognition of peptide-MHC complexes for their action. The two major classes of glycoproteins entrusted with antigen presentation are the MHC class I and class II molecules, which present antigenic peptides to CD8(+) T cells and CD4(+) T cells, respectively. This Review describes the essentials of antigen processing and presentation. These pathways are divided into six discrete steps that allow a comparison of the various means by which antigens destined for presentation are acquired and how the source proteins for these antigens are tagged for degradation, destroyed and ultimately displayed as peptides in complex with MHC molecules for T cell recognition.	[Pishesha, Novalia; Harmand, Thibault J.; Ploegh, Hidde L.] Harvard Med Sch, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Pishesha, Novalia] Harvard Univ, Cambridge, MA 02138 USA; [Pishesha, Novalia] Broad Inst MIT & Harvard, Klarman Cell Observ, Cambridge, MA 02142 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Ploegh, HL (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.	hidde.ploegh@childrens.harvard.edu		Ploegh, Hidde/0000-0002-1090-6071				Abualrous ET, 2021, CURR OPIN IMMUNOL, V70, P95, DOI 10.1016/j.coi.2021.04.009; Adams EJ, 2013, ANNU REV IMMUNOL, V31, P529, DOI 10.1146/annurev-immunol-032712-095912; Baker BM, 2012, IMMUNOL REV, V250, P10, DOI 10.1111/j.1600-065X.2012.01165.x; Barbet G, 2021, NAT IMMUNOL, V22, P497, DOI 10.1038/s41590-021-00903-7; Bard JAM, 2018, ANNU REV BIOCHEM, V87, P697, DOI 10.1146/annurev-biochem-062917-011931; Bassani-Sternberg M, 2015, MOL CELL PROTEOMICS, V14, P658, DOI 10.1074/mcp.M114.042812; Bauer D, 2002, Curr Top Microbiol Immunol, V269, P87; Berglund P, 2007, J VIROL, V81, P7220, DOI 10.1128/JVI.00137-07; Berry R, 2020, NAT REV IMMUNOL, V20, P113, DOI 10.1038/s41577-019-0225-5; Bhalla N, 2018, J THORAC DIS, V10, pS1447, DOI 10.21037/jtd.2018.05.107; Bhati M, 2014, PROTEIN SCI, V23, P260, DOI 10.1002/pro.2412; Blander JM, 2018, ANNU REV IMMUNOL, V36, P717, DOI 10.1146/annurev-immunol-041015-055523; Blander JM, 2016, IMMUNOL REV, V272, P65, DOI 10.1111/imr.12428; Blees A, 2017, NATURE, V551, P525, DOI 10.1038/nature24627; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Bontrop RE, 2006, HUM IMMUNOL, V67, P388, DOI 10.1016/j.humimm.2006.03.007; Borbulevych OY, 2011, J IMMUNOL, V186, P2950, DOI 10.4049/jimmunol.1003150; BOUVIER M, 1994, SCIENCE, V265, P398, DOI 10.1126/science.8023162; BROWNE H, 1990, NATURE, V347, P770, DOI 10.1038/347770a0; Busch R, 2005, IMMUNOL REV, V207, P242, DOI 10.1111/j.0105-2896.2005.00306.x; Call ME, 2005, ANNU REV IMMUNOL, V23, P101, DOI 10.1146/annurev.immunol.23.021704.115625; Cebrian I, 2011, CELL, V147, P1355, DOI 10.1016/j.cell.2011.11.021; Chancellor A, 2018, IMMUNOLOGY, V154, P196, DOI 10.1111/imm.12912; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; Choo SY, 2007, YONSEI MED J, V48, P11, DOI 10.3349/ymj.2007.48.1.11; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Colbert JD, 2020, CURR OPIN IMMUNOL, V64, P1, DOI 10.1016/j.coi.2019.12.005; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; Creech AL, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201700259; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; Cruz FM, 2017, ANNU REV IMMUNOL, V35, P149, DOI 10.1146/annurev-immunol-041015-055254; da Fonseca PCA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8573; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Dhatchinamoorthy K, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.636568; Dikic I, 2017, ANNU REV BIOCHEM, V86, P193, DOI 10.1146/annurev-biochem-061516-044908; Dolan BP, 2011, J IMMUNOL, V186, P2065, DOI 10.4049/jimmunol.1003096; Dulberger CL, 2017, IMMUNITY, V46, P1018, DOI 10.1016/j.immuni.2017.06.002; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Eggensperger S, 2015, BIOL CHEM, V396, P1059, DOI 10.1515/hsz-2014-0320; Farrell HE, 1997, NATURE, V386, P510, DOI 10.1038/386510a0; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Fisette O, 2020, P NATL ACAD SCI USA, V117, P20597, DOI 10.1073/pnas.2004445117; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Garbi N, 2000, NAT IMMUNOL, V1, P234, DOI 10.1038/79775; Grossmann N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6419; Gubler B, 1998, MOL IMMUNOL, V35, P427, DOI 10.1016/S0161-5890(98)00059-5; Hanada K, 2004, NATURE, V427, P252, DOI 10.1038/nature02240; Hattori A, 2013, J BIOCHEM, V154, P219, DOI 10.1093/jb/mvt066; Hewitt EW, 2003, IMMUNOLOGY, V110, P163, DOI 10.1046/j.1365-2567.2003.01738.x; HILL A, 1995, P NATL ACAD SCI USA, V92, P341, DOI 10.1073/pnas.92.2.341; Honey K, 2003, NAT REV IMMUNOL, V3, P472, DOI 10.1038/nri1110; Hong MH, 2020, CANCER CELL, V38, P473, DOI 10.1016/j.ccell.2020.07.005; Hughes EA, 1997, P NATL ACAD SCI USA, V94, P1896, DOI 10.1073/pnas.94.5.1896; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jensen PE, 2007, NAT IMMUNOL, V8, P1041, DOI 10.1038/ni1516; Jhunjhunwala S, 2021, NAT REV CANCER, V21, P298, DOI 10.1038/s41568-021-00339-z; Jiang JS, 2019, ADV EXP MED BIOL, V1172, P21, DOI 10.1007/978-981-13-9367-9_2; Jongsma MLM, 2016, CELL, V166, P152, DOI 10.1016/j.cell.2016.05.078; Kasahara M, 1999, IMMUNOL REV, V167, P17, DOI 10.1111/j.1600-065X.1999.tb01379.x; Kelly A, 2019, IMMUNOGENETICS, V71, P161, DOI 10.1007/s00251-018-1082-2; Kincaid EZ, 2012, NAT IMMUNOL, V13, P129, DOI 10.1038/ni.2203; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Kula T, 2019, CELL, V178, P1016, DOI 10.1016/j.cell.2019.07.009; Kyewski B, 2004, NAT REV IMMUNOL, V4, P688, DOI 10.1038/nri1436; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Lankar D, 2002, J EXP MED, V195, P461, DOI 10.1084/jem.20011543; Larsen MH, 2009, HUM IMMUNOL, V70, P1026, DOI 10.1016/j.humimm.2009.07.015; Lee JW, 2007, NAT IMMUNOL, V8, P181, DOI 10.1038/ni1427; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Li YL, 2010, J MOL BIOL, V399, P596, DOI 10.1016/j.jmb.2010.04.037; Lim JP, 2011, IMMUNOL CELL BIOL, V89, P836, DOI 10.1038/icb.2011.20; Lin JC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004554; Lizee G, 2003, NAT IMMUNOL, V4, P1065, DOI 10.1038/ni989; Loureiro J, 2006, ADV IMMUNOL, V92, P225, DOI 10.1016/S0065-2776(06)92006-9; Martin F, 2006, ANNU REV IMMUNOL, V24, P467, DOI 10.1146/annurev.immunol.24.021605.090517; MATSUMURA M, 1992, SCIENCE, V257, P927, DOI 10.1126/science.1323878; Mayassi T, 2021, NATURE, V595, P501, DOI 10.1038/s41586-021-03578-0; McWilliam HEG, 2020, P NATL ACAD SCI USA, V117, P24974, DOI 10.1073/pnas.2011260117; Miller MM, 2016, POULTRY SCI, V95, P375, DOI 10.3382/ps/pev379; Miller Z, 2013, CURR PHARM DESIGN, V19, P4140, DOI 10.2174/1381612811319220018; Mintern JD, 2015, AUTOPHAGY, V11, P906, DOI 10.1080/15548627.2015.1045178; Mittal SK, 2015, CURR OPIN IMMUNOL, V34, P22, DOI 10.1016/j.coi.2014.12.009; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Murata S, 2018, NAT IMMUNOL, V19, P923, DOI 10.1038/s41590-018-0186-z; Nair-Gupta P, 2014, CELL, V158, P506, DOI 10.1016/j.cell.2014.04.054; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; Parcej D, 2010, NAT CHEM BIOL, V6, P572, DOI [10.1038/NCHEMBIO.410, 10.1038/nchembio.410]; Parekh VV, 2017, P NATL ACAD SCI USA, V114, pE6371, DOI 10.1073/pnas.1706504114; Patel O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3142; Paul P, 2011, CELL, V145, P268, DOI 10.1016/j.cell.2011.03.023; Poluektov YO, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00260; Pos W, 2012, CELL, V151, P1557, DOI 10.1016/j.cell.2012.11.025; Raghavan M, 2008, TRENDS IMMUNOL, V29, P436, DOI 10.1016/j.it.2008.06.004; Reeves E, 2017, IMMUNOLOGY, V150, P16, DOI 10.1111/imm.12675; Reich M, 2011, CELL IMMUNOL, V269, P96, DOI 10.1016/j.cellimm.2011.03.012; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Robinson J, 2020, NUCLEIC ACIDS RES, V48, pD948, DOI 10.1093/nar/gkz950; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; Roche PA, 2015, NAT REV IMMUNOL, V15, P203, DOI 10.1038/nri3818; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Rodgers JR, 2005, NAT REV IMMUNOL, V5, P459, DOI 10.1038/nri1635; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Segura E, 2015, ADV IMMUNOL, V127, P1, DOI 10.1016/bs.ai.2015.03.002; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Shiina T, 2017, IMMUNOLOGY, V150, P127, DOI 10.1111/imm.12624; Shiina T, 2009, J HUM GENET, V54, P15, DOI 10.1038/jhg.2008.5; Siemasko K, 1998, J IMMUNOL, V160, P5203; da Silva AP, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8040637; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sollid LM, 2014, CURR OPIN IMMUNOL, V31, P24, DOI 10.1016/j.coi.2014.08.005; STERN LJ, 1994, STRUCTURE, V2, P245, DOI 10.1016/S0969-2126(00)00026-5; Stopfer LE, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16588-9; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Suzuki T, 2016, GENE, V577, P1, DOI 10.1016/j.gene.2015.11.021; Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39; Tanaka K, 1998, IMMUNOL REV, V163, P161; Tanaka K, 2012, BIOL CHEM, V393, P217, DOI 10.1515/hsz-2011-0285; ten Broeke T, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016873; Theisen DJ, 2018, SCIENCE, V362, P694, DOI 10.1126/science.aat5030; Thomas C, 2020, ANNU REV BIOCHEM, V89, P605, DOI 10.1146/annurev-biochem-011520-105201; Thomas C, 2019, CURR OPIN IMMUNOL, V58, P9, DOI 10.1016/j.coi.2019.01.001; Tomasec P, 2000, SCIENCE, V287, P1031, DOI 10.1126/science.287.5455.1031; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Trowitzsch S, 2020, ANNU REV BIOPHYS, V49, P135, DOI 10.1146/annurev-biophys-121219-081643; Truong HV, 2021, CURR OPIN IMMUNOL, V70, P122, DOI 10.1016/j.coi.2021.04.012; Tse SML, 2003, J BIOL CHEM, V278, P3331, DOI 10.1074/jbc.M207966200; Tumer G., 2021, GENETICS HUMAN MAJOR; Uebel S, 1997, P NATL ACAD SCI USA, V94, P8976, DOI 10.1073/pnas.94.17.8976; van de Weijer ML, 2015, SEMIN IMMUNOL, V27, P125, DOI 10.1016/j.smim.2015.03.010; van Hall T, 2010, MICROBES INFECT, V12, P910, DOI 10.1016/j.micinf.2010.07.011; van Kasteren SI, 2014, CURR OPIN IMMUNOL, V26, P21, DOI 10.1016/j.coi.2013.10.005; Van Rhijn I, 2015, NAT REV IMMUNOL, V15, P643, DOI 10.1038/nri3889; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; Vigneron N, 2004, SCIENCE, V304, P587, DOI 10.1126/science.1095522; Vigneron N, 2017, J BIOL CHEM, V292, P21170, DOI 10.1074/jbc.R117.807560; Villadangos JA, 1999, IMMUNOL REV, V172, P109, DOI 10.1111/j.1600-065X.1999.tb01360.x; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; Wang Y, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav7517; Watts C, 2010, CURR OPIN IMMUNOL, V22, P124, DOI 10.1016/j.coi.2009.12.005; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; West LC, 2013, CURR OPIN IMMUNOL, V25, P103, DOI 10.1016/j.coi.2012.11.006; Wieczorek M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00292; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; Wilson NS, 2004, BLOOD, V103, P2187, DOI 10.1182/blood-2003-08-2729; Winchester B, 2005, GLYCOBIOLOGY, V15, p1R, DOI 10.1093/glycob/cwi041; Woodham AW, 2020, NAT METHODS, V17, P1025, DOI 10.1038/s41592-020-0934-5; Wu D, 2008, BIOORGAN MED CHEM, V16, P1073, DOI 10.1016/j.bmc.2007.10.026; Wu HL, 2018, J IMMUNOL, V200, P49, DOI 10.4049/jimmunol.1700841; Yan JB, 2006, J EXP MED, V203, P647, DOI 10.1084/jem.20052271; Yewdell JW, 2007, J EXP MED, V204, P2501, DOI 10.1084/jem.20071986; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860; Zacharias M, 2004, BIOPHYS J, V87, P2203, DOI 10.1529/biophysj.104.044743; Zaitoua Anita J, 2020, F1000Res, V9, DOI 10.12688/f1000research.26935.1; Zajonc DM, 2005, NAT IMMUNOL, V6, P810, DOI 10.1038/ni1224	160	12	12	18	28	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2022	22	12					751	764		10.1038/s41577-022-00707-2	http://dx.doi.org/10.1038/s41577-022-00707-2		APR 2022	14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6M3AE	35418563				2022-12-18	WOS:000782359600001
J	Wagner, CE; Saad-Roy, CM; Crenfell, BT				Wagner, Caroline E.; Saad-Roy, Chadi M.; Crenfell, Bryan T.			Modelling vaccination strategies for COVID-19	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material							AGE	Despite the rapid development of safe and highly effective vaccines against coronavirus disease 2019 (COVID-19), the strategy for their distribution has been and remains contentious. Mathematical models can be used to guide and inform these strategies; however, uncertainties in critical immunological and evolutionary parameters of SARS-CoV-2 can limit the predictive power of models. Notwithstanding these ongoing uncertainties, we discuss how models have been applied to guide health policy decisions related to vaccination against COVID-19, and how they may be applied in the future in the context of booster doses under different scenarios related to disease-specific factors and global distribution. Mathematical models have been used to guide strategies for COVID-19 vaccine distribution. But with the emergence of new SARS-CoV-2 variants and waning immunity, how should vaccine distribution be prioritized?	[Wagner, Caroline E.] McGill Univ, Dept Bioengn, Montreal, PQ, Canada; [Saad-Roy, Chadi M.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Crenfell, Bryan T.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Crenfell, Bryan T.] Princeton Univ, Princeton Sch Publ & Int Affairs, Princeton, NJ 08544 USA	McGill University; Princeton University; Princeton University; Princeton University	Wagner, CE (corresponding author), McGill Univ, Dept Bioengn, Montreal, PQ, Canada.	caroline.wagner@mcgill.ca						ANDERSON R M, 1991; Bubar Kate M, 2021, medRxiv, DOI [10.1126/science.abe6959, 10.1101/2020.09.08.20190629]; Fitzpatrick MC, 2021, SCIENCE, V371, P890, DOI 10.1126/science.abg2334; Garcia-Beltran WF, 2022, CELL, V185, P457, DOI [10.1016/j.cell.2021.12.033, 10.1101/2021.12.14.21267755]; Goel RR, 2021, SCIENCE, V374, P1214, DOI 10.1126/science.abm0829; Lavine JS, 2021, SCIENCE, V371, P741, DOI 10.1126/science.abe6522; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; Tetteh JNA, 2021, J THEOR BIOL, V531, DOI 10.1016/j.jtbi.2021.110894; Viboud C, 2018, EPIDEMICS-NETH, V22, P13, DOI 10.1016/j.epidem.2017.08.002; Wagner CE, 2021, SCIENCE, V373, P1488, DOI 10.1126/science.abj7364	10	12	12	3	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAR	2022	22	3					139	141		10.1038/s41577-022-00687-3	http://dx.doi.org/10.1038/s41577-022-00687-3		FEB 2022	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZM0ED	35145245	Bronze, Green Published			2022-12-18	WOS:000753715100001
J	Zaiss, DMW; Coffer, PJ				Zaiss, Dietmar M. W.; Coffer, Paul J.			Forkhead box transcription factors as context-dependent regulators of lymphocyte homeostasis	NATURE REVIEWS IMMUNOLOGY			English	Review							NF-KAPPA-B; T-CELL FUNCTION; LIGASE CBL-B; ROR-GAMMA-T; FACTOR FOXO1; CUTTING EDGE; FACTOR FOXP3; EFFECTOR FUNCTIONS; GENE-EXPRESSION; PROMOTES TUMORIGENESIS	Lymphocytes have evolved to react rapidly and robustly to changes in their local environment by using transient adaptations and by regulating their terminal differentiation programmes. Forkhead box transcription factors (FTFs) can direct leukocyte-specific responses, and their functional diversification promotes a high degree of context-dependent specification. Many, often antagonistic, FTFs have overlapping expression patterns and can thereby compete for binding to the same chromosomal target sequences. Multiple molecular mechanisms also connect extracellular signals to the expression and functionality of specific FTFs and, in this way, fine-tune their activity. Through these diverse mechanisms, FTFs can function as context-dependent rheostats responding to diverse environmental stimuli. Focusing on the various mechanisms by which their functional activity is modulated, as well as on their mechanisms of action, we discuss how specific FTFs control lymphocyte function, allowing for the establishment and maintenance of immune homeostasis.	[Zaiss, Dietmar M. W.] Univ Edinburgh, Sch Biol Sci, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland; [Coffer, Paul J.] Univ Utrecht, UMC Utrecht, Ctr Mol Med, Utrecht, Netherlands; [Coffer, Paul J.] Univ Utrecht, UMC Utrecht, Div Pediat, Utrecht, Netherlands; [Coffer, Paul J.] Univ Utrecht, UMC Utrecht, Regenerat Med Ctr, Utrecht, Netherlands	University of Edinburgh; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Zaiss, DMW (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland.; Coffer, PJ (corresponding author), Univ Utrecht, UMC Utrecht, Ctr Mol Med, Utrecht, Netherlands.; Coffer, PJ (corresponding author), Univ Utrecht, UMC Utrecht, Div Pediat, Utrecht, Netherlands.; Coffer, PJ (corresponding author), Univ Utrecht, UMC Utrecht, Regenerat Med Ctr, Utrecht, Netherlands.	dietmar.zaiss@ed.ac.uk; pcoffer@umcutrecht.nl	Coffer, Paul/AAF-7970-2020	Zaiss, Dietmar M.W./0000-0003-3596-7062	Medical Research Council [MR/M011755/1]; European Union [CIG-631413]; Dutch Cancer Society [UU 2015-7838]; Dutch Reumatology Foundation [16-1-301]; MRC [MR/M011755/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Dutch Cancer Society(KWF Kankerbestrijding); Dutch Reumatology Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to apologise to any authors whose work could not be cited due to space contstraints. The Zaiss laboratory is supported by the Medical Research Council, grant MR/M011755/1, and the European Union, grant CIG-631413 ("EGF-R for Immunity"). The Coffer laboratory is supported by grants from the Dutch Cancer Society (UU 2015-7838) and Dutch Reumatology Foundation (16-1-301)	Akimova T, 2010, CLIN IMMUNOL, V136, P348, DOI 10.1016/j.clim.2010.04.018; Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Basu S, 2008, J IMMUNOL, V180, P5794, DOI 10.4049/jimmunol.180.9.5794; Beier UH, 2011, MOL CELL BIOL, V31, P1022, DOI 10.1128/MCB.01206-10; Benayoun BA, 2011, TRENDS GENET, V27, P224, DOI 10.1016/j.tig.2011.03.003; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Chen ZJ, 2013, IMMUNITY, V39, P272, DOI 10.1016/j.immuni.2013.08.006; Choi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008011; Chunder N, 2012, J IMMUNOL, V189, P5659, DOI 10.4049/jimmunol.1202313; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Delpoux A, 2018, J EXP MED, V215, P575, DOI 10.1084/jem.20170697; Delpoux A, 2017, P NATL ACAD SCI USA, V114, pE8865, DOI 10.1073/pnas.1618916114; Deng GP, 2015, J BIOL CHEM, V290, P20211, DOI 10.1074/jbc.M115.638221; Deng YC, 2015, IMMUNITY, V42, P457, DOI 10.1016/j.immuni.2015.02.006; Dominguez-Sola D, 2015, IMMUNITY, V43, P1064, DOI 10.1016/j.immuni.2015.10.015; Du XR, 2014, J IMMUNOL, V192, P1525, DOI 10.4049/jimmunol.1301060; Durek P, 2016, IMMUNITY, V45, P1148, DOI 10.1016/j.immuni.2016.10.022; Eijkelenboom A, 2013, CELL REP, V5, P1664, DOI 10.1016/j.celrep.2013.11.031; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Eijkelenboom A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.74; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Fabre S, 2008, J IMMUNOL, V181, P2980, DOI 10.4049/jimmunol.181.5.2980; Fagnoni FF, 1996, IMMUNOLOGY, V88, P501, DOI 10.1046/j.1365-2567.1996.d01-689.x; Feng XM, 2011, NAT IMMUNOL, V12, P544, DOI 10.1038/ni.2034; Feng XM, 2010, BLOOD, V115, P510, DOI 10.1182/blood-2009-07-232694; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Fox CJ, 2005, J EXP MED, V201, P259, DOI 10.1084/jem.20042020; Gerondalds S, 2014, NAT IMMUNOL, V15, P15, DOI 10.1038/ni.2785; Grabbe C, 2011, NAT REV MOL CELL BIO, V12, P295, DOI 10.1038/nrm3099; Harada Y, 2010, J EXP MED, V207, P1381, DOI 10.1084/jem.20100004; Hedrick SM, 2012, NAT REV IMMUNOL, V12, P649, DOI 10.1038/nri3278; Hedrick SM, 2009, NAT IMMUNOL, V10, P1057, DOI 10.1038/ni.1784; Herzog S, 2008, NAT IMMUNOL, V9, P623, DOI 10.1038/ni.1616; Hoogeboom D, 2008, J BIOL CHEM, V283, P9224, DOI 10.1074/jbc.M706638200; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; Huster KM, 2004, P NATL ACAD SCI USA, V101, P5610, DOI 10.1073/pnas.0308054101; Ichiyama K, 2016, IMMUNITY, V44, P1284, DOI 10.1016/j.immuni.2016.05.015; Inoue T, 2017, J EXP MED, V214, P1181, DOI 10.1084/jem.20161263; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jeng MY, 2018, J EXP MED, V215, P51, DOI 10.1084/jem.20161066; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Khattri R, 2001, J IMMUNOL, V167, P6312, DOI 10.4049/jimmunol.167.11.6312; Kim MV, 2013, IMMUNITY, V39, P286, DOI 10.1016/j.immuni.2013.07.013; Kwon HS, 2012, J IMMUNOL, V188, P2712, DOI 10.4049/jimmunol.1100903; Laine A, 2015, J IMMUNOL, V195, P1791, DOI 10.4049/jimmunol.1500849; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lin L, 2005, J IMMUNOL, V175, P951, DOI 10.4049/jimmunol.175.2.951; Lin L, 2004, SCIENCE, V303, P1017, DOI 10.1126/science.1093889; Lin L, 2006, J IMMUNOL, V176, P4793, DOI 10.4049/jimmunol.176.8.4793; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Liu YW, 2014, NAT MED, V20, P272, DOI 10.1038/nm.3485; Liu YJ, 2013, NAT MED, V19, P1173, DOI 10.1038/nm.3286; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Lozano T, 2015, J IMMUNOL, V195, P3180, DOI 10.4049/jimmunol.1402997; Luo CT, 2016, NATURE, V529, P532, DOI 10.1038/nature16486; Michelini RH, 2013, J EXP MED, V210, P1189, DOI 10.1084/jem.20130392; Morawski PA, 2013, J BIOL CHEM, V288, P24494, DOI 10.1074/jbc.M113.467704; Nie H, 2013, NAT MED, V19, P322, DOI 10.1038/nm.3085; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Ouyang WM, 2011, TRENDS IMMUNOL, V32, P26, DOI 10.1016/j.it.2010.10.005; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; Rao RR, 2012, IMMUNITY, V36, P374, DOI 10.1016/j.immuni.2012.01.015; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Sagardoy A, 2013, BLOOD, V121, P4311, DOI 10.1182/blood-2012-10-462846; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Sander S, 2015, IMMUNITY, V43, P1075, DOI 10.1016/j.immuni.2015.10.021; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; Song XM, 2012, CELL REPORTS, V1, P665, DOI 10.1016/j.celrep.2012.04.012; Srivatsan S, 2005, J IMMUNOL, V175, P7805, DOI 10.4049/jimmunol.175.12.7805; Stone EL, 2015, IMMUNITY, V42, P239, DOI 10.1016/j.immuni.2015.01.017; Sullivan JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002533; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Tejera MM, 2013, J IMMUNOL, V191, P187, DOI 10.4049/jimmunol.1300331; Thompson MG, 2015, J IMMUNOL, V195, P5637, DOI 10.4049/jimmunol.1501758; Tomiyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073874; Tone Y, 2014, J IMMUNOL, V192, P3915, DOI 10.4049/jimmunol.1302174; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tzelepis F, 2013, J IMMUNOL, V190, P1066, DOI 10.4049/jimmunol.1200639; Utzschneider DT, 2018, CELL REP, V22, P3454, DOI 10.1016/j.celrep.2018.03.020; van Boxtel R, 2013, CELL DEATH DIFFER, V20, P1219, DOI 10.1038/cdd.2013.81; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; van Gent R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098438; van Keimpema M, 2015, BLOOD, V126, P2098, DOI 10.1182/blood-2015-02-626176; van Keimpema M, 2014, BLOOD, V124, P3431, DOI 10.1182/blood-2014-01-553412; van Loosdregt J, 2014, TRENDS IMMUNOL, V35, P368, DOI 10.1016/j.it.2014.06.005; van Loosdregt J, 2013, IMMUNITY, V39, P259, DOI 10.1016/j.immuni.2013.05.018; van Loosdregt J, 2013, IMMUNITY, V39, P298, DOI 10.1016/j.immuni.2013.07.019; van Loosdregt J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019047; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; Walker MP, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005654; Wang D, 2012, P NATL ACAD SCI USA, V109, P9493, DOI 10.1073/pnas.1207293109; Wang F, 2012, ONCOGENE, V31, P1546, DOI 10.1038/onc.2011.347; Wang HK, 2014, NAT IMMUNOL, V15, P667, DOI 10.1038/ni.2890; Wehrens EJ, 2011, BLOOD, V118, P3538, DOI 10.1182/blood-2010-12-328187; Wei HR, 2016, J IMMUNOL, V196, P3537, DOI 10.4049/jimmunol.1501896; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wohlfert EA, 2006, J IMMUNOL, V176, P1316, DOI 10.4049/jimmunol.176.3.1316; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhang LJ, 2016, CELL REP, V14, P1206, DOI 10.1016/j.celrep.2015.12.095; Zhang N, 2009, IMMUNITY, V30, P458, DOI 10.1016/j.immuni.2008.12.022; Zhao YX, 2015, J IMMUNOL, V194, P1639, DOI 10.4049/jimmunol.1402434; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	128	12	13	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2018	18	11					703	715		10.1038/s41577-018-0048-9	http://dx.doi.org/10.1038/s41577-018-0048-9			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GY2WG	30177790	Green Submitted			2022-12-18	WOS:000448404500013
J	Wang, XC; Lu, XJ; Sun, BC				Wang, Xiaochen; Lu, Xiao-Jie; Sun, Beicheng			The pros and cons of dying tumour cells in adaptive immune responses	NATURE REVIEWS IMMUNOLOGY			English	Letter							EXHAUSTION; CANCER		[Wang, Xiaochen; Lu, Xiao-Jie; Sun, Beicheng] Nanjing Med Univ, Dept Liver Surg, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University	Sun, BC (corresponding author), Nanjing Med Univ, Dept Liver Surg, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China.	sunbc@njmu.edu.cn	Xiao-Jie, Lu/H-4942-2019	Xiao-Jie, Lu/0000-0002-1595-6414; Sun, Beicheng/0000-0002-8657-7024; Wang, Xiaochen/0000-0001-8911-3690	National Key Research and Development Program of China [2016YFC0905900]; State Key Program of National Natural Science Foundation [81430062]; Priority Academic Program of Jiangsu Higher Education Institutions	National Key Research and Development Program of China; State Key Program of National Natural Science Foundation; Priority Academic Program of Jiangsu Higher Education Institutions	This work was supported by grants from the National Key Research and Development Program of China (Grant Number: 2016YFC0905900 to B.S.); the State Key Program of National Natural Science Foundation (Grant Number: 81430062 to B.S.); this work was also supported in part by the Priority Academic Program of Jiangsu Higher Education Institutions. B.S. is Yangtze River Scholar of Distinguished Professor.	Ibrahim HM, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/148725; Krysko DV, 2012, NAT REV CANCER, V12, P860, DOI 10.1038/nrc3380; Long AH, 2015, NAT MED, V21, P581, DOI 10.1038/nm.3838; Schietinger A, 2016, IMMUNITY, V45, P389, DOI 10.1016/j.immuni.2016.07.011; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Terawaki S, 2011, J IMMUNOL, V186, P2772, DOI 10.4049/jimmunol.1003208; Wang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105636; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Woo SR, 2015, ANNU REV IMMUNOL, V33, P445, DOI 10.1146/annurev-immunol-032414-112043; Yatim N, 2017, NAT REV IMMUNOL, V17, P262, DOI 10.1038/nri.2017.9	10	12	13	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2017	17	9					591	591		10.1038/nri.2017.87	http://dx.doi.org/10.1038/nri.2017.87			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FF1VD	28757605	Bronze			2022-12-18	WOS:000408686300012
J	Kaufmann, SHE				Kaufmann, Stefan H. E.			Emil von Behring: translational medicine at the dawn of immunology	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material									[Kaufmann, Stefan H. E.] Max Planck Inst Infect Biol, Dept Immunol, Charitepl 1, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society	Kaufmann, SHE (corresponding author), Max Planck Inst Infect Biol, Dept Immunol, Charitepl 1, D-10117 Berlin, Germany.	Kaufmann@mpiib-berlin.mpg.de						[Anonymous], 1968, ZUSAMMENARBEIT BEHRI, V37; Behring E, 1898, DT MED WOCHENSCHR, V24, P595; Behring E, 1915, GESAMMELTE ABHANDLUN; Behring E. v, 1913, DEUT MED WOCHENSCHR, V39, P873, DOI [10.1055/s-0028-1128380, DOI 10.1055/S-0028-1128380]; Behring EKS., 1890, DEUT MED WOCHENSCHR, V16, P1113, DOI [10.1055/s-0029-1207589, DOI 10.1055/S-0029-1207589]; Behring Emil, 1890, DEUT MED WOCHENSCHR, V50, P1145, DOI 10.1055/s-0029-1207609; Hardy Anne I, 2006, Medizinhist J, V41, P51; Von Ehrlich P., 1894, DEUT MED WOCHENSCHR, V20, P353, DOI [10.1055/s-0029-1205722, DOI 10.1055/S-0029-1205722]; Wernicke E, 1913, HDB PATHOGENEN MIKRO, P1011; ZEISS HR, 1941, BEHRING GESTALT WERK	10	12	12	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2017	17	6					341	343		10.1038/nri.2017.37	http://dx.doi.org/10.1038/nri.2017.37			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EV8VO	28393925				2022-12-18	WOS:000402062500001
J	Alderton, GK				Alderton, Gemma K.			Turning macrophages on, off and on again	NATURE REVIEWS IMMUNOLOGY			English	News Item														Alderton, Gemma/0000-0003-3041-8451					0	12	13	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAR	2014	14	3								10.1038/nri3634	http://dx.doi.org/10.1038/nri3634			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB8DA	24566906	Bronze			2022-12-18	WOS:000332019100006
J	Pachon, G; Caragol, I; Petriz, J				Pachon, Gisela; Caragol, Isabel; Petriz, Jordi			Subjectivity and flow cytometric variability	NATURE REVIEWS IMMUNOLOGY			English	Letter							PROJECT		[Caragol, Isabel; Petriz, Jordi] VHIR, Barcelona 08035, Spain; [Pachon, Gisela] CIBERDEM, IISPV, Grp Investigacio Diabet & Alterac Metab Associade, Tarragona 43007, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV)	Petriz, J (corresponding author), VHIR, Barcelona 08035, Spain.	jordi.petriz@vhir.org	Petriz, Jordi/AAS-4943-2020; Petriz, Jordi/AAB-7293-2019	Petriz, Jordi/0000-0003-1085-0511; 				Fornas O, 2000, NAT MED, V6, P833, DOI 10.1038/77571; Lee JA, 2008, CYTOM PART A, V73A, P926, DOI 10.1002/cyto.a.20623; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Petriz J., 2003, 8 C SOC IB CIT, V20, P108; Roederer M, 2001, CYTOMETRY, V45, P194, DOI 10.1002/1097-0320(20011101)45:3<194::AID-CYTO1163>3.0.CO;2-C; Taylor CF, 2008, NAT BIOTECHNOL, V26, P889, DOI 10.1038/nbt.1411	6	12	12	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2012	12	5					396	396		10.1038/nri3158-c1	http://dx.doi.org/10.1038/nri3158-c1			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	933ET	22531327	Bronze			2022-12-18	WOS:000303343300014
J	Bell, E; Honey, K; Minton, K; Bird, L				Bell, E; Honey, K; Minton, K; Bird, L			From the editors	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material																			0	12	12	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2006	6	1					1	1		10.1038/nri1762	http://dx.doi.org/10.1038/nri1762			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	000FW		Bronze			2022-12-18	WOS:000234447300001
J	Bell, E				Bell, E			Il2 transcription - division not required	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887	1	12	12	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAR	2003	3	3					185	185		10.1038/nri1064	http://dx.doi.org/10.1038/nri1064			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	654EL					2022-12-18	WOS:000181481200006
J	Bell, E				Bell, E			Tipping the balance	NATURE REVIEWS IMMUNOLOGY			English	News Item							PREVENTS; CELLS											Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Hong S, 2001, NAT MED, V7, P1052, DOI 10.1038/nm0901-1052; Sharif S, 2001, NAT MED, V7, P1057, DOI 10.1038/nm0901-1057	3	12	12	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2001	1	1					4	4		10.1038/35095523	http://dx.doi.org/10.1038/35095523			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	635KK					2022-12-18	WOS:000180397900006
J	Pia, L; Rowland-Jones, S				Pia, Luisanna; Rowland-Jones, Sarah			OMICRON ENTRY ROUTE	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material									[Pia, Luisanna] Icahn Sch Med Mt Sinai, Preprint Club, New York, NY 10029 USA; [Rowland-Jones, Sarah] Univ Oxford, Preprint Club, Oxford, England	Icahn School of Medicine at Mount Sinai; University of Oxford	Pia, L (corresponding author), Icahn Sch Med Mt Sinai, Preprint Club, New York, NY 10029 USA.	highlights@preprintclub.com						Meng B., 2021, BIORXIV, V2021, P555, DOI [10.1101/2021.12.17.473248, DOI 10.1101/2021.12.17.473248, 10.1101/2021.12.17.473248v2, DOI 10.1101/2021.12.17.473248V2]; Peacock, SARS COV 2 VARIANT O, DOI [10.1101/2021.12.31.474653v1(2022), DOI 10.1101/2021.12.31.474653V1(2022)]; Pia, PREPRINT J CLUB PREP; Willett, HYPER TRANSMISSIBLE, DOI [10.1101/2022.01.03.21268111v1(2022), DOI 10.1101/2022.01.03.21268111V1(2022)]	4	11	11	1	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAR	2022	22	3					145	145		10.1038/s41577-022-00681-9	http://dx.doi.org/10.1038/s41577-022-00681-9		JAN 2022	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZM0ED	35082449	Green Published, Bronze			2022-12-18	WOS:000749245600001
J	Ginhoux, F; Guilliams, M; Merad, M				Ginhoux, Florent; Guilliams, Martin; Merad, Miriam			Expanding dendritic cell nomenclature in the single-cell era	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material								Single-cell technologies have enabled extensive profiling studies of human and mouse tissues and the identification of an ever-growing number of transcriptional clusters within the dendritic cell (DC) lineage. Here, we discuss the importance of differentiating cell subsets from cell states when annotating DC clusters and propose a revised nomenclature of the DC lineage that integrates experimentally validated knowledge and unbiased transcriptomic profiling results.	[Ginhoux, Florent] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore; [Ginhoux, Florent] Gustave Roussy Canc Campus, Villejuif, France; [Ginhoux, Florent] Gustave Roussy, Inserm U1015, Villejuif, France; [Ginhoux, Florent] Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Sch Med, Shanghai, Peoples R China; [Ginhoux, Florent] SingHlth Duke NUS Acad Med Ctr, Translat Immunol Inst, Singapore, Singapore; [Guilliams, Martin] VIB UGent Ctr Inflammat Res, Lab Myeloid Cell Biol Tissue Homeostasis & Regene, Ghent, Belgium; [Guilliams, Martin] Univ Ghent, Fac Sci, Dept Biomed Mol Biol, Ghent, Belgium; [Merad, Miriam] Tisch Canc Inst, Dept Ontol Sci, Human Immune Monitoring Ctr, Precis Immunol Inst, New York, NY 10029 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Chinese Academy of Sciences; Shanghai Jiao Tong University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Ginhoux, F (corresponding author), ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore.; Ginhoux, F (corresponding author), Gustave Roussy Canc Campus, Villejuif, France.; Ginhoux, F (corresponding author), Gustave Roussy, Inserm U1015, Villejuif, France.; Ginhoux, F (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Sch Med, Shanghai, Peoples R China.; Ginhoux, F (corresponding author), SingHlth Duke NUS Acad Med Ctr, Translat Immunol Inst, Singapore, Singapore.; Guilliams, M (corresponding author), VIB UGent Ctr Inflammat Res, Lab Myeloid Cell Biol Tissue Homeostasis & Regene, Ghent, Belgium.; Guilliams, M (corresponding author), Univ Ghent, Fac Sci, Dept Biomed Mol Biol, Ghent, Belgium.; Merad, M (corresponding author), Tisch Canc Inst, Dept Ontol Sci, Human Immune Monitoring Ctr, Precis Immunol Inst, New York, NY 10029 USA.	Florent_Ginhoux@immunol.a-star.edu.sg; Martin.guilliams@ugent.be; Miriam.merad@mssm.edu	Guilliams, Martin/N-7803-2013	Guilliams, Martin/0000-0003-3525-7570; Ginhoux, Florent/0000-0002-2857-7755				Ardouin L, 2016, IMMUNITY, V45, P305, DOI 10.1016/j.immuni.2016.07.019; Bourdely P, 2020, IMMUNITY, V53, P335, DOI 10.1016/j.immuni.2020.06.002; Cytlak U, 2020, IMMUNITY, V53, P353, DOI 10.1016/j.immuni.2020.07.003; Dutertre CA, 2019, IMMUNITY, V51, P573, DOI 10.1016/j.immuni.2019.08.008; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Maier B, 2020, NATURE, V580, P257, DOI 10.1038/s41586-020-2134-y; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Zhang QM, 2019, CELL, V179, P829, DOI 10.1016/j.cell.2019.10.003; Zilionis R, 2019, IMMUNITY, V50, P1317, DOI 10.1016/j.immuni.2019.03.009	10	11	11	5	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2022	22	2					67	68		10.1038/s41577-022-00675-7	http://dx.doi.org/10.1038/s41577-022-00675-7		JAN 2022	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YR8PV	35027741				2022-12-18	WOS:000742250400001
J	Manabe, T; Heneka, MT				Manabe, Tatsuya; Heneka, Michael T.			Cerebral dysfunctions caused by sepsis during ageing	NATURE REVIEWS IMMUNOLOGY			English	Review							NLRP3 INFLAMMASOME ACTIVATION; DOUBLE-STRANDED-RNA; TERM COGNITIVE IMPAIRMENT; NECROSIS-FACTOR-ALPHA; GAMMA-INDUCING FACTOR; A VIRUS-INFECTION; NF-KAPPA-B; INNATE IMMUNE; SICKNESS BEHAVIOR; MICROGLIAL ACTIVATION	Systemic inflammation elicited by sepsis can induce an acute cerebral dysfunction known as sepsis-associated encephalopathy (SAE). Recent evidence suggests that SAE is common but shows a dynamic trajectory over time. Half of all patients with sepsis develop SAE in the intensive care unit, and some survivors present with sustained cognitive impairments for several years after initial sepsis onset. It is not clear why some, but not all, patients develop SAE and also the factors that determine the persistence of SAE. Here, we first summarize the chronic pathology and the dynamic changes in cognitive functions seen after the onset of sepsis. We then outline the cerebral effects of sepsis, such as neuroinflammation, alterations in neuronal synapses and neurovascular changes. We discuss the key factors that might contribute to the development and persistence of SAE in older patients, including premorbid neurodegenerative pathology, side effects of sedatives, renal dysfunction and latent virus reactivation. Finally, we postulate that some of the mechanisms that underpin neuropathology in SAE may also be relevant to delirium and persisting cognitive impairments that are seen in patients with severe COVID-19. In this Review, Manabe and Heneka examine how the systemic inflammation associated with sepsis can lead to acute cerebral dysfunction known as sepsis-associated encephalopathy (SAE). Moreover, they suggest that some of the mechanisms involved in SAE may be relevant for understanding the cognitive impairments that develop in some patients with COVID-19.	[Manabe, Tatsuya; Heneka, Michael T.] Univ Bonn, Dept Neurodegenerat Dis & Geriatr Psychiat, Med Ctr, Bonn, Germany; [Manabe, Tatsuya; Heneka, Michael T.] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Heneka, Michael T.] Univ Massachusetts, Sch Med, Dept Infect Dis & Immunol, Worcester, MA 01605 USA	University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Massachusetts System; University of Massachusetts Worcester	Heneka, MT (corresponding author), Univ Bonn, Dept Neurodegenerat Dis & Geriatr Psychiat, Med Ctr, Bonn, Germany.; Heneka, MT (corresponding author), German Ctr Neurodegenerat Dis DZNE, Bonn, Germany.; Heneka, MT (corresponding author), Univ Massachusetts, Sch Med, Dept Infect Dis & Immunol, Worcester, MA 01605 USA.	michael.heneka@ukbonn.de		Manabe, Tatsuya/0000-0002-1424-5688	German Research Council (Deutsche Forschungsgemeinschaft) [HE 3350/11-1]	German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	Financial support for this article was provided by German Research Council (Deutsche Forschungsgemeinschaft) to M.T.H. (HE 3350/11-1).	Abraham MN, 2020, SHOCK, V54, P168, DOI 10.1097/SHK.0000000000001485; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Akiyoshi R, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0088-18.2018; Alexopoulos H, 2020, NEUROL-NEUROIMMUNOL, V7, DOI 10.1212/NXI.0000000000000893; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andonegui G, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99364; Andonegui G, 2009, SHOCK, V31, P423, DOI 10.1097/SHK.0b013e318188c273; [Anonymous], 2015, J AM COLL SURGEONS, V220, P136, DOI 10.1016/j.jamcollsurg.2014.10.019; Arshad A, 2021, J INTENSIVE CARE MED, V36, P1366, DOI 10.1177/0885066620956621; BANKS WA, 1994, NEUROSCI LETT, V179, P53, DOI 10.1016/0304-3940(94)90933-4; BANKS WA, 1991, J PHARMACOL EXP THER, V259, P988; Banks WA, 2010, BRAIN BEHAV IMMUN, V24, P102, DOI 10.1016/j.bbi.2009.09.001; Basak JM, 2021, NEUROBIOL DIS, V152, DOI 10.1016/j.nbd.2021.105292; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Beyer MMS, 2020, J NEUROSCI, V40, P5480, DOI 10.1523/JNEUROSCI.0200-20.2020; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; Blank T, 2016, IMMUNITY, V44, P901, DOI 10.1016/j.immuni.2016.04.005; Bobot M, 2020, J AM SOC NEPHROL, V31, P1509, DOI 10.1681/ASN.2019070728; Bodea LG, 2014, J NEUROSCI, V34, P8546, DOI 10.1523/JNEUROSCI.5002-13.2014; Brown GC, 2014, NAT REV NEUROSCI, V15, P209, DOI 10.1038/nrn3710; Cao CY, 1996, BRAIN RES, V733, P263, DOI 10.1016/0006-8993(96)00575-6; Cape E, 2014, J PSYCHOSOM RES, V77, P219, DOI 10.1016/j.jpsychores.2014.06.014; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Cavaillon JM, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201810128; Chang CW, 2021, EJNMMI RES, V11, DOI 10.1186/s13550-021-00768-9; Chapman GA, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-15-j0004.2000; Chavan SS, 2012, MOL MED, V18, P930, DOI 10.2119/molmed.2012.00195; Chelazzi C, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0741-z; Chen J, 2008, BRAIN BEHAV IMMUN, V22, P301, DOI 10.1016/j.bbi.2007.08.014; Chen ZG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5461; Chen ZH, 2012, J NEUROSCI, V32, P11706, DOI 10.1523/JNEUROSCI.0730-12.2012; Choi HB, 2007, J NEUROSCI, V27, P4957, DOI 10.1523/JNEUROSCI.5417-06.2007; Cohen O, 2003, J MOL NEUROSCI, V21, P199, DOI 10.1385/JMN:21:3:199; Collar AL, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.95417; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Cook CH, 2003, CRIT CARE MED, V31, P1923, DOI 10.1097/01.CCM.0000070222.11325.C4; Cook CH, 2006, J VIROL, V80, P9151, DOI 10.1128/JVI.00216-06; Cunningham C, 2007, BRAIN BEHAV IMMUN, V21, P490, DOI 10.1016/j.bbi.2006.12.007; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; da Silva EO, 2018, WORLD MYCOTOXIN J, V11, P113, DOI 10.3920/WMJ2017.2267; Davis DHJ, 2015, AM J GERIAT PSYCHIAT, V23, P403, DOI 10.1016/j.jagp.2014.08.005; de Rooij SE, 2007, J PSYCHOSOM RES, V62, P521, DOI 10.1016/j.jpsychores.2006.11.013; Doll JR, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008296; Drake TM, 2021, LANCET, V398, P223, DOI 10.1016/S0140-6736(21)00799-6; Dumitriu D, 2010, J NEUROSCI, V30, P7507, DOI 10.1523/JNEUROSCI.6410-09.2010; Ehler J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211184; Ehler J, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1850-7; Eidelman LA, 1996, JAMA-J AM MED ASSOC, V275, P470, DOI 10.1001/jama.275.6.470; Fajgenbaum DC, 2020, NEW ENGL J MED, V383, P2255, DOI 10.1056/NEJMra2026131; Field R, 2010, BRAIN BEHAV IMMUN, V24, P996, DOI 10.1016/j.bbi.2010.04.004; Filipello F, 2018, IMMUNITY, V48, P979, DOI 10.1016/j.immuni.2018.04.016; Finnema SJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6667; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; Flierl MA, 2009, CRIT CARE, V13, DOI 10.1186/cc7710; Fortier ME, 2004, AM J PHYSIOL-REG I, V287, pR759, DOI 10.1152/ajpregu.00293.2004; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173; Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913; Fritze T, 2021, NEUROL-NEUROIMMUNOL, V8, DOI 10.1212/NXI.0000000000000911; Garcia MA, 2021, J NEUROL SCI, V427, DOI 10.1016/j.jns.2021.117517; Garre JM, 2018, J MOL MED, V96, P873, DOI 10.1007/s00109-018-1672-3; Garre JM, 2017, NAT MED, V23, P714, DOI 10.1038/nm.4340; Gentile LF, 2012, J TRAUMA ACUTE CARE, V72, P1491, DOI 10.1097/TA.0b013e318256e000; Ghaly T, 2011, AM J PHYSIOL-RENAL, V301, pF802, DOI 10.1152/ajprenal.00124.2011; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Girard TD, 2018, LANCET RESP MED, V6, P213, DOI 10.1016/S2213-2600(18)30062-6; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Grigoleit JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028330; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Gunther ML, 2012, CRIT CARE MED, V40, P2022, DOI 10.1097/CCM.0b013e318250acc0; GUTIERREZ EG, 1993, J NEUROIMMUNOL, V47, P169, DOI 10.1016/0165-5728(93)90027-V; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Hansen MK, 1998, J NEUROSCI, V18, P2247; Harland M, 2020, J NEUROSCI, V40, P1756, DOI 10.1523/JNEUROSCI.2324-19.2020; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Haruwaka K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13812-z; Hawkins RB, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01511; Helms J, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03200-1; Heneka MT, 2015, NAT IMMUNOL, V16, P229, DOI 10.1038/ni.3102; Hippensteel JA, 2019, J CLIN INVEST, V129, P1779, DOI 10.1172/JCI124485; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hosoi T, 2000, AM J PHYSIOL-REG I, V279, pR141, DOI 10.1152/ajpregu.2000.279.1.R141; Hosokawa K, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0674-y; Hosseini S, 2021, FRONT CELL NEUROSCI, V15, DOI 10.3389/fncel.2021.643650; Hosseini S, 2018, J NEUROSCI, V38, P3060, DOI 10.1523/JNEUROSCI.1740-17.2018; Hotchkiss RS, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.45; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Huang CM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000812; Huang CL, 2021, LANCET, V397, P220, DOI 10.1016/S0140-6736(20)32656-8; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Huerta Patricio T, 2016, Mol Med, V22, P789, DOI 10.2119/molmed.2015.00201; Ishizuka K, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.173; Ising C, 2019, NATURE, V575, P669, DOI 10.1038/s41586-019-1769-z; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Jacob A, 2007, LAB INVEST, V87, P1186, DOI 10.1038/labinvest.3700686; Jafari M, 2021, NAT NEUROSCI, V24, P355, DOI 10.1038/s41593-020-00780-7; Jain S, 2015, NEW ENGL J MED, V373, P415, DOI [10.1056/NEJMoa1500245, 10.1056/NEJMc1511751]; Johansson JU, 2013, J NEUROSCI, V33, P16016, DOI 10.1523/JNEUROSCI.2203-13.2013; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Keane L., J CLIN INVEST, V2021; Kitazawa M, 2005, J NEUROSCI, V25, P8843, DOI 10.1523/JNEUROSCI.2868-05.2005; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Kondo S, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-27; Krabbe KS, 2005, BRAIN BEHAV IMMUN, V19, P453, DOI 10.1016/j.bbi.2005.04.010; Krstic D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-151; Laflamme N, 2003, EUR J IMMUNOL, V33, P1127, DOI 10.1002/eji.200323821; Laflamme N, 2001, FASEB J, V15, P155, DOI 10.1096/fj.00-0339com; Lau WL, 2020, TRANSL STROKE RES, V11, P122, DOI 10.1007/s12975-019-00698-8; Laye Sophie, 1995, American Journal of Physiology, V268, pR1327; Lee JW, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-37; Lemstra AW, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-4; Li SM, 2020, INT IMMUNOPHARMACOL, V87, DOI 10.1016/j.intimp.2020.106814; Li T, 2020, EMBO J, V39, DOI 10.15252/embj.2019104136; Li YK, 2003, J NEUROSCI, V23, P1605; Litvinchuk A, 2018, NEURON, V100, P1337, DOI 10.1016/j.neuron.2018.10.031; Liu XY, 2019, IMMUNITY, V50, P317, DOI [10.1016/j.immuni.2019.02.012, 10.1016/j.immuni.2018.12.012]; Ljungstrom L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225700; Looker KJ, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0114989, 10.1371/journal.pone.0140765]; Lopez-Rodriguez AB, 2021, ALZHEIMERS DEMENT, V17, P1735, DOI 10.1002/alz.12341; Louyeau A, 2015, TRENDS IMMUNOL, V36, P569, DOI 10.1016/j.it.2015.08.006; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Manabe T, 2021, J NEUROCHEM, V159, P525, DOI 10.1111/jnc.15491; Maphis N, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00196; Marcocci ME, 2020, TRENDS MICROBIOL, V28, P808, DOI 10.1016/j.tim.2020.03.003; Marschallinger J, 2020, NAT NEUROSCI, V23, P194, DOI 10.1038/s41593-019-0566-1; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Matschke J, 2020, LANCET NEUROL, V19, P919, DOI 10.1016/S1474-4422(20)30308-2; Matt SM, 2016, NEUROBIOL AGING, V47, P1, DOI 10.1016/j.neurobiolaging.2016.07.006; Mattsson N, 2019, JAMA NEUROL, V76, P791, DOI 10.1001/jamaneurol.2019.0765; McGarry N, 2021, BRAIN BEHAV IMMUN, V95, P413, DOI 10.1016/j.bbi.2021.04.016; McManus RM, 2014, NEUROBIOL AGING, V35, P109, DOI 10.1016/j.neurobiolaging.2013.07.025; MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416; Meinhardt J, 2021, NAT NEUROSCI, V24, P168, DOI 10.1038/s41593-020-00758-5; Mielke MM, 2019, NEUROLOGY, V93, pE252, DOI 10.1212/WNL.0000000000007767; Mingam R, 2008, BRAIN BEHAV IMMUN, V22, P234, DOI 10.1016/j.bbi.2007.08.007; Miyamoto A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12540; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Murray C, 2015, BRAIN BEHAV IMMUN, V48, P274, DOI 10.1016/j.bbi.2015.04.009; Muzambi R, 2021, LANCET HEALTH LONGEV, V2, pE426, DOI 10.1016/S2666-7568(21)00118-5; Nabulsi NB, 2016, J NUCL MED, V57, P777, DOI 10.2967/jnumed.115.168179; Nguyen DN, 2006, CRIT CARE MED, V34, P1967, DOI 10.1097/01.CCM.0000217218.51381.49; Odoj K, 2021, BRAIN BEHAV IMMUN, V96, P113, DOI 10.1016/j.bbi.2021.05.021; Orhun G, 2020, NEUROCRIT CARE, V32, P459, DOI 10.1007/s12028-019-00759-8; Ormerod BK, 2013, BRAIN BEHAV IMMUN, V29, P28, DOI 10.1016/j.bbi.2012.10.017; Perl DP, 2021, NEW ENGL J MED, V384, P481, DOI 10.1056/NEJMc2033369; Prescott HC, 2018, JAMA-J AM MED ASSOC, V319, P62, DOI 10.1001/jama.2017.17687; Prescott HC, 2015, JAMA-J AM MED ASSOC, V313, P1055, DOI 10.1001/jama.2015.1410; Pun BT, 2021, LANCET RESP MED, V9, P239, DOI 10.1016/S2213-2600(20)30552-X; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Ramani A, 2020, EMBO J, V39, DOI 10.15252/embj.2020106230; Ranzani OT, 2017, AM J RESP CRIT CARE, V196, P1287, DOI [10.1164/rccm.201611-2262OC, 10.1164/rccm.201611-2262oc]; Reade MC, 2014, NEW ENGL J MED, V370, P444, DOI 10.1056/NEJMra1208705; Reichenberg A, 2001, ARCH GEN PSYCHIAT, V58, P445, DOI 10.1001/archpsyc.58.5.445; Robinson JL, 2014, BRAIN, V137, P2578, DOI 10.1093/brain/awu190; Roe AD, 2011, EUR J NEUROSCI, V34, P448, DOI 10.1111/j.1460-9568.2011.07764.x; Roosevelt RW, 2006, BRAIN RES, V1119, P124, DOI 10.1016/j.brainres.2006.08.048; Rudd KE, 2020, LANCET, V395, P200, DOI 10.1016/S0140-6736(19)32989-7; Ruffoli R, 2011, J CHEM NEUROANAT, V42, P288, DOI 10.1016/j.jchemneu.2010.12.002; Sandiego CM, 2015, P NATL ACAD SCI USA, V112, P12468, DOI 10.1073/pnas.1511003112; Satizabal CL, 2012, NEUROLOGY, V78, P720, DOI 10.1212/WNL.0b013e318248e50f; Savva GM, 2009, NEW ENGL J MED, V360, P2302, DOI 10.1056/NEJMoa0806142; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Scott-Hewitt N, 2020, EMBO J, V39, DOI 10.15252/embj.2020105380; Semmler A, 2013, J NEUROL NEUROSUR PS, V84, P62, DOI 10.1136/jnnp-2012-302883; Semmler A, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-38; Serantes R, 2006, J BIOL CHEM, V281, P14632, DOI 10.1074/jbc.M512489200; Sharshar T, 2004, BRAIN PATHOL, V14, P21, DOI 10.1111/j.1750-3639.2004.tb00494.x; Sharshar T, 2003, LANCET, V362, P1799, DOI 10.1016/S0140-6736(03)14899-4; Shi QQ, 2015, J NEUROSCI, V35, P13029, DOI 10.1523/JNEUROSCI.1698-15.2015; Shoji H, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0191-9; Singer BH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149136; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Singh-Manoux A, 2014, NEUROLOGY, V83, P486, DOI 10.1212/WNL.0000000000000665; Skelly DT, 2019, MOL PSYCHIATR, V24, P1533, DOI 10.1038/s41380-018-0075-8; Skelly DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069123; Solomon IH, 2020, NEW ENGL J MED, V383, P989, DOI 10.1056/NEJMc2019373; Song ER, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100288; Song ER, 2021, J EXP MED, V218, DOI 10.1084/jem.20202135; Sonneville R, 2017, INTENS CARE MED, V43, P1075, DOI 10.1007/s00134-017-4807-z; Sparkman NL, 2006, J NEUROSCI, V26, P10709, DOI 10.1523/JNEUROSCI.3376-06.2006; Stephan AH, 2013, J NEUROSCI, V33, P13460, DOI 10.1523/JNEUROSCI.1333-13.2013; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Stortz JA, 2018, J TRAUMA ACUTE CARE, V84, P342, DOI 10.1097/TA.0000000000001758; Stubbs DJ, 2013, NAT REV NEUROL, V9, P551, DOI 10.1038/nrneurol.2013.177; Sudarmono P, 2017, LANCET GLOB HEALTH, V5, pE157, DOI 10.1016/S2214-109X(17)30007-4; Sy M, 2011, AM J PATHOL, V178, P2811, DOI 10.1016/j.ajpath.2011.02.012; Taquet M, 2021, LANCET PSYCHIAT, V8, P416, DOI 10.1016/S2215-0366(21)00084-5; Tejera D, 2019, EMBO J, V38, DOI 10.15252/embj.2018101064; Terrando N, 2010, CRIT CARE, V14, DOI 10.1186/cc9019; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Thakur KT, 2021, BRAIN, V144, P2696, DOI 10.1093/brain/awab148; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Thwaites RS, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abg9873; Torvell M, 2019, ALZH DEMENT-TRCI, V5, P579, DOI 10.1016/j.trci.2019.09.001; Valero J, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00083; van den Boogaard M, 2010, CRIT CARE, V14, DOI 10.1186/cc9001; van der Poll T, 2017, NAT REV IMMUNOL, V17, P407, DOI 10.1038/nri.2017.36; van Munster BC, 2008, J AM GERIATR SOC, V56, P1704, DOI 10.1111/j.1532-5415.2008.01851.x; van Ton AMP, 2020, BRAIN BEHAV IMMUN, V89, P656, DOI 10.1016/j.bbi.2020.06.027; Vanhaute H, 2020, NEUROLOGY, V95, pE545, DOI 10.1212/WNL.0000000000009818; Varatharaj A, 2017, BRAIN BEHAV IMMUN, V60, P1, DOI 10.1016/j.bbi.2016.03.010; Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283; Venegas C, 2017, NATURE, V552, P355, DOI 10.1038/nature25158; Viggiano D, 2020, NAT REV NEPHROL, V16, P452, DOI 10.1038/s41581-020-0266-9; Vincent JL, 2020, JAMA-J AM MED ASSOC, V323, P1478, DOI 10.1001/jama.2020.2717; Walton AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098819; Wardlaw JM, 2017, ALZHEIMERS DEMENT, V13, P634, DOI 10.1016/j.jalz.2016.09.006; Weberpals M, 2009, J NEUROSCI, V29, P14177, DOI 10.1523/JNEUROSCI.3238-09.2009; Weinhard L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03566-5; Wendeln AC, 2018, NATURE, V556, P332, DOI 10.1038/s41586-018-0023-4; White LE, 2013, J TRAUMA ACUTE CARE, V75, P432, DOI 10.1097/TA.0b013e31829de6cd; Widmann CN, 2014, LANCET NEUROL, V13, P630, DOI 10.1016/S1474-4422(14)70017-1; Wu L, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64200-3; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamato M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090950; Yang AC, 2021, NATURE, V595, P565, DOI 10.1038/s41586-021-03710-0; Yang Y, 2011, INTENS CARE MED, V37, P1613, DOI 10.1007/s00134-011-2319-9; Yende S, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.8686; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015; Youm YH, 2013, CELL METAB, V18, P519, DOI 10.1016/j.cmet.2013.09.010; Zhang SB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188273; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhao Z, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-1728-5; Zheng J, 2021, NATURE, V589, P603, DOI 10.1038/s41586-020-2943-z; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhu QF, 2017, J IMMUNOL, V198, P4210, DOI 10.4049/jimmunol.1700352; Zrzavy T, 2019, NEUROPATH APPL NEURO, V45, P278, DOI 10.1111/nan.12502	231	11	11	19	27	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUL	2022	22	7					444	458		10.1038/s41577-021-00643-7	http://dx.doi.org/10.1038/s41577-021-00643-7		NOV 2021	15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	2P0EH	34764472	Green Published, Bronze			2022-12-18	WOS:000717415700001
J	Bird, L				Bird, Lucy			Calming the cytokine storm	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material														Bird, Lucy/0000-0002-3914-6045					0	11	13	3	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUL	2018	18	7					417	417		10.1038/s41577-018-0030-6	http://dx.doi.org/10.1038/s41577-018-0030-6			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK8IE	29899366	Bronze			2022-12-18	WOS:000436463300001
J	Kawabe, T; Zhu, JF; Sher, A				Kawabe, Takeshi; Zhu, Jinfang; Sher, Alan			Foreign antigen-independent memory-phenotype CD4(+) T cells: a new player in innate immunity?	NATURE REVIEWS IMMUNOLOGY			English	Letter									[Kawabe, Takeshi; Sher, Alan] NIAID, Immunobiol Sect, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Zhu, Jinfang] NIAID, Mol & Cellular Immunoregulat Sect, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kawabe, T; Sher, A (corresponding author), NIAID, Immunobiol Sect, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	takeshi.kawabe@nih.gov; asher@niaid.nih.gov	Zhu, Jinfang/B-7574-2012	Zhu, Jinfang/0000-0002-0117-4745	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001044, ZIAAI001169] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors are grateful to R. N. Germain and the late W. E. Paul for their invaluable discussions and contributions to the work on this topic. T.K., J.Z. and A.S. are funded by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.	Kawabe T, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam9304; Kawabe T, 2013, J IMMUNOL, V190, P5788, DOI 10.4049/jimmunol.1203111; Kieper WC, 2005, J IMMUNOL, V174, P3158, DOI 10.4049/jimmunol.174.6.3158; Kim KS, 2016, SCIENCE, V351, P858, DOI 10.1126/science.aac5560; Mandl JN, 2013, IMMUNITY, V38, P263, DOI 10.1016/j.immuni.2012.09.011; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Sosinowski T, 2013, J IMMUNOL, V190, P1936, DOI 10.4049/jimmunol.1203149; Weinreich MA, 2010, NAT IMMUNOL, V11, P709, DOI 10.1038/ni.1898; White JT, 2017, NAT REV IMMUNOL, V17, P391, DOI 10.1038/nri.2017.34; White JT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11291; Younes SA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001171; 2017, NAT REV IMMUNOL, V17, P391	12	11	11	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAR	2018	18	3					1	1		10.1038/nri.2018.12	http://dx.doi.org/10.1038/nri.2018.12			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FX5KU	29480287	Bronze			2022-12-18	WOS:000426118500001
J	Orlova, DY; Herzenberg, LA; Walther, G				Orlova, Darya Y.; Herzenberg, Leonore A.; Walther, Guenther			Science not art: statistically sound methods for identifying subsets in multi-dimensional flow and mass cytometry data sets	NATURE REVIEWS IMMUNOLOGY			English	Letter									[Orlova, Darya Y.; Herzenberg, Leonore A.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Walther, Guenther] Stanford Univ, Dept Stat, Stanford, CA 94305 USA	Stanford University; Stanford University	Orlova, DY (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.; Walther, G (corresponding author), Stanford Univ, Dept Stat, Stanford, CA 94305 USA.	orlova@stanford.edu; gwalther@stanford.edu			Division Of Mathematical Sciences [1501767] Funding Source: National Science Foundation	Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Broad Institute, 2017, FLOW CYT GAT CLUST; Chen H, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005112; Friedman J., 2009, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-84858-7; Levina E., 2004, ADV NEURAL INFORM PR, V17; Meehan S, 2014, IMMUNOL RES, V58, P218, DOI 10.1007/s12026-014-8519-y; Orlova DY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151859; Saeys Y, 2016, NAT REV IMMUNOL, V16, P449, DOI 10.1038/nri.2016.56; Samusik N, 2016, NAT METHODS, V13, P493, DOI [10.1038/NMETH.3863, 10.1038/nmeth.3863]; Scott D. W., 1992, MULTIVARIATE DENSITY, DOI 10.1002/9780470316849; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579	10	11	11	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2018	18	1					77	+		10.1038/nri.2017.150	http://dx.doi.org/10.1038/nri.2017.150			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FT0GY	29269766	Bronze			2022-12-18	WOS:000422802500012
J	Leavy, O				Leavy, Olive			REPRODUCTIVE IMMUNOLOGY Evading immunosurveillance in endometriosis	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	11	15	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2015	15	12					729	729		10.1038/nri3942	http://dx.doi.org/10.1038/nri3942			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CY1FS	26567919	Bronze			2022-12-18	WOS:000366152700007
J	Baxter, AG				Baxter, AG			Louis Pasteur's beer of revenge	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material									Autoimmun Res Grp, Centenary Inst Canc Med & Cell Biol, Newtown, NSW 2042, Australia	University of Sydney; Centenary Institute	Baxter, AG (corresponding author), Autoimmun Res Grp, Centenary Inst Canc Med & Cell Biol, Locked Bag 6, Newtown, NSW 2042, Australia.		Baxter, Alan G/A-1412-2010	Baxter, Alan G/0000-0002-6960-9821				Brock TD., 1988, R KOCH LIFE MED BACT; Debre Patrice, 1994, LOUIS PASTEUR; PASTEUR L, 1882, Q C INT HYG DEMOGR, V1, P145; PASTEUR L, 1969, CORRESPONDENCE PASTE; PASTEUR L, 1872, COMPTES RENDUS TRAVA, P42; Pasteur L, 1879, KRAUS REPRINT; PASTEUR L, 1882, BR MED J        0408, P489; REDMAN NB, 1995, BREWER           SEP; VALLERYRADOT R, 1951, L PASTEUR CORRESPOND, V2; VALLERYRADOT R, 1906, LIFE PASTEUR	10	11	12	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2001	1	3					229	232		10.1038/35105083	http://dx.doi.org/10.1038/35105083			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	635KN	11905832				2022-12-18	WOS:000180398200025
J	Buzas, EI				Buzas, Edit I.			The roles of extracellular vesicles in the immune system	NATURE REVIEWS IMMUNOLOGY			English	Review; Early Access							CELL-DERIVED EXOSOMES; FOLLICULAR DENDRITIC CELLS; T-CELLS; B-CELLS; MEMBRANE-VESICLES; DOWN-MODULATE; EMERGING ROLE; MICROVESICLES; ANTIGEN; RELEASE	The twenty-first century has witnessed major developments in the field of extracellular vesicle (EV) research, including significant steps towards defining standard criteria for the separation and detection of EVs. The recent recognition that EVs have the potential to function as biomarkers or as therapeutic tools has attracted even greater attention to their study. With this progress in mind, an updated comprehensive overview of the roles of EVs in the immune system is timely. This Review summarizes the roles of EVs in basic processes of innate and adaptive immunity, including inflammation, antigen presentation, and the development and activation of B cells and T cells. It also highlights key progress related to deciphering the roles of EVs in antimicrobial defence and in allergic, autoimmune and antitumour immune responses. It ends with a focus on the relevance of EVs to immunotherapy and vaccination, drawing attention to ongoing or recently completed clinical trials that aim to harness the therapeutic potential of EVs. Extracellular vesicles (EVs) are increasingly recognized as having ubiquitous roles in the immune system. This Review focuses on the progress made in the field in the past 5 years, including the roles of EVs in innate and adaptive immunity and their potential use in diagnosis and therapy.	[Buzas, Edit I.] Semmelweis Univ, Dept Genet Cell & Immunobiol, Budapest, Hungary; [Buzas, Edit I.] HCEMM Extracellular Vesicles Res Grp, Budapest, Hungary; [Buzas, Edit I.] ELKH SE Immune Proteogen Extracellular Vesicles R, Budapest, Hungary	Semmelweis University	Buzas, EI (corresponding author), Semmelweis Univ, Dept Genet Cell & Immunobiol, Budapest, Hungary.; Buzas, EI (corresponding author), HCEMM Extracellular Vesicles Res Grp, Budapest, Hungary.; Buzas, EI (corresponding author), ELKH SE Immune Proteogen Extracellular Vesicles R, Budapest, Hungary.	buzas.edit@med.semmelweis-univ.hu		Buzas, Edit/0000-0002-3744-206X	National Research, Development and Innovation Office NKFIH, Hungary [NVKP_16-1-2016-0017]; Hungarian Scientific Research Fund [OTKA K120237]; Higher Education Excellence Program (FIKP) Therapeutic Thematic Programme; Hungarian Thematic Excellence Programme [TKP2020-NKA-26]; EU's Horizon 2020 Research and Innovation Programme [739593];  [VEKOP-2.3.2-16-2016-000002];  [VEKOP-2.3.3-15-2017-00016];  [H2020-MSCA-ITN-2017-722148 TRAIN EV]	National Research, Development and Innovation Office NKFIH, Hungary(National Research, Development & Innovation Office (NRDIO) - Hungary); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Higher Education Excellence Program (FIKP) Therapeutic Thematic Programme; Hungarian Thematic Excellence Programme; EU's Horizon 2020 Research and Innovation Programme; ; ; 	This work was supported by National Research, Development and Innovation Office NKFIH, Hungary, NVKP_16-1-2016-0017, the Hungarian Scientific Research Fund (OTKA K120237), VEKOP-2.3.2-16-2016-000002, VEKOP-2.3.3-15-2017-00016, H2020-MSCA-ITN-2017-722148 TRAIN EV and Higher Education Excellence Program (FIKP) Therapeutic Thematic Programme. This study was supported by the Hungarian Thematic Excellence Programme No. TKP2020-NKA-26. The project has received funding from the EU's Horizon 2020 Research and Innovation Programme under grant agreement No. 739593.	Acevedo R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00121; Admyre C, 2007, J ALLERGY CLIN IMMUN, V120, P1418, DOI 10.1016/j.jaci.2007.06.040; Amjadi MF, 2021, J LEUKOCYTE BIOL, V110, P917, DOI 10.1002/JLB.3AB0520-339RR; Andre F, 2004, J IMMUNOL, V172, P2126, DOI 10.4049/jimmunol.172.4.2126; Arya SB, 2022, NAT CELL BIOL, V24, P1019, DOI 10.1038/s41556-022-00934-8; Atkin-Smith GK, 2019, CELL REP, V29, P1821, DOI 10.1016/j.celrep.2019.10.014; Ayre DC, 2015, IMMUNOLOGY, V146, P217, DOI 10.1111/imm.12493; Bai XL, 2011, EXPERT OPIN BIOL TH, V11, P969, DOI 10.1517/14712598.2011.585965; Balan S, 2020, CANCER CELL, V37, P751, DOI 10.1016/j.ccell.2020.05.013; Balint S, 2020, SCIENCE, V368, P897, DOI 10.1126/science.aay9207; Barman B, 2022, DEV CELL, V57, P974, DOI 10.1016/j.devcel.2022.03.012; Beltraminelli T, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.108960; Bitto NJ, 2021, J EXTRACELL VESICLES, V10, DOI 10.1002/jev2.12080; Boilard E, 2018, J LIPID RES, V59, P2037, DOI 10.1194/jlr.R084640; Brown L, 2015, NAT REV MICROBIOL, V13, P620, DOI 10.1038/nrmicro3480; Budden CF, 2021, J EXTRACELL VESICLES, V10, DOI 10.1002/jev2.12127; Burgelman M, 2021, PHARMACEUTICALS-BASE, V14, DOI 10.3390/ph14080829; Busatto S, 2021, FASEB BIOADV, V3, P665, DOI 10.1096/fba.2021-00045; Buzas EI, 2018, SEMIN IMMUNOPATHOL, V40, P453, DOI 10.1007/s00281-018-0682-0; Buzas EI, 2014, NAT REV RHEUMATOL, V10, P356, DOI 10.1038/nrrheum.2014.19; Cao MQ, 2015, ELIFE, V4, DOI 10.7554/eLife.05242; Capello M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08109-6; Cespedes PF, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-31160-3; Chen G, 2018, NATURE, V560, P382, DOI 10.1038/s41586-018-0392-8; Cheng QQ, 2022, MOL THER, V30, P3066, DOI 10.1016/j.ymthe.2022.06.013; Choudhuri K, 2014, NATURE, V507, P118, DOI 10.1038/nature12951; Clayton A, 2008, J IMMUNOL, V180, P7249, DOI 10.4049/jimmunol.180.11.7249; Cocozza F, 2020, J EXTRACELL VESICLES, V10, DOI 10.1002/jev2.12050; Couch Y, 2021, J EXTRACELL VESICLES, V10, DOI 10.1002/jev2.12144; Craxton A, 2007, EUR J IMMUNOL, V37, P2715, DOI 10.1002/eji.200737327; Daassi D, 2020, NAT REV IMMUNOL, V20, P209, DOI 10.1038/s41577-019-0264-y; Denzer K, 2000, J IMMUNOL, V165, P1259, DOI 10.4049/jimmunol.165.3.1259; Di Vizio D, 2012, AM J PATHOL, V181, P1573, DOI 10.1016/j.ajpath.2012.07.030; Dieude M, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac9816; Duchez AC, 2015, P NATL ACAD SCI USA, V112, pE3564, DOI 10.1073/pnas.1507905112; El-Shennawy L, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-021-27893-2; Erttmann SF, 2022, IMMUNITY, V55, P847, DOI 10.1016/j.immuni.2022.04.006; Esser J, 2010, J ALLERGY CLIN IMMUN, V126, P1032, DOI 10.1016/j.jaci.2010.06.039; Fang SB, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.710372; Fendl B, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-86489-4; Fernandez-Messina L, 2020, EMBO REP, V21, DOI 10.15252/embr.201948925; Fischer SF, 2007, BLOOD, V110, P3978, DOI 10.1182/blood-2007-05-091306; Fitzgerald W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27190-x; Fu CM, 2020, P NATL ACAD SCI USA, V117, P23730, DOI 10.1073/pnas.2002345117; Fu WY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12321-3; Fujita Y, 2021, J EXTRACELL VESICLES, V10, DOI 10.1002/jev2.12092; Gao L, 2018, NAT IMMUNOL, V19, P233, DOI 10.1038/s41590-017-0043-5; Garcia-Contreras M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05787-y; Golebiewska JE, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10112989; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Habertheuer A, 2018, J THORAC CARDIOV SUR, V155, P2479, DOI 10.1016/j.jtcvs.2017.12.125; Hao QY, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23031461; Hartl J, 2021, J EXP MED, V218, DOI 10.1084/jem.20201138; Hedlund M, 2009, J IMMUNOL, V183, P340, DOI 10.4049/jimmunol.0803477; Hofmann L, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21114072; Huber V, 2005, GASTROENTEROLOGY, V128, P1796, DOI 10.1053/j.gastro.2005.03.045; Jeppesen DK, 2019, CELL, V177, P428, DOI 10.1016/j.cell.2019.02.029; Ji PP, 2021, MOL THER-NUCL ACIDS, V26, P987, DOI 10.1016/j.omtn.2021.10.009; Jiang LL, 2022, J EXTRACELL VESICLES, V11, DOI 10.1002/jev2.12192; Johnson LR, 2021, CELL, V184, P4981, DOI 10.1016/j.cell.2021.08.004; Johnston EL, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22031005; Katz-Kiriakos E, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.136166; Kerviel A, 2021, ANNU REV CELL DEV BI, V37, P171, DOI 10.1146/annurev-cellbio-040621-032416; Kim HK, 2022, J EXTRACELL VESICLES, V11, DOI 10.1002/jev2.12179; Kim HR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06090-8; Kolonics F, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9122718; Kovacs AF, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143457; Kuipers ME, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02182; Li F, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/3623898; Li YB, 2021, THERANOSTICS, V11, P7144, DOI 10.7150/thno.59152; Lima LG, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23946-8; Liu Q, 2016, J CLIN INVEST, V126, P2805, DOI 10.1172/JCI84577; Lu MR, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.566299; Lundberg V, 2016, SCI REP-UK, V6, DOI 10.1038/srep36479; Ma L, 2015, CELL RES, V25, P24, DOI 10.1038/cr.2014.135; Ma Y, 2022, MOL HUM REPROD, V28, DOI 10.1093/molehr/gaac002; Manning AJ, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-258; Marar C, 2021, NAT IMMUNOL, V22, P560, DOI 10.1038/s41590-021-00899-0; Marcoux G, 2021, BLOOD, V138, P2607, DOI 10.1182/blood.2020009957; Marino J, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaf8759; Marki A, 2022, IMMUNOL REV, V312, P52, DOI 10.1111/imr.13103; Marki A, 2021, J EXP MED, V218, DOI 10.1084/jem.20200551; Mathieu M, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24384-2; Mathieu M, 2019, NAT CELL BIOL, V21, P9, DOI 10.1038/s41556-018-0250-9; McAndrews KM, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100523; McMillan HM, 2021, EMBO J, V40, DOI 10.15252/embj.2021108174; Melentijevic I, 2017, NATURE, V542, P367, DOI 10.1038/nature21362; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Molfetta R, 2020, ALLERGY, V75, P1260, DOI 10.1111/all.14103; Morelli AE, 2017, CURR OPIN ORGAN TRAN, V22, P46, DOI 10.1097/MOT.0000000000000372; Morishita M, 2021, MOL PHARMACEUT, V18, P1080, DOI 10.1021/acs.molpharmaceut.0c01011; Nakazawa Y, 2021, ELIFE, V10, DOI [10.7554/eLife.61999, 10.7554/eLife.61999.sa0, 10.7554/eLife.61999.sa1, 10.7554/eLife.61999.sa2]; Okoye IS, 2014, IMMUNITY, V41, P89, DOI [10.1016/j.immuni.2014.05.019, 10.1016/j.immuni.2014.08.008]; Phan HD., 2021, J IMMUNOL, V12; Pilzer D, 2005, SPRINGER SEMIN IMMUN, V27, P375, DOI 10.1007/s00281-005-0004-1; Prado N, 2015, J IMMUNOL, V195, P445, DOI 10.4049/jimmunol.1500452; Qazi KR, 2009, BLOOD, V113, P2673, DOI 10.1182/blood-2008-04-153536; Rai A, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-01882-z; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Rodriguez-Muguruza S, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.790880; Rossaint J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13464; Roszkowiak J, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225577; Saliba DG, 2019, ELIFE, V8, DOI 10.7554/eLife.47528; Schmidt-Arras D, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.688314; Schorey JS, 2015, EMBO REP, V16, P24, DOI 10.15252/embr.201439363; Sengupta V, 2020, STEM CELLS DEV, V29, P747, DOI 10.1089/scd.2020.0080; Setz CS, 2019, EMBO J, V38, DOI 10.15252/embj.2018100249; Shelke GV, 2019, J EXTRACELL VESICLES, V8, DOI 10.1080/20013078.2019.1650458; Shen ZW, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.749192; Shinohara H, 2017, J IMMUNOL, V199, P1505, DOI 10.4049/jimmunol.1700167; Shlomovitz I, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-04317-z; Sisquella X, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02083-1; Skogberg G, 2015, IMMUNOL CELL BIOL, V93, P727, DOI 10.1038/icb.2015.33; Skokos D, 2003, J IMMUNOL, V170, P3037, DOI 10.4049/jimmunol.170.6.3037; Smyth LA, 2013, EUR J IMMUNOL, V43, P2430, DOI 10.1002/eji.201242909; STEIN JM, 1991, BIOCHEM J, V274, P381, DOI 10.1042/bj2740381; Stenqvist AC, 2013, J IMMUNOL, V191, P5515, DOI 10.4049/jimmunol.1301885; Sung BH, 2021, DEV CELL, V56, P1861, DOI 10.1016/j.devcel.2021.03.020; Szabo GT, 2014, CELL MOL LIFE SCI, V71, P4055, DOI 10.1007/s00018-014-1618-z; Szajnik M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011469; Szeifert V, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.671995; Tew JG, 1997, IMMUNOL REV, V156, P39, DOI 10.1111/j.1600-065X.1997.tb00957.x; Thery C, 2002, NAT IMMUNOL, V3, P1156, DOI 10.1038/ni854; Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750; Timar CI, 2013, BLOOD, V121, P510, DOI 10.1182/blood-2012-05-431114; Tong LJ, 2021, THERANOSTICS, V11, P8570, DOI 10.7150/thno.62046; Toyofuku M, 2019, NAT REV MICROBIOL, V17, P13, DOI 10.1038/s41579-018-0112-2; Tsai SJ, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101266; Tu F, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00825; Tulkens J, 2020, NAT PROTOC, V15, P40, DOI 10.1038/s41596-019-0236-5; Tung SL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24531-8; Uto K, 2022, RHEUMATOLOGY, V61, P1669, DOI 10.1093/rheumatology/keab588; Utsugi-Kobukai S, 2003, IMMUNOL LETT, V89, P125, DOI 10.1016/S0165-2478(03)00128-7; Valcz G, 2019, J EXTRACELL VESICLES, V8, DOI 10.1080/20013078.2019.1596668; Vallhov H, 2015, ALLERGY, V70, P1651, DOI 10.1111/all.12701; van der Grein SG, 2018, SEMIN IMMUNOPATHOL, V40, P491, DOI 10.1007/s00281-018-0678-9; van der Ley PA, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.781280; van Niel G, 2022, NAT REV MOL CELL BIO, V23, P369, DOI 10.1038/s41580-022-00460-3; Verweij FJ, 2021, NAT METHODS, V18, P1013, DOI 10.1038/s41592-021-01206-3; Vincent-Schneider H, 2002, INT IMMUNOL, V14, P713, DOI 10.1093/intimm/dxf048; Wahlgren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049723; Wang QY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00767-2; Whiteside TL, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10113054; Wieckowski EU, 2009, J IMMUNOL, V183, P3720, DOI 10.4049/jimmunol.0900970; Wozniak AL, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201912074; Wu Q, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-04171-z; Xiang XY, 2009, INT J CANCER, V124, P2621, DOI 10.1002/ijc.24249; Xie F, 2021, ADV MATER, V33, DOI 10.1002/adma.202103471; Xie M, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00013; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847; Yu SH, 2007, J IMMUNOL, V178, P6867, DOI 10.4049/jimmunol.178.11.6867; Zhang HY, 2018, NAT CELL BIOL, V20, P332, DOI 10.1038/s41556-018-0040-4; Zhang M, 2021, J ALLERGY CLIN IMMUN, V148, P1545, DOI 10.1016/j.jaci.2021.04.025; Zhang Q, 2021, NAT CELL BIOL, V23, P1240, DOI 10.1038/s41556-021-00805-8; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	156	10	10	48	48	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.												10.1038/s41577-022-00763-8	http://dx.doi.org/10.1038/s41577-022-00763-8		AUG 2022	15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3N4CV	35927511	Bronze, Green Published			2022-12-18	WOS:000836097900001
J	Trim, WV; Lynch, L				Trim, W., V; Lynch, L.			Immune and non-immune functions of adipose tissue leukocytes	NATURE REVIEWS IMMUNOLOGY			English	Review							REGULATORY T-CELLS; DIET-INDUCED OBESITY; INNATE LYMPHOID-CELLS; ALTERNATIVELY ACTIVATED MACROPHAGES; TRYPANOSOMA-CRUZI INFECTION; PROMOTE INSULIN-RESISTANCE; OMENTAL MILKY SPOTS; INVARIANT NKT CELLS; DENDRITIC CELLS; WEIGHT-LOSS	In this Review, Trim and Lynch provide an overview of the adipose tissue immune system and discuss the functional roles of adipose immune structures, as well as focusing on recently discovered 'non-immune' functions of adipose tissue immune cells. Adipose tissue is a complex dynamic organ with whole-body immunometabolic influence. Much of the work into understanding the role of immune cells in adipose tissue has been in the context of obesity. These investigations have also uncovered a range of typical (immune) and non-typical functions exerted by adipose tissue leukocytes. Here we provide an overview of the adipose tissue immune system, including its role as an immune reservoir in the whole-body response to infection and as a site of parasitic and viral infections. We also describe the functional roles of specialized immunological structures found within adipose tissue. However, our main focus is on the recently discovered 'non-immune' functions of adipose tissue immune cells, which include the regulation of adipocyte homeostasis, as well as responses to changing nutrient status and body temperature. In doing so, we outline the therapeutic potential of the adipose tissue immune system in health and disease.	[Trim, W., V; Lynch, L.] Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin, Ireland; [Trim, W., V; Lynch, L.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA	Trinity College Dublin; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Lynch, L (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin, Ireland.; Lynch, L (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA.	llynch@bwh.harvard.edu	Lynch, Lydia/ABD-5598-2021	Trim, William/0000-0002-5642-0608	NIH [R01 AI134861]; American Diabetes Association [1-16-JDF-061]; SFI [FRL3865]; ERC [679173]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); SFI(Science Foundation Ireland); ERC(European Research Council (ERC)European Commission)	This work was supported by NIH grant R01 AI134861, ERC Starting Grant (679173), SFI FRL3865 and an American Diabetes Association grant (1-16-JDF-061).	Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362; Agarwal N, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007148; Aleman JO, 2017, J ENDOCR SOC, V1, P625, DOI 10.1210/js.2017-00020; Amano SU, 2014, CELL METAB, V19, P162, DOI 10.1016/j.cmet.2013.11.017; Anhe FF, 2020, NAT METAB, V2, P233, DOI 10.1038/s42255-020-0178-9; Ansel KM, 2002, IMMUNITY, V16, P67, DOI 10.1016/S1074-7613(01)00257-6; Arner P, 1999, INT J OBESITY, V23, P10, DOI 10.1038/sj.ijo.0800789; Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; Bartness TJ, 2010, INT J OBESITY, V34, pS36, DOI 10.1038/ijo.2010.182; Beigier-Bompadre M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006676; Benezech C, 2015, NAT IMMUNOL, V16, P819, DOI 10.1038/ni.3215; Bertola A, 2012, DIABETES, V61, P2238, DOI 10.2337/db11-1274; Betz MJ, 2018, NAT REV ENDOCRINOL, V14, P77, DOI 10.1038/nrendo.2017.132; Beura LK, 2016, NATURE, V532, P512, DOI 10.1038/nature17655; Bolus WR, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13919; Boulenouar S, 2017, IMMUNITY, V46, P273, DOI 10.1016/j.immuni.2017.01.008; Bourgeois C, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02837; Bourlier V, 2008, CIRCULATION, V117, P806, DOI 10.1161/CIRCULATIONAHA.107.724096; Brand A, 2016, CELL METAB, V24, P657, DOI 10.1016/j.cmet.2016.08.011; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Brigger D, 2020, NAT METAB, V2, P688, DOI 10.1038/s42255-020-0228-3; Buechler MB, 2019, IMMUNITY, V51, P119, DOI 10.1016/j.immuni.2019.05.010; Cabalen ME, 2016, ONCOTARGET, V7, P13400, DOI 10.18632/oncotarget.7630; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; Caljon G, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005744; Camell CD, 2019, CELL METAB, V30, P1024, DOI 10.1016/j.cmet.2019.10.006; Camell CD, 2017, NATURE, V550, P119, DOI 10.1038/nature24022; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao W, 2014, J IMMUNOL, V192, P2920, DOI 10.4049/jimmunol.1302801; Carlow DA, 2009, J IMMUNOL, V183, P1155, DOI 10.4049/jimmunol.0900409; Carpentier AC, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00447; Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964; Cho CH, 2007, CIRC RES, V100, pE47, DOI 10.1161/01.RES.0000259564.92792.93; Chouchani ET, 2019, CELL METAB, V29, P27, DOI 10.1016/j.cmet.2018.11.002; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Cipolletta D, 2014, IMMUNOLOGY, V142, P517, DOI 10.1111/imm.12262; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Coats BR, 2017, CELL REP, V20, P3149, DOI 10.1016/j.celrep.2017.08.096; Combs TP, 2005, J BIOL CHEM, V280, P24085, DOI 10.1074/jbc.M412802200; Cox AR, 2019, ENDOCRINOLOGY, V160, P1645, DOI 10.1210/en.2019-00266; Damouche A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005153; Dutton GR, 2016, OBESITY, V24, P1962, DOI 10.1002/oby.21573; Eisele E, 2012, IMMUNITY, V37, P377, DOI 10.1016/j.immuni.2012.08.010; Ekelund U, 2002, AM J CLIN NUTR, V76, P935, DOI 10.1093/ajcn/76.5.935; Exley MA, 2014, J ENDOCRINOL, V223, pR41, DOI 10.1530/JOE-13-0516; Fabbiano S, 2016, CELL METAB, V24, P434, DOI 10.1016/j.cmet.2016.07.023; Fakhimi M, 2020, CELL J, V22, P236, DOI 10.22074/cellj.2020.6313; Fazeli PK, 2020, MOL METAB, V42, DOI 10.1016/j.molmet.2020.101082; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Figueiro F, 2016, PURINERG SIGNAL, V12, P303, DOI 10.1007/s11302-016-9505-8; Fischer K, 2017, NAT MED, V23, P623, DOI 10.1038/nm.4316; Frasca D, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00392; Frasca D, 2020, GERONTOLOGY, V66, P114, DOI 10.1159/000502036; Frasca D, 2017, FRONT IMMUNOL, V8, DOI [10.3389/fimmu.2017.01745, 10.3389/fimmu.2017.01003]; Frasca D, 2016, OBESITY, V24, P615, DOI 10.1002/oby.21383; Ganeshan K, 2019, CELL, V177, P399, DOI 10.1016/j.cell.2019.01.050; GarciaZepeda EA, 1996, NAT MED, V2, P449, DOI 10.1038/nm0496-449; GeurtsvanKessel CH, 2009, J EXP MED, V206, P2339, DOI 10.1084/jem.20090410; Ghosh AR, 2016, DIABETES, V65, P3440, DOI 10.2337/db16-0331; Giordano A, 2016, NAT REV DRUG DISCOV, V15, P405, DOI 10.1038/nrd.2016.31; Gnad T, 2014, NATURE, V516, P395, DOI 10.1038/nature13816; Goldberg EL, 2020, NAT METAB, V2, P50, DOI 10.1038/s42255-019-0160-6; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; GREY NJ, 1975, DIABETES, V24, P10, DOI 10.2337/diabetes.24.1.10; GRIGGIO MA, 1992, J COMP PHYSIOL B, V162, P602, DOI 10.1007/BF00296640; Ha SA, 2006, J EXP MED, V203, P2541, DOI 10.1084/jem.20061041; Haley PJ, 2003, TOXICOLOGY, V188, P49, DOI 10.1016/S0300-483X(03)00043-X; Han SJ, 2017, IMMUNITY, V47, P1154, DOI 10.1016/j.immuni.2017.11.009; Harman-Boehm I, 2007, J CLIN ENDOCR METAB, V92, P2240, DOI 10.1210/jc.2006-1811; Herber DL, 2010, NAT MED, V16, P880, DOI 10.1038/nm.2172; Hirai S, 2014, AM J PHYSIOL-ENDOC M, V306, pE247, DOI 10.1152/ajpendo.00056.2013; Honce R, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01071; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hu B, 2020, NATURE, V578, P610, DOI 10.1038/s41586-020-2028-z; Hu Y, 2010, J IMMUNOL, V184, P4307, DOI 10.4049/jimmunol.0903614; Hubler MJ, 2015, TRENDS ENDOCRIN MET, V26, P101, DOI 10.1016/j.tem.2014.12.005; Huh JY, 2013, MOL CELL BIOL, V33, P328, DOI 10.1128/MCB.00552-12; Ibrahim J, 2012, GASTROENTEROLOGY, V143, P1061, DOI 10.1053/j.gastro.2012.06.003; Ivanov S, 2016, J CLIN INVEST, V126, P1581, DOI 10.1172/JCI84518; Jackson-Jones LH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12651; Jackson-Jones LH, 2020, IMMUNITY, V52, P700, DOI 10.1016/j.immuni.2020.03.011; Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054; Jones JR, 2005, P NATL ACAD SCI USA, V102, P6207, DOI 10.1073/pnas.0306743102; Jordan S, 2019, CELL, V178, P1102, DOI 10.1016/j.cell.2019.07.050; Kalin S, 2017, CELL METAB, V26, P475, DOI 10.1016/j.cmet.2017.08.008; Kane H, 2019, TRENDS IMMUNOL, V40, P857, DOI 10.1016/j.it.2019.07.006; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Knights AJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16758-9; Kohlgruber AC, 2018, NAT IMMUNOL, V19, P464, DOI 10.1038/s41590-018-0094-2; Kolodin D, 2015, CELL METAB, V21, P543, DOI 10.1016/j.cmet.2015.03.005; Komi DEA, 2020, CLIN REV ALLERG IMMU, V58, P388, DOI 10.1007/s12016-020-08785-7; Korf H., 2019, IMMUNOMETABOLISM, V2; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Kovacikova M, 2011, INT J OBESITY, V35, P91, DOI 10.1038/ijo.2010.112; Kratz M, 2014, CELL METAB, V20, P614, DOI 10.1016/j.cmet.2014.08.010; Kuan EL, 2015, J IMMUNOL, V194, P5200, DOI 10.4049/jimmunol.1500221; LaMarche NM, 2020, CELL METAB, V32, P243, DOI 10.1016/j.cmet.2020.05.017; LaMarche NM, 2018, J IMMUNOL, V201, P1827, DOI 10.4049/jimmunol.1800556; Laparra A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00117; Lee BC, 2016, CELL METAB, V23, P685, DOI 10.1016/j.cmet.2016.03.002; Lee EH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28371-4; Lee MJ, 2013, MOL ASPECTS MED, V34, P1, DOI 10.1016/j.mam.2012.10.001; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Lee YH, 2013, CELL METAB, V18, P355, DOI 10.1016/j.cmet.2013.08.003; Li ZY, 2014, CNS NEUROSCI THER, V20, P344, DOI 10.1111/cns.12219; LILIENFELD DE, 1988, AM J INFECT CONTROL, V16, P3; Lim HY, 2018, IMMUNITY, V49, P326, DOI [10.1016/j.immuni.2018.12.009, 10.1016/j.immuni.2018.06.008]; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Liu MY, 2021, J LEUKOCYTE BIOL, V109, P717, DOI 10.1002/JLB.5MIR0720-271RR; Loffler D, 2017, INT J OBESITY, V41, P112, DOI 10.1038/ijo.2016.180; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Lynch L, 2016, CELL METAB, V24, P510, DOI 10.1016/j.cmet.2016.08.003; Lynch L, 2015, NAT IMMUNOL, V16, P85, DOI 10.1038/ni.3047; Lynch L, 2014, IMMUNOLOGY, V142, P337, DOI 10.1111/imm.12269; Lynch L, 2012, IMMUNITY, V37, P574, DOI 10.1016/j.immuni.2012.06.016; Lynch L, 2009, EUR J IMMUNOL, V39, P1893, DOI 10.1002/eji.200939349; Macdougall CE, 2019, IMMUNOLOGY, V156, P228, DOI 10.1111/imm.13034; Macdougall CE, 2018, CELL METAB, V27, P588, DOI 10.1016/j.cmet.2018.02.007; Magalhaes I, 2015, J CLIN INVEST, V125, P1752, DOI 10.1172/JCI78941; Mahlakoiv T, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aax0416; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; McLaughlin T, 2014, ARTERIOSCL THROM VAS, V34, P2637, DOI 10.1161/ATVBAHA.114.304636; Medrikova D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118534; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Meza-Perez S, 2017, TRENDS IMMUNOL, V38, P526, DOI 10.1016/j.it.2017.03.002; Michelet X, 2018, NAT IMMUNOL, V19, P1330, DOI 10.1038/s41590-018-0251-7; Misumi I, 2019, CELL REP, V27, P514, DOI 10.1016/j.celrep.2019.03.030; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Mora JR, 2009, SEMIN IMMUNOL, V21, P28, DOI 10.1016/j.smim.2008.08.002; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Moysidou M, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.95456; Muller MJ, 2016, CURR OBES REP, V5, P413, DOI 10.1007/s13679-016-0237-4; Muller MJ, 2015, AM J CLIN NUTR, V102, P807, DOI 10.3945/ajcn.115.109173; Nagai M, 2019, CELL, V178, P1072, DOI 10.1016/j.cell.2019.07.047; Nagajyothi F, 2008, OBESITY, V16, P1992, DOI 10.1038/oby.2008.331; Nagajyothi F, 2012, CELL MICROBIOL, V14, P634, DOI 10.1111/j.1462-5822.2012.01764.x; Nagajyothi F, 2010, J INFECT DIS, V202, P1104, DOI 10.1086/656189; Nei M, 2001, P NATL ACAD SCI USA, V98, P2497, DOI 10.1073/pnas.051611498; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Oldenhove G, 2018, CELL REP, V25, P2053, DOI 10.1016/j.celrep.2018.10.091; Pamir N, 2015, J BIOL CHEM, V290, P14656, DOI 10.1074/jbc.M115.645820; Pandolfi JB, 2016, J IMMUNOL, V196, P3287, DOI 10.4049/jimmunol.1502506; Pang C, 2008, AM J PHYSIOL-ENDOC M, V295, pE313, DOI 10.1152/ajpendo.90296.2008; Park J, 2019, GENE DEV, V33, P1657, DOI 10.1101/gad.329557.119; Perez-Shibayama C, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar4539; Pirzgalska RM, 2017, NAT MED, V23, P1309, DOI 10.1038/nm.4422; Pond, 2005, ADIPOCYTES, V1, P43; POND CM, 1995, J LIPID RES, V36, P2219; Porsche CE, 2020, MOL CELL ENDOCRINOL, V505, DOI 10.1016/j.mce.2020.110740; Portis B, 1924, J INFECT DIS, V34, P159, DOI 10.1093/infdis/34.2.159; Priest C, 2019, NAT METAB, V1, P1177, DOI 10.1038/s42255-019-0145-5; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Rakhshandehroo M, 2014, J BIOL CHEM, V289, P22128, DOI 10.1074/jbc.M114.551242; Ralchshandehroo M, 2019, BBA-MOL CELL BIOL L, V1864, P1157, DOI 10.1016/j.bbalip.2019.04.016; Rangel-Moreno J, 2009, IMMUNITY, V30, P731, DOI 10.1016/j.immuni.2009.03.014; Ranvier, 1874, ARCH PHYS NORM PATHO, V6, P429; Rao RR, 2014, CELL, V157, P1279, DOI 10.1016/j.cell.2014.03.065; Reilly SM, 2017, NAT REV ENDOCRINOL, V13, P633, DOI 10.1038/nrendo.2017.90; Sanghvi A, 2015, AM J CLIN NUTR, V102, P353, DOI 10.3945/ajcn.115.111070; Saslow LR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091027; Schuler PJ, 2014, CLIN EXP IMMUNOL, V177, P531, DOI 10.1111/cei.12354; SEYDOUX J, 1982, ENDOCRINOLOGY, V110, P432, DOI 10.1210/endo-110-2-432; Shay T, 2013, P NATL ACAD SCI USA, V110, P2946, DOI 10.1073/pnas.1222738110; Shen L, 2015, DIABETES, V64, P593, DOI 10.2337/db14-0554; Sheridan PA, 2012, INT J OBESITY, V36, P1072, DOI 10.1038/ijo.2011.208; Shimobayashi M, 2018, J CLIN INVEST, V128, P1538, DOI 10.1172/JCI96139; SHIMOTSUMA M, 1993, LYMPHOLOGY, V26, P90; Silva HM, 2019, J EXP MED, V216, P786, DOI 10.1084/jem.20181049; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Spallanzani RG, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw3658; Speakman JR, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.167254; Srikakulapu P, 2020, ARTERIOSCL THROM VAS, V40, P1110, DOI 10.1161/ATVBAHA.119.312467; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Tanaka A, 2011, AM J PHYSIOL-CELL PH, V301, pC1360, DOI 10.1152/ajpcell.00514.2010; Tanowitz HB, 2017, TRENDS PARASITOL, V33, P276, DOI 10.1016/j.pt.2016.11.008; Tao LL, 2017, TRENDS IMMUNOL, V38, P181, DOI 10.1016/j.it.2016.12.007; Theurich S, 2017, CELL METAB, V26, P171, DOI 10.1016/j.cmet.2017.05.018; Thompson D, 2012, PHYSIOL REV, V92, P157, DOI 10.1152/physrev.00012.2011; Toubal A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17307-0; Travers RL, 2015, INT J OBESITY, V39, P762, DOI 10.1038/ijo.2014.195; Trim W, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00169; Trindade S, 2016, CELL HOST MICROBE, V19, P837, DOI 10.1016/j.chom.2016.05.002; v Recklinghausen F., 1863, ARCH PATHOLOGISCHE A, V28, P157; Valiathan R, 2016, SCAND J IMMUNOL, V83, P255, DOI 10.1111/sji.12413; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085; Villarroya F, 2018, CELL METAB, V27, P954, DOI 10.1016/j.cmet.2018.04.006; Villarroya J, 2019, J ENDOCRINOL, V243, pR19, DOI 10.1530/JOE-19-0295; Wang HW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10299-6; Watanabe S, 2017, CURR OPIN CELL BIOL, V47, P64, DOI 10.1016/j.ceb.2017.02.013; Watanabe Y, 2019, FASEB J, V33, P11821, DOI 10.1096/fj.201900477RR; Weinstock Ada, 2019, Immunometabolism, V1, DOI 10.20900/immunometab20190008; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; WERTHEIMER E, 1948, PHYSIOL REV, V28, P451, DOI 10.1152/physrev.1948.28.4.451; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wolf Y, 2017, NAT IMMUNOL, V18, P665, DOI 10.1038/ni.3746; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wu L, 2012, P NATL ACAD SCI USA, V109, pE1143, DOI 10.1073/pnas.1200498109; Xu XY, 2013, CELL METAB, V18, P816, DOI 10.1016/j.cmet.2013.11.001; Yabut JM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14080-7; Ye JP, 2010, AGING-US, V2, P361, DOI 10.18632/aging.100155; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Zhang X, 2019, CELL REP, V28, P792, DOI 10.1016/j.celrep.2019.06.044; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	206	10	10	5	17	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2022	22	6					371	386		10.1038/s41577-021-00635-7	http://dx.doi.org/10.1038/s41577-021-00635-7		NOV 2021	16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1S3GR	34741167				2022-12-18	WOS:000714886500005
J	Haynes, BF				Haynes, Barton F.			SARS-CoV-2 and HIV-1-a tale of two vaccines	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material								The rapid development of COVID-19 vaccines and their deployment in less than a year is a scientific and medical triumph that has raised a key question. Why do we have several SARS-CoV-2 vaccines but do not have a single HIV-1 vaccine?	[Haynes, Barton F.] Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC 27710 USA; [Haynes, Barton F.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Haynes, Barton F.] Duke Univ, Sch Med, Dept Immunol, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Haynes, BF (corresponding author), Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC 27710 USA.; Haynes, BF (corresponding author), Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA.; Haynes, BF (corresponding author), Duke Univ, Sch Med, Dept Immunol, Durham, NC 27710 USA.	barton.haynes@duke.edu			NIH, NIAID, Division of AIDS [AI44371]	NIH, NIAID, Division of AIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	B.F.H. is supported by the NIH, NIAID, Division of AIDS grant AI44371 Consortium for HIV/AIDS Vaccine Development. The author acknowledges K. Saunders for provision of images of HIV-1 immunogens in Fig. 1.	Corbett KS, 2020, NATURE, V586, P567, DOI 10.1038/s41586-020-2622-0; Haynes BF, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaz2686; Haynes BF, 2014, SCIENCE, V344, P588, DOI 10.1126/science.1254990; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; McMahan K, 2021, NATURE, V590, DOI 10.1038/s41586-020-03041-6; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Pardi N, 2020, CURR OPIN IMMUNOL, V65, P14, DOI 10.1016/j.coi.2020.01.008; Sempowski GD, 2020, CELL, V181, P1458, DOI 10.1016/j.cell.2020.05.041; Sette A, 2021, CELL, V184, P861, DOI 10.1016/j.cell.2021.01.007; Tomaras GD, 2017, IMMUNOL REV, V275, P245, DOI 10.1111/imr.12514	10	10	9	0	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2021	21	9					543	544		10.1038/s41577-021-00589-w	http://dx.doi.org/10.1038/s41577-021-00589-w		JUL 2021	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UI9ET	34272508	Bronze, Green Published			2022-12-18	WOS:000674078600001
J	Warimwe, GM; Francis, MJ; Bowden, TA; Thumbi, SM; Charleston, B				Warimwe, George M.; Francis, Michael J.; Bowden, Thomas A.; Thumbi, Samuel M.; Charleston, Bryan			Using cross-species vaccination approaches to counter emerging infectious diseases	NATURE REVIEWS IMMUNOLOGY			English	Article							ANIMAL HEALTH; GAMMA-DELTA; CRYSTAL-STRUCTURE; FOOD SECURITY; T-CELLS; ANTIBODIES; SMALLPOX; IMPACT; BCG; BRUCELLOSIS	Since the initial use of vaccination in the eighteenth century, our understanding of human and animal immunology has greatly advanced and a wide range of vaccine technologies and delivery systems have been developed. The COVID-19 pandemic response leveraged these innovations to enable rapid development of candidate vaccines within weeks of the viral genetic sequence being made available. The development of vaccines to tackle emerging infectious diseases is a priority for the World Health Organization and other global entities. More than 70% of emerging infectious diseases are acquired from animals, with some causing illness and death in both humans and the respective animal host. Yet the study of critical host-pathogen interactions and the underlying immune mechanisms to inform the development of vaccines for their control is traditionally done in medical and veterinary immunology 'silos'. In this Perspective, we highlight a 'One Health vaccinology' approach and discuss some key areas of synergy in human and veterinary vaccinology that could be exploited to accelerate the development of effective vaccines against these shared health threats.	[Warimwe, George M.] Univ Oxford, Ctr Trop Med & Global Hlth, Oxford, England; [Warimwe, George M.] KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [Warimwe, George M.; Charleston, Bryan] Pirbright Inst, Woking, Surrey, England; [Francis, Michael J.] BioVacc Consulting Ltd, Amersham, England; [Bowden, Thomas A.] Univ Oxford, Wellcome Ctr Human Genet, Div Struct Biol, Oxford, England; [Thumbi, Samuel M.] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland; [Thumbi, Samuel M.] Univ Nairobi, Ctr Epidemiol Modelling & Anal, Inst Trop & Infect Dis, Nairobi, Kenya; [Thumbi, Samuel M.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA	University of Oxford; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Oxford; Wellcome Centre for Human Genetics; University of Edinburgh; University of Nairobi; Washington State University	Warimwe, GM (corresponding author), Univ Oxford, Ctr Trop Med & Global Hlth, Oxford, England.; Warimwe, GM (corresponding author), KEMRI Wellcome Trust Res Programme, Kilifi, Kenya.; Warimwe, GM (corresponding author), Pirbright Inst, Woking, Surrey, England.	george.warimwe@ndm.ox.ac.uk		Warimwe, George/0000-0002-4911-6333	Oak Foundation; Wellcome Trust [220991/Z/20/Z, 203077/Z/16/Z]; UK Medical Research Council [MR/S007555/1]; Wellcome Trust through the Wellcome Centre for Human Genetics [203141/Z/16/Z]; Wellcome Trust	Oak Foundation; Wellcome Trust(Wellcome Trust); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust through the Wellcome Centre for Human Genetics; Wellcome Trust(Wellcome Trust)	The authors are grateful to P. Bejon and M. Hamaluba for helpful discussions and comments on the manuscript. G.M.W. is supported by a fellowship from the Oak Foundation and grants from the Wellcome Trust (220991/Z/20/Z and 203077/Z/16/Z). T.A. B. is supported by the UK Medical Research Council (MR/S007555/1) and by the Wellcome Trust through the Wellcome Centre for Human Genetics (203141/Z/16/Z). As the authors are supported by the Wellcome Trust, for the purpose of open access, the authors have applied a CC-BY public copyright licence to any author accepted manuscript version arising from this submission.	Abdrakhmanov SK, 2018, TRANSBOUND EMERG DIS, V65, P1235, DOI 10.1111/tbed.12864; Abela-Ridder B, 2016, LANCET GLOB HEALTH, V4, pE780, DOI 10.1016/S2214-109X(16)30245-5; Alluwaimi AM, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.582287; Barrett ADT, 2016, NEW ENGL J MED, V375, P301, DOI 10.1056/NEJMp1606997; Bean AGD, 2013, NAT REV IMMUNOL, V13, P851, DOI 10.1038/nri3551; Berche P, 2012, CLIN MICROBIOL INFEC, V18, P1, DOI 10.1111/j.1469-0691.2012.03945.x; Bessell PR, 2017, PREV VET MED, V147, P108, DOI 10.1016/j.prevetmed.2017.08.022; Bhuju S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003077; Brende B, 2017, LANCET, V389, P233, DOI 10.1016/S0140-6736(17)30131-9; Brodin P, 2017, NAT REV IMMUNOL, V17, P21, DOI 10.1038/nri.2016.125; Bundle DR, 2017, ACCOUNTS CHEM RES, V50, P2958, DOI 10.1021/acs.accounts.7b00445; Clenet ML, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11926-2; Crank MC, 2019, SCIENCE, V365, P505, DOI 10.1126/science.aav9033; De Groot AS, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00442; Duffy PE, 2020, NPJ VACCINES, V5, DOI 10.1038/s41541-020-0196-3; Esparza J, 2020, VACCINE, V38, P4773, DOI 10.1016/j.vaccine.2020.05.037; FENNER F, 1993, HIST PHIL LIFE SCI, V15, P397; Francis MJ, 2020, BIOLOGIST, V67, P18; GALVmed, 2016, POL SCOP STUD HARM R; Gauger PC, 2014, VIROLOGY, V471, P93, DOI 10.1016/j.virol.2014.10.003; Graham BS, 2020, SCIENCE, V368, P945, DOI 10.1126/science.abb8923; Greenwood B, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0433; GROH V, 1989, J EXP MED, V169, P1277, DOI 10.1084/jem.169.4.1277; Gsell PS, 2017, LANCET INFECT DIS, V17, P1276, DOI 10.1016/S1473-3099(17)30541-8; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hamilton CA, 2016, VET RES, V47, DOI 10.1186/s13567-016-0367-4; Hampson K, 2019, LANCET INFECT DIS, V19, P102, DOI 10.1016/S1473-3099(18)30512-7; Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI [10.1371/journal.pntd.0003709, 10.1371/journal.pntd.0003786]; Hassan A, 2020, AM J TROP MED HYG, V103, P1649, DOI 10.4269/ajtmh.20-0387; Haydon DT, 2002, EMERG INFECT DIS, V8, P1468; Henderson DA, 2011, VACCINE, V29, pD7, DOI 10.1016/j.vaccine.2011.06.080; Holzer B, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02625; Holzer B, 2018, J IMMUNOL, V200, P4068, DOI 10.4049/jimmunol.1800142; Hsieh Ching-Lin, 2020, Science, V369, P1501, DOI [10.1101/2020.05.30.125484, 10.1126/science.abd0826]; Knueppel D, 2010, FOOD NUTR BULL, V31, P436, DOI 10.1177/156482651003100306; Koch K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08273-7; Luca Simona, 2013, Maedica (Bucur), V8, P53; Lyons NA, 2019, PREV VET MED, V163, P37, DOI 10.1016/j.prevetmed.2018.12.007; Mackay C R, 1989, Int Immunol, V1, P540, DOI 10.1093/intimm/1.5.540; Mariner JC, 2012, SCIENCE, V337, P1309, DOI 10.1126/science.1223805; Marsh TL, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601410; Matsumiya M, 2015, J INFECT DIS, V211, P1499, DOI 10.1093/infdis/jiu615; Mbabu M, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.106.4588; McElwain TF, 2017, REV SCI TECH OIE, V36, P423, DOI 10.20506/rst.36.2.2663; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Mehand MS, 2018, ANTIVIR RES, V159, P63, DOI 10.1016/j.antiviral.2018.09.009; Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5; Muyldermans S, 2016, CURR OPIN IMMUNOL, V40, P7, DOI 10.1016/j.coi.2016.02.003; Mwangi W, 2020, IMMUNOLOGY, V161, P25, DOI 10.1111/imm.13227; Ndomondo-Sigonda M, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10169-1; Overgaard NH, 2015, J LEUKOCYTE BIOL, V97, P31, DOI 10.1189/jlb.1RU0814-382; Pejchal R, 2010, P NATL ACAD SCI USA, V107, P11483, DOI 10.1073/pnas.1004600107; Perez O, 1997, J IND MICROBIOL BIOT, V18, P340, DOI 10.1038/sj.jim.2900391; PESCOVITZ MD, 1994, VET IMMUNOL IMMUNOP, V43, P53, DOI 10.1016/0165-2427(94)90120-1; Plotkin SA, 2015, NEW ENGL J MED, V373, P297, DOI 10.1056/NEJMp1506820; Pollard AJ, 2012, LANCET INFECT DIS, V12, P903, DOI 10.1016/S1473-3099(12)70292-X; Porta C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003255; Prentice S, 2021, LANCET INFECT DIS, V21, P993, DOI 10.1016/S1473-3099(20)30653-8; Rogers AN, 2005, J IMMUNOL, V174, P3386, DOI 10.4049/jimmunol.174.6.3386; Ronacher K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02209; Roth F, 2003, B WORLD HEALTH ORGAN, V81, P867; Roth JA, 2011, PROCEDIA VACCINOL, V5, P127, DOI 10.1016/j.provac.2011.10.009; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Settembre EC, 2014, HUM VACC IMMUNOTHER, V10, P600, DOI 10.4161/hv.27600; Sok D, 2017, NATURE, V548, P108, DOI 10.1038/nature23301; Stanfield R, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba0468; Stanfield RL, 2018, ADV IMMUNOL, V137, P135, DOI 10.1016/bs.ai.2017.12.004; Takamatsu HH, 2006, VET IMMUNOL IMMUNOP, V112, P49, DOI 10.1016/j.vetimm.2006.03.011; Tanner R, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01317; Taylor G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5757; Taylor G, 2013, CURR TOP MICROBIOL, V372, P327, DOI 10.1007/978-3-642-38919-1_16; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Tizard IR, 2020, VACCINE, V38, P5123, DOI 10.1016/j.vaccine.2020.06.026; Tungatt K, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007017; UK Vaccine R&D Network, 2020, VACC DEV PROC MAP; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Walsh EE, 2020, NEW ENGL J MED, V383, P2439, DOI 10.1056/NEJMoa2027906; Wang F, 2013, CELL, V153, P1379, DOI 10.1016/j.cell.2013.04.049; Warimwe GM, 2016, SCI REP-UK, V6, DOI 10.1038/srep20617; Waters WR, 2012, VACCINE, V30, P2611, DOI 10.1016/j.vaccine.2012.02.018; Whitehouse CA, 2004, ANTIVIR RES, V64, P145, DOI 10.1016/j.antiviral.2004.08.001; WHO European Region Member States, 2013, REV VACC PRIC DAT; Wouters OJ, 2021, LANCET, V397, P1023, DOI 10.1016/S0140-6736(21)00306-8; Yang H, 1997, IMMUNOLOGY, V92, P45, DOI 10.1046/j.1365-2567.1997.00308.x; Zhang BS, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0005-9; Zhu S, 2019, ECOHEALTH, V16, P356, DOI 10.1007/s10393-019-01413-7; Zhu XY, 2004, J MOL BIOL, V343, P1269, DOI 10.1016/j.jmb.2004.08.102; Zinsstag J, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf6984; Zuckermann FA, 1996, IMMUNOLOGY, V87, P500, DOI 10.1046/j.1365-2567.1996.494570.x; Zuckermann FA, 1996, IMMUNOLOGY, V87, P493, DOI 10.1046/j.1365-2567.1996.494570.x; Zufferey Christel, 2013, PLoS One, V8, pe77334, DOI 10.1371/journal.pone.0077334	91	10	10	0	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2021	21	12					814	821		10.1038/s41577-021-00567-2	http://dx.doi.org/10.1038/s41577-021-00567-2		JUN 2021	8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XD3NF	34140665	hybrid, Green Published, Green Accepted			2022-12-18	WOS:000662805300001
J	Osier, F; Ting, JPY; Fraser, J; Lambrecht, BN; Romano, M; Gazzinelli, RT; Bortoluci, KR; Zamboni, DS; Akbar, AN; Evans, J; Brown, DE; Patel, KD; Wu, YZ; Perez, AB; Perez, O; Kamradt, T; Falk, C; Barda-Saad, M; Ariel, A; Santoni, A; Annunziato, F; Cassatella, MA; Kiyono, H; Chereshnev, V; Dieye, A; Mbow, M; Mbengue, B; Niang, MDS; Suchard, M				Osier, Faith; Ting, Jenny P. Y.; Fraser, John; Lambrecht, Bart N.; Romano, Marta; Gazzinelli, Ricardo T.; Bortoluci, Karina R.; Zamboni, Dario S.; Akbar, Arne N.; Evans, Jennie; Brown, Doug E.; Patel, Kamala D.; Wu, Yuzhang; Perez, Ana B.; Perez, Oliver; Kamradt, Thomas; Falk, Christine; Barda-Saad, Mira; Ariel, Amiram; Santoni, Angela; Annunziato, Francesco; Cassatella, Marco A.; Kiyono, Hiroshi; Chereshnev, Valeriy; Dieye, Alioune; Mbow, Moustapha; Mbengue, Babacar; Niang, Maguette D. S.; Suchard, Melinda			The global response to the COVID-19 pandemic: how have immunology societies contributed?	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material								The COVID-19 pandemic is shining a spotlight on the field of immunology like never before. To appreciate the diverse ways in which immunologists have contributed,Nature Reviews Immunologyinvited the president of the International Union of Immunological Societies and the presidents of 15 other national immunology societies to discuss how they and their members responded following the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). For this Viewpoint,Nature Reviews Immunologyasked the presidents of 16 immunology societies from around the world to discuss how their society and its members responded to the COVID-19 pandemic. Their answers highlight the incredible contributions that immunologists around the globe have made following the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).	[Osier, Faith] KEMRI Wellcome, Biosci Dept, Kilifi, Kenya; [Osier, Faith] Heidelberg Univ Hosp, Parasitol Dept, Heidelberg, Germany; [Ting, Jenny P. Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Genet, Chapel Hill, NC 27515 USA; [Fraser, John] Univ Auckland, Fac Med & Hlth Sci, Auckland, New Zealand; [Lambrecht, Bart N.] VIB UGent, Ctr Inflammat Res, Ghent, Belgium; [Romano, Marta] Sciensano, Brussels, Belgium; [Gazzinelli, Ricardo T.] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil; [Bortoluci, Karina R.] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Zamboni, Dario S.] Univ Sao Paulo, Fac Med Ribeirao Preto, Sao Paulo, Brazil; [Akbar, Arne N.] UCL, Div Infect & Immun, London, England; [Evans, Jennie; Brown, Doug E.] British Soc Immunol, London, England; [Patel, Kamala D.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Patel, Kamala D.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Wu, Yuzhang] Army Med Univ, Inst Immunol, Chongqing, Peoples R China; [Perez, Ana B.] Pedro Kouri Inst, Havana, Cuba; [Perez, Oliver] Univ Ciencias Med Habana, Inst Ciencias Basicas & Preclin Victoria de Giron, Havana, Cuba; [Kamradt, Thomas] Inst Immunol, Jena, Germany; [Falk, Christine] Hannover Med Sch, DZIF, Hannover, Germany; [Barda-Saad, Mira] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Lab Mol & Appl Immunol, Ramat Gan, Israel; [Ariel, Amiram] Univ Haifa, Dept Human Biol, Fac Nat Sci, Haifa, Israel; [Santoni, Angela] Sapienza Univ Rome, Dept Mol Med, Rome, Italy; [Santoni, Angela] Cenci Bolognetti Fdn, Inst Pasteur Italia, Rome, Italy; [Annunziato, Francesco] Univ Florence, Sch Med, Florence, Italy; [Annunziato, Francesco] Careggi Univ Hosp, Flow Cytometry Diagnost Core, Florence, Italy; [Cassatella, Marco A.] Univ Verona, Verona, Italy; [Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Div Mucosal Immunol, Tokyo, Japan; [Kiyono, Hiroshi] Chiba Univ, Grad Sch Med, Inst Global Prominent Res, Chiba, Japan; [Kiyono, Hiroshi] Univ Calif San Diego, Sch Med, Dept Med, Ctr Mucosal Immunol Allergy & Vaccines,Div Gastro, San Diego, CA 92103 USA; [Chereshnev, Valeriy] Russian Acad Sci, Ural Branch, Inst Immunol & Physiol, Ekaterinburg, Russia; [Dieye, Alioune; Mbow, Moustapha; Mbengue, Babacar; Niang, Maguette D. S.] Cheikh Anta Diop Univ Dakar, Dept Immunol, Fac Med Pharm & Odontol, Dakar, Senegal; [Suchard, Melinda] Natl Inst Communicable Dis, Johannesburg, South Africa; [Suchard, Melinda] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa	Ruprecht Karls University Heidelberg; University of North Carolina; University of North Carolina Chapel Hill; University of Auckland; Flanders Institute for Biotechnology (VIB); Ghent University; Sciensano; Fundacao Oswaldo Cruz; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; University of London; University College London; University of Calgary; University of Calgary; Army Medical University; German Center for Infection Research; Hannover Medical School; Bar Ilan University; University of Haifa; Sapienza University Rome; Fondazione Cenci Bolognetti; University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Verona; University of Tokyo; Chiba University; University of California System; University of California San Diego; Institute of Immunology & Physiology UB RAS; Russian Academy of Sciences; University Cheikh Anta Diop Dakar; National Institute for Communicable Diseases (NICD); University of Witwatersrand	Osier, F (corresponding author), KEMRI Wellcome, Biosci Dept, Kilifi, Kenya.; Osier, F (corresponding author), Heidelberg Univ Hosp, Parasitol Dept, Heidelberg, Germany.; Ting, JPY (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Genet, Chapel Hill, NC 27515 USA.; Fraser, J (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Auckland, New Zealand.; Lambrecht, BN (corresponding author), VIB UGent, Ctr Inflammat Res, Ghent, Belgium.; Gazzinelli, RT (corresponding author), Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.; Akbar, AN (corresponding author), UCL, Div Infect & Immun, London, England.; Patel, KD (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada.; Patel, KD (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada.; Wu, YZ (corresponding author), Army Med Univ, Inst Immunol, Chongqing, Peoples R China.; Perez, AB (corresponding author), Pedro Kouri Inst, Havana, Cuba.; Kamradt, T (corresponding author), Inst Immunol, Jena, Germany.; Barda-Saad, M (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Lab Mol & Appl Immunol, Ramat Gan, Israel.; Santoni, A (corresponding author), Sapienza Univ Rome, Dept Mol Med, Rome, Italy.; Santoni, A (corresponding author), Cenci Bolognetti Fdn, Inst Pasteur Italia, Rome, Italy.; Kiyono, H (corresponding author), Univ Tokyo, Inst Med Sci, Div Mucosal Immunol, Tokyo, Japan.; Kiyono, H (corresponding author), Chiba Univ, Grad Sch Med, Inst Global Prominent Res, Chiba, Japan.; Kiyono, H (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, Ctr Mucosal Immunol Allergy & Vaccines,Div Gastro, San Diego, CA 92103 USA.; Chereshnev, V (corresponding author), Russian Acad Sci, Ural Branch, Inst Immunol & Physiol, Ekaterinburg, Russia.; Dieye, A (corresponding author), Cheikh Anta Diop Univ Dakar, Dept Immunol, Fac Med Pharm & Odontol, Dakar, Senegal.; Suchard, M (corresponding author), Natl Inst Communicable Dis, Johannesburg, South Africa.; Suchard, M (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa.	fosier@kemri-wellcome.org; jenny_ting@med.unc.edu; j.fraser@auckland.ac.nz; bart.lambrecht@ugent.be; ricardo.gazzinelli@fiocruz.br; a.akbar@ucl.ac.uk; kpatel@ucalgary.ca; wuyuzhang@tmmu.edu.cn; anab@ipk.sld.cu; thomas.kamradt@med.uni-jena.de; mira.barda-saad@biu.ac.il; angela.santoni@uniroma1.it; kiyono@ims.u-tokyo.ac.jp; mchereshneva@mail.ru; alioune.dieye@ucad.edu.sn; melindas@nicd.ac.za	Bortoluci, Karina/P-9296-2019; Chereshnev, Valeriy/P-7704-2017; Bortoluci, Karina R/C-6018-2012; Patel, Kamala D/AAX-1245-2021; Kiyono, Hiroshi/AAC-6735-2022; Zamboni, Dario S/D-3024-2012; Cassatella, M A/B-8037-2013; Pérez, Ana/GQA-6861-2022; Lambrecht, Bart N/K-2484-2014; ROMANO, Marta/ABD-9517-2021; Falk, Christine/Q-4143-2016	Bortoluci, Karina/0000-0001-6780-5397; Chereshnev, Valeriy/0000-0003-4329-147X; Bortoluci, Karina R/0000-0001-6780-5397; Zamboni, Dario S/0000-0002-7856-7512; Cassatella, M A/0000-0001-7824-1806; Lambrecht, Bart N/0000-0003-4376-6834; ROMANO, Marta/0000-0001-8996-7899; Suchard, Melinda Shelley/0000-0002-6978-4654; Ting, Jenny/0000-0002-7846-0395; Akbar, Arne/0000-0002-3763-9380; Reis, AlessanRSS/0000-0001-8486-7469; Wu, Yuzhang/0000-0002-4049-0214; Falk, Christine/0000-0003-1376-7318	Senegalese Ministry of Health and Social Action; Ministry of High Education, Research and Innovation; Lorna and Yuti Chernajovsky Biomedical Research Foundation; 10x Genomics; Fluidigm; Miltenyi Biotec; NanoString	Senegalese Ministry of Health and Social Action; Ministry of High Education, Research and Innovation; Lorna and Yuti Chernajovsky Biomedical Research Foundation; 10x Genomics; Fluidigm; Miltenyi Biotec; NanoString	F.O. acknowledges the members of the International Union of Immunological Societies (IUIS) Executive Committee and particularly the Secretary General for their contributions. She thanks the members of the publication committee led by R. Carsetti for their efforts and leadership in supporting the IUIS/Frontiers scientific webinars. She also thanks Frontiers for its continued partnership with the IUIS, which has been instrumental to the success of the webinars. A.D., M.M., B.M. and M.D.S.N. thank the Senegalese Ministry of Health and Social Action and Ministry of High Education, Research and Innovation for their support. The British Society for Immunology (BSI) coronavirus work is supported by the Lorna and Yuti Chernajovsky Biomedical Research Foundation, with additional support from the following BSI Gold Corporate Members: 10x Genomics, Fluidigm, Miltenyi Biotec and NanoString. H.K. acknowledges the great contribution of the Japanese Society for Immunology (JSI) executive board members K. Takeda (Osaka University), K. Hase (Keio University), O. Takeuchi (Kyoto University) and A. Takaoka (Hokkaido University) for supporting JSI's emphasis on solidarity for scientists, and extends sincere appreciation to them on behalf of all JSI members. M.S. thanks the following members of the South African Immunology Society Executive Committee for their input: E. Mayne (University of the Witwatersrand and National Health Laboratory Service), C. Gray (University of Cape Town and National Health Laboratory Service), K. Kgoadi (University of Cape Town), S. Buldeo (Neuberg Global Laboratory), C. Worsley (University of the Witwatersrand), H. Ranchod (National Institute for Communicable Diseases), J. Peter (University of Cape Town), T. Scriba (University of Cape Town) and R. Glashoff (Stellenbosch University). Nature Reviews Immunology apologizes to all of the regional and national immunology societies that we were not able to feature in this article for reasons of space restrictions. We encourage all of our readers to join and support the work of their relevant immunology societies. Finally, we thank all immunologists and immunology societies for their monumental contributions to tackling the COVID-19 pandemic.	Accademia Nazionale dei Lincei, 2020, COVID19 EX REP; [Anonymous], 2020, J IMMUNOL; Bao LN, 2020, NATURE, V583, P830, DOI 10.1038/s41586-020-2312-y; Bosteels C, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04451-7; British Society for Immunology, 2020, COR INF HUB BSI WEBS; British Society for Immunology, 2020, INF JOINT AC MED SCI; British Society for Immunology, 2020, JOINT AC MED SCI BRI; British Society for Immunology, 2020, BSI CONN COR WEB SER; Brugger SD, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005633; Cai XF, 2020, J INFECT DIS, V222, P189, DOI 10.1093/infdis/jiaa243; Canadian Society for Immunology, 2020, CSI COUNC STAT SYST; Cao YL, 2020, CELL, V182, P73, DOI 10.1016/j.cell.2020.05.025; Castellanos-Serra L, 2020, MEDICC REV, V22, P31, DOI 10.37757/MR2020.V22.N2.9; Chen XY, 2020, CELL MOL IMMUNOL, V17, P647, DOI 10.1038/s41423-020-0426-7; Diao B., 2020, HUMAN KIDNEY IS TARG, DOI 10.1101/2020.03.04.20031120; Diao B., 2020, DIAGNOSIS ACUTE RESP, DOI 10.1101/2020.03.07.20032524; Diao B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00827; Diaz-Canel Bermudez M., 2020, AN ACAD CIENC CUBA; Dominguez Horta M.d.C., 2020, CIGB 258 IMMUNOMODUL, DOI [10.1101/2020.05.27.20110601, DOI 10.1101/2020.05.27.20110601]; Gao Q, 2020, SCIENCE, V369, P77, DOI 10.1126/science.abc1932; Gavi, 2020, GAVI COVAX AMC; International Union of Immunological Societies, 2020, IUIS FRONT WEB SER C; Japanese Agency for Medical Research and Development, 2020, AMED NEW SCI OUTP RE; Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6; Maes B, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04453-5; Pereda R, 2020, J INTERF CYTOK RES, V40, P438, DOI 10.1089/jir.2020.0124; Qian GQ, 2020, INFECT DIS-NOR, V52, P511, DOI 10.1080/23744235.2020.1748705; Saavedra D, 2020, IMMUN AGEING, V17, DOI 10.1186/s12979-020-00207-8; Sun J, 2020, CELL, V182, P734, DOI 10.1016/j.cell.2020.06.010; The American Association of Immunologists, 2020, POST ABSTR IMMUNOLOG; The American Association of Immunologists, 2020, AAI COURS IMM; The American Association of Immunologists, 2020, AAI FELL; The American Association of Immunologists, 2020, COVID 19 RES INF CTR; The American Association of Immunologists, 2020, AM ASS IMM PUBL AFF; The Australian and New Zealand Society for Immunology, 2020, ASI FIR CHATS; The Australian and New Zealand Society for Immunology, 2020, ASI COMM; Wu Y, 2020, SCIENCE, V368, P1274, DOI 10.1126/science.abc2241; Xu XL, 2020, P NATL ACAD SCI USA, V117, P10970, DOI 10.1073/pnas.2005615117; Zhou YG, 2020, NATL SCI REV, V7, P998, DOI 10.1093/nsr/nwaa041; Zhu FC, 2020, LANCET, V395, P1845, DOI 10.1016/S0140-6736(20)31208-3	40	10	13	3	17	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2020	20	10					594	602		10.1038/s41577-020-00428-4	http://dx.doi.org/10.1038/s41577-020-00428-4		SEP 2020	9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NS7PF	32913283	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000568158700001
J	Hegde, S				Hegde, Samarth			Does asthma make COVID-19 worse?	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material; Early Access									[Hegde, Samarth] Icahn Sch Med Mt Sinai, Sinai Immunol Review Project, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Hegde, S (corresponding author), Icahn Sch Med Mt Sinai, Sinai Immunol Review Project, New York, NY 10029 USA.	sinai.immunology@gmail.com			NCI NIH HHS [K00 CA223043] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Sajuthi Satria P, 2020, bioRxiv, DOI 10.1101/2020.04.09.034454	1	10	10	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.												10.1038/s41577-020-0324-3	http://dx.doi.org/10.1038/s41577-020-0324-3		APR 2020	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LI4WM	32346090	Bronze, Green Published			2022-12-18	WOS:000529487700002
J	Bordon, Y				Bordon, Yvonne			TOX for tired T cells	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material														Bordon, Yvonne/0000-0002-9728-012X				Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Seo H, 2019, P NATL ACAD SCI USA, V116, P12410, DOI 10.1073/pnas.1905675116; Wang XC, 2019, J HEPATOL, V71, P731, DOI 10.1016/j.jhep.2019.05.015; Yao C, 2019, NAT IMMUNOL, V20, P890, DOI 10.1038/s41590-019-0403-4	6	10	10	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2019	19	8					476	476		10.1038/s41577-019-0193-9	http://dx.doi.org/10.1038/s41577-019-0193-9			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IN4WJ	31243349	Bronze			2022-12-18	WOS:000478677500005
J	Flemming, A				Flemming, Alexandra			The enigma of circular RNA	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material																		Liu CX, 2019, CELL, V177, P865, DOI 10.1016/j.cell.2019.03.046	1	10	11	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2019	19	6					351	351		10.1038/s41577-019-0173-0	http://dx.doi.org/10.1038/s41577-019-0173-0			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IA3GU	31053750	Bronze			2022-12-18	WOS:000469452300004
J	Bordon, Y				Bordon, Yvonne			Itaconate charges down inflammation	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material														Bordon, Yvonne/0000-0002-9728-012X					0	10	10	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2018	18	6					360	361		10.1038/s41577-018-0016-4	http://dx.doi.org/10.1038/s41577-018-0016-4			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GH2OH	29725119				2022-12-18	WOS:000433240700007
J	Minton, K				Minton, Kirsty			IMMUNE REGULATION IL-10 targets macrophage metabolism	NATURE REVIEWS IMMUNOLOGY			English	News Item														Minton, Kirsty/0000-0002-3857-8030					0	10	12	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2017	17	6								10.1038/nri.2017.57	http://dx.doi.org/10.1038/nri.2017.57			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EV8VO	28548135	Bronze			2022-12-18	WOS:000402062500002
J	Kugelberg, E				Kugelberg, Elisabeth			IL-17A mediates a path to autism	NATURE REVIEWS IMMUNOLOGY			English	News Item														Kugelberg, Elisabeth/0000-0002-8302-3595					0	10	11	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2016	16	4					205	205		10.1038/nri.2016.35	http://dx.doi.org/10.1038/nri.2016.35			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH7MD	26972722	Bronze			2022-12-18	WOS:000372977200004
J	Minton, K				Minton, Kirsty			GRANULOCYTES Eosinophils enable the antitumour T cell response	NATURE REVIEWS IMMUNOLOGY			English	News Item														Minton, Kirsty/0000-0002-3857-8030					0	10	10	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2015	15	6								10.1038/nri3861	http://dx.doi.org/10.1038/nri3861			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CJ0YB	25976512	Bronze			2022-12-18	WOS:000355205600004
J	Schwab, I; Lux, A; Nimmerjahn, F				Schwab, Inessa; Lux, Anja; Nimmerjahn, Falk			Reply to - IVIG pluripotency and the concept of Fc-sialylation: challenges to the scientist	NATURE REVIEWS IMMUNOLOGY			English	Letter							INTRAVENOUS IMMUNOGLOBULIN THERAPY; IMMUNE THROMBOCYTOPENIC PURPURA; RECEPTOR; EXPRESSION; ANTIBODY; CELLS		[Schwab, Inessa; Lux, Anja; Nimmerjahn, Falk] Univ Erlangen Nurnberg, Dept Biol, Inst Genet, D-91058 Erlangen, Germany	University of Erlangen Nuremberg	Nimmerjahn, F (corresponding author), Univ Erlangen Nurnberg, Dept Biol, Inst Genet, Staudtstr 5, D-91058 Erlangen, Germany.	falk.nimmerjahn@fau.de		Nimmerjahn, Falk/0000-0002-5418-316X; Lux, Anja/0000-0001-9475-2147				Abe J, 2005, J IMMUNOL, V174, P5837, DOI 10.4049/jimmunol.174.9.5837; Bayry J, 2011, NAT REV RHEUMATOL, V7, P349, DOI 10.1038/nrrheum.2011.61; Bazin R, 2006, BRIT J HAEMATOL, V135, P97, DOI 10.1111/j.1365-2141.2006.06245.x; Blank M, 2005, CLIN REV ALLERG IMMU, V29, P213, DOI 10.1385/CRIAI:29:3:213; CLARKSON SB, 1986, NEW ENGL J MED, V314, P1236, DOI 10.1056/NEJM198605083141907; DEBRE M, 1993, LANCET, V342, P945, DOI 10.1016/0140-6736(93)92000-J; Guhr T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021246; Kasermann F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037243; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Leontyev D, 2012, TRANSFUSION, V52, P1799, DOI 10.1111/j.1537-2995.2011.03517.x; Massoud AH, 2014, J ALLERGY CLIN IMMUN, V133, P853, DOI 10.1016/j.jaci.2013.09.029; Schwab I, 2014, EUR J IMMUNOL; Schwab I, 2013, NAT REV IMMUNOL, V13, P176, DOI 10.1038/nri3401; Tackenberg B, 2009, P NATL ACAD SCI USA, V106, P4788, DOI 10.1073/pnas.0807319106; von Gunten S, 2008, AUTOIMMUN REV, V7, P453, DOI 10.1016/j.autrev.2008.03.015; von Gunten S, 2014, NAT REV IMMUNOL, V14, P349, DOI 10.1038/nri3401-c1; 2013, NATURE REV IMMUNOL, V13, P176	17	10	10	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2014	14	5								10.1038/nri3401-c2	http://dx.doi.org/10.1038/nri3401-c2			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AF8ZB	24762828	Bronze			2022-12-18	WOS:000335003400016
J	Papatriantafyllou, M				Papatriantafyllou, Maria			The interferon paradox	NATURE REVIEWS IMMUNOLOGY			English	News Item													Papatriantafyllou, Maria/ADP-1463-2022						0	10	10	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2013	13	6					392	392		10.1038/nri3461	http://dx.doi.org/10.1038/nri3461			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	151FE	23648970				2022-12-18	WOS:000319445300002
J	Papatriantafyllou, M				Papatriantafyllou, Maria			T CELLS Neuropilin 1-distinguishing T-Reg cell subsets	NATURE REVIEWS IMMUNOLOGY			English	News Item													Papatriantafyllou, Maria/ADP-1463-2022					Hsieh CS, 2012, NAT REV IMMUNOL, V12, P157, DOI 10.1038/nri3155; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822	3	10	10	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2012	12	11								10.1038/nri3323	http://dx.doi.org/10.1038/nri3323			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	029UZ	23018290				2022-12-18	WOS:000310523400008
J	Cunha, A				Cunha, Andreia			INNATE IMMUNITY Pathogen and xenobiotic sensing - back to basics	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Melo JA, 2012, CELL, V149, P452, DOI 10.1016/j.cell.2012.02.050	1	10	10	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2012	12	6								10.1038/nri3237	http://dx.doi.org/10.1038/nri3237			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	947TJ	22627855				2022-12-18	WOS:000304453400007
J	Leavy, O				Leavy, Olive			IMMUNOTHERAPY Stopping monocytes in their tracks	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Leuschner F, 2011, NAT BIOTECHNOL, V29, P1005, DOI 10.1038/nbt.1989; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070	2	10	10	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2011	11	11					715	715		10.1038/nri3096	http://dx.doi.org/10.1038/nri3096			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	842GW	22025043	Bronze			2022-12-18	WOS:000296584700002
J	Bell, E				Bell, Elaine			INNATE IMMUNITY Endothelial cells as sentinels	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Andonegui G, 2009, J CLIN INVEST, V119, P1921, DOI 10.1172/JCI36411; Hickey MJ, 2009, NAT REV IMMUNOL, V9, P364, DOI 10.1038/nri2532	2	10	11	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2009	9	8					532	532		10.1038/nri2608	http://dx.doi.org/10.1038/nri2608			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	483KF					2022-12-18	WOS:000268962900006
J	Bayry, J; Lacroix-Desmazes, S; Dasgupta, S; Kazatchkine, MD; Kaveri, SV				Bayry, Jagadeesh; Lacroix-Desmazes, Sebastien; Dasgupta, Suryasarathi; Kazatchkine, Michel D.; Kaveri, Srini V.			Efficacy of regulatory T-cell immunotherapy: are inflammatory cytokines key determinants?	NATURE REVIEWS IMMUNOLOGY			English	Letter							TNF-ALPHA THERAPY; RHEUMATOID-ARTHRITIS; MONOCLONAL-ANTIBODY; SUPPRESSION; REVERSAL		[Bayry, Jagadeesh; Lacroix-Desmazes, Sebastien; Dasgupta, Suryasarathi; Kazatchkine, Michel D.; Kaveri, Srini V.] Univ Paris 06, Ctr Rech Cordeliers, INSERM, UMR S872, F-75006 Paris, France; [Bayry, Jagadeesh; Lacroix-Desmazes, Sebastien; Dasgupta, Suryasarathi; Kazatchkine, Michel D.; Kaveri, Srini V.] Univ Paris 05, INSERM, U872, F-75006 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Bayry, J (corresponding author), Univ Paris 06, Ctr Rech Cordeliers, INSERM, UMR S872, 15 Rue Ecole Med, F-75006 Paris, France.	jagadeesh.bayry@crc.jussieu.fr	Bayry, Jagadeesh/A-6589-2011	Bayry, Jagadeesh/0000-0003-0498-9808; Lacroix-Desmazes, Sebastien/0000-0001-5625-8447				Bardos T, 2003, ARTHRITIS RES THER, V5, pR106, DOI 10.1186/ar624; Bayry J, 2007, DRUG DISCOV TODAY, V12, P548, DOI 10.1016/j.drudis.2007.05.002; Bayry J, 2007, NAT CLIN PRACT RHEUM, V3, P262, DOI 10.1038/ncprheum0481; Bayry J, 2007, J IMMUNOL, V178, P4184, DOI 10.4049/jimmunol.178.7.4184; Buch MH, 2004, RHEUMATOLOGY, V43, P243, DOI 10.1093/rheumatology/keg454; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Frey O, 2005, ARTHRITIS RES THER, V7, pR291, DOI 10.1186/ar1484; Houot R, 2006, J IMMUNOL, V176, P5293, DOI 10.4049/jimmunol.176.9.5293; Leipe J, 2005, ARTHRITIS RES THER, V7, P93, DOI 10.1186/ar1718; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Nadkarni S, 2007, J EXP MED, V204, P33, DOI 10.1084/jem.20061531; Roncarolo MG, 2007, NAT REV IMMUNOL, V7, P585, DOI 10.1038/nri2138; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; van Amelsfort JMR, 2007, ARTHRITIS RHEUM, V56, P732, DOI 10.1002/art.22414; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579	15	10	10	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2008	8	1								10.1038/nri2138-c1	http://dx.doi.org/10.1038/nri2138-c1			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	249SS		Bronze			2022-12-18	WOS:000252250600018
J	Hafler, DA				Hafler, David A.			Cytokines and interventional immunology - Foreword	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material								Alterations in cytokine expression associated with inflammation have long been observed in individuals with immune-mediated disease. Clinical trials carried out almost a decade ago were the first to show that therapeutic manipulation of cytokines with monoclonal antibodies targeting tumour-necrosis factor could change the course of an autoimmune disease. With this finding, the modern era of interventional immunology emerged.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Broad Inst MIT & Harvard, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts Institute of Technology (MIT); Broad Institute	Hafler, DA (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Broad Inst MIT & Harvard, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	hafler@broad.mit.edu							0	10	10	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2007	7	6					423	423		10.1038/nri2101	http://dx.doi.org/10.1038/nri2101			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	172HN		Bronze			2022-12-18	WOS:000246794900011
J	Bell, E				Bell, E			TWEAK and TNF: Yin and Yang in innate immunity	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Maecker H, 2005, CELL, V123, P931, DOI 10.1016/j.cell.2005.09.022	1	10	10	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2006	6	2					91	91		10.1038/nri1790	http://dx.doi.org/10.1038/nri1790			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	006KZ					2022-12-18	WOS:000234897700010
J	Murphy, AJ; Febbraio, MA				Murphy, Andrew J.; Febbraio, Mark A.			Immune-based therapies in cardiovascular and metabolic diseases: past, present and future	NATURE REVIEWS IMMUNOLOGY			English	Review							HIGH-DENSITY-LIPOPROTEIN; NECROSIS-FACTOR-ALPHA; ATHEROSCLEROTIC LESION DEVELOPMENT; APOLIPOPROTEIN-A-I; HEMATOPOIETIC STEM; CLONAL HEMATOPOIESIS; ACCELERATED ATHEROSCLEROSIS; PROMOTES ATHEROSCLEROSIS; CORONARY ATHEROSCLEROSIS; SUCCINATE-DEHYDROGENASE	In this Perspective, Murphy and Febbraio reflect on the advances that have been made in the past 20 years in developing therapies for cardiovascular and metabolic diseases that target the immune system. They also consider the potential of emerging immune-based therapies for these diseases. Cardiometabolic disorders were originally thought to be driven primarily by changes in lipid metabolism that cause the accumulation of lipids in organs, thereby impairing their function. Thus, in the setting of cardiovascular disease, statins - a class of lipid-lowering drugs - have remained the frontline therapy. In the past 20 years, seminal discoveries have revealed a central role of both the innate and adaptive immune system in driving cardiometabolic disorders. As such, it is now appreciated that immune-based interventions may have an important role in reducing death and disability from cardiometabolic disorders. However, to date, there have been a limited number of clinical trials exploring this interventional strategy. Nonetheless, elegant preclinical research suggests that immune-targeted therapies can have a major impact in treating cardiometabolic disease. Here, we discuss the history and recent advancements in the use of immunotherapies to treat cardiometabolic disorders.	[Murphy, Andrew J.] Baker Heart & Diabet Inst, Melbourne, Vic, Australia; [Febbraio, Mark A.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia	Baker Heart and Diabetes Institute; Monash University	Murphy, AJ (corresponding author), Baker Heart & Diabet Inst, Melbourne, Vic, Australia.; Febbraio, MA (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia.	andrew.murphy@baker.edu.au		Murphy, Andrew/0000-0001-7039-7777; Febbraio, Mark/0000-0002-9296-4418	National Health & Medical Research Council (NHMRC) of Australia [APP1116936]; NHMRC [APP1194329, APP1194141]; CSL Centenary Award	National Health & Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); CSL Centenary Award	M.A.F. is supported by a Senior Principal Research Fellowship of the National Health & Medical Research Council (NHMRC) of Australia (APP1116936) and an NHMRC Investigator grant (APP1194141). A.J.M. is supported by a CSL Centenary Award and an NHMRC Investigator grant (APP1194329).	Aikawa R, 2001, BIOCHEM BIOPH RES CO, V289, P901, DOI 10.1006/bbrc.2001.6068; Al-Sharea A, 2019, CARDIOVASC RES, V115, P277, DOI 10.1093/cvr/cvy308; Al-Sharea A, 2019, HAEMATOLOGICA, V104, P456, DOI 10.3324/haematol.2018.192898; Al-Sharea A, 2017, ATHEROSCLEROSIS, V265, P47, DOI 10.1016/j.atherosclerosis.2017.08.010; Arnett DK, 2019, CIRCULATION, V140, pE596, DOI [10.1161/CIR.0000000000000678, 10.1016/j.jacc.2019.03.010, 10.1161/CIR.0000000000000677, 10.1016/j.jacc.2019.03.009]; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Barnabe C, 2011, ARTHRIT CARE RES, V63, P522, DOI 10.1002/acr.20371; Barrett TJ, 2019, CIRCULATION, V140, P1170, DOI 10.1161/CIRCULATIONAHA.119.039476; Bernstein LE, 2006, ARCH INTERN MED, V166, P902, DOI 10.1001/archinte.166.8.902; Bick AG, 2020, CIRCULATION, V141, P124, DOI 10.1161/CIRCULATIONAHA.119.044362; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Bozkurt B, 2001, CIRCULATION, V103, P1044, DOI 10.1161/01.CIR.103.8.1044; Bradham WS, 2002, CARDIOVASC RES, V53, P822, DOI 10.1016/S0008-6363(01)00503-X; Branen L, 2004, ARTERIOSCL THROM VAS, V24, P2137, DOI 10.1161/01.ATV.0000143933.20616.1b; Brennan EP, 2018, DIABETES, V67, P2657, DOI 10.2337/db17-1317; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Calabretta R, 2020, CIRCULATION, V142, P2396, DOI 10.1161/CIRCULATIONAHA.120.048708; Catapano AL, 2014, CARDIOVASC RES, V103, P372, DOI 10.1093/cvr/cvu150; Charlesworth CT, 2019, NAT MED, V25, P249, DOI 10.1038/s41591-018-0326-x; Chatzigeorgioua A, 2014, P NATL ACAD SCI USA, V111, P2686, DOI 10.1073/pnas.1400419111; Choy E, 2014, RHEUMATOLOGY, V53, P2143, DOI 10.1093/rheumatology/keu224; Chung ES, 2003, CIRCULATION, V107, P3133, DOI 10.1161/01.CIR.0000077913.60364.D2; Cipollone F, 2003, CIRCULATION, V108, P2776, DOI 10.1161/01.CIR.0000103700.05109.0D; Claria J, 2012, J IMMUNOL, V189, P2597, DOI 10.4049/jimmunol.1201272; Cordes T, 2016, J BIOL CHEM, V291, P14274, DOI 10.1074/jbc.M115.685792; Danzaki K, 2012, ARTERIOSCL THROM VAS, V32, P273, DOI 10.1161/ATVBAHA.111.229997; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; DINARELLO CA, 1977, P NATL ACAD SCI USA, V74, P4624, DOI 10.1073/pnas.74.10.4624; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Distel E, 2014, CIRC RES, V115, P759, DOI 10.1161/CIRCRESAHA.115.304164; Doring Y, 2020, CIRC RES, V126, P787, DOI 10.1161/CIRCRESAHA.119.316142; Doring Y, 2019, CIRCULATION, V139, P1338, DOI 10.1161/CIRCULATIONAHA.118.037953; Doring Y, 2017, CIRCULATION, V136, P388, DOI 10.1161/CIRCULATIONAHA.117.027646; Dragoljevic D, 2018, EUR HEART J, V39, P2158, DOI 10.1093/eurheartj/ehy119; Drobni ZD, 2020, CIRCULATION, V142, P2299, DOI 10.1161/CIRCULATIONAHA.120.049981; Drummond GR, 2019, NAT REV IMMUNOL, V19, P517, DOI 10.1038/s41577-019-0160-5; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Dumont A, 2021, MOL ASPECTS MED, V77, DOI 10.1016/j.mam.2020.100922; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Erbel C, 2009, J IMMUNOL, V183, P8167, DOI 10.4049/jimmunol.0901126; Esser N, 2015, EXPERT OPIN INV DRUG, V24, P283, DOI 10.1517/13543784.2015.974804; Fidler TP, 2021, NATURE, V592, P296, DOI 10.1038/s41586-021-03341-5; Flynn MC, 2020, CIRC RES, V127, P877, DOI 10.1161/CIRCRESAHA.120.316653; Fotakis P, 2019, ARTERIOSCL THROM VAS, V39, pE253, DOI 10.1161/ATVBAHA.119.313253; Fredman G, 2017, AM J PATHOL, V187, P1211, DOI 10.1016/j.ajpath.2017.01.018; Fredman G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12859; Fu Q, 2018, J IMMUNOL, V200; Fuster JJ, 2017, SCIENCE, V355, P842, DOI 10.1126/science.aag1381; Gaudelli NM, 2017, NATURE, V551, P464, DOI 10.1038/nature24644; Gerlach BD, 2020, CELL DEATH DIFFER, V27, P525, DOI 10.1038/s41418-019-0370-1; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Horckmans M, 2017, EUR HEART J, V38, P187, DOI 10.1093/eurheartj/ehw002; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Huang SCC, 2016, IMMUNITY, V45, P817, DOI 10.1016/j.immuni.2016.09.016; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Hultcrantz M, 2015, J CLIN ONCOL, V33, P2288, DOI 10.1200/JCO.2014.57.6652; Ip WKE, 2017, SCIENCE, V356, P513, DOI 10.1126/science.aal3535; Jaiswal S, 2017, NEW ENGL J MED, V377, P111, DOI 10.1056/NEJMoa1701719; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Kammoun HL, 2018, MOL METAB, V10, P66, DOI 10.1016/j.molmet.2018.02.001; Kanarek N, 2020, NATURE, V579, P507, DOI 10.1038/s41586-020-2124-0; Kang EH, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007393; Kim S, 2016, HYPERTENSION, V67, P574, DOI 10.1161/HYPERTENSIONAHA.115.06474; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Koenen RR, 2009, NAT MED, V15, P97, DOI 10.1038/nm.1898; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kondapalli L, 2020, CIRCULATION, V142, P2312, DOI 10.1161/CIRCULATIONAHA.120.051753; Kraakman MJ, 2013, DIABETES OBES METAB, V15, P170, DOI 10.1111/dom.12170; Kraakman MJ, 2017, J CLIN INVEST, V127, P2133, DOI 10.1172/JCI92450; Kraakman MJ, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.31; Kraakman MJ, 2015, CELL METAB, V21, P403, DOI 10.1016/j.cmet.2015.02.006; Kubota T, 1997, CIRC RES, V81, P627, DOI 10.1161/01.RES.81.4.627; Kumagai N, 2009, J CARDIOL, V54, P485, DOI 10.1016/j.jjcc.2009.03.001; Kurup R, 2021, HEART LUNG CIRC, V30, P795, DOI 10.1016/j.hlc.2020.11.010; Kyaw T, 2021, EUR HEART J, V42, P938, DOI 10.1093/eurheartj/ehaa995; Lee MKS, 2021, ARTERIOSCL THROM VAS, V41, P1167, DOI 10.1161/ATVBAHA.120.315369; Ley K, 2020, JACC-CARDIOONCOL, V2, P611, DOI 10.1016/j.jaccao.2020.08.008; Li A, 2020, MOL THER, V28, P1432, DOI 10.1016/j.ymthe.2020.04.017; Liles WC, 2003, BLOOD, V102, P2728, DOI 10.1182/blood-2003-02-0663; Linsel-Nitschke P, 2005, NAT REV DRUG DISCOV, V4, P193, DOI 10.1038/nrd1658; Liuzzo G, 2001, Rays, V26, P221; Ma C, 2016, NATURE, V531, P253, DOI 10.1038/nature16969; Ma KY, 2013, CARDIOVASC RES, V97, P349, DOI 10.1093/cvr/cvs330; Machlus KR, 2016, BLOOD, V127, P921, DOI 10.1182/blood-2015-05-644583; Maggi P, 2017, IN VIVO, V31, P125, DOI 10.21873/invivo.11035; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; Mantelmacher FD, 2019, NAT METAB, V1, P58, DOI 10.1038/s42255-018-0001-z; Marinkovic G, 2020, CIRC RES, V127, P664, DOI 10.1161/CIRCRESAHA.120.315865; Marinkovic G, 2019, EUR HEART J, V40, P2713, DOI 10.1093/eurheartj/ehz461; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Menu P, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.18; Meyer MAS, 2021, CIRCULATION, V143, P1841, DOI 10.1161/CIRCULATIONAHA.120.053318; Mills EL, 2018, NATURE, V556, P113, DOI 10.1038/nature25986; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Momtazi-Borojeni AA, 2019, EUR HEART J-CARD PHA, V5, P237, DOI 10.1093/ehjcvp/pvz022; Murphy AJ, 2008, ARTERIOSCL THROM VAS, V28, P2071, DOI 10.1161/ATVBAHA.108.168690; Murphy AJ, 2014, ARTERIOSCL THROM VAS, V34, P751, DOI 10.1161/ATVBAHA.113.302613; Murphy AJ, 2013, NAT MED, V19, P586, DOI 10.1038/nm.3150; Murphy AJ, 2011, J CLIN INVEST, V121, P4138, DOI 10.1172/JCI57559; Murphy AJ, 2011, ARTERIOSCL THROM VAS, V31, P1333, DOI 10.1161/ATVBAHA.111.226258; Musunuru K, 2021, NATURE, V593, P429, DOI 10.1038/s41586-021-03534-y; Nagareddy PR, 2020, ARTERIOSCL THROM VAS, V40, P2805, DOI 10.1161/ATVBAHA.120.314807; Nagareddy PR, 2014, CELL METAB, V19, P821, DOI 10.1016/j.cmet.2014.03.029; Nagareddy PR, 2013, CELL METAB, V17, P695, DOI 10.1016/j.cmet.2013.04.001; Nicholls SJ, 2006, J AM COLL CARDIOL, V47, P992, DOI 10.1016/j.jacc.2005.11.040; Nicholls SJ, 2005, CIRCULATION, V111, P1543, DOI 10.1161/01.CIR.0000159351.95399.50; Nidorf SM, 2020, NEW ENGL J MED, V383, P1838, DOI 10.1056/NEJMoa2021372; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Obstfeld AE, 2010, DIABETES, V59, P916, DOI 10.2337/db09-1403; Oesterle A, 2017, CIRC RES, V120, P229, DOI 10.1161/CIRCRESAHA.116.308537; Oieni J, 2020, METHODS, V177, P126, DOI 10.1016/j.ymeth.2019.11.013; Palmieri EM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14433-7; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Patel S, 2009, J AM COLL CARDIOL, V53, P962, DOI 10.1016/j.jacc.2008.12.008; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Piconi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28853; Poels K, 2020, JACC-CARDIOONCOL, V2, P599, DOI 10.1016/j.jaccao.2020.08.007; Poels K, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9091987; Pradhan AD, 2018, CIRCULATION, V138, P141, DOI [10.1161/CIRCULATIONAHA.118.034645, 10.1161/CIRCULATIONAHA.118.035432]; Rahman K, 2017, J CLIN INVEST, V127, P2904, DOI 10.1172/JCI75005; Rajavashisth T, 1998, J CLIN INVEST, V101, P2702, DOI 10.1172/JCI119891; Rayner KJ, 2011, J CLIN INVEST, V121, P2921, DOI 10.1172/JCI57275; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2019, NEW ENGL J MED, V380, P752, DOI 10.1056/NEJMoa1809798; Rothgangl T, 2021, NAT BIOTECHNOL, V39, P949, DOI 10.1038/s41587-021-00933-4; Rungapiromnan W, 2017, BRIT J DERMATOL, V176, P890, DOI 10.1111/bjd.14964; Sano S, 2018, CIRC RES, V123, P335, DOI 10.1161/CIRCRESAHA.118.313225; Sarrazy V, 2016, CIRC RES, V118, P1062, DOI 10.1161/CIRCRESAHA.115.307599; Savchenko AS, 2014, BLOOD, V123, P141, DOI 10.1182/blood-2013-07-514992; SCHEFFER MG, 1991, AM HEART J, V122, P573, DOI 10.1016/0002-8703(91)91019-J; Scheller J, 2012, LANCET, V380, P338, DOI 10.1016/S0140-6736(12)61246-X; Schreiber S, 2021, GASTROENTEROLOGY, V160, P2354, DOI 10.1053/j.gastro.2021.02.062; Schuett H, 2012, ARTERIOSCL THROM VAS, V32, P281, DOI 10.1161/ATVBAHA.111.229435; Seijkens TTP, 2018, J AM COLL CARDIOL, V71, P527, DOI 10.1016/j.jacc.2017.11.055; Sharma A, 2021, DIABETES, V70, P772, DOI 10.2337/db20-0357; Shaw JA, 2008, CIRC RES, V103, P1084, DOI 10.1161/CIRCRESAHA.108.182063; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Shimokawa H, 1996, J CLIN INVEST, V97, P769, DOI 10.1172/JCI118476; Smith E, 2010, CIRCULATION, V121, P1746, DOI 10.1161/CIRCULATIONAHA.109.924886; Sreejit G, 2020, CIRCULATION, V141, P1080, DOI 10.1161/CIRCULATIONAHA.119.043833; Suzuki M, 2010, CIRCULATION, V122, P1919, DOI 10.1161/CIRCULATIONAHA.110.961193; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Taleb S, 2015, ARTERIOSCL THROM VAS, V35, P258, DOI 10.1161/ATVBAHA.114.303567; Tall AR, 2018, CIRC RES, V122, P106, DOI 10.1161/CIRCRESAHA.117.311978; Tang Y, 2020, CARDIOVASC DRUG THER, V34, P145, DOI 10.1007/s10557-020-06943-9; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Tardif JC, 2007, JAMA-J AM MED ASSOC, V297, P1675, DOI 10.1001/jama.297.15.jpc70004; Tardif JC, 2019, NEW ENGL J MED, V381, P2497, DOI 10.1056/NEJMoa1912388; Todoric J, 2020, NAT METAB, V2, P1034, DOI 10.1038/s42255-020-0261-2; van den Berg SM, 2015, INT J OBESITY, V39, P782, DOI 10.1038/ijo.2014.198; van der Heijden T, 2017, ARTERIOSCL THROM VAS, V37, P1457, DOI 10.1161/ATVBAHA.117.309575; Vanrenterghem Y, 2011, TRANSPLANTATION, V91, P976, DOI 10.1097/TP.0b013e31820c10eb; Vasanthakumar A, 2020, NATURE, V579, P581, DOI 10.1038/s41586-020-2040-3; Wang JZ, 2020, PHARMACOL RES, V159, DOI 10.1016/j.phrs.2020.105010; Wang M, 2014, ARTERIOSCL THROM VAS, V34, P976, DOI 10.1161/ATVBAHA.113.303097; Wang W, 2018, CIRC RES, V123, pE35, DOI 10.1161/CIRCRESAHA.118.313283; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weissmann G, 2006, BULL HOSP JT DIS, V64, P12; Westerterp M, 2018, CIRCULATION, V138, P898, DOI 10.1161/CIRCULATIONAHA.117.032636; Westerterp M, 2017, CELL METAB, V25, P1294, DOI 10.1016/j.cmet.2017.04.005; Williams JW, 2019, IMMUNITY, V50, P941, DOI 10.1016/j.immuni.2019.03.007; Winter C, 2018, CELL METAB, V28, P175, DOI 10.1016/j.cmet.2018.05.002; Wolf D, 2019, CIRC RES, V124, P315, DOI 10.1161/CIRCRESAHA.118.313591; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Wu D, 2017, J EUR ACAD DERMATOL, V31, P992, DOI 10.1111/jdv.14125; Xanthoulea S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006113; Yeh WH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04580-3; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731; Zhao ZM, 2020, CELL, V181, P151, DOI 10.1016/j.cell.2020.02.001	175	9	10	1	17	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2021	21	10					669	679		10.1038/s41577-021-00580-5	http://dx.doi.org/10.1038/s41577-021-00580-5		JUL 2021	11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UX9XG	34285393				2022-12-18	WOS:000675063000001
J	Wang, LF; Gamage, AM; Chan, WOY; Hiller, M; Teeling, EC				Wang, Lin-Fa; Gamage, Akshamal M.; Chan, Wharton O. Y.; Hiller, Michael; Teeling, Emma C.			Decoding bat immunity: the need for a coordinated research approach	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material							GENOMES; EVOLUTION	Understanding antiviral immune responses in bats, which are reservoirs for many emerging viruses, could aid the response to future epidemics. Here, we discuss five key areas in which greater consensus among the bat research community is necessary to drive breakthroughs in the field. The COVID-19 pandemic has stressed the importance of understanding species such as bats that can serve as reservoirs for emerging viral threats. Here, Wang and colleagues call for greater consensus among the bat immunology community in five key areas.	[Wang, Lin-Fa; Gamage, Akshamal M.; Chan, Wharton O. Y.] Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore; [Wang, Lin-Fa] SingHlth DukeNUS Global Hlth Inst, Singapore, Singapore; [Hiller, Michael] LOEWE Ctr Translat Biodivers Genom, Frankfurt, Germany; [Hiller, Michael] Senckenberg Res Inst, Frankfurt, Germany; [Hiller, Michael] Goethe Univ, Fac Biosci, Frankfurt, Germany; [Teeling, Emma C.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin, Ireland	National University of Singapore; Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt; University College Dublin	Wang, LF (corresponding author), Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore.; Wang, LF (corresponding author), SingHlth DukeNUS Global Hlth Inst, Singapore, Singapore.	linfa.wang@duke-nus.edu.sg	wang, lili/HDL-7210-2022; wang, lin/GSE-3040-2022	Chan, Wharton O Yinn/0000-0002-4526-470X; Teeling, Emma/0000-0002-3309-1346				Ahn M, 2019, NAT MICROBIOL, V4, P789, DOI 10.1038/s41564-019-0371-3; Banerjee A, 2018, VIRUS RES, V248, P5, DOI 10.1016/j.virusres.2018.02.013; Irving AT, 2021, NATURE, V589, P363, DOI 10.1038/s41586-020-03128-0; Jebb D, 2020, NATURE, V583, P578, DOI 10.1038/s41586-020-2486-3; Letko M, 2020, NAT REV MICROBIOL, V18, P461, DOI 10.1038/s41579-020-0394-z; Mollentze N, 2020, P NATL ACAD SCI USA, V117, P9423, DOI 10.1073/pnas.1919176117; Teeling EC, 2018, ANNU REV ANIM BIOSCI, V6, P23, DOI 10.1146/annurev-animal-022516-022811; Zhang GJ, 2013, SCIENCE, V339, P456, DOI 10.1126/science.1230835; Zhou J, 2020, NAT MED, V26, P1077, DOI 10.1038/s41591-020-0912-6	9	9	9	2	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2021	21	5					269	271		10.1038/s41577-021-00523-0	http://dx.doi.org/10.1038/s41577-021-00523-0		MAR 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RX5DH	33649605	Bronze, Green Published			2022-12-18	WOS:000623717700002
J	Flemming, A				Flemming, Alexandra			Calming inflammation to prevent stroke damage	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material																		Liu QK, 2019, NAT IMMUNOL, V20, P1023, DOI 10.1038/s41590-019-0421-2	1	9	10	3	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2019	19	8					473	473		10.1038/s41577-019-0197-5	http://dx.doi.org/10.1038/s41577-019-0197-5			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IN4WJ	31292539	Bronze			2022-12-18	WOS:000478677500001
J	Bird, L				Bird, Lucy			Getting enough energy for immunity	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material														Bird, Lucy/0000-0002-3914-6045				Ganeshan K, 2019, CELL, V177, P399, DOI 10.1016/j.cell.2019.01.050	1	9	9	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2019	19	5					269	269		10.1038/s41577-019-0159-y	http://dx.doi.org/10.1038/s41577-019-0159-y			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HW0OS	30940933	Bronze			2022-12-18	WOS:000466381300002
J	Burel, JG; Peters, B				Burel, Julie G.; Peters, Bjoern			Discovering transcriptional signatures of disease for diagnosis versus mechanism	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material							TUBERCULOSIS		[Burel, Julie G.; Peters, Bjoern] La Jolla Inst Allergy & Immunol, Dept Vaccine Discovery, La Jolla, CA 92037 USA	La Jolla Institute for Immunology	Peters, B (corresponding author), La Jolla Inst Allergy & Immunol, Dept Vaccine Discovery, La Jolla, CA 92037 USA.	bpeters@lji.org			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI118626] Funding Source: NIH RePORTER; NIAID NIH HHS [U19 AI118626] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Burel JG, 2018, J IMMUNOL, V200, P3283, DOI 10.4049/jimmunol.1800118; Cliff JM, 2016, J INFECT DIS, V213, P485, DOI 10.1093/infdis/jiv447; Kaforou M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001538; Kim MJ, 2010, EMBO MOL MED, V2, P258, DOI 10.1002/emmm.201000079; Maertzdorf J, 2012, P NATL ACAD SCI USA, V109, P7853, DOI 10.1073/pnas.1121072109; Montoya D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009546; Roe JK, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87238; Sweeney TE, 2016, LANCET RESP MED, V4, P213, DOI 10.1016/S2213-2600(16)00048-5; Zak DE, 2016, LANCET, V387, P2312, DOI 10.1016/S0140-6736(15)01316-1	10	9	9	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2018	18	5					289	290		10.1038/nri.2018.26	http://dx.doi.org/10.1038/nri.2018.26			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GE1DD	29629714	Green Accepted			2022-12-18	WOS:000430956100001
J	Galluzzi, L; Buque, A; Kepp, O; Zitvogel, L; Kroemer, G				Galluzzi, Lorenzo; Buque, Aitziber; Kepp, Oliver; Zitvogel, Laurence; Kroemer, Guido			Immunosuppressive cell death in cancer REPLY	NATURE REVIEWS IMMUNOLOGY			English	Letter							IMMUNITY; PROMOTES; THERAPY; ESCAPE		[Galluzzi, Lorenzo] Weill Cornell Med Coll, Dept Radiat Oncol, New York, NY 10065 USA; [Galluzzi, Lorenzo; Buque, Aitziber; Kepp, Oliver; Kroemer, Guido] Univ Paris Descartes Paris V, Sorbonne Paris Cite, F-75006 Paris, France; [Buque, Aitziber; Kepp, Oliver; Kroemer, Guido] Univ Pierre & Marie Curie Paris VI, F-75006 Paris, France; [Buque, Aitziber; Kepp, Oliver; Kroemer, Guido] Ctr Rech Cordeliers, Equipe Labellisee Ligue Canc 11, F-75006 Paris, France; [Buque, Aitziber; Kepp, Oliver] INSERM, F-75006 Paris, France; [Buque, Aitziber; Kepp, Oliver; Kroemer, Guido] Gustave Roussy Comprehens Canc Inst, Metabol & Cell Biol Platforms, F-94805 Villejuif, France; [Zitvogel, Laurence] Gustave Roussy Comprehens Canc Inst, F-94805 Villejuif, France; INSERM, Le Kremlin Bicetre, France; [Zitvogel, Laurence; Kroemer, Guido] INSERM, U1015, F-94805 Villejuif, France; [Zitvogel, Laurence] Ctr Clin Investigat Biotherapies Canc CICBT, F-94805 Le Kremlin Bicetre, France; [Zitvogel, Laurence] Univ Paris Sud Paris XI, F-94270 Le Kremlin Bicetre, France; [Kroemer, Guido] Karolinska Univ Hosp, Dept Womens & Childrens Hlth, Karolinska Inst, S-17176 Stockholm, Sweden; [Kroemer, Guido] Hop Europeen, AP HP, F-75015 Paris, France	Cornell University; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Karolinska Institutet; Karolinska University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP	Galluzzi, L (corresponding author), Weill Cornell Med Coll, Dept Radiat Oncol, New York, NY 10065 USA.; Galluzzi, L; Kroemer, G (corresponding author), Univ Paris Descartes Paris V, Sorbonne Paris Cite, F-75006 Paris, France.	deadoc@vodafone.it; kroemer@orange.fr	Galluzzi, Lorenzo/AAH-3286-2021; Kepp, Oliver/N-2763-2017; Kepp, Oliver/GPX-8627-2022; Galluzzi, Lorenzo/AAG-6294-2019; Galluzzi, Lorenzo/AAG-6432-2019; KROEMER, Guido/B-4263-2013; Kroemer, Guido/AAY-9859-2020	Kepp, Oliver/0000-0002-6081-9558; KROEMER, Guido/0000-0002-9334-4405; , Aitziber/0000-0002-7698-8778; ZITVOGEL, laurence/0000-0003-1596-0998	Department of Radiation Oncology of Weill Cornell Medical College, New York, NY, USA; Sotio a.c., Prague, Czech Replublic; French Ligue contre le Cancer; French Agence National de la Recherche (ANR) - Projets Blancs; ANR; Association pour la recherche sur le cancer (ARC); Canceropole Ile-de-France; French Institut National du Cancer (INCa); Institut Universitaire de France; Fondation pour la Recherche Medicale (FRM); European Commission (ArtForce); European Research Council (ERC); LeDucq Foundation; LabEx Immuno-Oncology; Sites de Recherche Integree sur le Cancer (SIRIC) Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); SIRIC Cancer Research and Personalized Medicine (CARPEM); Paris Alliance of Cancer Research Institutes (PACRI)	Department of Radiation Oncology of Weill Cornell Medical College, New York, NY, USA; Sotio a.c., Prague, Czech Replublic; French Ligue contre le Cancer(Ligue nationale contre le cancer); French Agence National de la Recherche (ANR) - Projets Blancs(French National Research Agency (ANR)); ANR(French National Research Agency (ANR)); Association pour la recherche sur le cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Canceropole Ile-de-France(Region Ile-de-France); French Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Institut Universitaire de France; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); European Commission (ArtForce)(European CommissionEuropean Commission Joint Research Centre); European Research Council (ERC)(European Research Council (ERC)); LeDucq Foundation(Leducq Foundation); LabEx Immuno-Oncology; Sites de Recherche Integree sur le Cancer (SIRIC) Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); SIRIC Cancer Research and Personalized Medicine (CARPEM); Paris Alliance of Cancer Research Institutes (PACRI)	L.G. is supported by a start-up intramural grant from the Department of Radiation Oncology of Weill Cornell Medical College, New York, NY, USA, and Sotio a.c., Prague, Czech Replublic. A.B., O.K. and G.K. are supported by the French Ligue contre le Cancer (equipe labellisee); the French Agence National de la Recherche (ANR) - Projets Blancs; ANR under the frame of E-Rare-2 (the ERA-Net for Research on Rare Diseases); Association pour la recherche sur le cancer (ARC); Canceropole Ile-de-France; the French Institut National du Cancer (INCa); Institut Universitaire de France; Fondation pour la Recherche Medicale (FRM); the European Commission (ArtForce); the European Research Council (ERC); the LeDucq Foundation; the LabEx Immuno-Oncology; the Sites de Recherche Integree sur le Cancer (SIRIC) Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); the SIRIC Cancer Research and Personalized Medicine (CARPEM); and the Paris Alliance of Cancer Research Institutes (PACRI).	Bettigole SE, 2015, ANNU REV IMMUNOL, V33, P107, DOI 10.1146/annurev-immunol-032414-112116; Bidwell BN, 2012, NAT MED, V18, P1224, DOI 10.1038/nm.2830; Dewan MZ, 2009, CLIN CANCER RES, V15, P5379, DOI 10.1158/1078-0432.CCR-09-0265; Fucikova J, 2016, BLOOD, V128, P3113, DOI [10.1182/blood-2016-08-731737, 10.1182/blood-2016-08731737]; Fucikova J, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00402; Galluzzi L., 2017, NAT REV DRUG DISCOV; Galluzzi L, 2017, NAT REV CLIN ONCOL, V14, P247, DOI 10.1038/nrclinonc.2016.183; Galluzzi L, 2017, NAT REV IMMUNOL, V17, P97, DOI 10.1038/nri.2016.107; Katlinski KV, 2017, CANCER CELL, V31, P194, DOI 10.1016/j.ccell.2017.01.004; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Krysko DV, 2012, NAT REV CANCER, V12, P860, DOI 10.1038/nrc3380; Mohme M, 2017, NAT REV CLIN ONCOL, V14, P155, DOI 10.1038/nrclinonc.2016.144; Pasquier E, 2010, NAT REV CLIN ONCOL, V7, P455, DOI 10.1038/nrclinonc.2010.82; Vanpouille-Box C., 2017, NAT COMMUN IN PRESS; 2017, NAT REV IMMUNOL, V17, P97	15	9	9	2	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2017	17	6					402	402		10.1038/nri.2017.48	http://dx.doi.org/10.1038/nri.2017.48			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EV8VO	28480896	Bronze			2022-12-18	WOS:000402062500013
J	Hou, JJ; Greten, TF; Xia, Q				Hou, Jiajie; Greten, Tim F.; Xia, Qiang			Immunosuppressive cell death in cancer	NATURE REVIEWS IMMUNOLOGY			English	Letter							IMMUNE SUPPRESSION; MYELOID CELLS; METASTASIS; INTERLEUKIN-1-ALPHA; CHEMOTHERAPY; DISEASE; CXCL1; HMGB1		[Hou, Jiajie; Xia, Qiang] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Liver Surg, 160 Pujian Rd, Shanghai 200127, Peoples R China; [Greten, Tim F.] NCI, Gastrointestinal Malignancy Sect, Thorac & Gastrointestinal Oncol Branch, Ctr Canc Res, Bldg 10, Bethesda, MD 20892 USA	Shanghai Jiao Tong University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Xia, Q (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Liver Surg, 160 Pujian Rd, Shanghai 200127, Peoples R China.	xiaqiang@shsmu.edu.cn	Greten, Tim F/B-3127-2015; Hou, Jiajie/CAF-2235-2022	Greten, Tim F/0000-0002-0806-2535; Hou, Jiajie/0000-0002-9011-6837	NATIONAL CANCER INSTITUTE [ZIABC011343] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 CA999999] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; De Henau O, 2016, NATURE, V539, P443, DOI 10.1038/nature20554; Di Paolo NC, 2016, NAT IMMUNOL, V17, P906, DOI 10.1038/ni.3503; Eil R, 2016, NATURE, V537, P539, DOI 10.1038/nature19364; Galluzzi L, 2017, NAT REV IMMUNOL, V17, P97, DOI 10.1038/nri.2016.107; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hong DS, 2014, LANCET ONCOL, V15, P656, DOI 10.1016/S1470-2045(14)70155-X; Kang R, 2013, CLIN CANCER RES, V19, P4046, DOI 10.1158/1078-0432.CCR-13-0495; Liu Y, 2015, J HEPATOL, V63, P114, DOI 10.1016/j.jhep.2015.02.009; Price JG, 2015, NAT IMMUNOL, V16, P1060, DOI 10.1038/ni.3270; Richards CH, 2011, FUTURE ONCOL, V7, P1223, DOI [10.2217/fon.11.99, 10.2217/FON.11.99]; Seifert L, 2016, NATURE, V532, P245, DOI 10.1038/nature17403; Shalapour S, 2015, NATURE, V521, P94, DOI 10.1038/nature14395; Sistigu A, 2014, NAT MED, V20, P1301, DOI 10.1038/nm.3708	15	9	9	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2017	17	6					401	401		10.1038/nri.2017.46	http://dx.doi.org/10.1038/nri.2017.46			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EV8VO	28480899	Green Accepted, Bronze			2022-12-18	WOS:000402062500012
J	Minton, K				Minton, Kirsty			Stress-induced macrophage polarization	NATURE REVIEWS IMMUNOLOGY			English	News Item														Minton, Kirsty/0000-0002-3857-8030					0	9	10	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2017	17	5					277	277		10.1038/nri.2017.41	http://dx.doi.org/10.1038/nri.2017.41			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ET1SY	28393924	Bronze			2022-12-18	WOS:000400050400001
J	Galluzzi, L; Buque, A; Kepp, O; Zitvogel, L; Kroemer, G				Galluzzi, Lorenzo; Buque, Aitziber; Kepp, Oliver; Zitvogel, Laurence; Kroemer, Guido			The complement system is also important in immunogenic cell death REPLY	NATURE REVIEWS IMMUNOLOGY			English	Letter							APOPTOTIC CELLS; CLEARANCE; AUTOPHAGY; RECEPTOR		[Galluzzi, Lorenzo] Weill Cornell Med Coll, Dept Radiat Oncol, New York, NY 10065 USA; [Galluzzi, Lorenzo; Buque, Aitziber; Kepp, Oliver; Kroemer, Guido] Ctr Rech Cordeliers, Equipe Labellisee Ligue Canc 11, F-75006 Paris, France; [Galluzzi, Lorenzo; Buque, Aitziber; Kepp, Oliver; Kroemer, Guido] INSERM, U1138, F-75006 Paris, France; [Galluzzi, Lorenzo; Buque, Aitziber; Kepp, Oliver; Kroemer, Guido] Univ Pierre & Marie Curie Paris VI, F-75006 Paris, France; [Galluzzi, Lorenzo; Buque, Aitziber; Zitvogel, Laurence] Gustave Roussy Comprehens Canc Inst, F-94805 Villejuif, France; [Kepp, Oliver; Kroemer, Guido] Gustave Roussy Comprehens Canc Inst, Metabol Platform, F-94805 Villejuif, France; [Kepp, Oliver; Kroemer, Guido] Gustave Roussy Comprehens Canc Inst, Cell Biol Platform, F-94805 Villejuif, France; [Zitvogel, Laurence] INSERM, U1015, F-94805 Villejuif, France; [Zitvogel, Laurence] Ctr Clin Invest Biotherapies Canc CICBT 1428, F-94805 Villejuif, France; [Zitvogel, Laurence] Univ Paris Sud Paris XI, F-94270 Le Kremlin Bicetre, France; [Kroemer, Guido] Karolinska Univ Hosp, Karolinska Inst, Dept Womens & Childrens Hlth, S-17176 Stockholm, Sweden; [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, Pole Biol, F-75015 Paris, France	Cornell University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Karolinska Institutet; Karolinska University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Galluzzi, L (corresponding author), Weill Cornell Med Coll, Dept Radiat Oncol, New York, NY 10065 USA.; Galluzzi, L; Kroemer, G (corresponding author), Ctr Rech Cordeliers, Equipe Labellisee Ligue Canc 11, F-75006 Paris, France.; Galluzzi, L; Kroemer, G (corresponding author), INSERM, U1138, F-75006 Paris, France.; Galluzzi, L; Kroemer, G (corresponding author), Univ Pierre & Marie Curie Paris VI, F-75006 Paris, France.; Galluzzi, L (corresponding author), Gustave Roussy Comprehens Canc Inst, F-94805 Villejuif, France.; Kroemer, G (corresponding author), Gustave Roussy Comprehens Canc Inst, Metabol Platform, F-94805 Villejuif, France.; Kroemer, G (corresponding author), Gustave Roussy Comprehens Canc Inst, Cell Biol Platform, F-94805 Villejuif, France.; Kroemer, G (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Womens & Childrens Hlth, S-17176 Stockholm, Sweden.; Kroemer, G (corresponding author), Hop Europeen Georges Pompidou, AP HP, Pole Biol, F-75015 Paris, France.	deadoc@vodafone.it; kroemer@orange.fr	KROEMER, Guido/B-4263-2013; Kepp, Oliver/N-2763-2017; Kepp, Oliver/GPX-8627-2022; Galluzzi, Lorenzo/AAH-3286-2021; Galluzzi, Lorenzo/AAG-6432-2019; Kroemer, Guido/AAY-9859-2020; Galluzzi, Lorenzo/AAG-6294-2019	KROEMER, Guido/0000-0002-9334-4405; Kepp, Oliver/0000-0002-6081-9558; ZITVOGEL, laurence/0000-0003-1596-0998; , Aitziber/0000-0002-7698-8778				Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Galluzzi L, 2015, CANCER CELL, V28, P690, DOI 10.1016/j.ccell.2015.10.012; Kopf M, 2002, NAT MED, V8, P373, DOI 10.1038/nm0402-373; Kroemer, 2016, NAT REV IMMUNOL; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; Martinez J, 2016, NATURE, V533, P115, DOI 10.1038/nature17950; Martinez J, 2015, NAT CELL BIOL, V17, P893, DOI 10.1038/ncb3192; Morgan BP, 2015, NAT REV DRUG DISCOV, V14, P857, DOI 10.1038/nrd4657; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Sica V, 2015, MOL CELL, V59, P522, DOI 10.1016/j.molcel.2015.07.021; Sturfelt G, 2012, NAT REV RHEUMATOL, V8, P458, DOI 10.1038/nrrheum.2012.75	12	9	9	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2017	17	2								10.1038/nri.2016.143	http://dx.doi.org/10.1038/nri.2016.143			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FZ8SG	28028312	Bronze			2022-12-18	WOS:000427879700001
J	Minton, K				Minton, Kirsty			Anti-inflammatory effect of mitophagy	NATURE REVIEWS IMMUNOLOGY			English	News Item														Minton, Kirsty/0000-0002-3857-8030					0	9	9	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2016	16	4								10.1038/nri.2016.33	http://dx.doi.org/10.1038/nri.2016.33			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH7MD	26972724	Bronze			2022-12-18	WOS:000372977200006
J	Bordon, Y				Bordon, Yvonne			INNATE IMMUNITY A new vein of TLR biology	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X				WEST XZ, 2010, NATURE          1003, DOI DOI 10.1038/NATURE09421	1	9	9	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2010	10	11								10.1038/nri2875	http://dx.doi.org/10.1038/nri2875			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	670NM	21080611				2022-12-18	WOS:000283431100004
J	Leavy, O				Leavy, Olive			REGULATORY T CELLS CD8(+) T-Reg cells join the fold	NATURE REVIEWS IMMUNOLOGY			English	News Item																		KIM HJ, 2010, NATURE          0915, DOI DOI 10.1038/NATURE09370	1	9	9	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2010	10	10					680	680		10.1038/nri2862	http://dx.doi.org/10.1038/nri2862			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	653YV	20879168	Bronze			2022-12-18	WOS:000282136100009
J	Akbari, O				Akbari, O			Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergy-induced airway hyperreactivity.	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	9	9	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2002	2	9					629	629		10.1038/nm745	http://dx.doi.org/10.1038/nm745			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	636DL					2022-12-18	WOS:000180439200013
J	Marchi, S; Guilbaud, E; Tait, SWG; Yamazaki, T; Galluzzi, L				Marchi, Saverio; Guilbaud, Emma; Tait, Stephen W. G.; Yamazaki, Takahiro; Galluzzi, Lorenzo			Mitochondrial control of inflammation	NATURE REVIEWS IMMUNOLOGY			English	Review; Early Access							NF-KAPPA-B; CELL-DEATH RECOMMENDATIONS; TRIGGER NLRP3 INFLAMMASOME; EXTRACELLULAR CYTOCHROME-C; AIM2 INFLAMMASOME; OXIDATIVE STRESS; TRANSCRIPTION-FACTOR; GENOMIC INSTABILITY; ALZHEIMERS-DISEASE; I INTERFERONS	Lorenzo Galluzzi and colleagues discuss the molecular mechanisms through which mitochondrial dysfunction elicits inflammatory reactions, the cellular pathways that are in place to control them and how the dysregulation of these systems contributes to pathology. Numerous mitochondrial constituents and metabolic products can function as damage-associated molecular patterns (DAMPs) and promote inflammation when released into the cytosol or extracellular milieu. Several safeguards are normally in place to prevent mitochondria from eliciting detrimental inflammatory reactions, including the autophagic disposal of permeabilized mitochondria. However, when the homeostatic capacity of such systems is exceeded or when such systems are defective, inflammatory reactions elicited by mitochondria can become pathogenic and contribute to the aetiology of human disorders linked to autoreactivity. In addition, inefficient inflammatory pathways induced by mitochondrial DAMPs can be pathogenic as they enable the establishment or progression of infectious and neoplastic disorders. Here we discuss the molecular mechanisms through which mitochondria control inflammatory responses, the cellular pathways that are in place to control mitochondria-driven inflammation and the pathological consequences of dysregulated inflammatory reactions elicited by mitochondrial DAMPs.	[Marchi, Saverio] Marche Polytech Univ, Dept Clin & Mol Sci, Ancona, Italy; [Guilbaud, Emma; Yamazaki, Takahiro; Galluzzi, Lorenzo] Weill Cornell Med Coll, Dept Radiat Oncol, New York, NY 10065 USA; [Tait, Stephen W. G.] Canc Res UK Beatson Inst, Glasgow, Lanark, Scotland; [Tait, Stephen W. G.] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland; [Galluzzi, Lorenzo] Sandra & Edward Meyer Canc Ctr, New York, NY 10065 USA; [Galluzzi, Lorenzo] Caryl & Israel Englander Inst Precis Med, New York, NY 10021 USA	Marche Polytechnic University; Cornell University; Beatson Institute; University of Glasgow	Yamazaki, T; Galluzzi, L (corresponding author), Weill Cornell Med Coll, Dept Radiat Oncol, New York, NY 10065 USA.; Galluzzi, L (corresponding author), Sandra & Edward Meyer Canc Ctr, New York, NY 10065 USA.; Galluzzi, L (corresponding author), Caryl & Israel Englander Inst Precis Med, New York, NY 10021 USA.	tay2007@med.cornell.edu; deadoc80@gmail.com		Tait, Stephen/0000-0001-7697-132X; Guilbaud, Emma/0000-0001-5261-1944	Italian Ministry of Health [GR-2016-02364602]; Nanoblend and local funds from Marche Polytechnic University (Ancona, Italy); Cancer Research UK; Prostate Cancer UK; Tenovus Scotland; Swiss National Science Foundation; US Department of Defense Breast Cancer Research Program [W81XWH2120034, BC180476P1, BC210945]; NCI of the NIH [CA274291]; Stand Up to Cancer [ZP-6177]; Leukaemia and Lymphoma Society; Functional Genomics Initiative (New York, USA); Department of Radiation Oncology at Weill Cornell Medicine (New York, USA)	Italian Ministry of Health(Ministry of Health, Italy); Nanoblend and local funds from Marche Polytechnic University (Ancona, Italy); Cancer Research UK(Cancer Research UK); Prostate Cancer UK; Tenovus Scotland; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); US Department of Defense Breast Cancer Research Program(United States Department of Defense); NCI of the NIH; Stand Up to Cancer; Leukaemia and Lymphoma Society; Functional Genomics Initiative (New York, USA); Department of Radiation Oncology at Weill Cornell Medicine (New York, USA)	S.M. is supported by the Italian Ministry of Health (GR-2016-02364602), Nanoblend and local funds from Marche Polytechnic University (Ancona, Italy). S.W.G.T. is supported by funding from Cancer Research UK, Prostate Cancer UK, Tenovus Scotland and the Swiss National Science Foundation. The laboratory of L.G. (as a principal investigator unless otherwise indicated) is or has been supported by two Breakthrough Level 2 grants from the US Department of Defense Breast Cancer Research Program (BC180476P1 and BC210945), by a Transformative Breast Cancer Consortium Grant from the US Department of Defense Breast Cancer Research Program (W81XWH2120034; principal investigator Formenti), by a U54 grant from the NCI of the NIH (CA274291; principal investigators Deasy, Formenti and Weichselbaum), by the 2019 Laura Ziskin Prize in Translational Research (ZP-6177; principal investigator Formenti) from Stand Up to Cancer, by a Mantle Cell Lymphoma Research Initiative grant from the Leukaemia and Lymphoma Society (principal investigator Chen-Kiang), by a Rapid Response Grant from the Functional Genomics Initiative (New York, USA), by start-up funds from the Department of Radiation Oncology at Weill Cornell Medicine (New York, USA), by industrial collaborations with Lytix Biopharma (Oslo, Norway) and Promontory (New York, USA), and by donations from Promontory (New York, USA), the Luke Heller TECPR2 Foundation (Boston, USA), Sotio a.s. (Prague, Czech Republic), Lytix Biopharma (Oslo, Norway), Onxeo (Paris, France), Ricerchiamo (Brescia, Italy) and Noxopharm (Chatswood, Australia).	Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Allam R, 2014, EMBO REP, V15, P982, DOI 10.15252/embr.201438463; Amgalan D, 2020, NAT CANCER, V1, P315, DOI 10.1038/s43018-020-0039-1; Andreeva L, 2017, NATURE, V549, P394, DOI 10.1038/nature23890; Bai JL, 2017, P NATL ACAD SCI USA, V114, P12196, DOI 10.1073/pnas.1708744114; Bakhoum SF, 2018, NATURE, V553, P467, DOI 10.1038/nature25432; Bao DK, 2019, ONCOGENE, V38, P5007, DOI 10.1038/s41388-019-0772-z; Basso PJ, 2021, NAT REV NEPHROL, V17, P465, DOI 10.1038/s41581-021-00413-7; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Belcher JD, 2014, BLOOD, V123, P377, DOI 10.1182/blood-2013-04-495887; Bell C, 2022, NORD J PSYCHIAT, DOI [10.1038/s41588-022-01024-z, 10.1080/08039488.2022.2128869]; Benmerzoug S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07425-1; Bernardini JP, 2019, EMBO J, V38, DOI 10.15252/embj.201899916; Billingham LK, 2022, NAT IMMUNOL, V23, P692, DOI 10.1038/s41590-022-01185-3; Boada-Romero E, 2020, NAT REV MOL CELL BIO, V21, P398, DOI 10.1038/s41580-020-0232-1; Bock FJ, 2020, NAT REV MOL CELL BIO, V21, P85, DOI 10.1038/s41580-019-0173-8; Bolivar BE, 2021, J IMMUNOL, V206, P1878, DOI 10.4049/jimmunol.2000226; Bonora M, 2022, NAT REV MOL CELL BIO, V23, P266, DOI 10.1038/s41580-021-00433-y; Borsche M, 2020, BRAIN, V143, P3041, DOI 10.1093/brain/awaa246; Brokatzky D, 2019, EMBO J, V38, DOI 10.15252/embj.2018100907; Buque A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17644-0; Buque A, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1655364; Cadete VJJ, 2016, J PHYSIOL-LONDON, V594, P5343, DOI 10.1113/JP272703; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Caielli S, 2021, CELL, V184, P4464, DOI 10.1016/j.cell.2021.07.021; Caielli S, 2016, J EXP MED, V213, P697, DOI 10.1084/jem.20151876; Cao K, 2022, DEV CELL, V57, P1211, DOI 10.1016/j.devcel.2022.03.019; Chauhan D, 2018, CELL REP, V25, P2354, DOI 10.1016/j.celrep.2018.10.087; Chen H, 2022, VIROL J, V19, DOI 10.1186/s12985-022-01785-3; Chen KH, 2019, FASEB J, V33, P4571, DOI 10.1096/fj.201801749RRR; Christensen MH, 2016, EMBO J, V35, P1385, DOI 10.15252/embj.201593458; Chung KW, 2019, CELL METAB, V30, P784, DOI 10.1016/j.cmet.2019.08.003; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; de Brachene AC, 2021, AUTOIMMUN HIGHLIGHTS, V12, DOI 10.1186/s13317-021-00148-2; Corrales L, 2016, J IMMUNOL, V196, P3191, DOI 10.4049/jimmunol.1502538; Cosentino K, 2022, MOL CELL, V82, P933, DOI 10.1016/j.molcel.2022.01.008; Costa TJ, 2022, VASC PHARMACOL, V142, DOI 10.1016/j.vph.2021.106946; Crane DD, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00438; Dang EV, 2017, CELL, V171, P1057, DOI 10.1016/j.cell.2017.09.029; Danthi P, 2016, ANNU REV VIROL, V3, P533, DOI 10.1146/annurev-virology-110615-042435; De Leo MG, 2016, NAT CELL BIOL, V18, P839, DOI 10.1038/ncb3386; Decout A, 2021, NAT REV IMMUNOL, V21, P548, DOI 10.1038/s41577-021-00524-z; Dhir A, 2018, NATURE, V560, P238, DOI 10.1038/s41586-018-0363-0; Di Domizio J, 2022, NATURE, V603, P145, DOI 10.1038/s41586-022-04421-w; Di Micco A, 2016, P NATL ACAD SCI USA, V113, pE4671, DOI 10.1073/pnas.1602419113; Di Rita A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05722-3; Diepstraten ST, 2022, NAT REV CANCER, V22, P45, DOI 10.1038/s41568-021-00407-4; Dieude M, 2011, J IMMUNOL, V186, P4771, DOI 10.4049/jimmunol.1000921; Dorflinger B, 2022, CELL DEATH DIFFER, V29, P2218, DOI 10.1038/s41418-022-01009-9; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Rodriguez-Ruiz ME, 2020, NAT IMMUNOL, V21, P120, DOI 10.1038/s41590-019-0561-4; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fang EF, 2019, NAT NEUROSCI, V22, P401, DOI 10.1038/s41593-018-0332-9; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Flores-Romero H, 2022, EMBO J, V41, DOI 10.15252/embj.2021108690; Franchi L, 2014, J IMMUNOL, V193, P4214, DOI 10.4049/jimmunol.1400582; Fuchs Y, 2015, NAT REV MOL CELL BIO, V16, P329, DOI 10.1038/nrm3999; Galluzzi L, 2015, CELL DEATH DIFFER, V22, P58, DOI 10.1038/cdd.2014.137; Galluzzi L, 2020, NAT REV CLIN ONCOL, V17, P725, DOI 10.1038/s41571-020-0413-z; Galluzzi L, 2018, NAT REV MOL CELL BIO, V19, P731, DOI 10.1038/s41580-018-0068-0; Galluzzi L, 2018, CELL, V173, DOI 10.1016/j.cell.2018.03.015; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Galluzzi L, 2017, EMBO J, V36, P1811, DOI 10.15252/embj.201796697; Galluzzi L, 2017, NAT REV DRUG DISCOV, V16, P487, DOI 10.1038/nrd.2017.22; Galluzzi L, 2016, CANCER IMMUNOL RES, V4, P895, DOI 10.1158/2326-6066.CIR-16-0197; Galluzzi L, 2016, IMMUNITY, V44, P221, DOI 10.1016/j.immuni.2016.01.020; Galluzzi L, 2015, EMBO J, V34, P856, DOI 10.15252/embj.201490784; Galluzzi L, 2012, EMBO REP, V13, P322, DOI 10.1038/embor.2012.19; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Giampazolias E, 2017, NAT CELL BIOL, V19, P1116, DOI 10.1038/ncb3596; Giordano L, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11030369; Glab JA, 2020, INT REV CEL MOL BIO, V351, P1, DOI 10.1016/bs.ircmb.2019.12.001; Gouveia A, 2017, BBA-GEN SUBJECTS, V1861, P2274, DOI 10.1016/j.bbagen.2017.06.017; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Han CH, 2020, NAT IMMUNOL, V21, P546, DOI 10.1038/s41590-020-0641-5; Harapas CR, 2022, NAT REV IMMUNOL, V22, P535, DOI 10.1038/s41577-022-00682-8; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Heng JB, 2006, BIOPHYS J, V90, P1098, DOI 10.1529/biophysj.105.070672; Hur S, 2019, ANNU REV IMMUNOL, V37, P349, DOI 10.1146/annurev-immunol-042718-041356; Ichim G, 2015, MOL CELL, V57, P860, DOI 10.1016/j.molcel.2015.01.018; Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001; J. W. Guarnieri, 2022, bioRxiv, DOI 10.1101/2022.02.19.481139; Jabir MS, 2015, AUTOPHAGY, V11, P166, DOI 10.4161/15548627.2014.981915; Jackson DN, 2020, GUT, V69, P1928, DOI 10.1136/gutjnl-2019-319523; Kang D, 2007, MITOCHONDRION, V7, P39, DOI 10.1016/j.mito.2006.11.017; Kasten M, 2018, MOVEMENT DISORD, V33, P730, DOI 10.1002/mds.27352; Kepp O, 2021, EMBO J, V40, DOI 10.15252/embj.2021108130; Khaloian S, 2020, GUT, V69, P1939, DOI 10.1136/gutjnl-2019-319514; Kim J, 2019, SCIENCE, V366, P1531, DOI 10.1126/science.aav4011; King KR, 2017, NAT MED, V23, P1481, DOI 10.1038/nm.4428; Klionsky DJ, 2021, EMBO J, V40, DOI 10.15252/embj.2021108863; Konecna B, 2021, J TRAUMA ACUTE CARE, V90, P46, DOI 10.1097/TA.0000000000002973; Kroemer G, 2022, NAT IMMUNOL, V23, P487, DOI 10.1038/s41590-022-01132-2; Kruglov AG, 2021, FASEB J, V35, DOI 10.1096/fj.202100596R; Kuo CL, 2020, CANCER LETT, V474, P138, DOI 10.1016/j.canlet.2020.01.019; Kwon WY, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2018538118; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Le Naour J, 2020, ONCOIMMUNOLOGY, V9, DOI 10.1080/2162402X.2020.1777624; Lecis D, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.449; Lekakis V, 2022, CLIN J GASTROENTEROL, V15, P271, DOI 10.1007/s12328-021-01585-2; Leslie DS, 2008, IMMUNOLOGY, V125, P289, DOI 10.1111/j.1365-2567.2008.02842.x; Li CF, 2018, DEV CELL, V46, P441, DOI 10.1016/j.devcel.2018.07.012; Li HJ, 2021, INT REV CEL MOL BIO, V364, P241, DOI 10.1016/bs.ircmb.2021.05.004; Li SF, 2020, CELL REP, V30, P4370, DOI 10.1016/j.celrep.2020.02.105; Li SJ, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2020.108631; Li T, 2021, SCIENCE, V371, P1221, DOI 10.1126/science.abc5386; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Lin S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-46; Lindqvist LM, 2018, CELL DEATH DIFFER, V25, P782, DOI 10.1038/s41418-017-0017-z; Little JP, 2014, MOL CELL NEUROSCI, V60, P88, DOI 10.1016/j.mcn.2014.04.003; Liu Y, 2015, J HEPATOL, V63, P114, DOI 10.1016/j.jhep.2015.02.009; Lood C, 2016, NAT MED, V22, P146, DOI 10.1038/nm.4027; Lopez A, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28741-7; Ma Y, 2013, IMMUNITY, V38, P729, DOI 10.1016/j.immuni.2013.03.003; Maekawa H, 2019, CELL REP, V29, P1261, DOI 10.1016/j.celrep.2019.09.050; Mangelinck A, 2021, INT REV CEL MOL BIO, V364, P1, DOI 10.1016/bs.ircmb.2021.06.002; Mantovani A, 2019, J INTERN MED, V285, P524, DOI 10.1111/joim.12886; Marchi S, 2022, TRENDS MICROBIOL, V30, P452, DOI 10.1016/j.tim.2021.09.010; Marques PE, 2012, HEPATOLOGY, V56, P1971, DOI 10.1002/hep.25801; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; May O, 2021, FEBS J, V288, P3448, DOI 10.1111/febs.15667; McArthur K, 2018, SCIENCE, V359, P883, DOI 10.1126/science.aao6047; McArthur K, 2018, TRENDS CELL BIOL, V28, P475, DOI 10.1016/j.tcb.2018.02.003; Mehta MM, 2017, NAT REV IMMUNOL, V17, P608, DOI 10.1038/nri.2017.66; Melki I, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.aav5928; Michalski S, 2020, NATURE, V587, P678, DOI 10.1038/s41586-020-2748-0; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Moriyama M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12632-5; Mouton-Liger F, 2018, GLIA, V66, P1736, DOI 10.1002/glia.23337; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Neginskaya MA, 2020, J GEN PHYSIOL, V152, DOI 10.1085/jgp.202012631; Neufeldt CJ, 2022, COMMUN BIOL, V5, DOI 10.1038/s42003-021-02983-5; Niemi K, 2011, J IMMUNOL, V186, P6119, DOI 10.4049/jimmunol.1002843; Ning XH, 2019, MOL CELL, V74, P19, DOI 10.1016/j.molcel.2019.02.013; Noda S, 2020, NEUROBIOL DIS, V136, DOI 10.1016/j.nbd.2019.104717; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Patrushev M, 2004, CELL MOL LIFE SCI, V61, P3100, DOI 10.1007/s00018-004-4424-1; Pervaiz S, 2020, INT REV CEL MOL BIO, V352, P189, DOI 10.1016/bs.ircmb.2020.03.002; Petroni G, 2022, NAT REV DRUG DISCOV, V21, P440, DOI 10.1038/s41573-022-00415-5; Platnich JM, 2018, CELL REP, V25, P1525, DOI 10.1016/j.celrep.2018.09.071; Pullerits R, 2005, RHEUMATOLOGY, V44, P32, DOI 10.1093/rheumatology/keh406; Rabas N, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202006049; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Renaudin X, 2021, INT REV CEL MOL BIO, V364, P139, DOI 10.1016/bs.ircmb.2021.04.001; Reyna DE, 2017, CANCER CELL, V32, P490, DOI 10.1016/j.ccell.2017.09.001; Richter B, 2016, P NATL ACAD SCI USA, V113, P4039, DOI 10.1073/pnas.1523926113; Riley JS, 2020, EMBO REP, V21, DOI 10.15252/embr.201949799; Riley JS, 2018, EMBO J, V37, DOI 10.15252/embj.201899238; Rizk J, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aaw3469; Roca-Agujetas V, 2021, MOL NEURODEGENER, V16, DOI 10.1186/s13024-021-00435-6; Roda G, 2020, NAT REV DIS PRIMERS, V6, DOI 10.1038/s41572-020-0156-2; Rodriguez-Ruiz ME, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1655964; Roger AJ, 2017, CURR BIOL, V27, pR1177, DOI 10.1016/j.cub.2017.09.015; Rogers C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09397-2; Rongvaux A, 2014, CELL, V159, P1563, DOI 10.1016/j.cell.2014.11.037; Ross C, 2022, ANNU REV IMMUNOL, V40, P249, DOI 10.1146/annurev-immunol-101220-030653; Saffran HA, 2007, EMBO REP, V8, P188, DOI 10.1038/sj.embor.7400878; Sansone P, 2017, P NATL ACAD SCI USA, V114, pE9066, DOI 10.1073/pnas.1704862114; Saxena G, 2010, J BIOL CHEM, V285, P3997, DOI 10.1074/jbc.M109.034421; Schmidts A, 2021, ANNU REV MED, V72, P365, DOI 10.1146/annurev-med-061119-015600; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Singel KL, 2019, BRIT J CANCER, V120, P207, DOI 10.1038/s41416-018-0339-8; Sliter DA, 2018, NATURE, V561, P258, DOI 10.1038/s41586-018-0448-9; Spitz AZ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21224-1; Stark K, 2021, NAT REV CARDIOL, V18, P666, DOI 10.1038/s41569-021-00552-1; Sun B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03932-1; SWANSON SKH, 1992, P NATL ACAD SCI USA, V89, P3741, DOI 10.1073/pnas.89.9.3741; Tang CY, 2018, AUTOPHAGY, V14, P880, DOI 10.1080/15548627.2017.1405880; Tansey MG, 2022, NAT REV IMMUNOL, V22, P657, DOI 10.1038/s41577-022-00684-6; Thomsen MK, 2016, HEPATOLOGY, V64, P746, DOI 10.1002/hep.28685; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Tigano M, 2021, NATURE, V591, P477, DOI 10.1038/s41586-021-03269-w; Todkar K, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21984-w; Vanpouille-Box C, 2019, NAT REV DRUG DISCOV, V18, P845, DOI 10.1038/s41573-019-0043-2; Vanpouille-Box C, 2018, CANCER CELL, V34, P361, DOI 10.1016/j.ccell.2018.05.013; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vince JE, 2018, CELL REP, V25, P2339, DOI 10.1016/j.celrep.2018.10.103; Wang YD, 2013, AUTOPHAGY, V9, P1624, DOI 10.4161/auto.25873; Wang YP, 2017, NATURE, V547, P99, DOI 10.1038/nature22393; Wang YT, 2017, IMMUNITY, V46, P393, DOI 10.1016/j.immuni.2017.02.011; Wein T, 2022, NAT REV IMMUNOL, V22, P629, DOI 10.1038/s41577-022-00705-4; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036; Wiegman CH, 2015, J ALLERGY CLIN IMMUN, V136, P769, DOI 10.1016/j.jaci.2015.01.046; Wiens KE, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005809; Wilkins HM, 2015, J ALZHEIMERS DIS, V45, P305, DOI 10.3233/JAD-142334; Willemsen J, 2021, CELL REP, V37, DOI 10.1016/j.celrep.2021.109977; Xian HX, 2021, IMMUNITY, V54, P1463, DOI 10.1016/j.immuni.2021.05.004; Xu L, 2021, AM J PHYSIOL-GASTR L, V320, pG1034, DOI 10.1152/ajpgi.00431.2020; Xu YJ, 2008, J BIOL CHEM, V283, P1563, DOI 10.1074/jbc.M707997200; Yamazaki T, 2022, CELL DEATH DIFFER, V29, P1296, DOI 10.1038/s41418-022-00985-2; Yamazaki T, 2020, NAT IMMUNOL, V21, P1160, DOI 10.1038/s41590-020-0751-0; Yatim N, 2015, SCIENCE, V350, P328, DOI 10.1126/science.aad0395; Yu CH, 2020, CELL, V183, P636, DOI 10.1016/j.cell.2020.09.020; Yum S, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2100225118; Zengeler KE, 2021, NAT REV IMMUNOL, V21, P454, DOI 10.1038/s41577-020-00487-7; Zhang JQ, 2019, CELL REP, V27, P2679, DOI 10.1016/j.celrep.2019.04.111; Zhang NP, 2019, LAB INVEST, V99, P749, DOI 10.1038/s41374-018-0177-6; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhao BY, 2020, NATURE, V587, P673, DOI 10.1038/s41586-020-2749-z; Zhong ZY, 2018, NATURE, V560, P198, DOI 10.1038/s41586-018-0372-z; Zhong ZY, 2016, CELL, V164, P896, DOI 10.1016/j.cell.2015.12.057; Zhou CM, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2020.101928; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831; Zierhut C, 2019, CELL, V178, P302, DOI 10.1016/j.cell.2019.05.035	214	8	8	36	36	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.												10.1038/s41577-022-00760-x	http://dx.doi.org/10.1038/s41577-022-00760-x		JUL 2022	15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3F7RR	35879417	Green Published, Bronze			2022-12-18	WOS:000830862200001
J	Mills, KHG				Mills, Kingston H. G.			IL-17 and IL-17-producing cells in protection versus pathology	NATURE REVIEWS IMMUNOLOGY			English	Review; Early Access							DELTA-T-CELLS; INNATE LYMPHOID-CELLS; COLLAGEN-INDUCED ARTHRITIS; SYNCYTIAL VIRUS-INFECTION; CENTRAL-NERVOUS-SYSTEM; MUCOSAL HOST-DEFENSE; TH17 CELLS; GAMMA-DELTA; INTERLEUKIN 17; T(H)17 CELLS	IL-17 cytokines drive biological responses that protect the host against many infections but can also contribute to host pathology in the context of infection and autoimmunity. Here, Kingston Mills highlights the different cellular sources of IL-17 and compares the pathological versus protective functions of these cytokines. IL-17 cytokine family members have diverse biological functions, promoting protective immunity against many pathogens but also driving inflammatory pathology during infection and autoimmunity. IL-17A and IL-17F are produced by CD4(+) and CD8(+) T cells, gamma delta T cells, and various innate immune cell populations in response to IL-1 beta and IL-23, and they mediate protective immunity against fungi and bacteria by promoting neutrophil recruitment, antimicrobial peptide production and enhanced barrier function. IL-17-driven inflammation is normally controlled by regulatory T cells and the anti-inflammatory cytokines IL-10, TGF beta and IL-35. However, if dysregulated, IL-17 responses can promote immunopathology in the context of infection or autoimmunity. Moreover, IL-17 has been implicated in the pathogenesis of many other disorders with an inflammatory basis, including cardiovascular and neurological diseases. Consequently, the IL-17 pathway is now a key drug target in many autoimmune and chronic inflammatory disorders; therapeutic monoclonal antibodies targeting IL-17A, both IL-17A and IL-17F, the IL-17 receptor, or IL-23 are highly effective in some of these diseases. However, new approaches are needed to specifically regulate IL-17-mediated immunopathology in chronic inflammation and autoimmunity without compromising protective immunity to infection.	[Mills, Kingston H. G.] Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin, Ireland	Trinity College Dublin	Mills, KHG (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin, Ireland.	kingston.mills@tcd.ie	Mills, Kingston/F-5684-2013	Mills, Kingston/0000-0003-3646-8222	Science Foundation Ireland [16/IA/4468, 20/SPP/3685]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	K.H.G.M. acknowledges funding from Science Foundation Ireland (16/IA/4468 and 20/SPP/3685). He is grateful to L. Borkner, D. Jazayeri, C. Ni Chasaide, W. McCormack and J. Fletcher for comments and discussion.	Agak GW, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI141594; Aguilo N, 2016, J INFECT DIS, V213, P831, DOI 10.1093/infdis/jiv503; Ajendra J, 2020, MUCOSAL IMMUNOL, V13, P958, DOI 10.1038/s41385-020-0318-2; Allen AC, 2018, MUCOSAL IMMUNOL, V11, P1763, DOI 10.1038/s41385-018-0080-x; Alnahas S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01562; Alvarez-Coiradas E, 2020, INT IMMUNOPHARMACOL, V89, DOI 10.1016/j.intimp.2020.107026; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Asad M, 2021, FASEB J, V35, DOI 10.1096/fj.202002356RR; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Avdeev SN, 2021, CYTOKINE, V146, DOI 10.1016/j.cyto.2021.155627; Bar E, 2014, IMMUNITY, V40, P117, DOI 10.1016/j.immuni.2013.12.002; Baeten D, 2013, LANCET, V382, P1705, DOI 10.1016/S0140-6736(13)61134-4; Bagri P, 2017, J VIROL, V91, DOI 10.1128/JVI.01234-17; Basdeo SA, 2017, J IMMUNOL, V198, P2249, DOI 10.4049/jimmunol.1600737; Batalla A, 2015, J DERMATOL SCI, V80, P111, DOI 10.1016/j.jdermsci.2015.06.011; Bera MM, 2011, J IMMUNOL, V187, P4245, DOI 10.4049/jimmunol.1101789; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Blanco FJ, 2017, ARTHRITIS RHEUMATOL, V69, P1144, DOI 10.1002/art.40070; Boisson B, 2013, IMMUNITY, V39, P676, DOI 10.1016/j.immuni.2013.09.002; Borkner L, 2021, MUCOSAL IMMUNOL, V14, P1183, DOI 10.1038/s41385-021-00407-5; Break TJ, 2021, SCIENCE, V371, P252, DOI 10.1126/science.aay5731; Brigas HC, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109574; Burstein VL, 2018, J INVEST DERMATOL, V138, P1744, DOI 10.1016/j.jid.2018.02.042; Cachem FCOF, 2017, IMMUNOLOGY, V151, P167, DOI 10.1111/imm.12720; Carlino MS, 2021, LANCET, V398, P1002, DOI 10.1016/S0140-6736(21)01206-X; Chang Q, 2012, J GASTROEN HEPATOL, V27, P273, DOI 10.1111/j.1440-1746.2011.06782.x; Chen L, 2015, MUCOSAL IMMUNOL, V8, P390, DOI 10.1038/mi.2014.77; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Choi GB, 2016, SCIENCE, V351, P933, DOI 10.1126/science.aad0314; Chung DR, 2003, J IMMUNOL, V170, P1958, DOI 10.4049/jimmunol.170.4.1958; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; Conti HR, 2014, J EXP MED, V211, P2075, DOI 10.1084/jem.20130877; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Correale J, 2021, IMMUNOLOGY, V164, P569, DOI 10.1111/imm.13389; Cristiano C, 2019, BRIT J PHARMACOL, V176, P3544, DOI 10.1111/bph.14586; Crowe CR, 2009, J IMMUNOL, V183, P5301, DOI 10.4049/jimmunol.0900995; Puerta-Arias JD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163985; Davidson L, 2022, LANCET REG HEALTH-EU, V13, DOI 10.1016/j.lanepe.2021.100266; Dick AD, 2013, OPHTHALMOLOGY, V120, P777, DOI 10.1016/j.ophtha.2012.09.040; Dong XH, 2022, NEUROSCI LETT, V776, DOI 10.1016/j.neulet.2022.136563; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Dungan LS, 2014, EUR J IMMUNOL, V44, P2903, DOI 10.1002/eji.201444612; Edwards SC, 2020, J EXP MED, V217, DOI 10.1084/jem.20190834; Elliott DE, 2008, J IMMUNOL, V181, P2414, DOI 10.4049/jimmunol.181.4.2414; Emamaullee JA, 2009, DIABETES, V58, P1302, DOI 10.2337/db08-1113; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Essilfie AT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002244; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; Finlay CM, 2016, J IMMUNOL, V196, P703, DOI 10.4049/jimmunol.1501820; Fletcher JM, 2009, J IMMUNOL, V183, P7602, DOI 10.4049/jimmunol.0901881; Flierl MA, 2008, FASEB J, V22, P2198, DOI 10.1096/fj.07-105221; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Fujiwara H, 2014, J IMMUNOL, V193, P2565, DOI 10.4049/jimmunol.1400954; Garg AV, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003699; Ge Y, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01558; Geng JJ, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00760-8; Gil-Pulido J, 2022, CARDIOVASC RES, V118, P2932, DOI 10.1093/cvr/cvab359; Gladiator A, 2013, J IMMUNOL, V190, P521, DOI 10.4049/jimmunol.1202924; Goepfert A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08360-9; Gonzalez-Lombana C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003243; Guiton R, 2010, J INFECT DIS, V202, P427, DOI 10.1086/653738; Guo XZJ, 2018, IMMUNITY, V49, P531, DOI 10.1016/j.immuni.2018.07.011; Guttman-Yassky E, 2018, ARCH DERMATOL RES, V310, P607, DOI 10.1007/s00403-018-1853-5; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Habibi MS, 2020, SCIENCE, V370, P188, DOI 10.1126/science.aba9301; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Hamada S, 2008, J IMMUNOL, V181, P3456, DOI 10.4049/jimmunol.181.5.3456; Hansen ES, 2013, INFECT IMMUN, V81, P4421, DOI 10.1128/IAI.01129-13; Harley ITW, 2014, HEPATOLOGY, V59, P1830, DOI 10.1002/hep.26746; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hasan MZ, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-96110-3; Hassane M, 2017, MUCOSAL IMMUNOL, V10, P1056, DOI 10.1038/mi.2016.113; Havrdova E, 2016, J NEUROL, V263, P1287, DOI 10.1007/s00415-016-8128-x; Hellings PW, 2003, AM J RESP CELL MOL, V28, P42, DOI 10.1165/rcmb.4832; Hernandez-Santos N, 2013, MUCOSAL IMMUNOL, V6, P900, DOI 10.1038/mi.2012.128; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Hofmann MA, 2021, CLIN TRANSL ALLERGY, V11, DOI 10.1002/clt2.12047; Honkanen J, 2010, J IMMUNOL, V185, P1959, DOI 10.4049/jimmunol.1000788; Huang HQ, 2015, IMMUNOL CELL BIOL, V93, P126, DOI 10.1038/icb.2014.79; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Hymowitz SG, 2001, EMBO J, V20, P5332, DOI 10.1093/emboj/20.19.5332; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jeon YJ, 2020, AM J RESP CELL MOL, V62, P95, DOI 10.1165/rcmb.2018-0377OC; Jiang H, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.761448; Jin MM, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22158042; Kader M, 2009, MUCOSAL IMMUNOL, V2, P439, DOI 10.1038/mi.2009.90; Kang ZZ, 2012, IMMUNITY, V36, P821, DOI 10.1016/j.immuni.2012.03.021; Kashetsky N, 2022, J CUTAN MED SURG, V26, P79, DOI 10.1177/12034754211035667; Ke Y, 2009, J IMMUNOL, V182, P3183, DOI 10.4049/jimmunol.0802487; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kelly MN, 2005, INFECT IMMUN, V73, P617, DOI 10.1128/IAI.73.1.617-621.2005; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kim HY, 2014, NAT MED, V20, P54, DOI 10.1038/nm.3423; Kim JH, 2016, NAT IMMUNOL, V17, P1159, DOI 10.1038/ni.3523; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Kohlgruber AC, 2018, NAT IMMUNOL, V19, P464, DOI 10.1038/s41590-018-0094-2; Kohyama S, 2007, J IMMUNOL, V179, P3917, DOI 10.4049/jimmunol.179.6.3917; Korenaga H, 2010, FISH SHELLFISH IMMUN, V28, P809, DOI 10.1016/j.fsi.2010.01.016; Kostka SL, 2009, J IMMUNOL, V182, P3039, DOI 10.4049/jimmunol.0713598; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Lalor SJ, 2011, J IMMUNOL, V186, P5738, DOI 10.4049/jimmunol.1003597; Langley RG, 2014, NEW ENGL J MED, V371, P326, DOI 10.1056/NEJMoa1314258; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Leal FE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002028; Lee JS, 2015, IMMUNITY, V43, P727, DOI 10.1016/j.immuni.2015.09.003; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Lee YK, 2009, CURR OPIN IMMUNOL, V21, P274, DOI 10.1016/j.coi.2009.05.021; Leija-Martinez JJ, 2020, MED HYPOTHESES, V144, DOI 10.1016/j.mehy.2020.109935; Levy R, 2016, P NATL ACAD SCI USA, V113, pE8277, DOI 10.1073/pnas.1618300114; Li CG, 2012, CELL RES, V22, P528, DOI 10.1038/cr.2011.165; Li J, 2017, CURR OPIN MICROBIOL, V40, P46, DOI 10.1016/j.mib.2017.10.016; Li QS, 2021, CANCER IMMUNOL IMMUN, V70, P1789, DOI 10.1007/s00262-020-02795-2; Nascimento MSL, 2015, J INFECT DIS, V211, P1015, DOI 10.1093/infdis/jiu531; Lin YY, 2009, IMMUNITY, V31, P799, DOI 10.1016/j.immuni.2009.08.025; Liu HY, 2017, CELL HOST MICROBE, V22, P653, DOI 10.1016/j.chom.2017.10.006; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; Lu L, 2021, INT IMMUNOPHARMACOL, V96, DOI 10.1016/j.intimp.2021.107678; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Luo H, 2019, CELL REP, V29, P2384, DOI 10.1016/j.celrep.2019.10.085; Luzza F, 2000, J IMMUNOL, V165, P5332, DOI 10.4049/jimmunol.165.9.5332; Machhi J, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-021-02308-7; Magalhaes LMD, 2013, J INFECT DIS, V207, P661, DOI 10.1093/infdis/jis724; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Marchitto MC, 2019, P NATL ACAD SCI USA, V116, P10917, DOI 10.1073/pnas.1818256116; Mardiguian S, 2013, AM J PATHOL, V182, P2071, DOI 10.1016/j.ajpath.2013.02.029; Marks BR, 2009, NAT IMMUNOL, V10, P1125, DOI 10.1038/ni.1783; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Maslennikov R, 2021, EUR CYTOKINE NETW, V32, P8, DOI 10.1684/ecn.2021.0463; Masso-Silva JA, 2022, CLIN INFECT DIS, V74, P479, DOI 10.1093/cid/ciab437; Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206; Mbow M, 2013, J INFECT DIS, V207, P186, DOI 10.1093/infdis/jis654; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McGinley AM, 2020, IMMUNITY, V52, P342, DOI 10.1016/j.immuni.2020.01.002; McKinstry KK, 2009, J IMMUNOL, V182, P7353, DOI 10.4049/jimmunol.0900657; Mease PJ, 2015, NEW ENGL J MED, V373, P1329, DOI 10.1056/NEJMoa1412679; Meller S, 2015, NAT IMMUNOL, V16, P970, DOI 10.1038/ni.3211; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; Misiak A, 2017, J IMMUNOL, V198, P363, DOI 10.4049/jimmunol.1601024; Miyazaki Y, 2010, J IMMUNOL, V185, P1150, DOI 10.4049/jimmunol.0900047; Moaaz M, 2019, J NEUROIMMUNOL, V337, DOI 10.1016/j.jneuroim.2019.577071; Monteiro M, 2013, J IMMUNOL, V190, P805, DOI 10.4049/jimmunol.1201010; Moran B, 2017, J INVEST DERMATOL, V137, P2389, DOI 10.1016/j.jid.2017.05.033; Morrison PJ, 2013, MUCOSAL IMMUNOL, V6, P1143, DOI 10.1038/mi.2013.11; Murphy AG, 2014, J IMMUNOL, V192, P3697, DOI 10.4049/jimmunol.1303420; Nagata DED, 2014, AM J PATHOL, V184, P1807, DOI 10.1016/j.ajpath.2014.02.004; Newcomb DC, 2013, THORAX, V68, P717, DOI 10.1136/thoraxjnl-2012-202404; Nie K, 2013, NEUROSCI LETT, V541, P111, DOI 10.1016/j.neulet.2013.02.024; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; Omenetti S, 2019, IMMUNITY, V51, P77, DOI 10.1016/j.immuni.2019.05.004; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pitta MGR, 2009, J CLIN INVEST, V119, P2379, DOI 10.1172/JCI38813; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Qin XL, 2017, 2017 IEEE INTERNATIONAL CONFERENCE ON PROGNOSTICS AND HEALTH MANAGEMENT (ICPHM), P1, DOI 10.1109/ICPHM.2017.7998297; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Rajput C, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121882; Vidal-Castineira JR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158905; Reich K, 2021, NEW ENGL J MED, V385, P142, DOI 10.1056/NEJMoa2102383; Reynolds AD, 2010, J IMMUNOL, V184, P2261, DOI 10.4049/jimmunol.0901852; Reynolds JM, 2015, IMMUNITY, V42, P692, DOI 10.1016/j.immuni.2015.03.008; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Roark CL, 2007, J IMMUNOL, V179, P5576, DOI 10.4049/jimmunol.179.8.5576; Robert M, 2017, AUTOIMMUN REV, V16, P984, DOI 10.1016/j.autrev.2017.07.009; Romagnoli PA, 2016, P NATL ACAD SCI USA, V113, P8502, DOI 10.1073/pnas.1600713113; Ross PJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003264; ROUVIER E, 1993, J IMMUNOL, V150, P5445; Rowan AG, 2008, J IMMUNOL, V181, P4485, DOI 10.4049/jimmunol.181.7.4485; Rutitzky LI, 2011, EUR J IMMUNOL, V41, P2677, DOI 10.1002/eji.201041327; Rutitzky LI, 2005, J IMMUNOL, V175, P3920, DOI 10.4049/jimmunol.175.6.3920; Sadeghi A, 2021, J CELL PHYSIOL, V236, P2829, DOI 10.1002/jcp.30047; Sato K, 2020, J IMMUNOL, V205, P686, DOI 10.4049/jimmunol.1901238; Sauer A, 2012, J INFECT DIS, V206, P1319, DOI 10.1093/infdis/jis486; Saunte DM, 2017, BRIT J DERMATOL, V177, P47, DOI 10.1111/bjd.15015; Schmidt C, 2015, NAT BIOTECHNOL, V33, P894, DOI 10.1038/nbt0915-894b; Schmidt T, 2018, MOL IMMUNOL, V104, P90, DOI 10.1016/j.molimm.2018.09.005; Schnell A, 2021, CELL, V184, P6281, DOI 10.1016/j.cell.2021.11.018; Serrano C, 2013, MUCOSAL IMMUNOL, V6, P950, DOI 10.1038/mi.2012.133; Sheel M, 2015, J IMMUNOL, V195, P5707, DOI 10.4049/jimmunol.1501046; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Singh TP, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009693; Skepner J, 2014, J IMMUNOL, V192, P2564, DOI 10.4049/jimmunol.1302190; Smolen JS, 2017, ANN RHEUM DIS, V76, DOI 10.1136/annrheumdis-2016-209831; Solans L, 2018, MUCOSAL IMMUNOL, V11, P1753, DOI 10.1038/s41385-018-0073-9; Sommer A, 2018, CELL STEM CELL, V23, P123, DOI 10.1016/j.stem.2018.06.015; Song XY, 2011, NAT IMMUNOL, V12, P1151, DOI 10.1038/ni.2155; Steel KJA, 2020, ARTHRITIS RHEUMATOL, V72, P435, DOI 10.1002/art.41156; Stout-Delgado HW, 2009, CELL HOST MICROBE, V6, P446, DOI 10.1016/j.chom.2009.09.011; Strauss M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61965-5; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Sun HQ, 2012, J VIRAL HEPATITIS, V19, P396, DOI 10.1111/j.1365-2893.2011.01561.x; Suryawanshi A, 2011, J IMMUNOL, V187, P1919, DOI 10.4049/jimmunol.1100736; Sutherland TE, 2014, NAT IMMUNOL, V15, P1116, DOI 10.1038/ni.3023; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Sweeney CM, 2011, BRAIN BEHAV IMMUN, V25, P1170, DOI 10.1016/j.bbi.2011.03.007; Tamassia N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00795; Tanaka S, 2009, J IMMUNOL, V183, P7523, DOI 10.4049/jimmunol.0803828; Tang C, 2018, NAT IMMUNOL, V19, P755, DOI 10.1038/s41590-018-0134-y; Targan SR, 2016, AM J GASTROENTEROL, V111, P1599, DOI 10.1038/ajg.2016.298; Taylor PR, 2014, NAT IMMUNOL, V15, P143, DOI 10.1038/ni.2797; Tian J, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20190435; Boari JT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002658; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; van Hamburg JP, 2011, ARTHRITIS RHEUM-US, V63, P73, DOI 10.1002/art.30093; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vesely MCA, 2019, CELL, V178, P1176, DOI 10.1016/j.cell.2019.07.032; Vitiello GA, 2020, J EXP MED, V217, DOI 10.1084/jem.20190456; Walsh KP, 2009, J IMMUNOL, V183, P1577, DOI 10.4049/jimmunol.0803803; Wang J, 2014, J EXP MED, V211, P2397, DOI 10.1084/jem.20140625; Wang LY, 2011, INT J MOL MED, V27, P385, DOI 10.3892/ijmm.2011.594; Wang R, 2015, INFLAMM BOWEL DIS, V21, P973, DOI 10.1097/MIB.0000000000000353; Wang RS, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.715510; Wang X., 2021, NAT COMMUN, V12, DOI [10.1038/s41467-021-22242-91:CAS:528:DC%2BB3MXnslCksL4%3D, DOI 10.1038/S41467-021-22242-91:CAS:528:DC%2BB3MXNSLCKSL4%3D]; Wang YN, 2020, ONCOL LETT, V20, P611, DOI 10.3892/ol.2020.11618; Wang Y, 2021, FRONT CARDIOVASC MED, V8, DOI 10.3389/fcvm.2021.667768; Warren RB, 2021, NEW ENGL J MED, V385, P130, DOI 10.1056/NEJMoa2102388; Wei Q, 2021, ALLERGY ASTHMA CL IM, V17, DOI 10.1186/s13223-020-00504-3; Wen XY, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001399; Whibley N, 2016, J LEUKOCYTE BIOL, V99, P1153, DOI 10.1189/jlb.4A0915-428R; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Wu JH, 2021, MBIO, V12, DOI 10.1128/mBio.01599-21; Xie MM, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20181987; Xie Y, 2022, J ALLERGY CLIN IMMUN, V149, P467, DOI 10.1016/j.jaci.2021.12.769; Xu L, 2022, MOL NEUROBIOL, V59, P2116, DOI 10.1007/s12035-022-02749-y; Yang BH, 2016, MUCOSAL IMMUNOL, V9, P444, DOI 10.1038/mi.2015.74; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; YOO ZB, 1995, J IMMUNOL, V155, P5483; Yuan J, 2010, J IMMUNOL, V185, P4004, DOI 10.4049/jimmunol.1001718; Zhang HJ, 2018, MOL IMMUNOL, V93, P166, DOI 10.1016/j.molimm.2017.11.020; Zhang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039214; Zhao JJ, 2020, J EXP MED, V217, DOI 10.1084/jem.20190297; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	245	8	8	16	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.												10.1038/s41577-022-00746-9	http://dx.doi.org/10.1038/s41577-022-00746-9		JUL 2022	17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	2S7QJ	35790881	Green Published, Bronze			2022-12-18	WOS:000821984200001
J	Wolf, NK; Kissiov, DU; Raulet, DH				Wolf, Natalie K.; Kissiov, Djem U.; Raulet, David H.			Roles of natural killer cells in immunity to cancer, and applications to immunotherapy	NATURE REVIEWS IMMUNOLOGY			English	Review; Early Access							MHC CLASS-I; RECOMBINANT HUMAN INTERLEUKIN-12; INTERFERON-GAMMA PRODUCTION; NK CELLS; T-CELL; NKG2D RECEPTOR; INHIBITORY RECEPTORS; MONOCLONAL-ANTIBODY; ANTITUMOR-ACTIVITY; TRANSCRIPTION FACTORS	This Review explains how natural killer (NK) cells promote immunity to tumours. The authors cover the therapeutic approaches that are being developed to mobilize NK cells in patients with cancer, including NK cell activators, checkpoint blockade, cellular therapies, and bispecific and trispecific NK cell activating antibodies. Great strides have been made in recent years towards understanding the roles of natural killer (NK) cells in immunity to tumours and viruses. NK cells are cytotoxic innate lymphoid cells that produce inflammatory cytokines and chemokines. By lysing transformed or infected cells, they limit tumour growth and viral infections. Whereas T cells recognize peptides presented by MHC molecules, NK cells display receptors that recognize stress-induced autologous proteins on cancer cells. At the same time, their functional activity is inhibited by MHC molecules displayed on such cells. The enormous potential of NK cells for immunotherapy for cancer is illustrated by their broad recognition of stressed cells regardless of neoantigen presentation, and enhanced activity against tumours that have lost expression of MHC class I owing to acquired resistance mechanisms. As a result, many efforts are under way to mobilize endogenous NK cells with therapeutics, or to provide populations of ex vivo-expanded NK cells as a cellular therapy, in some cases by equipping the NK cells with chimeric antigen receptors. Here we consider the key features that underlie why NK cells are emerging as important new additions to the cancer therapeutic arsenal.	[Wolf, Natalie K.; Kissiov, Djem U.; Raulet, David H.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Mol Med, 229 Stanley Hall, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Raulet, DH (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Mol Med, 229 Stanley Hall, Berkeley, CA 94720 USA.	raulet@berkeley.edu		Kissiov, Djem/0000-0001-6279-342X	US National Institute of Health [R01AI113041]; US National Science Foundation [DGE 1752814]; QB3 Frontiers in Medical Research predoctoral fellowship; Cancer Research Coordinating Committee of the University of California; University of California, Berkeley Immunotherapeutics and Vaccine Research Initiative - Aduro Biotech [045535, 045538]	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); QB3 Frontiers in Medical Research predoctoral fellowship; Cancer Research Coordinating Committee of the University of California(University of California System); University of California, Berkeley Immunotherapeutics and Vaccine Research Initiative - Aduro Biotech(University of California System)	Research in the authors' laboratory was supported by US National Institute of Health grant R01AI113041 (D.H.R.) and the University of California, Berkeley Immunotherapeutics and Vaccine Research Initiative supported by Aduro Biotech (045535 and 045538) (D.H.R.). N.K.W. was supported by a US National Science Foundation predoctoral fellowship (DGE 1752814) and a QB3 Frontiers in Medical Research predoctoral fellowship. D.U.K. was supported by a predoctoral fellowship from the Cancer Research Coordinating Committee of the University of California.	Ablasser A, 2019, SCIENCE, V363, P1055, DOI 10.1126/science.aat8657; Andre P, 2018, CELL, V175, P1731, DOI 10.1016/j.cell.2018.10.014; Arai S, 2008, CYTOTHERAPY, V10, P625, DOI 10.1080/14653240802301872; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Ardolino M, 2014, J CLIN INVEST, V124, P4781, DOI 10.1172/JCI74337; Armand P, 2021, LEUKEMIA, V35, P777, DOI 10.1038/s41375-020-0939-1; Barber GN, 2015, NAT REV IMMUNOL, V15, P760, DOI 10.1038/nri3921; Barrow AD, 2018, CELL, V172, P534, DOI 10.1016/j.cell.2017.11.037; Barrow AD, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00909; Barry KC, 2018, NAT MED, V24, P1178, DOI 10.1038/s41591-018-0085-8; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Beldi-Ferchiou A, 2016, ONCOTARGET, V7, P72961, DOI 10.18632/oncotarget.12150; Benson DM, 2011, BLOOD, V118, P6387, DOI 10.1182/blood-2011-06-360255; Benson DM, 2010, BLOOD, V116, P2286, DOI 10.1182/blood-2010-02-271874; Bentebibel SE, 2019, CANCER DISCOV, V9, P711, DOI 10.1158/2159-8290.CD-18-1495; Bern MD, 2019, J EXP MED, V216, P99, DOI 10.1084/jem.20181076; Bhatnagar N, 2014, EUR J IMMUNOL, V44, P3368, DOI 10.1002/eji.201444515; Bi JC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00760; Bi JC, 2014, HEPATOLOGY, V60, P1389, DOI 10.1002/hep.27245; Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; Bonavita E, 2020, IMMUNITY, V53, P1215, DOI 10.1016/j.immuni.2020.10.020; Brodin P, 2009, BLOOD, V113, P2434, DOI 10.1182/blood-2008-05-156836; Bruno A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00771; Carayannopoulos LN, 2002, J IMMUNOL, V169, P4079, DOI 10.4049/jimmunol.169.8.4079; Carlsten M, 2016, CLIN CANCER RES, V22, P5211, DOI 10.1158/1078-0432.CCR-16-1108; Carlyle JR, 2008, SEMIN IMMUNOL, V20, P321, DOI 10.1016/j.smim.2008.05.004; Carozza JA, 2020, NAT CANCER, V1, P184, DOI 10.1038/s43018-020-0028-4; Carson WE, 2000, BLOOD, V96, P1465, DOI 10.1182/blood.V96.4.1465.h8001465_1465_1473; Castriconi R, 2003, P NATL ACAD SCI USA, V100, P4120, DOI 10.1073/pnas.0730640100; Cerwenka A, 2001, P NATL ACAD SCI USA, V98, P11521, DOI 10.1073/pnas.201238598; Champsaur M, 2010, J IMMUNOL, V185, P157, DOI 10.4049/jimmunol.1000397; Chan CJ, 2014, NAT IMMUNOL, V15, P431, DOI 10.1038/ni.2850; Charych DH, 2016, CLIN CANCER RES, V22, P680, DOI 10.1158/1078-0432.CCR-15-1631; Chen R, 2017, J CLIN ONCOL, V35, P2125, DOI 10.1200/JCO.2016.72.1316; Chin EN, 2020, SCIENCE, V369, P993, DOI 10.1126/science.abb4255; Chitadze G, 2013, INT J CANCER, V133, P1557, DOI 10.1002/ijc.28174; Concha-Benavente F, 2018, CANCER IMMUNOL RES, V6, P1548, DOI 10.1158/2326-6066.CIR-18-0062; Cooper MA, 2009, P NATL ACAD SCI USA, V106, P1915, DOI 10.1073/pnas.0813192106; Cordova AF, 2021, ACS CENTRAL SCI, V7, P1073, DOI 10.1021/acscentsci.1c00440; Coudert JD, 2008, BLOOD, V111, P3571, DOI 10.1182/blood-2007-07-100057; Coughlin CM, 1998, J CLIN INVEST, V101, P1441, DOI 10.1172/JCI1555; Cozar B, 2021, CANCER DISCOV, V11, P34, DOI 10.1158/2159-8290.CD-20-0655; Crinier A, 2018, IMMUNITY, V49, P971, DOI 10.1016/j.immuni.2018.09.009; Cursons J, 2019, CANCER IMMUNOL RES, V7, P1162, DOI 10.1158/2326-6066.CIR-18-0500; Daher M, 2021, CANCER DISCOV, V11, P45, DOI 10.1158/2159-8290.CD-20-0556; de Andrade LF, 2018, SCIENCE, V359, P1537, DOI 10.1126/science.aao0505; Deng WW, 2015, SCIENCE, V348, P136, DOI 10.1126/science.1258867; Deuse T, 2021, J EXP MED, V218, DOI 10.1084/jem.20200839; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Dogra P, 2020, CELL, V180, P749, DOI 10.1016/j.cell.2020.01.022; Doorduijn EM, 2017, CANCER IMMUNOL RES, V5, P642, DOI 10.1158/2326-6066.CIR-16-0334; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Fernandez-Messina L, 2010, J BIOL CHEM, V285, P8543, DOI 10.1074/jbc.M109.045906; Freud AG, 2017, IMMUNITY, V47, P820, DOI 10.1016/j.immuni.2017.10.008; Gang M, 2020, BLOOD, V136, P2308, DOI 10.1182/blood.2020006619; Gao YL, 2017, NAT IMMUNOL, V18, P1004, DOI 10.1038/ni.3800; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gauthier L, 2019, CELL, V177, P1701, DOI 10.1016/j.cell.2019.04.041; Ghiringhelli F, 2006, IMMUNOL REV, V214, P229, DOI 10.1111/j.1600-065X.2006.00445.x; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Gowen BG, 2015, ELIFE, V4, DOI 10.7554/eLife.08474; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Guma M, 2004, BLOOD, V104, P3664, DOI 10.1182/blood-2004-05-2058; Hammer Q, 2018, NAT IMMUNOL, V19, P453, DOI 10.1038/s41590-018-0082-6; Hanke T, 1999, IMMUNITY, V11, P67, DOI 10.1016/S1074-7613(00)80082-5; Harding SM, 2017, NATURE, V548, P466, DOI 10.1038/nature23470; Harly C, 2018, J EXP MED, V215, P249, DOI 10.1084/jem.20170832; Harrington KJ, 2018, ANN ONCOL, V29, P712; He H, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-24; HERBERMAN RB, 1975, INT J CANCER, V16, P230, DOI 10.1002/ijc.2910160205; Ho SSW, 2016, IMMUNITY, V44, P1177, DOI 10.1016/j.immuni.2016.04.010; Horowitz A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006702; Hosomi S, 2017, J EXP MED, V214, P2985, DOI 10.1084/jem.20162041; Hsu J, 2018, J CLIN INVEST, V128, P4654, DOI 10.1172/JCI99317; Jamieson AM, 2004, J IMMUNOL, V172, P864, DOI 10.4049/jimmunol.172.2.864; Johansson S, 2005, J EXP MED, V201, P1145, DOI 10.1084/jem.20050167; Johnston RJ, 2014, CANCER CELL, V26, P923, DOI 10.1016/j.ccell.2014.10.018; Joncker NT, 2010, J EXP MED, V207, P2065, DOI 10.1084/jem.20100570; Joncker NT, 2009, J IMMUNOL, V182, P4572, DOI 10.4049/jimmunol.0803900; Jung H, 2012, J EXP MED, V209, P2409, DOI 10.1084/jem.20120565; Jung K, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1438800; Kamiya T, 2019, J CLIN INVEST, V129, P2094, DOI 10.1172/JCI123955; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kerdiles Y, 2013, J EXP MED, V210, P1065, DOI 10.1084/jem.20130960; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Klebanoff CA, 2004, P NATL ACAD SCI USA, V101, P1969, DOI 10.1073/pnas.0307298101; Kobayashi H, 2005, BLOOD, V105, P721, DOI 10.1182/blood-2003-12-4187; Koh CY, 2001, BLOOD, V97, P3132, DOI 10.1182/blood.V97.10.3132; Konno H, 2018, ONCOGENE, V37, P2037, DOI 10.1038/s41388-017-0120-0; Korde N, 2014, HAEMATOLOGICA, V99, pE81, DOI 10.3324/haematol.2013.103085; Lahey LJ, 2020, MOL CELL, V80, P578, DOI 10.1016/j.molcel.2020.10.021; Lam AR, 2014, CANCER RES, V74, P2193, DOI 10.1158/0008-5472.CAN-13-1703; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Levin AM, 2012, NATURE, V484, P529, DOI 10.1038/nature10975; Li J, 2021, CANCER DISCOV, V11, P1212, DOI 10.1158/2159-8290.CD-20-0387; Li Y, 2018, CELL STEM CELL, V23, P181, DOI 10.1016/j.stem.2018.06.002; LIAO NS, 1991, SCIENCE, V253, P199, DOI 10.1126/science.1853205; Liu EL, 2020, NEW ENGL J MED, V382, P545, DOI 10.1056/NEJMoa1910607; Liu Y, 2017, ONCOGENE, V36, P6143, DOI 10.1038/onc.2017.209; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Lopez-Verges S, 2011, P NATL ACAD SCI USA, V108, P14725, DOI 10.1073/pnas.1110900108; Lowry LE, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01061; Lu SJ, 2015, CLIN CANCER RES, V21, P4819, DOI 10.1158/1078-0432.CCR-15-0845; Luteijn RD, 2019, NATURE, V573, P434, DOI 10.1038/s41586-019-1553-0; Madera S, 2016, J EXP MED, V213, P225, DOI 10.1084/jem.20150712; Mancusi A, 2016, BLOOD, V128, P2616, DOI 10.1182/blood-2016-07-730564; Mansurov A, 2020, NAT BIOMED ENG, DOI 10.1038/s41551-020-0549-2; Marcus A, 2018, IMMUNITY, V49, P754, DOI 10.1016/j.immuni.2018.09.016; Martinez J, 2008, J IMMUNOL, V180, P1592, DOI 10.4049/jimmunol.180.3.1592; Mattei F, 2001, J IMMUNOL, V167, P1179, DOI 10.4049/jimmunol.167.3.1179; McWhirter SM, 2009, J EXP MED, V206, P1899, DOI 10.1084/jem.20082874; Melaiu O, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.03038; Meric-Bernstam F, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.2507; Michelet X, 2018, NAT IMMUNOL, V19, P1330, DOI 10.1038/s41590-018-0251-7; Miller JS, 2005, BLOOD, V105, P3051, DOI 10.1182/blood-2004-07-2974; MILLER SC, 1982, J IMMUNOL, V129, P2282; Miyake T, 2009, J IMMUNOL, V183, P2522, DOI 10.4049/jimmunol.0901500; Miyazaki T, 2021, J IMMUNOTHER CANCER, V9, DOI 10.1136/jitc-2020-002024; Motzer RJ, 1998, CLIN CANCER RES, V4, P1183; Mullard A, 2021, NAT REV DRUG DISCOV, V20, P163, DOI 10.1038/d41573-021-00034-6; Narni-Mancinelli E, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam9628; Nguyen KG, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.575597; Ni J, 2012, J EXP MED, V209, P2351, DOI 10.1084/jem.20120944; Nice TJ, 2009, J EXP MED, V206, P287, DOI 10.1084/jem.20081335; Nicolai CJ, 2020, SCIENCE, V368, P943, DOI 10.1126/science.abc2502; Nicolai CJ, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aaz2738; Niehrs A, 2019, NAT IMMUNOL, V20, P1129, DOI 10.1038/s41590-019-0448-4; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; O'Shea D, 2019, CANCERS, V11, DOI 10.3390/cancers11040573; O'Sullivan TE, 2015, IMMUNITY, V43, P634, DOI 10.1016/j.immuni.2015.09.013; Obiedat A, 2020, J MOL MED, V98, P135, DOI 10.1007/s00109-019-01859-w; Ogasawara K, 2003, IMMUNITY, V18, P41, DOI 10.1016/S1074-7613(02)00505-8; OHLEN C, 1989, SCIENCE, V246, P666, DOI 10.1126/science.2814488; Oppenheim DE, 2005, NAT IMMUNOL, V6, P928, DOI 10.1038/ni1239; Osaki T, 1998, J IMMUNOL, V160, P1742; Pan BS, 2020, SCIENCE, V369, P935, DOI 10.1126/science.aba6098; Park CG, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar1916; Paust S, 2017, J VIROL, V91, DOI 10.1128/JVI.00169-17; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Pende D, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01179; Poznanski SM, 2021, CELL METAB, V33, P1205, DOI 10.1016/j.cmet.2021.03.023; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Raulet DH, 2004, NAT IMMUNOL, V5, P996, DOI 10.1038/ni1114; Raulet DH, 2001, ANNU REV IMMUNOL, V19, P291, DOI 10.1146/annurev.immunol.19.1.291; Rebmann V, 2007, CLIN IMMUNOL, V123, P114, DOI 10.1016/j.clim.2006.11.007; Rhode PR, 2016, CANCER IMMUNOL RES, V4, P49, DOI 10.1158/2326-6066.CIR-15-0093-T; Ritchie C, 2019, MOL CELL, V75, P372, DOI 10.1016/j.molcel.2019.05.006; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; Roemer MGM, 2016, CANCER IMMUNOL RES, V4, P910, DOI 10.1158/2326-6066.CIR-16-0201; Romagne F, 2009, BLOOD, V114, P2667, DOI 10.1182/blood-2009-02-206532; Romee R, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2341; Romee R, 2012, BLOOD, V120, P4751, DOI 10.1182/blood-2012-04-419283; ROSENBERG SA, 1987, NEW ENGL J MED, V316, P889, DOI 10.1056/NEJM198704093161501; ROSENBERG SA, 1985, J EXP MED, V161, P1169, DOI 10.1084/jem.161.5.1169; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Salih HR, 2006, HUM IMMUNOL, V67, P188, DOI 10.1016/j.humimm.2006.02.008; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; Sarha D, 2018, BLOOD ADV, V2, P1459, DOI 10.1182/bloodadvances.2017012369; Schadt L, 2019, CELL REP, V29, P1236, DOI 10.1016/j.celrep.2019.09.065; SCHARTON TM, 1993, J EXP MED, V178, P567, DOI 10.1084/jem.178.2.567; SEAMAN WE, 1987, J IMMUNOL, V138, P4539; Seillet C, 2014, J EXP MED, V211, P1733, DOI 10.1084/jem.20140145; Silva DA, 2019, NATURE, V565, P186, DOI 10.1038/s41586-018-0830-7; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Smyth MJ, 2000, J IMMUNOL, V165, P2665, DOI 10.4049/jimmunol.165.5.2665; Smyth MJ, 2001, INT IMMUNOL, V13, P459, DOI 10.1093/intimm/13.4.459; Srivastava S, 2010, CURR MED CHEM, V17, P3353, DOI 10.2174/092986710793176348; Stanietsky N, 2009, P NATL ACAD SCI USA, V106, P17858, DOI 10.1073/pnas.0903474106; Street SEA, 2004, J EXP MED, V199, P879, DOI 10.1084/jem.20031981; Suck G, 2016, CANCER IMMUNOL IMMUN, V65, P485, DOI 10.1007/s00262-015-1761-x; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Takaki R, 2005, J IMMUNOL, V175, P2167, DOI 10.4049/jimmunol.175.4.2167; Tam YK, 2003, CYTOTHERAPY, V5, P259, DOI 10.1080/14653240310001523; Terren I, 2020, SEMIN HEMATOL, V57, P213, DOI 10.1053/j.seminhematol.2020.10.003; Terren I, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02278; Textor S, 2011, CANCER RES, V71, P5998, DOI 10.1158/0008-5472.CAN-10-3211; Thompson TW, 2018, ELIFE, V7, DOI 10.7554/eLife.32919; Thompson TW, 2017, ELIFE, V6, DOI 10.7554/eLife.30881; Tomura M, 1998, J IMMUNOL, V160, P4738; Vari F, 2018, BLOOD, V131, P1809, DOI 10.1182/blood-2017-07-796342; Varn FS, 2017, CANCER RES, V77, P1271, DOI 10.1158/0008-5472.CAN-16-2490; Veldman J, 2020, CANCER TREAT REV, V82, DOI 10.1016/j.ctrv.2019.101931; Vey Norbert, 2018, Oncotarget, V9, P17675, DOI 10.18632/oncotarget.24832; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Voskoboinik I, 2015, NAT REV IMMUNOL, V15, P388, DOI 10.1038/nri3839; Wagner JA, 2017, J CLIN INVEST, V127, P4042, DOI 10.1172/JCI90387; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wang RP, 2012, J LEUKOCYTE BIOL, V91, P299, DOI 10.1189/jlb.0611308; Weiss GR, 2003, J IMMUNOTHER, V26, P343, DOI 10.1097/00002371-200307000-00006; Wiedemann GM, 2021, NAT IMMUNOL, V22, P627, DOI 10.1038/s41590-021-00909-1; Wolf Natalie K, 2022, Proc Natl Acad Sci U S A, V119, pe2200568119, DOI 10.1073/pnas.2200568119; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Wrangle JM, 2018, LANCET ONCOL, V19, P694, DOI 10.1016/S1470-2045(18)30148-7; Xia TL, 2016, CANCER RES, V76, P6747, DOI 10.1158/0008-5472.CAN-16-1404; Xia TL, 2016, CELL REP, V14, P282, DOI 10.1016/j.celrep.2015.12.029; Yang KM, 2013, CANCER RES, V73, P6679, DOI 10.1158/0008-5472.CAN-13-0891; Yawata M, 2008, BLOOD, V112, P2369, DOI 10.1182/blood-2008-03-143727; YOKOYAMA WM, 1993, ANNU REV IMMUNOL, V11, P613, DOI 10.1146/annurev.iy.11.040193.003145; Young A, 2018, CANCER RES, V78, P1003, DOI 10.1158/0008-5472.CAN-17-2826; Zamai L, 1998, J EXP MED, V188, P2375, DOI 10.1084/jem.188.12.2375; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015; Zhang ML, 2018, P NATL ACAD SCI USA, V115, pE10915, DOI 10.1073/pnas.1811615115; Zhang Q, 2018, NAT IMMUNOL, V19, P723, DOI 10.1038/s41590-018-0132-0; Zhang ZB, 2020, NATURE, V579, P415, DOI 10.1038/s41586-020-2071-9; Zhou C, 2020, IMMUNITY, V52, P767, DOI 10.1016/j.immuni.2020.03.016; Zhou T, 2020, NATURE, V583, P609, DOI 10.1038/s41586-020-2422-6; Zhou ZW, 2020, SCIENCE, V368, P965, DOI 10.1126/science.aaz7548; Zhu EF, 2015, CANCER CELL, V27, P489, DOI 10.1016/j.ccell.2015.03.004; Zingoni A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00447; Zook EC, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao2139; Zuo JM, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aai8904	216	8	8	12	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.												10.1038/s41577-022-00732-1	http://dx.doi.org/10.1038/s41577-022-00732-1		MAY 2022	16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1Q8IT	35637393				2022-12-18	WOS:000802926400002
J	Miyauchi, E; Shimokawa, C; Steimle, A; Desai, MS; Ohno, H				Miyauchi, Eiji; Shimokawa, Chikako; Steimle, Alex; Desai, Mahesh S.; Ohno, Hiroshi			The impact of the gut microbiome on extra-intestinal autoimmune diseases	NATURE REVIEWS IMMUNOLOGY			English	Review; Early Access							REGULATORY T-CELLS; MULTIPLE-SCLEROSIS PATIENTS; SEGMENTED FILAMENTOUS BACTERIA; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PATHOGENIC TH17 CELLS; INTESTINAL MICROBIOTA; RHEUMATOID-ARTHRITIS; COMMENSAL MICROBIOTA; CYTOKINE PRODUCTION; ADOPTIVE TRANSFER	The prevalence of autoimmune diseases (ADs) worldwide has rapidly increased over the past few decades. Thus, in addition to the classical risk factors for ADs, such as genetic polymorphisms, infections and smoking, environmental triggers have been considered. Recent sequencing-based approaches have revealed that patients with extra-intestinal ADs, such as multiple sclerosis, rheumatoid arthritis, type 1 diabetes and systemic lupus erythematosus, have distinct gut microbiota compositions compared to healthy controls. Faecal microbiota transplantation or inoculation with specific microbes in animal models of ADs support the hypothesis that alterations of gut microbiota influence autoimmune responses and disease outcome. Here, we describe the compositional and functional changes in the gut microbiota in patients with extra-intestinal AD and discuss how the gut microbiota affects immunity. Moreover, we examine how the gut microbiota might be modulated in patients with ADs as a potential preventive or therapeutic approach. Patients with autoimmune diseases, such as multiple sclerosis, rheumatoid arthritis, type 1 diabetes and systemic lupus erythematosus, have distinct gut microbiota compositions compared to healthy controls. This Review explores how the gut microbiota influence autoimmune responses in extra-intestinal autoimmune diseases and discusses potential preventative and therapeutic strategies targeted at the microbiota-immune interface.	[Miyauchi, Eiji; Shimokawa, Chikako; Ohno, Hiroshi] RIKEN Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Shimokawa, Chikako] Natl Inst Infect Dis, Dept Parasitol, Tokyo, Japan; [Steimle, Alex; Desai, Mahesh S.] Luxembourg Inst Hlth, Dept Infect & Immun, Luxembourg, Luxembourg; [Desai, Mahesh S.] Univ Southern Denmark, Odense Univ Hosp, Odense Res Ctr Anaphylaxis, Dept Dermatol, Odense, Denmark; [Desai, Mahesh S.] Univ Southern Denmark, Odense Univ Hosp, Allergy Ctr, Odense, Denmark; [Ohno, Hiroshi] Yokohama City Univ, Grad Sch Med Life Sci, Immunobiol Lab, Yokohama, Kanagawa, Japan; [Ohno, Hiroshi] Chiba Univ, Grad Sch Med, Lab Immune Regulat, Chiba, Chiba, Japan; [Miyauchi, Eiji] Gunma Univ, Inst Mol & Cellular Regulat, Haebashi, Gunma, Japan	RIKEN; National Institute of Infectious Diseases (NIID); Luxembourg Institute of Health; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; Yokohama City University; Chiba University; Gunma University	Ohno, H (corresponding author), RIKEN Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan.; Desai, MS (corresponding author), Luxembourg Inst Hlth, Dept Infect & Immun, Luxembourg, Luxembourg.; Desai, MS (corresponding author), Univ Southern Denmark, Odense Univ Hosp, Odense Res Ctr Anaphylaxis, Dept Dermatol, Odense, Denmark.; Desai, MS (corresponding author), Univ Southern Denmark, Odense Univ Hosp, Allergy Ctr, Odense, Denmark.; Ohno, H (corresponding author), Yokohama City Univ, Grad Sch Med Life Sci, Immunobiol Lab, Yokohama, Kanagawa, Japan.; Ohno, H (corresponding author), Chiba Univ, Grad Sch Med, Lab Immune Regulat, Chiba, Chiba, Japan.	mahesh.desai@lih.lu; hiroshi.ohno@riken.jp	Ohno, Hiroshi/L-7899-2014	Ohno, Hiroshi/0000-0001-8776-9661; Desai, Mahesh S/0000-0002-9223-2209	Astellas Foundation for Research on Metabolic Disorders; JSPS KAKENHI [19H01030, 19K05907]; Naito foundation; Yakult Bio-Science Foundation; Shiseido Female Researcher Science Grant; Nakajima Foundation; Uehara Memorial Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Luxembourg National Research Fund (FNR) CORE grant [C18/BM/12585940]; FNR INTER Mobility grant [16/11455695]; AMED-CREST [19gm0710009h0006]; Food Science Institute Foundation	Astellas Foundation for Research on Metabolic Disorders; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Naito foundation(Naito Memorial Foundation); Yakult Bio-Science Foundation; Shiseido Female Researcher Science Grant(Shiseido Company, Limited); Nakajima Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Luxembourg National Research Fund (FNR) CORE grant; FNR INTER Mobility grant; AMED-CREST; Food Science Institute Foundation	Work in the authors' laboratory was supported by the following grants: the research grant of Astellas Foundation for Research on Metabolic Disorders and JSPS KAKENHI Grant Number 19K05907 to E.M.; JSPS KAKENHI Grant Number 19K16682, Naito foundation, Yakult Bio-Science Foundation, Shiseido Female Researcher Science Grant, The Nakajima Foundation, Uehara Memorial Foundation, and Mochida Memorial Foundation for Medical and Pharmaceutical Research to C.S.; Luxembourg National Research Fund (FNR) CORE grant (C18/BM/12585940) and FNR INTER Mobility grant (16/11455695) to M.S.D.; and AMED-CREST (19gm0710009h0006), JSPS KAKENHI Grant Number 19H01030, and the Food Science Institute Foundation to H.O.	Abdollahpour I, 2018, ACTA NEUROL SCAND, V138, P308, DOI 10.1111/ane.12958; Al Khalili Ayida, 2019, JAAD Case Rep, V5, P682, DOI 10.1016/j.jdcr.2019.05.022; Alkanani AK, 2015, DIABETES, V64, P3510, DOI 10.2337/db14-1847; Alpizar-Rodriguez D, 2019, ANN RHEUM DIS, V78, P590, DOI 10.1136/annrheumdis-2018-214514; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Aykut B, 2019, NATURE, V574, P264, DOI 10.1038/s41586-019-1608-2; Ayyappan P, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00658; Azzouz D, 2019, ANN RHEUM DIS, V78, P947, DOI 10.1136/annrheumdis-2018-214856; Bach JF, 2018, NAT REV IMMUNOL, V18, P105, DOI 10.1038/nri.2017.111; Bacher P, 2019, CELL, V176, P1340, DOI 10.1016/j.cell.2019.01.041; Baldin E, 2021, NEUROEPIDEMIOLOGY, V55, P224, DOI 10.1159/000515682; Becattini S, 2016, TRENDS MOL MED, V22, P458, DOI 10.1016/j.molmed.2016.04.003; Berer K, 2017, P NATL ACAD SCI USA, V114, P10719, DOI 10.1073/pnas.1711233114; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Birchenough GMH, 2016, SCIENCE, V352, P1535, DOI 10.1126/science.aaf7419; Borody T, 2011, AM J GASTROENTEROL, V106, pS352; Brucklacher-Waldert V, 2009, BRAIN, V132, P3329, DOI 10.1093/brain/awp289; Burrack AL, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00343; Burrows MP, 2015, P NATL ACAD SCI USA, V112, P9973, DOI 10.1073/pnas.1508740112; Buscarinu MC, 2018, NEUROTHERAPEUTICS, V15, P68, DOI 10.1007/s13311-017-0582-3; Calvo-Barreiro L, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040906; Cassotta A, 2019, NAT MED, V25, P1402, DOI 10.1038/s41591-019-0568-2; Cekanaviciute E, 2017, P NATL ACAD SCI USA, V114, P10713, DOI 10.1073/pnas.1711235114; Chang HF, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21134660; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; Chelakkot C, 2018, EXP MOL MED, V50, DOI 10.1038/emm.2017.282; Chen J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28484; Chen J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0299-7; Chen T, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1552-y; Choi IY, 2016, CELL REP, V15, P2136, DOI 10.1016/j.celrep.2016.05.009; Ciccia F, 2017, ANN RHEUM DIS, V76, P1123, DOI 10.1136/annrheumdis-2016-210000; Correale J, 2015, ACTA NEUROL SCAND, V132, P46, DOI 10.1111/ane.12431; Correale J, 2007, ANN NEUROL, V61, P97, DOI 10.1002/ana.21067; Correale J, 2009, BRAIN, V132, P1146, DOI 10.1093/brain/awp033; Cosorich I, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700492; Costea PI, 2017, NAT BIOTECHNOL, V35, P1069, DOI 10.1038/nbt.3960; DANIEL D, 1995, EUR J IMMUNOL, V25, P1056, DOI 10.1002/eji.1830250430; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Davidson TS, 2011, EUR J IMMUNOL, V41, P2862, DOI 10.1002/eji.201141503; Davis-Richardson AG, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00678; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dehner C, 2019, CURR OPIN RHEUMATOL, V31, P201, DOI 10.1097/BOR.0000000000000574; Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043; Dorner T, 2019, LANCET, V393, P2344, DOI 10.1016/S0140-6736(19)30546-X; Doonan J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09361-0; Duc D, 2019, CELL REP, V29, P378, DOI 10.1016/j.celrep.2019.09.002; Duncan ID, 2019, P NATL ACAD SCI USA, V116, P24922, DOI 10.1073/pnas.1918897116; Duscha A, 2020, CELL, V180, P1067, DOI 10.1016/j.cell.2020.02.035; Engen SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104306; Mejia-Leon ME, 2014, SCI REP-UK, V4, DOI 10.1038/srep03814; Farez MF, 2015, J NEUROL NEUROSUR PS, V86, P26, DOI 10.1136/jnnp-2014-307928; Fasano A, 2012, CLIN REV ALLERG IMMU, V42, P71, DOI 10.1007/s12016-011-8291-x; Fitzgerald KC, 2018, NEUROLOGY, V90, pE1, DOI 10.1212/WNL.0000000000004768; Fletcher JM, 2009, J IMMUNOL, V183, P7602, DOI 10.4049/jimmunol.0901881; Fousteri G, 2017, CURR DIABETES REV, V13, P322, DOI 10.2174/1573399812666160427104157; FUJINAMI RS, 1985, SCIENCE, V230, P1043, DOI 10.1126/science.2414848; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gergianaki I, 2018, BEST PRACT RES CL RH, V32, P188, DOI 10.1016/j.berh.2018.09.004; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Geva-Zatorsky N, 2017, CELL, V168, P928, DOI 10.1016/j.cell.2017.01.022; Gibson GR, 2017, NAT REV GASTRO HEPAT, V14, P491, DOI 10.1038/nrgastro.2017.75; Godel C, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01766-9; Greiling TM, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan2306; Haas J, 2005, EUR J IMMUNOL, V35, P3343, DOI 10.1002/eji.200526065; Haghikia A, 2015, IMMUNITY, V43, P817, DOI 10.1016/j.immuni.2015.09.007; Harbison JE, 2019, PEDIATR DIABETES, V20, P574, DOI 10.1111/pedi.12865; Harkiolaki M, 2009, IMMUNITY, V30, P348, DOI 10.1016/j.immuni.2009.01.009; Hartung DM, 2015, NEUROLOGY, V84, P2185, DOI 10.1212/WNL.0000000000001608; Hauser SL, 2017, NEW ENGL J MED, V376, P221, DOI 10.1056/NEJMoa1601277; Hayashi T, 2009, P NATL ACAD SCI USA, V106, P2764, DOI 10.1073/pnas.0813037106; He BK, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00385; He ZX, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0146-9; Hegazy AN, 2017, GASTROENTEROLOGY, V153, P1320, DOI 10.1053/j.gastro.2017.07.047; Hemmer B, 2017, NAT REV NEUROL, V13, P72, DOI 10.1038/nrneurol.2017.2; Hevia A, 2014, MBIO, V5, DOI 10.1128/mBio.01548-14; Holodniy M, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014764, 10.1371/journal.pone.0025792]; Horwitz DA, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2511; Huan J, 2005, J NEUROSCI RES, V81, P45, DOI 10.1002/jnr.20522; Hussman JP, 2016, GENES IMMUN, V17, P305, DOI 10.1038/gene.2016.23; Iliev ID, 2017, NAT REV IMMUNOL, V17, P635, DOI 10.1038/nri.2017.55; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jacob N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76109-y; Jangi S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12015; Jenkins TP, 2019, TRENDS PARASITOL, V35, P13, DOI 10.1016/j.pt.2018.10.007; Jin X, 2019, J DIABETES, V11, P440, DOI 10.1111/1753-0407.12870; Joyce SA, 2016, ANNU REV FOOD SCI T, V7, P313, DOI 10.1146/annurev-food-041715-033159; Kadowaki A, 2019, BRAIN, V142, P916, DOI 10.1093/brain/awz012; Kalincik T, 2017, LANCET NEUROL, V16, P271, DOI 10.1016/S1474-4422(17)30007-8; KATZ J, 1993, EUR J IMMUNOL, V23, P3358, DOI 10.1002/eji.1830231244; Kishikawa T, 2020, ANN RHEUM DIS, V79, P103, DOI 10.1136/annrheumdis-2019-215743; Knip M, 2014, JAMA-J AM MED ASSOC, V311, P2279, DOI 10.1001/jama.2014.5610; Kobayashi M, 2007, J IMMUNOL, V179, P2082, DOI 10.4049/jimmunol.179.4.2082; Kohm AP, 2003, TRENDS MICROBIOL, V11, P101, DOI 10.1016/S0966-842X(03)00006-4; Konig MF, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaj1921; Korn T, 2007, J NEUROIMMUNOL, V191, P51, DOI 10.1016/j.jneuroim.2007.09.009; Kostic AD, 2015, CELL HOST MICROBE, V17, P260, DOI 10.1016/j.chom.2015.01.001; Kouchaki E, 2017, CLIN NUTR, V36, P1245, DOI 10.1016/j.clnu.2016.08.015; Krebs CF, 2016, IMMUNITY, V45, P1078, DOI 10.1016/j.immuni.2016.10.020; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; Kwon HK, 2013, CLIN IMMUNOL, V146, P217, DOI 10.1016/j.clim.2013.01.001; Lee JY, 2020, CELL, V180, P79, DOI 10.1016/j.cell.2019.11.026; Lee YH, 2008, J IMMUNOL, V180, P825, DOI 10.4049/jimmunol.180.2.825; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Lerner A, 2015, AUTOIMMUN REV, V14, P479, DOI 10.1016/j.autrev.2015.01.009; Libbey JE, 2020, BENEF MICROBES, V11, P669, DOI 10.3920/BM2020.0012; Libera DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021386; Lin R, 2015, INT J CLIN EXP PATHO, V8, P5153; Louis P, 2017, ENVIRON MICROBIOL, V19, P29, DOI 10.1111/1462-2920.13589; Loza MJ, 2011, CELL IMMUNOL, V271, P110, DOI 10.1016/j.cellimm.2011.06.010; Luckel C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13731-z; Lumb FE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01651-1; Lund-Blix NA, 2015, DIABETES CARE, V38, P257, DOI 10.2337/dc14-1130; Luo XM, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02288-17; Ma K, 2016, J NEUROCHEM, V139, P1151, DOI 10.1111/jnc.13871; Maeda Y, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0283-6; Maeda Y, 2016, ARTHRITIS RHEUMATOL, V68, P2646, DOI 10.1002/art.39783; Maizels RM, 2016, J ALLERGY CLIN IMMUN, V138, P666, DOI 10.1016/j.jaci.2016.07.007; Makhlouf L, 2004, TRANSPLANTATION, V77, P990, DOI 10.1097/01.TP.0000118410.61419.59; Makkawi S, 2018, NEUROL-NEUROIMMUNOL, V5, DOI 10.1212/NXI.0000000000000459; Mangalam A, 2017, CELL REP, V20, P1269, DOI 10.1016/j.celrep.2017.07.031; Marietta E, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.573079; Marietta EV, 2016, ARTHRITIS RHEUMATOL, V68, P2878, DOI 10.1002/art.39785; Marino E, 2017, NAT IMMUNOL, V18, P552, DOI 10.1038/ni.3713; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; McMurran CE, 2019, P NATL ACAD SCI USA, V116, P25311, DOI 10.1073/pnas.1905787116; Mikkelsen KH, 2017, DIABETIC MED, V34, P272, DOI 10.1111/dme.13262; Miller SD, 1997, NAT MED, V3, P1133, DOI 10.1038/nm1097-1133; Miyake S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137429; Miyauchi E, 2020, NATURE, V585, P102, DOI 10.1038/s41586-020-2634-9; Morgan ME, 2005, ARTHRITIS RHEUM-US, V52, P2212, DOI 10.1002/art.21195; Morton AM, 2014, P NATL ACAD SCI USA, V111, P6696, DOI 10.1073/pnas.1405634111; Mu QH, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00608; Mutengo Mable M, 2018, J Parasitol Res, V2018, P9754060, DOI 10.1155/2018/9754060; Najafian N, 2003, J CLIN INVEST, V112, P1037, DOI 10.1172/JCI200317935; Nicholas E., 2016, LANCET NEUROL, V18, P88; Nichols JR, 2009, J IMMUNOL, V182, P7119, DOI 10.4049/jimmunol.0802656; Ochoa-Reparaz J, 2010, MUCOSAL IMMUNOL, V3, P487, DOI 10.1038/mi.2010.29; Ochoa-Reparaz J, 2017, TRANSL RES, V179, P126, DOI 10.1016/j.trsl.2016.07.016; OLHAGEN B, 1968, ACTA MED SCAND, V184, P395; Olia A, 2020, PARASITOL INT, V76, DOI 10.1016/j.parint.2020.102057; Olsen JK, 2001, J CLIN INVEST, V108, P311; Parfrey LW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182205; Parrish A, 2022, TRENDS MOL MED, V28, P36, DOI 10.1016/j.molmed.2021.10.004; Peres RS, 2015, P NATL ACAD SCI USA, V112, P2509, DOI 10.1073/pnas.1424792112; Pianta A, 2017, J CLIN INVEST, V127, P2946, DOI 10.1172/JCI93450; Pianta A, 2017, ARTHRITIS RHEUMATOL, V69, P964, DOI 10.1002/art.40003; Piermattei A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00191; Pugliese A, 2017, J CLIN INVEST, V127, P2881, DOI 10.1172/JCI94549; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quraishi MN, 2017, ALIMENT PHARM THER, V46, P479, DOI 10.1111/apt.14201; Restorick SM, 2017, BRAIN BEHAV IMMUN, V64, P71, DOI 10.1016/j.bbi.2017.03.008; Reynolds JM, 2012, P NATL ACAD SCI USA, V109, P13064, DOI 10.1073/pnas.1120585109; Rinaldi M, 2013, CLIN REV ALLERG IMMU, V45, P152, DOI 10.1007/s12016-012-8344-9; Rodgers Jane M., 2012, Yale Journal of Biology and Medicine, V85, P447; Rothhammer V, 2016, CURR OPIN IMMUNOL, V43, P46, DOI 10.1016/j.coi.2016.09.002; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Rutayisire E, 2016, BMC GASTROENTEROL, V16, DOI 10.1186/s12876-016-0498-0; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schenker M, 1999, DIABETOLOGIA, V42, P671, DOI 10.1007/s001250051214; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Schultz V, 2017, GLIA, V65, P1350, DOI 10.1002/glia.23167; Seregin SS, 2017, CELL REP, V19, P733, DOI 10.1016/j.celrep.2017.03.080; Shalapour S, 2017, NATURE, V551, P340, DOI 10.1038/nature24302; Shimokawa C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15857-x; Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839; Smallwood TB, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00453; Sokol H, 2017, GUT, V66, P1039, DOI [10.1136/gutjnl-2015-310746, 10.1136/gutjnl-20]; Song H, 2018, JAMA-J AM MED ASSOC, V319, P2388, DOI 10.1001/jama.2018.7028; Sonnenburg ED, 2014, CELL METAB, V20, P779, DOI 10.1016/j.cmet.2014.07.003; Standaert-Vitse A, 2006, GASTROENTEROLOGY, V130, P1764, DOI 10.1053/j.gastro.2006.02.009; Statovci D, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00838; Steimle A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22136855; Steimle A, 2019, MOL THER, V27, P1974, DOI 10.1016/j.ymthe.2019.07.007; Steimle A, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000334; Stewart CJ, 2018, NATURE, V562, P583, DOI 10.1038/s41586-018-0617-x; Su LF, 2013, IMMUNITY, V38, P373, DOI 10.1016/j.immuni.2012.10.021; Sun J, 2015, IMMUNITY, V43, P304, DOI 10.1016/j.immuni.2015.07.013; SWANK RL, 1990, LANCET, V336, P37, DOI 10.1016/0140-6736(90)91533-G; Tajik N, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15831-7; Takewaki D, 2020, P NATL ACAD SCI USA, V117, P22402, DOI 10.1073/pnas.2011703117; Tankou SK, 2018, ANN NEUROL, V83, P1147, DOI 10.1002/ana.25244; Tankou SK, 2018, MULT SCLER J, V24, P58, DOI 10.1177/1352458517737390; Teixeira B, 2013, CLIN IMMUNOL, V148, P209, DOI 10.1016/j.clim.2013.05.012; Teng F, 2016, IMMUNITY, V44, P875, DOI 10.1016/j.immuni.2016.03.013; Ternak G, 2020, IN VIVO, V34, P3467, DOI 10.21873/invivo.12186; Thompson CL, 2012, ENVIRON MICROBIOL, V14, P1454, DOI 10.1111/j.1462-2920.2012.02731.x; Thorburn AN, 2014, IMMUNITY, V40, P833, DOI 10.1016/j.immuni.2014.05.014; Timmermans S, 2014, J NEUROIMMUNE PHARM, V9, P209, DOI 10.1007/s11481-013-9502-4; Tonkin DR, 2008, J IMMUNOL, V181, P4516, DOI 10.4049/jimmunol.181.7.4516; van der Meulen TA, 2019, J AUTOIMMUN, V97, P77, DOI 10.1016/j.jaut.2018.10.009; Van Praet JT, 2015, EMBO J, V34, P466, DOI 10.15252/embj.201489966; Vatanen T, 2018, NATURE, V562, P589, DOI 10.1038/s41586-018-0620-2; Venken K, 2010, TRENDS MOL MED, V16, P58, DOI 10.1016/j.molmed.2009.12.003; Ventura RE, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52894-z; Vural M, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.491160; Wang DJ, 2009, IMMUNOL INVEST, V38, P602, DOI 10.1080/08820130903062194; Wang Y, 2014, GUT MICROBES, V5, P552, DOI 10.4161/gmic.29797; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wilson BC, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00002; Wolter M, 2021, NAT REV GASTRO HEPAT, V18, P885, DOI 10.1038/s41575-021-00512-7; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Xiao L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22052-y; Yadav V, 2016, MULT SCLER RELAT DIS, V9, P80, DOI 10.1016/j.msard.2016.07.001; Yokote H, 2008, AM J PATHOL, V173, P1714, DOI 10.2353/ajpath.2008.080622; Young EF, 2009, AUTOIMMUNITY, V42, P678, DOI 10.3109/08916930903213993; Yu H, 2017, P NATL ACAD SCI USA, V114, P10443, DOI 10.1073/pnas.1705599114; Zhang X, 2020, TRENDS MOL MED, V26, P862, DOI 10.1016/j.molmed.2020.04.001; Zhang X, 2015, NAT MED, V21, P895, DOI 10.1038/nm.3914; Zhao Y, 2018, MUCOSAL IMMUNOL, V11, P752, DOI 10.1038/mi.2017.118; Zmora N, 2018, CELL, V174, P1388, DOI 10.1016/j.cell.2018.08.041	214	8	8	20	35	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.												10.1038/s41577-022-00727-y	http://dx.doi.org/10.1038/s41577-022-00727-y		MAY 2022	15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1B6ZE	35534624				2022-12-18	WOS:000792582600001
J	Flemming, A				Flemming, Alexandra			mRNA vaccine shows promise in autoimmunity	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material												a.flemming@nature.com						Krienke Christina, 2021, Science, V371, P145, DOI 10.1126/science.aay3638	1	8	8	1	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2021	21	2					72	72		10.1038/s41577-021-00504-3	http://dx.doi.org/10.1038/s41577-021-00504-3		JAN 2021	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QB3OS	33437044	Green Published, Bronze			2022-12-18	WOS:000607344500001
J	Douglas, AD; Hill, AVS				Douglas, Alexander D.; Hill, Adrian V. S.			Immunological considerations for SARS-CoV-2 human challenge studies	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material								The ethics and practicalities of controlled human infection with SARS-CoV-2 have been widely discussed. Potential risks are clear. The case in favour hinges upon whether these risks can be mitigated to an acceptable, very low, level and whether the studies will provide substantial benefits that could not readily be obtained by other means. Here, we discuss the immunological considerations relating to each side of this balance.	[Douglas, Alexander D.; Hill, Adrian V. S.] Univ Oxford, Nuffield Dept Med, Jenner Inst, Oxford, England	University of Oxford; Jenner Institute	Douglas, AD (corresponding author), Univ Oxford, Nuffield Dept Med, Jenner Inst, Oxford, England.	sandy.douglas@ndm.ox.ac.uk	Douglas, Alexander/E-7040-2012	Douglas, Alexander/0000-0002-5410-7562; Hill, Adrian/0000-0003-0900-9629				CALLOW KA, 1990, EPIDEMIOL INFECT, V105, P435, DOI 10.1017/S0950268800048019; Catchpole Andrew P, 2018, BMC Res Notes, V11, P620, DOI 10.1186/s13104-018-3636-7; Deming ME, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2020076; Innis BL, 2019, VACCINE, V37, P4830, DOI 10.1016/j.vaccine.2019.06.053; Jamrozik E, 2020, LANCET INFECT DIS, V20, pE198, DOI 10.1016/S1473-3099(20)30438-2; Roestenberg M, 2018, LANCET INFECT DIS, V18, pE312, DOI 10.1016/S1473-3099(18)30177-4; TYRRELL DAJ, 1992, ANTIVIR RES, V18, P105, DOI 10.1016/0166-3542(92)90032-Z	7	8	8	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2020	20	12					715	716		10.1038/s41577-020-00472-0	http://dx.doi.org/10.1038/s41577-020-00472-0		OCT 2020	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OV9YZ	33087904	Bronze, Green Published			2022-12-18	WOS:000580992000001
J	Kugelberg, E				Kugelberg, Elisabeth			IMMUNE MEMORY Inflammasomes drive NK cell memory	NATURE REVIEWS IMMUNOLOGY			English	News Item														Kugelberg, Elisabeth/0000-0002-8302-3595					0	8	8	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUL	2016	16	7					405	405		10.1038/nri.2016.74	http://dx.doi.org/10.1038/nri.2016.74			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP9SR	27320316	Bronze			2022-12-18	WOS:000378837900007
J	Pollard, J				Pollard, Jeffrey			BACTERIA, INFLAMMATION AND CANCER	NATURE REVIEWS IMMUNOLOGY			English	News Item									Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, Edinburgh EH16 4TJ, Midlothian, Scotland	University of Edinburgh	Pollard, J (corresponding author), Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, Edinburgh EH16 4TJ, Midlothian, Scotland.	Jeff.Pollard@ed.ac.uk							0	8	8	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2015	15	9					528	528		10.1038/nri3899	http://dx.doi.org/10.1038/nri3899			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CR1JO	26272296	Bronze			2022-12-18	WOS:000361081200005
J	Valle, A; Maugeri, N; Manfredi, AA; Battaglia, M				Valle, Andrea; Maugeri, Norma; Manfredi, Angelo A.; Battaglia, Manuela			Standardization in flow cytometry: correct sample handling as a priority	NATURE REVIEWS IMMUNOLOGY			English	Letter							ACTIVATED PLATELETS; HUMAN IMMUNOLOGY; EXPRESSION; LEUKOCYTE; MONOCYTES; BLOOD; NEUTROPHILS; CLEARANCE; LYSIS		[Valle, Andrea; Battaglia, Manuela] Ist Sci Osped San Raffaele, San Raffaele Sci Inst, Diabet Res Inst, I-20132 Milan, Italy; [Valle, Andrea; Battaglia, Manuela] Ist Sci Osped San Raffaele, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy; [Maugeri, Norma; Manfredi, Angelo A.] Ist Sci Osped San Raffaele, Div Regenerat Med Stem Cells & Gene Therapy, I-20132 Milan, Italy; [Manfredi, Angelo A.] Univ Vita Salute San Raffaele, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Battaglia, M (corresponding author), Ist Sci Osped San Raffaele, San Raffaele Sci Inst, Diabet Res Inst, Via Olgettina 58, I-20132 Milan, Italy.	battaglia.manuela@hsr.it	Manfredi, Angelo A./C-7018-2014; Maugeri, Norma/K-2429-2018	Manfredi, Angelo A./0000-0001-8370-6970; Maugeri, Norma/0000-0003-3931-0412; Battaglia, Manuela/0000-0003-4535-3152				Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; ISLAM D, 1995, CYTOMETRY, V22, P128, DOI 10.1002/cyto.990220208; LUNDAHL J, 1995, J IMMUNOL METHODS, V180, P93, DOI 10.1016/0022-1759(94)00303-E; Macey M.G., 2007, FLOW CYTOMETRY PRINC, P1; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Maugeri N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039484; Maugeri N, 2011, BLOOD, V118, P3359, DOI 10.1182/blood-2011-02-337337; Maugeri N, 2011, J IMMUNOL, V187, P970, DOI 10.4049/jimmunol.1100261; Maugeri N, 2009, AUTOIMMUNITY, V42, P386, DOI 10.1080/08916930902832629; Maugeri N, 2009, BLOOD, V113, P5254, DOI 10.1182/blood-2008-09-180794; Nieto JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031297; Puga I, 2012, NAT IMMUNOL, V13, P170, DOI 10.1038/ni.2194; Rodenburg RJT, 1998, J IMMUNOL METHODS, V221, P169, DOI 10.1016/S0022-1759(98)00183-5; Souques F, 1997, J IMMUNOL METHODS, V204, P153, DOI 10.1016/S0022-1759(97)00039-2; TAMUL KR, 1995, CLIN DIAGN LAB IMMUN, V2, P337, DOI 10.1128/CDLI.2.3.337-342.1995; 2012, NATURE REV IMMUNOL, V12, P191	17	8	8	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2012	12	12					864	864		10.1038/nri3158-c3	http://dx.doi.org/10.1038/nri3158-c3			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	042OC	23154226	Bronze			2022-12-18	WOS:000311479500015
J	Leavy, O				Leavy, Olive			T CELL DEVELOPMENT Tonsils turn out T cells too	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	8	9	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2012	12	4					232	232		10.1038/nri3196	http://dx.doi.org/10.1038/nri3196			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	916WA	22402672	Bronze			2022-12-18	WOS:000302132700007
J	Bird, L				Bird, Lucy			METABOLISM AND IMMUNOLOGY Gut microbiota influences liver disease	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bird, Lucy/0000-0002-3914-6045					0	8	9	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	MAR	2012	12	3					153	153		10.1038/nri3177	http://dx.doi.org/10.1038/nri3177			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899CJ	22343570	Bronze			2022-12-18	WOS:000300790600006
J	Leavy, O				Leavy, Olive			INNATE IMMUNITY Quieting the inflammasome	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	8	10	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	MAR	2012	12	3					150	150		10.1038/nri3171	http://dx.doi.org/10.1038/nri3171			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899CJ	22322318				2022-12-18	WOS:000300790600002
J	Chen, GY; Nunez, G				Chen, Grace Y.; Nunez, Gabriel			Are heat shock proteins DAMPs?	NATURE REVIEWS IMMUNOLOGY			English	Letter							IMMUNE-RESPONSES; LIPOPOLYSACCHARIDE		[Chen, Grace Y.] Univ Michigan, Dept Internal Med, Div Hematol Oncol, Ann Arbor, MI 48109 USA; [Chen, Grace Y.; Nunez, Gabriel] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Nunez, Gabriel] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chen, GY (corresponding author), Univ Michigan, Dept Internal Med, Div Hematol Oncol, Ann Arbor, MI 48109 USA.	gchenry@umich.edu; bclx@umich.edu	Nuñez, Gabriel/A-7160-2014					Bausinger H, 2002, EUR J IMMUNOL, V32, P3708, DOI 10.1002/1521-4141(200212)32:12<3708::AID-IMMU3708>3.0.CO;2-C; Broere F, 2011, NAT REV IMMUNOL, V11, P565, DOI 10.1038/nri2873-c1; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Gao BC, 2003, J BIOL CHEM, V278, P174, DOI 10.1074/jbc.M208742200; Habich C, 2005, J IMMUNOL, V174, P1298, DOI 10.4049/jimmunol.174.3.1298; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Li ZH, 2002, CURR OPIN IMMUNOL, V14, P45, DOI 10.1016/S0952-7915(01)00297-7; Osterloh A, 2007, J BIOL CHEM, V282, P4669, DOI 10.1074/jbc.M608666200; Warger T, 2006, J BIOL CHEM, V281, P22545, DOI 10.1074/jbc.M502900200	9	8	9	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2011	11	8								10.1038/nri2873-c2	http://dx.doi.org/10.1038/nri2873-c2			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	796RN		Bronze			2022-12-18	WOS:000293069600017
J	Marodi, L; Casanova, JL				Marodi, Laszlo; Casanova, Jean-Laurent			Can primary immunodeficiencies help to provide insights into infectious risks of therapeutic antibodies?	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material							IFN-GAMMA; COMPLICATIONS; RITUXIMAB; AUTOANTIBODIES; LYMPHOMA		[Marodi, Laszlo] Univ Debrecen, Dept Infect & Pediat Immunol, H-4012 Debrecen, Hungary; [Marodi, Laszlo] Hlth Sci Ctr, Debrecen, Hungary; [Casanova, Jean-Laurent] Rockefeller Univ, Rockefeller Univ Hosp, Rockefeller Branch, Lab Human Genet Infect, New York, NY 10021 USA; [Casanova, Jean-Laurent] Paris Descartes Univ, Necker Branch, Necker Med Sch, Paris, France	University of Debrecen; Rockefeller University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Marodi, L (corresponding author), Univ Debrecen, Dept Infect & Pediat Immunol, H-4012 Debrecen, Hungary.	lmarodi@dote.hu; jean-laurent.casanova@rockefeller.edu	Casanova, Jean-Laurent/I-3418-2017; Marodi, Laszlo/AAU-9915-2020	Casanova, Jean-Laurent/0000-0002-7782-4169				Aksoy S, 2009, LEUKEMIA LYMPHOMA, V50, P357, DOI 10.1080/10428190902730219; Bustarnante J, 2008, CURR OPIN IMMUNOL, V20, P39, DOI 10.1016/j.coi.2007.10.005; Carrasco Ruy, 2004, Paediatr Drugs, V6, P137, DOI 10.2165/00148581-200406030-00001; CARSON KR, 2009, NEW ENGL J MED, V361, P816; Casanova JL, 2007, SCIENCE, V317, P617, DOI 10.1126/science.1142963; Desai SB, 2006, BEST PRACT RES CL RH, V20, P757, DOI 10.1016/j.berh.2006.06.002; Kampmann B, 2005, J CLIN INVEST, V115, P2480, DOI 10.1172/JCI19316; Kanbayashi Y, 2009, EUR J HAEMATOL, V82, P26, DOI 10.1111/j.1600-0609.2008.01165.x; Kiani-Alikhan S, 2009, BRIT J HAEMATOL, V146, P333, DOI 10.1111/j.1365-2141.2009.07748.x; Kimby E, 2005, CANCER TREAT REV, V31, P456, DOI 10.1016/j.ctrv.2005.05.007; Major EO, 2009, NEW ENGL J MED, V361, P1041, DOI 10.1056/NEJMp0906248; Marodi L, 2007, NAT REV IMMUNOL, V7, P851, DOI 10.1038/nri2195; Marodi L, 2009, LANCET, V373, P2179, DOI 10.1016/S0140-6736(09)61171-5; Martin-Mola E, 2009, RHEUM DIS CLIN N AM, V35, P183, DOI 10.1016/j.rdc.2009.03.009; Martinez-Moczygemba M, 2008, J EXP MED, V205, P2711, DOI 10.1084/jem.20080759; Padate BP, 2006, CLIN LAB HAEMATOL, V28, P69, DOI 10.1111/j.1365-2257.2006.00751.x; Patel SY, 2005, J IMMUNOL, V175, P4769, DOI 10.4049/jimmunol.175.7.4769; PICARD C, 1988, MEDICINE IN PRESS; Quartier P, 2003, CLIN INFECT DIS, V36, pE47, DOI 10.1086/345746; Ram R, 2009, LEUKEMIA LYMPHOMA, V50, P1083, DOI 10.1080/10428190902934944; Suzuki T, 2008, J EXP MED, V205, P2703, DOI 10.1084/jem.20080990; Toth B, 2009, MOL IMMUNOL, V46, P2140, DOI 10.1016/j.molimm.2009.03.012; Wallis RS, 2009, CURR OPIN INFECT DIS, V22, P403, DOI 10.1097/QCO.0b013e32832dda55; Zhang SY, 2008, IMMUNOL REV, V226, P29, DOI 10.1111/j.1600-065X.2008.00698.x	24	8	8	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2010	10	5					298	299		10.1038/nri2764	http://dx.doi.org/10.1038/nri2764			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	586ZD	20422788				2022-12-18	WOS:000276953900011
J	Ryan, G				Ryan, Gemma			T CELL SIGNALLING CD3 conformation is crucial for signalling	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Wang YB, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000253	1	8	8	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2010	10	1					7	7		10.1038/nri2703	http://dx.doi.org/10.1038/nri2703			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	535SW		Bronze			2022-12-18	WOS:000272992100003
J	Minton, K				Minton, Kirsty			HIV: Ironing out the causes of B-cell dysfunction	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Swingler S, 2008, CELL HOST MICROBE, V4, P63, DOI 10.1016/j.chom.2008.05.015	1	8	9	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2008	8	9					662	662		10.1038/nri2401	http://dx.doi.org/10.1038/nri2401			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	341LS		Bronze			2022-12-18	WOS:000258716600010
J	Bell, E				Bell, E			IgG effector function: a question of balance	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948	1	8	8	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2006	6	1					4	5		10.1038/nri1766	http://dx.doi.org/10.1038/nri1766			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	000FW					2022-12-18	WOS:000234447300007
J	Webster, S				Webster, S			Science and society - Art and science collaborations in the United Kingdom	NATURE REVIEWS IMMUNOLOGY			English	Article								In this Perspective article, I consider ways in which the contemporary arts and sciences can interact with each other, and I outline the current opportunities for funding in the United Kingdom. I examine the view that, in an art - science collaboration, it is the artist who benefits most, and I cautiously suggest that this is an oversimplification. Evidence from interviews with scientists who have been involved in these collaborations shows that artistic experience and skills are of value in the scientific research process.	Univ London Imperial Coll Sci Technol & Med, Human Programme, Sci Commun Grp, London SW7 2AZ, England	Imperial College London	Webster, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Human Programme, Sci Commun Grp, London SW7 2AZ, England.	stephen.webster@imperial.ac.uk						*ARTS COUNC ENGL, 2004, ARTS SCI RES FELL SC; Augenbraun E, 2005, NATURE, V433, P357, DOI 10.1038/433357a; BODMER WF, 1986, PUBLIC UNDERSTANDING; DELEVAL MR, 1988, J THORAC CARDIOV SUR, V96, P682; Gere C, 2004, STUD HIST PHILOS BIO, V35, P415, DOI [10.1016/j.shpsc.2004.03.013, DOI 10.1016/J.SHPSC.2004.03.013]; KEMP M, 2000, SPECTACULAR BODIES A; KEMP M, 2000, VISUALISATIONS NATUR; Kilner PJ, 2000, NATURE, V404, P759, DOI 10.1038/35008075; Kitcher P., 1995, ADV SCI; MACKRELL J, 2005, GUARDIAN LOND   0908; Seamon David, 1998, GOETHES WAY SCI PHEN; Suppe F., 1974, STRUCTURE SCI THEORI; WOLPERT L, 2002, OBSERVER LOND   0310; 2004, NATURE IMMUNOL, V5, P863	14	8	8	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2005	5	12					965	U1		10.1038/nri1730	http://dx.doi.org/10.1038/nri1730			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	990WT	16322749				2022-12-18	WOS:000233774600013
J	Wein, T; Sorek, R				Wein, Tanita; Sorek, Rotem			Bacterial origins of human cell-autonomous innate immune mechanisms	NATURE REVIEWS IMMUNOLOGY			English	Article							CYCLIC GMP-AMP; PATTERN-RECOGNITION RECEPTORS; NAD(+) CLEAVAGE ACTIVITY; CYTOSOLIC DNA SENSOR; CRYSTAL-STRUCTURE; TIR DOMAINS; GASDERMIN D; ANTIVIRAL IMMUNITY; GENETIC ELEMENTS; RNA INTERFERENCE	The cell-autonomous innate immune system has long been considered an evolutionary innovation of metazoans; however, recent evidence challenges this dogma. This Perspective describes the components of antiviral immunity that are conserved from bacteria to humans, and presents potential evolutionary scenarios to explain the observed conservation. The cell-autonomous innate immune system enables animal cells to resist viral infection. This system comprises an array of sensors that, after detecting viral molecules, activate the expression of antiviral proteins and the interferon response. The repertoire of immune sensors and antiviral proteins has long been considered to be derived from extensive evolutionary innovation in vertebrates, but new data challenge this dogma. Recent studies show that central components of the cell-autonomous innate immune system have ancient evolutionary roots in prokaryotic genes that protect bacteria from phages. These include the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway, Toll/IL-1 receptor (TIR) domain-containing pathogen receptors, the viperin family of antiviral proteins, SAMHD1-like nucleotide-depletion enzymes, gasdermin proteins and key components of the RNA interference pathway. This Perspective details current knowledge of the elements of antiviral immunity that are conserved from bacteria to humans, and presents possible evolutionary scenarios to explain the observed conservation.	[Wein, Tanita; Sorek, Rotem] Weizmann Inst Sci, Dept Mol Genet, Rehovot, Israel	Weizmann Institute of Science	Sorek, R (corresponding author), Weizmann Inst Sci, Dept Mol Genet, Rehovot, Israel.	rotem.sorek@weizmann.ac.il	Wein, Tanita/GRS-2427-2022		European Research Council [ERC-AdG GA 101018520]; Israel Science Foundation [ISF 296/21]; Deutsche Forschungsgemeinschaft [SPP 2330, 464312965]; Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; Minerva Foundation; Federal German Ministry for Education and Research; Knell Family Center for Microbiology; Minerva Foundation postdoctoral fellowship; European Molecular Biology Organization (EMBO) [ALTF 946-2020]	European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; Minerva Foundation; Federal German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Knell Family Center for Microbiology; Minerva Foundation postdoctoral fellowship; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO))	The authors thank P. Kranzusch, as well as the Sorek laboratory members, for fruitful discussion and comments on this manuscript. R.S. is supported, in part, by the European Research Council (grant ERC-AdG GA 101018520), Israel Science Foundation (grant ISF 296/21), the Deutsche Forschungsgemeinschaft (SPP 2330, grant 464312965), the Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine, the Minerva Foundation with funding from the Federal German Ministry for Education and Research, and the Knell Family Center for Microbiology. T.W. is supported by a Minerva Foundation postdoctoral fellowship and by a European Molecular Biology Organization (EMBO) postdoctoral fellowship (ALTF 946-2020).	Ablasser A, 2019, SCIENCE, V363, P1055, DOI 10.1126/science.aat8657; Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ayinde D, 2012, NAT REV MICROBIOL, V10, P675, DOI 10.1038/nrmicro2862; Bailey CC, 2014, ANNU REV VIROL, V1, P261, DOI 10.1146/annurev-virology-031413-085537; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Balint-Kurti P, 2019, MOL PLANT PATHOL, V20, P1163, DOI 10.1111/mpp.12821; Barnes CO, 2019, P NATL ACAD SCI USA, V116, P9333, DOI 10.1073/pnas.1814999116; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bayless AM, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00539; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Berkhout B, 2018, CURR OPIN VIROL, V32, P9, DOI 10.1016/j.coviro.2018.07.008; Bernheim A, 2021, NATURE, V589, P120, DOI 10.1038/s41586-020-2762-2; Bernheim A, 2020, NAT REV MICROBIOL, V18, P113, DOI 10.1038/s41579-019-0278-2; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Billings EA, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aac6250; Blanga-Kanfi S, 2006, NUCLEIC ACIDS RES, V34, P3209, DOI 10.1093/nar/gkl415; Broz P, 2020, NAT REV IMMUNOL, V20, P143, DOI 10.1038/s41577-019-0228-2; Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; Brueckner J, 2020, GENOME BIOL EVOL, V12, P282, DOI 10.1093/gbe/evaa047; Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7; Burch-Smith Tessa M, 2007, Sci STKE, V2007, ppe46; Burroughs AM, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1267; Chemudupati M, 2019, BBA-MOL CELL RES, V1866, P382, DOI 10.1016/j.bbamcr.2018.09.012; Chen YG, 2022, NAT REV MOL CELL BIO, V23, P286, DOI 10.1038/s41580-021-00430-1; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Cohen D, 2019, NATURE, V574, P691, DOI 10.1038/s41586-019-1605-5; Daskalov A, 2020, P NATL ACAD SCI USA, V117, P18600, DOI 10.1073/pnas.2004876117; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; De Schutter E, 2021, TRENDS CELL BIOL, V31, P500, DOI 10.1016/j.tcb.2021.03.004; Depardieu F, 2016, CELL HOST MICROBE, V20, P471, DOI 10.1016/j.chom.2016.08.010; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Ding SW, 2018, CURR OPIN IMMUNOL, V54, P109, DOI 10.1016/j.coi.2018.06.010; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Doron S, 2018, SCIENCE, V359, DOI 10.1126/science.aar4120; Duncan-Lowey B, 2021, MOL CELL, V81, P5039, DOI 10.1016/j.molcel.2021.10.020; Duxbury Z, 2020, P NATL ACAD SCI USA, V117, P18832, DOI 10.1073/pnas.2001185117; Ebert D, 2020, NAT REV GENET, V21, P754, DOI 10.1038/s41576-020-0269-1; Esser C, 2004, MOL BIOL EVOL, V21, P1643, DOI 10.1093/molbev/msh160; Essuman K, 2017, NEURON, V93, P1334, DOI 10.1016/j.neuron.2017.02.022; Fenwick MK, 2017, P NATL ACAD SCI USA, V114, P6806, DOI 10.1073/pnas.1705402114; Gao LY, 2020, SCIENCE, V369, P1077, DOI 10.1126/science.aba0372; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Garb J., 2021, MULTIPLE PHAGE RESIS, DOI [10.1101/2021.12.14.472415, DOI 10.1101/2021.12.14.472415]; Gizzi AS, 2018, NATURE, V558, P610, DOI 10.1038/s41586-018-0238-4; Goldfarb T, 2015, EMBO J, V34, P169, DOI 10.15252/embj.201489455; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Govande AA, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109206; Guo ZX, 2019, NAT REV IMMUNOL, V19, P31, DOI 10.1038/s41577-018-0071-x; Haasnoot J, 2007, NAT BIOTECHNOL, V25, P1435, DOI 10.1038/nbt1369; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hampton HG, 2020, NATURE, V577, P327, DOI 10.1038/s41586-019-1894-8; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Hegge JW, 2019, NUCLEIC ACIDS RES, V47, P5809, DOI 10.1093/nar/gkz306; Helbig KJ, 2014, J MOL BIOL, V426, P1210, DOI 10.1016/j.jmb.2013.10.019; Hille F, 2018, CELL, V172, P1239, DOI 10.1016/j.cell.2017.11.032; Hollenbaugh JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003481; Hopfner KP, 2020, NAT REV MOL CELL BIO, V21, P501, DOI 10.1038/s41580-020-0244-x; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Horsefield S, 2019, SCIENCE, V365, P793, DOI 10.1126/science.aax1911; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jiang S, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd2591; Johnson AG, 2022, SCIENCE, V375, P221, DOI 10.1126/science.abj8432; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kaya E, 2016, P NATL ACAD SCI USA, V113, P4057, DOI 10.1073/pnas.1524385113; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Kieser KJ, 2017, NAT REV IMMUNOL, V17, P376, DOI 10.1038/nri.2017.25; Kondo N, 2008, EXTREMOPHILES, V12, P217, DOI 10.1007/s00792-007-0118-6; Koonin EV, 2017, BIOL DIRECT, V12, DOI 10.1186/s13062-017-0177-2; Koyuncu E, 2014, MBIO, V5, DOI 10.1128/mBio.02249-14; Kranzusch PJ, 2019, CURR OPIN STRUC BIOL, V59, P178, DOI 10.1016/j.sbi.2019.08.003; Kranzusch PJ, 2015, MOL CELL, V59, P891, DOI 10.1016/j.molcel.2015.07.022; Kranzusch PJ, 2014, CELL, V158, P1011, DOI 10.1016/j.cell.2014.07.028; Kranzusch PJ, 2013, CELL REP, V3, P1362, DOI 10.1016/j.celrep.2013.05.008; Krasteva PV, 2017, NAT CHEM BIOL, V13, P350, DOI 10.1038/nchembio.2337; Kropocheva E, 2021, NUCLEIC ACIDS RES, V49, P4054, DOI 10.1093/nar/gkab182; Ku C, 2015, NATURE, V524, P427, DOI 10.1038/nature14963; Kuzmenko A, 2020, NATURE, V587, P632, DOI 10.1038/s41586-020-2605-1; Kuzmenko A, 2019, NUCLEIC ACIDS RES, V47, P5822, DOI 10.1093/nar/gkz379; Lachowicz JC, 2021, BIOCHEMISTRY-US, V60, P2116, DOI 10.1021/acs.biochem.0c00958; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lau RK, 2020, MOL CELL, V77, P723, DOI 10.1016/j.molcel.2019.12.010; Leulier F, 2008, NAT REV GENET, V9, P165, DOI 10.1038/nrg2303; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Li N, 2000, IMMUNOL LETT, V74, P221, DOI 10.1016/S0165-2478(00)00276-5; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Litman GW, 2005, NAT REV IMMUNOL, V5, P866, DOI 10.1038/nri1712; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Liu ZH, 2019, IMMUNITY, V51, P43, DOI 10.1016/j.immuni.2019.04.017; Lopatina A, 2020, ANNU REV VIROL, V7, P371, DOI 10.1146/annurev-virology-011620-040628; Lowey B, 2020, CELL, V182, P38, DOI 10.1016/j.cell.2020.05.019; Makarova KS, 2011, J BACTERIOL, V193, P6039, DOI 10.1128/JB.05535-11; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-29; Margolis SR, 2017, TRENDS IMMUNOL, V38, P733, DOI 10.1016/j.it.2017.03.004; Martin WF, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0330; Mega R, 2009, FEBS J, V276, P3211, DOI 10.1111/j.1742-4658.2009.07035.x; Millman A, 2020, CELL, V183, P1551, DOI 10.1016/j.cell.2020.09.065; Millman A, 2020, NAT MICROBIOL, V5, P1608, DOI 10.1038/s41564-020-0777-y; Morehouse BR, 2020, NATURE, V586, P429, DOI 10.1038/s41586-020-2719-5; Motwani M, 2019, NAT REV GENET, V20, P657, DOI 10.1038/s41576-019-0151-1; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Obbard DJ, 2011, MOL BIOL EVOL, V28, P1043, DOI 10.1093/molbev/msq280; Ofir G, 2021, NATURE, V600, P116, DOI 10.1038/s41586-021-04098-7; Oliveira PH, 2014, NUCLEIC ACIDS RES, V42, P10618, DOI 10.1093/nar/gku734; Olovnikov I, 2013, MOL CELL, V51, P594, DOI 10.1016/j.molcel.2013.08.014; Owen SV, 2021, CELL HOST MICROBE, V29, P1620, DOI 10.1016/j.chom.2021.09.002; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; PENNER M, 1995, J MOL BIOL, V249, P857, DOI 10.1006/jmbi.1995.0343; Peterson SB, 2020, CURR BIOL, V30, pR1203, DOI 10.1016/j.cub.2020.06.103; Poirier EZ, 2021, SCIENCE, V373, P231, DOI 10.1126/science.abg2264; Raja P, 2008, J VIROL, V82, P8997, DOI 10.1128/JVI.00719-08; Raja P, 2014, J VIROL, V88, P2611, DOI 10.1128/JVI.02305-13; Randow F, 2013, SCIENCE, V340, P701, DOI 10.1126/science.1233028; Rivera-Serrano EE, 2020, ANNU REV VIROL, V7, P421, DOI 10.1146/annurev-virology-011720-095930; Ruan JB, 2018, NATURE, V557, P62, DOI 10.1038/s41586-018-0058-6; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; Schoggins JW, 2019, ANNU REV VIROL, V6, P567, DOI 10.1146/annurev-virology-092818-015756; Seifert M, 2021, ELIFE, V10, DOI [10.7554/eLife.70968, 10.7554/eLife.70968.sa1, 10.7554/eLife.70968.sa2]; Seo JY, 2011, CELL HOST MICROBE, V10, P534, DOI 10.1016/j.chom.2011.11.004; Severin G., 2021, BROADLY CONSERVED DE, DOI [10.1101/2021.03.31.437871, DOI 10.1101/2021.03.31.437871]; Severin GB, 2018, P NATL ACAD SCI USA, V115, pE6048, DOI 10.1073/pnas.1801233115; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Sheng G, 2014, P NATL ACAD SCI USA, V111, P652, DOI 10.1073/pnas.1321032111; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Singh D, 2015, J BIOL CHEM, V290, P10418, DOI 10.1074/jbc.M115.636936; Slavik KM, 2021, NATURE, V597, P109, DOI 10.1038/s41586-021-03743-5; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Spence JS, 2019, NAT CHEM BIOL, V15, P259, DOI 10.1038/s41589-018-0213-2; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Swarts DC, 2017, MOL CELL, V65, P985, DOI 10.1016/j.molcel.2017.01.033; Swarts DC, 2015, NUCLEIC ACIDS RES, V43, P5120, DOI 10.1093/nar/gkv415; Swarts DC, 2014, NAT STRUCT MOL BIOL, V21, P743, DOI 10.1038/nsmb.2879; Swarts DC, 2014, NATURE, V507, P258, DOI 10.1038/nature12971; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tal N., NAT MICROBIOL; Tal N, 2021, CELL, V184, P5728, DOI 10.1016/j.cell.2021.09.031; Tan XJ, 2018, ANNU REV MICROBIOL, V72, P447, DOI 10.1146/annurev-micro-102215-095605; Tock MR, 2005, CURR OPIN MICROBIOL, V8, P466, DOI 10.1016/j.mib.2005.06.003; Toshchakov VY, 2020, IMMUNOGENETICS, V72, P181, DOI 10.1007/s00251-020-01157-7; Wan L, 2019, SCIENCE, V365, P799, DOI 10.1126/science.aax1771; Whiteley AT, 2019, NATURE, V567, P194, DOI 10.1038/s41586-019-0953-5; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Wu XM, 2014, NUCLEIC ACIDS RES, V42, P8243, DOI 10.1093/nar/gku569; Xia SY, 2021, NATURE, V593, P607, DOI 10.1038/s41586-021-03478-3; Ye QZ, 2020, MOL CELL, V77, P709, DOI 10.1016/j.molcel.2019.12.009; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011; Zander A, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.34; Zaremba M., 2021, SIR2 DOMAIN ASS SHOR, DOI [10.1101/2021.12.14.472599, DOI 10.1101/2021.12.14.472599]; Zeng Z., 2021, SHORT PROKARYOTIC AR, DOI [10.1101/2021.12.09.471704, DOI 10.1101/2021.12.09.471704]; Zhu DY, 2014, MOL CELL, V55, P931, DOI 10.1016/j.molcel.2014.08.001	162	7	7	13	21	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2022	22	10					629	638		10.1038/s41577-022-00705-4	http://dx.doi.org/10.1038/s41577-022-00705-4		APR 2022	10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	4Y3ZM	35396464				2022-12-18	WOS:000779864800003
J	Lazzerini, PE; Laghi-Pasini, F; Boutjdir, M; Capecchi, PL				Lazzerini, Pietro Enea; Laghi-Pasini, Franco; Boutjdir, Mohamed; Capecchi, Pier Leopoldo			Inflammatory cytokines and cardiac arrhythmias: the lesson from COVID-19	NATURE REVIEWS IMMUNOLOGY			English	Article								COVID-19 is associated with an unexpectedly high prevalence of arrhythmic events. In this Comment, Lazzerini et al. discuss how systemic inflammation is linked to cardiac arrhythmias. Although inflammatory cytokines are implicated in the pathogenesis of cardiac arrhythmias, inflammation is still largely overlooked in the current management of heart rhythm disorders. Now, COVID-19, a systemic inflammatory disease, causes an unexpectedly high prevalence of arrhythmic events, emphasizing the relevance of inflammation in the pathogenesis of cardiac arrhythmias.	[Lazzerini, Pietro Enea; Laghi-Pasini, Franco; Capecchi, Pier Leopoldo] Univ Siena, Dept Med Sci Surg & Neurosci, Siena, Italy; [Boutjdir, Mohamed] SUNY Downstate Hlth Sci Univ, New York, NY USA; [Boutjdir, Mohamed] NYU, Sch Med, New York, NY USA; [Boutjdir, Mohamed] VA New York Harbor Healthcare Syst, New York, NY USA	University of Siena; New York University	Lazzerini, PE (corresponding author), Univ Siena, Dept Med Sci Surg & Neurosci, Siena, Italy.	lazzerini7@unisi.it		Lazzerini, Pietro Enea/0000-0001-6721-1214	BANDO RICERCA COVID-19 REGIONE TOSCANA, 2021, ProgettoPRECARVID	BANDO RICERCA COVID-19 REGIONE TOSCANA, 2021, ProgettoPRECARVID	This paper was funded by BANDO RICERCA COVID-19 REGIONE TOSCANA, 2021, ProgettoPRECARVID.	Elsaid O, 2020, AM J CARDIOL, V135, P177, DOI 10.1016/j.amjcard.2020.08.033; Guan HQ, 2021, J ELECTROCARDIOL, V65, P96, DOI 10.1016/j.jelectrocard.2021.01.012; Jirak P, 2021, FRONT CARDIOVASC MED, V8, DOI 10.3389/fcvm.2021.763827; Kochav SM, 2020, CIRC-ARRHYTHMIA ELEC, V13, DOI 10.1161/CIRCEP.120.008719; Lazzerini PE, 2017, EUR HEART J, V38, P1717, DOI 10.1093/eurheartj/ehw208; Musikantow DR, 2021, JACC-CLIN ELECTROPHY, V7, P1120, DOI 10.1016/j.jacep.2021.02.009; Rubin GA, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.6842; Shankar-Hari M, 2021, JAMA-J AM MED ASSOC, V326, P499, DOI 10.1001/jama.2021.11330; Siddiq MM, 2022, J VIROL, V96, DOI 10.1128/JVI.01063-21; Wang YS, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.00147	10	7	7	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2022	22	5					270	272		10.1038/s41577-022-00714-3	http://dx.doi.org/10.1038/s41577-022-00714-3		MAR 2022	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0Y3TX	35347295	Green Published, Bronze			2022-12-18	WOS:000773855000001
J	Board, NL; Moskovljevic, M; Wu, FT; Siliciano, RF; Siliciano, JD				Board, Nathan L.; Moskovljevic, Milica; Wu, Fengting; Siliciano, Robert F.; Siliciano, Janet D.			Engaging innate immunity in HIV-1 cure strategies	NATURE REVIEWS IMMUNOLOGY			English	Review							DEPENDENT CELLULAR CYTOTOXICITY; PLASMACYTOID DENDRITIC CELLS; HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; MUCOSAL SHIV CHALLENGE; IN-VIVO; LATENT RESERVOIR; NK CELLS; MEDIATED CYTOTOXICITY; HLA-C	Current strategies for HIV-1 cure have not been successful in eliminating the latent reservoir. This Review highlights potential therapeutic strategies that engage the immunology of dendritic cells and natural killer cells in efforts to achieve HIV-1 cure. Combination antiretroviral therapy (ART) can block multiple stages of the HIV-1 life cycle to prevent progression to AIDS in people living with HIV-1. However, owing to the persistence of a reservoir of latently infected CD4(+) T cells, life-long ART is necessary to prevent viral rebound. One strategy currently under consideration for curing HIV-1 infection is known as 'shock and kill'. This strategy uses latency-reversing agents to induce expression of HIV-1 genes, allowing for infected cells to be cleared by cytolytic immune cells. The role of innate immunity in HIV-1 pathogenesis is best understood in the context of acute infection. Here, we suggest that innate immunity can also be used to improve the efficacy of HIV-1 cure strategies, with a particular focus on dendritic cells (DCs) and natural killer cells. We discuss novel latency-reversing agents targeting DCs as well as DC-based strategies to enhance the clearance of infected cells by CD8(+) T cells and strategies to improve the killing activity of natural killer cells.	[Board, Nathan L.; Moskovljevic, Milica; Wu, Fengting; Siliciano, Robert F.; Siliciano, Janet D.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Siliciano, Robert F.] Howard Hughes Med Inst, Baltimore, MD 20815 USA	Johns Hopkins University; Howard Hughes Medical Institute	Siliciano, RF; Siliciano, JD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.; Siliciano, RF (corresponding author), Howard Hughes Med Inst, Baltimore, MD 20815 USA.	rsiliciano@jhmi.edu; jsilicia@jhmi.edu		Wu, Fengting/0000-0001-6320-8288; Board, Nathan/0000-0002-5208-9970; Moskovljevic, Milica/0000-0003-0436-6854				Ackerman ME, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005315; Allard SD, 2012, CLIN IMMUNOL, V142, P252, DOI 10.1016/j.clim.2011.10.010; Alter G, 2011, NATURE, V476, P96, DOI 10.1038/nature10237; Altfeld M, 2015, NAT IMMUNOL, V16, P554, DOI 10.1038/ni.3157; Apps R, 2016, CELL HOST MICROBE, V19, P686, DOI 10.1016/j.chom.2016.04.005; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Archin NM, 2017, J CLIN INVEST, V127, P3126, DOI [10.1172/JCI92684, 10.1172/jci92684]; Archin NM, 2014, NAT REV MICROBIOL, V12, P750, DOI 10.1038/nrmicro3352; ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; Asokan M, 2020, P NATL ACAD SCI USA, V117, P18754, DOI 10.1073/pnas.2008236117; Astronomo RD, 2016, EBIOMEDICINE, V14, P97, DOI 10.1016/j.ebiom.2016.11.024; Azzoni L, 2013, J INFECT DIS, V207, P213, DOI 10.1093/infdis/jis663; Bar KJ, 2016, NEW ENGL J MED, V375, P2037, DOI 10.1056/NEJMoa1608243; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Barron MA, 2003, J INFECT DIS, V187, P26, DOI 10.1086/345957; Baum LL, 1996, J IMMUNOL, V157, P2168; Bhardwaj N, 2020, NAT CANCER, V1, P1204, DOI 10.1038/s43018-020-00143-y; Blankson AKR, 2018, J VIROL, V93, P1; Bonsignori M, 2012, J VIROL, V86, P11521, DOI 10.1128/JVI.01023-12; Borducchi EN, 2018, NATURE, V563, P360, DOI 10.1038/s41586-018-0600-6; Borducchi EN, 2016, NATURE, V540, P284, DOI 10.1038/nature20583; Bournazos S, 2014, CELL, V158, P1243, DOI 10.1016/j.cell.2014.08.023; Bousso P, 2008, NAT REV IMMUNOL, V8, P675, DOI 10.1038/nri2379; Bruel T, 2017, J VIROL, V91, DOI 10.1128/JVI.02440-16; Bruel T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10844; Bruner KM, 2019, NATURE, V566, P120, DOI 10.1038/s41586-019-0898-8; Bullen CK, 2014, NAT MED, V20, P425, DOI 10.1038/nm.3489; Coelho AVC, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17121985; Caskey M, 2017, NAT MED, V23, P185, DOI 10.1038/nm.4268; Cerboni C, 2007, J GEN VIROL, V88, P242, DOI 10.1099/vir.0.82125-0; Chen X, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02322; Chew GM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005349; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chung AW, 2015, CELL, V163, P988, DOI 10.1016/j.cell.2015.10.027; Chung AW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007736; Chung AW, 2011, JAIDS-J ACQ IMM DEF, V58, P127, DOI 10.1097/QAI.0b013e31822c62b9; Chung AW, 2011, P NATL ACAD SCI USA, V108, P7505, DOI 10.1073/pnas.1016048108; Chung AW, 2011, VIRAL IMMUNOL, V24, P171, DOI 10.1089/vim.2010.0108; CLARK EA, 1986, P NATL ACAD SCI USA, V83, P4494, DOI 10.1073/pnas.83.12.4494; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Cohen YZ, 2018, J EXP MED, V215, P2311, DOI 10.1084/jem.20180936; Collin M, 2013, IMMUNOLOGY, V140, P22, DOI 10.1111/imm.12117; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; DeChristopher BA, 2012, NAT CHEM, V4, P705, DOI [10.1038/nchem.1395, 10.1038/NCHEM.1395]; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Di Domizio J, 2009, BLOOD, V114, P1794, DOI 10.1182/blood-2009-04-216770; Dinoso JB, 2009, J VIROL, V83, P9247, DOI 10.1128/JVI.00840-09; Donaghy H, 2001, BLOOD, V98, P2574, DOI 10.1182/blood.V98.8.2574; Ellebaek E, 2012, CANCER IMMUNOL IMMUN, V61, P1791, DOI 10.1007/s00262-012-1242-4; Elliott JH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004473; Ellis-Connell AL, 2018, J VIROL, V92, DOI 10.1128/JVI.01748-17; Fernandez S, 2011, J INFECT DIS, V204, P1927, DOI 10.1093/infdis/jir659; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Flamar AL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207794; Forthal DN, 2010, J IMMUNOL, V185, P6876, DOI 10.4049/jimmunol.1002600; Garcia F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004682; Garcia F, 2011, J INFECT DIS, V203, P473, DOI 10.1093/infdis/jiq077; Garrido C, 2018, J VIROL, V92, DOI 10.1128/JVI.00235-18; Gautam R, 2016, NATURE, V533, P105, DOI 10.1038/nature17677; Gay CL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61878-3; Gay CL, 2018, AIDS RES HUM RETROV, V34, P111, DOI 10.1089/aid.2017.0071; Gibson SJ, 2002, CELL IMMUNOL, V218, P74, DOI 10.1016/S0008-8749(02)00517-8; Gondim MVP, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abd8179; Grewal IS, 1996, IMMUNOL TODAY, V17, P410, DOI 10.1016/0167-5699(96)10030-X; Han KP, 2011, CYTOKINE, V56, P804, DOI 10.1016/j.cyto.2011.09.028; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Herbeuval JP, 2006, P NATL ACAD SCI USA, V103, P7000, DOI 10.1073/pnas.0600363103; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hessell AJ, 2018, J VIROL, V92, DOI 10.1128/JVI.02198-17; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hill AL, 2014, P NATL ACAD SCI USA, V111, P13475, DOI 10.1073/pnas.1406663111; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Hosmane NN, 2017, J EXP MED, V214, P959, DOI 10.1084/jem.20170193; Hua S, 2018, CLIN INFECT DIS, V66, P1910, DOI 10.1093/cid/cix1111; Ide F, 2006, J MED VIROL, V78, P711, DOI 10.1002/jmv.20612; Idoyaga J, 2011, P NATL ACAD SCI USA, V108, P2384, DOI 10.1073/pnas.1019547108; Iyer SS, 2017, P NATL ACAD SCI USA, V114, pE590, DOI 10.1073/pnas.1620144114; Jacobson JM, 2016, JAIDS-J ACQ IMM DEF, V72, P31, DOI 10.1097/QAI.0000000000000926; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; Johansson SE, 2011, VIRAL IMMUNOL, V24, P359, DOI 10.1089/vim.2011.0025; Jones RB, 2016, J CLIN INVEST, V126, P455, DOI 10.1172/JCI80566; Jones RB, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004287; Julg B, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal1321; Kalinski P, 2011, IMMUNOL RES, V50, P235, DOI 10.1007/s12026-011-8224-z; Kanda Y, 2007, GLYCOBIOLOGY, V17, P104, DOI 10.1093/glycob/cwl057; Karn J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006916; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Kim Y, 2018, CELL HOST MICROBE, V23, P14, DOI 10.1016/j.chom.2017.12.004; Korner C, 2017, CELL HOST MICROBE, V22, P111, DOI 10.1016/j.chom.2017.06.008; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kristoff J, 2019, EBIOMEDICINE, V43, P295, DOI 10.1016/j.ebiom.2019.03.077; Kwon KJ, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aax6795; Laird GM, 2016, METHODS MOL BIOL, V1354, P239, DOI 10.1007/978-1-4939-3046-3_16; Laird GM, 2015, J CLIN INVEST, V125, P1901, DOI 10.1172/JCI80142; Lambotte O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074855; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Le Gall S, 1998, IMMUNITY, V8, P483, DOI 10.1016/S1074-7613(00)80553-1; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Lee WS, 2016, J VIROL, V90, P2021, DOI 10.1128/JVI.02717-15; Li JZ, 2016, AIDS, V30, P343, DOI 10.1097/QAD.0000000000000953; Lim SY, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao4521; Liu JY, 2016, SCIENCE, V353, P1045, DOI 10.1126/science.aag0491; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Lu W, 2004, NAT MED, V10, P1359, DOI 10.1038/nm1147; Luban J, 2012, CELL HOST MICROBE, V12, P408, DOI 10.1016/j.chom.2012.10.002; Ma DY, 2009, SEMIN IMMUNOL, V21, P265, DOI 10.1016/j.smim.2009.05.010; Macatangay BJC, 2016, J INFECT DIS, V213, P1400, DOI 10.1093/infdis/jiv582; Macatangay BJC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009852; Madhavi V, 2017, J VIROL, V91, DOI 10.1128/JVI.00700-17; Madhavi V, 2014, AIDS, V28, P1859, DOI 10.1097/QAD.0000000000000310; Mailliard RB, 2004, CANCER RES, V64, P5934, DOI 10.1158/0008-5472.CAN-04-1261; Manion M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030306; Margolis DM, 2011, CURR OPIN HIV AIDS, V6, P25, DOI 10.1097/COH.0b013e328341242d; Martin-Moreno A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02485; Martinson JA, 2007, CELL IMMUNOL, V250, P75, DOI 10.1016/j.cellimm.2008.01.007; Masterman KA, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-000691; Mavilio D, 2005, P NATL ACAD SCI USA, V102, P2886, DOI 10.1073/pnas.0409872102; Mayr LM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12883-6; McBrien JB, 2020, J VIROL, V94, DOI 10.1128/JVI.00755-20; McBrien JB, 2020, NATURE, V578, P154, DOI 10.1038/s41586-020-1946-0; Mendoza P, 2018, NATURE, V561, P479, DOI 10.1038/s41586-018-0531-2; Miller E, 2013, IMMUNOL REV, V254, P170, DOI 10.1111/imr.12082; Miller EA, 2012, JAIDS-J ACQ IMM DEF, V61, P535, DOI 10.1097/QAI.0b013e31826afbce; Mimoto F, 2013, MABS-AUSTIN, V5, P229, DOI 10.4161/mabs.23452; Mitchell JL, 2020, J CLIN INVEST, V130, P2845, DOI 10.1172/JCI130597; Moldt B, 2012, J VIROL, V86, P6189, DOI 10.1128/JVI.00491-12; MOLITOR JA, 1990, P NATL ACAD SCI USA, V87, P10028, DOI 10.1073/pnas.87.24.10028; Moog C, 2014, MUCOSAL IMMUNOL, V7, P46, DOI 10.1038/mi.2013.23; Mujib S, 2017, J VIROL, V91, DOI 10.1128/JVI.00634-17; Muthuswamy R, 2008, CANCER RES, V68, P5972, DOI 10.1158/0008-5472.CAN-07-6818; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Nishimura Y, 2017, NATURE, V543, P559, DOI 10.1038/nature21435; Norton TD, 2015, GENE THER, V22, P227, DOI 10.1038/gt.2014.117; Novis CL, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-119; Pace M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005782; Pan XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep26294; Papasavvas E, 2019, J IMMUNOL, V203, P705, DOI 10.4049/jimmunol.1801511; Pegu A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9447; Pollara J, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00713; Rajashekar JK, 2021, CELL HOST MICROBE, V29, P904, DOI 10.1016/j.chom.2021.04.014; Ramadoss NS, 2020, AIDS, V34, P1313, DOI 10.1097/QAD.0000000000002543; Rasmussen TA, 2014, LANCET HIV, V1, pE13, DOI 10.1016/S2352-3018(14)70014-1; Ren YQ, 2020, J CLIN INVEST, V130, P2542, DOI 10.1172/JCI132374; Rhode PR, 2016, CANCER IMMUNOL RES, V4, P49, DOI 10.1158/2326-6066.CIR-15-0093-T; Rhodes JW, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01088; Richard J, 2015, P NATL ACAD SCI USA, V112, pE2687, DOI 10.1073/pnas.1506755112; Richard J, 2010, BLOOD, V115, P1354, DOI 10.1182/blood-2009-08-237370; Riddler SA, 2021, CLIN INFECT DIS, V72, pE815, DOI 10.1093/cid/ciaa1534; Sabado RL, 2017, CELL RES, V27, P74, DOI 10.1038/cr.2016.157; Salantes DB, 2018, J CLIN INVEST, V128, P3102, DOI 10.1172/JCI120194; Santra S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005042; Sapp M, 1999, IMMUNOL LETT, V66, P121, DOI 10.1016/S0165-2478(98)00169-2; Scheid JF, 2016, NATURE, V535, P556, DOI 10.1038/nature18929; Schmidt B, 2005, VIROLOGY, V343, P256, DOI 10.1016/j.virol.2005.09.059; Schon A, 2006, BIOCHEMISTRY-US, V45, P10973, DOI 10.1021/bi061193r; Seay K, 2015, J VIROL, V89, P6264, DOI 10.1128/JVI.00563-15; SenGupta D, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abg3071; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Sloan DD, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005233; Smalls-Mantey A, 2012, J VIROL, V86, P8672, DOI 10.1128/JVI.00287-12; Sogaard OS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005142; Spivak AM, 2018, ANNU REV MED, V69, P421, DOI 10.1146/annurev-med-052716-031710; Stavenhagen JB, 2007, CANCER RES, V67, P8882, DOI 10.1158/0008-5472.CAN-07-0696; Sung JA, 2017, EBIOMEDICINE, V23, P52, DOI 10.1016/j.ebiom.2017.07.019; Sung JAM, 2015, J CLIN INVEST, V125, P4077, DOI 10.1172/JCI82314; Suthers AN, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00775; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; Thans TV, 2019, J VIROL, V93, DOI 10.1128/JVI.00719-19; Thibault S, 2009, VIROLOGY, V389, P20, DOI 10.1016/j.virol.2009.04.019; Timmons A, 2020, P NATL ACAD SCI USA, V117, P15763, DOI 10.1073/pnas.1916290117; Tsai A, 2017, J VIROL, V91, DOI [10.1128/JVI.02166-16, 10.1128/jvi.02166-16]; Van der Sluis RM, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008151; van der Sluis RM, 2015, AIDS, V29, P1003, DOI 10.1097/QAD.0000000000000637; van Montfort T, 2019, EBIOMEDICINE, V42, P97, DOI 10.1016/j.ebiom.2019.02.014; van Willigen WW, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02265; Vatner RE, 2019, MOL IMMUNOL, V110, P13, DOI 10.1016/j.molimm.2017.12.001; Veillette M, 2015, J VIROL, V89, P545, DOI 10.1128/JVI.02868-14; Veillette M, 2014, J VIROL, V88, P2633, DOI 10.1128/JVI.03230-13; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Vieira PL, 2000, J IMMUNOL, V164, P4507, DOI 10.4049/jimmunol.164.9.4507; von Bredow B, 2016, J VIROL, V90, P6127, DOI 10.1128/JVI.00347-16; Wang PF, 2020, P NATL ACAD SCI USA, V117, P18002, DOI 10.1073/pnas.2008190117; Wang Z, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0404-7; Ward J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000613; Ward JP, 2004, AIDS, V18, P1769, DOI 10.1097/00002030-200409030-00005; Webb GM, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008339; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yamane-Ohnuki N, 2004, BIOTECHNOL BIOENG, V87, P614, DOI 10.1002/bit.20151; Zhang ZK, 2018, CELL REP, V25, P3371, DOI 10.1016/j.celrep.2018.11.081	197	7	7	2	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2022	22	8					499	512		10.1038/s41577-021-00649-1	http://dx.doi.org/10.1038/s41577-021-00649-1		NOV 2021	14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3I4HH	34824401	Bronze			2022-12-18	WOS:000722493800001
J	Cobaleda, C; Vicente-Duenas, C; Sanchez-Garcia, I				Cobaleda, Cesar; Vicente-Duenas, Carolina; Sanchez-Garcia, Isidro			Infectious triggers and novel therapeutic opportunities in childhood B cell leukaemia	NATURE REVIEWS IMMUNOLOGY			English	Review							ACUTE LYMPHOBLASTIC-LEUKEMIA; DAY-CARE ATTENDANCE; EARLY IMMUNE STIMULATION; GENETIC-VARIATION; INTERNATIONAL INCIDENCE; CESAREAN DELIVERY; GENOMIC LANDSCAPE; CLONAL EVOLUTION; PRENATAL ORIGIN; HIGH-FREQUENCY	B cell acute lymphoblastic leukaemia (B-ALL) is the most common form of childhood cancer. Although treatment has advanced remarkably in the past 50 years, it still fails in similar to 20% of patients. Recent studies revealed that more than 5% of healthy newborns carry preleukaemic clones that originate in utero, but only a small percentage of these carriers will progress to overt B-ALL. The drivers of progression are unclear, but B-ALL incidence seems to be increasing in parallel with the adoption of modern lifestyles. Emerging evidence shows that a major driver for the conversion from the preleukaemic state to the B-ALL state is exposure to immune stressors, such as infection. Here, we discuss our current understanding of the environmental triggers and genetic predispositions that may lead to B-ALL, highlighting lessons from epidemiology, the clinic and animal models, and identifying priority areas for future research.	[Cobaleda, Cesar] CSIC, Ctr Biol Mol Severo Ochoa, Immune Syst Dev & Funct Unit, Madrid, Spain; [Cobaleda, Cesar] Univ Autonoma Madrid, Madrid, Spain; [Vicente-Duenas, Carolina; Sanchez-Garcia, Isidro] Inst Biomed Res Salamanca IBSAL, Salamanca, Spain; [Sanchez-Garcia, Isidro] CSIC, Inst Biol Mol & Celular Canc, Expt Therapeut & Translat Oncol Program, Salamanca, Spain; [Sanchez-Garcia, Isidro] Univ Salamanca, Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Cobaleda, C (corresponding author), CSIC, Ctr Biol Mol Severo Ochoa, Immune Syst Dev & Funct Unit, Madrid, Spain.; Cobaleda, C (corresponding author), Univ Autonoma Madrid, Madrid, Spain.; Sanchez-Garcia, I (corresponding author), Inst Biomed Res Salamanca IBSAL, Salamanca, Spain.; Sanchez-Garcia, I (corresponding author), CSIC, Inst Biol Mol & Celular Canc, Expt Therapeut & Translat Oncol Program, Salamanca, Spain.; Sanchez-Garcia, I (corresponding author), Univ Salamanca, Salamanca, Spain.	cesar.cobaledae@csic.es; isg@usal.es		SANCHEZ-GARCIA, ISIDRO/0000-0001-6989-9905; Vicente-Duenas, Carolina/0000-0002-5401-8295; Cobaleda, Cesar/0000-0003-3807-9204	European Regional Development Fund (FEDER)/MINECO [SAF2017-83061-R]; Fundacion Ramon Areces; Fundacion Sindrome de WolfHirschhorn o 4p-; Banco de Santander to Centro de Biologia Molecular Severo Ochoa; EU COST Action LEGEND [CA16223]; FEDER Miguel Servet grant from Instituto de Salud Carlos III (Ministerio de Economia y Competitividad) [CPII19/00024 - AES 2017-2020]; Fondo de Investigaciones Sanitarias/Instituto de Salud Carlos III [PI17/00167]; FEDER; MINECO/FEDER [SAF201564420-R]; MCIU/AEI/FEDER [RTI2018-093314-B-I00]; Junta de Castilla y Leon [UIC-017, CSI234P18, CSI144P20]; German Carreras Foundation (DJCLS) [07R/2019]; Fundacion Unoentrecienmil (CUNINA project); European Union under the Seventh Framework Programme; German Federal Office for Radiation Protection (BfS) [3618S32274]	European Regional Development Fund (FEDER)/MINECO; Fundacion Ramon Areces; Fundacion Sindrome de WolfHirschhorn o 4p-; Banco de Santander to Centro de Biologia Molecular Severo Ochoa; EU COST Action LEGEND; FEDER Miguel Servet grant from Instituto de Salud Carlos III (Ministerio de Economia y Competitividad); Fondo de Investigaciones Sanitarias/Instituto de Salud Carlos III(Instituto de Salud Carlos III); FEDER(European Commission); MINECO/FEDER(Spanish Government); MCIU/AEI/FEDER; Junta de Castilla y Leon(Junta de Castilla y Leon); German Carreras Foundation (DJCLS); Fundacion Unoentrecienmil (CUNINA project); European Union under the Seventh Framework Programme; German Federal Office for Radiation Protection (BfS)	The authors thank all the scientists who have contributed to this exciting field and apologize to those colleagues they were unable to cite. They thank the reviewers for their suggestions and comments, and A. Borkhardt, U. Fischer and all members of their groups for their generosity and useful discussions before the preparation of the manuscript, where several of the concepts examined have been investigated together. Research at C.C.'s laboratory was partially supported by the European Regional Development Fund (FEDER)/MINECO (SAF2017-83061-R), Fundacion Ramon Areces and a research contract with Fundacion Sindrome de WolfHirschhorn o 4p-. Institutional grants from Fundacion Ramon Areces and Banco de Santander to Centro de Biologia Molecular Severo Ochoa are also acknowledged. The C.C. and C.V.-D. laboratories are members of the EU COST Action LEGEND (CA16223). Research in the C.V.-D. group is partially supported by an FEDER Miguel Servet grant (CPII19/00024 -AES 2017-2020) from Instituto de Salud Carlos III (Ministerio de Economia y Competitividad), Fondo de Investigaciones Sanitarias/Instituto de Salud Carlos III (PI17/00167). Research in the I.S.-G. group is partially supported by the FEDER and by MINECO/FEDER (SAF201564420-R), MCIU/AEI/FEDER (RTI2018-093314-B-I00), Junta de Castilla y Leon (UIC-017, CSI001U16, CSI234P18 and CSI144P20), the German Carreras Foundation (DJCLS 07R/2019) and Fundacion Unoentrecienmil (CUNINA project). The I.S.-G. laboratory is a member of EuroSyStem and the DECIDE Network funded by the European Union under the Seventh Framework Programme. C.V.-D. and I.S.-G. have been supported by the German Federal Office for Radiation Protection (BfS) (FKZ: 3618S32274).	Ajrouche R, 2015, BRIT J CANCER, V112, P1017, DOI 10.1038/bjc.2015.53; Amitay EL, 2015, JAMA PEDIATR, V169, DOI 10.1001/jamapediatrics.2015.1025; Andersson AK, 2015, NAT GENET, V47, P330, DOI 10.1038/ng.3230; [Anonymous], 2000, Br J Cancer, V82, P1073; Auer F, 2014, LEUKEMIA, V28, P1136, DOI 10.1038/leu.2013.363; Beneforti L, 2020, BRIT J HAEMATOL, V190, P262, DOI 10.1111/bjh.16523; Biondi A, 2012, LANCET ONCOL, V13, P936, DOI 10.1016/S1470-2045(12)70377-7; Boiers C, 2018, DEV CELL, V44, P362, DOI 10.1016/j.devcel.2017.12.005; Boulianne B, 2017, CELL REP, V18, P1687, DOI 10.1016/j.celrep.2017.01.057; Buffler PA, 2005, CANCER INVEST, V23, P60, DOI 10.1081/CNV-200046402; Campos-Sanchez E, 2019, BIOELECTROMAGNETICS, V40, P343, DOI 10.1002/bem.22193; Cardwell CR, 2008, BRIT J CANCER, V99, P1529, DOI 10.1038/sj.bjc.6604696; Caughey RW, 2009, INT J CANCER, V124, P2658, DOI 10.1002/ijc.24225; Cazzaniga G, 2017, LEUKEMIA, V31, P1819, DOI 10.1038/leu.2017.127; Cazzaniga G, 2011, BLOOD, V118, P5559, DOI 10.1182/blood-2011-07-366542; Chan LN, 2017, EXP HEMATOL, V53, P1, DOI 10.1016/j.exphem.2017.06.004; Churchman ML, 2018, CANCER CELL, V33, P937, DOI 10.1016/j.ccell.2018.03.021; Churchman ML, 2015, CANCER CELL, V28, P343, DOI 10.1016/j.ccell.2015.07.016; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Comstock GW, 2003, AM J EPIDEMIOL, V157, P183, DOI 10.1093/aje/kwf206; Crouch S, 2012, AM J EPIDEMIOL, V176, P402, DOI 10.1093/aje/kws180; Dockerty JD, 2001, INT J EPIDEMIOL, V30, P1428, DOI 10.1093/ije/30.6.1428; Doll R, 1997, BRIT J RADIOL, V70, P130, DOI 10.1259/bjr.70.830.9135438; Duployez N, 2021, BLOOD, V137, P1424, DOI 10.1182/blood.2020005756; Fidanza M, 2016, LEUKEMIA, V30, P2116, DOI 10.1038/leu.2016.152; Fidanza M, 2017, EUR J IMMUNOL, V47, P892, DOI 10.1002/eji.201646806; Fischer U, 2020, BLOOD CANCER DISCOV, V1, P224, DOI 10.1158/2643-3230.BCD-20-0011; Ford AM, 1998, P NATL ACAD SCI USA, V95, P4584, DOI 10.1073/pnas.95.8.4584; Francis SS, 2012, CHEM-BIOL INTERACT, V196, P102, DOI 10.1016/j.cbi.2011.02.019; Francis SS, 2017, BLOOD, V129, P1680, DOI 10.1182/blood-2016-07-723148; Gilbert JA, 2018, NAT MED, V24, P392, DOI 10.1038/nm.4517; Gilham C, 2005, BMJ-BRIT MED J, V330, P1294, DOI 10.1136/bmj.38428.521042.8F; Gocho Y, 2019, BLOOD, V134, P793, DOI 10.1182/blood.2018852400; GOODMAN RA, 1984, PEDIATRICS, V74, P134; Grabas MR, 2020, ACTA ONCOL, V59, P588, DOI 10.1080/0284186X.2020.1725239; Greaves M, 2006, NAT REV CANCER, V6, P193, DOI 10.1038/nrc1816; Greaves M, 2018, NAT REV CANCER, V18, P471, DOI 10.1038/s41568-018-0015-6; GREAVES MF, 1985, LEUKEMIA RES, V9, P715, DOI 10.1016/0145-2126(85)90281-4; GREAVES MF, 1988, LEUKEMIA, V2, P120; Greenbaum S, 2018, J PEDIATR-US, V197, P292, DOI 10.1016/j.jpeds.2017.12.049; Grobner SN, 2018, NATURE, V555, P321, DOI 10.1038/nature25480; Gu ZH, 2019, NAT GENET, V51, P296, DOI 10.1038/s41588-018-0315-5; Hagan T, 2019, CELL, V178, P1313, DOI 10.1016/j.cell.2019.08.010; Hein D, 2020, CANCER METAST REV, V39, P161, DOI 10.1007/s10555-019-09841-1; Hein D, 2019, BLOOD, V134, P1355, DOI 10.1182/blood.2019002215; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Hu YG, 2017, CURR OPIN HEMATOL, V24, P345, DOI 10.1097/MOH.0000000000000352; Hyrenius-Wittsten A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04180-1; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2002, IARC MONOGRAPHS EVAL, DOI DOI 10.1002/BEM.22228; Inaba H, 2013, LANCET, V381, P1943, DOI 10.1016/S0140-6736(12)62187-4; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kaatsch P, 2008, RADIAT PROT DOSIM, V132, P107, DOI 10.1093/rpd/ncn259; Kalafati L, 2020, CELL, V183, P771, DOI 10.1016/j.cell.2020.09.058; Kamper-Jorgensen M, 2008, LEUKEMIA, V22, P189, DOI 10.1038/sj.leu.2404884; Kendall GM, 2013, LEUKEMIA, V27, P3, DOI 10.1038/leu.2012.151; Kimura S, 2020, BEST PRACT RES CL HA, V33, DOI 10.1016/j.beha.2020.101193; Kinlen L, 2011, BRIT J CANCER, V104, P12, DOI 10.1038/sj.bjc.6605982; KINLEN L, 1988, LANCET, V2, P1323; Kinlen LJ, 2012, BRIT J CANCER, V107, P1163, DOI 10.1038/bjc.2012.402; KINLEN LJ, 1995, BRIT J CANCER, V71, P1, DOI 10.1038/bjc.1995.1; Kosik P, 2017, ONCOTARGET, V8, P35824, DOI 10.18632/oncotarget.16211; Kratz CP, 2016, EUR J MED GENET, V59, P111, DOI 10.1016/j.ejmg.2015.10.003; Kreis C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170020; Kreis C, 2016, INT J CANCER, V138, P2127, DOI 10.1002/ijc.29955; Kroll ME, 2011, BRIT J CANCER, V105, P1783, DOI 10.1038/bjc.2011.415; Lahoud MH, 2001, GENOME RES, V11, P1327, DOI 10.1101/gr.168801; Laurier D, 2008, RADIAT PROT DOSIM, V132, P182, DOI 10.1093/rpd/ncn262; Laurier D, 2014, J RADIOL PROT, V34, pR53, DOI 10.1088/0952-4746/34/3/R53; Linabery AM, 2008, CANCER, V112, P416, DOI 10.1002/cncr.23169; Linet MS, 2016, INT J CANCER, V138, P1862, DOI 10.1002/ijc.29924; Ma X, 2002, BRIT J CANCER, V86, P1419, DOI 10.1038/sj.bjc.6600274; Ma XT, 2018, NATURE, V555, P371, DOI 10.1038/nature25795; Maia AT, 2003, LEUKEMIA, V17, P2202, DOI 10.1038/sj.leu.2403101; Marcotte EL, 2016, LANCET HAEMATOL, V3, pE176, DOI 10.1016/S2352-3026(16)00002-8; Marschalek R, 2011, BRIT J HAEMATOL, V152, P141, DOI 10.1111/j.1365-2141.2010.08459.x; Martin-Lorenzo A, 2018, CANCER RES, V78, P2669, DOI 10.1158/0008-5472.CAN-17-3262; Martin-Lorenzo A, 2015, CANCER DISCOV, V5, P1328, DOI 10.1158/2159-8290.CD-15-0892; McNally RJQ, 2004, BRIT J HAEMATOL, V127, P243, DOI 10.1111/j.1365-2141.2004.05166.x; Melazzini F, 2016, HAEMATOLOGICA, V101, P1333, DOI 10.3324/haematol.2016.147496; Mendez-Ferrer S, 2015, ANN NY ACAD SCI, V1335, P32, DOI 10.1111/nyas.12641; Migliorini G, 2013, BLOOD, V122, P3298, DOI 10.1182/blood-2013-03-491316; Miller A., 2020, CORRELATION UNIVERSA, DOI 10.1101/2020.03.24.20042937; Mina MJ, 2019, SCIENCE, V366, P599, DOI 10.1126/science.aay6485; Molina O, 2020, BLOOD, V136, P313, DOI 10.1182/blood.2019002538; Mori H, 2002, P NATL ACAD SCI USA, V99, P8242, DOI 10.1073/pnas.112218799; Moriyama T, 2015, LANCET ONCOL, V16, P1659, DOI 10.1016/S1470-2045(15)00369-1; Moriyama T, 2015, BLOOD, V125, P3988, DOI 10.1182/blood-2014-12-580001; Morra ME, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16067-0; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2014, HEMATOL-AM SOC HEMAT, P174, DOI 10.1182/asheducation-2014.1.174; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Neglia JP, 2000, BRIT J CANCER, V82, P234, DOI 10.1054/bjoc.1999.0905; Netea MG, 2020, NAT REV IMMUNOL, V20, P375, DOI 10.1038/s41577-020-0285-6; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Ng AP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16828-y; Nishimoto N, 2010, INT J HEMATOL, V92, P194, DOI 10.1007/s12185-010-0612-y; Noetzli L, 2015, NAT GENET, V47, P535, DOI 10.1038/ng.3253; O'Neill KA, 2012, EXPERT REV HEMATOL, V5, P559, DOI [10.1586/ehm.12.39, 10.1586/EHM.12.39]; Pang SHM, 2014, CURR TOP MICROBIOL, V381, P189, DOI 10.1007/82_2014_377; Papaemmanuil E, 2014, NAT GENET, V46, P116, DOI 10.1038/ng.2874; Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430; PARKIN DM, 1988, INT J CANCER, V42, P511, DOI 10.1002/ijc.2910420408; Paulsson K, 2015, NAT GENET, V47, P672, DOI 10.1038/ng.3301; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Perez-Andreu V, 2013, NAT GENET, V45, P1494, DOI 10.1038/ng.2803; Perez-Garcia A, 2013, BLOOD, V122, P2425, DOI 10.1182/blood-2013-05-500850; Petrova VN, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aay6125; Poore GD, 2020, NATURE, V579, P567, DOI 10.1038/s41586-020-2095-1; Portale F, 2019, EXP HEMATOL, V73, P7, DOI 10.1016/j.exphem.2019.02.006; Prasad V, 2016, NATURE, V537, pS63, DOI 10.1038/537S63a; Priem B, 2020, CELL, V183, P786, DOI 10.1016/j.cell.2020.09.059; Pui CH, 2019, NAT REV CLIN ONCOL, V16, P227, DOI 10.1038/s41571-018-0136-6; Pui CH, 2017, CL LYMPH MYELOM LEUK, V17, P464, DOI 10.1016/j.clml.2017.03.299; Qian MX, 2019, BLOOD, V133, P724, DOI 10.1182/blood-2018-07-862946; Qian MX, 2017, GENOME RES, V27, P185, DOI 10.1101/gr.209163.116; Roberts KG, 2018, HEMATOL-AM SOC HEMAT, P137, DOI 10.1182/asheducation-2018.1.137; Roberts KG, 2017, J CLIN ONCOL, V35, P394, DOI 10.1200/JCO.2016.69.0073; Rodriguez-Hernandez G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13570-y; Rodriguez-Hernandez G, 2017, CANCER RES, V77, P4365, DOI 10.1158/0008-5472.CAN-17-0701; Roman E, 2007, AM J EPIDEMIOL, V165, P496, DOI 10.1093/aje/kwk039; Roman E, 2009, BLOOD CELL MOL DIS, V42, P126, DOI 10.1016/j.bcmd.2008.10.007; Roy A, 2020, BLOOD, V136, P1995, DOI 10.1182/blood.2020008907; Rubery ED., 1985, J SOC RADIOL PROT, V5, P187, DOI [10.1088/0260-2814/5/4/405, DOI 10.1088/0260-2814/5/4/405]; Rudant J, 2015, AM J EPIDEMIOL, V181, P549, DOI 10.1093/aje/kwu298; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Sanjuan-Pla A, 2015, BLOOD, V126, P2676, DOI 10.1182/blood-2015-09-667378; Schafer D, 2018, BLOOD, V131, P821, DOI 10.1182/blood-2017-09-808402; Schindler JW, 2009, CELL STEM CELL, V5, P43, DOI 10.1016/j.stem.2009.04.019; Schuz J, 2016, BIOELECTROMAGNETICS, V37, P183, DOI 10.1002/bem.21963; Schultz KR, 2014, LEUKEMIA, V28, P1467, DOI 10.1038/leu.2014.30; Shah S, 2013, NAT GENET, V45, P1226, DOI 10.1038/ng.2754; SHIMKIN MB, 1975, WESTERN J MED, V122, P185; Soegaard SH, 2018, CANCER RES, V78, P5458, DOI 10.1158/0008-5472.CAN-18-0831; Sondergaard E, 2019, CELL REP, V29, P2756, DOI 10.1016/j.celrep.2019.10.098; Sood R, 2017, BLOOD, V129, P2070, DOI 10.1182/blood-2016-10-687830; Steinmaus C, 2004, ENVIRON HEALTH PERSP, V112, P766, DOI 10.1289/ehp.6592; Steliarova-Foucher E, 2018, LANCET ONCOL, V19, P1159, DOI 10.1016/S1470-2045(18)30423-6; Steliarova-Foucher E, 2017, LANCET ONCOL, V18, P719, DOI 10.1016/S1470-2045(17)30186-9; Swaminathan S, 2015, ONCOTARGET, V6, P16798, DOI 10.18632/oncotarget.4630; Swaminathan S, 2015, NAT IMMUNOL, V16, P766, DOI 10.1038/ni.3160; Tannock IF, 2016, NEW ENGL J MED, V375, P1289, DOI 10.1056/NEJMsb1607705; Taub JW, 2002, BLOOD, V99, P2992, DOI 10.1182/blood.V99.8.2992; Teng G, 2015, CELL, V162, P751, DOI 10.1016/j.cell.2015.07.009; Topka S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005262; Trevino LR, 2009, NAT GENET, V41, P1001, DOI 10.1038/ng.432; Urayama KY, 2010, INT J EPIDEMIOL, V39, P718, DOI 10.1093/ije/dyp378; Urayama KY, 2008, RADIAT PROT DOSIM, V132, P259, DOI 10.1093/rpd/ncn271; Vicente-Duenas C, 2020, BLOOD, V136, P2003, DOI 10.1182/blood.2019004381; Vicente-Duenas C, 2018, TRENDS CANCER, V4, P408, DOI 10.1016/j.trecan.2018.04.007; Vijayakrishnan J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13069-6; Waanders E, 2017, LEUKEMIA, V31, P821, DOI 10.1038/leu.2016.277; Wakeford R, 2013, J RADIOL PROT, V33, P1, DOI 10.1088/0952-4746/33/1/1; Wang R, 2017, AM J EPIDEMIOL, V185, P96, DOI 10.1093/aje/kww153; Ward G., 1917, BR J CHILD DIS, V14, P11; Wiemels JL, 1999, LANCET, V354, P1499, DOI 10.1016/S0140-6736(99)09403-9; Wiemels JL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02596-9; Xu H, 2013, JNCI-J NATL CANCER I, V105, P733, DOI 10.1093/jnci/djt042; Yasuda T, 2016, NAT GENET, V48, P1591, DOI 10.1038/ng1216-1587a; Yen HJ, 2020, BLOOD, V135, P1847, DOI 10.1182/blood.2019003858; Zamora AE, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat8549; Zhang MY, 2015, NAT GENET, V47, P180, DOI 10.1038/ng.3177	163	7	7	1	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2021	21	9					570	581		10.1038/s41577-021-00505-2	http://dx.doi.org/10.1038/s41577-021-00505-2		FEB 2021	12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UI9ET	33558682				2022-12-18	WOS:000616036600001
J	Doherty, PC				Doherty, Peter C.			What have we learnt so far from COVID-19?	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material								While COVID-19 shows us the enormous power of modern molecular medicine, it also reminds us of the basic contradictions and limitations of the human condition. As it is highly likely we will experience further such events through the twenty-first century, we should regard COVID-19 as a training run for something that could be much worse, and organize our governance, global interactions, institutions and practices accordingly.	[Doherty, Peter C.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia	University of Melbourne	Doherty, PC (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia.	pcd@unimelb.edu.au	Doherty, Peter Charles/C-4185-2013	Doherty, Peter Charles/0000-0002-5028-3489					0	7	7	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2021	21	2					67	68		10.1038/s41577-021-00498-y	http://dx.doi.org/10.1038/s41577-021-00498-y		JAN 2021	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QB3OS	33442033	Bronze, Green Published			2022-12-18	WOS:000608148000002
J	Crunkhorn, S				Crunkhorn, Sarah			Strengthening the sting of immunotherapy	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material; Early Access												a.flemming@nature.com						Chin EN, 2020, SCIENCE, V369, P993, DOI 10.1126/science.abb4255; Pan BS, 2020, SCIENCE, V369, P935, DOI 10.1126/science.aba6098	2	7	7	1	21	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.												10.1038/s41577-020-00447-1	http://dx.doi.org/10.1038/s41577-020-00447-1		SEP 2020	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NL4DL	32901152				2022-12-18	WOS:000567368600001
J	Bird, L				Bird, Lucy			MDSC metabolite stuns T cells	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material								A new study shows how myeloid-derived suppressor cells paralyse CD8(+) T cell effector functions by transferring the metabolite methylglyoxal directly into the T cell cytosol, where it depletes essential amino acids.				l.bird@nature.com						Baumann T, 2020, NAT IMMUNOL, V21, P555, DOI 10.1038/s41590-020-0666-9	1	7	7	0	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2020	20	6					352	353		10.1038/s41577-020-0336-z	http://dx.doi.org/10.1038/s41577-020-0336-z		MAY 2020	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LT4QN	32367052				2022-12-18	WOS:000530214200002
J	Risson, E				Risson, Emma			Inactivated vaccine for SARS-CoV-2	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material; Early Access									[Risson, Emma] Icahn Sch Med Mt Sinai, Sinai Immunol Review Project, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Risson, E (corresponding author), Icahn Sch Med Mt Sinai, Sinai Immunol Review Project, New York, NY 10029 USA.	sinai.immunology@gmail.com		Risson, Emma/0000-0002-0371-9067				Cai X., 2020, J CLEAN PROD, V258, DOI [10.1101/2020.04.17.046375, DOI 10.1101/2020.04.17.046375]	1	7	7	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.												10.1038/s41577-020-0334-1	http://dx.doi.org/10.1038/s41577-020-0334-1		APR 2020	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LJ0GJ	32355330	Green Published, Bronze			2022-12-18	WOS:000529852600002
J	Kugelberg, E				Kugelberg, Elisabeth			Diet can protect against type 1 diabetes	NATURE REVIEWS IMMUNOLOGY			English	News Item														Kugelberg, Elisabeth/0000-0002-8302-3595					0	7	8	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2017	17	5					279	279		10.1038/nri.2017.40	http://dx.doi.org/10.1038/nri.2017.40			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ET1SY	28422177	Bronze			2022-12-18	WOS:000400050400004
J	Shipman, L				Shipman, Lydia			Interrogating intratumoral T-reg cells	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	7	7	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2017	17	1					4	5						2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EH6TX	27916981				2022-12-18	WOS:000391907900006
J	Kugelberg, E				Kugelberg, Elisabeth			INNATE IMMUNITY IL-1 beta activation under scrutiny	NATURE REVIEWS IMMUNOLOGY			English	News Item														Kugelberg, Elisabeth/0000-0002-8302-3595				LaRock CN, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah3539	1	7	7	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2016	16	10								10.1038/nri.2016.102	http://dx.doi.org/10.1038/nri.2016.102			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DX7FL	27616587				2022-12-18	WOS:000384551900003
J	Bird, L				Bird, Lucy			Hunker down with HOBIT and BLIMP1	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bird, Lucy/0000-0002-3914-6045					0	7	7	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2016	16	6					338	338		10.1038/nri.2016.61	http://dx.doi.org/10.1038/nri.2016.61			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DN0GP	27180814				2022-12-18	WOS:000376742700005
J	Alp, OS; Radbruch, A				Alp, Oezen Sercan; Radbruch, Andreas			The lifestyle of memory CD8(+) T cells	NATURE REVIEWS IMMUNOLOGY			English	Letter							BONE-MARROW; PROLIFERATION		[Alp, Oezen Sercan; Radbruch, Andreas] German Rheumatism Res Ctr, Dept Cell Biol, Charitepl 1, D-10117 Berlin, Germany	Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Radbruch, A (corresponding author), German Rheumatism Res Ctr, Dept Cell Biol, Charitepl 1, D-10117 Berlin, Germany.	radbruch@drfz.de						Alp OS, 2015, EUR J IMMUNOL, V45, P975, DOI 10.1002/eji.201445295; Becker TC, 2005, J IMMUNOL, V174, P1269, DOI 10.4049/jimmunol.174.3.1269; Choo DK, 2010, J IMMUNOL, V185, P3436, DOI 10.4049/jimmunol.1001421; Di Rosa F., 2016, NAT REV IMMUNOL; Geerman S, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00660; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Laidlaw BJ, 2014, IMMUNITY, V41, P633, DOI 10.1016/j.immuni.2014.09.007; Mazzucchelli RI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007637; Okhrimenko A, 2014, P NATL ACAD SCI USA, V111, P9229, DOI 10.1073/pnas.1318731111; PABST R, 1986, IMMUNOLOGY, V59, P217; Parretta E, 2005, J IMMUNOL, V174, P7654, DOI 10.4049/jimmunol.174.12.7654; Parretta E, 2008, J IMMUNOL, V180, P7230, DOI 10.4049/jimmunol.180.11.7230; Schenkel JM, 2014, J IMMUNOL, V192, P2961, DOI 10.4049/jimmunol.1400003; Shinoda K, 2012, P NATL ACAD SCI USA, V109, P7409, DOI 10.1073/pnas.1118539109; Tokoyoda K, 2010, NAT REV IMMUNOL, V10, P193, DOI 10.1038/nri2727; Tokoyoda K, 2009, IMMUNITY, V30, P721, DOI 10.1016/j.immuni.2009.03.015	16	7	7	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2016	16	4												1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH7MD					2022-12-18	WOS:000372977200013
J	Flemming, A				Flemming, Alexandra			Nanoparticles engineered for antigen-specific immunotherapy	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	7	7	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2016	16	4								10.1038/nri.2016.39	http://dx.doi.org/10.1038/nri.2016.39			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH7MD	27026072				2022-12-18	WOS:000372977200003
J	Alderton, GK				Alderton, Gemma K.			Intestinal bacteria are in command	NATURE REVIEWS IMMUNOLOGY			English	News Item														Alderton, Gemma/0000-0003-3041-8451					0	7	7	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2016	16	1					5	5		10.1038/nri.2015.13	http://dx.doi.org/10.1038/nri.2015.13			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ7AH	26655627	Bronze			2022-12-18	WOS:000367251800007
J	Kugelberg, E				Kugelberg, Elisabeth			Controlling innate immune memory	NATURE REVIEWS IMMUNOLOGY			English	News Item														Kugelberg, Elisabeth/0000-0002-8302-3595				Yoshida K., 2015, NAT IMMUNOL	1	7	7	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2015	15	10					596	596		10.1038/nri3914	http://dx.doi.org/10.1038/nri3914			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CS2PE	26358394				2022-12-18	WOS:000361912600002
J	Leavy, O				Leavy, Olive			NETting a one-two punch	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	7	7	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2015	15	9					526	527		10.1038/nri3898	http://dx.doi.org/10.1038/nri3898			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CR1JO	26228903				2022-12-18	WOS:000361081200003
J	Bordon, Y				Bordon, Yvonne			IMMUNOMETABOLISM IL-6, the resistance fighter	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X					0	7	7	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2014	14	5					282	282		10.1038/nri3670	http://dx.doi.org/10.1038/nri3670			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AF8ZB	24751953				2022-12-18	WOS:000335003400002
J	Kugelberg, E				Kugelberg, Elisabeth			MUCOSAL IMMUNOLOGY Bacteria get T-Reg cells into shape	NATURE REVIEWS IMMUNOLOGY			English	News Item														Kugelberg, Elisabeth/0000-0002-8302-3595					0	7	7	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2014	14	1					2	2		10.1038/nri3583	http://dx.doi.org/10.1038/nri3583			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	279LT	24287865				2022-12-18	WOS:000328962200002
J	Kugelberg, E				Kugelberg, Elisabeth			INNATE IMMUNITY Making mice more human the TLR8 way	NATURE REVIEWS IMMUNOLOGY			English	News Item														Kugelberg, Elisabeth/0000-0002-8302-3595					0	7	9	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2014	14	1					6	6		10.1038/nri3587	http://dx.doi.org/10.1038/nri3587			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	279LT	24336104	Bronze			2022-12-18	WOS:000328962200007
J	Leavy, O				Leavy, Olive			T CELLS Mitochondria and T cell activation	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020	1	7	7	2	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2013	13	4					224	224		10.1038/nri3424	http://dx.doi.org/10.1038/nri3424			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	112US	23449340				2022-12-18	WOS:000316620100007
J	Leavy, O				Leavy, Olive			INFLAMMATION Trauma kicks up a storm	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354	1	7	8	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2012	12	1					3	3		10.1038/nri3138	http://dx.doi.org/10.1038/nri3138			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	866GM	22173479	Bronze			2022-12-18	WOS:000298368500004
J	Leavy, O				Leavy, Olive			T CELLS Shaping Il4 gene expression	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Tanaka S, 2011, NAT IMMUNOL, V12, P77, DOI 10.1038/ni.1966; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487	2	7	8	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2011	11	1					3	3		10.1038/nri2908	http://dx.doi.org/10.1038/nri2908			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	698DR	22173479	Bronze			2022-12-18	WOS:000285572600002
J	David, R				David, Rachel			REGULATORY T CELLS A helping hand from Bacteroides fragilis	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	7	7	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2010	10	8					540	540		10.1038/nri2827	http://dx.doi.org/10.1038/nri2827			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	629KX	20677358				2022-12-18	WOS:000280198400003
J	David, R				David, Rachel			REGULATORY T CELLS Fine-tuning T-Reg cells	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Franceschini D, 2009, J CLIN INVEST, V119, P551, DOI 10.1172/JCI36604	1	7	7	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2009	9	4					226	226		10.1038/nri2537	http://dx.doi.org/10.1038/nri2537			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	423MT					2022-12-18	WOS:000264501100009
J	Honey, K				Honey, K			T-cell activation - CCL3 and CCL4 actively recruit CD8(+) T cells	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651	1	7	7	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2006	6	6					427	427		10.1038/nri1862	http://dx.doi.org/10.1038/nri1862			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	056NF					2022-12-18	WOS:000238529700003
J	Debard, N; Py, P; Kraehenbuhl, JP; Fuchs, J				Debard, N; Py, P; Kraehenbuhl, JP; Fuchs, J			Science and society - The influence of the Internet on immunology education	NATURE REVIEWS IMMUNOLOGY			English	Article								The potential of the Internet as a medium through which to teach basic and applied immunology lies in the ability to illustrate complex concepts in new ways for audiences that are diverse and often geographically dispersed. This article explores two collaborative Internet-based learning projects ( also known as e-learning projects) that are under development: Immunology Online, which will present an Internet-based curriculum in basic and clinical immunology to Swiss undergraduate and graduate students across five campuses; and the OCTAVE project, which will offer online training to an international cadre of new investigators, the members of which are carrying out clinical trials of vaccines against HIV infection.	Swiss Inst Expt Canc Res, EuroVacc Fdn, CH-1066 Epalinges, Switzerland; CHU Vaudois, Div Immunol & Allergy, CH-1011 Lausanne, Switzerland; Univ Zurich, Dept Psychiat Res, CH-8032 Zurich, Switzerland; San Francisco Dept Publ Hlth, HIV Res Sect, San Francisco, CA 94102 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94117 USA; Fred Hutchinson Canc Res Ctr, HIV Vaccine Trials Network, Seattle, WA 98109 USA	Swiss Institute Experimental Cancer Research; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Zurich; San Francisco Department of Public Health; University of California System; University of California San Francisco; Fred Hutchinson Cancer Center	Kraehenbuhl, JP (corresponding author), Swiss Inst Expt Canc Res, EuroVacc Fdn, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.	jean-pierre.kraehenbuhl@isrec.ch						Artelt C., 2004, LERNEN LERNEN VORAUS; Davis Mary V, 2004, J Public Health Manag Pract, V10, P556; Johnson S. D., 2000, Journal of Interactive Learning Research, V11, P29; *JOINT UN PROGR HI, 2003, AIDS EP UPD 2003; Kelly JA, 2004, SCIENCE, V305, P1953, DOI 10.1126/science.1100733; Paulson W., 1997, TROUBADOUR KNOWLEDGE	6	7	9	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2005	5	9					736	740		10.1038/nri1687	http://dx.doi.org/10.1038/nri1687			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	960NW	16110314	Bronze			2022-12-18	WOS:000231601400013
J	Ivanyi, J				Ivanyi, J			Opinion - Milan Hasek and the discovery of immunological tolerance	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material							TRANSPLANTATION; INDUCTION; CELLS; MICE		Kings Coll London, London SE1 9RT, England	University of London; King's College London	Ivanyi, J (corresponding author), Kings Coll London, Guys Campus,28 Floor Guys Tower, London SE1 9RT, England.	juraj.ivanyi@kcl.ac.uk						BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; BRENT L, 1988, HIST TRANSPLANTATION; BURNET FM, 1950, AUST J EXP BIOL MED, V28, P291, DOI 10.1038/icb.1950.29; Burnet FM, 1949, PRODUCTION ANTIBODIE; FELTON LD, 1949, J IMMUNOL, V61, P107; FRANKENBERGER Z, 1955, CS BIOL, V18, P118; GLUSHCHENKO IE, 1951, VEGETATIVE HYBRIDIZA; GORCZYNSKI RM, 1980, P NATL ACAD SCI-BIOL, V77, P2871, DOI 10.1073/pnas.77.5.2871; GRMEK MD, 1981, ERICE LECT, V3; HARRIS M, 1948, J EXP ZOOL, V107, P439, DOI 10.1002/jez.1401070304; HASEK M, 1967, FOLIA BIOL-PRAGUE, V13, P208; HASEK M, 1963, FOLIA BIOL-PRAGUE, V9, P1; Hasek M., 1956, Proceedings of the Royal Society, V146B, P67, DOI 10.1098/rspb.1956.0072; HASEK M, 1955, NATURE, V175, P764, DOI 10.1038/175764a0; HASEK M, 1961, ADV IMMUNOL, V1, P1, DOI 10.1016/S0065-2776(08)60762-2; HASEK M, 1954, CSL BIOLOGIE, V3, P327; Hasek M., 1953, CESCOSL BIOL, V2, P265; HASEK M, 1954, VEGETATIVE HYBRIDIZA; HASEK M, 1955, CS BIOL, V18, P121; HASEK M, 1955, FOLIA BIOL-PRAGUE, V1, P1; HASEK M, 1962, MECH IMMUNOLOGICAL T; HAVLIK M, 1998, THESIS PRAGUE; IVANYI J, 1966, FOLIA BIOL-PRAGUE, V12, P36; Ivanyi Paul, 1989, REALM TOLERANCE; JANKO J, 1996, FOLIA MENDELIANA, V81, P17; Jonker M, 2002, TRANSPLANTATION, V73, P874, DOI 10.1097/00007890-200203270-00008; Kahan BD, 2001, TRANSPLANT P, V33, P3035, DOI 10.1016/S0041-1345(01)02300-4; KLEIN J, 1985, IMMUNOGENETICS, V21, P105, DOI 10.1007/BF00364861; Lechler RI, 2003, NAT REV IMMUNOL, V3, P147, DOI 10.1038/nri1002; Li YS, 1999, NAT MED, V5, P1298, DOI 10.1038/15256; MATALOVA A, 1997, BIOL INTEGRATING SCI, P423; McLaren A, 1999, TRENDS GENET, V15, P169, DOI 10.1016/S0168-9525(99)01732-1; MEDAWAR PB, 1984, MEMOIR THINKING RADI; MICHIE D, 1962, PROC R SOC SER B-BIO, V156, P280, DOI 10.1098/rspb.1962.0044; OWEN RD, 1945, SCIENCE, V102, P400, DOI 10.1126/science.102.2651.400; RUTHERFORD SL, 1998, NATURE, V150, P563; Sebille F, 2003, XENOTRANSPLANTATION, V10, P4; SEKERAK J, 1997, FOLIA MENDELIANA, V81, P29; SEKERAK J, 1998, FOLIA MENDELIANA, V83, P79; SVOBODA J, 1961, MECH IMMUNOLOGICAL T, P199; Thomas F, 2000, MICROSURG, V20, P435, DOI 10.1002/1098-2752(2000)20:8<435::AID-MICR15>3.0.CO;2-2; VINOGRADOVA TV, 1950, BASICS MICHURINIST B; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0	43	7	7	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JUL	2003	3	7					591	597		10.1038/nri1133	http://dx.doi.org/10.1038/nri1133			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	699RN	12876561				2022-12-18	WOS:000184069900023
J	Bell, J				Bell, J			Friend or foe?	NATURE REVIEWS IMMUNOLOGY			English	News Item																		HEPPNER FL, 2001, SCIENCE         0906	1	7	7	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2001	1	1					7	7		10.1038/35095537	http://dx.doi.org/10.1038/35095537			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	635KK					2022-12-18	WOS:000180397900011
J	Lum, FM; Torres-Ruesta, A; Tay, MZ; Lin, RTP; Lye, DC; Renia, L; Ng, LFP				Lum, Fok-Moon; Torres-Ruesta, Anthony; Tay, Matthew Z.; Lin, Raymond T. P.; Lye, David C.; Renia, Laurent; Ng, Lisa F. P.			Monkeypox: disease epidemiology, host immunity and clinical interventions	NATURE REVIEWS IMMUNOLOGY			English	Review							T-CELL RESPONSES; VACCINIA VIRUS-INFECTION; HUMAN-ANTIBODY RESPONSES; SMALLPOX VACCINE; IFN-GAMMA; BINDING-PROTEIN; DENDRITIC CELLS; VARIOLA VIRUS; IMPORTED MONKEYPOX; MATURE VIRIONS	Monkeypox virus (MPXV), which causes disease in humans, has for many years been restricted to the African continent, with only a handful of sporadic cases in other parts of the world. However, unprecedented outbreaks of monkeypox in non-endemic regions have recently taken the world by surprise. In less than 4 months, the number of detected MPXV infections has soared to more than 48,000 cases, recording a total of 13 deaths. In this Review, we discuss the clinical, epidemiological and immunological features of MPXV infections. We also highlight important research questions and new opportunities to tackle the ongoing monkeypox outbreak. In this Review, Ng and colleagues examine the clinical, epidemiological and immunological aspects of monkeypox virus (MPXV) infections, with a focus on mechanisms of host immunity to MPXV. The authors also consider the unique epidemiological and pathological characteristics of the current non-endemic outbreak of the virus and discuss vaccines, therapeutics and outstanding research questions.	[Lum, Fok-Moon; Torres-Ruesta, Anthony; Tay, Matthew Z.; Renia, Laurent; Ng, Lisa F. P.] ASTAR, A STAR Infect Dis Labs, Singapore, Singapore; [Lin, Raymond T. P.] Natl Publ Hlth Lab, Singapore, Singapore; [Lin, Raymond T. P.; Lye, David C.] Natl Ctr Infect Dis, Singapore, Singapore; [Lin, Raymond T. P.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore, Singapore; [Lye, David C.; Renia, Laurent] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore; [Lye, David C.] Tan TockSeng Hosp, Singapore, Singapore; [Lye, David C.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore; [Renia, Laurent] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Ng, Lisa F. P.] Univ Liverpool, Natl Inst Hlth Res, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England; [Ng, Lisa F. P.] Univ Liverpool, Inst Infect Vet & Ecol Sci, Liverpool, Merseyside, England	Agency for Science Technology & Research (A*STAR); A*STAR Infectious Disease Labs (ID Labs); National Centre for Infectious Diseases Singapore; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Tan Tock Seng Hospital; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Liverpool; University of Liverpool	Ng, LFP (corresponding author), ASTAR, A STAR Infect Dis Labs, Singapore, Singapore.; Ng, LFP (corresponding author), Univ Liverpool, Natl Inst Hlth Res, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England.; Ng, LFP (corresponding author), Univ Liverpool, Inst Infect Vet & Ecol Sci, Liverpool, Merseyside, England.	Lisa_Ng@idlabs.a-star.edu.sg	Torres-Ruesta, Anthony/GYQ-9112-2022; Lum, Fok Moon/GYQ-7878-2022; Renia, Laurent/HCH-4853-2022	Torres-Ruesta, Anthony/0000-0003-0447-3131; Lum, Fok Moon/0000-0002-5645-7048; Renia, Laurent/0000-0003-0349-1557; Ng, Lisa/0000-0003-4071-5222	A*STAR Infectious Diseases Labs (ID Labs) through the Biomedical Medical Research Council (BMRC), A*STAR; PREPARE (Programme for Research in Epidemic Preparedness and REsponse) [PREPARE-SF-2022-001]	A*STAR Infectious Diseases Labs (ID Labs) through the Biomedical Medical Research Council (BMRC), A*STAR(Agency for Science Technology & Research (A*STAR)); PREPARE (Programme for Research in Epidemic Preparedness and REsponse)	The authors thank D. Ackerman of Insight Editing London for his valuable inputs on an early draft. This work was supported by core funds at the A*STAR Infectious Diseases Labs (ID Labs) through the Biomedical Medical Research Council (BMRC), A*STAR and the PREPARE (Programme for Research in Epidemic Preparedness and REsponse) Outbreak Research Strategic Funds (PREPARE-SF-2022-001).	Adler Hugh, 2022, Lancet Infect Dis, V22, P1153, DOI 10.1016/S1473-3099(22)00228-6; Aggio JB, 2021, J IMMUNOL, V206, P776, DOI 10.4049/jimmunol.2000928; Alakunle E, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12111257; Alvarez-de Miranda FJ, 2021, PATHOGENS, V10, DOI 10.3390/pathogens10081065; Ando J, 2020, CYTOTHERAPY, V22, P642, DOI 10.1016/j.jcyt.2020.04.098; Andrei G, 2010, VIRUSES-BASEL, V2, P2803, DOI 10.3390/v2122803; [Anonymous], 2022, CHANNEL NEWS ASIA; Antinori A, 2022, EUROSURVEILLANCE, V27, DOI 10.2807/1560-7917.ES.2022.27.22.2200421; Arndt WD, 2015, J VIROL, V89, P10489, DOI 10.1128/JVI.00304-15; Bahar MW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040005; Beauchamp NM, 2010, J VIROL, V84, P10191, DOI 10.1128/JVI.00892-10; Berhanu A, 2015, ANTIMICROB AGENTS CH, V59, P4296, DOI 10.1128/AAC.00208-15; Berthet N, 2011, LANCET, V378, P1354, DOI 10.1016/S0140-6736(11)61142-2; Bloomer DT, 2019, BIOCHEM J, V476, P1335, DOI 10.1042/BCJ20190202; Born TL, 2000, J IMMUNOL, V164, P3246, DOI 10.4049/jimmunol.164.6.3246; BREMAN JG, 1980, B WORLD HEALTH ORGAN, V58, P165; BREMAN JG, 1977, AM J TROP MED HYG, V26, P273, DOI 10.4269/ajtmh.1977.26.273; BUKOWSKI JF, 1983, J IMMUNOL, V131, P1531; Bunge Eveline M, 2022, PLoS Negl Trop Dis, V16, pe0010141, DOI 10.1371/journal.pntd.0010141; Byrd D, 2014, J VIROL, V88, P6819, DOI 10.1128/JVI.03726-13; Byun M, 2009, CELL HOST MICROBE, V6, P422, DOI 10.1016/j.chom.2009.09.012; C. M. Gigante, 2022, bioRxiv, DOI 10.1101/2022.06.10.495526; Calvo-Calle JM, 2007, PLOS PATHOG, V3, P1511, DOI 10.1371/journal.ppat.0030144; Campbell JA, 2007, J EXP MED, V204, P1311, DOI 10.1084/jem.20062026; Cann JA, 2013, J COMP PATHOL, V148, P6, DOI 10.1016/j.jcpa.2012.06.007; Centers for Disease Control and Prevention, CLIN CONS MONK CHILD; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1168; Centers for Disease Control and Prevention [CDC], 2022, WHAT IS HLTH EQUITY; Chahroudi A, 2005, J VIROL, V79, P10397, DOI 10.1128/JVI.79.16.10397-10407.2005; CHANG HW, 1992, P NATL ACAD SCI USA, V89, P4825, DOI 10.1073/pnas.89.11.4825; Chapman JL, 2010, VET PATHOL, V47, P852, DOI 10.1177/0300985810378649; Chen NH, 2005, VIROLOGY, V340, P46, DOI 10.1016/j.virol.2005.05.030; Chen ZC, 2006, P NATL ACAD SCI USA, V103, P1882, DOI 10.1073/pnas.0510598103; CHERRY JD, 1977, J INFECT DIS, V135, P145, DOI 10.1093/infdis/135.1.145; Chiu WL, 2007, J VIROL, V81, P2149, DOI 10.1128/JVI.02302-06; CHO CT, 1973, BACTERIOL REV, V37, P1; Chung CS, 1998, J VIROL, V72, P1577, DOI 10.1128/JVI.72.2.1577-1585.1998; Cohen CA, 2021, NAT COMMUN, V12, DOI [10.1101/2021.02.02.21250988, 10.1038/s41467-021-24938-4]; Cohen J, 2022, SCIENCE, V376, P902, DOI 10.1126/science.add1583; COLAMONICI OR, 1995, J BIOL CHEM, V270, P15974, DOI 10.1074/jbc.270.27.15974; Costello V, 2022, EMERG INFECT DIS, V28, P1002, DOI [10.3201/eid2805.220292, 10.3201/eid2805.220292eid2805.220292]; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Dai PH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003989; Dai R, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.727046; Dasgupta A, 2007, J IMMUNOL, V178, P1654, DOI 10.4049/jimmunol.178.3.1654; Daskalakis D, 2022, ANN INTERN MED, V175, P1177, DOI 10.7326/M22-1748; Davido B, 2022, J TRAVEL MED, V29, DOI 10.1093/jtm/taac077; Davies ML, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006435; de Motes CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002430; de Marco MDF, 2010, FASEB J, V24, P1479, DOI 10.1096/fj.09-144733; Deng L, 2008, J VIROL, V82, P10735, DOI 10.1128/JVI.01305-08; Denzler KL, 2011, VACCINE, V29, P9684, DOI 10.1016/j.vaccine.2011.09.135; Desingu P.A., 2022, BIORXIV, DOI [10.1101/2022.06.28.497936, DOI 10.1101/2022.06.28.497936]; Devadas S, 2006, IMMUNITY, V25, P237, DOI 10.1016/j.immuni.2006.06.011; Di Pilato M, 2017, J VIROL, V91, DOI 10.1128/JVI.00575-17; Doshi RH, 2019, EMERG INFECT DIS, V25, P273, DOI 10.3201/eid2502.181222; DOWNIE AW, 1947, LANCET, V252, P550; Dubois ME, 2012, VECTOR-BORNE ZOONOT, V12, P400, DOI 10.1089/vbz.2011.0779; Duque MP, 2022, EUROSURVEILLANCE, V27, DOI 10.2807/1560-7917.ES.2022.27.22.2200424; Dutta P, 2014, IMMUNOL REV, V262, P167, DOI 10.1111/imr.12219; Earl PL, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008505; Edghill-Smith Y, 2005, J INFECT DIS, V191, P372, DOI 10.1086/427265; Edghill-Smith Y, 2005, NAT MED, V11, P740, DOI 10.1038/nm1261; Elde NC, 2012, CELL, V150, P831, DOI 10.1016/j.cell.2012.05.049; Engelmayer J, 1999, J IMMUNOL, V163, P6762; Ennis FA, 2002, J INFECT DIS, V185, P1657, DOI 10.1086/340517; Erez N, 2019, EMERG INFECT DIS, V25, P980, DOI 10.3201/eid2505.190076; Estep RD, 2011, J VIROL, V85, P9527, DOI 10.1128/JVI.00199-11; Fang M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040030; Fang M, 2012, P NATL ACAD SCI USA, V109, P9983, DOI 10.1073/pnas.1202143109; Fang M, 2011, IMMUNITY, V34, P579, DOI 10.1016/j.immuni.2011.02.015; Fenner F, 2000, FEMS MICROBIOL REV, V24, P123, DOI 10.1111/j.1574-6976.2000.tb00536.x; FINE PEM, 1988, INT J EPIDEMIOL, V17, P643, DOI 10.1093/ije/17.3.643; Fischer MA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002374; Food and Drug Administration, 2019, BLA CLIN REV MEMORAN; Formenty P, 2010, EMERG INFECT DIS, V16, P1539, DOI 10.3201/eid1610.100713; Forrester JV., 2022, FRONT OPHTHALMOL, DOI [10.3389/fopht.2022.869046, DOI 10.3389/FOPHT.2022.869046]; FOSTER SO, 1972, B WORLD HEALTH ORGAN, V46, P569; Franz KM, 2017, MOL CELL, V66, P750, DOI 10.1016/j.molcel.2017.05.009; Gilchuk I, 2016, CELL, V167, P684, DOI 10.1016/j.cell.2016.09.049; Goulding J, 2014, J IMMUNOL, V192, P5415, DOI 10.4049/jimmunol.1400256; Graham SC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000128; Hammarlund E, 2005, NAT MED, V11, P1005, DOI 10.1038/nm1273; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Hammarlund E, 2008, P NATL ACAD SCI USA, V105, P14567, DOI 10.1073/pnas.0800589105; Hammerschlag Y, 2022, EUROSURVEILLANCE, V27, DOI 10.2807/1560-7917.ES.2022.27.22.2200411; Heinonen S, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaw0268; Henao-Restrepo AM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3740; Heymann DL, 1998, BRIT MED BULL, V54, P693, DOI 10.1093/oxfordjournals.bmb.a011720; Hickman HD, 2013, CELL HOST MICROBE, V13, P155, DOI 10.1016/j.chom.2013.01.004; Hijano DR, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00566; Hobson G, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.32.2100745; Hopkins RJ, 2004, CLIN INFECT DIS, V39, P819, DOI 10.1086/422999; Howard AR, 2008, J VIROL, V82, P12384, DOI 10.1128/JVI.01524-08; Howell MD, 2006, IMMUNITY, V24, P341, DOI 10.1016/j.immuni.2006.02.006; Hsiao JC, 1999, J VIROL, V73, P8750, DOI 10.1128/JVI.73.10.8750-8761.1999; HU FQ, 1994, VIROLOGY, V204, P343, DOI 10.1006/viro.1994.1539; Huggins J, 2009, ANTIMICROB AGENTS CH, V53, P2620, DOI 10.1128/AAC.00021-09; Huhn GD, 2005, CLIN INFECT DIS, V41, P1742, DOI 10.1086/498115; Humlova Z, 2002, J GEN VIROL, V83, P2821, DOI 10.1099/0022-1317-83-11-2821; Humrich JY, 2007, EUR J IMMUNOL, V37, P954, DOI 10.1002/eji.200636230; Hutson CL, 2021, MSPHERE, V6, DOI 10.1128/mSphere.00927-20; Institute of Medicine (US), 1999, ASS FUT SCI NEEDS LI; Isidro J, 2022, NAT MED, V28, DOI 10.1038/s41591-022-01907-y; Jacobs BL, 2009, ANTIVIR RES, V84, P1, DOI 10.1016/j.antiviral.2009.06.006; Jahrling PB, 2004, P NATL ACAD SCI USA, V101, P15196, DOI 10.1073/pnas.0405954101; Jayani I., 2020, Journal of Physics: Conference Series, V1569, DOI 10.1088/1742-6596/1569/3/032066; Jayaraman A, 2014, MUCOSAL IMMUNOL, V7, P1151, DOI 10.1038/mi.2014.2; Jefferies CA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00325; JEZEK Z, 1986, AM J EPIDEMIOL, V123, P1004, DOI 10.1093/oxfordjournals.aje.a114328; JEZEK Z, 1987, J INFECT DIS, V156, P293, DOI 10.1093/infdis/156.2.293; JEZEK Z, 1988, B WORLD HEALTH ORGAN, V66, P459; Johnson RF, 2011, J VIROL, V85, P2112, DOI 10.1128/JVI.01931-10; Johnston SC, 2015, J CLIN VIROL, V63, P42, DOI 10.1016/j.jcv.2014.12.001; Johnston SC, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-5; Karem KL, 2007, CLIN VACCINE IMMUNOL, V14, P1318, DOI 10.1128/CVI.00148-07; Keasey S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015547; Keckler MS, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8030396; Keckler MS, 2013, VACCINE, V31, P5192, DOI 10.1016/j.vaccine.2013.08.039; Kelley CF, 2017, MUCOSAL IMMUNOL, V10, P996, DOI 10.1038/mi.2016.97; KEMPE CH, 1961, B WORLD HEALTH ORGAN, V25, P41; Kennedy R, 2007, REV MED VIROL, V17, P93, DOI 10.1002/rmv.527; Kennedy RB, 2010, VIROLOGY, V408, P232, DOI 10.1016/j.virol.2010.09.013; KHODAKEVICH L, 1985, B SOC PATHOL EXOT, V78, P311; Khoury G, 2017, J INFECT DIS, V215, P911, DOI 10.1093/infdis/jix039; Kimball S, 2022, CNBC; KOMIYAMA T, 1994, J BIOL CHEM, V269, P19331; KOTWAL GJ, 1988, NATURE, V335, P176, DOI 10.1038/335176a0; Kraemer MUG, 2022, LANCET INFECT DIS, V22, P941, DOI 10.1016/S1473-3099(22)00359-0; Kugelman JR, 2014, EMERG INFECT DIS, V20, P232, DOI 10.3201/eid2002.130118; LALEZARI JP, 1995, J INFECT DIS, V171, P788, DOI 10.1093/infdis/171.4.788; Lavelle EC, 2022, NAT REV IMMUNOL, V22, P236, DOI 10.1038/s41577-021-00583-2; Learned LA, 2005, AM J TROP MED HYG, V73, P428, DOI 10.4269/ajtmh.2005.73.428; Li P, 2005, J IMMUNOL, V175, P6481, DOI 10.4049/jimmunol.175.10.6481; Likos AM, 2005, J GEN VIROL, V86, P2661, DOI 10.1099/vir.0.81215-0; Lin CL, 2000, J VIROL, V74, P3353, DOI 10.1128/JVI.74.7.3353-3365.2000; Liszewski MK, 2006, J IMMUNOL, V176, P3725, DOI 10.4049/jimmunol.176.6.3725; LITTAURA RA, 1992, J VIROL, V66, P2274, DOI 10.1128/JVI.66.4.2274-2280.1992; Liu LZ, 2005, J VIROL, V79, P7363, DOI 10.1128/JVI.79.12.7363-7370.2005; Luna N, 2022, TRAVEL MED INFECT DI, V49, DOI 10.1016/j.tmaid.2022.102402; Nguyen LBL, 2022, NAT MED, V28, P1983, DOI 10.1038/d41591-022-00077-1; MACK TM, 1972, AM J TROP MED HYG, V21, P214, DOI 10.4269/ajtmh.1972.21.214; MacLeod MKL, 2009, SEMIN IMMUNOL, V21, P53, DOI 10.1016/j.smim.2009.02.006; Marotte H, 2014, EXPERT OPIN BIOL TH, V14, P569, DOI 10.1517/14712598.2014.896334; Mbala PK, 2017, J INFECT DIS, V216, P824, DOI 10.1093/infdis/jix260; McClain DJ, 1997, J INFECT DIS, V175, P756, DOI 10.1086/513968; McCollum AM, 2014, CLIN INFECT DIS, V58, P260, DOI 10.1093/cid/cit703; McFadden G, 2005, NAT REV MICROBIOL, V3, P201, DOI 10.1038/nrmicro1099; Merouze F, 1983, Med Trop (Mars), V43, P145; Meyer A, 1991, Med Trop (Mars), V51, P53; Midgley CM, 2008, J GEN VIROL, V89, P2992, DOI 10.1099/vir.0.2008/004440-0; Mikulak J, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00314; Miller CG, 1997, VIROLOGY, V229, P126, DOI 10.1006/viro.1996.8396; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Minhaj FS, 2022, MMWR-MORBID MORTAL W, V71, P764, DOI 10.15585/mmwr.mm7123e1; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Mohamed MR, 2009, CELL CYCLE, V8, P3125, DOI 10.4161/cc.8.19.9683; Molero-Abraham M, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/738020; Moss B, 2016, SEMIN CELL DEV BIOL, V60, P89, DOI 10.1016/j.semcdb.2016.07.015; Moulton EA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000249; Mucker EM, 2022, MOL THER-NUCL ACIDS, V28, P847, DOI 10.1016/j.omtn.2022.05.025; Mucker EM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006581; Mulkey SB, 2020, JAMA PEDIATR, V174, P269, DOI 10.1001/jamapediatrics.2019.5204; Munier CML, 2016, VACCINE, V34, P5251, DOI 10.1016/j.vaccine.2016.09.009; Nagata N, 2014, INT J CLIN EXP PATHO, V7, P4359; Nakoune E, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx168; Nalca A, 2010, DRUG DES DEV THER, V4, P71; Nichols DB, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9080215; Nigeria Centre for Disease Control, 2022, UPD MONK MPX NIG; Nkengasong JN, 2020, CELL, V183, P296, DOI 10.1016/j.cell.2020.09.041; Norbury CC, 2002, NAT IMMUNOL, V3, P265, DOI 10.1038/ni762; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Ortiz A, 2005, ANTIVIR THER, V10, P185; Otu Akaninyene, 2022, Lancet Microbe, V3, pe554, DOI 10.1016/S2666-5247(22)00153-7; P. R. Pittman, 2022, medRxiv, DOI 10.1101/2022.05.26.22273379; Paust S, 2010, IMMUNOL REV, V235, P286, DOI 10.1111/j.0105-2896.2010.00906.x; Petersen BW, 2016, MMWR-MORBID MORTAL W, V65, P257, DOI 10.15585/mmwr.mm6510a2; Pollard AJ, 2021, NAT REV IMMUNOL, V21, P83, DOI 10.1038/s41577-020-00479-7; Pontejo SM, 2015, J BIOL CHEM, V290, P15973, DOI 10.1074/jbc.M115.650119; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Prow NA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03662-6; Pugh C, 2014, CLIN VACCINE IMMUNOL, V21, P877, DOI 10.1128/CVI.00035-14; Qin L, 2014, J VIROL, V88, P5277, DOI 10.1128/JVI.00022-14; QUAN LT, 1995, J BIOL CHEM, V270, P10377, DOI 10.1074/jbc.270.18.10377; Rao AK, 2022, MMWR-MORBID MORTAL W, V71, P734, DOI 10.15585/mmwr.mm7122e1; Rao AK, 2022, MMWR-MORBID MORTAL W, V71, P509, DOI 10.15585/mmwr.mm7114a1; Remakus S, 2013, CELL HOST MICROBE, V13, P546, DOI 10.1016/j.chom.2013.04.004; Resch W, 2007, VIROLOGY, V358, P233, DOI 10.1016/j.virol.2006.08.025; Reynolds MG, 2007, EMERG INFECT DIS, V13, P1332, DOI 10.3201/eid1309.070175; Reynolds MG, 2019, EMERG INFECT DIS, V25, P1023, DOI 10.3201/eid2505.180832; Reynolds MG, 2013, AM J TROP MED HYG, V88, P982, DOI 10.4269/ajtmh.12-0758; Reynolds MG, 2012, TRENDS MICROBIOL, V20, P80, DOI 10.1016/j.tim.2011.12.001; Reynoso GV, 2019, NAT IMMUNOL, V20, P602, DOI 10.1038/s41590-019-0342-0; Rimoin AW, 2010, P NATL ACAD SCI USA, V107, P16262, DOI 10.1073/pnas.1005769107; Rubins KH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015615; Rubins KH, 2004, P NATL ACAD SCI USA, V101, P15190, DOI 10.1073/pnas.0405759101; Ruiz-Arguello MB, 2008, J VIROL, V82, P917, DOI 10.1128/JVI.02111-07; Russo AT, 2021, EXPERT REV ANTI-INFE, V19, P331, DOI 10.1080/14787210.2020.1819791; Russo AT, 2018, J INFECT DIS, V218, P1490, DOI 10.1093/infdis/jiy326; Ryan MAK, 2008, CLIN INFECT DIS, V46, pS221, DOI 10.1086/524744; Sanjuan R, 2016, CELL MOL LIFE SCI, V73, P4433, DOI 10.1007/s00018-016-2299-6; Seregin SV, 1996, FEBS LETT, V382, P79, DOI 10.1016/0014-5793(96)00069-5; Sette A, 2009, VACCINE, V27, pG21, DOI 10.1016/j.vaccine.2009.10.011; Shchelkunov SN, 2020, ACTA NATURAE, V12, P33, DOI 10.32607/actanaturae.10935; Shchelkunov SN, 2012, ADV VIROL, V2012, DOI 10.1155/2012/524743; Shchelkunov SN, 2002, VIROLOGY, V297, P172, DOI 10.1006/viro.2002.1446; Shchelkunov SN, 2001, FEBS LETT, V509, P66, DOI 10.1016/S0014-5793(01)03144-1; Shisler JL, 2004, J VIROL, V78, P3553, DOI 10.1128/JVI.78.7.3553-3560.2004; Silverman RH, 2015, CELL HOST MICROBE, V17, P287, DOI 10.1016/j.chom.2015.02.013; Sklenovska N, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00241; Smith GL, 2013, J GEN VIROL, V94, P2367, DOI 10.1099/vir.0.055921-0; Song HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077804; Song HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060533; Srivastava RM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02916; Stabenow J, 2010, J VIROL, V84, P3909, DOI 10.1128/JVI.02012-09; Stanford MM, 2007, IMMUNOL CELL BIOL, V85, P93, DOI 10.1038/sj.icb.7100033; STRASSBURG MA, 1982, AM J INFECT CONTROL, V10, P53, DOI 10.1016/0196-6553(82)90003-7; Sukhumvittaya S., 2016, ADV MICROBIOL, V6, P169, DOI DOI 10.4236/AIM.2016.63017; Suraweera CD, 2021, PATHOGENS, V10, DOI 10.3390/pathogens10010006; TCHOKOTEU PF, 1991, ANN SOC BELG MED TR, V71, P123; Teo TH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06227-9; Teo TH, 2018, EMBO MOL MED, V10, P121, DOI 10.15252/emmm.201707885; Thakur A, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/1356540; Thornhill JP, 2022, NEW ENGL J MED, DOI 10.1056/NEJMoa2207323; Toh ZQ, 2022, JAMA NETW OPEN, V5, DOI 10.1001/jamanetworkopen.2022.1313; Torres-Ruesta A, 2022, LIFE SCI ALLIANCE, V5, DOI 10.26508/lsa.202101272; UK Health Security Agency, 2022, MONK OUTBR VACC STRA; UPTON C, 1992, SCIENCE, V258, P1369, DOI 10.1126/science.1455233; Uvarova EA, 2001, VIRUS RES, V81, P39, DOI 10.1016/S0168-1702(01)00332-X; van den Broek M, 2000, J IMMUNOL, V164, P371, DOI 10.4049/jimmunol.164.1.371; Vance RE, 1999, J EXP MED, V190, P1801, DOI 10.1084/jem.190.12.1801; Vaughan A, 2020, EMERG INFECT DIS, V26, P782, DOI 10.3201/eid2604.191164; Vaughan A, 2018, EUROSURVEILLANCE, V23, P2, DOI 10.2807/1560-7917.ES.2018.23.38.1800509; Veyer DL, 2014, J GEN VIROL, V95, P2757, DOI 10.1099/vir.0.068833-0; Wachsman M, 1996, ANTIVIR RES, V29, P153, DOI 10.1016/0166-3542(95)00829-2; Walsh SR, 2009, VACCINE, V27, P4990, DOI 10.1016/j.vaccine.2009.05.077; Walzer T, 2005, EUR J IMMUNOL, V35, P391, DOI 10.1002/eji.200425669; Weaver JR, 2008, IMMUNOL REV, V225, P96, DOI 10.1111/j.1600-065X.2008.00691.x; WOLFFE EJ, 1995, VIROLOGY, V211, P53, DOI 10.1006/viro.1995.1378; Xu RH, 2008, J EXP MED, V205, P981, DOI 10.1084/jem.20071854; Yinka-Ogunleye A, 2019, LANCET INFECT DIS, V19, P872, DOI 10.1016/S1473-3099(19)30294-4; Yohannes E., 2013, ENCY SYSTEMBIOL, P2078; Yong SEF, 2020, EMERG INFECT DIS, V26, P1826, DOI 10.3201/eid2608.191387; Yoshida M, 2022, NATURE, V602, P321, DOI 10.1038/s41586-021-04345-x; Yu HB, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9070765; Zaucha GM, 2001, LAB INVEST, V81, P1581, DOI 10.1038/labinvest.3780373; Zhang P, 2008, J VIROL, V82, P840, DOI 10.1128/JVI.01891-07; Zhao Y, 2011, VIRAL IMMUNOL, V24, P387, DOI 10.1089/vim.2011.0020; Zumla A, 2022, LANCET INFECT DIS, V22, P929, DOI [10.1016/S1473-3099(22)00354-1, 10.1016/S1473-3099(21)00672-1]	249	6	6	26	26	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2022	22	10					597	613		10.1038/s41577-022-00775-4	http://dx.doi.org/10.1038/s41577-022-00775-4		SEP 2022	17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	4Y3ZM	36064780	Green Published, Bronze			2022-12-18	WOS:000850031500001
J	Spits, H; Mjosberg, J				Spits, Hergen; Mjosberg, Jenny			Heterogeneity of type 2 innate lymphoid cells	NATURE REVIEWS IMMUNOLOGY			English	Review							PLASTICITY; IMMUNOTHERAPY; HOMEOSTASIS; INDUCTION; INFECTION; CRTH2; IL-4	Type 2 innate lymphoid cells (ILC2s) have diverse phenotypes across different tissues and disease states. Recent insights into ILC2 biology raise new possibilities for the improved treatment of cancer and of metabolic, infectious and chronic inflammatory diseases. More than a decade ago, type 2 innate lymphoid cells (ILC2s) were discovered to be members of a family of innate immune cells consisting of five subsets that form a first line of defence against infections before the recruitment of adaptive immune cells. Initially, ILC2s were implicated in the early immune response to parasitic infections, but it is now clear that ILC2s are highly diverse and have crucial roles in the regulation of tissue homeostasis and repair. ILC2s can also regulate the functions of other type 2 immune cells, including T helper 2 cells, type 2 macrophages and eosinophils. Dysregulation of ILC2s contributes to type 2-mediated pathology in a wide variety of diseases, potentially making ILC2s attractive targets for therapeutic interventions. In this Review, we focus on the spectrum of ILC2 phenotypes that have been described across different tissues and disease states with an emphasis on human ILC2s. We discuss recent insights in ILC2 biology and suggest how this knowledge might be used for novel disease treatments and improved human health.	[Spits, Hergen] Univ Amsterdam, Locat AMC, Amsterdam UMC, Dept Expt Immunol, Amsterdam, Netherlands; [Mjosberg, Jenny] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Med Huddinge, Ctr Infect Med, Stockholm, Sweden	University of Amsterdam; Karolinska Institutet; Karolinska University Hospital	Spits, H (corresponding author), Univ Amsterdam, Locat AMC, Amsterdam UMC, Dept Expt Immunol, Amsterdam, Netherlands.; Mjosberg, J (corresponding author), Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Med Huddinge, Ctr Infect Med, Stockholm, Sweden.	hergen.spits@amsterdamumc.nl; jenny.mjosberg@ki.se		Spits, Hergen/0000-0003-3269-8338				Alisjahbana A, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.752104; Alkon N, 2022, J ALLERGY CLIN IMMUN, V149, P624, DOI 10.1016/j.jaci.2021.07.025; Almeida FF, 2016, MUCOSAL IMMUNOL, V9, P1103, DOI 10.1038/mi.2016.64; Bacharier LB, 2021, NEW ENGL J MED, V385, P2230, DOI 10.1056/NEJMoa2106567; Bal SM, 2020, NAT REV IMMUNOL, V20, P552, DOI 10.1038/s41577-020-0282-9; Bal SM, 2016, NAT IMMUNOL, V17, P636, DOI 10.1038/ni.3444; Bando JK, 2020, J EXP MED, V217, DOI 10.1084/jem.20191520; Batyrova B, 2020, IMMUN INFLAMM DIS, V8, P8, DOI 10.1002/iid3.279; Bernink JH, 2019, NAT IMMUNOL, V20, P992, DOI 10.1038/s41590-019-0423-0; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Bielecki P, 2021, NATURE, V592, P128, DOI 10.1038/s41586-021-03188-w; Boonpiyathad T, 2021, J ALLERGY CLIN IMMUN, V147, P1507, DOI 10.1016/j.jaci.2020.10.029; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Bruce DW, 2021, BLOOD ADV, V5, P4578, DOI 10.1182/bloodadvances.2020001514; Campbell L, 2019, J EXP MED, V216, P2714, DOI 10.1084/jem.20180610; Cardoso F, 2021, NATURE, V597, P410, DOI 10.1038/s41586-021-03830-7; Chantveerawong T, 2022, ALLERGY, V77, P681, DOI 10.1111/all.15145; Chen RC, 2017, AM J RESP CRIT CARE, V196, P700, DOI 10.1164/rccm.201612-2427OC; Dhariwal J, 2021, AM J RESP CRIT CARE, V204, P1259, DOI 10.1164/rccm.202010-3754OC; DuPage M, 2016, NAT REV IMMUNOL, V16, P149, DOI 10.1038/nri.2015.18; Ercolano G, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22764-2; Ercolano G, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02801; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Fonseca R, 2020, NAT IMMUNOL, V21, P412, DOI 10.1038/s41590-020-0607-7; Fonseca W, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.675169; Fonseca W, 2020, MUCOSAL IMMUNOL, V13, P691, DOI 10.1038/s41385-020-0264-z; Forkel M, 2019, J CROHNS COLITIS, V13, P67, DOI 10.1093/ecco-jcc/jjy119; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Galle-Treger L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08449-x; Garcia M, 2020, CLIN TRANSL IMMUNOL, V9, DOI 10.1002/cti2.1224; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Goc J, 2021, CELL, V184, P5015, DOI 10.1016/j.cell.2021.07.029; Golebski K, 2021, IMMUNITY, V54, P291, DOI 10.1016/j.immuni.2020.12.013; Golebski K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09883-7; Gomez-Cadena A, 2021, CELL MOL IMMUNOL, V18, P484, DOI 10.1038/s41423-020-00596-2; He J, 2022, MUCOSAL IMMUNOL, V15, P314, DOI 10.1038/s41385-021-00460-0; Heinrich B, 2022, GUT, V71, P1161, DOI 10.1136/gutjnl-2021-325288; Hepworth MR, 2015, SCIENCE, V348, P1031, DOI 10.1126/science.aaa4812; Hernandez DC, 2021, IMMUNITY, V54, P2417, DOI 10.1016/j.immuni.2021.07.019; Hochdorfer T, 2019, EUR J IMMUNOL, V49, P884, DOI 10.1002/eji.201848006; Howard E, 2021, J ALLERGY CLIN IMMUN, V147, P1281, DOI 10.1016/j.jaci.2020.08.024; Huang QS, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.202012305; Huang QT, 2021, CANCERS, V13, DOI 10.3390/cancers13030559; Huang YF, 2018, SCIENCE, V359, P114, DOI 10.1126/science.aam5809; Hurrell BP, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.542818; Jacquelot N, 2021, NAT IMMUNOL, V22, P851, DOI 10.1038/s41590-021-00943-z; Jegatheeswaran S, 2021, J IMMUNOL, V207, P1949, DOI 10.4049/jimmunol.2100661; Karagiannis F, 2020, IMMUNITY, V52, P620, DOI 10.1016/j.immuni.2020.03.003; Kim BS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005374; Kloverpris HN, 2016, IMMUNITY, V44, P391, DOI 10.1016/j.immuni.2016.01.006; Koga S, 2018, J EXP MED, V215, P1609, DOI 10.1084/jem.20172310; Kramer B, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006373; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Li N, 2019, NAT IMMUNOL, V20, P301, DOI 10.1038/s41590-018-0294-9; Lim AI, 2016, J EXP MED, V213, P569, DOI 10.1084/jem.20151750; Liu SC, 2020, J ALLERGY CLIN IMMUN, V146, P390, DOI 10.1016/j.jaci.2020.01.038; Mao KR, 2018, NATURE, V554, P255, DOI 10.1038/nature25437; Maric J, 2019, J ALLERGY CLIN IMMUN, V143, P2202, DOI 10.1016/j.jaci.2018.10.069; Mayer JU, 2021, NAT IMMUNOL, V22, P1538, DOI 10.1038/s41590-021-01067-0; Mazzurana L, 2021, CELL RES, V31, P554, DOI 10.1038/s41422-020-00445-x; Miller MM, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aay3994; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moral JA, 2020, NATURE, V579, P130, DOI 10.1038/s41586-020-2015-4; Morita H, 2019, J ALLERGY CLIN IMMUN, V143, P2190, DOI 10.1016/j.jaci.2018.12.1018; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Nagasawa M, 2019, J EXP MED, V216, P1762, DOI 10.1084/jem.20190490; Nagasawa M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01047; Nagashima H, 2019, IMMUNITY, V51, P682, DOI 10.1016/j.immuni.2019.06.009; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Ohne Y, 2016, NAT IMMUNOL, V17, P646, DOI 10.1038/ni.3447; Ordovas-Montanes J, 2018, NATURE, V560, P649, DOI 10.1038/s41586-018-0449-8; Oyesola OO, 2020, J IMMUNOL, V204, P1001, DOI 10.4049/jimmunol.1900745; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Pu QQ, 2021, J IMMUNOL, V207, P257, DOI 10.4049/jimmunol.2001304; Puttur F, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav7638; Qi JJ, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100353; Rajput C, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.649520; Rana BMJ, 2019, J EXP MED, V216, P1999, DOI 10.1084/jem.20190689; Ricardo-Gonzalez RR, 2020, J EXP MED, V217, DOI 10.1084/jem.20191172; Ricardo-Gonzalez RR, 2018, NAT IMMUNOL, V19, P1093, DOI 10.1038/s41590-018-0201-4; Rodriguez-Rodriguez N, 2021, ANNU REV IMMUNOL, V39, P167, DOI 10.1146/annurev-immunol-110119-091711; Saco T, 2021, ANN ALLERG ASTHMA IM, V127, P627, DOI 10.1016/j.anai.2021.09.009; Satoh-Takayama N, 2020, IMMUNITY, V52, P635, DOI 10.1016/j.immuni.2020.03.002; Schneider C, 2019, IMMUNITY, V50, P1425, DOI 10.1016/j.immuni.2019.04.019; Schneider C, 2018, CELL, V174, P271, DOI 10.1016/j.cell.2018.05.014; Schreurs RRCE, 2019, IMMUNITY, V50, P462, DOI 10.1016/j.immuni.2018.12.010; Schuijs MJ, 2020, NAT IMMUNOL, V21, P998, DOI 10.1038/s41590-020-0745-y; Schulz-Kuhnt A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00691; Seehus CR, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02023-z; Shan B, 2021, GENE DEV, V35, P1333, DOI 10.1101/gad.348762.121; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Silver JS, 2016, NAT IMMUNOL, V17, P626, DOI 10.1038/ni.3443; Sui PF, 2018, SCIENCE, V360, P1086, DOI 10.1126/science.aan8546; Surace L, 2021, NAT IMMUNOL, V22, P1367, DOI 10.1038/s41590-021-01043-8; Teunissen MBM, 2014, J INVEST DERMATOL, V134, P2351, DOI 10.1038/jid.2014.146; Thio CLP, 2018, J ALLERGY CLIN IMMUN, V142, P1867, DOI 10.1016/j.jaci.2018.02.032; Trabanelli S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00678-2; van der Ploeg EK, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abd3489; Vu LD, 2019, AM J RESP CRIT CARE, V200, P1414, DOI 10.1164/rccm.201812-2366OC; Wallrapp A, 2019, IMMUNITY, V51, P709, DOI 10.1016/j.immuni.2019.09.005; Wallrapp A, 2017, NATURE, V549, P351, DOI 10.1038/nature24029; Wang S, 2020, CELL RES, V30, P610, DOI 10.1038/s41422-020-0312-y; Warren KJ, 2021, RESP RES, V22, DOI 10.1186/s12931-021-01799-5; Winkler C, 2019, J ALLERGY CLIN IMMUN, V144, P61, DOI 10.1016/j.jaci.2019.01.027; Wojno EDT, 2015, MUCOSAL IMMUNOL, V8, P1313, DOI 10.1038/mi.2015.21; Wu LM, 2020, LEUKEMIA, V34, P3028, DOI 10.1038/s41375-020-0843-8; Xiao SY, 2003, CELL RES, V13, P265, DOI 10.1038/sj.cr.7290171; Xu XY, 2021, HEPATOLOGY, V74, P2526, DOI 10.1002/hep.31855; Zeis P, 2020, IMMUNITY, V53, P775, DOI 10.1016/j.immuni.2020.09.002; Zhang JJ, 2022, NAT IMMUNOL, V23, P237, DOI 10.1038/s41590-021-01097-8	112	6	6	3	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2022	22	11					701	712		10.1038/s41577-022-00704-5	http://dx.doi.org/10.1038/s41577-022-00704-5		MAR 2022	12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	5U0ZY	35354980	Green Published, Bronze			2022-12-18	WOS:000775945600001
J	Harapas, CR; Idiiatullina, E; Al-Azab, M; Hrovat-Schaale, K; Reygaerts, T; Steiner, A; Laohamonthonkul, P; Davidson, S; Yu, CH; Booty, L; Masters, SL				Harapas, Cassandra R.; Idiiatullina, Elina; Al-Azab, Mahmoud; Hrovat-Schaale, Katja; Reygaerts, Thomas; Steiner, Annemarie; Laohamonthonkul, Pawat; Davidson, Sophia; Yu, Chien-Hsiung; Booty, Lee; Masters, Seth L.			Organellar homeostasis and innate immune sensing	NATURE REVIEWS IMMUNOLOGY			English	Review							NEUTROPHIL EXTRACELLULAR TRAPS; DOUBLE-STRANDED-RNA; NLRP3 INFLAMMASOME ACTIVATION; ENDOPLASMIC-RETICULUM STRESS; AICARDI-GOUTIERES-SYNDROME; MITOCHONDRIAL-DNA; ER STRESS; IL-1-BETA PRODUCTION; PYRIN INFLAMMASOME; PROTEIN-KINASE	This Review from Masters and colleagues highlights how damage to intracellular organelles is linked to activation of the innate immune system. The authors propose that a better appreciation of such organellar homeostasis could lead to the identification of novel innate immune pathways and have therapeutic implications. A cell is delimited by numerous borders that define specific organelles. The walls of some organelles are particularly robust, such as in mitochondria or endoplasmic reticulum, but some are more fluid such as in phase-separated stress granules. Either way, all organelles can be damaged at times, leading their contents to leak out into the surrounding environment. Therefore, an elegant way to construct an innate immune defence system is to recognize host molecules that do not normally reside within a particular compartment. Here, we provide several examples where organellar homeostasis is lost, leading to the activation of a specific innate immune sensor; these include NLRP3 activation owing to a disrupted trans-Golgi network, Pyrin activation due to cytoskeletal damage, and cGAS-STING activation following the leakage of nuclear or mitochondrial DNA. Frequently, organelle damage is observed downstream of pathogenic infection but it can also occur in sterile settings as associated with auto-inflammatory disease. Therefore, understanding organellar homeostasis is central to efforts that will identify new innate immune pathways, and therapeutics that balance organellar homeostasis, or target the breakdown pathways that trigger innate immune sensors, could be useful treatments for infection and chronic inflammatory diseases.	[Harapas, Cassandra R.; Hrovat-Schaale, Katja; Reygaerts, Thomas; Steiner, Annemarie; Laohamonthonkul, Pawat; Davidson, Sophia; Yu, Chien-Hsiung; Masters, Seth L.] Walter & Eliza Hall Inst Med Res, Inflammat Div, Parkville, Vic, Australia; [Harapas, Cassandra R.; Hrovat-Schaale, Katja; Reygaerts, Thomas; Steiner, Annemarie; Davidson, Sophia; Yu, Chien-Hsiung; Masters, Seth L.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Idiiatullina, Elina; Al-Azab, Mahmoud; Masters, Seth L.] Guangzhou Women & Childrens Med Ctr, Immunol Lab Guangzhou Inst Paediat, Guangzhou, Guangdong, Peoples R China; [Steiner, Annemarie] Univ Bonn, Inst Biol Struct, Fac Med, Bonn, Germany; [Booty, Lee] Res Immunol Unit, Immunol Network, GSK, Stevenage, Herts, England	Walter & Eliza Hall Institute; University of Melbourne; University of Bonn; GlaxoSmithKline	Masters, SL (corresponding author), Walter & Eliza Hall Inst Med Res, Inflammat Div, Parkville, Vic, Australia.; Masters, SL (corresponding author), Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia.; Masters, SL (corresponding author), Guangzhou Women & Childrens Med Ctr, Immunol Lab Guangzhou Inst Paediat, Guangzhou, Guangdong, Peoples R China.	masters@wehi.edu.au	Al-Azab, Mahmoud/AAE-7743-2020	Yu, Chien-Hsiung Alan/0000-0003-1744-3791; Booty, Lee/0000-0003-3003-5872; Idiiatullina, Elina/0000-0001-5324-2896	NHMRC [2003159]; Sylvia and Charles Viertel Foundation; HHMI-Wellcome International Research Scholarship; DFG [GRK2168]; University of Melbourne through the International Research and Research Training Fund; Bonn-Melbourne PhD program [IRTG2168]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Foundation; HHMI-Wellcome International Research Scholarship; DFG(German Research Foundation (DFG)); University of Melbourne through the International Research and Research Training Fund; Bonn-Melbourne PhD program	S.L.M. acknowledges funding from NHMRC grant (2003159), The Sylvia and Charles Viertel Foundation, and HHMI-Wellcome International Research Scholarship. S.L.M. is a scientific advisor for IFM therapeutics and NRG therapeutics. A.S. is supported by the DFG (GRK2168) and the University of Melbourne through the International Research and Research Training Fund and is a student in the Bonn-Melbourne PhD program IRTG2168 (DFG).	Abdisalaam S, 2020, J BIOL CHEM, V295, P11144, DOI 10.1074/jbc.RA120.012962; Adams CJ, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00011; Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Ahrens S, 2012, IMMUNITY, V36, P635, DOI 10.1016/j.immuni.2012.03.008; Akula MK, 2016, NAT IMMUNOL, V17, P922, DOI 10.1038/ni.3487; Allam R, 2014, J MOL MED, V92, P465, DOI 10.1007/s00109-014-1148-z; ALONI Y, 1971, P NATL ACAD SCI USA, V68, P1757, DOI 10.1073/pnas.68.8.1757; Amor-Gueret M, 2006, CANCER LETT, V236, P1, DOI 10.1016/j.canlet.2005.04.023; Andreeva L, 2017, NATURE, V549, P394, DOI 10.1038/nature23890; Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Bakhoum SF, 2018, NATURE, V553, P467, DOI 10.1038/nature25432; Bartsch K, 2017, HUM MOL GENET, V26, P3960, DOI 10.1093/hmg/ddx283; Bauernfried S, 2021, SCIENCE, V371, P482, DOI 10.1126/science.abd0811; Baum R, 2015, J IMMUNOL, V194, P873, DOI 10.4049/jimmunol.1402573; Bernardini JP, 2019, EMBO J, V38, DOI 10.15252/embj.201899916; Bertheloot D, 2017, CELL MOL IMMUNOL, V14, P43, DOI 10.1038/cmi.2016.34; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bielig H, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004351; Briard B, 2020, NATURE, V588, P688, DOI 10.1038/s41586-020-2996-z; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Campden RI, 2019, ARCH BIOCHEM BIOPHYS, V670, P32, DOI 10.1016/j.abb.2019.02.015; Canton J, 2021, NAT IMMUNOL, V22, P140, DOI 10.1038/s41590-020-00824-x; Cao SS, 2016, INFLAMM BOWEL DIS, V22, P984, DOI 10.1097/MIB.0000000000000660; CARDON LR, 1994, P NATL ACAD SCI USA, V91, P3799, DOI 10.1073/pnas.91.9.3799; Case LB, 2019, SCIENCE, V363, P1093, DOI 10.1126/science.aau6313; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chen JQ, 2018, NATURE, V564, P71, DOI 10.1038/s41586-018-0761-3; Chen W, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005462; Chu TT, 2021, NATURE, V596, P570, DOI 10.1038/s41586-021-03762-2; Coquel F, 2018, NATURE, V557, P57, DOI 10.1038/s41586-018-0050-1; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Deng ZM, 2020, J EXP MED, V217, DOI 10.1084/jem.20201045; Dhir A, 2018, NATURE, V560, P238, DOI 10.1038/s41586-018-0363-0; Di Micco A, 2016, P NATL ACAD SCI USA, V113, pE4671, DOI 10.1073/pnas.1602419113; Dobbs N, 2015, CELL HOST MICROBE, V18, P157, DOI 10.1016/j.chom.2015.07.001; Du MJ, 2018, SCIENCE, V361, P704, DOI 10.1126/science.aat1022; Fermaintt CS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10319-5; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Fritz T, 2011, GUT, V60, P1580, DOI 10.1136/gut.2009.206466; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fukazawa A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000228; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Gehrke N, 2013, IMMUNITY, V39, P482, DOI 10.1016/j.immuni.2013.08.004; Gicquel T, 2015, FASEB J, V29, P4162, DOI 10.1096/fj.14-267393; Gkirtzimanaki K, 2018, CELL REP, V25, P921, DOI 10.1016/j.celrep.2018.09.001; Gonugunta VK, 2017, CELL REP, V21, P3234, DOI 10.1016/j.celrep.2017.11.061; Gratia M, 2019, J EXP MED, V216, P1199, DOI 10.1084/jem.20181329; Green RS, 2007, IMMUNITY, V27, P308, DOI 10.1016/j.immuni.2007.06.008; Gross CJ, 2016, IMMUNITY, V45, P761, DOI 10.1016/j.immuni.2016.08.010; Gui X, 2019, NATURE, V567, P262, DOI 10.1038/s41586-019-1006-9; Gul E, 2018, J ALLERGY CLIN IMMUN, V142, P246, DOI 10.1016/j.jaci.2017.10.030; Harada Y, 2013, J BIOL CHEM, V288, P32673, DOI 10.1074/jbc.M113.486985; Harris J, 2011, J BIOL CHEM, V286, P9587, DOI 10.1074/jbc.M110.202911; Hasan M, 2015, IMMUNITY, V43, P463, DOI 10.1016/j.immuni.2015.07.022; Hasnain SZ, 2012, IMMUNOL CELL BIOL, V90, P260, DOI 10.1038/icb.2011.112; Hatch EM, 2013, CELL, V154, P47, DOI 10.1016/j.cell.2013.06.007; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hoang HD, 2018, J MOL BIOL, V430, P1965, DOI 10.1016/j.jmb.2018.04.040; Jakobs C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131702; Jena KK, 2020, EMBO REP, V21, DOI 10.15252/embr.202050051; Jia C, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2021-3; Jiang PZ, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00268; Karagoz GE, 2017, ELIFE, V6, DOI 10.7554/eLife.30700; Keestra AM, 2013, NATURE, V496, P233, DOI 10.1038/nature12025; Keestra-Gounder AM, 2016, NATURE, V532, P394, DOI 10.1038/nature17631; Kim J, 2019, SCIENCE, V366, P1531, DOI 10.1126/science.aav4011; Kim ML, 2015, J EXP MED, V212, P927, DOI 10.1084/jem.20142384; Kim Y, 2018, MOL CELL, V71, P1051, DOI 10.1016/j.molcel.2018.07.029; Kimura T, 2015, J CELL BIOL, V210, P973, DOI 10.1083/jcb.201503023; Kokkola R, 2003, ARTHRITIS RHEUM, V48, P2052, DOI 10.1002/art.11161; Konno H, 2013, CELL, V155, P688, DOI 10.1016/j.cell.2013.09.049; Krebs J, 2015, BIOCHEM BIOPH RES CO, V460, P114, DOI 10.1016/j.bbrc.2015.02.004; Kufer TA, 2008, CELL MICROBIOL, V10, P477, DOI 10.1111/j.1462-5822.2007.01062.x; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Lai JJ, 2020, IMMUNITY, V52, P123, DOI 10.1016/j.immuni.2019.11.013; Lan YY, 2014, CELL REP, V9, P180, DOI 10.1016/j.celrep.2014.08.074; Langereis MA, 2013, J VIROL, V87, P6314, DOI 10.1128/JVI.03213-12; Latonen L, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00151; Legrand-Poels S, 2007, J CELL SCI, V120, P1299, DOI 10.1242/jcs.03424; Lepelley A., 2021, J EXP MED, V218; Lepelley A, 2020, J EXP MED, V217, DOI 10.1084/jem.20200600; LEVIN D, 1978, P NATL ACAD SCI USA, V75, P1121, DOI 10.1073/pnas.75.3.1121; Li T, 2021, SCIENCE, V371, P1221, DOI 10.1126/science.abc5386; Liu-Bryan R, 2010, ARTHRITIS RHEUM-US, V62, P2004, DOI 10.1002/art.27475; Lood C, 2016, NAT MED, V22, P146, DOI 10.1038/nm.4027; Ma WR, 2018, CELL, V175, P1492, DOI 10.1016/j.cell.2018.10.007; Mackenzie KJ, 2017, NATURE, V548, P461, DOI 10.1038/nature23449; Magupalli VG, 2020, SCIENCE, V369, P1448, DOI 10.1126/science.aas8995; Martin SK, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108775; Masters SL, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1471; Masters SL, 2011, TRENDS MOL MED, V17, P276, DOI 10.1016/j.molmed.2011.01.005; Matilainen S, 2017, HUM MOL GENET, V26, P3352, DOI 10.1093/hmg/ddx221; McAlpine W, 2018, P NATL ACAD SCI USA, V115, pE11523, DOI 10.1073/pnas.1814753115; McArthur K, 2018, SCIENCE, V359, P883, DOI 10.1126/science.aao6047; McCormick C, 2017, NAT REV IMMUNOL, V17, P647, DOI 10.1038/nri.2017.63; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Mehto S, 2019, MOL CELL, V73, P429, DOI 10.1016/j.molcel.2018.11.018; Meng GX, 2009, IMMUNITY, V30, P860, DOI 10.1016/j.immuni.2009.04.012; Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051; Min J, 2019, GENE DEV, V33, P814, DOI 10.1101/gad.324905.119; Molinaro R, 2019, J BIOL CHEM, V294, P9007, DOI 10.1074/jbc.RA119.007997; Monteith AJ, 2016, P NATL ACAD SCI USA, V113, pE2142, DOI 10.1073/pnas.1513943113; Mostowy S, 2012, NAT REV MOL CELL BIO, V13, P183, DOI 10.1038/nrm3284; Mukai K, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20234-9; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Ogawa E, 2018, BIOCHEM BIOPH RES CO, V503, P138, DOI 10.1016/j.bbrc.2018.05.199; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Okonski KM, 2013, J VIROL, V87, P756, DOI 10.1128/JVI.02270-12; Olzscha H, 2019, BIOL CHEM, V400, P895, DOI 10.1515/hsz-2018-0458; Onomoto K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043031; Orlowski GM, 2015, J IMMUNOL, V195, P1685, DOI 10.4049/jimmunol.1500509; Papa R, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.604206; Papayannopoulos V, 2018, NAT REV IMMUNOL, V18, P134, DOI 10.1038/nri.2017.105; Park YH, 2020, NAT IMMUNOL, V21, P857, DOI 10.1038/s41590-020-0705-6; Park YH, 2016, NAT IMMUNOL, V17, P914, DOI 10.1038/ni.3457; Patrushev M, 2006, MITOCHONDRION, V6, P43, DOI 10.1016/j.mito.2005.12.001; Patrushev M, 2004, CELL MOL LIFE SCI, V61, P3100, DOI 10.1007/s00018-004-4424-1; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Pokatayev V, 2016, J EXP MED, V213, P329, DOI 10.1084/jem.20151464; Raab M, 2016, SCIENCE, V352, P359, DOI 10.1126/science.aad7611; Reineke LC, 2015, MBIO, V6, DOI 10.1128/mBio.02486-14; Rongvaux A, 2014, CELL, V159, P1563, DOI 10.1016/j.cell.2014.11.037; Roy CR, 2006, NAT REV IMMUNOL, V6, P136, DOI 10.1038/nri1775; Saito Y, 2019, CELL DEATH DIFFER, V26, P470, DOI 10.1038/s41418-018-0131-6; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Samir P, 2019, NATURE, V573, P590, DOI 10.1038/s41586-019-1551-2; Sanman LE, 2016, ELIFE, V5, DOI 10.7554/eLife.13663; Schulz O, 2018, CELL REP, V24, P419, DOI 10.1016/j.celrep.2018.06.038; Shen C, 2021, CELL, V184, P5759, DOI 10.1016/j.cell.2021.09.032; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Sliter DA, 2018, NATURE, V561, P258, DOI 10.1038/s41586-018-0448-9; Song X, 2019, J NEUROSCI, V39, P6378, DOI 10.1523/JNEUROSCI.0774-19.2019; Spalinger MR, 2017, AUTOPHAGY, V13, P1590, DOI 10.1080/15548627.2017.1341453; Srikanth S, 2019, NAT IMMUNOL, V20, P152, DOI 10.1038/s41590-018-0287-8; Stensland HMFR, 2008, MOL GENET METAB, V94, P476, DOI 10.1016/j.ymgme.2008.04.010; Sun SY, 2015, NAT CELL BIOL, V17, P1546, DOI 10.1038/ncb3266; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Uggenti C, 2020, NAT GENET, V52, P1364, DOI 10.1038/s41588-020-00737-3; Uhlorn BL, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.201900636; Vitre BD, 2012, CURR OPIN CELL BIOL, V24, P809, DOI 10.1016/j.ceb.2012.10.006; Vyleta ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036044; Wan L, 2021, MOL CELL, V81, P2808, DOI 10.1016/j.molcel.2021.05.018; White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Yamashiro LH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17156-x; YOUNG PG, 1975, BIOCHEM BIOPH RES CO, V65, P1201, DOI 10.1016/S0006-291X(75)80357-3; Yu CH, 2020, CELL, V183, P636, DOI 10.1016/j.cell.2020.09.020; Yu JW, 2007, MOL CELL, V28, P214, DOI 10.1016/j.molcel.2007.08.029; Zhang JG, 2012, IMMUNITY, V36, P646, DOI 10.1016/j.immuni.2012.03.009; Zhang ZY, 2015, IMMUNITY, V43, P1137, DOI 10.1016/j.immuni.2015.10.018	155	6	6	6	18	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2022	22	9					535	549		10.1038/s41577-022-00682-8	http://dx.doi.org/10.1038/s41577-022-00682-8		FEB 2022	15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	4E2XF	35197578				2022-12-18	WOS:000760016700001
J	Zhang, Y; Zhang, XF; Dai, HQ; Hu, HL; Alt, FW				Zhang, Yu; Zhang, Xuefei; Dai, Hai-Qiang; Hu, Hongli; Alt, Frederick W.			The role of chromatin loop extrusion in antibody diversification	NATURE REVIEWS IMMUNOLOGY			English	Review							CLASS-SWITCH RECOMBINATION; HEAVY-CHAIN LOCUS; ANTISENSE INTERGENIC TRANSCRIPTION; TOPOLOGICALLY ASSOCIATING DOMAINS; IGH INTRONIC ENHANCER; V(D)J RECOMBINATION; B-CELL; INSULATED NEIGHBORHOODS; SOMATIC HYPERMUTATION; GENOMIC INTERACTIONS	Cohesin mediates chromatin loop formation across the genome by extruding chromatin between convergently oriented CTCF-binding elements. Recent studies indicate that cohesin-mediated loop extrusion in developing B cells presents immunoglobulin heavy chain (Igh) variable (V), diversity (D) and joining (J) gene segments to RAG endonuclease through a process referred to as RAG chromatin scanning. RAG initiates V(D)J recombinational joining of these gene segments to generate the large number of different Igh variable region exons that are required for immune responses to diverse pathogens. Antigen-activated mature B cells also use chromatin loop extrusion to mediate the synapsis, breakage and end joining of switch regions flanking Igh constant region exons during class-switch recombination, which allows for the expression of different antibody constant region isotypes that optimize the functions of antigen-specific antibodies to eliminate pathogens. Here, we review recent advances in our understanding of chromatin loop extrusion during V(D)J recombination and class-switch recombination at the Igh locus. Alt and colleagues review recent advances in our understanding of the mechanistic role of cohesin-mediated chromatin loop extrusion in V(D)J recombination and class-switch recombination at the immunoglobulin heavy chain locus.	[Zhang, Yu] Western Michigan Univ, Ctr Immunobiol, Dept Investigat Med, Homer Stryker MD Sch Med, Kalamazoo, MI 49008 USA; [Zhang, Xuefei; Dai, Hai-Qiang; Hu, Hongli; Alt, Frederick W.] Boston Childrens Hosp, Howard Hughes Med Inst, Program Cellular & Mol Med, Boston, MA 02115 USA; [Zhang, Xuefei; Dai, Hai-Qiang; Hu, Hongli; Alt, Frederick W.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Zhang, Xuefei] Peking Univ, Biomed Pioneering Innovat Ctr BIOPIC, Beijing Adv Innovat Ctr Genom ICG, Beijing, Peoples R China; [Dai, Hai-Qiang] Chinese Acad Sci, Ctr Excellence Mol Cell Sci, Shanghai, Peoples R China	Western Michigan University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Peking University; Chinese Academy of Sciences	Zhang, Y (corresponding author), Western Michigan Univ, Ctr Immunobiol, Dept Investigat Med, Homer Stryker MD Sch Med, Kalamazoo, MI 49008 USA.; Alt, FW (corresponding author), Boston Childrens Hosp, Howard Hughes Med Inst, Program Cellular & Mol Med, Boston, MA 02115 USA.; Alt, FW (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.	yu.zhang@med.wmich.edu; alt@enders.tch.harvard.edu		Dai, Hai-Qiang/0000-0003-4337-9770; Zhang, Yu/0000-0002-1126-770X	US National Institutes of Health (NIH) [R01AI020047, R01AI077595, R01AI155775]	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by US National Institutes of Health (NIH) grants (R01AI020047 and R01AI077595 to F.W.A.; R01AI155775 to Y.Z.). H.-Q. D. was a fellow of the Cancer Research Institute (CRI) of New York. H.H. is a fellow of CRI. F.W.A. is an investigator of the Howard Hughes Medical Institute.	Aiden EL, 2015, CELL, V162, P708, DOI 10.1016/j.cell.2015.07.034; Alipour E, 2012, NUCLEIC ACIDS RES, V40, P11202, DOI 10.1093/nar/gks925; Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; Arnould C, 2021, NATURE, V590, DOI 10.1038/s41586-021-03193-z; Ba ZQ, 2020, NATURE, V586, P305, DOI 10.1038/s41586-020-2578-0; Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001; Beilinson HA, 2021, J EXP MED, V218, DOI 10.1084/jem.20210250; Benner C, 2015, P NATL ACAD SCI USA, V112, P12776, DOI 10.1073/pnas.1512995112; Bolland DJ, 2007, MOL CELL BIOL, V27, P5523, DOI 10.1128/MCB.02407-06; Bolland DJ, 2016, CELL REP, V15, P2475, DOI 10.1016/j.celrep.2016.05.020; Bolland DJ, 2004, NAT IMMUNOL, V5, P630, DOI 10.1038/ni1068; Bossen C, 2012, ANNU REV IMMUNOL, V30, P337, DOI 10.1146/annurev-immunol-020711-075003; Bottaro A, 1998, INT IMMUNOL, V10, P799, DOI 10.1093/intimm/10.6.799; Bouwman BAM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0730-1; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Carico Z, 2015, ADV IMMUNOL, V128, P307, DOI 10.1016/bs.ai.2015.07.005; Cascalho M, 1998, SCIENCE, V279, P1207, DOI 10.1126/science.279.5354.1207; Chakraborty T, 2007, MOL CELL, V27, P842, DOI 10.1016/j.molcel.2007.07.010; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Choi NM, 2013, J IMMUNOL, V191, P2393, DOI 10.4049/jimmunol.1301279; Collins PL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16926-x; Dai HQ, 2021, NATURE, V590, DOI 10.1038/s41586-020-03121-7; Davidson IF, 2021, NAT REV MOL CELL BIO, V22, P445, DOI 10.1038/s41580-021-00349-7; Davidson IF, 2019, SCIENCE, V366, P1338, DOI 10.1126/science.aaz3418; de Almeida CR, 2015, ADV IMMUNOL, V128, P183, DOI 10.1016/bs.ai.2015.07.004; de Almeida CR, 2011, IMMUNITY, V35, P501, DOI 10.1016/j.immuni.2011.07.014; de Wit E, 2015, MOL CELL, V60, P676, DOI 10.1016/j.molcel.2015.09.023; Degner SC, 2011, P NATL ACAD SCI USA, V108, P9566, DOI 10.1073/pnas.1019391108; Degner SC, 2009, J IMMUNOL, V182, P44, DOI 10.4049/jimmunol.182.1.44; Dekker J, 2016, CELL, V164, P1110, DOI 10.1016/j.cell.2016.02.007; Desiderio S, 2010, SEMIN IMMUNOL, V22, P362, DOI 10.1016/j.smim.2010.09.001; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dong JC, 2015, NATURE, V525, P134, DOI 10.1038/nature14970; Dorsett D, 2013, CURR OPIN CELL BIOL, V25, P327, DOI 10.1016/j.ceb.2013.02.003; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Dudley DD, 2002, P NATL ACAD SCI USA, V99, P9984, DOI 10.1073/pnas.152333499; Ebert A, 2015, ADV IMMUNOL, V128, P93, DOI 10.1016/bs.ai.2015.07.006; Ebert A, 2011, IMMUNITY, V34, P175, DOI 10.1016/j.immuni.2011.02.005; Fischer C, 2002, GENOMICS, V79, P241, DOI 10.1006/geno.2002.6688; Fitzsimmons SP, 2007, J IMMUNOL, V179, P5264, DOI 10.4049/jimmunol.179.8.5264; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fudenberg G, 2016, CELL REP, V15, P2038, DOI 10.1016/j.celrep.2016.04.085; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Garrett FE, 2005, MOL CELL BIOL, V25, P1511, DOI 10.1128/MCB.25.4.1511-1525.2005; Gassler J, 2017, EMBO J, V36, P3600, DOI 10.15252/embj.201798083; GAUSS GH, 1992, GENE DEV, V6, P1553, DOI 10.1101/gad.6.8.1553; Golfier S, 2020, ELIFE, V9, DOI 10.7554/eLife.53885; Grundy GJ, 2009, MOL CELL, V35, P217, DOI 10.1016/j.molcel.2009.06.022; Guo CG, 2011, NATURE, V477, P424, DOI 10.1038/nature10495; Guo Y, 2015, CELL, V162, P900, DOI 10.1016/j.cell.2015.07.038; Haarhuis JHI, 2017, CELL, V169, P693, DOI 10.1016/j.cell.2017.04.013; Hansen AS, 2018, NUCLEUS-PHILA, V9, P20, DOI 10.1080/19491034.2017.1389365; Hansen AS, 2017, ELIFE, V6, DOI 10.7554/eLife.25776; HARRIMAN W, 1993, ANNU REV IMMUNOL, V11, P361, DOI 10.1146/annurev.iy.11.040193.002045; Helmink BA, 2012, ANNU REV IMMUNOL, V30, P175, DOI 10.1146/annurev-immunol-030409-101320; Hesslein DGT, 2003, GENE DEV, V17, P37, DOI 10.1101/gad.1031403; Hill L, 2020, NATURE, V584, P142, DOI 10.1038/s41586-020-2454-y; Hnisz D, 2016, CELL, V167, P1188, DOI 10.1016/j.cell.2016.10.024; Hsieh THS, 2020, MOL CELL, V78, P539, DOI 10.1016/j.molcel.2020.03.002; Hu JZ, 2015, CELL, V163, P947, DOI 10.1016/j.cell.2015.10.016; Hwang JK, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0037-2014; Jain S, 2018, CELL, V174, P102, DOI 10.1016/j.cell.2018.04.035; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Ji YH, 2010, CELL, V141, P419, DOI 10.1016/j.cell.2010.03.010; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Khanna N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10628-9; Kim MS, 2018, MOL CELL, V70, P358, DOI 10.1016/j.molcel.2018.03.008; Kim MS, 2015, NATURE, V518, P507, DOI 10.1038/nature14174; Kim Y, 2019, SCIENCE, V366, P1345, DOI 10.1126/science.aaz4475; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Kraft K, 2019, NAT CELL BIOL, V21, P305, DOI 10.1038/s41556-019-0273-x; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Lee SH, 2019, NATURE, V570, P344, DOI 10.1038/s41586-019-1305-1; Li FB, 2010, J IMMUNOL, V185, P6049, DOI 10.4049/jimmunol.0902992; Li KV, 2020, P NATL ACAD SCI USA, V117, P21354, DOI 10.1073/pnas.2002126117; Li Y, 2020, NATURE, V578, P472, DOI 10.1038/s41586-019-1910-z; Lin SG, 2018, ADV IMMUNOL, V139, P93, DOI 10.1016/bs.ai.2018.07.001; Lin SG, 2015, P NATL ACAD SCI USA, V112, P1815, DOI 10.1073/pnas.1424936112; Lin YC, 2012, NAT IMMUNOL, V13, P1196, DOI 10.1038/ni.2432; Liu Z, 2006, IMMUNITY, V24, P405, DOI 10.1016/j.immuni.2006.02.001; Lucas JS, 2014, CELL, V158, P339, DOI 10.1016/j.cell.2014.05.036; Lundqvist ML, 2001, J BIOL CHEM, V276, P46729, DOI 10.1074/jbc.M106221200; MacPherson MJ, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-101; Majumder K, 2015, ADV IMMUNOL, V128, P273, DOI 10.1016/bs.ai.2015.07.001; MANDLER R, 1993, J IMMUNOL, V150, P407; Medvedovic J, 2013, IMMUNITY, V39, P229, DOI 10.1016/j.immuni.2013.08.011; Merkenschlager M, 2016, ANNU REV GENOM HUM G, V17, P17, DOI 10.1146/annurev-genom-083115-022339; Methot SP, 2017, ADV IMMUNOL, V133, P37, DOI 10.1016/bs.ai.2016.11.002; Mirny Leonid, 2022, Cold Spring Harb Perspect Biol, V14, DOI 10.1101/cshperspect.a040147; Mirny LA, 2021, NATURE, V590, P554, DOI 10.1038/d41586-021-00351-1; Moindrot B, 2012, NUCLEIC ACIDS RES, V40, P9470, DOI 10.1093/nar/gks736; Montefiori L, 2016, CELL REP, V14, P896, DOI 10.1016/j.celrep.2015.12.083; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nakahashi H, 2013, CELL REP, V3, P1678, DOI 10.1016/j.celrep.2013.04.024; Narendra V, 2015, SCIENCE, V347, P1017, DOI 10.1126/science.1262088; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Nichols MH, 2015, CELL, V162, P702, DOI 10.1016/j.cell.2015.07.053; Nishana M., 2020, GENOME BIOL, V21; Nora EP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19283-x; Nora EP, 2017, CELL, V169, P930, DOI 10.1016/j.cell.2017.05.004; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; Ochs F, 2019, NATURE, V574, P571, DOI 10.1038/s41586-019-1659-4; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Perlot T, 2005, P NATL ACAD SCI USA, V102, P14362, DOI 10.1073/pnas.0507090102; Pinaud E, 2001, IMMUNITY, V15, P187, DOI 10.1016/S1074-7613(01)00181-9; Pope BD, 2014, NATURE, V515, P402, DOI 10.1038/nature13986; Proudhon C, 2015, ADV IMMUNOL, V128, P123, DOI 10.1016/bs.ai.2015.07.003; Pugacheva EM, 2020, P NATL ACAD SCI USA, V117, P2020, DOI 10.1073/pnas.1911708117; Qiu X, 2018, MOL CELL, V70, P21, DOI 10.1016/j.molcel.2018.02.020; Ranganath S, 2008, J IMMUNOL, V180, P2339, DOI 10.4049/jimmunol.180.4.2339; Rao SSP, 2017, CELL, V171, P305, DOI 10.1016/j.cell.2017.09.026; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rogers CH, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.633705; Roldan E, 2005, NAT IMMUNOL, V6, P31, DOI 10.1038/ni1150; Rother MB, 2016, NUCLEIC ACIDS RES, V44, P175, DOI 10.1093/nar/gkv928; Rowley MJ, 2018, NAT REV GENET, V19, P789, DOI 10.1038/s41576-018-0060-8; Ru H, 2018, NAT STRUCT MOL BIOL, V25, P732, DOI 10.1038/s41594-018-0098-5; Ru H, 2015, CELL, V163, P1138, DOI 10.1016/j.cell.2015.10.055; Rudan MV, 2015, CELL REP, V10, P1297, DOI 10.1016/j.celrep.2015.02.004; Saintamand A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10730; Sakai E, 1999, INT IMMUNOL, V11, P1709, DOI 10.1093/intimm/11.10.1709; Sanborn AL, 2015, P NATL ACAD SCI USA, V112, pE6456, DOI 10.1073/pnas.1518552112; Sayegh C, 2005, GENE DEV, V19, P322, DOI 10.1101/gad.1254305; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; Schwarzer W, 2017, NATURE, V551, P51, DOI 10.1038/nature24281; Seidl KJ, 1999, P NATL ACAD SCI USA, V96, P3000, DOI 10.1073/pnas.96.6.3000; Stadhouders R, 2019, NATURE, V569, P345, DOI 10.1038/s41586-019-1182-7; Stadhouders R, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001791; Teng G, 2015, ADV IMMUNOL, V128, P1, DOI 10.1016/bs.ai.2015.07.002; Teng G, 2015, CELL, V162, P751, DOI 10.1016/j.cell.2015.07.009; Tepsuporn S, 2014, CANCER IMMUNOL RES, V2, P857, DOI 10.1158/2326-6066.CIR-14-0090; Thiecke MJ, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107929; Verma-Gaur J, 2012, P NATL ACAD SCI USA, V109, P17004, DOI 10.1073/pnas.1208398109; Vian L, 2018, CELL, V173, P1165, DOI 10.1016/j.cell.2018.03.072; Vincent-Fabert C, 2010, BLOOD, V116, P1895, DOI 10.1182/blood-2010-01-264689; Wang XBS, 2020, DNA REPAIR, V94, DOI 10.1016/j.dnarep.2020.102874; Wei PC, 2016, CELL, V164, P644, DOI 10.1016/j.cell.2015.12.039; WOOD C, 1983, P NATL ACAD SCI-BIOL, V80, P3030, DOI 10.1073/pnas.80.10.3030; Wuerffe R, 2007, IMMUNITY, V27, P711, DOI 10.1016/j.immuni.2007.09.007; Wutz G, 2017, EMBO J, V36, P3573, DOI 10.15252/embj.201798004; Xiang YG, 2013, J IMMUNOL, V190, P1819, DOI 10.4049/jimmunol.1203127; Xiang YG, 2011, J IMMUNOL, V186, P5356, DOI 10.4049/jimmunol.1003794; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Xiong HZ, 2012, J EXP MED, V209, P353, DOI 10.1084/jem.20111941; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2; YANCOPOULOS GD, 1986, CELL, V44, P251, DOI 10.1016/0092-8674(86)90759-2; YANCOPOULOS GD, 1984, NATURE, V311, P727, DOI 10.1038/311727a0; Yeap LS, 2019, ADV IMMUNOL, V141, P51, DOI 10.1016/bs.ai.2019.01.002; Yu K., 2021, P NATL ACAD SCI US, V118; Zhang TT, 2010, P NATL ACAD SCI USA, V107, P3040, DOI 10.1073/pnas.0915072107; Zhang X., 2021, P NATL ACAD SCI US, V118; Zhang Y, 2019, NATURE, V573, P600, DOI 10.1038/s41586-019-1547-y; Zhao BL, 2020, NAT REV MOL CELL BIO, V21, P765, DOI 10.1038/s41580-020-00297-8; Zhao Y, 2000, IMMUNOLOGY, V101, P348, DOI 10.1046/j.1365-2567.2000.00106.x; Zuin J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004153	159	6	6	4	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2022	22	9					550	566		10.1038/s41577-022-00679-3	http://dx.doi.org/10.1038/s41577-022-00679-3		FEB 2022	17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	4E2XF	35169260				2022-12-18	WOS:000755417500004
J	Crotty, S				Crotty, Shane			THE DISCOVERY OF INNATE LYMPHOID CELLS	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material							T-CELLS; HELPER; BCL6		[Crotty, Shane] La Jolla Inst Immunol, Ctr Infect Dis & Vaccine Res, La Jolla, CA USA	La Jolla Institute for Immunology	Crotty, S (corresponding author), La Jolla Inst Immunol, Ctr Infect Dis & Vaccine Res, La Jolla, CA USA.	shane@lji.org						Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002	5	6	6	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2021	21	10					616	617		10.1038/s41577-021-00591-2	http://dx.doi.org/10.1038/s41577-021-00591-2			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UX9XG	34580448				2022-12-18	WOS:000701188100004
J	Pollard, AJ; Bijker, EM				Pollard, Andrew J.; Bijker, Else M.			A guide to vaccinology: from basic principles to new developments (Dec, 10.1038/s41577-020-00479-7, 2020)	NATURE REVIEWS IMMUNOLOGY			English	Correction												andrew.pollard@paediatrics.ox.ac.uk	Bijker, Else/ABF-1664-2021	Bijker, Else/0000-0002-2367-5874; Pollard, Andrew/0000-0001-7361-719X				Pollard AJ, 2021, NAT REV IMMUNOL, V21, P83, DOI 10.1038/s41577-020-00479-7	1	6	6	2	12	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2021	21	2					129	129		10.1038/s41577-020-00497-5	http://dx.doi.org/10.1038/s41577-020-00497-5		JAN 2021	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QB3OS	33402728	Bronze, Green Published			2022-12-18	WOS:000605095700003
J	Bordon, Y				Bordon, Yvonne			An RNA vaccine for advanced melanoma	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material												y.bordon@nature.com						Sahin U, 2020, NATURE, V585, P107, DOI 10.1038/s41586-020-2537-9	1	6	6	0	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2020	20	9					517	517		10.1038/s41577-020-00417-7	http://dx.doi.org/10.1038/s41577-020-00417-7		AUG 2020	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NF2RF	32753762				2022-12-18	WOS:000555774700002
J	Tabachnikova, A; Chen, SVT				Tabachnikova, Alexandra; Chen, Steven T.			Roles for eosinophils and basophils in COVID-19?	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material; Early Access									[Tabachnikova, Alexandra; Chen, Steven T.] Icahn Sch Med Mt Sinai, Sinai Immunol Review Project, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Tabachnikova, A (corresponding author), Icahn Sch Med Mt Sinai, Sinai Immunol Review Project, New York, NY 10029 USA.	sinai.immunology@gmail.com; sinai.immunology@gmail.com		Tabachnikova, Alexandra/0000-0003-4695-2480				Rodriguez L, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100078	1	6	6	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.												10.1038/s41577-020-0379-1	http://dx.doi.org/10.1038/s41577-020-0379-1		JUN 2020	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MA7WP	32572245	Bronze, Green Published			2022-12-18	WOS:000542123000003
J	Risitano, AM; Mastellos, DC; Huber-Lang, M; Yancopoulou, D; Garlanda, C; Ciceri, F; Lambris, JD				Risitano, Antonio M.; Mastellos, Dimitrios C.; Huber-Lang, Markus; Yancopoulou, Despina; Garlanda, Cecilia; Ciceri, Fabio; Lambris, John D.			Complement as a target in COVID-19? (vol 20, pg 343, 2020)	NATURE REVIEWS IMMUNOLOGY			English	Correction									[Garlanda, Cecilia] Humanitas Clin & Res Ctr, IRCCS, Milan, Italy; [Garlanda, Cecilia] Humanitas Univ, Milan, Italy	Humanitas University	Garlanda, C (corresponding author), Humanitas Clin & Res Ctr, IRCCS, Milan, Italy.; Garlanda, C (corresponding author), Humanitas Univ, Milan, Italy.	ciceri.fabio@hsr.it; lambris@pennmedicine.upenn.edu	Garlanda, Cecilia/K-4601-2016; Lambris, John/Q-5633-2018	Garlanda, Cecilia/0000-0002-1510-7703; Mastellos, Dimitrios/0000-0002-6634-3271; Lambris, John/0000-0002-9370-5776				Risitano AM, 2020, NAT REV IMMUNOL, V20, P343, DOI 10.1038/s41577-020-0320-7	1	6	6	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUL	2020	20	7					448	448		10.1038/s41577-020-0366-6	http://dx.doi.org/10.1038/s41577-020-0366-6		JUN 2020	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NI4DD	32533108	Green Published, Bronze			2022-12-18	WOS:000551419200001
J	Conde, CD; Teichmann, SA				Dominguez Conde, Cecilia; Teichmann, Sarah A.			Deciphering immunity at high plexity and resolution	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material								Key advances The combination of single-cell RNA sequencing (scRNA-seq) with flow cytometry and imaging mass cytometry has provided a new perspective on the haematopoietic functions of the human embryonic and fetal liver. Mass cytometry and scRNA-seq have been used to dissect the CD4+ T cell landscape in the human intestinal lamina propria during pregnancy, showing that the human fetal gut contains memory-like CD4+ T cells. Exploring the transcriptomic landscape of regulatory T (Treg) cells across lymphoid and non-lymphoid tissues has shown the gene expression programmes that are involved in the tissue adaptation trajectories of Treg cells. The identification of increased numbers of lipid-associated macrophages in obesity shows how single-cell technologies can be used to investigate disease pathogenesis. In patients with ulcerative colitis, scRNA-seq has uncovered the rewiring of immune cell networks involved in disease and therapy resistance. Single-cell sequencing studies in 2019 have led to exciting discoveries relevant to the roles of the immune system in development, homeostasis and disease. The power of single-cell genomics stems from the ability to explore cell types and cell states in an unbiased way, which can lead to surprising new insights relating to developmental changes, tissue architecture and disease mechanisms. 2019 has yielded an exceptional number of high-quality, single-cell studies of the immune system in development, homeostasis and disease. Here, we highlight a selection of these.	[Dominguez Conde, Cecilia; Teichmann, Sarah A.] Wellcome Sanger Inst, Wellcome Genome Campus, Hinxton, Cambridge, England; [Teichmann, Sarah A.] Univ Cambridge, Dept Phys, Cavendish Lab, Theory Condensed Matter Grp, Cambridge, England	Wellcome Trust Sanger Institute; University of Cambridge	Teichmann, SA (corresponding author), Wellcome Sanger Inst, Wellcome Genome Campus, Hinxton, Cambridge, England.; Teichmann, SA (corresponding author), Univ Cambridge, Dept Phys, Cavendish Lab, Theory Condensed Matter Grp, Cambridge, England.	st9@sanger.ac.uk	Dominguez Conde, Cecilia/U-4890-2017	Dominguez Conde, Cecilia/0000-0002-8684-4655				Gomes T, 2019, TRENDS IMMUNOL, V40, P1011, DOI 10.1016/j.it.2019.09.004; Hill DA, 2018, P NATL ACAD SCI USA, V115, pE5096, DOI 10.1073/pnas.1802611115; Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054; Li N, 2019, NAT IMMUNOL, V20, P301, DOI 10.1038/s41590-018-0294-9; Miragaia RJ, 2019, IMMUNITY, V50, P493, DOI 10.1016/j.immuni.2019.01.001; Popescu DM, 2019, NATURE, V574, P365, DOI 10.1038/s41586-019-1652-y; Schneider C, 2019, IMMUNITY, V50, P1425, DOI 10.1016/j.immuni.2019.04.019; Smillie CS, 2019, CELL, V178, P714, DOI 10.1016/j.cell.2019.06.029; West NR, 2017, NAT MED, V23, P579, DOI 10.1038/nm.4307	9	6	6	1	16	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2020	20	2					77	78		10.1038/s41577-019-0254-0	http://dx.doi.org/10.1038/s41577-019-0254-0			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KI2EH	31797907				2022-12-18	WOS:000511159600003
J	Flemming, A				Flemming, Alexandra			Tumour heterogeneity determines immune response	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material																		Wolf Y, 2019, CELL, V179, P219, DOI 10.1016/j.cell.2019.08.032	1	6	6	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2019	19	11					662	663						2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JI6FX					2022-12-18	WOS:000493564300006
J	Flemming, A				Flemming, Alexandra			Butyrate boosts microbicidal macrophages	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material																			0	6	6	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAR	2019	19	3					135	135		10.1038/s41577-019-0132-9	http://dx.doi.org/10.1038/s41577-019-0132-9			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HM7UD	30723307	Bronze			2022-12-18	WOS:000459684300001
J	Kanneganti, TD				Kanneganti, Thirumala-Devi			Journal Club	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material									[Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	Thirumala-devi.kanneganti@stjude.org	Kanneganti, Thirumala-Devi/Y-2503-2019; Kanneganti, Thirumala-Devi/M-9435-2018	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Kanneganti, Thirumala-Devi/0000-0002-6395-6443					0	6	6	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2018	18	8					483	483		10.1038/s41577-018-0027-1	http://dx.doi.org/10.1038/s41577-018-0027-1			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GO3CD	29858587	Bronze			2022-12-18	WOS:000439863400007
J	Minton, K				Minton, Kirsty			Viperin breaks viral chains	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material														Minton, Kirsty/0000-0002-3857-8030					0	6	6	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2018	18	8					480	481		10.1038/s41577-018-0035-1	http://dx.doi.org/10.1038/s41577-018-0035-1			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GO3CD	29950609				2022-12-18	WOS:000439863400002
J	Diamond, MS; Coyne, CB				Diamond, Michael S.; Coyne, Carolyn B.			Closing in on a Zika virus vaccine	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material							PROTECTION	Over the past 2 years, Zika virus (ZIKV) has emerged as a pathogen capable of causing devastating congenital malformations in the developing fetus and significant neurological disease in adults. In 2017, substantial progress has been made towards the development, immunological analysis and preclinical evaluation of vaccine platforms to prevent the pathologies associated with ZIKV infection.	[Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA; [Coyne, Carolyn B.] Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15224 USA; [Coyne, Carolyn B.] Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, Ctr Microbial Pathogenesis, Pittsburgh, PA 15224 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.; Coyne, CB (corresponding author), Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15224 USA.; Coyne, CB (corresponding author), Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, Ctr Microbial Pathogenesis, Pittsburgh, PA 15224 USA.	mdiamond@wustl.edu; coynec2@pitt.edu	Diamond, Michael/AAH-1733-2019	Diamond, Michael/0000-0002-8791-3165				Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157; Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137; George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1; Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952; Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010; Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428; Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040; Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017; Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8; Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322; Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36	11	6	6	0	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2018	18	2					89	+		10.1038/nri.2017.132	http://dx.doi.org/10.1038/nri.2017.132			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FU0NY	29199280				2022-12-18	WOS:000423548800010
J	Dahal, LN				Dahal, Lekh N.			The dichotomy of T helper 17 cells in cancer	NATURE REVIEWS IMMUNOLOGY			English	Letter							INFLAMMATION; IL-17		[Dahal, Lekh N.] Univ Southampton, Antibody & Vaccine Grp, Canc Sci Unit, Fac Med,Southampton Gen Hosp, Southampton SO16 6YD, Hants, England	University of Southampton	Dahal, LN (corresponding author), Univ Southampton, Antibody & Vaccine Grp, Canc Sci Unit, Fac Med,Southampton Gen Hosp, Southampton SO16 6YD, Hants, England.	L.N.Dahal@soton.ac.uk	Dahal, Lekh/AAB-1268-2021					Charles KA, 2009, J CLIN INVEST, V119, P3011, DOI 10.1172/JCI39065; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; He DG, 2010, J IMMUNOL, V184, P2281, DOI 10.4049/jimmunol.0902574; Hinrichs CS, 2009, BLOOD, V114, P596, DOI 10.1182/blood-2009-02-203935; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Kulig P, 2016, CANCER IMMUNOL RES, V4, P26, DOI 10.1158/2326-6066.CIR-15-0154; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Sfanos KS, 2008, CLIN CANCER RES, V14, P3254, DOI 10.1158/1078-0432.CCR-07-5164; Stockinger B., 2017, NAT REV IMMUNOL; Tosolini M., CANC RES	14	6	6	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2017	17	9					592	593		10.1038/nri.2017.93	http://dx.doi.org/10.1038/nri.2017.93			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FF1VD	28825420	Bronze			2022-12-18	WOS:000408686300013
J	Leavy, O				Leavy, Olive			NLRC3 inhibits mTOR in colorectal cancer	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	6	7	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2017	17	2					79	79		10.1038/nri.2016.152	http://dx.doi.org/10.1038/nri.2016.152			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EK2CD	28044056	Bronze			2022-12-18	WOS:000393734100004
J	Medzhitov, R				Medzhitov, Ruslan			BRINGING WARBURG TO LYMPHOCYTES	NATURE REVIEWS IMMUNOLOGY			English	News Item									[Medzhitov, Ruslan] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	Yale University; Howard Hughes Medical Institute; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA.	ruslan.medzhitov@yale.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Krauss S, 2001, IMMUNITY, V15, P497, DOI 10.1016/S1074-7613(01)00205-9	3	6	6	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2015	15	10								10.1038/nri3918	http://dx.doi.org/10.1038/nri3918			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CS2PE	26403193				2022-12-18	WOS:000361912600006
J	Leavy, O				Leavy, Olive			An IFN gamma bias in severe asthma	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; Raundhal M., 2015, J CLIN INVEST	2	6	6	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2015	15	8					466	466		10.1038/nri3891	http://dx.doi.org/10.1038/nri3891			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CN5DZ	26184713				2022-12-18	WOS:000358451300002
J	Bordon, Y				Bordon, Yvonne			Live long and prosper with Siglecs	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X					0	6	6	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2015	15	5					266	266		10.1038/nri3851	http://dx.doi.org/10.1038/nri3851			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG6YV	25882243				2022-12-18	WOS:000353449800002
J	Hooper, LV; Macpherson, AJ				Hooper, Lora V.; Macpherson, Andrew J.			Immune adaptations that maintain homeostasis with the intestinal microbiota (vol 10, pg 159, 2010)	NATURE REVIEWS IMMUNOLOGY			English	Correction																		Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710	1	6	8	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2015	15	5								10.1038/nri3848	http://dx.doi.org/10.1038/nri3848			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG6YV		Bronze			2022-12-18	WOS:000353449800014
J	Minton, K				Minton, Kirsty			ANTIBACTERIAL IMMUNITY A pinch of salt	NATURE REVIEWS IMMUNOLOGY			English	News Item														Minton, Kirsty/0000-0002-3857-8030					0	6	6	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2015	15	4					202	202		10.1038/nri3835	http://dx.doi.org/10.1038/nri3835			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CE5CH	25765202	Bronze			2022-12-18	WOS:000351847200004
J	Kugelberg, E				Kugelberg, Elisabeth			Making sense in humans	NATURE REVIEWS IMMUNOLOGY			English	News Item														Kugelberg, Elisabeth/0000-0002-8302-3595					0	6	6	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAR	2015	15	3					133	133		10.1038/nri3822	http://dx.doi.org/10.1038/nri3822			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CC4MR	25656708	Bronze			2022-12-18	WOS:000350328000005
J	Bird, L				Bird, Lucy			Endogenous agonists for orphan ROR gamma	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bird, Lucy/0000-0002-3914-6045					0	6	6	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2015	15	2								10.1038/nri3812	http://dx.doi.org/10.1038/nri3812			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CA0ZQ	25614317	Bronze			2022-12-18	WOS:000348642400005
J	Minton, K				Minton, Kirsty			Silencing the immune response of apoptotic cells	NATURE REVIEWS IMMUNOLOGY			English	News Item														Minton, Kirsty/0000-0002-3857-8030					0	6	6	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2015	15	2					68	68		10.1038/nri3808	http://dx.doi.org/10.1038/nri3808			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CA0ZQ	25598532				2022-12-18	WOS:000348642400002
J	Minton, K				Minton, Kirsty			NATURAL KILLER CELLS A TACTILE restraint	NATURE REVIEWS IMMUNOLOGY			English	News Item														Minton, Kirsty/0000-0002-3857-8030					0	6	8	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2014	14	5					285	285		10.1038/nri3664	http://dx.doi.org/10.1038/nri3664			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AF8ZB	24705706	Bronze			2022-12-18	WOS:000335003400007
J	Minton, K				Minton, Kirsty			The inside story on complement activation	NATURE REVIEWS IMMUNOLOGY			English	News Item														Minton, Kirsty/0000-0002-3857-8030				Liszewski MK, 2013, IMMUNITY, V39, P1143, DOI 10.1016/j.immuni.2013.10.018	1	6	6	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2014	14	2					61	61		10.1038/nri3603	http://dx.doi.org/10.1038/nri3603			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA3VI	24378841	Bronze			2022-12-18	WOS:000331022400001
J	Minton, K				Minton, Kirsty			IMMUNODEFICIENCY Magnesium regulates antiviral immunity	NATURE REVIEWS IMMUNOLOGY			English	News Item														Minton, Kirsty/0000-0002-3857-8030					0	6	6	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2013	13	8					548	548		10.1038/nri3501	http://dx.doi.org/10.1038/nri3501			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	188TS	23868218				2022-12-18	WOS:000322217500008
J	Papatriantafyllou, M				Papatriantafyllou, Maria			SIGNAL TRANSDUCTION LCK regulation is hidden in details	NATURE REVIEWS IMMUNOLOGY			English	News Item													Papatriantafyllou, Maria/ADP-1463-2022					Brownlie R. J., NATURE REV IMMUNOL; Stirnweiss A, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003607	2	6	6	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2013	13	4					222	222		10.1038/nri3429	http://dx.doi.org/10.1038/nri3429			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	112US	23470319				2022-12-18	WOS:000316620100005
J	Leavy, O				Leavy, Olive			INNATE-LIKE LYMPHOCYTES Will the real ILC1 please stand up?	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	6	7	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2013	13	2					67	67		10.1038/nri3397	http://dx.doi.org/10.1038/nri3397			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	089JK	23348410	Bronze			2022-12-18	WOS:000314906600001
J	Bordon, Y				Bordon, Yvonne			TLR13, unlucky, but just for some	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X					0	6	7	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2012	12	9					618	618		10.1038/nri3284	http://dx.doi.org/10.1038/nri3284			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	998NZ	22878812				2022-12-18	WOS:000308248200005
J	Bird, L				Bird, Lucy			MUCOSAL IMMUNOLOGY IL-22 keeps commensals in their place	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bird, Lucy/0000-0002-3914-6045				Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551	1	6	6	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2012	12	8					550	550		10.1038/nri3263	http://dx.doi.org/10.1038/nri3263			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	978RI	22767156				2022-12-18	WOS:000306762500002
J	Leavy, O				Leavy, Olive			TOLERANCE Induced T-Reg cells evolved to protect the fetus	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Samstein RM, 2012, CELL, V150, P29, DOI 10.1016/j.cell.2012.05.031	1	6	7	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2012	12	8					554	554		10.1038/nri3274	http://dx.doi.org/10.1038/nri3274			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	978RI	22828910	Bronze			2022-12-18	WOS:000306762500008
J	Bordon, Y				Bordon, Yvonne			IMMUNE REGULATION Lysosomes at the heart of inflammation	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X				He YZ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001450	1	6	6	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2011	11	8								10.1038/nri3035	http://dx.doi.org/10.1038/nri3035			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	796RN	21779035	Bronze			2022-12-18	WOS:000293069600007
J	Bird, L				Bird, Lucy			REGULATORY T CELLS Nurtured by TGF beta	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bird, Lucy/0000-0002-3914-6045				Ouyang WM, 2010, IMMUNITY, V32, P642, DOI 10.1016/j.immuni.2010.04.012; Shevach EM, 2010, IMMUNITY, V32, P585, DOI 10.1016/j.immuni.2010.04.014	2	6	6	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JUL	2010	10	7					466	466		10.1038/nri2812	http://dx.doi.org/10.1038/nri2812			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	615QS	20589991	Bronze			2022-12-18	WOS:000279151100007
J	Bergtold, A				Bergtold, A			Cell surface recycling of internalized antigen permits dendritic cell priming of B cells.	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013	1	6	6	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2006	6	1					8	8						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	000FW					2022-12-18	WOS:000234447300013
J	Fournie, JJ; Gaits, F; Bonneville, M				Fournie, JJ; Gaits, F; Bonneville, M			Science and society - Promoting the learning of immunology in developing countries	NATURE REVIEWS IMMUNOLOGY			English	Article								In 2005, the economic gap between developing and developed countries is bigger than ever, and this has consequences for public health. So, to sustain education and research in the most resource-constrained regions, it is necessary to promote local teaching of the immunology of infectious diseases. This Perspective article reviews the use and expected efficiency of current Internet-based tools for higher education in the biomedical sciences in developing countries. We also discuss other approaches to improve access to updated training in immunology for students in the poorest countries.	CHU Purpan, Dept Oncogenese & Signalisat Cellules Hematopoi, Inst Natl Sante & Rech Med, Unite 563,Ctr Physiopathol Toulouse Purpan, F-31024 Toulouse, France; Inst Natl Sante & Rech Med, Unite 601, F-44035 Nantes, France	CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	Fournie, JJ (corresponding author), CHU Purpan, Dept Oncogenese & Signalisat Cellules Hematopoi, Inst Natl Sante & Rech Med, Unite 563,Ctr Physiopathol Toulouse Purpan, BP3028, F-31024 Toulouse, France.	fournie@toulouse.inserm.fr	Fournie, Jean-Jacques/J-7805-2013	Fournie, Jean-Jacques/0000-0001-6542-6908; Gaits-Iacovoni, Frederique/0000-0002-9853-0442				Annan Kofi A, 2004, Food Nutr Bull, V25, pS3; BOLLAG B, 2001, AMELIORATION ENSEIGN; *CTR INT EARTH SCI, 2000, GRIDD POP WORLD; HUITEMA C, 1995, DIEU CREA INTERNET; *JOINT UN PROGR HI, 2004, AIDS EP UPD 2004; RAMONET I, 1999, TYRANNIE COMMUNICATI, P198; Sibanda EN, 2001, CURR OPIN IMMUNOL, V13, P528, DOI 10.1016/S0952-7915(00)00252-1; SIMONCORTES N, 2004, VIETNAM UNE COOPERAT; *UN DEV PROGR, 2003, HUM DEV REP 2003, P237; Winter Gerard, 2002, IMPATIENCE PAUVRES	10	6	7	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2005	5	11					893	898		10.1038/nri1709	http://dx.doi.org/10.1038/nri1709			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	979TC	16175179	Bronze			2022-12-18	WOS:000232966700013
J	Balkwill, F				Balkwill, F			Immunology for the next generation	NATURE REVIEWS IMMUNOLOGY			English	Article								Immunologists need to establish a vibrant dialogue with young people. This is not only important for the continuation and progress of biomedical research, but it can also contribute to the fight against diseases such as HIV/AIDS and can help young people to make informed decisions about lifestyle, medical treatment and ethical issues. Good communication skills are crucial to any scientific career, and the lessons learned from talking with nonscientists can also be useful when writing scientific papers and grants. This article is a personal account of one scientist's experience of communicating biomedical science to young people.	Barts & London Queen Marys Sch Med & Dent, Barts & The London, Translat Oncol Lab, Canc Res UK, London EC1M 6BQ, England	Cancer Research UK; University of London; Queen Mary University London	Balkwill, F (corresponding author), Barts & London Queen Marys Sch Med & Dent, Barts & The London, Translat Oncol Lab, Canc Res UK, Charterhouse Sq, London EC1M 6BQ, England.			Balkwill, Frances/0000-0002-5587-9759	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BALKWILL F, 2002, GENE MACHINES; BALKWILL F, 1990, CELL WARS; BALKWILL F, 2002, STAYING ALIVE FIGHTI; BALKWILL F, 2002, ENJOY YOUR CELLS; BALKWILL F, 2005, YOU ME HIV KNOWLEDGE; BALKWILL FR, 2002, HAVE NICE DNA; Balkwill Fran, 2002, GERM ZAPPERS; *JOINT UN PROGR HI, 2004, REP GLOB AIDS EP 4 G; ROSE S, 1997, BRAINBOX	9	6	7	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2005	5	6					509	512		10.1038/nri1628	http://dx.doi.org/10.1038/nri1628			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	934EG	15905863				2022-12-18	WOS:000229689100014
J	Bird, L				Bird, L			Immune regulation - Co-stimulation with TIMs	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Meyers JH, 2005, NAT IMMUNOL, V6, P455, DOI 10.1038/ni1185; Umetsu SE, 2005, NAT IMMUNOL, V6, P447, DOI 10.1038/ni1186	2	6	6	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2005	5	5					356	356		10.1038/nri1634	http://dx.doi.org/10.1038/nri1634			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	922JN		Bronze			2022-12-18	WOS:000228833700003
J	Bell, J				Bell, J			Wake-up call	NATURE REVIEWS IMMUNOLOGY			English	News Item							ABSENCE; MEMORY											Kassiotis G, 2002, NAT IMMUNOL, V3, P244, DOI 10.1038/ni766; Swain SL, 2000, PHILOS T ROY SOC B, V355, P407, DOI 10.1098/rstb.2000.0581	2	6	6	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAR	2002	2	3					143	143		10.1038/nri766	http://dx.doi.org/10.1038/nri766			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	636CZ		Bronze			2022-12-18	WOS:000180438100001
J	Bell, E				Bell, E			Building the bigger picture	NATURE REVIEWS IMMUNOLOGY			English	News Item							BAFF											Gross JA, 2001, IMMUNITY, V15, P289, DOI 10.1016/S1074-7613(01)00183-2; Laabi Y, 2000, SCIENCE, V289, P883, DOI 10.1126/science.289.5481.883; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965	4	6	6	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2001	1	1					5	5		10.1038/35095526	http://dx.doi.org/10.1038/35095526			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	635KK		Bronze			2022-12-18	WOS:000180397900007
J	Bell, E				Bell, E			Manipulating melanoma	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Kedl RM, 2001, P NATL ACAD SCI USA, V98, P10811, DOI 10.1073/pnas.191371898	1	6	6	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2001	1	1					6	6		10.1038/35095534	http://dx.doi.org/10.1038/35095534			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	635KK					2022-12-18	WOS:000180397900010
J	Goswami, S; Anandhan, S; Raychaudhuri, D; Sharma, P				Goswami, Sangeeta; Anandhan, Swetha; Raychaudhuri, Deblina; Sharma, Padmanee			Myeloid cell-targeted therapies for solid tumours	NATURE REVIEWS IMMUNOLOGY			English	Review; Early Access							REDUCED CLINICAL BENEFIT; ANTI-VEGF THERAPY; IMMUNE-CHECKPOINT; INFILTRATING MACROPHAGES; SCAVENGER RECEPTOR; ADOPTIVE TRANSFER; SUPPRESSOR-CELLS; DENDRITIC CELLS; PD-1 BLOCKADE; UP-REGULATION	Myeloid cells contribute to the immunosuppressive tumour microenvironment and can be responsible for resistance to cancer immunotherapy. Here, the authors describe the current therapies that aim to modulate the functional activities of myeloid cell populations, impacting their recruitment, survival and activity in the tumour microenvironment, acting at the level of cell surface receptors, signalling pathways, epigenetic machinery and metabolic regulators. Myeloid cells are the most abundant immune components of the tumour microenvironment, where they have a variety of functions, ranging from immunosuppressive to immunostimulatory roles. The myeloid cell compartment comprises many different cell types, including monocytes, macrophages, dendritic cells and granulocytes, that are highly plastic and can differentiate into diverse phenotypes depending on cues received from their microenvironment. In the past few decades, we have gained a better appreciation of the complexity of myeloid cell subsets and how they are involved in tumour progression and resistance to cancer therapies, including immunotherapy. In this Review, we highlight key features of monocyte and macrophage biology that are being explored as potential targets for cancer therapies and what aspects of myeloid cells need a deeper understanding to identify rational combinatorial strategies to improve clinical outcomes of patients with cancer. We discuss therapies that aim to modulate the functional activities of myeloid cell populations, impacting their recruitment, survival and activity in the tumour microenvironment, acting at the level of cell surface receptors, signalling pathways, epigenetic machinery and metabolic regulators. We also describe advances in the development of genetically engineered myeloid cells for cancer therapy.	[Goswami, Sangeeta; Anandhan, Swetha; Sharma, Padmanee] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Goswami, Sangeeta; Raychaudhuri, Deblina; Sharma, Padmanee] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Anandhan, Swetha] Univ Texas MD Anderson Canc Ctr, MD Anderson UT Hlth Grad Sch Biomed Sci, Houston, TX 77030 USA; [Sharma, Padmanee] Univ Texas MD Anderson Canc Ctr, Immunotherapy Platform, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Sharma, P (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA.; Sharma, P (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.; Sharma, P (corresponding author), Univ Texas MD Anderson Canc Ctr, Immunotherapy Platform, Houston, TX 77030 USA.	padsharma@mdanderson.org			MD Anderson Physician Scientist Award; Khalifa Physician Scientist Award; Andrew Sabin Family Foundation Fellows Award; Clinic and Laboratory Integration Program Award	MD Anderson Physician Scientist Award; Khalifa Physician Scientist Award; Andrew Sabin Family Foundation Fellows Award; Clinic and Laboratory Integration Program Award	S.G. is supported by the MD Anderson Physician Scientist Award, Khalifa Physician Scientist Award, Andrew Sabin Family Foundation Fellows Award and Clinic and Laboratory Integration Program Award. P.S. is a member of the Parker Institute for Cancer Immunotherapy.	Abad C, 2014, J LEUKOCYTE BIOL, V95, P357, DOI 10.1189/jlb.1012531; Advani R, 2018, NEW ENGL J MED, V379, P1711, DOI 10.1056/NEJMoa1807315; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Akkari L, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaw7843; Algars A, 2012, INT J CANCER, V131, P864, DOI 10.1002/ijc.26457; Amit I, 2016, NAT IMMUNOL, V17, P18, DOI 10.1038/ni.3325; Ammar A, 2011, ANAL CELL PATHOL, V34, P67, DOI [10.1155/2011/291769, 10.3233/ACP-2011-0002]; Anassi Enock, 2011, P T, V36, P197; Anderson AC, 2016, IMMUNITY, V44, P989, DOI 10.1016/j.immuni.2016.05.001; Anderson NR, 2021, CANCER RES, V81, P1201, DOI 10.1158/0008-5472.CAN-20-2990; ANDREESEN R, 1990, CANCER RES, V50, P7450; Antunes ARP, 2021, NAT NEUROSCI, V24, P595, DOI 10.1038/s41593-020-00789-y; Bald T, 2014, CANCER DISCOV, V4, P674, DOI 10.1158/2159-8290.CD-13-0458; Barkal AA, 2019, NATURE, V572, P392, DOI 10.1038/s41586-019-1456-0; Barkal AA, 2018, NAT IMMUNOL, V19, P76, DOI 10.1038/s41590-017-0004-z; Basavarajappa D, 2020, P NATL ACAD SCI USA, V117, P8573, DOI 10.1073/pnas.1916249117; Bassler K, 2019, ANNU REV IMMUNOL, V37, P269, DOI 10.1146/annurev-immunol-042718-041728; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Beebe JD, 2018, PHARMACOL THERAPEUT, V191, P74, DOI 10.1016/j.pharmthera.2018.06.006; Belderbos RA, 2019, MOL THER-ONCOLYTICS, V13, P67, DOI 10.1016/j.omto.2019.03.007; Bergenfelz C, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00109; Bian Z, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23442-z; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bono P, 2021, J CLIN ONCOL, V39, DOI 10.1200/JCO.2021.39.15_suppl.e14530; Boukhaled GM, 2021, ANNU REV PATHOL-MECH, V16, P167, DOI 10.1146/annurev-pathol-031920-093932; Brempelis KJ, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-001356; Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Calcinotto A, 2018, NATURE, V559, P363, DOI 10.1038/s41586-018-0266-0; Cali B, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.718098; Campesato LF, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17750-z; Cannarile MA, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0257-y; Casanova-Acebes M, 2021, NATURE, V595, P578, DOI 10.1038/s41586-021-03651-8; Casazza A, 2013, CANCER CELL, V24, P695, DOI 10.1016/j.ccr.2013.11.007; Cassetta L, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00038; Chaib M, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00351; Charles J, 2020, ONCOIMMUNOLOGY, V9, DOI 10.1080/2162402X.2020.1738812; Chen BS, 2020, CANCER IMMUNOL RES, V8, P451, DOI 10.1158/2326-6066.CIR-19-0282; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Chen HM, 2018, J CLIN INVEST, V128, P5647, DOI 10.1172/JCI97570; Cheng SJ, 2021, CELL, V184, P792, DOI 10.1016/j.cell.2021.01.010; Cheng X, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.646523; Chevrier S, 2017, CELL, V169, P736, DOI 10.1016/j.cell.2017.04.016; Chiu DKC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00530-7; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Cunha LD, 2018, CELL, V175, P429, DOI 10.1016/j.cell.2018.08.061; Dai HH, 2020, SCIENCE, V368, P1122, DOI 10.1126/science.aax4040; Dalton HJ, 2017, CLIN CANCER RES, V23, P7034, DOI 10.1158/1078-0432.CCR-17-0647; De Henau O, 2016, NATURE, V539, P443, DOI 10.1038/nature20554; de Palma M, 2017, NAT REV CANCER, V17, P457, DOI 10.1038/nrc.2017.51; DeNardo DG, 2019, NAT REV IMMUNOL, V19, P369, DOI 10.1038/s41577-019-0127-6; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Drissen R, 2016, NAT IMMUNOL, V17, P666, DOI 10.1038/ni.3412; Dumond A, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00662; Eckert F, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03018; Eisinger S, 2020, P NATL ACAD SCI USA, V117, P32005, DOI 10.1073/pnas.2015343117; Engblom C, 2016, NAT REV CANCER, V16, P447, DOI 10.1038/nrc.2016.54; Ferrara N, 2016, NAT REV DRUG DISCOV, V15, P385, DOI 10.1038/nrd.2015.17; Fionda C, 2016, CURR MED CHEM, V23, P2618, DOI 10.2174/0929867323666160727105101; Fisher GA, 2020, J CLIN ONCOL, V38; Frey B, 2015, CANCER LETT, V368, P230, DOI 10.1016/j.canlet.2015.04.010; Fu LQ, 2020, CELL IMMUNOL, V353, DOI 10.1016/j.cellimm.2020.104119; Gao JJ, 2017, NAT MED, V23, P551, DOI 10.1038/nm.4308; Garcia-Diaz A, 2017, CELL REP, V19, P1189, DOI 10.1016/j.celrep.2017.04.031; Garg AD, 2017, TRENDS IMMUNOL, V38, P577, DOI 10.1016/j.it.2017.05.006; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Georgoudaki AM, 2016, CELL REP, V15, P2000, DOI 10.1016/j.celrep.2016.04.084; Gocher AM, 2022, NAT REV IMMUNOL, V22, P158, DOI 10.1038/s41577-021-00566-3; Goswami S, 2020, NAT MED, V26, P39, DOI 10.1038/s41591-019-0694-x; Goswami S, 2018, J CLIN INVEST, V128, P3813, DOI 10.1172/JCI99760; Gubin MM, 2018, CELL, V175, P1014, DOI 10.1016/j.cell.2018.09.030; Guerriero JL, 2017, NATURE, V543, P428, DOI 10.1038/nature21409; Guo N, 2020, CURR RES TRANSL MED, V68, P119, DOI 10.1016/j.retram.2020.05.003; Gyori D, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120631; Harari A, 2020, NAT REV DRUG DISCOV, V19, P635, DOI 10.1038/s41573-020-0074-8; Hashimoto A, 2021, CANCER RES, V81; Henze AT, 2016, J CLIN INVEST, V126, P3672, DOI 10.1172/JCI84427; Hofbauer LC, 2021, NAT REV CLIN ONCOL, V18, P488, DOI 10.1038/s41571-021-00499-9; Holmgaard RB, 2015, CELL REP, V13, P412, DOI 10.1016/j.celrep.2015.08.077; Hou AH, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00783; Hughes R, 2015, CANCER RES, V75, P3479, DOI 10.1158/0008-5472.CAN-14-3587; Humeau J, 2021, ONCOIMMUNOLOGY, V10, DOI 10.1080/2162402X.2021.1984677; Irvine DJ, 2020, NAT REV IMMUNOL, V20, P321, DOI 10.1038/s41577-019-0269-6; Jacquelot N, 2019, CELL RES, V29, P846, DOI 10.1038/s41422-019-0224-x; Jahchan NS, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01611; Jaillon S, 2020, NAT REV CANCER, V20, P485, DOI 10.1038/s41568-020-0281-y; Jing WQ, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0573-5; June CH, 2018, NEW ENGL J MED, V379, P64, DOI 10.1056/NEJMra1706169; Kaczanowska S, 2021, CELL, V184, P2033, DOI 10.1016/j.cell.2021.02.048; Kamber RA, 2021, NATURE, V597, P549, DOI 10.1038/s41586-021-03879-4; Kaneda MM, 2016, NATURE, V539, P437, DOI 10.1038/nature19834; Kaneda MM, 2016, CANCER DISCOV, V6, P870, DOI 10.1158/2159-8290.CD-15-1346; Katzenelenbogen Y, 2020, CELL, V182, P872, DOI 10.1016/j.cell.2020.06.032; Klebanoff CA, 2006, IMMUNOL REV, V211, P214, DOI 10.1111/j.0105-2896.2006.00391.x; Klichinsky M, 2020, NAT BIOTECHNOL, V38, P947, DOI 10.1038/s41587-020-0462-y; Kloepper J, 2016, P NATL ACAD SCI USA, V113, P4476, DOI 10.1073/pnas.1525360113; Klug F, 2013, CANCER CELL, V24, P589, DOI 10.1016/j.ccr.2013.09.014; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Kortylewski M, 2009, CANCER CELL, V15, P114, DOI 10.1016/j.ccr.2008.12.018; Kozin SV, 2010, CANCER RES, V70, P5679, DOI 10.1158/0008-5472.CAN-09-4446; Kumagai Shogo, 2021, Nat Rev Cancer, V21, P181, DOI 10.1038/s41568-020-00322-0; Kumar V, 2017, CANCER CELL, V32, P654, DOI 10.1016/j.ccell.2017.10.005; Kumar V, 2016, TRENDS IMMUNOL, V37, P208, DOI 10.1016/j.it.2016.01.004; Kwok I, 2020, IMMUNITY, V53, P303, DOI 10.1016/j.immuni.2020.06.005; Kzhyshkowska J, 2006, J CELL MOL MED, V10, P635, DOI 10.1111/j.1582-4934.2006.tb00425.x; La Fleur L, 2021, CANCER RES, V81, P956, DOI 10.1158/0008-5472.CAN-20-1885; Labani-Motlagh A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00940; Lam KC, 2021, CELL, V184, P5338, DOI 10.1016/j.cell.2021.09.019; Larionova I, 2021, CANCERS, V13, DOI 10.3390/cancers13133253; Larionova I, 2020, CANCERS, V12, DOI 10.3390/cancers12061411; Le Naour J, 2020, ONCOIMMUNOLOGY, V9, DOI 10.1080/2162402X.2020.1777624; Lee H, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.649004; Lee JB, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.681320; Li BH, 2020, MOL IMMUNOL, V117, P201, DOI 10.1016/j.molimm.2019.11.014; Li DK, 2020, ONCOL LETT, V20, DOI 10.3892/ol.2020.12037; Li TH, 2021, CLIN MED INSIGHTS-ON, V15, DOI 10.1177/11795549211035540; Li T, 2020, NAT CANCER, V1, DOI 10.1038/s43018-020-0061-3; Liang W, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.626812; Lichterman JN, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10061270; Liljenfeldt L, 2014, CANCER GENE THER, V21, P95, DOI 10.1038/cgt.2014.2; Liu PS, 2017, NAT IMMUNOL, V18, P985, DOI 10.1038/ni.3796; Liu XT, 2021, J IMMUNOTHER CANCER, V9, DOI 10.1136/jitc-2020-001460; Lodewijk I, 2021, CLIN EPIGENETICS, V13, DOI 10.1186/s13148-021-01046-0; Logtenberg MEW, 2020, IMMUNITY, V52, P742, DOI 10.1016/j.immuni.2020.04.011; Lopez-Yrigoyen M, 2021, ANN NY ACAD SCI, V1499, P18, DOI 10.1111/nyas.14377; Lu GM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7676; Lu ZH, 2020, NATURE, V579, P284, DOI 10.1038/s41586-020-2054-x; Lucas KG, 2011, J NEURO-ONCOL, V103, P231, DOI 10.1007/s11060-010-0383-6; Mackert JR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12968-2; Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; Marone G, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.02103; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Mijatovic S, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9050374; Mitchem JB, 2013, CANCER RES, V73, P1128, DOI 10.1158/0008-5472.CAN-12-2731; Mohapatra S, 2021, MOL CANCER, V20, DOI 10.1186/s12943-021-01313-x; Moi D, 2018, CYTOTHERAPY, V20, pS18, DOI 10.1016/j.jcyt.2018.02.038; Molgora M, 2020, CELL, V182, P886, DOI 10.1016/j.cell.2020.07.013; Morello S, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1108515; Morotti M, 2021, BRIT J CANCER, V124, P1759, DOI 10.1038/s41416-021-01353-6; Neophytou CM, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00899; Nguyen NT, 2010, P NATL ACAD SCI USA, V107, P19961, DOI 10.1073/pnas.1014465107; Obaid M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80291-4; Ochocka N, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21407-w; Oh MH, 2020, J CLIN INVEST, V130, P3865, DOI 10.1172/JCI131859; Okla K, 2021, J EXP MED, V218, DOI 10.1084/jem.20201605; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Palani S, 2016, J IMMUNOL, V196, P115, DOI 10.4049/jimmunol.1500257; Papadopoulos KP, 2017, CLIN CANCER RES, V23, P5703, DOI 10.1158/1078-0432.CCR-16-3261; Park JE, 2019, ONCOGENE, V38, P5158, DOI 10.1038/s41388-019-0782-x; Pathria P, 2019, TRENDS IMMUNOL, V40, P310, DOI 10.1016/j.it.2019.02.003; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Perez CR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13368-y; Pitt JM, 2016, IMMUNITY, V44, P1255, DOI 10.1016/j.immuni.2016.06.001; Pu D, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.637504; Qu Y, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107873; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Razak ARA, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-001006; Reebye V, 2018, ONCOGENE, V37, P3216, DOI 10.1038/s41388-018-0126-2; Reinfeld BI, 2021, NATURE, V593, P282, DOI 10.1038/s41586-021-03442-1; Ren HW, 2006, CELL IMMUNOL, V244, P50, DOI 10.1016/j.cellimm.2007.02.009; Reni M, 2021, LANCET ONCOL, V22, P10, DOI 10.1016/S1470-2045(20)30724-5; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Roy S, 2018, CANCER RES, V78, P5600, DOI 10.1158/0008-5472.CAN-18-0562; Sabado RL, 2017, CELL RES, V27, P74, DOI 10.1038/cr.2016.157; Sakai Y, 2019, CANCER SCI, V110, P903, DOI 10.1111/cas.13944; Salah A, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.686544; Sato-Kaneko F, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93397; Saxena M, 2018, TRENDS CANCER, V4, P119, DOI 10.1016/j.trecan.2017.12.007; Schalper KA, 2020, NAT MED, V26, P688, DOI 10.1038/s41591-020-0856-x; Seifert L, 2016, GASTROENTEROLOGY, V150, P1659, DOI 10.1053/j.gastro.2016.02.070; Sharma N, 2021, J EXP MED, V218, DOI 10.1084/jem.20201811; Sharma P, 2021, CANCER DISCOV, V11, P838, DOI 10.1158/2159-8290.CD-20-1680; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Shekarian T, 2017, ANN ONCOL, V28, P1756, DOI 10.1093/annonc/mdx179; Shi LZ, 2019, CANCER IMMUNOL RES, V7, P1803, DOI 10.1158/2326-6066.CIR-18-0873; Shields CW, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz6579; Shojaei F, 2009, P NATL ACAD SCI USA, V106, P6742, DOI 10.1073/pnas.0902280106; Steitz AM, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2438-8; Su YL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061803; Sun LJ, 2021, CANCER CELL, V39, P1361, DOI 10.1016/j.ccell.2021.08.005; Sun L, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126853; Tadayon S, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.602122; Tang K, 2021, J HEMATOL ONCOL, V14, DOI 10.1186/s13045-021-01080-8; Tian XY, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0772-z; Topper MJ, 2020, NAT REV CLIN ONCOL, V17, P75, DOI 10.1038/s41571-019-0266-5; Urban-Wojciuk Z, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02388; Varricchi G, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1393134; Veglia F, 2021, NAT REV IMMUNOL, V21, P485, DOI 10.1038/s41577-020-00490-y; Velazquez EJ, 2018, CANCER RES, V78, DOI 10.1158/1538-7445.AM2018-2563; Vigano S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00925; Viitala M, 2019, CLIN CANCER RES, V25, P3289, DOI 10.1158/1078-0432.CCR-18-3016; Vitale I, 2019, CELL METAB, V30, P36, DOI 10.1016/j.cmet.2019.06.001; Vonderheide RH, 2020, ANNU REV MED, V71, P47, DOI 10.1146/annurev-med-062518-045435; Wang J, 2019, NAT MED, V25, P656, DOI 10.1038/s41591-019-0374-x; Wang PF, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1494113; Wang S, 2016, P NATL ACAD SCI USA, V113, pE7240, DOI 10.1073/pnas.1608555113; Wang T, 2015, CLIN CANCER RES, V21, P1652, DOI 10.1158/1078-0432.CCR-14-1554; Wculek SK, 2020, NAT REV IMMUNOL, V20, P7, DOI 10.1038/s41577-019-0210-z; Weissleder R, 2020, NAT BIOMED ENG, V4, P489, DOI 10.1038/s41551-020-0524-y; Wenes M, 2016, CELL METAB, V24, P701, DOI 10.1016/j.cmet.2016.09.008; Wu CJ, 2020, J IMMUNOL, V204, P212, DOI 10.4049/jimmunol.1900930; Xu M, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.618501; Xu WW, 2019, CANCER IMMUNOL RES, V7, P1497, DOI 10.1158/2326-6066.CIR-18-0489; Yan JW, 2020, TRENDS CELL BIOL, V30, P979, DOI 10.1016/j.tcb.2020.09.006; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Yuen KC, 2020, NAT MED, V26, P693, DOI 10.1038/s41591-020-0860-1; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015; Zhang L, 2020, CELL, V181, P442, DOI 10.1016/j.cell.2020.03.048; Zhou DL, 2005, IMMUNITY, V22, P571, DOI 10.1016/j.immuni.2005.03.009; Zou SL, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01258-7	210	5	5	18	19	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.												10.1038/s41577-022-00737-w	http://dx.doi.org/10.1038/s41577-022-00737-w		JUN 2022	15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	2B6XR	35697799				2022-12-18	WOS:000810329800001
J	Goldblatt, D				Goldblatt, David			SARS-CoV-2: from herd immunity to hybrid immunity COMMENT	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material								Herd immunity, where a pathogen can no longer efficiently spread in a population, is achieved when a large proportion of the population becomes immune, making the spread of infection from person to person unlikely and protecting those without immunity. Despite the global spread of SARS-CoV-2, the failure of virus- and vaccine-induced immunity to prevent transmission, combined with the emergence of antigenically distinct variants, has made herd immunity to SARS-CoV-2 unachievable thus far. Where does this leave us?	[Goldblatt, David] UCL, Great Ormond St Inst Child Hlth, London, England	University of London; University College London	Goldblatt, D (corresponding author), UCL, Great Ormond St Inst Child Hlth, London, England.	d.goldblatt@ucl.ac.uk	Goldblatt, David/C-5972-2008	Goldblatt, David/0000-0002-0769-5242				Andrews N, 2022, NEW ENGL J MED, V386, P340, DOI 10.1056/NEJMoa2115481; Clifford S, 2021, EFFECTIVENESS BNT162, DOI DOI 10.1101/2021.11.24.21266401; Hall VJ, 2021, LANCET, V397, P1459, DOI 10.1016/S0140-6736(21)00675-9; Nordstrom P, 2022, LANCET INFECT DIS, V22, P781, DOI 10.1016/S1473-3099(22)00143-8; Pouwels KB, 2021, NAT MED, V27, P2127, DOI 10.1038/s41591-021-01548-7; Pulliam JRC, 2022, SCIENCE, V376, P596, DOI 10.1126/science.abn4947; Roltgen K, 2022, CELL, V185, P1025, DOI 10.1016/j.cell.2022.01.018; Sun K, 2022, PERSISTENCE SARS COV, V2022; Swadling L, 2022, NATURE, V601, DOI 10.1038/s41586-021-04186-8; Zhang Zeli, 2022, bioRxiv, DOI 10.1101/2022.03.18.484953	10	5	5	5	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2022	22	6					333	334		10.1038/s41577-022-00725-0	http://dx.doi.org/10.1038/s41577-022-00725-0		APR 2022	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1S3GR	35440758	Green Published, Bronze			2022-12-18	WOS:000784843300001
J	Aguilera-Lizarraga, J; Hussein, H; Boeckxstaens, GE				Aguilera-Lizarraga, Javier; Hussein, Hind; Boeckxstaens, Guy E.			Immune activation in irritable bowel syndrome: what is the evidence?	NATURE REVIEWS IMMUNOLOGY			English	Review							FUNCTIONAL GASTROINTESTINAL DISORDERS; ALTERED RECTAL PERCEPTION; SERINE-PROTEASE ACTIVITY; PLACEBO-CONTROLLED TRIAL; MAST-CELLS; ABDOMINAL-PAIN; VISCERAL PAIN; INTESTINAL INFLAMMATION; COLONIC PERMEABILITY; FECAL MICROBIOTA	Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal disorder that is characterized by abdominal pain and an altered defecation pattern. It affects between 5 and 20% of the general population and can seriously impact quality of life. The pathophysiology of IBS is rather complex and multifactorial including, for example, altered signalling by the gut-brain axis, dysbiosis, abnormal visceral pain signalling and intestinal immune activation. The latter has gained particular interest in recent years, with growing insight into the bidirectional communication between the nervous system and the immune system. In this Review, we detail the current evidence suggesting that immune activation contributes to the pathology seen in patients with IBS and discuss the potential mechanisms involved. Moreover, we describe how immune mediators, particularly those released by mast cells, can directly activate or sensitize pain-transmitting nerves, leading to increased pain signalling and abdominal pain. Finally, we discuss the potential of interventions targeting immune activation as a new therapeutic strategy for patients suffering from IBS.	[Aguilera-Lizarraga, Javier; Hussein, Hind; Boeckxstaens, Guy E.] Katholieke Univ Leuven, Lab Intestinal Neuroimmune Interact, Translat Res Ctr Gastrointestinal Disorders, Dept Chron Dis Metab & Ageing, Leuven, Belgium	KU Leuven	Boeckxstaens, GE (corresponding author), Katholieke Univ Leuven, Lab Intestinal Neuroimmune Interact, Translat Res Ctr Gastrointestinal Disorders, Dept Chron Dis Metab & Ageing, Leuven, Belgium.	guy.boeckxstaens@kuleuven.be		Aguilera-Lizarraga, Javier/0000-0002-8135-9933; Hussein, Hind/0000-0001-6309-8242	FWO postdoctoral fellowship [12X9820N]; European Research Council (ERC) [833816-NEUMACS]; KU Leuven internal funding grant C1 [C14/18/086]	FWO postdoctoral fellowship(FWO); European Research Council (ERC)(European Research Council (ERC)European Commission); KU Leuven internal funding grant C1	J.A.-L. is supported by a FWO postdoctoral fellowship (12X9820N). G.E.B. is funded by the European Research Council (ERC) Advanced Grant (833816-NEUMACS) and the KU Leuven internal funding grant C1 (C14/18/086).	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Aguilera-Lizarraga J., 2019, NEUROGASTROENT MOTIL, V31; Aguilera-Lizarraga J, 2021, NATURE, V590, P151, DOI 10.1038/s41586-020-03118-2; Albert-Bayo M, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020135; Amadesi S, 2004, J NEUROSCI, V24, P4300, DOI 10.1523/JNEUROSCI.5679-03.2004; Annahazi A, 2013, AM J GASTROENTEROL, V108, P1322, DOI 10.1038/ajg.2013.152; Balemans D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12618-7; Barbara G, 2004, GASTROENTEROLOGY, V126, P693, DOI 10.1053/j.gastro.2003.11.055; Barbara G, 2007, GASTROENTEROLOGY, V132, P26, DOI 10.1053/j.gastro.2006.11.039; Barbara G, 2016, GUT, V65, P82, DOI 10.1136/gutjnl-2014-308188; Barrett JS, 2010, ALIMENT PHARM THER, V31, P874, DOI 10.1111/j.1365-2036.2010.04237.x; Bashashati M, 2018, NEUROGASTROENT MOTIL, V30, DOI 10.1111/nmo.13192; Bashashati M, 2014, NEUROGASTROENT MOTIL, V26, P1036, DOI 10.1111/nmo.12358; Batemans D, 2019, AM J PHYSIOL-GASTR L, V316, pG338, DOI 10.1152/ajpgi.00116.2018; Bennet SMP, 2018, NEUROGASTROENT MOTIL, V30, DOI 10.1111/nmo.13468; Bennet SMP, 2016, AM J GASTROENTEROL, V111, P1165, DOI 10.1038/ajg.2016.223; Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; Black CJ, 2020, GUT, V69, P74, DOI 10.1136/gutjnl-2018-318160; Bohn L, 2013, AM J GASTROENTEROL, V108, P634, DOI 10.1038/ajg.2013.105; Botschuijver S, 2017, GASTROENTEROLOGY, V153, P1026, DOI 10.1053/j.gastro.2017.06.004; Boue J, 2014, GASTROENTEROLOGY, V146, P166, DOI 10.1053/j.gastro.2013.09.020; Bouziat R, 2017, SCIENCE, V356, P44, DOI 10.1126/science.aah5298; Brierley SM, 2004, GASTROENTEROLOGY, V127, P166, DOI 10.1053/j.gastro.2004.04.008; Brierley SM, 2014, NAT REV GASTRO HEPAT, V11, P611, DOI 10.1038/nrgastro.2014.103; Brizuela M, 2021, AM J PHYSIOL-GASTR L, V320, pG1131, DOI 10.1152/ajpgi.00331.2020; Brookes SJH, 2013, NAT REV GASTRO HEPAT, V10, P286, DOI 10.1038/nrgastro.2013.29; Buhner S, 2009, GASTROENTEROLOGY, V137, P1425, DOI 10.1053/j.gastro.2009.07.005; Camilleri M, 2021, JAMA-J AM MED ASSOC, V325, P865, DOI 10.1001/jama.2020.22532; Caminero A, 2019, NAT REV GASTRO HEPAT, V16, P7, DOI 10.1038/s41575-018-0064-z; Castagliuolo I, 1996, AM J PHYSIOL-GASTR L, V271, pG884, DOI 10.1152/ajpgi.1996.271.5.G884; Cenac N, 2007, J CLIN INVEST, V117, P636, DOI 10.1172/JCI29255; Cenac N, 2010, GUT, V59, P481, DOI 10.1136/gut.2009.192567; Chiu IM, 2012, NAT NEUROSCI, V15, P1063, DOI 10.1038/nn.3144; Cibert-Goton V, 2021, CLIN TRANSL GASTROEN, V12, DOI 10.14309/ctg.0000000000000313; Coughlan S, 2021, GUT MICROBES, V13, DOI 10.1080/19490976.2021.1887719; Cremon C, 2011, AM J GASTROENTEROL, V106, P1290, DOI 10.1038/ajg.2011.86; da Fonseca DM, 2015, CELL, V163, P354, DOI 10.1016/j.cell.2015.08.030; Dai Y, 2007, J CLIN INVEST, V117, P1979, DOI 10.1172/JCI30951; Dothel G, 2015, GASTROENTEROLOGY, V148, P1002, DOI 10.1053/j.gastro.2015.01.042; DROSSMAN DA, 1993, DIGEST DIS SCI, V38, P1569, DOI 10.1007/BF01303162; Dunlop SP, 2006, AM J GASTROENTEROL, V101, P1288, DOI 10.1111/j.1572-0241.2006.00672.x; Dunlop SP, 2003, ALIMENT PHARM THER, V18, P77, DOI 10.1046/j.1365-2036.2003.01640.x; Esquerre N, 2019, CELL MOL GASTROENTER, V7, P185, DOI 10.1016/j.jcmgh.2018.09.012; Faria AMC, 2005, IMMUNOL REV, V206, P232, DOI 10.1111/j.0105-2896.2005.00280.x; Feng B, 2011, AM J PHYSIOL-GASTR L, V300, pG170, DOI 10.1152/ajpgi.00406.2010; Ford AC, 2020, LANCET, V396, P1675, DOI 10.1016/S0140-6736(20)31548-8; Ford AC, 2018, ALIMENT PHARM THER, V48, P1044, DOI 10.1111/apt.15001; Fritscher-Ravens A, 2019, GASTROENTEROLOGY, V157, P109, DOI 10.1053/j.gastro.2019.03.046; Fritscher-Ravens A, 2014, GASTROENTEROLOGY, V147, P1012, DOI 10.1053/j.gastro.2014.07.046; Frossard CP, 2015, CLIN EXP IMMUNOL, V180, P118, DOI 10.1111/cei.12561; Frost F, 2019, GUT, V68, P1131, DOI 10.1136/gutjnl-2018-316502; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Gecse K, 2008, GUT, V57, P591, DOI 10.1136/gut.2007.140210; Gold MS, 2010, NAT MED, V16, P1248, DOI 10.1038/nm.2235; Grant AD, 2007, J PHYSIOL-LONDON, V578, P715, DOI 10.1113/jphysiol.2006.121111; Green DP, 2019, NEURON, V101, P412, DOI 10.1016/j.neuron.2019.01.012; Greger JL, 1997, CRIT REV CL LAB SCI, V34, P439, DOI 10.3109/10408369709006422; Grundy L, 2019, ANNU REV PHYSIOL, V81, P261, DOI 10.1146/annurev-physiol-020518-114525; Gwee KA, 1999, GUT, V44, P400, DOI 10.1136/gut.44.3.400; Hadizadeh F, 2018, GUT, V67, P778, DOI 10.1136/gutjnl-2017-314792; Hammad H, 2015, IMMUNITY, V43, P29, DOI 10.1016/j.immuni.2015.07.007; Hanning N, 2021, THER ADV GASTROENTER, V14, DOI 10.1177/1756284821993586; Hepworth MR, 2012, GUT MICROBES, V3, P476, DOI 10.4161/gmic.21507; HIATT RB, 1962, AM J GASTROENTEROL, V37, P541; Hockley JRF, 2019, GUT, V68, P633, DOI 10.1136/gutjnl-2017-315631; Hucho T, 2007, NEURON, V55, P365, DOI 10.1016/j.neuron.2007.07.008; Hugerth LW, 2020, GUT, V69, P1076, DOI 10.1136/gutjnl-2019-318717; Hughes PA, 2009, GUT, V58, P1333, DOI 10.1136/gut.2008.170811; Hughes PA, 2013, GUT, V62, P1456, DOI 10.1136/gutjnl-2011-301856; Iliev ID, 2009, GUT, V58, P1481, DOI 10.1136/gut.2008.175166; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Jalanka J, 2021, J NEUROGASTROENTEROL, V27, P279, DOI 10.5056/jnm20205; Jeffery IB, 2012, GUT, V61, P997, DOI 10.1136/gutjnl-2011-301501; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Jiang W, 2011, GUT, V60, P281, DOI 10.1136/gut.2010.229799; Jimenez-Vargas NN, 2018, P NATL ACAD SCI USA, V115, pE7438, DOI 10.1073/pnas.1721891115; Jones MP, 2014, ALIMENT PHARM THER, V40, P382, DOI 10.1111/apt.12846; Junker Y, 2012, J EXP MED, V209, P2395, DOI 10.1084/jem.20102660; Kassinen A, 2007, GASTROENTEROLOGY, V133, P24, DOI 10.1053/j.gastro.2007.04.005; Kempuraj D, 2004, ENDOCRINOLOGY, V145, P43, DOI 10.1210/en.2003-0805; Khoshbin K, 2021, GASTROENTEROLOGY, V161, P463, DOI 10.1053/j.gastro.2021.04.020; Klem F, 2017, GASTROENTEROLOGY, V152, P1042, DOI 10.1053/j.gastro.2016.12.039; Klooker TK, 2010, GUT, V59, P1213, DOI 10.1136/gut.2010.213108; Krystel-Whittemore M, 2016, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00620; Lam C, 2016, GUT, V65, P91, DOI 10.1136/gutjnl-2015-309122; Larauche M, 2012, EXP NEUROL, V233, P49, DOI 10.1016/j.expneurol.2011.04.020; LEMBO T, 1994, GASTROENTEROLOGY, V107, P1686, DOI 10.1016/0016-5085(94)90809-5; Liew FY, 2016, NAT REV IMMUNOL, V16, P676, DOI 10.1038/nri.2016.95; Linley JE, 2010, PFLUG ARCH EUR J PHY, V459, P657, DOI 10.1007/s00424-010-0784-6; Lobo B, 2017, UNITED EUR GASTROENT, V5, P887, DOI 10.1177/2050640617691690; Lovell RM, 2012, CLIN GASTROENTEROL H, V10, P712, DOI 10.1016/j.cgh.2012.02.029; Lyte M, 2014, ADV EXP MED BIOL, V817, P3, DOI 10.1007/978-1-4939-0897-4_1; Ma HT, 2021, J LEUKOCYTE BIOL, V109, P339, DOI 10.1002/JLB.3RU0220-111; Major G, 2017, GASTROENTEROLOGY, V152, P124, DOI 10.1053/j.gastro.2016.09.062; Mars RAT, 2020, CELL, V182, P1460, DOI 10.1016/j.cell.2020.08.007; Matricon J, 2012, ALIMENT PHARM THER, V36, P1009, DOI 10.1111/apt.12080; McGuire C, 2018, GUT, V67, P86, DOI 10.1136/gutjnl-2016-311629; McNeil BD, 2015, NATURE, V519, P237, DOI 10.1038/nature14022; Mearin Fermin, 2016, Gastroenterology, DOI 10.1053/j.gastro.2016.02.031; Meixiong J, 2019, IMMUNITY, V50, P1163, DOI 10.1016/j.immuni.2019.03.013; MERTZ H, 1995, GASTROENTEROLOGY, V109, P40, DOI 10.1016/0016-5085(95)90267-8; Mihindukulasuriya KA, 2021, GASTROENTEROLOGY, V161, P1194, DOI 10.1053/j.gastro.2021.06.077; Nakajima S, 2020, ALLERGOL INT, V69, P197, DOI 10.1016/j.alit.2020.01.001; O'Toole PW, 2021, GASTROENTEROLOGY, V160, P15, DOI 10.1053/j.gastro.2020.10.023; Odenwald MA, 2017, NAT REV GASTRO HEPAT, V14, P9, DOI 10.1038/nrgastro.2016.169; Pattison LA, 2021, PAIN, V162, P714, DOI 10.1097/j.pain.0000000000002174; Pearson JS, 2015, THER ADV GASTROENTER, V8, P270, DOI 10.1177/1756283X15588875; Piche T, 2009, GUT, V58, P196, DOI 10.1136/gut.2007.140806; Pimentel M, 2011, NEW ENGL J MED, V364, P22, DOI 10.1056/NEJMoa1004409; Pittayanon R, 2019, GASTROENTEROLOGY, V157, P97, DOI 10.1053/j.gastro.2019.03.049; Posserud I, 2007, GASTROENTEROLOGY, V133, P1113, DOI 10.1053/j.gastro.2007.07.024; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Qin HY, 2014, WORLD J GASTROENTERO, V20, P14126, DOI 10.3748/wjg.v20.i39.14126; Redegeld FA, 2018, IMMUNOL REV, V282, P87, DOI 10.1111/imr.12629; RITCHIE J, 1973, GUT, V14, P125, DOI 10.1136/gut.14.2.125; Roka R, 2007, CLIN GASTROENTEROL H, V5, P550, DOI 10.1016/j.cgh.2006.12.004; Rolland-Fourcade C, 2017, GUT, V66, P1767, DOI 10.1136/gutjnl-2016-312094; Rothenberg ME, 2021, NEW ENGL J MED, V384, P2156, DOI 10.1056/NEJMcibr2104146; Schoepfer AM, 2008, NEUROGASTROENT MOTIL, V20, P1110, DOI 10.1111/j.1365-2982.2008.01166.x; Shanahan F, 2021, GASTROENTEROLOGY, V160, P483, DOI 10.1053/j.gastro.2020.09.057; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Shen TC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153911; Simren M, 2018, GUT, V67, P255, DOI 10.1136/gutjnl-2016-312361; Soderholm JD, 2002, GASTROENTEROLOGY, V123, P1099, DOI 10.1053/gast.2002.36019; Spiller RC, 2000, GUT, V47, P804, DOI 10.1136/gut.47.6.804; Staudacher HM, 2017, GUT, V66, P1517, DOI 10.1136/gutjnl-2017-313750; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Tooth D, 2014, GUT, V63, P753, DOI 10.1136/gutjnl-2012-304042; Tornblom H, 2014, GUT, V63, P1441, DOI 10.1136/gutjnl-2013-305853; Tulic MK, 2016, GUT, V65, P757, DOI 10.1136/gutjnl-2015-310523; Valdez-Morales EE, 2013, AM J GASTROENTEROL, V108, P1634, DOI 10.1038/ajg.2013.241; van den Wijngaard RM, 2009, NEUROGASTROENT MOTIL, V21, DOI 10.1111/j.1365-2982.2009.01339.x; van Wanrooij SJM, 2014, AM J GASTROENTEROL, V109, P99, DOI 10.1038/ajg.2013.371; Vergnolle N, 2005, GUT, V54, P867, DOI 10.1136/gut.2004.048876; Vergnolle N, 2001, TRENDS PHARMACOL SCI, V22, P146, DOI 10.1016/S0165-6147(00)01634-5; Vervier K, 2021, GUT, DOI 10.1136/gutjnl-2021-325177; Vicario M, 2015, GUT, V64, P1379, DOI 10.1136/gutjnl-2013-306236; Vivinus-Nebot M, 2012, AM J GASTROENTEROL, V107, P75, DOI 10.1038/ajg.2011.315; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; WHITEHEAD WE, 1990, GASTROENTEROLOGY, V98, P1187, DOI 10.1016/0016-5085(90)90332-U; Wilcz-Villega EM, 2013, AM J GASTROENTEROL, V108, P1140, DOI 10.1038/ajg.2013.92; Wouters MM, 2016, GASTROENTEROLOGY, V150, P875, DOI 10.1053/j.gastro.2015.12.034; Xu DB, 2019, AM J GASTROENTEROL, V114, P1043, DOI 10.14309/ajg.0000000000000198; Yoo BB, 2017, IMMUNITY, V46, P910, DOI 10.1016/j.immuni.2017.05.011; Yu W, 2016, NAT REV IMMUNOL, V16, P751, DOI 10.1038/nri.2016.111; Yu YB, 2012, GUT, V61, P685, DOI 10.1136/gutjnl-2011-300265; Zevallos VF, 2017, GASTROENTEROLOGY, V152, P1100, DOI 10.1053/j.gastro.2016.12.006; Zhou SY, 2018, J CLIN INVEST, V128, P267, DOI 10.1172/JCI92390	149	5	5	3	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2022	22	11					674	686		10.1038/s41577-022-00700-9	http://dx.doi.org/10.1038/s41577-022-00700-9		MAR 2022	13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	5U0ZY	35296814				2022-12-18	WOS:000769828300002
J	Mohammed, A; Tomori, O; Nkengasong, JN				Mohammed, Abdulaziz; Tomori, Oyewale; Nkengasong, John N.			Lessons from the elimination of poliomyelitis in Africa	NATURE REVIEWS IMMUNOLOGY			English	Article							NATIONAL STOP TRANSMISSION; POLIO ERADICATION; NORTHERN NIGERIA; PROGRAM; INFRASTRUCTURE; VACCINATION; LEGACY; TRUST	In August 2020, Africa was declared free of poliomyelitis (polio), bringing to fruition a goal that took more than 30 years to achieve. This Perspective chronicles global, continental, national and community actions taken by diverse stakeholders that finally led to the elimination of transmission of wild poliovirus in Africa. The cascade of events started with the development of polio vaccines and the realization that polio, much like smallpox, could be eradicated. After a 1988 pledge by the World Health Assembly to eradicate polio globally, concerted and deliberate efforts were made in Africa to achieve this goal. This included the use of evidence-based approaches for the harmonization and standardization of public health strategies, using a network of polio laboratories and emergency operation centres and actively pursuing underserved populations. Innovative solutions to counter challenges such as conflict and vaccine hesitancy may be of use in future public health interventions.	[Mohammed, Abdulaziz; Nkengasong, John N.] Africa Ctr Dis Control & Prevent, Addis Ababa, Ethiopia; [Tomori, Oyewale] Redeemers Univ, Ede, Nigeria	Redeemers University	Nkengasong, JN (corresponding author), Africa Ctr Dis Control & Prevent, Addis Ababa, Ethiopia.	nkengasongJ@africa-union.org	TOMORI, OYEWALE/GWQ-4419-2022	TOMORI, OYEWALE/0000-0002-6959-5749				Africa CDC, 2020, REG INT SURV LAB NET; Asghar H, 2014, J INFECT DIS, V210, pS294, DOI 10.1093/infdis/jiu384; Chen Cecilia, 2004, Afr Health Sci, V4, P205; College of Physicians Philadelphia, 2021, HIST VACC; Craig AS, 2017, J INFECT DIS, V216, pS343, DOI 10.1093/infdis/jix034; Deressa W, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09879-9; Diop OM, 2017, J INFECT DIS, V216, pS299, DOI 10.1093/infdis/jix092; Duru JI, 2019, AM J TROP MED HYG, V101, P74, DOI 10.4269/ajtmh.19-0068; El-Kebisy, 2013, AL JAZEERA; Ester Pablo Viguera, 2011, J Public Health Afr, V2, pe27, DOI 10.4081/jphia.2011.e27; Gidado SO, 2014, J INFECT DIS, V210, pS118, DOI 10.1093/infdis/jiu197; Global Polio Eradication Initiative, 2019, OUTBR PREP RESP STRA; Global Polio Eradication Initiative, 2020, NOV OR POL VACC TYP; Global Polio Eradication Initiative, 2018, THES PLAC PROV OUR B; Global Polio Eradication Initiative, VIRUS-JAPAN; Global Polio Eradication Initiative, 2020, HIST POL; Global Polio Eradication Initiative, 2020, GLOB POL LAB NETW; GPEI, 2020, GLOBAL POLIO ERADICA; GPEI, 2017, EXP SOC MOB APPR PRO; Gumede N, 2016, VACCINE, V34, P5164, DOI 10.1016/j.vaccine.2016.05.055; Haddison EC, 2018, VACCINE, V36, P6961, DOI 10.1016/j.vaccine.2018.10.004; Hagen J. E., 2015, MMWR; Hampton L, 2009, AM J PUBLIC HEALTH, V99, P34, DOI 10.2105/AJPH.2007.117952; Haydarov RAS., 2016, GLOB HLTH COMMUN, V2, P11, DOI [10.1080/23762004.2016.1205890, DOI 10.1080/23762004.2016.1205890]; HEYMANN DL, 1983, B WORLD HEALTH ORGAN, V61, P501; Higgins J, 2019, INT J HEALTH GEOGR, V18, DOI 10.1186/s12942-019-0175-y; Khan F, 2018, MMWR-MORBID MORTAL W, V67, P524, DOI 10.15585/mmwr.mm6718a4; Michael CA, 2017, J INFECT DIS, V216, pS373, DOI 10.1093/infdis/jix014; Mohammed Abdulaziz, 2014, Pan Afr Med J, V18 Suppl 1, P10, DOI 10.11694/pamj.supp.2014.18.1.4187; Nasir UN, 2016, HUM VACC IMMUNOTHER, V12, P658, DOI 10.1080/21645515.2015.1088617; Nasiru SG, 2012, PATHOG GLOB HEALTH, V106, P166, DOI 10.1179/2047773212Y.0000000018; Nkwogu L, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6188-9; Obadare E, 2005, PATTERNS PREJUDICE, V39, P265, DOI 10.1080/00313220500198185; OFOSUAMAAH S, 1977, BRIT MED J, V1, P1012, DOI 10.1136/bmj.1.6067.1012; SABIN AB, 1980, B WORLD HEALTH ORGAN, V58, P141; Sever JL, 2017, J INFECT DIS, V216, pS355, DOI 10.1093/infdis/jiw556; Talisuna A, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001312; Tegegne AA, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-017-2904-9; Thuriaux M C, 1982, Trop Geogr Med, V34, P163; UNICEF, 2002, DESP CONFL HORN AFR; US CDC, 2013, CDC GLOB POL ER IN; Usman S, 2019, AM J TROP MED HYG, V101, P68, DOI 10.4269/ajtmh.19-0143; Vaz RG, 2016, J INFECT DIS, V213, pS140, DOI 10.1093/infdis/jiv581; Waziri NE, 2014, J INFECT DIS, V210, pS111, DOI 10.1093/infdis/jiu199; World Health Organization, 2017, REP 23 INF CONS GLOB; World Health Organization, 2020, FRAM PUBL HLTH EM OP; World Health Organization, 2017, POL VACC DER POL; World Health Organization, 2004, KAN STAT NIG FULL EN; World Health Organization, 2020, WHO AFR HLTH TOP POL; World Health Organization, 2015, WHO CALL RET DECL AL; World Health Organization, 2010, SMALLP ER PROGR SEP; World Health Organization, 2020, POLIO; World Health Organization, 2019, POL	53	5	5	0	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2021	21	12					822	827		10.1038/s41577-021-00640-w	http://dx.doi.org/10.1038/s41577-021-00640-w		OCT 2021	6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XD3NF	34697501	Green Published, Bronze			2022-12-18	WOS:000710814500001
J	Brown, M; Bhardwaj, N				Brown, Matthew; Bhardwaj, Nina			Super(antigen) target for SARS-CoV-2	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material									[Brown, Matthew; Bhardwaj, Nina] Icahn Sch Med Mt Sinai, OxMS Preprint Journal Club, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Brown, M (corresponding author), Icahn Sch Med Mt Sinai, OxMS Preprint Journal Club, New York, NY 10029 USA.							Brown M, 2020, OXFORD MOUNT SINAI O; Cheng Mary Hongying, 2020, bioRxiv, DOI [10.1016/j.str.2021.04.005, 10.1101/2020.11.24.395079]	2	5	7	2	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2021	21	2					72	72		10.1038/s41577-021-00502-5	http://dx.doi.org/10.1038/s41577-021-00502-5		JAN 2021	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QB3OS	33432128	Green Published, Bronze			2022-12-18	WOS:000607043300005
J	Bird, L				Bird, Lucy			Microbial metabolite boosts immunotherapy	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material																		Mager LF, 2020, SCIENCE, V369, P1481, DOI 10.1126/science.abc3421	1	5	5	1	5	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2020	20	11					648	649						2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OI7ET	33024282				2022-12-18	WOS:000583437900010
J	Bird, L				Bird, Lucy			Microbial metabolite boosts immunotherapy	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material; Early Access								Microbial metabolite inosine improves antitumour responses to immune checkpoint blockade therapy.				l.bird@nature.com						Mager LF, 2020, SCIENCE, V369, P1481, DOI 10.1126/science.abc3421	1	5	5	1	5	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.												10.1038/s41577-020-00465-z	http://dx.doi.org/10.1038/s41577-020-00465-z		OCT 2020	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NX5KO	33024282				2022-12-18	WOS:000575750000002
J	Wang, QL; Colonna, M				Wang, Qianli; Colonna, Marco			Keeping time in group 3 innate lymphoid cells	NATURE REVIEWS IMMUNOLOGY			English	Article							REV-ERB-ALPHA; ROR-GAMMA-T; PERIPHERAL-TISSUES; CYTOLYTIC FACTORS; METABOLISM; MICROBIOTA; RHYTHMS; IDENTIFICATION; TRANSCRIPTION; FUCOSYLATION	In this Progress article, Wang and Colonna highlight a flurry of recent reports that have shaped our understanding of how environmental cues and clock genes regulate group 3 innate lymphoid cells. They consider the implications of these findings for intestinal immunity. Each day, the gastrointestinal tract encounters an influx of microbial and nutrient-derived signals and its physiological activities often adhere to a circadian rhythm. As such, group 3 innate lymphoid cells (ILC3s) that reside in the intestinal mucosa must function within a highly dynamic environment. In this Progress article, we highlight a series of recent reports that have characterized the circadian clock in ILC3s. We discuss how these studies have illustrated the roles of environmental cues and clock genes in regulating ILC3 biology and consider the implications for intestinal immunity.	[Wang, Qianli; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	mcolonna@wustl.edu		Colonna, Marco/0000-0001-5222-4987; Wang, Qianli/0000-0002-9042-9622	National Institutes of Health (NIH) [AI095542, DE025884, AI134236, AI134035, T32 GM007200]; Pfizer; Crohn's & Colitis Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); Crohn's & Colitis Foundation	The authors thank S. Gilfillan and B. Bhattarai for helpful feedback. This work was supported by National Institutes of Health (NIH) grants AI095542, DE025884, AI134236 and AI134035 (to M.C.) and T32 GM007200 (to Q.W.). M.C. receives research support from Pfizer, Crohn's & Colitis Foundation and an anonymous donor in New York.	Aparicio-Domingo P, 2015, J EXP MED, V212, P1783, DOI 10.1084/jem.20150318; Arjona A, 2005, J IMMUNOL, V174, P7618, DOI 10.4049/jimmunol.174.12.7618; Asher G, 2015, CELL, V161, P84, DOI 10.1016/j.cell.2015.03.015; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Bechtold DA, 2013, TRENDS NEUROSCI, V36, P74, DOI 10.1016/j.tins.2012.12.007; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Duez H, 2008, GASTROENTEROLOGY, V135, P689, DOI 10.1053/j.gastro.2008.05.035; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Godinho-Silva C, 2019, NATURE, V574, P254, DOI 10.1038/s41586-019-1579-3; Goto Y, 2014, SCIENCE, V345, P1310, DOI 10.1126/science.1254009; He WY, 2018, IMMUNITY, V49, P1175, DOI 10.1016/j.immuni.2018.10.007; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Iwasaki Mari, 2019, F1000Res, V8, DOI 10.12688/f1000research.18039.1; Kim HY, 2014, NAT MED, V20, P54, DOI 10.1038/nm.3423; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kuang Z, 2019, SCIENCE, V365, P1428, DOI 10.1126/science.aaw3134; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; Logan RW, 2013, J INTERF CYTOK RES, V33, P108, DOI 10.1089/jir.2012.0092; Manoogian ENC, 2017, AGEING RES REV, V39, P59, DOI 10.1016/j.arr.2016.12.006; Mao KR, 2018, NATURE, V554, P255, DOI 10.1038/nature25437; Mendoza J, 2008, J PHYSIOL-LONDON, V586, P5901, DOI 10.1113/jphysiol.2008.159566; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Nakagawa T, 2016, J MED MICROBIOL, V65, P821, DOI 10.1099/jmm.0.000273; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; Pham TAN, 2014, CELL HOST MICROBE, V16, P504, DOI 10.1016/j.chom.2014.08.017; Pickard JM, 2014, NATURE, V514, P638, DOI 10.1038/nature13823; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Rankin LC, 2013, NAT IMMUNOL, V14, P389, DOI 10.1038/ni.2545; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Saleh MM, 2019, CELL HOST MICROBE, V25, P756, DOI 10.1016/j.chom.2019.03.003; Santori FR, 2015, CELL METAB, V21, P286, DOI 10.1016/j.cmet.2015.01.004; Sasaki T, 2019, CELL REP, V28, P202, DOI 10.1016/j.celrep.2019.06.016; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Savage AK, 2017, J IMMUNOL, V199, P1912, DOI 10.4049/jimmunol.1700155; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Seillet C, 2020, NAT IMMUNOL, V21, P168, DOI 10.1038/s41590-019-0567-y; Sengupta S, 2016, FREE RADICAL BIO MED, V93, P177, DOI 10.1016/j.freeradbiomed.2016.02.004; Seshadri S, 2018, J IMMUNOL, V201, P1267, DOI 10.4049/jimmunol.1800484; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Sitaula S, 2017, BIOCHEM PHARMACOL, V131, P68, DOI 10.1016/j.bcp.2017.02.006; Song C, 2015, J EXP MED, V212, P1869, DOI 10.1084/jem.20151403; Soroosh P, 2014, P NATL ACAD SCI USA, V111, P12163, DOI 10.1073/pnas.1322807111; Talbot J, 2020, NATURE, V579, P575, DOI 10.1038/s41586-020-2039-9; Teng F, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aax1215; Thaiss CA, 2016, CELL, V167, P1495, DOI 10.1016/j.cell.2016.11.003; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Wang QL, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aay7501; Wang YH, 2017, SCIENCE, V357, P913, DOI 10.1126/science.aan0677; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213; Yu H, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00037-17; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	65	5	5	2	13	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2020	20	12					720	726		10.1038/s41577-020-0397-z	http://dx.doi.org/10.1038/s41577-020-0397-z		AUG 2020	7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OV9YZ	32759971				2022-12-18	WOS:000556148600001
J	Vabret, N				Vabret, Nicolas			Preclinical data from SARS-CoV-2 mRNA vaccine	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material; Early Access									[Vabret, Nicolas] Icahn Sch Med Mt Sinai, Sinai Immunol Review Project, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Vabret, N (corresponding author), Icahn Sch Med Mt Sinai, Sinai Immunol Review Project, New York, NY 10029 USA.	sinai.immunology@gmail.com						Corbett Kizzmekia S, 2020, bioRxiv, DOI [10.1038/s41586-020-2622-0, 10.1101/2020.06.11.145920]	1	5	5	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.												10.1038/s41577-020-0377-3	http://dx.doi.org/10.1038/s41577-020-0377-3		JUN 2020	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MA7WP	32572246	Green Published, Bronze			2022-12-18	WOS:000542123000002
J	Villanueva, MT				Villanueva, M. Teresa			Macrophages get a CAR	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material								Macrophages equipped with chimeric antigen receptors (CARs) show promise in mouse models of solid tumours.				t.villanueva@nature.com						Klichinsky M, 2020, NAT BIOTECHNOL, V38, P947, DOI 10.1038/s41587-020-0462-y	1	5	5	5	14	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2020	20	5					273	273		10.1038/s41577-020-0302-9	http://dx.doi.org/10.1038/s41577-020-0302-9		APR 2020	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LI8WW	32251377	Bronze			2022-12-18	WOS:000523950300001
J	Bordon, Y				Bordon, Yvonne			A microbial trigger for colitis	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material														Bordon, Yvonne/0000-0002-9728-012X				Caruso R, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw4341	1	5	5	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2019	19	6					350	+		10.1038/s41577-019-0175-y	http://dx.doi.org/10.1038/s41577-019-0175-y			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IA3GU	31068684				2022-12-18	WOS:000469452300003
J	Bordon, Y				Bordon, Yvonne			Trans-Golgi network breaks away to activate NLRP3	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material														Bordon, Yvonne/0000-0002-9728-012X					0	5	5	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2019	19	2					68	69		10.1038/s41577-018-0111-6	http://dx.doi.org/10.1038/s41577-018-0111-6			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HJ4PH	30602732				2022-12-18	WOS:000457155400003
J	Mathis, D				Mathis, Diane			Organismal immunometabolism: advances in both directions	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material								Immunometabolism is a relatively new field, first cited on PubMed in 2011. It is also a field that is increasingly 'en vogue', with over 200 PubMed citations so far in 2018. Since its beginning, the field of immuno-metabolism has been operating on two different planes: one set of investigators works at the organismal level, studying interactions between the immune and metabolic systems; a second set operates at the cellular level, examining metabolic aspects of immunocytes. The focus here is on organismal immunometabolism. One topic related to the control of metabolism by the immune system and, conversely, one concerning metabolic control of the immune system will be highlighted.	[Mathis, Diane] Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Mathis, D (corresponding author), Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA.	dm@hms.harvard.edu			JPB Foundation; NIH [DK092541]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092541] Funding Source: NIH RePORTER	JPB Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	D.M. is supported by the JPB Foundation and by the NIH (DK092541).	DiSpirito JR, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat5861; Hotamisligil GS, 2017, IMMUNITY, V47, P406, DOI 10.1016/j.immuni.2017.08.009; Kohlgruber AC, 2018, NAT IMMUNOL, V19, P464, DOI 10.1038/s41590-018-0094-2; Li CR, 2018, CELL, V174, P285, DOI 10.1016/j.cell.2018.05.004; McQuade JL, 2018, LANCET ONCOL, V19, P310, DOI 10.1016/S1470-2045(18)30078-0; Michelet X, 2018, NAT IMMUNOL, V19, P1330, DOI 10.1038/s41590-018-0251-7; Park J, 2014, NAT REV ENDOCRINOL, V10, P455, DOI 10.1038/nrendo.2014.94; Ricardo-Gonzalez RR, 2018, NAT IMMUNOL, V19, P1093, DOI 10.1038/s41590-018-0201-4; Wang ZM, 2019, NAT MED, V25, P141, DOI 10.1038/s41591-018-0221-5	9	5	5	2	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2019	19	2					83	84		10.1038/s41577-018-0118-z	http://dx.doi.org/10.1038/s41577-018-0118-z			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HJ4PH	30635620				2022-12-18	WOS:000457155400013
J	Harding, SD; Faccenda, E; Southan, C; Maffia, P; Davies, JA				Harding, Simon D.; Faccenda, Elena; Southan, Chris; Maffia, Pasquale; Davies, Jamie A.			A NEW GUIDE TO IMMUNOPHARMACOLOGY	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material									[Harding, Simon D.; Faccenda, Elena; Southan, Chris; Davies, Jamie A.] Univ Edinburgh, Deanery Biomed Sci, Edinburgh, Midlothian, Scotland; [Maffia, Pasquale] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland	University of Edinburgh; University of Glasgow	Harding, SD (corresponding author), Univ Edinburgh, Deanery Biomed Sci, Edinburgh, Midlothian, Scotland.		Davies, Jamie/AAE-7111-2019; HARDING, SIMON/ABF-7652-2020	Davies, Jamie/0000-0001-6660-4032; HARDING, SIMON/0000-0002-9262-8318; Faccenda, Elena/0000-0001-9855-7103; Southan, Christopher/0000-0001-9580-0446				Harding SD, 2018, NUCLEIC ACIDS RES, V46, pD1091, DOI 10.1093/nar/gkx1121	1	5	5	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2018	18	12					729	729		10.1038/s41577-018-0079-2	http://dx.doi.org/10.1038/s41577-018-0079-2			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HB6WR	30327546	Bronze			2022-12-18	WOS:000451214700004
J	Bird, L				Bird, Lucy			Statins as adjuvants	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material														Bird, Lucy/0000-0002-3914-6045					0	5	5	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2018	18	11					669	669		10.1038/s41577-018-0076-5	http://dx.doi.org/10.1038/s41577-018-0076-5			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GY2WG	30297717	Bronze			2022-12-18	WOS:000448404500010
J	Divangahi, M				Divangahi, Maziar			Are tolerance and training required to end TB?	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material							IMMUNITY; TUBERCULOSIS	Host defence strategies against Mycobacterium tuberculosis (Mtb), the bacterium that causes tuberculosis (TB), include host resistance and disease tolerance. To date, most studies have focused on resistance mechanisms, but developing new strategies to eradicate Mtb will require an understanding of the entire landscape of immunity in TB. Here I discuss two evolutionarily conserved host defence strategies, disease tolerance and trained immunity (memory-like innate immune responses), and their role in Mtb infection.	[Divangahi, Maziar] McGill Univ, McGill Int TB Ctr, Meakins Christie Labs, Dept Med, Montreal, PQ, Canada; [Divangahi, Maziar] McGill Univ, McGill Int TB Ctr, Meakins Christie Labs, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Divangahi, Maziar] McGill Univ, McGill Int TB Ctr, Meakins Christie Labs, Dept Pathol, Montreal, PQ, Canada; [Divangahi, Maziar] McGill Univ, Ctr Hlth, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University	Divangahi, M (corresponding author), McGill Univ, McGill Int TB Ctr, Meakins Christie Labs, Dept Med, Montreal, PQ, Canada.; Divangahi, M (corresponding author), McGill Univ, McGill Int TB Ctr, Meakins Christie Labs, Dept Microbiol & Immunol, Montreal, PQ, Canada.; Divangahi, M (corresponding author), McGill Univ, McGill Int TB Ctr, Meakins Christie Labs, Dept Pathol, Montreal, PQ, Canada.; Divangahi, M (corresponding author), McGill Univ, Ctr Hlth, Montreal, PQ, Canada.	maziar.divangahi@mcgill.ca			Canadian Institute of Health Research (CIHR) Foundation [FDN-143273]; Fonds de la Recherche du Quebec- Sante (FRQS) Award	Canadian Institute of Health Research (CIHR) Foundation; Fonds de la Recherche du Quebec- Sante (FRQS) Award	This work was supported by the Canadian Institute of Health Research (CIHR) Foundation Grant (FDN-143273) to M.D. and M.D. holds a Fonds de la Recherche du Quebec- Sante (FRQS) Award and the Strauss Chair in Respiratory Diseases.	Cadena AM, 2017, NAT REV IMMUNOL, V17, P691, DOI 10.1038/nri.2017.69; Fleming-Davies AE, 2018, SCIENCE, V359, P1030, DOI 10.1126/science.aao2140; Gieseck RL, 2018, NAT REV IMMUNOL, V18, P62, DOI 10.1038/nri.2017.90; Kaufmann E, 2018, CELL, V172, P176, DOI 10.1016/j.cell.2017.12.031; Mishra BB, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.72; Nemes E, 2018, NEW ENGL J MED, V379, P138, DOI [10.1056/nejmoa1714021, 10.1056/NEJMoa1714021]; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Nunes-Alves C, 2014, NAT REV MICROBIOL, V12, P289, DOI 10.1038/nrmicro3230; Pai M, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.76; Tzelepis F, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar4135	10	5	5	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2018	18	11					661	663		10.1038/s41577-018-0070-y	http://dx.doi.org/10.1038/s41577-018-0070-y			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GY2WG	30267017				2022-12-18	WOS:000448404500001
J	Bordon, Y				Bordon, Yvonne			mtDNA synthesis ignites the inflammasome	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material														Bordon, Yvonne/0000-0002-9728-012X					0	5	5	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2018	18	9					539	539		10.1038/s41577-018-0049-8	http://dx.doi.org/10.1038/s41577-018-0049-8			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR7UI	30072793	Bronze			2022-12-18	WOS:000442900900002
J	Kedl, RM; White, JT				Kedl, Ross M.; White, Jason T.			Foreign antigen-independent memory-phenotype CD4(+) T cells: a new player in innate immunity?	NATURE REVIEWS IMMUNOLOGY			English	Letter									[Kedl, Ross M.] Univ Colorado Denver, Sch Med, Dept Immunol & Microbiol, Anschutz Med Campus, Denver, CO 80204 USA; [White, Jason T.] Univ Melbourne, Peter Doherty Inst, Dept Microbiol & Immunol, Melbourne, Vic, Australia	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Melbourne	Kedl, RM (corresponding author), Univ Colorado Denver, Sch Med, Dept Immunol & Microbiol, Anschutz Med Campus, Denver, CO 80204 USA.	ross.kedl@ucdenver.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066121, R01AI101205, R01AI117918] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI117918, R01 AI066121, R01 AI101205] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Kawabe T., 2018, NAT REV IMMUNOL; Kawabe T, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam9304; Kim KS, 2016, SCIENCE, V351, P858, DOI 10.1126/science.aac5560; White JT, 2017, NAT REV IMMUNOL, V17, P391, DOI 10.1038/nri.2017.34; Younes SA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001171; 2017, NAT REV IMMUNOL, V17, P391	6	5	5	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAR	2018	18	3								10.1038/nri.2018.13	http://dx.doi.org/10.1038/nri.2018.13			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FX5KU	29480288	Bronze, Green Accepted			2022-12-18	WOS:000426118500002
J	Saeys, Y; Van Gassen, S; Lambrecht, B				Saeys, Yvan; Van Gassen, Sofie; Lambrecht, Bart			Response to Orlova et al. "Science not art: statistically sound methods for identifying subsets in multi-dimensional flow and mass cytometry data sets"	NATURE REVIEWS IMMUNOLOGY			English	Letter									[Saeys, Yvan; Van Gassen, Sofie; Lambrecht, Bart] VIB Inflammat Res Ctr, Technol Pk 927, B-9052 Ghent, Belgium	Flanders Institute for Biotechnology (VIB)	Saeys, Y (corresponding author), VIB Inflammat Res Ctr, Technol Pk 927, B-9052 Ghent, Belgium.	yvan.saeys@ugent.be	Saeys, Yvan/C-1311-2009	Saeys, Yvan/0000-0002-0415-1506; Van Gassen, Sofie/0000-0002-7119-5330				Aghaeepour N, 2013, NAT METHODS, V10, P445, DOI [10.1038/nmeth0513-445c, 10.1038/nmeth0513-445e]; Orlova D. Y., 2017, NAT REV IMMUNOL; Saeys Y, 2016, NAT REV IMMUNOL, V16, P449, DOI 10.1038/nri.2016.56; Weber LM, 2016, CYTOM PART A, V89A, P1084, DOI 10.1002/cyto.a.23030; 2016, NAT REV IMMUNOL, V16, P449	5	5	5	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2018	18	1					78	78		10.1038/nri.2017.151	http://dx.doi.org/10.1038/nri.2017.151			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FT0GY	29269765	Bronze			2022-12-18	WOS:000422802500013
J	Bordon, Y				Bordon, Yvonne			TUMOUR IMMUNOLOGY Checkpoint parley	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X					0	5	5	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2015	15	1					6	6		10.1038/nri3792	http://dx.doi.org/10.1038/nri3792			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AX3JJ	25475446	Bronze			2022-12-18	WOS:000346835400006
J	Villanueva, MT				Villanueva, M. Teresa			TUMOUR IMMUNOLOGY The new midfielders in the tumour microenvironment	NATURE REVIEWS IMMUNOLOGY			English	News Item									Nat Reviews Canc, Tokyo, Japan		Villanueva, MT (corresponding author), Nat Reviews Canc, Tokyo, Japan.								0	5	5	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2014	14	12								10.1038/nri3781	http://dx.doi.org/10.1038/nri3781			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU4FW	25421696				2022-12-18	WOS:000345566400006
J	Minton, K				Minton, Kirsty			INFLAMMASOMES Ubiquitin lines up for inflammasome activity	NATURE REVIEWS IMMUNOLOGY			English	News Item														Minton, Kirsty/0000-0002-3857-8030				Rodgers MA, 2014, J EXP MED, V211, P1331, DOI 10.1084/jem.20132486	1	5	6	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2014	14	9					580	580		10.1038/nri3730	http://dx.doi.org/10.1038/nri3730			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO5KL	25086647				2022-12-18	WOS:000341383600002
J	Bird, L				Bird, Lucy			T CELLS IL-9 breaks down barriers	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bird, Lucy/0000-0002-3914-6045					0	5	5	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUL	2014	14	7					433	433		10.1038/nri3709	http://dx.doi.org/10.1038/nri3709			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AL0UB	24948365	Bronze			2022-12-18	WOS:000338841200006
J	Kugelberg, E				Kugelberg, Elisabeth			Mycobacteria hide from TLRs	NATURE REVIEWS IMMUNOLOGY			English	News Item														Kugelberg, Elisabeth/0000-0002-8302-3595				Cambier CJ, 2014, NATURE, V505, P218, DOI 10.1038/nature12799	1	5	5	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2014	14	2					62	63		10.1038/nri3604	http://dx.doi.org/10.1038/nri3604			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA3VI	24378842				2022-12-18	WOS:000331022400003
J	Leavy, O				Leavy, Olive			Diet and airway inflammation	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Kim HY, 2014, NAT MED, V20, P54, DOI 10.1038/nm.3423; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444	2	5	6	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2014	14	2					64	65		10.1038/nri3612	http://dx.doi.org/10.1038/nri3612			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA3VI	24457477	Bronze			2022-12-18	WOS:000331022400006
J	Bordon, Y				Bordon, Yvonne			INFECTIOUS DISEASE Hushing mTOR boosts immunity to pathogens	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X				Ivanov SS, 2013, NAT IMMUNOL, V14, P1219, DOI 10.1038/ni.2740; Keating R, 2013, NAT IMMUNOL, V14, P1266, DOI 10.1038/ni.2741	2	5	5	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2013	13	12					847	847		10.1038/nri3562	http://dx.doi.org/10.1038/nri3562			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	262EU	24189577	Bronze			2022-12-18	WOS:000327717900008
J	Leavy, O				Leavy, Olive			NATURAL KILLER CELLS A virtual pick and mix	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Horowitz A., 2013, SCI TRANSL MED, DOI DOI 10.1126/SCITRANSLMED.3006702	1	5	5	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2013	13	12								10.1038/nri3566	http://dx.doi.org/10.1038/nri3566			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	262EU	24189575				2022-12-18	WOS:000327717900004
J	Stow, JL				Stow, Jennifer L.			COMMENT Nobel Prize discovery paves the way for immunological traffic	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material									Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	University of Queensland	Stow, JL (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	j.stow@imb.uq.edu.au	Stow, Jennifer L/I-4723-2013	Stow, Jennifer L/0000-0002-5409-9101				Boswell KL, 2012, J CELL BIOL, V197, P301, DOI 10.1083/jcb.201109132; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Garg S, 2011, IMMUNITY, V35, P182, DOI 10.1016/j.immuni.2011.06.009; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Itakura E, 2012, CELL, V151, P1256, DOI 10.1016/j.cell.2012.11.001; Murray RZ, 2005, SCIENCE, V310, P1492, DOI 10.1126/science.1120225; Rothman JE, 2002, NAT MED, V8, P1059, DOI 10.1038/nm770; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0	9	5	6	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2013	13	12					830	841		10.1038/nri3564	http://dx.doi.org/10.1038/nri3564			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	262EU	24270771				2022-12-18	WOS:000327717900001
J	Papatriantafyllou, M				Papatriantafyllou, Maria			CYTOKINES True to their family name	NATURE REVIEWS IMMUNOLOGY			English	News Item													Papatriantafyllou, Maria/ADP-1463-2022						0	5	5	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2013	13	8					544	544		10.1038/nri3496	http://dx.doi.org/10.1038/nri3496			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	188TS	23827957				2022-12-18	WOS:000322217500002
J	Minton, K				Minton, Kirsty			Unravelling the motheaten phenotype	NATURE REVIEWS IMMUNOLOGY			English	News Item														Minton, Kirsty/0000-0002-3857-8030				Abram CL, 2013, IMMUNITY, V38, P489, DOI 10.1016/j.immuni.2013.02.018	1	5	5	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2013	13	5								10.1038/nri3450	http://dx.doi.org/10.1038/nri3450			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	132MK	23584421				2022-12-18	WOS:000318072400006
J	Leavy, O				Leavy, Olive			IL-21 promotes B10 cell population expansion	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	5	5	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2012	12	12					808	808		10.1038/nri3346	http://dx.doi.org/10.1038/nri3346			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	042OC	23154223				2022-12-18	WOS:000311479500005
J	Maecker, HT; McCoy, JP; Nussenblatt, R				Maecker, Holden T.; McCoy, J. Philip; Nussenblatt, Robert			Reducing variability in flow cytometry	NATURE REVIEWS IMMUNOLOGY			English	Letter									[Maecker, Holden T.] Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [McCoy, J. Philip; Nussenblatt, Robert] Natl Inst Hlth, Ctr Human Immunol Autoimmun & Inflammat, Bethesda, MD 20892 USA; [McCoy, J. Philip] Natl Heart Lung & Blood Inst, Natl Inst Hlth, Bethesda, MD 20892 USA; [Nussenblatt, Robert] NEI, Natl Inst Hlth, Bethesda, MD 20893 USA	Stanford University; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Maecker, HT (corresponding author), Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA.	maecker@stanford.edu	mccoy, john philip/ABD-9348-2021					Lee JA, 2008, CYTOM PART A, V73A, P926, DOI 10.1002/cyto.a.20623; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Pachon G, 2012, NAT REV IMMUNOL, V12, P396, DOI 10.1038/nri3158-c1; Roederer M, 2001, CYTOMETRY, V45, P194, DOI 10.1002/1097-0320(20011101)45:3<194::AID-CYTO1163>3.0.CO;2-C	4	5	5	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2012	12	5								10.1038/nri3158-c2	http://dx.doi.org/10.1038/nri3158-c2			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	933ET		Bronze			2022-12-18	WOS:000303343300015
J	Bird, L				Bird, Lucy			INNATE IMMUNITY Linking mitochondria and microbes to inflammasomes	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bird, Lucy/0000-0002-3914-6045					0	5	6	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2012	12	4					229	229		10.1038/nri3195	http://dx.doi.org/10.1038/nri3195			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	916WA	22402669	Bronze			2022-12-18	WOS:000302132700004
J	Leavy, O				Leavy, Olive			TUMOUR IMMUNOLOGY A close-range dual hit for tumour immunity	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	5	5	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2012	12	4					227	227		10.1038/nri3189	http://dx.doi.org/10.1038/nri3189			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	916WA	22362306				2022-12-18	WOS:000302132700001
J	Papatriantafyllou, M				Papatriantafyllou, Maria			T CELL MEMORY The stem of T cell memory	NATURE REVIEWS IMMUNOLOGY			English	News Item													Papatriantafyllou, Maria/ADP-1463-2022					Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446	1	5	5	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2011	11	11					716	716		10.1038/nri3098	http://dx.doi.org/10.1038/nri3098			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	842GW	22025045	Bronze			2022-12-18	WOS:000296584700003
J	Leavy, O				Leavy, Olive			INFLAMMASOME NAIPs: pathogen-sensing proteins	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Kofoed E. M., 2011, NATURE          0828, DOI [10.1038/nature10394, DOI 10.1038/NATURE10394]	1	5	5	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2011	11	10					644	644		10.1038/nri3069	http://dx.doi.org/10.1038/nri3069			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	823WC	21904388	Bronze			2022-12-18	WOS:000295156600011
J	Papatriantafyllou, M				Papatriantafyllou, Maria			MUCOSAL IMMUNOLOGY Inflammasome shapes the microbiota	NATURE REVIEWS IMMUNOLOGY			English	News Item													Papatriantafyllou, Maria/ADP-1463-2022						0	5	5	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JUL	2011	11	7					439	439		10.1038/nri3012	http://dx.doi.org/10.1038/nri3012			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	782QS	21681196				2022-12-18	WOS:000292025300002
J	Leavy, O				Leavy, Olive			Dual TLR hit for vaccine success	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737	1	5	5	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2011	11	4								10.1038/nri2966	http://dx.doi.org/10.1038/nri2966			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	740HE	21553709				2022-12-18	WOS:000288781400002
J	Minton, K				Minton, Kirsty			MACROPHAGES A transcription factor to call their own	NATURE REVIEWS IMMUNOLOGY			English	News Item														Minton, Kirsty/0000-0002-3857-8030				Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990	1	5	5	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2011	11	2								10.1038/nri2934	http://dx.doi.org/10.1038/nri2934			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	711KD	21467977	Bronze			2022-12-18	WOS:000286589300006
J	Bird, L				Bird, Lucy			T CELL RESPONSES IL-2 overrules tolerogenic liver responses	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bird, Lucy/0000-0002-3914-6045				Schurich A, 2010, J IMMUNOL, V184, P4107, DOI 10.4049/jimmunol.0902580	1	5	5	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2010	10	5					289	289		10.1038/nri2777	http://dx.doi.org/10.1038/nri2777			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	586ZD	20425916	Bronze			2022-12-18	WOS:000276953900004
J	Bell, E				Bell, Elaine			TLR4 signalling	NATURE REVIEWS IMMUNOLOGY			English	News Item																		KAGAN JC, 2008, NATURE IMMUNOL  0224	1	5	5	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2008	8	4					241	241		10.1038/nri2301	http://dx.doi.org/10.1038/nri2301			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	278MC		Bronze			2022-12-18	WOS:000254289100002
J	Leavy, O				Leavy, Olive			TIM3: dual role in immunity	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536	1	5	6	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2008	8	1					4	4		10.1038/nri2239	http://dx.doi.org/10.1038/nri2239			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	249SS					2022-12-18	WOS:000252250600004
J	Bowcock, AM; Krueger, JG				Bowcock, AM; Krueger, JG			Getting under the skin: The immunogenetics of psoriasis (vol 5, pg 699, 2005)	NATURE REVIEWS IMMUNOLOGY			English	Correction																		Bowcock AM, 2005, NAT REV IMMUNOL, V5, P699, DOI 10.1038/nri1689	1	5	5	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2005	5	10					826	826		10.1038/nri1734	http://dx.doi.org/10.1038/nri1734			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	969JE		Bronze			2022-12-18	WOS:000232229600018
J	Chaudhuri, J; Alt, FW				Chaudhuri, J; Alt, FW			Class-switch recombination: Interplay of transcription, DNA deamination and DNA repair (vol 4, pg 541, 2004)	NATURE REVIEWS IMMUNOLOGY			English	Correction																		Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395	1	5	5	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2004	4	8					655	655		10.1038/nri1425	http://dx.doi.org/10.1038/nri1425			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	843DD		Bronze			2022-12-18	WOS:000223055000018
J	Bell, E				Bell, E			DC maturation	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106	1	5	5	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2003	3	4					267	267		10.1038/nri1071	http://dx.doi.org/10.1038/nri1071			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	666VA		Bronze			2022-12-18	WOS:000182196100009
J	Bell, E				Bell, E			Competitive success	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Kedl RM, 2002, NAT IMMUNOL, V3, P27, DOI 10.1038/ni742	1	5	5	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2002	2	1					3	3		10.1038/nri713	http://dx.doi.org/10.1038/nri713			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	635KP					2022-12-18	WOS:000180398300001
J	Bell, E				Bell, E			HIV: effective protection?	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Belyakov IM, 2001, NAT MED, V7, P1320, DOI 10.1038/nm1201-1320	1	5	5	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2002	2	1					7	7		10.1038/nri707	http://dx.doi.org/10.1038/nri707			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	635KP		Bronze			2022-12-18	WOS:000180398300011
J	Bell, J				Bell, J			New toll bridge	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835	3	5	5	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2001	1	1					9	9		10.1038/35095548	http://dx.doi.org/10.1038/35095548			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	635KK		Bronze			2022-12-18	WOS:000180397900018
J	Buckland, J				Buckland, J			We seek him here...	NATURE REVIEWS IMMUNOLOGY			English	News Item							INTRAEPITHELIAL LYMPHOCYTES											Fahrer AM, 2001, P NATL ACAD SCI USA, V98, P10261, DOI 10.1073/pnas.171320798; Shires J, 2001, IMMUNITY, V15, P419, DOI 10.1016/S1074-7613(01)00192-3	2	5	5	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2001	1	1					3	3		10.1038/35095518	http://dx.doi.org/10.1038/35095518			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	635KK		Bronze			2022-12-18	WOS:000180397900001
J	Ebina-Shibuya, R; Leonard, WJ				Ebina-Shibuya, Risa; Leonard, Warren J.			Role of thymic stromal lymphopoietin in allergy and beyond	NATURE REVIEWS IMMUNOLOGY			English	Review; Early Access							RESPIRATORY SYNCYTIAL VIRUS; INNATE LYMPHOID-CELLS; GENOME-WIDE ASSOCIATION; AIRWAY EPITHELIAL-CELLS; VISCERAL ADIPOSE-TISSUE; REGULATORY T-CELLS; DENDRITIC CELLS; IMMUNE-RESPONSES; TSLP EXPRESSION; UNCONTROLLED ASTHMA	The cytokine thymic stromal lymphopoietin (TSLP) has pleiotropic functions beyond allergic diseases and T helper 2-type immune responses. Here, the authors highlight the roles of TSLP - beneficial or deleterious - in infectious disease, chronic inflammatory disease and cancer by acting on many different cell types. Thymic stromal lymphopoietin (TSLP) is a pleiotropic cytokine that acts on multiple cell lineages, including dendritic cells, T cells, B cells, neutrophils, mast cells, eosinophils and innate lymphoid cells, affecting their maturation, survival and recruitment. It is best known for its role in promoting type 2 immune responses such as in allergic diseases and, in 2021, a monoclonal antibody targeting TSLP was approved for the treatment of severe asthma. However, it is now clear that TSLP has many other important roles in a variety of settings. Indeed, several genetic variants for TSLP are linked to disease severity, and chromosomal alterations in TSLP are common in certain cancers, indicating important roles of TSLP in disease. In this Review, we discuss recent advances in TSLP biology, highlighting how it regulates the tissue environment not only in allergic disease but also in infectious diseases, inflammatory diseases and cancer. Encouragingly, therapies targeting the TSLP pathway are being actively pursued for several diseases.	[Ebina-Shibuya, Risa] Tohoku Univ, Grad Sch Med, Dept Resp Med, Sendai, Miyagi, Japan; [Leonard, Warren J.] NHLBI, Lab Mol Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA	Tohoku University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Leonard, WJ (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA.	leonardw@nhlbi.nih.gov			Division of Intramural Research National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA	Division of Intramural Research National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA	We thank R. Spolski and J.-X. Lin for critical comments on the manuscript. We acknowledge funding by Division of Intramural Research National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.	Abraham C, 2011, GASTROENTEROLOGY, V140, P1729, DOI 10.1053/j.gastro.2011.02.012; Al-Shami A, 2005, J EXP MED, V202, P829, DOI 10.1084/jem.20050199; Al-Shami A, 2004, J EXP MED, V200, P159, DOI 10.1084/jem.20031975; Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211; Alpizar S, 2021, J ASTHMA ALLERGY, V14, P381, DOI 10.2147/JAA.S305114; Astrakhan A, 2007, NAT IMMUNOL, V8, P522, DOI 10.1038/ni1452; Bacharier LB, 2012, J ALLERGY CLIN IMMUN, V130, P91, DOI 10.1016/j.jaci.2012.02.010; Barooei R, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0653-4; Barros R, 2017, CLIN NUTR, V36, P1068, DOI 10.1016/j.clnu.2016.06.023; Bergot AS, 2015, IMMUNOL CELL BIOL, V93, P540, DOI 10.1038/icb.2014.123; Binnewies M, 2018, NAT MED, V24, P541, DOI 10.1038/s41591-018-0014-x; Bjerkan L, 2015, MUCOSAL IMMUNOL, V8, P49, DOI 10.1038/mi.2014.41; Braile M, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10082012; Brandelius A, 2011, PULM PHARMACOL THER, V24, P59, DOI 10.1016/j.pupt.2010.10.004; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Brunetto E, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0521-4; Burkard-Mandel L, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1419115; Calven J, 2012, J INNATE IMMUN, V4, P86, DOI 10.1159/000329131; Cardoso V, 2017, NATURE, V549, P277, DOI 10.1038/nature23469; Caterino M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82426-7; Chan LKY, 2021, CANCERS, V13, DOI 10.3390/cancers13050980; Chang J, 2017, JAMA DERMATOL, V153, P275, DOI 10.1001/jamadermatol.2016.4467; Chang YC, 2021, BLOOD, V138, P2313, DOI 10.1182/blood.2020006846; Choa R, 2021, SCIENCE, V373, P532, DOI 10.1126/science.abd2893; Choi JP, 2020, ALLERGY, V75, P1133, DOI 10.1111/all.14129; Choreno-Parra JA, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.593595; Chu C, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abe3218; Cildir G, 2013, TRENDS MOL MED, V19, P487, DOI 10.1016/j.molmed.2013.05.001; Clausen ML, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78943-6; Corren J, 2021, ANN ALLERG ASTHMA IM, V126, P187, DOI 10.1016/j.anai.2020.10.008; Corren J, 2019, NAT IMMUNOL, V20, P1603, DOI 10.1038/s41590-019-0524-9; Corren J, 2017, NEW ENGL J MED, V377, P936, DOI 10.1056/NEJMoa1704064; Cox AJ, 2015, LANCET DIABETES ENDO, V3, P207, DOI 10.1016/S2213-8587(14)70134-2; Datta A, 2013, J IMMUNOL, V191, P4867, DOI 10.4049/jimmunol.1300588; De Monte L, 2016, CANCER RES, V76, P1792, DOI 10.1158/0008-5472.CAN-15-1801-T; De Monte L, 2011, J EXP MED, V208, P469, DOI 10.1084/jem.20101876; Demehri S, 2016, J CLIN INVEST, V126, P1458, DOI 10.1172/JCI83724; Demehri S, 2012, CANCER CELL, V22, P494, DOI 10.1016/j.ccr.2012.08.017; Demehri S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000067; Di Piazza M, 2012, CANCER CELL, V22, P479, DOI 10.1016/j.ccr.2012.08.016; Ding SN, 2021, INT IMMUNOPHARMACOL, V100, DOI 10.1016/j.intimp.2021.108122; Diver S, 2021, LANCET RESP MED, V9, P1299, DOI 10.1016/S2213-2600(21)00226-5; Dong HM, 2016, SCI REP-UK, V6, DOI 10.1038/srep39559; DUFFY DL, 1990, AM REV RESPIR DIS, V142, P1351, DOI 10.1164/ajrccm/142.6_Pt_1.1351; Ebina-Shibuya R, 2021, ELIFE, V10, DOI 10.7554/eLife.61912; Ellis J, 2019, BRIT J CLIN PHARMACO, V85, P304, DOI 10.1111/bcp.13748; Emson C, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01513-x; Feng QH, 2012, GYNECOL ONCOL, V127, P412, DOI 10.1016/j.ygyno.2012.07.098; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fontenot D, 2009, P NATL ACAD SCI USA, V106, P16776, DOI 10.1073/pnas.0907347106; Fornasa G, 2015, J ALLERGY CLIN IMMUN, V136, P413, DOI 10.1016/j.jaci.2015.04.011; FRIEND SL, 1994, EXP HEMATOL, V22, P321; Gandolfo Saviana, 2019, Clin Exp Rheumatol, V37 Suppl 118, P55; Gao PS, 2010, J ALLERGY CLIN IMMUN, V125, P1403, DOI 10.1016/j.jaci.2010.03.016; Gao W, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.672312; Ghirelli C, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1178438; Gilliet M, 2003, J EXP MED, V197, P1059, DOI 10.1084/jem.20030240; Gluck J, 2022, INT ARCH ALLERGY IMM, DOI 10.1159/000521456; Hammad H, 2015, IMMUNITY, V43, P29, DOI 10.1016/j.immuni.2015.07.007; Hams E, 2012, CURR OPIN PHARMACOL, V12, P503, DOI 10.1016/j.coph.2012.06.001; Han H, 2012, MUCOSAL IMMUNOL, V5, P342, DOI 10.1038/mi.2012.14; Han JY, 2012, J ALLERGY CLIN IMMUN, V130, P1175, DOI 10.1016/j.jaci.2012.08.033; Harada M, 2011, AM J RESP CELL MOL, V44, P787, DOI 10.1165/rcmb.2009-0418OC; Harada M, 2009, AM J RESP CELL MOL, V40, P368, DOI 10.1165/rcmb.2008-0041OC; Hartgring SAY, 2011, ARTHRITIS RHEUM-US, V63, P1878, DOI 10.1002/art.30336; Hirota T, 2011, NAT GENET, V43, P893, DOI 10.1038/ng.887; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Jeong HJ, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4104; Jian JL, 2013, J LEUKOCYTE BIOL, V93, P199, DOI 10.1189/jlb.0812429; Kabata H, 2020, MUCOSAL IMMUNOL, V13, P626, DOI 10.1038/s41385-020-0266-x; Kashyap M, 2011, J IMMUNOL, V187, P1207, DOI 10.4049/jimmunol.1100355; Kato A, 2007, J IMMUNOL, V179, P1080, DOI 10.4049/jimmunol.179.2.1080; Kawasaki J, 2011, J DERMATOL SCI, V62, P131, DOI 10.1016/j.jdermsci.2011.02.005; Keegan A. D., 2022, PAUL FUNDAMENTAL IMM, V8th; Kim BS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005374; Kim R, 2006, CANCER RES, V66, P5527, DOI 10.1158/0008-5472.CAN-05-4128; Kitajima M, 2011, EUR J IMMUNOL, V41, P1862, DOI 10.1002/eji.201041195; Klose CSN, 2017, NATURE, V549, P282, DOI 10.1038/nature23676; Ko HK, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-86179-1; Kobayashi T, 2019, CELL, V176, P982, DOI 10.1016/j.cell.2018.12.031; Kolodin D, 2015, CELL METAB, V21, P543, DOI 10.1016/j.cmet.2015.03.005; Koschut D, 2021, ONCOGENE, V40, P746, DOI 10.1038/s41388-020-01567-7; Kowalewska J, 2007, AM J PATHOL, V170, P981, DOI 10.2353/ajpath.2007.060474; Koyama K, 2007, BIOCHEM BIOPH RES CO, V357, P99, DOI 10.1016/j.bbrc.2007.03.081; Kuan EL, 2018, NAT IMMUNOL, V19, P366, DOI 10.1038/s41590-018-0066-6; Lee HC, 2007, P NATL ACAD SCI USA, V104, P914, DOI 10.1073/pnas.0607305104; Lee HC, 2013, HEPATOLOGY, V57, P1314, DOI 10.1002/hep.26128; Lee HC, 2012, J ALLERGY CLIN IMMUN, V130, P1187, DOI 10.1016/j.jaci.2012.07.031; Lee JU, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0380-z; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Leyva-Castillo JM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3847; Li H, 2011, CANCER IMMUNOL IMMUN, V60, P1587, DOI 10.1007/s00262-011-1059-6; Lin CM, 2020, CANCER IMMUNOL IMMUN, V69, P549, DOI 10.1007/s00262-020-02488-w; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Lu N, 2009, J EXP MED, V206, P2111, DOI 10.1084/jem.20090153; Luo Y, 2014, CLIN EXP DERMATOL, V39, P48, DOI 10.1111/ced.12206; Lv JJ, 2018, EUR J IMMUNOL, V48, P1838, DOI 10.1002/eji.201847663; Ma L, 2020, CYTOKINE, V136, DOI 10.1016/j.cyto.2020.155284; Majewski S, 2019, J CLIN MED, V8, DOI 10.3390/jcm8101590; Malinczak CA, 2021, J IMMUNOL, V206, P1315, DOI 10.4049/jimmunol.2001205; Malinczak CA, 2019, MUCOSAL IMMUNOL, V12, P969, DOI 10.1038/s41385-019-0171-3; Massacand JC, 2009, P NATL ACAD SCI USA, V106, P13968, DOI 10.1073/pnas.0906367106; Mena AM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01052; Menzies-Gow A, 2021, NEW ENGL J MED, V384, P1800, DOI 10.1056/NEJMoa2034975; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Moorman Jeanne E, 2012, Vital Health Stat 3, P1; Moret FM, 2014, ARTHRITIS RHEUMATOL, V66, P1176, DOI 10.1002/art.38338; Moriyama S, 2019, ADV IMMUNOL, V143, P1, DOI 10.1016/bs.ai.2019.08.001; Murrison LB, 2022, J ALLERGY CLIN IMMUN, V149, P79, DOI 10.1016/j.jaci.2021.05.033; Nagashima H, 2019, IMMUNITY, V51, P682, DOI 10.1016/j.immuni.2019.06.009; Nakamura Y, 2008, J ALLERGY CLIN IMMUN, V122, P1208, DOI 10.1016/j.jaci.2008.09.022; NIEMINEN MM, 1991, CHEST, V100, P70, DOI 10.1378/chest.100.1.70; Noti M, 2013, NAT MED, V19, P1005, DOI 10.1038/nm.3281; Ochiai S, 2018, P NATL ACAD SCI USA, V115, P1033, DOI 10.1073/pnas.1714348115; Okayama Y, 2009, EUR RESPIR J, V34, P425, DOI 10.1183/09031936.00121008; Olkhanud PB, 2011, J IMMUNOL, V186, P5656, DOI 10.4049/jimmunol.1100463; Ordonez F, 2012, INFLAMM BOWEL DIS, V18, P1809, DOI 10.1002/ibd.22864; Palmi C, 2016, ONCOTARGET, V7, P59260, DOI 10.18632/oncotarget.10610; Pandey A, 2000, NAT IMMUNOL, V1, P59, DOI 10.1038/76923; Park LS, 2000, J EXP MED, V192, P659, DOI 10.1084/jem.192.5.659; Pattarini L, 2017, J EXP MED, V214, P1529, DOI 10.1084/jem.20150402; Pedroza-Gonzalez A, 2011, J EXP MED, V208, P479, DOI 10.1084/jem.20102131; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Pham TH, 2021, ANN ALLERG ASTHMA IM, V127, P689, DOI 10.1016/j.anai.2021.08.008; Plumb AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050199; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Ragonnaud E, 2019, CANCER RES, V79, P5826, DOI 10.1158/0008-5472.CAN-19-1058; Rivellese F, 2018, ANN RHEUM DIS, V77, P1773, DOI 10.1136/annrheumdis-2018-213418; Roan F, 2019, J CLIN INVEST, V129, P1441, DOI 10.1172/JCI124606; Roan F, 2012, J LEUKOCYTE BIOL, V91, P877, DOI 10.1189/jlb.1211622; Roberts KG, 2014, NEW ENGL J MED, V371, P1005, DOI 10.1056/NEJMoa1403088; Rochman I, 2007, J IMMUNOL, V178, P6720, DOI 10.4049/jimmunol.178.11.6720; Rochman Y, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aam8858; Rochman Y, 2010, P NATL ACAD SCI USA, V107, P19455, DOI 10.1073/pnas.1008271107; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Rochman Y, 2008, J IMMUNOL, V181, P7699, DOI 10.4049/jimmunol.181.11.7699; Salabert-Le Guen N, 2018, J ALLERGY CLIN IMMUN, V141, P1476, DOI 10.1016/j.jaci.2017.11.012; Schaper K, 2016, PHARMACOL RES, V113, P209, DOI 10.1016/j.phrs.2016.08.001; Schaper-Gerhardt K, 2020, BRIT J PHARMACOL, V177, P490, DOI 10.1111/bph.14550; Semlali A, 2021, GENES-BASEL, V12, DOI 10.3390/genes12091386; Shane HL, 2014, J IMMUNOL, V192, P2261, DOI 10.4049/jimmunol.1302085; Shikotra A, 2012, J ALLERGY CLIN IMMUN, V129, P104, DOI 10.1016/j.jaci.2011.08.031; Sims JE, 2000, J EXP MED, V192, P671, DOI 10.1084/jem.192.5.671; Siracusa MC, 2011, NATURE, V477, P229, DOI 10.1038/nature10329; Smelter DF, 2010, J IMMUNOL, V185, P3035, DOI 10.4049/jimmunol.1000252; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Stier MT, 2016, J ALLERGY CLIN IMMUN, V138, P814, DOI 10.1016/j.jaci.2016.01.050; Sugimoto H, 2010, CLIN IMMUNOL, V136, P205, DOI 10.1016/j.clim.2010.04.006; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tahaghoghi-Hajghorbani S, 2019, AUTOIMMUN HIGHLIGHTS, V10, DOI 10.1186/s13317-019-0110-z; Takahashi N, 2016, CANCER RES, V76, P6241, DOI 10.1158/0008-5472.CAN-16-0992; Takai T, 2012, ALLERGOL INT, V61, P3, DOI 10.2332/allergolint.11-RAI-0395; Taylor BC, 2009, J EXP MED, V206, P655, DOI 10.1084/jem.20081499; Terabe M, 2000, NAT IMMUNOL, V1, P515, DOI 10.1038/82771; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Tourdot S, 2008, CLIN EXP ALLERGY, V38, P1016, DOI 10.1111/j.1365-2222.2008.02974.x; Van Dyken SJ, 2016, NAT IMMUNOL, V17, P1381, DOI 10.1038/ni.3582; Varricchi G, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01595; Verstraete K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14937; VIJAYAKUMAR T, 1986, CANCER IMMUNOL IMMUN, V22, P76; Wallmeyer L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00670-2; Wallrapp A, 2019, IMMUNITY, V51, P709, DOI 10.1016/j.immuni.2019.09.005; Wallrapp A, 2017, NATURE, V549, P351, DOI 10.1038/nature24029; Wang IJ, 2016, ANN ALLERG ASTHMA IM, V116, P139, DOI 10.1016/j.anai.2015.11.016; Wang Q, 2015, J ALLERGY CLIN IMMUN, V135, P781, DOI 10.1016/j.jaci.2014.09.015; Wang W, 2018, J IMMUNOL, V201, P2221, DOI 10.4049/jimmunol.1800709; Wang WW, 2019, EUR ARCH OTO-RHINO-L, V276, P1655, DOI 10.1007/s00405-019-05369-w; Wang WF, 2021, IMMUNOBIOLOGY, V226, DOI 10.1016/j.imbio.2021.152055; Watanabe J, 2015, YONAGO ACTA MED, V58, P137; Wechsler ME, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01503-z; West EE, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaf8471; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wu TC, 2018, CANCER RES, V78, P5243, DOI 10.1158/0008-5472.CAN-18-0413; Xie F, 2015, CANCER LETT, V364, P106, DOI 10.1016/j.canlet.2015.04.029; Xie Y, 2012, J DERMATOL SCI, V66, P233, DOI 10.1016/j.jdermsci.2012.03.007; Xu HP, 2019, IMMUNITY, V51, P696, DOI 10.1016/j.immuni.2019.09.004; Xu L, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20190116; Yadava K, 2013, MUCOSAL IMMUNOL, V6, P83, DOI 10.1038/mi.2012.50; Yang L, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01907; Ye L, 2019, NAT IMMUNOL, V20, P593, DOI 10.1038/s41590-019-0345-x; Ying S, 2008, J IMMUNOL, V181, P2790, DOI 10.4049/jimmunol.181.4.2790; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Yue WJ, 2016, ONCOTARGET, V7, P16840, DOI 10.18632/oncotarget.7614; Zhang B, 2017, ONCOL LETT, V14, P7483, DOI 10.3892/ol.2017.7121; Zhang YL, 2012, EUR J IMMUNOL, V42, P1735, DOI 10.1002/eji.201142123; Zhang Z, 2009, P NATL ACAD SCI USA, V106, P1536, DOI 10.1073/pnas.0812668106; Zhou WJ, 2017, ONCOL LETT, V14, P7910, DOI 10.3892/ol.2017.7260; Ziegler SF, 2013, ADV PHARMACOL, V66, P129, DOI 10.1016/B978-0-12-404717-4.00004-4	189	4	4	5	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.												10.1038/s41577-022-00735-y	http://dx.doi.org/10.1038/s41577-022-00735-y		JUN 2022	14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1T1SA	35650271	Green Published, Bronze			2022-12-18	WOS:000804516200001
J	Alwan, NA				Alwan, Nisreen A.			Lessons from Long COVID: working with patients to design better research	NATURE REVIEWS IMMUNOLOGY			English	Article								In this Comment article, Nisreen Alwan discusses what her experience as both a public health academic and a person living with Long COVID has taught her about the importance of including those with lived experience of a condition in setting the research agenda. The perspectives of people with lived experience of any condition being researched must actively inform the research questions asked and the way in which we go about answering them. The experience of Long Covid gives a contemporary example of how working together with patients is integral to medical research.	[Alwan, Nisreen A.] Univ Southampton, Fac Med, Sch Primary Care Populat Sci & Med Educ, Southampton, Hants, England; [Alwan, Nisreen A.] Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Alwan, Nisreen A.] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England; [Alwan, Nisreen A.] NIHR Appl Res Collaborat Wessex, Southampton, Hants, England	University of Southampton; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust	Alwan, NA (corresponding author), Univ Southampton, Fac Med, Sch Primary Care Populat Sci & Med Educ, Southampton, Hants, England.; Alwan, NA (corresponding author), Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England.; Alwan, NA (corresponding author), Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England.; Alwan, NA (corresponding author), NIHR Appl Res Collaborat Wessex, Southampton, Hants, England.	N.A.Alwan@soton.ac.uk	Alwan, Nisreen A./AFP-0662-2022	Alwan, Nisreen A./0000-0002-4134-8463				Alwan Nisreen A, 2021, Commun Med (Lond), V1, P15, DOI 10.1038/s43856-021-00016-0; Alwan NA, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3565; Alwan NA, 2020, NATURE, V584, P170, DOI 10.1038/d41586-020-02335-z; Callard F, 2021, SOC SCI MED, V268, DOI 10.1016/j.socscimed.2020.113426; Garcia-Abellan J, 2021, J CLIN IMMUNOL, V41, P1490, DOI 10.1007/s10875-021-01083-7; Matta J, 2022, JAMA INTERN MED, V182, P19, DOI 10.1001/jamainternmed.2021.6454; Molnar T, 2021, J CLIN MED, V10, DOI 10.3390/jcm10194337; Su YP, 2022, CELL, V185, P881, DOI 10.1016/j.cell.2022.01.014; Walker AJ, 2021, BRIT J GEN PRACT, V71, pE806, DOI 10.3399/BJGP.2021.0301; ZOE COVID Study, DOES COVID INF GUAR	10	4	4	1	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2022	22	4					201	202		10.1038/s41577-022-00692-6	http://dx.doi.org/10.1038/s41577-022-00692-6		FEB 2022	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0F2ER	35169259	Green Published, Bronze			2022-12-18	WOS:000755417500002
J	Persson, C				Persson, Carl			'Bedside' observations challenge aspects of the 'epithelial barrier hypothesis'	NATURE REVIEWS IMMUNOLOGY			English	Letter							ABSORPTION; PERMEABILITY		[Persson, Carl] Univ Hosp Lund, Dept Lab Med, Lund, Sweden	Lund University; Skane University Hospital	Persson, C (corresponding author), Univ Hosp Lund, Dept Lab Med, Lund, Sweden.	Carl.persson@med.lu.se						Akdis CA, 2021, NAT REV IMMUNOL, V21, P739, DOI 10.1038/s41577-021-00538-7; Cohen MB, 1930, J IMMUNOL, V18, P419; DelDonno M, 1997, CHEST, V111, P1255, DOI 10.1378/chest.111.5.1255; Georas S, 2019, J ASTHMA, V56, P1257, DOI 10.1080/02770903.2018.1536145; Greiff L, 1997, AM J RESP CRIT CARE, V156, P783, DOI 10.1164/ajrccm.156.3.9607013; Greiff L, 2002, CLIN PHYSIOL FUNCT I, V22, P55, DOI 10.1046/j.1365-2281.2002.00401.x; OBYRNE PM, 1984, J APPL PHYSIOL, V57, P77, DOI 10.1152/jappl.1984.57.1.77; Persson C, 2021, SCAND J IMMUNOL, V93, DOI 10.1111/sji.13024; Persson C, 2020, J INNATE IMMUN, V12, P373, DOI 10.1159/000506515; Persson C, 2019, J ALLERGY CLIN IMMUN, V143, P1271, DOI 10.1016/j.jaci.2018.07.037	10	4	4	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2021	21	12					828	828		10.1038/s41577-021-00650-8	http://dx.doi.org/10.1038/s41577-021-00650-8		NOV 2021	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XD3NF	34728825	Bronze			2022-12-18	WOS:000713927000001
J	Wolchok, JD				Wolchok, Jedd D.			CHECKPOINT BLOCKADE: THE END OF THE BEGINNING	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material									[Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Wolchok, JD (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.	wolchokj@mskcc.org		Wolchok, Jedd/0000-0001-6718-2222				Hodi FS, 2003, P NATL ACAD SCI USA, V100, P4712, DOI 10.1073/pnas.0830997100; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Phan GQ, 2003, P NATL ACAD SCI USA, V100, P8372, DOI 10.1073/pnas.1533209100	3	4	4	0	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2021	21	10					621	621						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UX9XG	34580460				2022-12-18	WOS:000701188100015
J	Rana, MS; Ikram, A; Salman, M; Usman, M; Umair, M				Rana, Muhammad Suleman; Ikram, Aamer; Salman, Muhammad; Usman, Muhammad; Umair, Massab			Negative impact of the COVID-19 pandemic on routine childhood immunization: experience from Pakistan	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material							VACCINATION	The COVID-19 pandemic has disrupted routine childhood immunization coverage for many vaccine-preventable diseases at the global, regional and national levels. In Pakistan, more than 40 million children were unable to receive measles vaccination and around 50 million children missed polio vaccination in 2020. Moreover, more than 36 million children did not receive vitamin A supplementation in 2020. Implementing catch-up vaccination services to prevent outbreaks of vaccine-preventable diseases, particularly polio and measles, in malnourished children is urgently required to prevent a global resurgence of these deadly diseases.	[Rana, Muhammad Suleman; Ikram, Aamer; Salman, Muhammad; Usman, Muhammad; Umair, Massab] Natl Inst Hlth, Islamabad, Pakistan		Rana, MS (corresponding author), Natl Inst Hlth, Islamabad, Pakistan.	ranavirologist@gmail.com	Rana, Dr. Muhammad Suleman/HCH-1540-2022					[Anonymous], 2012, Wkly Epidemiol Rec, V87, P1; Haqqi A, 2021, J MED VIROL, V93, P141, DOI 10.1002/jmv.26240; Kelland K, 2020, REUTERS; Li X, 2021, LANCET, V397, P398, DOI 10.1016/S0140-6736(20)32657-X; Rana MS, 2021, NAT MED, V27, P1127, DOI 10.1038/s41591-021-01430-6; Takahashi S, 2015, SCIENCE, V347, P1240, DOI 10.1126/science.aaa3438; UNICEF, 2021, IMM SERV BEG SLOW RE; UNICEF, 2020, ADD 6 7 MILL CHILDR; United Nations Children's Fund (UNICEF), 2020, DISR CHILDH VACC S A; WHO, 2021, COVID 19 CONT DISR E	10	4	4	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2021	21	11					689	690		10.1038/s41577-021-00627-7	http://dx.doi.org/10.1038/s41577-021-00627-7		SEP 2021	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WM9XX	34522031	Bronze, Green Published			2022-12-18	WOS:000695767400001
J	Bordon, Y				Bordon, Yvonne			Protect the species with mitohormesis?	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material												y.bordon@nature.com						Timblin GA, 2021, NAT METAB, V3, P618, DOI 10.1038/s42255-021-00392-w	1	4	4	1	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUL	2021	21	7					407	407		10.1038/s41577-021-00570-7	http://dx.doi.org/10.1038/s41577-021-00570-7		JUN 2021	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TC3LT	34075228				2022-12-18	WOS:000656801800001
J	Alrubayyi, A; Peppa, D				Alrubayyi, Aljawharah; Peppa, Dimitra			SEEING SARS-COV-2 VARIANTS THROUGH THE EYES OF T CELLS	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material									[Alrubayyi, Aljawharah; Peppa, Dimitra] Univ Oxford, Nuffield Dept Clin Med, OxMS Preprint Journal Club, Oxford, England	University of Oxford	Alrubayyi, A (corresponding author), Univ Oxford, Nuffield Dept Clin Med, OxMS Preprint Journal Club, Oxford, England.	highlights@preprintclub.com						Alrubayyi A, 2021, OXFORD MOUNT SINAI O; Tarke Alison, 2021, bioRxiv, DOI 10.1101/2021.02.27.433180	2	4	4	0	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2021	21	5					275	275		10.1038/s41577-021-00551-w	http://dx.doi.org/10.1038/s41577-021-00551-w		APR 2021	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RX5DH	33854230	Bronze, Green Published			2022-12-18	WOS:000640138100002
J	Bordon, Y				Bordon, Yvonne			Immune readouts from the Oxford COVID-19 vaccine	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material												y.bordon@nature.com						Barrett JR, 2021, NAT MED, V27, P279, DOI 10.1038/s41591-020-01179-4; Ewer KJ, 2021, NAT MED, V27, P270, DOI 10.1038/s41591-020-01194-5	2	4	4	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2021	21	2					70	71		10.1038/s41577-021-00503-4	http://dx.doi.org/10.1038/s41577-021-00503-4		JAN 2021	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QB3OS	33432129	Bronze, Green Published			2022-12-18	WOS:000607043300001
J	[Anonymous]				[Anonymous]			Watching preprints evolve	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material								In February 2021, Nature Reviews Immunology launches the first of its monthly 'Preprint Watch' columns. Here, we explain the rationale for our coverage of preprints and the precautions we have taken to guard against their improper use.										[Anonymous], 2019, Nature, V569, P307, DOI 10.1038/d41586-019-01493-z; Catalan-Dibene Jovani, 2020, Nat Rev Immunol, V20, P350, DOI 10.1038/s41577-020-0313-6; Coveney Clarissa, 2020, Nat Rev Immunol, V20, P462, DOI 10.1038/s41577-020-0383-5; Ju B., 2020, BIORXIV, DOI [10.1101/2020.03.21.990770, 10.1101/ 2020.03.21.990770, DOI 10.1101/2020.03.21.990770]; Ju B, 2020, NATURE, V584, P115, DOI 10.1038/s41586-020-2380-z; University of Oxford Immunology network, 2020, SARS COV 2 RNA DET B; Vabret N, 2020, NAT REV IMMUNOL, V20, P338, DOI 10.1038/s41577-020-0319-0	7	4	5	0	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2021	21	2					65	66		10.1038/s41577-020-00489-5	http://dx.doi.org/10.1038/s41577-020-00489-5		JAN 2021	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QB3OS	33432126	Green Published, Bronze			2022-12-18	WOS:000607043300004
J	Flemming, A				Flemming, Alexandra			GZMK(+) T cells a hallmark of immune ageing	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material								A systematic analysis of the ageing immune system of the mouse revealed the emergence of a novel T cell subset that displays markers of exhaustion. A similar T cell subset was also identified in ageing humans.				a.flemming@nature.com						Mogilenko DA, 2021, IMMUNITY, V54, P99, DOI 10.1016/j.immuni.2020.11.005	1	4	4	2	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2021	21	1					1	1		10.1038/s41577-020-00486-8	http://dx.doi.org/10.1038/s41577-020-00486-8		DEC 2020	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PO1XX	33303954				2022-12-18	WOS:000597442300001
J	Whalley, K				Whalley, Katherine			Brain-spleen link tunes immunity	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material																			0	4	4	1	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUL	2020	20	7					406	+		10.1038/s41577-020-0347-9	http://dx.doi.org/10.1038/s41577-020-0347-9			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NI4DD	32404989				2022-12-18	WOS:000565303700008
J	Molofsky, AB; Locksley, RM				Molofsky, Ari B.; Locksley, Richard M.			Tissue immunity broadcasts near and far	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material								Several studies from 2019 have highlighted emerging routes of communication between tissue-resident immune cells and local neurons, stromal cells, endothelial cells and epithelial cells to exert effects beyond the local tissue. Key advances Skin epidermal innate lymphoid cells (ILCs) represent a transitional subset with features of both ILC2s and ILC3s that limit sebaceous gland growth and regulate the skin microbiome. Sensory neurons are a rapid means of broadcasting local tissue perturbations to regional sites, acting through innate lymphocytes to prime these sites for subsequent challenge. Mesenteric lymph nodes drain discrete regions of the intestine, maintaining an anatomical patterning that promotes immune tolerance at proximal sites and immune effector function at distal sites. Mesenchymal stromal cells communicate with tissue-resident lymphocytes within distinct niches in adipose tissue, lung and elsewhere, contributing to organ function and regional immunity. Research advances in tissue immunology have begun to decipher how organ physiology is integrated with resident immune cells during tissue development, healthspan and disease states. Here, we review a selection of studies from 2019 that highlight how resident lymphocytes communicate with epithelia, neurons and stromal cells in tissues to coordinate regional and systemic remodelling in response to local perturbations.	[Molofsky, Ari B.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA USA; [Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Molofsky, AB (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA USA.; Locksley, RM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA USA.	ari.molofsky@ucsf.edu; richard.locksley@ucsf.edu		Molofsky, Ari/0000-0003-0764-3175				Cohen JA, 2019, CELL, V178, P919, DOI 10.1016/j.cell.2019.06.022; Dahlgren MW, 2019, IMMUNITY, V50, P707, DOI 10.1016/j.immuni.2019.02.002; Esterhazy D, 2019, NATURE, V569, P126, DOI 10.1038/s41586-019-1125-3; Fan X, 2016, CELL, V164, P1198, DOI 10.1016/j.cell.2016.02.048; Kashem SW, 2015, IMMUNITY, V43, P515, DOI 10.1016/j.immuni.2015.08.016; Kobayashi T, 2019, CELL, V176, P982, DOI 10.1016/j.cell.2018.12.031; Mahlakoiv T, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aax0416; Rana BMJ, 2019, J EXP MED, V216, P1999, DOI 10.1084/jem.20190689; Schneider C, 2019, IMMUNITY, V50, P1425, DOI 10.1016/j.immuni.2019.04.019; Spallanzani RG, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw3658	10	4	4	0	11	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2020	20	2					93	94		10.1038/s41577-019-0250-4	http://dx.doi.org/10.1038/s41577-019-0250-4			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KI2EH	31748703				2022-12-18	WOS:000511159600011
J	Bird, L				Bird, Lucy			Exercise lowers leptin and leukocytosis	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material																		Frodermann V, 2019, NAT MED, V25, P1761, DOI 10.1038/s41591-019-0633-x	1	4	4	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2020	20	1					2	3		10.1038/s41577-019-0253-1	http://dx.doi.org/10.1038/s41577-019-0253-1			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KA2KC	31776481				2022-12-18	WOS:000505625400004
J	Kanneganti, TD				Kanneganti, Thirumala-Devi			The signposts and winding roads to immunity and inflammation	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material								The field of innate immunity has been rapidly evolving and expanding its horizons during the past few years. 2018 was no exception, with the publication of several ground-breaking studies that bring into light new activators, regulators and signalling networks that drive innate immune responses and inflammation.	[Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	Thirumala-Devi.Kanneganti@STJUDE.ORG	Kanneganti, Thirumala-Devi/Y-2503-2019	Kanneganti, Thirumala-Devi/0000-0002-6395-6443				Hara H, 2018, CELL, V175, P1651, DOI 10.1016/j.cell.2018.09.047; Karki R, 2018, CELL, V173, P920, DOI 10.1016/j.cell.2018.02.055; Malireddi RKS, 2018, J EXP MED, V215, P1023, DOI 10.1084/jem.20171922; Orning P, 2018, SCIENCE, V362, P1064, DOI 10.1126/science.aau2818; Sharma D, 2016, J CELL BIOL, V213, P617, DOI 10.1083/jcb.201602089; Xu DC, 2018, CELL, V174, P1477, DOI 10.1016/j.cell.2018.07.041; Zhou P, 2018, NATURE, V561, P122, DOI 10.1038/s41586-018-0433-3	7	4	4	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2019	19	2					81	82		10.1038/s41577-018-0108-1	http://dx.doi.org/10.1038/s41577-018-0108-1			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HJ4PH	30602731				2022-12-18	WOS:000457155400012
J	Minton, K				Minton, Kirsty			Cytokine boost for CAR T cells	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material														Minton, Kirsty/0000-0002-3857-8030					0	4	4	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAR	2018	18	3								10.1038/nri.2018.8	http://dx.doi.org/10.1038/nri.2018.8			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FX5KU	29430015				2022-12-18	WOS:000426118500005
J	Crotty, S				Crotty, Shane			RAGING EVOLUTION OF A B CELL RESPONSE TO A VIRAL INFECTION	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material									[Crotty, Shane] La Jolla Inst Allergy & Immunol LJI, 9420 Athena Circle, La Jolla, CA 92037 USA		Crotty, S (corresponding author), La Jolla Inst Allergy & Immunol LJI, 9420 Athena Circle, La Jolla, CA 92037 USA.	shane@lji.org	Crotty, Shane/AAE-8446-2019; Crotty, Shane/AAC-6703-2019	Crotty, Shane/0000-0002-6484-6262				Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053	1	4	4	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2018	18	2					79	79		10.1038/nri.2017.219	http://dx.doi.org/10.1038/nri.2017.219			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FU0NY	29292394				2022-12-18	WOS:000423548800005
J	Kinder, JM; Stelzer, IA; Arck, PC; Way, SS				Kinder, Jeremy M.; Stelzer, Ina A.; Arck, Petra C.; Way, Sing Sing			Reply: Breastfeeding-related maternal microchimerism	NATURE REVIEWS IMMUNOLOGY			English	Letter							TOLERANCE; ANTIGENS; CELLS; MICE		[Kinder, Jeremy M.; Stelzer, Ina A.; Way, Sing Sing] Cincinnati Childrens Hosp, Div Infect Dis, 3333 Burnet Ave,MLC 7017, Cincinnati, OH 45229 USA; [Kinder, Jeremy M.; Stelzer, Ina A.; Way, Sing Sing] Cincinnati Childrens Hosp, Perinatal Inst, 3333 Burnet Ave,MLC 7017, Cincinnati, OH 45229 USA; [Arck, Petra C.] Univ Med Ctr Hamburg Eppendorf, Lab Expt Fetomaternal Med, Dept Obstet & Prenatal Med, D-20246 Hamburg, Germany	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University of Hamburg; University Medical Center Hamburg-Eppendorf	Way, SS (corresponding author), Cincinnati Childrens Hosp, Div Infect Dis, 3333 Burnet Ave,MLC 7017, Cincinnati, OH 45229 USA.; Way, SS (corresponding author), Cincinnati Childrens Hosp, Perinatal Inst, 3333 Burnet Ave,MLC 7017, Cincinnati, OH 45229 USA.	singsing.way@cchmc.org		Way, Sing Sing/0000-0001-8948-1952; Kinder, Jeremy/0000-0001-5145-1344; Stelzer, Ina/0000-0002-9974-4661	Cusanuswerk-Studienforderung; Deutsche Forschungsgemeinschaft [AR232/25-1, AR232/27-1]; US National Institutes of Health, Office of the Director [DP1AI131080]; US National Institute of Allergy and Infectious Disease [R01AI100934, R01AI120202]; March of Dimes Foundation [FY15-254]	Cusanuswerk-Studienforderung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); US National Institutes of Health, Office of the Director; US National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); March of Dimes Foundation(March of Dimes)	The writing of this correspondence was made possible through funding by Cusanuswerk-Studienforderung (to I.A.S.); Deutsche Forschungsgemeinschaft (AR232/25-1 in KFO296 and AR232/27-1 to P.C.A.); the US National Institutes of Health, Office of the Director (DP1AI131080 to S.S.W.); the US National Institute of Allergy and Infectious Disease (R01AI100934 and R01AI120202 to S.S.W.); and the March of Dimes Foundation (FY15-254 to S.S.W.). S.S.W. is a Burroughs Wellcome Fund Investigator in the pathogenesis of infectious disease and Howard Hughes Medical Institute Faculty Scholar.	Andrassy J, 2003, J IMMUNOL, V171, P5554, DOI 10.4049/jimmunol.171.10.5554; Burlingham WJ, 1998, NEW ENGL J MED, V339, P1657, DOI 10.1056/NEJM199812033392302; CAMPBELL DA, 1984, TRANSPLANTATION, V37, P340, DOI 10.1097/00007890-198404000-00004; Dutta P, 2009, CURR OPIN ORGAN TRAN, V14, P439, DOI 10.1097/MOT.0b013e32832d6683; Harrington WE, 2017, J INFECT DIS, V215, P1445, DOI 10.1093/infdis/jix129; Khosrotehrani K, 2006, J INVEST DERMATOL, V126, P345, DOI 10.1038/sj.jid.5700060; Kinder JM, 2017, NAT REV IMMUNOL, V17, P483, DOI 10.1038/nri.2017.38; Kinder JM, 2015, CELL, V162, P505, DOI 10.1016/j.cell.2015.07.006; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Moles J. P, 2017, NAT REV IMMUNOL; Nelson JL, 2007, P NATL ACAD SCI USA, V104, P1637, DOI 10.1073/pnas.0606169104; Nelson JL, 2012, TRENDS IMMUNOL, V33, P421, DOI 10.1016/j.it.2012.03.002; OWEN RD, 1954, P NATL ACAD SCI USA, V40, P420, DOI 10.1073/pnas.40.6.420; Stevens A. M, LANCET, V362; Ye J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086985	15	4	4	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2017	17	11					730	730		10.1038/nri.2017.117	http://dx.doi.org/10.1038/nri.2017.117			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FL1LO	28972207	Bronze			2022-12-18	WOS:000413976600012
J	Starling, S				Starling, Shimona			A mother's greatest gift is TIM3	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material														Starling, Shimona/0000-0001-6059-8006					0	4	4	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2017	17	11					662	662		10.1038/nri.2017.120	http://dx.doi.org/10.1038/nri.2017.120			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FL1LO	29034907	Bronze			2022-12-18	WOS:000413976600002
J	Bordon, Y				Bordon, Yvonne			JAK in the itch	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material														Bordon, Yvonne/0000-0002-9728-012X					0	4	4	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2017	17	10					591	591		10.1038/nri.2017.114	http://dx.doi.org/10.1038/nri.2017.114			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FI3RF	28920589				2022-12-18	WOS:000411884600001
J	Starling, S				Starling, Shimona			Interfering with intestinal inflammation	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material														Starling, Shimona/0000-0001-6059-8006					0	4	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2017	17	10								10.1038/nri.2017.113	http://dx.doi.org/10.1038/nri.2017.113			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FI3RF	28920586	Bronze			2022-12-18	WOS:000411884600007
J	Moffett, A				Moffett, Ashley			Journal club	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material									[Moffett, Ashley] Univ Cambridge, Dept Pathol, Cambridge, England	University of Cambridge	Moffett, A (corresponding author), Univ Cambridge, Dept Pathol, Cambridge, England.	am485@cam.ac.uk			British Heart Foundation [PG/09/077/27964] Funding Source: Medline	British Heart Foundation(British Heart Foundation)			0	4	4	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2017	17	8					466	466		10.1038/nri.2017.23	http://dx.doi.org/10.1038/nri.2017.23			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FB8YL	28555674	Bronze			2022-12-18	WOS:000406426200003
J	Bordon, Y				Bordon, Yvonne			T CELLS Staying alive with S1P	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X					0	4	5	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUL	2017	17	7								10.1038/nri.2017.73	http://dx.doi.org/10.1038/nri.2017.73			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY6TP	28652598				2022-12-18	WOS:000404116500006
J	Kugelberg, E				Kugelberg, Elisabeth			TSLP complements neutrophil killing of bacteria	NATURE REVIEWS IMMUNOLOGY			English	News Item														Kugelberg, Elisabeth/0000-0002-8302-3595					0	4	5	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2017	17	1					4	5		10.1038/nri.2016.139	http://dx.doi.org/10.1038/nri.2016.139			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EH6TX	27941890	Bronze			2022-12-18	WOS:000391907900005
J	Minton, K				Minton, Kirsty			Granuloma macrophage differentiation	NATURE REVIEWS IMMUNOLOGY			English	News Item														Minton, Kirsty/0000-0002-3857-8030					0	4	4	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2016	16	12								10.1038/nri.2016.132	http://dx.doi.org/10.1038/nri.2016.132			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ED8PX	27885281				2022-12-18	WOS:000389134500003
J	Bordon, Y				Bordon, Yvonne			DENDRITIC CELLS Sorting, sorted!	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X					0	4	4	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2016	16	11					657	657		10.1038/nri.2016.115	http://dx.doi.org/10.1038/nri.2016.115			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EB1RF	27748396				2022-12-18	WOS:000387131400001
J	Iwasaki, A				Iwasaki, Akiko			ANTIVIRAL RESPONSES OF INBRED MICE	NATURE REVIEWS IMMUNOLOGY			English	News Item									[Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University	Iwasaki, A (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06520 USA.	akiko.iwasaki@yale.edu	Iwasaki, Akiko/Z-1591-2019	Iwasaki, Akiko/0000-0002-7824-9856					0	4	4	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2016	16	6					340	340		10.1038/nri.2016.44	http://dx.doi.org/10.1038/nri.2016.44			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DN0GP	27108522				2022-12-18	WOS:000376742700007
J	Bird, L				Bird, Lucy			TUMOUR IMMUNOLOGY Neutrophils help tumours spread	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bird, Lucy/0000-0002-3914-6045				Wculek S. K., 2015, NATURE, V17, P57	1	4	4	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2016	16	2								10.1038/nri.2016.17	http://dx.doi.org/10.1038/nri.2016.17			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DC4IG	26831524				2022-12-18	WOS:000369183800006
J	Leavy, O				Leavy, Olive			CELL DEATH Pathways for cross-priming	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	4	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2015	15	12					725	725		10.1038/nri3933	http://dx.doi.org/10.1038/nri3933			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CY1FS	26493941				2022-12-18	WOS:000366152700001
J	Minton, K				Minton, Kirsty			T CELL RESPONSES A long-chain reaction	NATURE REVIEWS IMMUNOLOGY			English	News Item														Minton, Kirsty/0000-0002-3857-8030					0	4	6	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2015	15	12					726	727		10.1038/nri3934	http://dx.doi.org/10.1038/nri3934			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CY1FS	26515077				2022-12-18	WOS:000366152700002
J	Bird, L				Bird, Lucy			TET2: the terminator	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bird, Lucy/0000-0002-3914-6045				Zhang Q., 2015, NATURE	1	4	5	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2015	15	10					598	598		10.1038/nri3912	http://dx.doi.org/10.1038/nri3912			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CS2PE	26358395				2022-12-18	WOS:000361912600005
J	Fahy, JV				Fahy, John V.			Type 2 inflammation in asthma - present in most, absent in many (vol 15, pg 57, 2015)	NATURE REVIEWS IMMUNOLOGY			English	Correction																		Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786	1	4	4	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2015	15	2					130	130		10.1038/nri3807	http://dx.doi.org/10.1038/nri3807			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CA0ZQ		Bronze			2022-12-18	WOS:000348642400011
J	Leavy, O				Leavy, Olive			INFECTIOUS DISEASE The tolerance of superspreaders	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	4	4	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2014	14	12								10.1038/nri3776	http://dx.doi.org/10.1038/nri3776			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU4FW	25394945	Bronze			2022-12-18	WOS:000345566400004
J	Nataf, S				Nataf, Serge			The sensory immune system: a neural twist to the antigenic discontinuity theory	NATURE REVIEWS IMMUNOLOGY			English	Letter									Univ Lyon 1, INSERM CNRS UMR5292 1028, Lyon Neurosci Res Ctr,Hosp Civils Lyon, Banque Tissus & Cellules,Hop Edouard Herriot,Lyon, F-69000 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Nataf, S (corresponding author), Univ Lyon 1, INSERM CNRS UMR5292 1028, Lyon Neurosci Res Ctr,Hosp Civils Lyon, Banque Tissus & Cellules,Hop Edouard Herriot,Lyon, F-69000 Lyon, France.	serge.nataf@inserm.fr		Nataf, Serge/0000-0003-3462-579X				Anderson CC, 2001, NAT MED, V7, P80, DOI 10.1038/83393; Bar-Yosef O, 2002, J NEUROSCI, V22, P8619; Burnet FM, 1949, PRODUCTION ANTIBODIE; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; Lakatos P, 2013, NEURON, V77, P750, DOI 10.1016/j.neuron.2012.11.034; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Okamoto H, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-44; Pradeu T, 2013, NAT REV IMMUNOL, V13, P764, DOI 10.1038/nri3521; Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024; Rabinowitz NC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001710; Rauschecker J. P., 2013, HUM BRAIN MAPP; Tauber AI, 1994, IMMUNE SELF THEORY M; Tauber Alfred, 2012, STANFORD ENCY PHILOS; Zhao GP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002270; 2013, NATURE REV IMMUNOL, V13, P764	16	4	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2014	14	4								10.1038/nri3521-c1	http://dx.doi.org/10.1038/nri3521-c1			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AD6YY	24662388	Bronze			2022-12-18	WOS:000333408800015
J	Bordon, Y				Bordon, Yvonne			Spotting the troublemakers	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X				Ramesh R, 2014, J EXP MED, V211, P89, DOI 10.1084/jem.20130301	1	4	4	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2014	14	2					64	65		10.1038/nri3610	http://dx.doi.org/10.1038/nri3610			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA3VI	24457476				2022-12-18	WOS:000331022400005
J	Bird, L				Bird, Lucy			Immunometabolism: Regulatory B cells weigh in	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	4	4	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2014	14	1								10.1038/nri3588	http://dx.doi.org/10.1038/nri3588			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	279LT	24336103				2022-12-18	WOS:000328962200008
J	Kugelberg, E				Kugelberg, Elisabeth			IMMUNE HOMEOSTASIS Balancing the gut	NATURE REVIEWS IMMUNOLOGY			English	News Item														Kugelberg, Elisabeth/0000-0002-8302-3595				Alenghat T, 2013, NATURE, V504, P153, DOI 10.1038/nature12687	1	4	5	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2013	13	12								10.1038/nri3577	http://dx.doi.org/10.1038/nri3577			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	262EU	24409526				2022-12-18	WOS:000327717900010
J	Leavy, O				Leavy, Olive			ASTHMA AND ALLERGY A fibrinogen root to airway inflammation	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	4	4	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2013	13	10					704	704		10.1038/nri3538	http://dx.doi.org/10.1038/nri3538			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	224GH	24037415	Bronze			2022-12-18	WOS:000324870400002
J	Minton, K				Minton, Kirsty			IMMUNOMETABOLISM What is the point of Warburg?	NATURE REVIEWS IMMUNOLOGY			English	News Item														Minton, Kirsty/0000-0002-3857-8030					0	4	4	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JUL	2013	13	7					472	472		10.1038/nri3485	http://dx.doi.org/10.1038/nri3485			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	170LT	23765057				2022-12-18	WOS:000320853100005
J	Leavy, O				Leavy, Olive			Regenerating muscles the type 2 way	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	4	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2013	13	6					395	395		10.1038/nri3460	http://dx.doi.org/10.1038/nri3460			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	151FE	23648971				2022-12-18	WOS:000319445300007
J	Leavy, O				Leavy, Olive			T CELLS Salt promotes pathogenic T(H)17 cells	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Kleinewietfeld M., 2013, NATURE          0306, DOI [10.1038/nature11868, DOI 10.1038/NATURE11868]; Wu C., 2013, NATURE          0306, DOI [10.1038/nature11984, DOI 10.1038/NATURE11984]; Yosef N., 2013, NATURE          0306, DOI [10.1038/nature11981, DOI 10.1038/NATURE11981]	3	4	4	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2013	13	4					225	225		10.1038/nri3432	http://dx.doi.org/10.1038/nri3432			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	112US	23493117	Bronze			2022-12-18	WOS:000316620100008
J	Minton, K				Minton, Kirsty			MUCOSAL IMMUNOLOGY Don't forget our fungal friends	NATURE REVIEWS IMMUNOLOGY			English	News Item														Minton, Kirsty/0000-0002-3857-8030					0	4	4	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JUL	2012	12	7					476	476		10.1038/nri3252	http://dx.doi.org/10.1038/nri3252			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	965YF	22728523				2022-12-18	WOS:000305803000005
J	Papatriantafyllou, M				Papatriantafyllou, Maria			TRAFFICKING Tracking immune cells on the lymph node map	NATURE REVIEWS IMMUNOLOGY			English	News Item													Papatriantafyllou, Maria/ADP-1463-2022					Braun A, 2011, NAT IMMUNOL, V12, P879, DOI 10.1038/ni.2085	1	4	4	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2011	11	10					644	644		10.1038/nri3068	http://dx.doi.org/10.1038/nri3068			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	823WC	21904386	Bronze			2022-12-18	WOS:000295156600010
J	Papatriantafyllou, M				Papatriantafyllou, Maria			Regulatory T cells: Pursuing a germinal centre career	NATURE REVIEWS IMMUNOLOGY			English	News Item													Papatriantafyllou, Maria/ADP-1463-2022					Campbell DJ, 2011, NAT MED, V17, P929, DOI 10.1038/nm.2433; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425	4	4	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2011	11	9					572	572		10.1038/nri3053	http://dx.doi.org/10.1038/nri3053			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	811XB	21970029	Bronze			2022-12-18	WOS:000294250400008
J	Papatriantafyllou, M				Papatriantafyllou, Maria			TOLERANCE Both natural and induced T-Reg talents needed	NATURE REVIEWS IMMUNOLOGY			English	News Item													Papatriantafyllou, Maria/ADP-1463-2022					HARIBHAI D, 2011, IMMUNITY        0630, DOI DOI 10.1016/J.IMMUNI.2011.03.029	1	4	5	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2011	11	8					500	500		10.1038/nri3030	http://dx.doi.org/10.1038/nri3030			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	796RN	21779034				2022-12-18	WOS:000293069600003
J	Leavy, O				Leavy, Olive			IMMUNE REGULATION Macrophages join the FOXP3 suppressor gang	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	4	4	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JUL	2011	11	7					438	438		10.1038/nri3015	http://dx.doi.org/10.1038/nri3015			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	782QS	21701515				2022-12-18	WOS:000292025300001
J	Leavy, O				Leavy, Olive			ANTIVIRAL IMMUNITY SAMHD1-stopping HIV in its tracks	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	4	4	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JUL	2011	11	7								10.1038/nri3018	http://dx.doi.org/10.1038/nri3018			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	782QS	21701517	Bronze			2022-12-18	WOS:000292025300005
J	Papatriantafyllou, M				Papatriantafyllou, Maria			CYTOKINES GM-CSF in focus	NATURE REVIEWS IMMUNOLOGY			English	News Item													Papatriantafyllou, Maria/ADP-1463-2022					CODARRI L, 2011, NATURE IMMUNOL, V123, P123; ELBEHI M, 2011, NATURE IMMUNOL, V123, P123	2	4	6	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2011	11	6								10.1038/nri2996	http://dx.doi.org/10.1038/nri2996			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	768PT	21597474				2022-12-18	WOS:000290948600006
J	Bordon, Y				Bordon, Yvonne			IMMUNE RESPONSES IL-7 goes antiviral	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X				PELLEGRINI M, 2011, CELL            0203, DOI DOI 10.1016/J.CELL.2011.01.011	1	4	4	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	MAR	2011	11	3								10.1038/nri2949	http://dx.doi.org/10.1038/nri2949			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	726OG	21456116				2022-12-18	WOS:000287732500004
J	Leavy, O				Leavy, Olive			NEUROIMMUNOLOGY The T(H)17 kiss of death for neurons	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Egen JG, 2010, IMMUNITY, V33, P298, DOI 10.1016/j.immuni.2010.09.004; Siffrin V, 2010, IMMUNITY, V33, P424, DOI 10.1016/j.immuni.2010.08.018	2	4	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2010	10	11								10.1038/nri2876	http://dx.doi.org/10.1038/nri2876			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	670NM	21080612				2022-12-18	WOS:000283431100008
J	Irving, K				Irving, Karen			ASTHMA AND ALLERGY Complementing the IL-17 axis in asthma	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926	1	4	5	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2010	10	10					676	676		10.1038/nri2863	http://dx.doi.org/10.1038/nri2863			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	653YV	20879164				2022-12-18	WOS:000282136100002
J	Cua, DJ; Tato, CM				Cua, Daniel J.; Tato, Cristina M.			Innate IL-17-producing cells: the sentinels of the immune system (vol 10, pg 479, 2010)	NATURE REVIEWS IMMUNOLOGY			English	Correction																		Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800	1	4	5	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2010	10	8					612	612		10.1038/nri2819	http://dx.doi.org/10.1038/nri2819			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	629KX		Bronze			2022-12-18	WOS:000280198400015
J	Leavy, O				Leavy, Olive			HIV VACCINE RESULTS CONTROVERSY	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	4	4	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2009	9	11								10.1038/nri2668	http://dx.doi.org/10.1038/nri2668			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	510GG		Bronze			2022-12-18	WOS:000271075500008
J	Allan, S				Allan, Sarah			INNATE IMMUNITY Seeing mTOR in a new light	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012	1	4	4	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2008	8	12					904	904		10.1038/nri2457	http://dx.doi.org/10.1038/nri2457			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	376QD		Bronze			2022-12-18	WOS:000261197200001
J	Lodish, HF; Zhou, BY; Liu, G; Chen, CZ				Lodish, Harvey F.; Zhou, Beiyan; Liu, Gwen; Chen, Chang-Zheng			Micromanagement of the immune system by microRNAs (vol 8, pg 120, 2008)	NATURE REVIEWS IMMUNOLOGY			English	Correction																		Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252	1	4	4	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	MAR	2008	8	3					238	238		10.1038/nri2280	http://dx.doi.org/10.1038/nri2280			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	267ZV		Bronze			2022-12-18	WOS:000253548600018
J	Tufet, M				Tufet, Marta			Innate immunity - NF-kappa B is not alone	NATURE REVIEWS IMMUNOLOGY			English	News Item							DROSOPHILA											Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Goto A, 2008, NAT IMMUNOL, V9, P97, DOI 10.1038/ni1543	2	4	4	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2008	8	2					90	90		10.1038/nri2259	http://dx.doi.org/10.1038/nri2259			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	255QE					2022-12-18	WOS:000252671700004
J	Brandacher, G; Margreiter, R; Fuchs, D				Brandacher, Gerald; Margreiter, Raimund; Fuchs, Dietmar			Interferons, immunity and cancer immunoediting leading to impaired immune function in cancer patients	NATURE REVIEWS IMMUNOLOGY			English	Letter							GAMMA; TRYPTOPHAN; EXPRESSION; NEOPTERIN; CELLS		Innsbruck Med Univ, Tyrolean Canc Res Inst, Dept Gen & Transplant Surg, A-6020 Innsbruck, Austria; Innsbruck Med Univ, Div Biol Chem, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck	Brandacher, G (corresponding author), Innsbruck Med Univ, Tyrolean Canc Res Inst, Dept Gen & Transplant Surg, Anichstr 35, A-6020 Innsbruck, Austria.	gerald.brandacher@uki.at	Fuchs, Dietmar/AAL-8011-2021; Brandacher, Gerald/L-7540-2016	Fuchs, Dietmar/0000-0003-1627-9563; Brandacher, Gerald/0000-0001-7790-441X				Brandacher G, 2006, CLIN CANCER RES, V12, P1144, DOI 10.1158/1078-0432.CCR-05-1966; Brandacher G, 2006, CURR DRUG METAB, V7, P599, DOI 10.2174/138920006778017768; DENZ H, 1990, EUR J HAEMATOL, V44, P186; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; FUCHS D, 1988, IMMUNOL TODAY, V9, P150, DOI 10.1016/0167-5699(88)91203-0; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Wirleitner B, 2003, CURR MED CHEM, V10, P1581, DOI 10.2174/0929867033457179	7	4	4	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2007	7	1												2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	119TP					2022-12-18	WOS:000243036700018
J	Weiner, HL; Frenkel, D				Weiner, Howard L.; Frenkel, Dan			Immunology and immunotherapy of Alzheimer's disease (vol 6, pg 404, 2006)	NATURE REVIEWS IMMUNOLOGY			English	Correction																		Weiner HL, 2006, NAT REV IMMUNOL, V6, P404, DOI 10.1038/nri1843	1	4	4	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2006	6	6					490	490		10.1038/nri1881	http://dx.doi.org/10.1038/nri1881			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	056NF		Bronze			2022-12-18	WOS:000238529700018
J	Panesar, NS				Panesar, NS			Glucocorticoid treatment of patients with SARS: implications for mechanisms of immunopathology	NATURE REVIEWS IMMUNOLOGY			English	Letter							CORTICOSTEROIDS		Chinese Univ Hong Kong, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong	Panesar, NS (corresponding author), Chinese Univ Hong Kong, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China.	nspanesar@cuhk.edu.hk						Gu J, 2005, J EXP MED, V202, P415, DOI 10.1084/jem.20050828; Oba Y, 2003, NEW ENGL J MED, V348, P2034; Perlman S, 2005, NAT REV IMMUNOL, V5, P917, DOI 10.1038/nri1732; Petrovsky N, 1998, CYTOKINE, V10, P307, DOI 10.1006/cyto.1997.0289; Sung JJY, 2004, THORAX, V59, P414, DOI 10.1136/thx.2003.014076; Wang HJ, 2003, NEW ENGL J MED, V349, P507, DOI 10.1056/NEJM200307313490519	6	4	4	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2006	6	4								10.1038/nri1835-c1	http://dx.doi.org/10.1038/nri1835-c1			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	025YJ		Green Published, Bronze			2022-12-18	WOS:000236303200022
J	Bird, L				Bird, L			Immune responses: Inhibition zipped	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	4	4	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2006	6	1					6	6		10.1038/nri1774	http://dx.doi.org/10.1038/nri1774			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	000FW		Bronze			2022-12-18	WOS:000234447300009
J	Honey, K				Honey, K			In the news - Ebola vaccine trials	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	4	5	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2004	4	1					4	4		10.1038/nri1282	http://dx.doi.org/10.1038/nri1282			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	759PF		Bronze			2022-12-18	WOS:000187745500002
J	Moffett-King, A				Moffett-King, A			Natural killer cells and pregnancy (vol 2, pg 656, 2002)	NATURE REVIEWS IMMUNOLOGY			English	Correction																		Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886	1	4	4	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2002	2	12					975	975		10.1038/nri967	http://dx.doi.org/10.1038/nri967			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	636DT		Bronze			2022-12-18	WOS:000180439800018
J	Wang, J				Wang, J			The critical role of LIGHT, a TNF family member, in T cell development.	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	4	4	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2001	1	3					175	175						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	635KN					2022-12-18	WOS:000180398200015
J	Bell, J				Bell, J			Decisions, decisions	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Koch U, 2001, IMMUNITY, V15, P225, DOI 10.1016/S1074-7613(01)00189-3	1	4	4	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2001	1	1					8	8		10.1038/35095545	http://dx.doi.org/10.1038/35095545			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	635KK		Bronze			2022-12-18	WOS:000180397900017
J	Du, HX; Bartleson, JM; Butenko, S; Alonso, V; Liu, WF; Winer, DA; Butte, MJ				Du, Huixun; Bartleson, Juliet M.; Butenko, Sergei; Alonso, Valentina; Liu, Wendy F.; Winer, Daniel A.; Butte, Manish J.			Tuning immunity through tissue mechanotransduction	NATURE REVIEWS IMMUNOLOGY			English	Review; Early Access							SHEAR-WAVE ELASTOGRAPHY; SPLEEN STIFFNESS; QUANTITATIVE ELASTOGRAPHY; ALPHA-2-BETA-1 INTEGRIN; MACROPHAGE POLARIZATION; TRANSCRIPTION FACTORS; CELL-PROLIFERATION; MECHANICAL FORCES; GENE-EXPRESSION; ARP2/3 COMPLEX	Immune responses are governed by signals from the tissue microenvironment, and in addition to biochemical signals, mechanical cues and forces arising from the tissue, its extracellular matrix and its constituent cells shape immune cell function. Indeed, changes in biophysical properties of tissue alter the mechanical signals experienced by cells in many disease conditions, in inflammatory states and in the context of ageing. These mechanical cues are converted into biochemical signals through the process of mechanotransduction, and multiple pathways of mechanotransduction have been identified in immune cells. Such pathways impact important cellular functions including cell activation, cytokine production, metabolism, proliferation and trafficking. Changes in tissue mechanics may also represent a new form of 'danger signal' that alerts the innate and adaptive immune systems to the possibility of injury or infection. Tissue mechanics can change temporally during an infection or inflammatory response, offering a novel layer of dynamic immune regulation. Here, we review the emerging field of mechanoimmunology, focusing on how mechanical cues at the scale of the tissue environment regulate immune cell behaviours to initiate, propagate and resolve the immune response. This Review considers how the biophysical properties of a tissue are able to shape immune cell function through the process of mechanotransduction. There are multiple mechanotransduction pathways that operate in immune cells and the authors highlight these and the emerging field of mechanoimmunology.	[Du, Huixun; Bartleson, Juliet M.; Winer, Daniel A.] Buck Inst Res Aging, Novato, CA 94945 USA; [Du, Huixun; Winer, Daniel A.] Univ Southern Calif, Leonard Davis Sch Gerontol, Los Angeles, CA 90007 USA; [Butenko, Sergei; Liu, Wendy F.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA; [Butenko, Sergei; Liu, Wendy F.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Butenko, Sergei; Liu, Wendy F.] Univ Calif Irvine, UCI Edwards Sci Fdn, Cardiovasc Innovat & Res Ctr CIRC, Irvine, CA 92697 USA; [Alonso, Valentina; Butte, Manish J.] Univ Calif Los Angeles, Dept Microbiol immunol & Mol Genet, Los Angeles, CA 90095 USA; [Liu, Wendy F.] Univ Calif Irvine, Dept Biomol & Chem Engn, Irvine, CA 92697 USA; [Liu, Wendy F.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Liu, Wendy F.] Univ Calif Irvine, Inst Immunol, Irvine, CA 92697 USA; [Winer, Daniel A.] Univ Hlth Network, Toronto Gen Hosp Res Inst TGHRI, Div Cellular & Mol Biol, Toronto, ON, Canada; [Winer, Daniel A.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Winer, Daniel A.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Butte, Manish J.] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA	Buck Institute for Research on Aging; University of Southern California; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Los Angeles; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of California System; University of California Los Angeles	Winer, DA (corresponding author), Buck Inst Res Aging, Novato, CA 94945 USA.; Winer, DA (corresponding author), Univ Southern Calif, Leonard Davis Sch Gerontol, Los Angeles, CA 90007 USA.; Liu, WF (corresponding author), Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA.; Liu, WF (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA.; Liu, WF (corresponding author), Univ Calif Irvine, UCI Edwards Sci Fdn, Cardiovasc Innovat & Res Ctr CIRC, Irvine, CA 92697 USA.; Butte, MJ (corresponding author), Univ Calif Los Angeles, Dept Microbiol immunol & Mol Genet, Los Angeles, CA 90095 USA.; Liu, WF (corresponding author), Univ Calif Irvine, Dept Biomol & Chem Engn, Irvine, CA 92697 USA.; Liu, WF (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.; Liu, WF (corresponding author), Univ Calif Irvine, Inst Immunol, Irvine, CA 92697 USA.; Winer, DA (corresponding author), Univ Hlth Network, Toronto Gen Hosp Res Inst TGHRI, Div Cellular & Mol Biol, Toronto, ON, Canada.; Winer, DA (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.; Winer, DA (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.; Butte, MJ (corresponding author), Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA.	wendy.liu@uci.edu; dwiner@buckinstitute.org; mbutte@mednet.ucla.edu		Du, Huixun/0000-0001-9739-6774; Bartleson, Juliet/0000-0003-2342-1839; Butenko, Sergei/0000-0001-9759-9897; Butte, Manish/0000-0002-4490-5595	National Institutes of Health (NIH) [AG000266]; Huiying Memorial Foundation; Canadian Institutes of Health Research [PJT169175]; National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) [R01 AI151301]; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R21 AR077288]; National Institute of Aging (NIA) [R21 G069067]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Huiying Memorial Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	J.M.B. is a recipient of a National Institutes of Health (NIH) T32 (AG000266) postdoctoral fellowship award. This work was funded, in part, through the Huiying Memorial Foundation (D.A.W.), the Canadian Institutes of Health Research PJT169175 (D.A.W.), and the National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) R01 AI151301 (W.F.L.), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) R21 AR077288 (W.F.L.) and the National Institute of Aging (NIA) R21 G069067 (W.F.L).	Acerbi I, 2015, INTEGR BIOL-UK, V7, P1120, DOI 10.1039/c5ib00040h; Acevedo-Acevedo S, 2015, J NEGAT RESULTS BIOM, V14, DOI 10.1186/s12952-015-0042-8; ADAMSON P, 1992, J BIOL CHEM, V267, P20033; Alam SG, 2016, SCI REP-UK, V6, DOI 10.1038/srep38063; Altorki T, 2021, BMC IMMUNOL, V22, DOI 10.1186/s12865-020-00394-5; Amann KJ, 2001, P NATL ACAD SCI USA, V98, P15009, DOI 10.1073/pnas.211556398; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Arda K, 2011, AM J ROENTGENOL, V197, P532, DOI 10.2214/AJR.10.5449; Atcha H, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23482-5; Aykut B, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abb5168; Baratchi S, 2020, CIRCULATION, V142, P1092, DOI 10.1161/CIRCULATIONAHA.120.045536; Bartleson Juliet M, 2021, Nat Aging, V1, P769, DOI 10.1038/s43587-021-00114-7; Basu R, 2016, CELL, V165, P100, DOI 10.1016/j.cell.2016.01.021; Ben-Shmuel A, 2019, J LEUKOCYTE BIOL, V105, P1261, DOI 10.1002/JLB.MR0718-267R; Blumenthal D, 2020, ELIFE, V9, DOI 10.7554/eLife.55995; Bollyky PL, 2010, CELL MOL IMMUNOL, V7, P211, DOI 10.1038/cmi.2010.9; Booth AJ, 2012, AM J RESP CRIT CARE, V186, P866, DOI 10.1164/rccm.201204-0754OC; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P9398, DOI 10.1073/pnas.152665399; Byeon SE, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/512926; Cambria E, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9071736; Celsus A. C, 1935, DE MEDICINA; Chakraborty M, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2020.108609; Chen MM, 2020, BIOACT MATER, V5, P880, DOI 10.1016/j.bioactmat.2020.05.004; Colecchia A, 2012, GASTROENTEROLOGY, V143, P646, DOI 10.1053/j.gastro.2012.05.035; Comrie WA, 2015, J CELL BIOL, V208, P457, DOI 10.1083/jcb.201406120; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Costello P, 2015, BLOOD, V125, P1244, DOI 10.1182/blood-2014-08-595603; Cukierman E, 2010, SEMIN CANCER BIOL, V20, P139, DOI 10.1016/j.semcancer.2010.04.004; Darwish A., 2022, STATPEARLS; de la Zerda A, 2018, APL BIOENG, V2, DOI 10.1063/1.5006599; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Diridollou S, 2001, Int J Cosmet Sci, V23, P353, DOI 10.1046/j.0412-5463.2001.00105.x; Donahue DA, 2017, J VIROL, V91, DOI 10.1128/JVI.02303-16; Drake TM, 2020, AM J RESP CRIT CARE, V202, P1656, DOI 10.1164/rccm.202007-2794OC; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Dutta B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.570195; E. Condiff, 2022, bioRxiv, DOI 10.1101/2022.01.18.476683; Esposito AJ, 2020, AM J RESP CRIT CARE, V202, P1710, DOI 10.1164/rccm.202006-2441LE; Evans RC, 2006, BIOPHYS J, V91, P1541, DOI 10.1529/biophysj.105.080366; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Feng Y, 2018, J BIOL CHEM, V293, P19290, DOI 10.1074/jbc.RA118.005457; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Feske S, 2015, ANNU REV IMMUNOL, V33, P291, DOI 10.1146/annurev-immunol-032414-112212; Fitzgerald JB, 2006, J BIOL CHEM, V281, P24095, DOI 10.1074/jbc.M510858200; Garoffolo G, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121607; Gaspari R, 2009, J ULTRAS MED, V28, P855, DOI 10.7863/jum.2009.28.7.855; Geng J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23683-y; Geng J, 2017, NAT IMMUNOL, V18, P800, DOI 10.1038/ni.3748; Gonzalez-Granado JM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004872; Greenberg RS, 2006, FASEB J, V20, P1006, DOI 10.1096/fj.05-4838fje; Guenther C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01138; Guimaraes CF, 2020, NAT REV MATER, V5, P351, DOI 10.1038/s41578-019-0169-1; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hennes A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38376-8; Hickey JW, 2019, ADV MATER, V31, DOI 10.1002/adma.201807359; Hodge RG, 2016, NAT REV MOL CELL BIO, V17, P496, DOI 10.1038/nrm.2016.67; Hsiai TK, 2003, FASEB J, V17, P1648, DOI 10.1096/fj.02-1064com; Hsieh JY, 2019, APL BIOENG, V3, DOI 10.1063/1.5067301; Hsieh JY, 2017, ACTA BIOMATER, V47, P14, DOI 10.1016/j.actbio.2016.09.024; Hu KK, 2014, IMMUNOL RES, V58, P211, DOI 10.1007/s12026-014-8510-7; Huse M, 2017, NAT REV IMMUNOL, V17, P679, DOI 10.1038/nri.2017.74; Le HQ, 2016, NAT CELL BIOL, V18, P864, DOI 10.1038/ncb3387; Casal JI, 2018, BBA-REV CANCER, V1869, P321, DOI 10.1016/j.bbcan.2018.04.005; Jacobson EC, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0608-2; Jain N, 2019, ANNU REV BIOMED ENG, V21, P267, DOI 10.1146/annurev-bioeng-062117-121224; Jain N, 2018, NAT MATER, V17, P1134, DOI 10.1038/s41563-018-0190-6; Jain N, 2013, P NATL ACAD SCI USA, V110, P11349, DOI 10.1073/pnas.1300801110; Jairaman A, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abg5859; Jansen LE, 2015, J MECH BEHAV BIOMED, V50, P299, DOI 10.1016/j.jmbbm.2015.06.023; Jansson L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032013; Jaumouille V, 2019, NAT CELL BIOL, V21, P1357, DOI 10.1038/s41556-019-0414-2; KATAYAMA M, 1991, J BIOL CHEM, V266, P12639; Kawano S, 2015, CANCER SCI, V106, P1232, DOI 10.1111/cas.12720; Kennedy P, 2018, RADIOLOGY, V286, P738, DOI 10.1148/radiol.2018170601; Kim TH, 2016, J CELL SCI, V129, P4563, DOI 10.1242/jcs.194803; Klemke M, 2008, IMMUNITY, V29, P404, DOI 10.1016/j.immuni.2008.06.016; Kohler R, 2006, ARTERIOSCL THROM VAS, V26, P1495, DOI 10.1161/01.ATV.0000225698.36212.6a; Koo JH, 2018, CELL METAB, V28, P196, DOI 10.1016/j.cmet.2018.07.010; Krishnamurty AT, 2020, NAT IMMUNOL, V21, P369, DOI 10.1038/s41590-020-0635-3; Kuczek DE, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0556-6; Kuehlmann B, 2020, J CLIN MED, V9, DOI 10.3390/jcm9051423; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Lebid A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00580; Leung VYF, 2013, RADIOLOGY, V269, P910, DOI 10.1148/radiol.13130128; Li D, 2009, J BIOL CHEM, V284, P21001, DOI 10.1074/jbc.M109.002865; Li J, 2014, NATURE, V515, P279, DOI 10.1038/nature13701; Liu CSC, 2018, J IMMUNOL, V200, P1255, DOI 10.4049/jimmunol.1701118; Liu YY, 2021, CANCER RES, V81, P476, DOI 10.1158/0008-5472.CAN-20-2569; Loh C, 1996, MOL CELL BIOL, V16, P3945; Lombardi ML, 2011, J BIOL CHEM, V286, P26743, DOI 10.1074/jbc.M111.233700; Mair I, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00264; Majedi FS, 2020, BIOMATERIALS, V252, DOI 10.1016/j.biomaterials.2020.120058; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; Mascharak S, 2021, SCIENCE, V372, P362, DOI 10.1126/science.aba2374; Matalon O, 2018, EMBO J, V37, DOI 10.15252/embj.201696264; Meli VS, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb8471; Meli VS, 2019, J LEUKOCYTE BIOL, V106, P283, DOI 10.1002/JLB.MR0318-126R; Meng KP, 2020, J EXP MED, V217, DOI 10.1084/jem.20200053; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Michalick L, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00413; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Mokalled MH, 2015, DEV BIOL, V406, P109, DOI 10.1016/j.ydbio.2015.09.006; Mokalled MH, 2010, DEVELOPMENT, V137, P2365, DOI 10.1242/dev.047605; Moore EM, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abj5830; Morikis VA, 2020, J LEUKOCYTE BIOL, V108, P1815, DOI 10.1002/JLB.3A0520-100RR; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Murphy MC, 2011, J MAGN RESON IMAGING, V34, P494, DOI 10.1002/jmri.22707; Nagy N, 2019, MATRIX BIOL, V78-79, P292, DOI 10.1016/j.matbio.2018.03.022; Naik SK, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101206; Ni HT, 2001, J IMMUNOL, V166, P6523, DOI 10.4049/jimmunol.166.11.6523; Ni XH, 2018, CANCER DISCOV, V8, P1026, DOI 10.1158/2159-8290.CD-17-1124; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; Oberoi TK, 2012, EMBO J, V31, P14, DOI 10.1038/emboj.2011.423; Ogawa R, 2011, WOUND REPAIR REGEN, V19, pS2, DOI 10.1111/j.1524-475X.2011.00707.x; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; Pageon SV, 2018, MOL BIOL CELL, V29, P1919, DOI 10.1091/mbc.E18-02-0120; Pairet N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196055; Pakshir P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09709-6; Panciera T, 2017, NAT REV MOL CELL BIO, V18, P758, DOI 10.1038/nrm.2017.87; Paul CD, 2016, ANNU REV BIOMED ENG, V18, P159, DOI 10.1146/annurev-bioeng-071114-040654; Pawlus A, 2016, ABDOM RADIOL, V41, P2169, DOI 10.1007/s00261-016-0834-4; Plodinec M, 2012, NAT NANOTECHNOL, V7, P757, DOI [10.1038/nnano.2012.167, 10.1038/NNANO.2012.167]; Ramiao NG, 2016, BIOMECH MODEL MECHAN, V15, P1307, DOI 10.1007/s10237-016-0763-8; Record J, 2015, BLOOD, V126, P1527, DOI 10.1182/blood-2014-12-611012; Renkawitz J, 2019, NATURE, V568, P546, DOI 10.1038/s41586-019-1087-5; Rowley AT, 2019, ADV HEALTHC MATER, V8, DOI 10.1002/adhm.201801578; Roy NH, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aat3178; Ruppert SM, 2014, IMMUNOL RES, V58, P186, DOI 10.1007/s12026-014-8495-2; Rutkowski JM, 2007, TRENDS CELL BIOL, V17, P44, DOI 10.1016/j.tcb.2006.11.007; Sachot N, 2014, CURR ORG CHEM, V18, P2299, DOI 10.2174/1385272819666140806200355; Saez A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176109; Saitakis M, 2017, ELIFE, V6, DOI 10.7554/eLife.23190; Salmon H, 2012, J CLIN INVEST, V122, P899, DOI 10.1172/JCI45817; Sasaki Y, 2019, DENTOMAXILLOFAC RAD, V48, DOI 10.1259/dmfr.20180454; Scheraga RG, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01211; Scheraga RG, 2020, J IMMUNOL, V204, P1310, DOI 10.4049/jimmunol.1901033; Shaheen S, 2017, ELIFE, V6, DOI 10.7554/eLife.23060; Shen B, 2021, NATURE, V591, P438, DOI 10.1038/s41586-021-03298-5; Shimbori C, 2019, THORAX, V74, P455, DOI 10.1136/thoraxjnl-2018-211516; Sicard D, 2018, AM J PHYSIOL-LUNG C, V314, pL946, DOI 10.1152/ajplung.00415.2017; Smith TD, 2017, ADV DRUG DELIVER REV, V114, P193, DOI 10.1016/j.addr.2017.04.012; Solis AG, 2019, NATURE, V573, P69, DOI 10.1038/s41586-019-1485-8; Spillane KM, 2017, J CELL BIOL, V216, P217, DOI 10.1083/jcb.201607064; Sridharan R, 2019, ACTA BIOMATER, V89, P47, DOI 10.1016/j.actbio.2019.02.048; Stavenschi E, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1025-8; Stotesbury C, 2020, J IMMUNOL, V204, P1582, DOI 10.4049/jimmunol.1900927; Sugimura K, 2016, DEVELOPMENT, V143, P186, DOI 10.1242/dev.119776; Sulk M., 2015, TRP CHANNELS THERAPE, DOI [10. 1016/B978-0-12-420024-1. 00017-5, DOI 10.1016/B978-0-12-420024-1.00017-5]; Sun WJ, 2021, ARTIF ORGANS, V45, P577, DOI 10.1111/aor.13874; Sun ZQ, 2016, J CELL BIOL, V215, P445, DOI 10.1083/jcb.201609037; Tajik A, 2016, NAT MATER, V15, P1287, DOI [10.1038/NMAT4729, 10.1038/nmat4729]; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Tansey EA, 2019, ADV PHYSIOL EDUC, V43, P423, DOI 10.1152/advan.00182.2018; Tate MLK, 2003, J BIOMECH, V36, P1409, DOI 10.1016/S0021-9290(03)00123-4; Tello-Lafoz M, 2021, IMMUNITY, V54, P1037, DOI 10.1016/j.immuni.2021.02.020; Thauland TJ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02706; Thauland TJ, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aah3737; Thery M, 2006, P NATL ACAD SCI USA, V103, P19771, DOI 10.1073/pnas.0609267103; Totaro A, 2018, NAT CELL BIOL, V20, P888, DOI 10.1038/s41556-018-0142-z; Uyeda TQP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026200; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Vedadghavami A, 2017, ACTA BIOMATER, V62, P42, DOI 10.1016/j.actbio.2017.07.028; Venkatesh SK, 2013, J MAGN RESON IMAGING, V37, P544, DOI 10.1002/jmri.23731; Versaevel M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1668; Vining KH, 2017, NAT REV MOL CELL BIO, V18, P728, DOI 10.1038/nrm.2017.108; Vogel V, 2018, ANNU REV PHYSIOL, V80, P353, DOI 10.1146/annurev-physiol-021317-121312; Wahl A, 2019, P NATL ACAD SCI USA, V116, P5908, DOI 10.1073/pnas.1811516116; Wang C, 2010, J IMMUNOL, V185, P7487, DOI 10.4049/jimmunol.1001424; Wang L, 2016, NATURE, V540, P579, DOI 10.1038/nature20602; Wang LY, 2017, ULTRASOUND MED BIOL, V43, P1339, DOI 10.1016/j.ultrasmedbio.2017.02.009; Wang N, 2017, J PHYS D APPL PHYS, V50, DOI 10.1088/1361-6463/aa6e18; Wang S, 2017, NAT IMMUNOL, V18, P733, DOI 10.1038/ni.3744; Wells RG, 2013, BBA-MOL BASIS DIS, V1832, P884, DOI 10.1016/j.bbadis.2013.02.007; Wong NR, 2021, IMMUNITY, V54, P2072, DOI 10.1016/j.immuni.2021.07.003; Wong VW, 2012, NAT MED, V18, P148, DOI 10.1038/nm.2574; Xiao ZH, 2006, BIOPHYS J, V90, P2221, DOI 10.1529/biophysj.105.065789; Zeng YY, 2015, EUR J IMMUNOL, V45, P1621, DOI 10.1002/eji.201444777; Zhang Q, 2017, NAT CELL BIOL, V19, P362, DOI 10.1038/ncb3496; Zheng J, 2013, COMPR PHYSIOL, V3, P221, DOI 10.1002/cphy.c120001; Zhou TF, 2020, ELIFE, V9, DOI 10.7554/eLife.52779; Zhou X, 2019, CELL REP, V27, P1176, DOI 10.1016/j.celrep.2019.03.028; Zhu C, 2019, NAT IMMUNOL, V20, P1269, DOI 10.1038/s41590-019-0491-1	186	3	3	17	17	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.												10.1038/s41577-022-00761-w	http://dx.doi.org/10.1038/s41577-022-00761-w		AUG 2022	15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3U7DB	35974148	Bronze, Green Published			2022-12-18	WOS:000841126300001
J	Martineau, AR; Cantorna, MT				Martineau, Adrian R.; Cantorna, Margherita T.			Vitamin D for COVID-19: where are we now?	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material								Vitamin D has received much interest during the COVID-19 pandemic as a potential prophylactic or therapeutic agent - but do the available data support its use?	[Martineau, Adrian R.] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, Ctr Immunobiol, London, England; [Cantorna, Margherita T.] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA	University of London; Queen Mary University London; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Martineau, AR (corresponding author), Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, Ctr Immunobiol, London, England.	a.martineau@qmul.ac.uk						Arora J., 2022, BIORXIV, DOI [10.1101/2022.06.29.498158, DOI 10.1101/2022.06.29.498158]; Butler-Laporte G, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003605; Chauss D, 2022, NAT IMMUNOL, V23, P62, DOI 10.1038/s41590-021-01080-3; Dissanayake HA, 2022, J CLIN ENDOCR METAB, V107, P1484, DOI 10.1210/clinem/dgab892; Entrenas Castillo Marta, 2020, J Steroid Biochem Mol Biol, V203, P105751, DOI 10.1016/j.jsbmb.2020.105751; Jolliffe DA., 2022, PREPRINT, DOI [10.1101/2022.03.22.22271707, DOI 10.1101/2022.03.22.22271707]; Kongsbak-Wismann M, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.758154; Murai IH, 2021, JAMA-J AM MED ASSOC, V325, P1053, DOI 10.1001/jama.2020.26848; Villasis-Keever MA, 2022, ARCH MED RES, V53, P423, DOI 10.1016/j.arcmed.2022.04.003; Wang C, 2021, ACS INFECT DIS, V7, P1545, DOI 10.1021/acsinfecdis.1c00096	10	3	3	3	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2022	22	9					529	530		10.1038/s41577-022-00765-6	http://dx.doi.org/10.1038/s41577-022-00765-6		JUL 2022	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	4E2XF	35869321	Bronze, Green Published			2022-12-18	WOS:000828938500003
J	Diamond, MS; Lambris, JD; Ting, JP; Tsang, JS				Diamond, Michael S.; Lambris, John D.; Ting, Jenny P.; Tsang, John S.			Considering innate immune responses in SARS-CoV-2 infection and COVID-19	NATURE REVIEWS IMMUNOLOGY			English	Article							AUTOANTIBODIES	In early 2022, staff from the NIAID at the NIH organized a workshop focusing on the innate immune response to SARS-CoV-2. In this Viewpoint article, some of the organizers and invited speakers share their thoughts on key outcomes of this meeting. During the COVID-19 pandemic, much of the media focus has been on adaptive immunity, particularly antibody levels and memory T cells. However, immunologists have been striving to decipher how SARS-CoV-2 infection impacts our first line of defence, namely the innate immune system. In early 2022, Program staff from the NIAID at the NIH organized a workshop focusing on the innate immune response to SARS-CoV-2 infection and during COVID-19, which was chaired by Ralph Baric, Jenny Ting and John Lambris. Following the meeting, Nature Reviews Immunology invited some of the organizers and speakers to share their thoughts on the key discussion points.	[Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Immunol, St Louis, MO 63110 USA; [Lambris, John D.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ting, Jenny P.] Univ N Carolina, Dept Genet, Lineberger Comprehens Canc Ctr, Ctr Translat Immunol, Chapel Hill, NC 27515 USA; [Ting, Jenny P.] Univ N Carolina, Dept Microbiol, Lineberger Comprehens Canc Ctr, Ctr Translat Immunol, Chapel Hill, NC 27515 USA; [Ting, Jenny P.] Univ N Carolina, Dept Immunol, Lineberger Comprehens Canc Ctr, Ctr Translat Immunol, Chapel Hill, NC 27515 USA; [Tsang, John S.] NIAID, Multiscale Syst Biol Sect, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Tsang, John S.] NIAID, NIH Ctr Human Immunol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Tsang, John S.] Yale Univ, Sch Med, Dept Lmmunobiol, New Haven, CT 06511 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Pennsylvania; Pennsylvania Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Yale University	Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Immunol, St Louis, MO 63110 USA.; Lambris, JD (corresponding author), Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA.; Ting, JP (corresponding author), Univ N Carolina, Dept Genet, Lineberger Comprehens Canc Ctr, Ctr Translat Immunol, Chapel Hill, NC 27515 USA.; Ting, JP (corresponding author), Univ N Carolina, Dept Microbiol, Lineberger Comprehens Canc Ctr, Ctr Translat Immunol, Chapel Hill, NC 27515 USA.; Ting, JP (corresponding author), Univ N Carolina, Dept Immunol, Lineberger Comprehens Canc Ctr, Ctr Translat Immunol, Chapel Hill, NC 27515 USA.; Tsang, JS (corresponding author), NIAID, Multiscale Syst Biol Sect, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Tsang, JS (corresponding author), NIAID, NIH Ctr Human Immunol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Tsang, JS (corresponding author), Yale Univ, Sch Med, Dept Lmmunobiol, New Haven, CT 06511 USA.	mdiamond@wustl.edu; lambris@pennmedicine.upenn.edu; jenny_ting@med.unc.edu; john.tsang@nih.gov	Lambris, John/Q-5633-2018	Lambris, John/0000-0002-9370-5776; Ting, Jenny/0000-0002-7846-0395	Intramural Program of NIAID	Intramural Program of NIAID	Nature Reviews Immunology and the authors thank the Program Staff at the extramural Division of Allergy Immunology and Transplantation at the NIAID, NIH - specifically N. Vazquez-Maldonado, Q. Liu and W. Leitner - for their key roles in conceiving and organizing the workshop on which this article has been based. J.S.T. is supported by the Intramural Program of NIAID.	Abers MS, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.144455; Afzali B, 2022, NAT REV IMMUNOL, V22, P77, DOI 10.1038/s41577-021-00665-1; Asano T, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl4348; Bastard P, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl4340; Bastard P, 2021, J EXP MED, V218, DOI 10.1084/jem.20210554; Bastard P, 2021, J CLIN IMMUNOL, V41, P931, DOI 10.1007/s10875-021-01023-5; Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585; Channappanavar R, 2020, J CLIN INVEST, V130, P6204, DOI 10.1172/JCI144115; COVID-19 Host Genetics Initiative, NATURE 2021, V600, P477, DOI [10.1038/s41586-021-03767-x1:CAS:528:DC%2BB3MXis1WhsbbN, DOI 10.1038/S41586-021-03767-X1:CAS:528:DC%2BB3MXIS1WHSBBN]; Day JD, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.754127; de Prost N, 2021, J CLIN IMMUNOL, V41, P536, DOI 10.1007/s10875-021-00994-9; DeDiego ML, 2008, VIROLOGY, V376, P379, DOI 10.1016/j.virol.2008.03.005; Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283; Enocsson H, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.791716; Falck-Jones S, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI144734; Fitzgerald K., 2022, PREPRINT, DOI [10.21203/rs.3.rs-1576788/v1, DOI 10.21203/RS.3.RS-1576788/V1]; Gale M., 2022, NIAIDNIH WORKSHOP IN; Gralinski LE, 2018, MBIO, V9, DOI 10.1128/mBio.01753-18; Halfmann PJ, 2022, NATURE, V603, P687, DOI 10.1038/s41586-022-04441-6; Hoagland DA, 2021, IMMUNITY, V54, P557, DOI 10.1016/j.immuni.2021.01.017; Kalil AC, 2021, LANCET RESP MED, V9, P1365, DOI 10.1016/S2213-2600(21)00384-2; Karki R, 2021, CELL, V184, P149, DOI 10.1016/j.cell.2020.11.025; Koning R, 2021, INTENS CARE MED, V47, P704, DOI 10.1007/s00134-021-06392-4; Kramer B, 2021, IMMUNITY, V54, P2650, DOI 10.1016/j.immuni.2021.09.002; Li CF, 2022, NAT IMMUNOL, V23, P543, DOI 10.1038/s41590-022-01163-9; Li N, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109091; Liu C, 2021, CELL, V184, P1836, DOI 10.1016/j.cell.2021.02.018; Liu GQ, 2021, NAT MICROBIOL, V6, P467, DOI 10.1038/s41564-021-00884-1; Lopez J, 2021, J EXP MED, V218, DOI 10.1084/jem.2021121108132021c; Martin-Sancho L, 2021, MOL CELL, V81, P2656, DOI 10.1016/j.molcel.2021.04.008; Meng B, 2022, NATURE, V603, P706, DOI 10.1038/s41586-022-04474-x; Netland J, 2008, J VIROL, V82, P7264, DOI 10.1128/JVI.00737-08; Pairo-Castineira E, 2021, NATURE, V591, P92, DOI 10.1038/s41586-020-03065-y; Peacock TP., 2022, SARS COV 2 VARIANT O, DOI [10.1101/2021.12.31.474653, DOI 10.1101/2021.12.31.474653]; Pfaender S, 2020, NAT MICROBIOL, V5, P1330, DOI [10.1038/s41564-020-0769-y, 10.1101/2020.03.05.979260]; Phetsouphanh C, 2022, NAT IMMUNOL, V23, P210, DOI 10.1038/s41590-021-01113-x; Baric RS, 2022, bioRxiv, DOI 10.1101/2022.06.01.494461; Sparks R, 2022, medRxiv, DOI 10.1101/2022.02.17.22271138; Ramlall V, 2020, NAT MED, V26, P1609, DOI 10.1038/s41591-020-1021-2; Reyes Miguel, 2020, bioRxiv, DOI 10.1101/2020.09.02.280180; Risitano AM, 2020, NAT REV IMMUNOL, V20, P343, DOI 10.1038/s41577-020-0320-7; Rovina N, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02897-4; Sefik E, 2022, NATURE, V606, P585, DOI 10.1038/s41586-022-04802-1; Shuai HP, 2022, NATURE, V603, P693, DOI 10.1038/s41586-022-04442-5; Skendros P, 2020, J CLIN INVEST, V130, P6151, DOI 10.1172/JCI141374; tenOever B. R., 2022, NIAIDNIH WORKSHOP IN; Troya J, 2021, J CLIN IMMUNOL, V41, P914, DOI 10.1007/s10875-021-01036-0; Wahl A, 2021, NATURE, V591, P451, DOI 10.1038/s41586-021-03312-w; Wang EY, 2021, NATURE, V595, P283, DOI [10.1038/s41586-021-03631-y, 10.1101/2020.12.10.20247205]; Wang S, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1009587; Wilk AJ, 2021, J EXP MED, V218, DOI [10.1084/jem.20210582, 10.1126/sciimmunol.aay6017]; Wilk AJ, 2020, NAT MED, V26, P1070, DOI [10.1038/s41591-020-0944-y, 10.1101/2020.04.17.20069930]; Winkler ES, 2020, NAT IMMUNOL, V21, P1327, DOI 10.1038/s41590-020-0778-2; Wong LYR, 2022, NATURE, V605, P146, DOI 10.1038/s41586-022-04630-3; Yamada T, 2021, NAT IMMUNOL, V22, P820, DOI 10.1038/s41590-021-00942-0; Yin X, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2020.108628; Yu J, 2020, BLOOD, V136, P2080, DOI 10.1182/blood.2020008248; Zhang Q, 2020, SCIENCE, V370, DOI 10.1126/science.abd4570; Zheng M, 2021, NAT IMMUNOL, V22, P829, DOI 10.1038/s41590-021-00937-x	59	3	3	6	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2022	22	8					465	470		10.1038/s41577-022-00744-x	http://dx.doi.org/10.1038/s41577-022-00744-x		JUL 2022	6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3I4HH	35788185	Bronze, Green Published			2022-12-18	WOS:000821434000001
J	Hamilton, PT; Anholt, BR; Nelson, BH				Hamilton, Phineas T.; Anholt, Bradley R.; Nelson, Brad H.			Tumour immunotherapy: lessons from predator-prey theory	NATURE REVIEWS IMMUNOLOGY			English	Review							TERTIARY LYMPHOID STRUCTURES; T-CELL THERAPY; B-CELL; METABOLIC COMPETITION; FUNCTIONAL-RESPONSES; PASSENGER MUTATIONS; IMMUNE-SYSTEM; LUNG-CANCER; SURVIVAL; EVOLUTION	With the burgeoning use of immune-based treatments for cancer, never has there been a greater need to understand the tumour microenvironment within which immune cells function and how it can be perturbed to inhibit tumour growth. Yet, current challenges in identifying optimal combinations of immunotherapies and engineering new cell-based therapies highlight the limitations of conventional paradigms for the study of the tumour microenvironment. Ecology has a rich history of studying predator-prey dynamics to discern factors that drive prey to extinction. Here, we describe the basic tenets of predator-prey theory as applied to 'predation' by immune cells and the 'extinction' of cancer cells. Our synthesis reveals fundamental mechanisms by which antitumour immunity might fail in sometimes counterintuitive ways and provides a fresh yet evidence-based framework to better understand and therapeutically target the immune-cancer interface. Improving on current cancer immunotherapies will require engaging immune effectors beyond T cells alone. Predator-prey theory can reveal understudied and counterintuitive facets of antitumour immunity, inspiring new approaches to manipulate the tumour ecosystem in favour of cancer cell extinction.	[Hamilton, Phineas T.; Nelson, Brad H.] BC Canc, Deeley Res Ctr, Victoria, BC, Canada; [Anholt, Bradley R.] Univ Victoria, Dept Biol, Victoria, BC, Canada; [Nelson, Brad H.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada; [Nelson, Brad H.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada	University of Victoria; University of Victoria; University of British Columbia	Nelson, BH (corresponding author), BC Canc, Deeley Res Ctr, Victoria, BC, Canada.; Nelson, BH (corresponding author), Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada.; Nelson, BH (corresponding author), Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada.	bnelson@bccrc.ca		, Brad/0000-0001-9642-4489; Nelson, Brad/0000-0002-4445-5539				AbdulJabbar K, 2020, NAT MED, V26, P1054, DOI 10.1038/s41591-020-0900-x; Abrams PA, 2009, ECOL LETT, V12, P462, DOI 10.1111/j.1461-0248.2009.01282.x; Aktipis CA, 2013, NAT REV CANCER, V13, P883, DOI 10.1038/nrc3606; Andor N, 2017, CANCER RES, V77, P2179, DOI 10.1158/0008-5472.CAN-16-1553; Angelova M, 2018, CELL, V175, P751, DOI 10.1016/j.cell.2018.09.018; Anikeeva N, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101033; Aspuria PJ, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abg7565; Banchereau R, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24112-w; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Bertrand F, 2013, P NATL ACAD SCI USA, V110, P6073, DOI 10.1073/pnas.1218640110; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Boulch M, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abd4344; Breart B, 2008, J CLIN INVEST, V118, P1390, DOI 10.1172/JCI34388; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Brunner-Weinzierl MC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02737; Cabrita R, 2020, NATURE, V577, P561, DOI 10.1038/s41586-019-1914-8; Cescon DW, 2020, NAT CANCER, V1, P276, DOI 10.1038/s43018-020-0043-5; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Cressler CE, 2014, ECOL LETT, V17, P284, DOI 10.1111/ele.12229; Cross W, 2018, NAT ECOL EVOL, V2, P1661, DOI 10.1038/s41559-018-0642-z; Cunningham JJ, 2019, NAT ECOL EVOL, V3, P996, DOI 10.1038/s41559-019-0927-x; Cunningham JJ, 2018, J THEOR BIOL, V459, P67, DOI 10.1016/j.jtbi.2018.09.022; Denny M, 2017, J EXP BIOL, V220, P139, DOI 10.1242/jeb.140368; Eftimie R, 2011, B MATH BIOL, V73, P2, DOI 10.1007/s11538-010-9526-3; Fagan WF, 2006, ECOL LETT, V9, P51, DOI 10.1111/j.1461-0248.2005.00845.x; Fultang L, 2020, BLOOD, V136, P1155, DOI 10.1182/blood.2019004500; Gatenby RA, 2020, NAT REV CLIN ONCOL, V17, P675, DOI 10.1038/s41571-020-0411-1; Gatenby RA, 2020, CANCER RES, V80, P613, DOI 10.1158/0008-5472.CAN-19-1941; Gatenby RA, 2019, CANCER RES, V79, P3174, DOI 10.1158/0008-5472.CAN-19-0807; Gatenby RA, 2009, NATURE, V459, P508, DOI 10.1038/459508a; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Giraldo NA, 2017, CLIN CANCER RES, V23, P4416, DOI 10.1158/1078-0432.CCR-16-2848; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Hammill E, 2015, OECOLOGIA, V178, P549, DOI 10.1007/s00442-015-3244-3; Hanna NH, 2020, J CLIN ONCOL, V38, P1608, DOI 10.1200/JCO.19.03022; Havel JJ, 2019, NAT REV CANCER, V19, P133, DOI 10.1038/s41568-019-0116-x; Hegde M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17175-8; Helmink BA, 2020, NATURE, V577, P549, DOI 10.1038/s41586-019-1922-8; Hillebrand H, 2004, ECOL LETT, V7, P192, DOI 10.1111/j.1461-0248.2004.00570.x; Hirayama AV, 2019, BLOOD, V133, P1876, DOI 10.1182/blood-2018-11-887067; Holling C. S., 1959, Canadian Entomologist, V91, P385; Holt RD, 1997, AM NAT, V149, P745, DOI 10.1086/286018; Hong MH, 2020, CANCER CELL, V38, P473, DOI 10.1016/j.ccell.2020.07.005; Hu XH, 2019, NAT GENET, V51, P560, DOI 10.1038/s41588-018-0339-x; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Jeschke JM, 2004, BIOL REV, V79, P337, DOI 10.1017/S1464793103006286; Jeschke JM, 2002, ECOL MONOGR, V72, P95, DOI 10.1890/0012-9615(2002)072[0095:PFRDBH]2.0.CO;2; Jeschke JM, 2006, J THEOR BIOL, V242, P900, DOI 10.1016/j.jtbi.2006.05.017; Johnston CJC, 2016, CELL IMMUNOL, V299, P14, DOI 10.1016/j.cellimm.2015.10.006; Joseph RW, 2018, CLIN CANCER RES, V24, P4960, DOI 10.1158/1078-0432.CCR-17-2386; Kareva I, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.668221; Kareva I, 2015, J THEOR BIOL, V380, P463, DOI 10.1016/j.jtbi.2015.06.007; Khazen R, 2021, EMBO J, V40, DOI 10.15252/embj.2020106658; Kilgour MK, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe1174; Kirschner D, 1998, J MATH BIOL, V37, P235, DOI 10.1007/s002850050127; Kochenderfer JN, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2016.71.3024; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Kratina P, 2007, ECOLOGY, V88, P1917, DOI 10.1890/06-1507.1; Kroeger DR, 2016, CLIN CANCER RES, V22, P3005, DOI 10.1158/1078-0432.CCR-15-2762; KUZNETSOV VA, 1994, B MATH BIOL, V56, P295, DOI 10.1007/BF02460644; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Legendre P., 2012, NUMERICAL ECOLOGY, DOI DOI 10.1017/CB09781107415324.004; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lu YW, 2020, CELL, V180, P1081, DOI 10.1016/j.cell.2020.02.015; LYNCH M, 1995, AM NAT, V146, P489, DOI 10.1086/285812; LYNCH M, 1990, EVOLUTION, V44, P1725, DOI 10.1111/j.1558-5646.1990.tb05244.x; MacKay M, 2020, NAT BIOTECHNOL, V38, P233, DOI 10.1038/s41587-019-0329-2; Maley CC, 2017, NAT REV CANCER, V17, P605, DOI 10.1038/nrc.2017.69; Marty R, 2018, CELL, V175, P416, DOI 10.1016/j.cell.2018.08.048; McArthur HL, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.TPS598; McFarland CD, 2014, P NATL ACAD SCI USA, V111, P15138, DOI 10.1073/pnas.1404341111; McFarland CD, 2013, P NATL ACAD SCI USA, V110, P2910, DOI 10.1073/pnas.1213968110; McGranahan N, 2017, CELL, V170, P825, DOI 10.1016/j.cell.2017.08.012; McGranahan N, 2017, CELL, V168, P613, DOI 10.1016/j.cell.2017.01.018; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Melenhorst JJ, 2022, NATURE, V602, P503, DOI 10.1038/s41586-021-04390-6; Miranda A, 2019, P NATL ACAD SCI USA, V116, P9020, DOI 10.1073/pnas.1818210116; Mueller KT, 2017, BLOOD, V130, P2317, DOI 10.1182/blood-2017-06-786129; Nawaz S, 2015, MODERN PATHOL, V28, P766, DOI 10.1038/modpathol.2015.37; Ngwa W, 2018, NAT REV CANCER, V18, P313, DOI 10.1038/nrc.2018.6; Niku J, 2019, METHODS ECOL EVOL, V10, P2173, DOI 10.1111/2041-210X.13303; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Oh SA, 2020, NAT CANCER, V1, P681, DOI 10.1038/s43018-020-0075-x; Okuyama T, 2008, ECOL RES, V23, P665, DOI 10.1007/s11284-007-0425-5; Oliver TH, 2015, TRENDS ECOL EVOL, V30, P673, DOI 10.1016/j.tree.2015.08.009; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Park DS, 2019, CANCER RES, V79, P5302, DOI 10.1158/0008-5472.CAN-18-3712; Peplinski J, 2021, FRONT ECOL EVOL, V9, DOI 10.3389/fevo.2021.682504; Persi E, 2021, NAT REV GENET, V22, P251, DOI 10.1038/s41576-020-00299-4; Persi E, 2018, P NATL ACAD SCI USA, V115, pE11101, DOI 10.1073/pnas.1807256115; Petitprez F, 2020, NATURE, V577, P556, DOI 10.1038/s41586-019-1906-8; Poleszczuk JT, 2016, CANCER RES, V76, P1009, DOI 10.1158/0008-5472.CAN-15-1423; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; Raje N, 2019, NEW ENGL J MED, V380, P1726, DOI 10.1056/NEJMoa1817226; Roberts DR, 2017, ECOGRAPHY, V40, P913, DOI 10.1111/ecog.02881; Robertson-Tessi M, 2012, J THEOR BIOL, V294, P56, DOI 10.1016/j.jtbi.2011.10.027; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Rosenthal R, 2019, NATURE, V567, P479, DOI 10.1038/s41586-019-1032-7; Roumenina LT, 2019, NAT REV CANCER, V19, P698, DOI 10.1038/s41568-019-0210-0; SALE P F, 1978, Environmental Biology of Fishes, V3, P85, DOI 10.1007/BF00006310; Schneider D, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abc6401; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schultz LM, 2018, BLOOD, V132, DOI 10.1182/blood-2018-99-117445; Seth R, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.20.00198; Sharma P, 2020, NAT REV IMMUNOL, V20, P75, DOI 10.1038/s41577-020-0275-8; Sottoriva A, 2015, NAT GENET, V47, P209, DOI 10.1038/ng.3214; Stearns SC, 2000, P NATL ACAD SCI USA, V97, P3309, DOI 10.1073/pnas.060289597; STINNER RE, 1977, ANNU REV ENTOMOL, V22, P515, DOI 10.1146/annurev.en.22.010177.002503; Takahashi F., 1964, Researches on Population Ecology Kyoto University, V6, P28, DOI 10.1007/BF02524942; Talhouk A, 2019, CLIN CANCER RES, V25, P2537, DOI 10.1158/1078-0432.CCR-18-3241; Tarabichi M, 2018, NAT GENET, V50, P1630, DOI 10.1038/s41588-018-0258-x; Thorsson V, 2018, IMMUNITY, V48, P812, DOI 10.1016/j.immuni.2018.03.023; Tikhonov G, 2020, METHODS ECOL EVOL, V11, P442, DOI 10.1111/2041-210X.13345; Turajlic S, 2018, CELL, V173, P595, DOI 10.1016/j.cell.2018.03.043; Turajlic S, 2018, CELL, V173, P581, DOI 10.1016/j.cell.2018.03.057; Turtle CJ, 2016, J CLIN INVEST, V126, P2123, DOI 10.1172/JCI85309; Van den Eynden J, 2019, NAT GENET, V51, P1741, DOI 10.1038/s41588-019-0532-6; Vanhersecke L, 2021, NAT CANCER, V2, P794, DOI 10.1038/s43018-021-00232-6; Vellend M, 2010, Q REV BIOL, V85, P183, DOI 10.1086/652373; Warton DI, 2015, TRENDS ECOL EVOL, V30, P766, DOI 10.1016/j.tree.2015.09.007; Webb JR, 2016, GYNECOL ONCOL, V141, P293, DOI 10.1016/j.ygyno.2016.03.008; West J, 2019, JCO CLIN CANCER INFO, V3, DOI 10.1200/CCI.18.00078; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wiedemann A, 2006, P NATL ACAD SCI USA, V103, P10985, DOI 10.1073/pnas.0600651103; Wijeyesinghe S, 2021, NATURE, V592, P457, DOI 10.1038/s41586-021-03351-3; Williams MJ, 2016, NAT GENET, V48, P238, DOI 10.1038/ng.3489; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wolf Y, 2019, CELL, V179, P219, DOI 10.1016/j.cell.2019.08.032; Wouters MCA, 2018, CLIN CANCER RES, V24, P6125, DOI 10.1158/1078-0432.CCR-18-1481; Yang L, 2010, TRENDS IMMUNOL, V31, P220, DOI 10.1016/j.it.2010.04.002; Yost KE, 2019, NAT MED, V25, P1251, DOI 10.1038/s41591-019-0522-3; Zappasodi R, 2018, CANCER CELL, V33, P581, DOI 10.1016/j.ccell.2018.03.005; Zhang AW, 2018, CELL, V173, P1755, DOI 10.1016/j.cell.2018.03.073; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zhang Q, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abg6986; Zhang X, 2017, NAT COMMUN, V8, P1, DOI [10.1038/s41467-017-01968-5, 10.1038/ncomms14542, 10.1038/s41467-017-00321-0]	140	3	3	10	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2022	22	12					765	775		10.1038/s41577-022-00719-y	http://dx.doi.org/10.1038/s41577-022-00719-y		MAY 2022	11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6M3AE	35513493				2022-12-18	WOS:000791115000001
J	Lanahan, SM; Wymann, MP; Lucas, CL				Lanahan, Stephen M.; Wymann, Matthias P.; Lucas, Carrie L.			The role of PI3K gamma in the immune system: new insights and translational implications	NATURE REVIEWS IMMUNOLOGY			English	Review							PHOSPHOINOSITIDE 3-KINASE GAMMA; T-CELL-ACTIVATION; PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE; MOLECULAR DETERMINANTS; TARGETING PI3K-GAMMA; P110-GAMMA ISOFORM; PRESSURE-OVERLOAD; RECEPTOR FUNCTION; RAS BINDING; MAST-CELLS	Over the past two decades, new insights have positioned phosphoinositide 3-kinase-gamma (PI3K gamma) as a context-dependent modulator of immunity and inflammation. Recent advances in protein structure determination and drug development have allowed for generation of highly specific PI3K gamma inhibitors, with the first now in clinical trials for several oncology indications. Recently, a monogenic immune disorder caused by PI3K gamma deficiency was discovered in humans and modelled in mice. Human inactivated PI3K gamma syndrome confirms the immunomodulatory roles of PI3K gamma and strengthens newly defined roles of this molecule in modulating inflammatory cytokine release in macrophages. Here, we review the functions of PI3K gamma in the immune system and discuss how our understanding of its potential as a therapeutic target has evolved. This Review discusses the immunomodulatory properties of phosphoinositide 3-kinase-gamma (PI3K gamma) in health and in the context of various diseases, ranging from cardiovascular disease to auto-immunity and cancer, and discusses the therapeutic potential of PI3K gamma inhibitors, which have entered clinical trials for cancer.	[Lanahan, Stephen M.; Lucas, Carrie L.] Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA; [Wymann, Matthias P.] Univ Basel, Dept Biomed, Basel, Switzerland	Yale University; University of Basel	Lucas, CL (corresponding author), Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA.	Carrie.Lucas@yale.edu	Wymann, Matthias P/C-3227-2008	Wymann, Matthias P/0000-0003-3349-4281	National Institutes of Health [NIAID R21AI144315]; Mathers Foundation; Swiss National Science Foundation [SNF 316030_198526, 310030_189065]; Innosuisse [37213.1 IP-LS]; Horizon 2020 project [ITN 675392]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Innosuisse; Horizon 2020 project	C.L.L. acknowledges funding from the National Institutes of Health (NIAID R21AI144315) and Mathers Foundation. The authors thank K. Jones for her helpful comments on their manuscript. M.P.W. was funded by the Swiss National Science Foundation (grants SNF 316030_198526 and 310030_189065), Innosuisse (grant 37213.1 IP-LS) and the Horizon 2020 project ITN 675392.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Ali K, 2014, NATURE, V510, P407, DOI 10.1038/nature13444; Andreotti AH, 2018, ANNU REV IMMUNOL, V36, P549, DOI 10.1146/annurev-immunol-042617-053344; Andrews Simon, 2007, Sci STKE, V2007, pcm3, DOI 10.1126/stke.4072007cm3; Angulo I, 2013, SCIENCE, V342, P866, DOI 10.1126/science.1243292; Anzinger JJ, 2012, J LIPID RES, V53, P34, DOI 10.1194/jlr.M018887; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Ban K, 2008, CIRC RES, V103, P643, DOI 10.1161/CIRCRESAHA.108.175018; Barber DF, 2005, NAT MED, V11, P933, DOI 10.1038/nm1291; Becattini B, 2011, P NATL ACAD SCI USA, V108, pE854, DOI 10.1073/pnas.1106698108; Beer-Hammer S, 2010, J LEUKOCYTE BIOL, V87, P1083, DOI 10.1189/jlb.0809585; Bell K, 2012, BIOORG MED CHEM LETT, V22, P5257, DOI 10.1016/j.bmcl.2012.06.049; Bergamini G, 2012, NAT CHEM BIOL, V8, P576, DOI [10.1038/NCHEMBIO.957, 10.1038/nchembio.957]; Beura LK, 2016, NATURE, V532, P512, DOI 10.1038/nature17655; Blair HA, 2018, DRUGS, V78, P1847, DOI 10.1007/s40265-018-1013-4; Bohnacker T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000259; Breasson L, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aaf2969; Bruce I, 2012, BIOORG MED CHEM LETT, V22, P5445, DOI 10.1016/j.bmcl.2012.07.042; Burke JE, 2015, TRENDS BIOCHEM SCI, V40, P88, DOI 10.1016/j.tibs.2014.12.003; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Canobbio I, 2009, BLOOD, V114, P2193, DOI 10.1182/blood-2009-03-208074; Carnevale D, 2012, CARDIOVASC RES, V93, P200, DOI 10.1093/cvr/cvr288; Chang JD, 2007, P NATL ACAD SCI USA, V104, P8077, DOI 10.1073/pnas.0702663104; Ciraolo E, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1161577; Collier PN, 2015, J MED CHEM, V58, P5684, DOI 10.1021/acs.jmedchem.5b00498; Collier PN, 2015, J MED CHEM, V58, P517, DOI 10.1021/jm500362j; Collmann E, 2013, J ALLERGY CLIN IMMUN, V132, P959, DOI 10.1016/j.jaci.2013.03.008; Come JH, 2018, J MED CHEM, V61, P5245, DOI 10.1021/acs.jmedchem.8b00085; Comerford I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045095; Condliffe AM, 2005, BLOOD, V106, P1432, DOI 10.1182/blood-2005-03-0944; Conley ME, 2012, J EXP MED, V209, P463, DOI 10.1084/jem.20112533; Cosemans JMEM, 2006, BLOOD, V108, P3045, DOI 10.1182/blood-2006-03-006338; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; Czech MP, 2017, NAT MED, V23, P804, DOI 10.1038/nm.4350; Davids MS, 2020, CLIN CANCER RES, V26, P2096, DOI 10.1158/1078-0432.CCR-19-3061; De Henau O, 2016, NATURE, V539, P443, DOI 10.1038/nature20554; Deau MC, 2015, J CLIN INVEST, V125, P1764, DOI 10.1172/JCI81746; Del Prete A, 2004, EMBO J, V23, P3505, DOI 10.1038/sj.emboj.7600361; Deladeriere A, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005564; Doukas J, 2006, P NATL ACAD SCI USA, V103, P19866, DOI 10.1073/pnas.0606956103; Doukas J, 2009, J PHARMACOL EXP THER, V328, P758, DOI 10.1124/jpet.108.144311; Endo D, 2009, INT ARCH ALLERGY IMM, V149, P66, DOI 10.1159/000211375; Evans CA, 2016, ACS MED CHEM LETT, V7, P862, DOI 10.1021/acsmedchemlett.6b00238; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; Foubert P, 2017, CANCER IMMUNOL RES, V5, P957, DOI 10.1158/2326-6066.CIR-17-0143; Fougerat A, 2008, CIRCULATION, V117, P1310, DOI 10.1161/CIRCULATIONAHA.107.720466; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Gangadhara G, 2019, NAT CHEM BIOL, V15, P348, DOI 10.1038/s41589-018-0215-0; Garcia CC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00975; Gistera A, 2017, NAT REV NEPHROL, V13, DOI 10.1038/nrneph.2017.51; Haeusler RA, 2018, NAT REV MOL CELL BIO, V19, P31, DOI 10.1038/nrm.2017.89; Hannigan M, 2002, P NATL ACAD SCI USA, V99, P3603, DOI 10.1073/pnas.052010699; Harris SJ, 2012, EUR J IMMUNOL, V42, P3394, DOI 10.1002/eji.201242463; HASLAM RJ, 1993, NATURE, V363, P309, DOI 10.1038/363309b0; Haubner BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009350; Hawkins PT, 2007, SCIENCE, V318, P64, DOI 10.1126/science.1145420; HAWKINS PT, 1992, NATURE, V358, P157, DOI 10.1038/358157a0; Hayer S, 2009, FASEB J, V23, P4288, DOI 10.1096/fj.09-135160; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Hirsch E, 2001, FASEB J, V15, P2019, DOI 10.1096/fj.00-0810fje; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Huang XJ, 2016, CIRCULATION, V133, P1093, DOI 10.1161/CIRCULATIONAHA.115.020918; Ivanov SS, 2013, NAT IMMUNOL, V14, P1219, DOI 10.1038/ni.2740; Janku F, 2018, NAT REV CLIN ONCOL, V15, P273, DOI 10.1038/nrclinonc.2018.28; Kachele M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144494; Kaneda MM, 2016, NATURE, V539, P437, DOI 10.1038/nature19834; Kaneda MM, 2016, CANCER DISCOV, V6, P870, DOI 10.1158/2159-8290.CD-15-1346; Kobayashi N, 2011, P NATL ACAD SCI USA, V108, P5753, DOI 10.1073/pnas.1016430108; Kurig B, 2009, P NATL ACAD SCI USA, V106, P20312, DOI 10.1073/pnas.0905506106; Ladygina N, 2013, EUR J IMMUNOL, V43, P3183, DOI 10.1002/eji.201343812; Laffargue M, 2002, IMMUNITY, V16, P441, DOI 10.1016/S1074-7613(02)00282-0; Lemmon MA, 2001, BIOCHEM SOC T, V29, P377, DOI 10.1042/BST0290377; Li H, 2013, NEUROSCIENCE, V253, P89, DOI 10.1016/j.neuroscience.2013.08.051; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Lian LR, 2005, BLOOD, V106, P110, DOI 10.1182/blood-2004-05-2005; Liu PD, 2015, CANCER DISCOV, V5, P1194, DOI 10.1158/2159-8290.CD-15-0460; Lova P, 2003, J BIOL CHEM, V278, P131, DOI 10.1074/jbc.M204821200; Lucas CL, 2014, J EXP MED, V211, P2537, DOI 10.1084/jem.20141759; Lucas CL, 2014, NAT IMMUNOL, V15, P88, DOI 10.1038/ni.2771; Luo LW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4069; Luo L, 2018, CELL REP, V24, P3033, DOI 10.1016/j.celrep.2018.08.028; Lupia E, 2004, AM J PATHOL, V165, P2003, DOI 10.1016/S0002-9440(10)63251-8; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Martin AL, 2008, J IMMUNOL, V180, P2081, DOI 10.4049/jimmunol.180.4.2081; Molinaro A, 2019, CELL METAB, V29, P1400, DOI 10.1016/j.cmet.2019.03.010; Moore SF., 2019, SCI REP-UK, V9; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nienaber JJ, 2003, J CLIN INVEST, V112, P1067, DOI 10.1172/JCI200318213; Nobs SP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005508; Nobs SP, 2015, IMMUNITY, V43, P674, DOI 10.1016/j.immuni.2015.09.006; Nombela-Arrieta C, 2004, IMMUNITY, V21, P429, DOI 10.1016/j.immuni.2004.07.012; Norton Laura, 2015, Advances in Biological Regulation, V60, P36, DOI 10.1016/j.jbior.2015.10.005; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; Pemberton N, 2018, J MED CHEM, V61, P5435, DOI 10.1021/acs.jmedchem.8b00447; Perino A, 2011, MOL CELL, V42, P84, DOI 10.1016/j.molcel.2011.01.030; Perrotta M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111858; Perry MWD, 2021, J MED CHEM, V64, P8053, DOI 10.1021/acs.jmedchem.1c00434; Pomel V, 2006, J MED CHEM, V49, P3857, DOI 10.1021/jm0601598; Postow M, 2020, J IMMUNOTHER CANCER, V8, pA264, DOI 10.1136/jitc-2020-SITC2020.0434; Quignard JF, 2001, J BIOL CHEM, V276, P32545, DOI 10.1074/jbc.M102582200; Rathinaswamy MK, 2021, ELIFE, V10, DOI 10.7554/eLife.64691; Rathinaswamy Manoj K., 2020, Advances in Biological Regulation, V75, P100657, DOI 10.1016/j.jbior.2019.100657; Reese TA, 2016, CELL HOST MICROBE, V19, P713, DOI 10.1016/j.chom.2016.04.003; Rodrigues DH, 2010, J NEUROIMMUNOL, V222, P90, DOI 10.1016/j.jneuroim.2010.02.016; Rommel C, 2007, NAT REV IMMUNOL, V7, P191, DOI 10.1038/nri2036; Rubiol I, 1999, EUR J BIOCHEM, V266, P70, DOI 10.1046/j.1432-1327.1999.00815.x; Sadiq MW, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.congress-2019.PA4220; Saigusa R, 2020, NAT REV CARDIOL, V17, P387, DOI 10.1038/s41569-020-0352-5; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Saudemont A, 2009, P NATL ACAD SCI USA, V106, P5795, DOI 10.1073/pnas.0808594106; Schmid MC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060226, 10.1371/journal.pone.0061623]; Schmid MC, 2011, CANCER CELL, V19, P715, DOI 10.1016/j.ccr.2011.04.016; Seropian IM, 2010, J CARDIOVASC PHARM, V56, P651, DOI 10.1097/FJC.0b013e3181f9a905; Shiraishi Y, 2009, J ALLERGY CLIN IMMUN, V123, pS56, DOI 10.1016/j.jaci.2008.11.047; Silva MC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03986-3; Siragusa M, 2010, CIRC RES, V106, P757, DOI 10.1161/CIRCRESAHA.109.207449; Smirnova NF, 2014, J EXP MED, V211, P1779, DOI 10.1084/jem.20131276; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; Suire S, 2005, CURR BIOL, V15, P566, DOI 10.1016/j.cub.2005.02.020; Suire S, 2002, CURR BIOL, V12, P1068, DOI 10.1016/S0960-9822(02)00933-8; Suire S, 2006, NAT CELL BIOL, V8, P1303, DOI 10.1038/ncb1494; Sullivan RJ, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.3013; Swan DJ, 2019, HAEMATOLOGICA, V104, pE483, DOI 10.3324/haematol.2018.208397; Takeda AJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12311-5; Tang WW, 2011, DEV CELL, V21, P1038, DOI 10.1016/j.devcel.2011.10.023; Tassi I, 2007, IMMUNITY, V27, P214, DOI 10.1016/j.immuni.2007.07.014; Thian M, 2020, HAEMATOLOGICA, V105, pE488, DOI 10.3324/haematol.2019.231399; Thomas MS, 2008, J LEUKOCYTE BIOL, V84, P814, DOI 10.1189/jlb.0807561; Tomczak P, 2021, J CLIN ONCOL, V39, DOI 10.1200/JCO.2021.39.6_suppl.436; TRAYNORKAPLAN AE, 1988, NATURE, V334, P353, DOI 10.1038/334353a0; Vadas O, 2013, P NATL ACAD SCI USA, V110, P18862, DOI 10.1073/pnas.1304801110; Van Keymeulen A, 2006, J CELL BIOL, V174, P437, DOI 10.1083/jcb.200604113; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Vecchione C, 2005, J EXP MED, V201, P1217, DOI 10.1084/jem.20040995; Venable JD, 2010, RECENT PATENTS INFLA, V4, P1, DOI 10.2174/187221310789895603; Viard P, 1999, FASEB J, V13, P685, DOI 10.1096/fasebj.13.6.685; Vinnikov IA, 2014, J NEUROSCI, V34, P10659, DOI 10.1523/JNEUROSCI.4251-13.2014; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Wall AA, 2017, J BIOL CHEM, V292, P4411, DOI 10.1074/jbc.M116.766337; Walser R, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001587; Webb LMC, 2005, J IMMUNOL, V175, P2783, DOI 10.4049/jimmunol.175.5.2783; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Weichhart T, 2015, NAT REV IMMUNOL, V15, P599, DOI 10.1038/nri3901; Weiss-Haljiti C, 2004, J BIOL CHEM, V279, P43273, DOI 10.1074/jbc.M402924200; Winkler DG, 2013, CHEM BIOL, V20, P1364, DOI 10.1016/j.chembiol.2013.09.017; Wymann Matthias, 2012, Subcell Biochem, V58, P111, DOI 10.1007/978-94-007-3012-0_5; Wymann MP, 2013, ANN NY ACAD SCI, V1280, P44, DOI 10.1111/nyas.12037; Wymann MP, 2005, CURR OPIN CELL BIOL, V17, P141, DOI 10.1016/j.ceb.2005.02.011; Wymann MP, 2003, TRENDS PHARMACOL SCI, V24, P366, DOI 10.1016/S0165-6147(03)00163-9; Wymann MP, 2003, BIOCHEM SOC T, V31, P275, DOI 10.1042/bst0310275; Yu QH, 2019, ARTERIOSCL THROM VAS, V39, pE91, DOI 10.1161/ATVBAHA.118.312212; Yuan HX, 2015, CANCER DISCOV, V5, P1127, DOI 10.1158/2159-8290.CD-15-1125; Zotes TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072674	159	3	3	6	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2022	22	11					687	700		10.1038/s41577-022-00701-8	http://dx.doi.org/10.1038/s41577-022-00701-8		MAR 2022	14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	5U0ZY	35322259				2022-12-18	WOS:000772270800002
J	Walker, LSK				Walker, Lucy S. K.			The link between circulating follicular helper T cells and autoimmunity	NATURE REVIEWS IMMUNOLOGY			English	Article							MEMORY TFH CELLS; TRANSCRIPTION FACTOR; B-CELLS; IMMUNE DYSREGULATION; I INTERFERONS; MEDIATED SUPPRESSION; BONE LOSS; INTERLEUKIN-2; INDUCTION; DIFFERENTIATION	Individuals with autoimmunity often have an increased frequency of T cells bearing features of follicular helper T cells in their blood. Lucy Walker proposes that alterations in pathways that regulate autoimmunity are coupled to alterations in follicular helper T cell homeostasis. Follicular helper T (T-FH) cells provide help to B cells, supporting the formation of germinal centres that allow affinity maturation of antibody responses. Although usually located in secondary lymphoid organs, T cells bearing features of T-FH cells can also be identified in human blood, and their frequency and phenotype are often altered in people with autoimmune diseases. In this Perspective article, I discuss the increase in circulating T-FH cells seen in autoimmune settings and explore potential explanations for this phenomenon. I consider the multistep regulation of T-FH cell differentiation by the CTLA4 and IL-2 pathways as well as by regulatory T cells and highlight that these same pathways are crucial for regulating autoimmune diseases. The propensity of infection to serve as a cue for T-FH cell differentiation and a potential trigger for autoimmune disease development is also discussed. Overall, I postulate that alterations in pathways that regulate autoimmunity are coupled to alterations in T-FH cell homeostasis, suggesting that this population may serve as a core sentinel of dysregulated immunity.	[Walker, Lucy S. K.] UCL, Inst Immun & Transplantat, Div Infect & Immun, Royal Free Campus, London, England	University of London; University College London	Walker, LSK (corresponding author), UCL, Inst Immun & Transplantat, Div Infect & Immun, Royal Free Campus, London, England.	lucy.walker@ucl.ac.uk		Walker, Lucy/0000-0001-5986-5015	Medical Research Council Programme Grant; Wellcome Trust Investigator Award	Medical Research Council Programme Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Investigator Award(Wellcome Trust)	I am grateful to M. A. Linterman, P. Tolar, N. M. Edner, C. J. Wang and L. Petersone for valuable feedback on the manuscript draft and for assistance with the figures. I am supported by a Medical Research Council Programme Grant and a Wellcome Trust Investigator Award.	Alroqi FJ, 2018, J ALLERGY CLIN IMMUN, V141, P1050, DOI 10.1016/j.jaci.2017.05.022; Apaolaza PS, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abd6527; Asrir A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00843-7; Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; Baumjohann D, 2013, NAT IMMUNOL, V14, P840, DOI 10.1038/ni.2642; Baumjohann D, 2013, IMMUNITY, V38, P596, DOI 10.1016/j.immuni.2012.11.020; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; Bentebibel SE, 2011, P NATL ACAD SCI USA, V108, pE488, DOI 10.1073/pnas.1100898108; Betz BC, 2010, J EXP MED, V207, P933, DOI 10.1084/jem.20091548; Beziat V, 2021, CELL, V184, P3812, DOI 10.1016/j.cell.2021.06.004; Bjornevik K, 2022, SCIENCE, V375, P296, DOI 10.1126/science.abj8222; Bossaller L, 2006, J IMMUNOL, V177, P4927, DOI 10.4049/jimmunol.177.7.4927; Botta D, 2017, NAT IMMUNOL, V18, P1249, DOI 10.1038/ni.3837; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Cerosaletti K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083811; Chinen T, 2016, NAT IMMUNOL, V17, P1322, DOI 10.1038/ni.3540; Choi JY, 2020, NAT IMMUNOL, V21, P777, DOI 10.1038/s41590-020-0706-5; Choi YS, 2013, J IMMUNOL, V190, P4014, DOI 10.4049/jimmunol.1202963; Choi YS, 2013, J IMMUNOL, V190, P3049, DOI 10.4049/jimmunol.1203032; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Clement RL, 2019, NAT IMMUNOL, V20, P1360, DOI 10.1038/s41590-019-0472-4; Clough LE, 2008, J IMMUNOL, V180, P5393, DOI 10.4049/jimmunol.180.8.5393; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Crotty S, 2019, IMMUNITY, V50, P1132, DOI 10.1016/j.immuni.2019.04.011; Cucak H, 2009, IMMUNITY, V31, P491, DOI 10.1016/j.immuni.2009.07.005; Dan JM, 2016, J IMMUNOL, V197, P983, DOI 10.4049/jimmunol.1600318; De Giovanni M, 2020, NAT IMMUNOL, V21, P321, DOI 10.1038/s41590-020-0596-6; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Deng J, 2019, NAT REV RHEUMATOL, V15, P475, DOI 10.1038/s41584-019-0254-2; DiToro D, 2018, SCIENCE, V361, P1086, DOI 10.1126/science.aao2933; Edner NM, 2020, NAT IMMUNOL, V21, P1244, DOI 10.1038/s41590-020-0744-z; Engdahl C, 2017, J BONE MINER RES, V32, P1681, DOI 10.1002/jbmr.3158; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; Faliti CE, 2019, J EXP MED, V216, P317, DOI 10.1084/jem.20171976; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Ferguson SE, 1996, J IMMUNOL, V156, P4576; Ferreira RC, 2015, DIABETOLOGIA, V58, P781, DOI 10.1007/s00125-015-3509-8; Ferreira RC, 2014, DIABETES, V63, P2538, DOI 10.2337/db13-1777; Fonseca VR, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan1487; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fu WW, 2018, J EXP MED, V215, P815, DOI 10.1084/jem.20170901; Glatigny S, 2019, J IMMUNOL, V202, P1373, DOI 10.4049/jimmunol.1801425; Gonzalez-Figueroa P, 2021, CELL, V184, P1775, DOI 10.1016/j.cell.2021.02.027; Greczmiel U, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam8686; Hale JS, 2013, IMMUNITY, V38, P805, DOI 10.1016/j.immuni.2013.02.020; Hall JC, 2010, NAT REV RHEUMATOL, V6, P40, DOI 10.1038/nrrheum.2009.237; Harbers SO, 2007, J CLIN INVEST, V117, P1361, DOI 10.1172/JCI29470; Harre U, 2012, J CLIN INVEST, V122, P1791, DOI 10.1172/JCI60975; He J, 2016, NAT MED, V22, P991, DOI 10.1038/nm.4148; He J, 2013, IMMUNITY, V39, P770, DOI 10.1016/j.immuni.2013.09.007; Heit A, 2017, J EXP MED, V214, P2139, DOI 10.1084/jem.20161794; Hill DL, 2019, J EXP MED, V216, P1857, DOI 10.1084/jem.20190301; Huber JE, 2020, J IMMUNOL, V204, P1101, DOI 10.4049/jimmunol.1900955; Hunziker L, 2003, NAT IMMUNOL, V4, P343, DOI 10.1038/ni911; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Jackson SW, 2016, J EXP MED, V213, P733, DOI 10.1084/jem.20151724; Jacobsen JT, 2021, SCIENCE, V373, DOI 10.1126/science.abe5146; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kenefeck R, 2015, J CLIN INVEST, V125, P292, DOI 10.1172/JCI76238; Kinnunen T, 2013, BLOOD, V121, P1595, DOI 10.1182/blood-2012-09-457465; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Konig MF, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaj1921; Kuehn HS, 2014, SCIENCE, V345, P1623, DOI 10.1126/science.1255904; Lanz Tobias V, 2022, Nature, V603, P321, DOI 10.1038/s41586-022-04432-7; Li JH, 2016, NATURE, V533, P110, DOI 10.1038/nature17947; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Liu B, 2021, NATURE, V592, DOI 10.1038/s41586-021-03239-2; Liu XD, 2014, NATURE, V507, P513, DOI 10.1038/nature12910; Lo B, 2015, SCIENCE, V349, P436, DOI 10.1126/science.aaa1663; Locci M, 2016, NAT IMMUNOL, V17, P976, DOI 10.1038/ni.3494; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Lochhead RB, 2021, NAT REV RHEUMATOL, V17, P449, DOI 10.1038/s41584-021-00648-5; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Lu Y., 2021, J EXP MED, V218; Ma CS, 2015, J ALLERGY CLIN IMMUN, V136, P993, DOI 10.1016/j.jaci.2015.05.036; Ma CS, 2012, BLOOD, V119, P3997, DOI 10.1182/blood-2011-11-392985; Mandelbrot DA, 1999, J EXP MED, V189, P435, DOI 10.1084/jem.189.2.435; Marshall HD, 2015, ELIFE, V4, DOI 10.7554/eLife.04851; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Nakayamada S, 2014, J IMMUNOL, V192, P2156, DOI 10.4049/jimmunol.1300675; Nurieva RI, 2012, J BIOL CHEM, V287, P11234, DOI 10.1074/jbc.M111.324046; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Oestreich KJ, 2012, NAT IMMUNOL, V13, P405, DOI 10.1038/ni.2242; Ohkura N, 2020, IMMUNITY, V52, P1119, DOI 10.1016/j.immuni.2020.04.006; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Ovcinnikovs V, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw0902; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Papillion A, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw7636; Peluso I, 2007, J IMMUNOL, V178, P732, DOI 10.4049/jimmunol.178.2.732; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Piantoni S, 2018, CLIN EXP RHEUMATOL, V36, P685; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Qiu CC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02608; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Ray JP, 2014, IMMUNITY, V40, P367, DOI 10.1016/j.immuni.2014.02.005; Richardson SJ, 2013, DIABETOLOGIA, V56, P185, DOI 10.1007/s00125-012-2745-4; Ritvo PGG, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan0368; Rodriguez-Calvo T, 2018, CURR DIABETES REP, V18, DOI 10.1007/s11892-018-1077-2; Rolf J, 2010, J IMMUNOL, V185, P4042, DOI 10.4049/jimmunol.1001730; Rosenzwajg M, 2019, ANN RHEUM DIS, V78, P209, DOI 10.1136/annrheumdis-2018-214229; Sabatos CA, 2008, IMMUNITY, V29, P238, DOI 10.1016/j.immuni.2008.05.017; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Sage PT, 2016, NAT IMMUNOL, V17, P1436, DOI 10.1038/ni.3578; Sage PT, 2014, IMMUNITY, V41, P1026, DOI 10.1016/j.immuni.2014.12.005; Sage PT, 2014, J CLIN INVEST, V124, P5191, DOI 10.1172/JCI76861; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Sanderson NSR, 2017, P NATL ACAD SCI USA, V114, P734, DOI 10.1073/pnas.1614472114; Schmitt N, 2014, TRENDS IMMUNOL, V35, P436, DOI 10.1016/j.it.2014.06.002; Schmitt N, 2014, NAT IMMUNOL, V15, P856, DOI 10.1038/ni.2947; Schubert D, 2014, NAT MED, V20, P1410, DOI 10.1038/nm.3746; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Schwickert TA, 2009, J EXP MED, V206, P2907, DOI 10.1084/jem.20091225; Sebina I, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005999; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shulman Z, 2013, SCIENCE, V341, P673, DOI 10.1126/science.1241680; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Spolski R, 2014, NAT REV DRUG DISCOV, V13, P381, DOI 10.1038/nrd4296; Stebegg M, 2020, ELIFE, V9, DOI 10.7554/eLife.52473; Steelman AJ, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00520; Suurmond J, 2015, J CLIN INVEST, V125, P2194, DOI 10.1172/JCI78084; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Ueno H, 2016, CURR OPIN IMMUNOL, V43, P24, DOI 10.1016/j.coi.2016.08.003; Ueno H, 2015, NAT IMMUNOL, V16, P142, DOI 10.1038/ni.3054; van Baarsen LGM, 2006, GENES IMMUN, V7, P522, DOI 10.1038/sj.gene.6364324; Van Ghelue M, 2003, J AUTOIMMUN, V20, P171, DOI 10.1016/S0896-8411(02)00110-5; Vehik K, 2019, NAT MED, V25, P1865, DOI 10.1038/s41591-019-0667-0; Vella LA, 2019, J CLIN INVEST, V129, P3185, DOI 10.1172/JCI125628; Verstappen GM, 2017, ARTHRITIS RHEUMATOL, V69, P1850, DOI 10.1002/art.40165; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Walker LSK, 1999, J EXP MED, V190, P1115, DOI 10.1084/jem.190.8.1115; Wang CJ, 2015, P NATL ACAD SCI USA, V112, P524, DOI 10.1073/pnas.1414576112; Wang EY, 2021, NATURE, V595, P283, DOI [10.1038/s41586-021-03631-y, 10.1101/2020.12.10.20247205]; Wang K, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.706964; Ward NC, 2020, DIABETES, V69, P2400, DOI 10.2337/db20-0186; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Weber JP, 2015, J EXP MED, V212, P217, DOI 10.1084/jem.20141432; Weber JP, 2012, EUR J IMMUNOL, V42, P1981, DOI 10.1002/eji.201242540; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Wiede F, 2019, DIABETES, V68, P1251, DOI 10.2337/db18-1362; Wildin RS, 2002, J MED GENET, V39, P537, DOI 10.1136/jmg.39.8.537; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Wing JB, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01910; Wing JB, 2017, P NATL ACAD SCI USA, V114, pE6400, DOI 10.1073/pnas.1705551114; Wing JB, 2014, IMMUNITY, V41, P1013, DOI 10.1016/j.immuni.2014.12.006; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Wong MT, 2015, CELL REP, V11, P1822, DOI 10.1016/j.celrep.2015.05.022; Wu H, 2016, EUR J IMMUNOL, V46, P1152, DOI 10.1002/eji.201546094; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zhang ZN, 2019, J EXP MED, V216, P1311, DOI 10.1084/jem.20182304; Zhao ZH, 2019, ANN RHEUM DIS, V78, P380, DOI 10.1136/annrheumdis-2018-214125	164	3	3	4	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2022	22	9					567	575		10.1038/s41577-022-00693-5	http://dx.doi.org/10.1038/s41577-022-00693-5		MAR 2022	9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	4E2XF	35277664	Bronze, Green Submitted, Green Published			2022-12-18	WOS:000767753500001
J	Lubitz, GS; Brody, JD				Lubitz, Gabrielle S.; Brody, Joshua D.			NOT JUST NEIGHBOURS: POSITIVE FEEDBACK BETWEEN TUMOUR-ASSOCIATED MACROPHAGES AND EXHAUSTED T CELLS	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material									[Lubitz, Gabrielle S.; Brody, Joshua D.] Icahn Sch Med Mt Sinai, OxMS Preprint Journal Club, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Lubitz, GS (corresponding author), Icahn Sch Med Mt Sinai, OxMS Preprint Journal Club, New York, NY 10029 USA.	highlights@preprintclub.com; highlights@preprintclub.com	Lubitz, Gabrielle/U-7293-2018	Lubitz, Gabrielle/0000-0002-1534-0169				Hu KH, 2020, NAT METHODS, V17, P833, DOI 10.1038/s41592-020-0880-2; Kersten K., 2021, SPATIOTEMPORAL CODEP, DOI [10.1101/2021.09.27.461866, DOI 10.1101/2021.09.27.461866]; Lubitz, OXFORD MOUNT SINAI O	3	3	3	2	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2022	22	1					3	3		10.1038/s41577-021-00660-6	http://dx.doi.org/10.1038/s41577-021-00660-6		NOV 2021	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YA8ZK	34789868				2022-12-18	WOS:000719695500001
J	Liu, C; Zhang, YH; Liu, CC; Schatz, DG				Liu, Chang; Zhang, Yuhang; Liu, Catherine C.; Schatz, David G.			Structural insights into the evolution of the RAG recombinase	NATURE REVIEWS IMMUNOLOGY			English	Review							NON-CORE REGIONS; V-H REPLACEMENT; V(D)J RECOMBINATION; HISTONE H3; STRUCTURE REQUIREMENTS; TRANSPOSABLE ELEMENTS; DNA TRANSPOSITION; CRYSTAL-STRUCTURE; SIGNAL SEQUENCES; DOMAIN	Adaptive immunity in jawed vertebrates relies on the assembly of antigen receptor genes by the recombination activating gene 1 (RAG1)-RAG2 (collectively RAG) recombinase in a reaction known as V(D)J recombination. Extensive biochemical and structural evidence indicates that RAG and V(D)J recombination evolved from the components of a RAG-like (RAGL) transposable element through a process known as transposon molecular domestication. This Review describes recent advances in our understanding of the functional and structural transitions that occurred during RAG evolution. We use the structures of RAG and RAGL enzymes to trace the evolutionary adaptations that yielded a RAG recombinase with exquisitely regulated cleavage activity and a multilayered array of mechanisms to suppress transposition. We describe how changes in modes of DNA binding, alterations in the dynamics of protein-DNA complexes, single amino acid mutations and a modular design likely enabled RAG family enzymes to survive and spread in the genomes of eukaryotes. These advances highlight the insight that can be gained from viewing evolution of vertebrate immunity through the lens of comparative genome analyses coupled with structural biology and biochemistry. This Review describes our current understanding of the functional and structural transitions that occurred during the evolution of the recombination activating gene 1 (RAG1)-RAG2 (collectively RAG) recombinase, yielding a RAG recombinase in jawed vertebrates with tightly regulated cleavage activity and strongly suppressed transposition activity.	[Liu, Chang; Schatz, David G.] Yale Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Zhang, Yuhang] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai, Peoples R China; [Liu, Catherine C.] MIT, Dept Biol, Cambridge, MA USA	Yale University; Shanghai Jiao Tong University; Massachusetts Institute of Technology (MIT)	Schatz, DG (corresponding author), Yale Sch Med, Dept Immunobiol, New Haven, CT 06510 USA.	david.schatz@yale.edu		Liu, Catherine/0000-0002-2093-7170; Schatz, David/0000-0002-5669-1176	US National Institutes of Health (NIH) [AI137079, AI32524]	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank E. Martin and A. Petrescu for sequence and structural analyses that contributed to developing the conceptual framework for this Review, and A. Roger and D. Pisani for advice on the timing of divergence of metazoan lineages. This work was supported by US National Institutes of Health (NIH) grants AI137079 and AI32524 (to D.G.S.).	Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; Alder MN, 2005, SCIENCE, V310, P1970, DOI 10.1126/science.1119420; Arbuckle JL, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-23; Barsoum E, 2010, GENE DEV, V24, P33, DOI 10.1101/gad.557310; Bednarski JJ, 2019, NAT REV IMMUNOL, V19, P231, DOI 10.1038/s41577-019-0135-6; Beilinson HA, 2021, J EXP MED, V218, DOI 10.1084/jem.20210250; Bellon SF, 1997, NAT STRUCT BIOL, V4, P586, DOI 10.1038/nsb0797-586; Boehm T, 2018, ANNU REV IMMUNOL, V36, P19, DOI 10.1146/annurev-immunol-042617-053028; Brecht RM, 2020, P NATL ACAD SCI USA, V117, P4300, DOI 10.1073/pnas.1920021117; Burns KH, 2020, ANNU REV PATHOL-MECH, V15, P51, DOI 10.1146/annurev-pathmechdis-012419-032633; Callebaut I, 1998, CELL MOL LIFE SCI, V54, P880, DOI 10.1007/s000180050216; Carmona LM, 2017, FEBS J, V284, P1590, DOI 10.1111/febs.13990; Carmona LM, 2016, GENE DEV, V30, P909, DOI 10.1101/gad.278432.116; Chatterji M, 2006, MOL CELL BIOL, V26, P1558, DOI 10.1128/MCB.26.4.1558-1568.2006; Chen S, 2008, GENE, V408, P51, DOI 10.1016/j.gene.2007.10.015; Chen XM, 2021, CURR OPIN STRUC BIOL, V71, P79, DOI 10.1016/j.sbi.2021.05.014; Chen XM, 2020, NAT STRUCT MOL BIOL, V27, P119, DOI 10.1038/s41594-019-0363-2; Chen XM, 2020, NAT STRUCT MOL BIOL, V27, P127, DOI 10.1038/s41594-019-0366-z; Cheng CY, 2016, GENE DEV, V30, P2724, DOI 10.1101/gad.290460.116; Cheng CY, 2010, MOL BIOL CELL, V21, P1753, DOI 10.1091/mbc.E09-12-1079; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; Cosby RL, 2021, SCIENCE, V371, P797, DOI 10.1126/science.abc6405; Coussens MA, 2013, CELL REP, V4, P870, DOI 10.1016/j.celrep.2013.07.041; Craig NL, 2015, MOBILE DNA 3, P3, DOI [DOI 10.1128/MICROBIOLSPEC.MDNA3-0062-2014Z, 10.1128/9781555819217.ch1]; Cuomo CA, 1996, MOL CELL BIOL, V16, P5683; Curry JD, 2007, J EXP MED, V204, P2293, DOI 10.1084/jem.20070583; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; DOOLITTLE WF, 1980, NATURE, V284, P601, DOI 10.1038/284601a0; dos Reis M, 2015, CURR BIOL, V25, P2939, DOI 10.1016/j.cub.2015.09.066; Feng LF, 2017, NUCLEIC ACIDS RES, V45, P9481, DOI 10.1093/nar/gkx652; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Flajnik MF, 2014, CURR BIOL, V24, pR1060, DOI 10.1016/j.cub.2014.09.070; Fugmann SD, 2006, P NATL ACAD SCI USA, V103, P3728, DOI 10.1073/pnas.0509720103; Fugmann SD, 2010, SEMIN IMMUNOL, V22, P10, DOI 10.1016/j.smim.2009.11.004; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Grazini U, 2010, MOL CELL, V37, P282, DOI 10.1016/j.molcel.2009.12.035; Grundy GJ, 2010, P NATL ACAD SCI USA, V107, P22487, DOI 10.1073/pnas.1014958107; Hancks DC, 2016, MOBILE DNA-UK, V7, DOI 10.1186/s13100-016-0065-9; HANIFORD DB, 1989, CELL, V59, P385, DOI 10.1016/0092-8674(89)90299-7; Hanson SJ, 2017, GENETICS, V206, P9, DOI 10.1534/genetics.117.202036; Helmink BA, 2012, ANNU REV IMMUNOL, V30, P175, DOI 10.1146/annurev-immunol-030409-101320; Hencken CG, 2012, NAT STRUCT MOL BIOL, V19, P834, DOI 10.1038/nsmb.2338; Henssen AG, 2015, ELIFE, V4, DOI 10.7554/eLife.10565; Hickman AB, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0034-2014; Hickman AB, 2010, CRIT REV BIOCHEM MOL, V45, P50, DOI 10.3109/10409230903505596; Hiom K, 1998, CELL, V94, P463, DOI 10.1016/S0092-8674(00)81587-1; Hirano M, 2011, ADV IMMUNOL, V109, P125, DOI 10.1016/B978-0-12-387664-5.00004-2; Hu JZ, 2015, CELL, V163, P947, DOI 10.1016/j.cell.2015.10.016; Huang SF, 2016, CELL, V166, P102, DOI 10.1016/j.cell.2016.05.032; Jangam D, 2017, TRENDS GENET, V33, P817, DOI 10.1016/j.tig.2017.07.011; Ji YH, 2010, CELL, V141, P419, DOI 10.1016/j.cell.2010.03.010; Jones JM, 2009, ARCH IMMUNOL THER EX, V57, P105, DOI 10.1007/s00005-009-0011-3; Jones JM, 2003, P NATL ACAD SCI USA, V100, P15446, DOI 10.1073/pnas.2637012100; Kapitonov VV, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0055-8; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; Kapitonov VV, 2003, P NATL ACAD SCI USA, V100, P6569, DOI 10.1073/pnas.0732024100; Kesselring L, 2020, NUCLEIC ACIDS RES, V48, P316, DOI 10.1093/nar/gkz1119; Kim MS, 2018, MOL CELL, V70, P358, DOI 10.1016/j.molcel.2018.03.008; Kim MS, 2015, NATURE, V518, P507, DOI 10.1038/nature14174; Koonin EV, 2020, NAT REV GENET, V21, P119, DOI 10.1038/s41576-019-0172-9; Koralov SB, 2006, IMMUNITY, V25, P43, DOI 10.1016/j.immuni.2006.04.016; Kriatchko AN, 2006, MOL CELL BIOL, V26, P4712, DOI 10.1128/MCB.02487-05; Krishnan A, 2018, P NATL ACAD SCI USA, V115, pE3201, DOI 10.1073/pnas.1720897115; Lapkouski M, 2015, J BIOL CHEM, V290, P14618, DOI 10.1074/jbc.M115.641787; Lescale C, 2017, MECH AGEING DEV, V165, P3, DOI 10.1016/j.mad.2016.11.003; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; Li XH, 2013, P NATL ACAD SCI USA, V110, pE2279, DOI 10.1073/pnas.1305987110; Lieber MR, 2016, NAT REV CANCER, V16, P387, DOI 10.1038/nrc.2016.40; Liu C, 2019, NATURE, V575, P540, DOI 10.1038/s41586-019-1753-7; Liu MC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04273-x; Liu Y, 2007, IMMUNITY, V27, P561, DOI 10.1016/j.immuni.2007.09.005; Lu C, 2015, CELL REP, V10, P29, DOI 10.1016/j.celrep.2014.12.001; Majumdar S, 2013, SCIENCE, V339, P446, DOI 10.1126/science.1231789; Maman Y, 2016, NUCLEIC ACIDS RES, V44, P9624, DOI 10.1093/nar/gkw633; Marculescu R, 2006, DNA REPAIR, V5, P1246, DOI 10.1016/j.dnarep.2006.05.015; Martin EC, 2020, MOBILE DNA-UK, V11, DOI 10.1186/s13100-020-00214-y; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; MCCLINTOCK B, 1953, GENETICS, V38, P579; Montano SP, 2011, CURR OPIN STRUC BIOL, V21, P370, DOI 10.1016/j.sbi.2011.03.004; Morimoto R, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aba0925; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; ORGEL LE, 1980, NATURE, V288, P645, DOI 10.1038/288645a0; Panchin Y, 2008, BIOCHEM BIOPH RES CO, V369, P818, DOI 10.1016/j.bbrc.2008.02.097; Papaemmanuil E, 2014, NAT GENET, V46, P116, DOI 10.1038/ng.2874; Payer LM, 2019, NAT REV GENET, V20, P760, DOI 10.1038/s41576-019-0165-8; Poole JRM, 2017, IMMUNOGENETICS, V69, P391, DOI 10.1007/s00251-017-0979-5; Rajaei N, 2014, P NATL ACAD SCI USA, V111, P15491, DOI 10.1073/pnas.1406027111; Ramsden DA, 1996, EMBO J, V15, P3197, DOI 10.1002/j.1460-2075.1996.tb00682.x; Reddy YVR, 2006, GENE DEV, V20, P1575, DOI 10.1101/gad.1432706; Reth M., 2015, MOL BIOL B CELLS, V9, P133; Rice PA, 2001, NAT STRUCT BIOL, V8, P302, DOI 10.1038/86166; Ru H, 2018, CURR OPIN STRUC BIOL, V53, P178, DOI 10.1016/j.sbi.2018.11.001; Ru H, 2018, NAT STRUCT MOL BIOL, V25, P732, DOI 10.1038/s41594-018-0098-5; Ru H, 2015, CELL, V163, P1138, DOI 10.1016/j.cell.2015.10.055; SAKANO H, 1979, NATURE, V280, P288, DOI 10.1038/280288a0; Schabla NM, 2018, J IMMUNOL, V201, P930, DOI 10.4049/jimmunol.1800054; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; Shimazaki N, 2009, MOL CELL, V34, P535, DOI 10.1016/j.molcel.2009.05.011; Singh SK, 2015, P NATL ACAD SCI USA, V112, P8579, DOI 10.1073/pnas.1510464112; Sinzelle L, 2009, CELL MOL LIFE SCI, V66, P1073, DOI 10.1007/s00018-009-8376-3; Swanson PC, 2004, IMMUNOL REV, V200, P90, DOI 10.1111/j.0105-2896.2004.00159.x; Teng G, 2015, CELL, V162, P751, DOI 10.1016/j.cell.2015.07.009; THOMPSON CB, 1995, IMMUNITY, V3, P531, DOI 10.1016/1074-7613(95)90124-8; vanGent DC, 1996, SCIENCE, V271, P1592, DOI 10.1126/science.271.5255.1592; Ward A, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00159-18; Wilson DR, 2008, DEV COMP IMMUNOL, V32, P1221, DOI 10.1016/j.dci.2008.03.012; Yin FF, 2009, NAT STRUCT MOL BIOL, V16, P499, DOI 10.1038/nsmb.1593; Yurchenko V, 2003, GENE DEV, V17, P581, DOI 10.1101/gad.1058103; Zhang M, 2008, J BIOL CHEM, V283, P6717, DOI 10.1074/jbc.M710301200; Zhang YH, 2020, EMBO J, V39, DOI 10.15252/embj.2020105857; Zhang YH, 2019, NATURE, V569, P79, DOI 10.1038/s41586-019-1093-7; Zhang ZX, 2007, TRENDS IMMUNOL, V28, P132, DOI 10.1016/j.it.2007.01.003	114	3	3	3	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2022	22	6					353	370		10.1038/s41577-021-00628-6	http://dx.doi.org/10.1038/s41577-021-00628-6		OCT 2021	18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1S3GR	34675378				2022-12-18	WOS:000709699600001
J	Pearce, EL				Pearce, Erika L.			METABOLISM AS A DRIVER OF IMMUNITY	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material									[Pearce, Erika L.] Johns Hopkins Univ, Baltimore, MD 21218 USA	Johns Hopkins University	Pearce, EL (corresponding author), Johns Hopkins Univ, Baltimore, MD 21218 USA.	epearce6@jhmi.edu						Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021	5	3	3	0	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2021	21	10					619	619		10.1038/s41577-021-00601-3	http://dx.doi.org/10.1038/s41577-021-00601-3			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UX9XG	34580450				2022-12-18	WOS:000701188100010
J	[Anonymous]				[Anonymous]			Do rogue antibodies make the difference between mild versus severe COVID-19?	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material																			0	3	2	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAR	2021	21	3					136	136						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QR3TZ	33542500	Green Published, Bronze			2022-12-18	WOS:000625136400008
J	Flemming, A				Flemming, Alexandra			Deciphering the protective features of the antibody response	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material												a.flemming@nature.com						Roltgen K, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abe0240	1	3	3	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2021	21	2					71	71		10.1038/s41577-020-00496-6	http://dx.doi.org/10.1038/s41577-020-00496-6			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QB3OS	33402724	Green Published, Bronze			2022-12-18	WOS:000614052000005
J	Teuwen, LA; Geldhof, V; Pasut, A; Carmeliet, P				Teuwen, Laure-Anne; Geldhof, Vincent; Pasut, Alessandra; Carmeliet, Peter			COVID-19: the vasculature unleashed (vol 82, pg 613, 2020)	NATURE REVIEWS IMMUNOLOGY			English	Correction												peter.carmeliet@kuleuven.vib.be	Carmeliet, Peter/AAQ-5140-2020	Carmeliet, Peter/0000-0001-7961-1821				Teuwen LA, 2020, NAT REV IMMUNOL, V20, P389, DOI 10.1038/s41577-020-0343-0	1	3	3	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUL	2020	20	7					448	448		10.1038/s41577-020-0356-8	http://dx.doi.org/10.1038/s41577-020-0356-8		JUN 2020	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NI4DD	32499635	Bronze, Green Published			2022-12-18	WOS:000537988100001
J	Flemming, A				Flemming, Alexandra			Tumours use NETs as physical shields	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material																		Baumann T, 2020, NAT IMMUNOL, V21, P555, DOI 10.1038/s41590-020-0666-9	1	3	3	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2020	20	6					352	353		10.1038/s41577-020-0327-0	http://dx.doi.org/10.1038/s41577-020-0327-0		APR 2020	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LT4QN	32377012				2022-12-18	WOS:000529852600004
J	Minton, K				Minton, Kirsty			IL-17A brings new recruits to EAE	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material																			0	3	3	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAR	2020	20	3					137	137						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KU1CK	32034302	Bronze			2022-12-18	WOS:000519447500006
J	Minton, K				Minton, Kirsty			IL-17A brings new recruits to EAE	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material; Early Access								McGinley et al. describe a new role for IL-17A in the induction phase of experimental autoimmune encephalomyelitis by indirectly recruiting IL-1 beta-producing myeloid cells.				k.minton@nature.com						McGinley AM, 2020, IMMUNITY, V52, P342, DOI 10.1016/j.immuni.2020.01.002	1	3	3	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.												10.1038/s41577-020-0286-5	http://dx.doi.org/10.1038/s41577-020-0286-5		FEB 2020	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KJ0JB	32034302	Bronze			2022-12-18	WOS:000511743200001
J	Minton, K				Minton, Kirsty			DAMP-driven metabolic adaptation	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material																		Di Gioia M, 2020, NAT IMMUNOL, V21, P42, DOI 10.1038/s41590-019-0539-2	1	3	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2020	20	1					1	1		10.1038/s41577-019-0258-9	http://dx.doi.org/10.1038/s41577-019-0258-9			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KA2KC	31792373	Bronze			2022-12-18	WOS:000505625400010
J	Minton, K				Minton, Kirsty			Connecting angiogenesis and autoimmunity	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material																		Yoo SA, 2019, NAT IMMUNOL, V20, P1348, DOI 10.1038/s41590-019-0456-4	1	3	3	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2019	19	10					596	+		10.1038/s41577-019-0217-5	http://dx.doi.org/10.1038/s41577-019-0217-5			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JA6DJ	31435008				2022-12-18	WOS:000487931400003
J	Bordon, Y				Bordon, Yvonne			Stromal support from IL-17	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material														Bordon, Yvonne/0000-0002-9728-012X				Goossens P, 2019, CELL METAB, V29, P1376, DOI 10.1016/j.cmet.2019.02.016	1	3	4	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2019	19	5					270	271		10.1038/s41577-019-0163-2	http://dx.doi.org/10.1038/s41577-019-0163-2			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HW0OS	30971770				2022-12-18	WOS:000466381300005
J	Sonnenberg, GF; Artis, D				Sonnenberg, Gregory F.; Artis, David			Novel connections and precision approaches	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material							TRIGGERS; IMMUNE; CELLS	Research in mucosal immunology has continued to generate exciting advances in cellular and molecular biology and to pave the way for a better understanding of human health and disease. In 2018, numerous groups defined bidirectional circuits of communication between the mucosal immune system, non-haematopoietic cell types and microbial communities, while also developing precision approaches to define and manipulate host-microbiota interactions in the gut.	[Sonnenberg, Gregory F.; Artis, David] Cornell Univ, Joan & Sanford I Weill Dept Med, Div Gastroenterol, Dept Microbiol & Immunol,Weill Cornell Med, New York, NY 10021 USA; [Sonnenberg, Gregory F.; Artis, David] Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Weill Cornell Med, New York, NY 10021 USA	Cornell University; Cornell University	Sonnenberg, GF; Artis, D (corresponding author), Cornell Univ, Joan & Sanford I Weill Dept Med, Div Gastroenterol, Dept Microbiol & Immunol,Weill Cornell Med, New York, NY 10021 USA.; Sonnenberg, GF; Artis, D (corresponding author), Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Weill Cornell Med, New York, NY 10021 USA.	gfsonnenberg@med.cornell.edu; dartis@med.cornell.edu		Artis, David/0000-0002-1753-4100	National Institutes of Health [R01AI123368, R21DK110262, U01AI095608, AI074878, AI095466, AI095608, AI102942]; Burroughs Wellcome Fund; Crohn's & Colitis Foundation; Cure for IBD; Rosanne H. Silberman Foundation; NIAID Mucosal Immunology Studies Team (MIST); Searle Scholars Program; American Asthma Foundation Scholar Award; Cancer Research Institute	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Crohn's & Colitis Foundation; Cure for IBD; Rosanne H. Silberman Foundation; NIAID Mucosal Immunology Studies Team (MIST); Searle Scholars Program; American Asthma Foundation Scholar Award; Cancer Research Institute	The Artis laboratory is supported by the National Institutes of Health (AI074878, AI095466, AI095608 and AI102942), the Burroughs Wellcome Fund, the Crohn's & Colitis Foundation, Cure for IBD and the Rosanne H. Silberman Foundation. The Sonnenberg laboratory is supported by the National Institutes of Health (R01AI123368, R21DK110262 and U01AI095608), the NIAID Mucosal Immunology Studies Team (MIST), the Crohn's & Colitis Foundation, the Searle Scholars Program, the American Asthma Foundation Scholar Award, the Burroughs Wellcome Fund and The Cancer Research Institute.	Campbell C, 2018, IMMUNITY, V48, P1245, DOI 10.1016/j.immuni.2018.04.013; Donaldson GP, 2018, SCIENCE, V360, P795, DOI 10.1126/science.aaq0926; Lei WW, 2018, P NATL ACAD SCI USA, V115, P5552, DOI 10.1073/pnas.1720758115; Mohanan V, 2018, SCIENCE, V359, P1161, DOI 10.1126/science.aan0814; Moriyama S, 2018, SCIENCE, V359, P1056, DOI 10.1126/science.aan4829; Nadjsombati MS, 2018, IMMUNITY, V49, P33, DOI 10.1016/j.immuni.2018.06.016; Schneider C, 2018, CELL, V174, P271, DOI 10.1016/j.cell.2018.05.014; Sui PF, 2018, SCIENCE, V360, P1086, DOI 10.1126/science.aan8546; Uchimura Y, 2018, IMMUNITY, V49, P545, DOI 10.1016/j.immuni.2018.08.004; Veiga-Fernandes H, 2018, SCIENCE, V359, P1465, DOI 10.1126/science.aap9598; Zhu WH, 2018, NATURE, V553, P208, DOI 10.1038/nature25172	11	3	5	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2019	19	2					75	76		10.1038/s41577-018-0114-3	http://dx.doi.org/10.1038/s41577-018-0114-3			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HJ4PH	30622346				2022-12-18	WOS:000457155400009
J	Kingwell, K				Kingwell, Katie			Translational target for checkpoint inhibitors	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material																			0	3	3	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2018	18	12					728	729		10.1038/s41577-018-0091-6	http://dx.doi.org/10.1038/s41577-018-0091-6			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HB6WR	30451955				2022-12-18	WOS:000451214700002
J	Bommareddy, PK; Shettigar, M; Kaufman, HL				Bommareddy, Praveen K.; Shettigar, Megha; Kaufman, Howard L.			Integrating oncolytic viruses in combination cancer immunotherapy (vol 18, pg 498, 2018)	NATURE REVIEWS IMMUNOLOGY			English	Correction													Shettigar, Megha/AAV-2748-2021					Bommareddy PK, 2018, NAT REV IMMUNOL, V18, P498, DOI 10.1038/s41577-018-0014-6	1	3	3	2	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2018	18	8					535	535		10.1038/s41577-018-0031-5	http://dx.doi.org/10.1038/s41577-018-0031-5			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GO3CD	29930315	Bronze			2022-12-18	WOS:000439863400012
J	Casanova, JL				Casanova, Jean-Laurent			ADAPTIVE IMMUNITY BY CONVERGENT EVOLUTION	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material									[Casanova, Jean-Laurent] Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA	Rockefeller University	Casanova, JL (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	jean-laurent.casanova@mail.rockefeller.edu			NIAID NIH HHS [P01 AI061093] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI061093] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))			0	3	3	2	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2018	18	5								10.1038/nri.2018.28	http://dx.doi.org/10.1038/nri.2018.28			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GE1DD	29692420	Green Accepted, Bronze			2022-12-18	WOS:000430956100007
J	Harjes, U				Harjes, Ulrike			Tear down this wall	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material																			0	3	3	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2018	18	4					221	221		10.1038/nri.2018.20	http://dx.doi.org/10.1038/nri.2018.20			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GA5UH	29545641				2022-12-18	WOS:000428398900001
J	Wu, W; Shi, XS; Xu, CQ				Wu, Wei; Shi, Xiaoshan; Xu, Chenqi			Regulation of T cell signalling by membrane lipids (vol 16, pg 690, 2016)	NATURE REVIEWS IMMUNOLOGY			English	Correction													Shi, Xiaoshan/AAH-7734-2021	Shi, Xiaoshan/0000-0001-7931-8684				Wu W, 2016, NAT REV IMMUNOL, V16, P690, DOI 10.1038/nri.2016.103	1	3	3	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAR	2018	18	3												1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FX5KU					2022-12-18	WOS:000426118500015
J	Bordon, Y				Bordon, Yvonne			INNATE IMMUNITY Platelets on the prowl	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material														Bordon, Yvonne/0000-0002-9728-012X					0	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2018	18	1					3	3		10.1038/nri.2017.147	http://dx.doi.org/10.1038/nri.2017.147			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FT0GY	29226912	Bronze			2022-12-18	WOS:000422802500004
J	Minton, K				Minton, Kirsty			Managing migration	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material														Minton, Kirsty/0000-0002-3857-8030					0	3	3	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2017	17	12								10.1038/nri.2017.128	http://dx.doi.org/10.1038/nri.2017.128			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FN6YI	29129914				2022-12-18	WOS:000416162500003
J	Starling, S				Starling, Shimona			Immune editing shapes the cancer landscape	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material														Starling, Shimona/0000-0001-6059-8006					0	3	3	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2017	17	12					729	729		10.1038/nri.2017.129	http://dx.doi.org/10.1038/nri.2017.129			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FN6YI	29129915				2022-12-18	WOS:000416162500001
J	Wrighton, KH				Wrighton, Katharine H.			Probiotic induction of tolerogenic T cells in the gut	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material														Wrighton, Katharine/0000-0001-7075-3399					0	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2017	17	10								10.1038/nri.2017.110	http://dx.doi.org/10.1038/nri.2017.110			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FI3RF	28891558	Bronze			2022-12-18	WOS:000411884600003
J	Bordon, Y				Bordon, Yvonne			TUMOUR IMMUNOLOGY Platelets - a new target in cancer immunotherapy?	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X					0	3	3	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2017	17	6								10.1038/nri.2017.61	http://dx.doi.org/10.1038/nri.2017.61			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EV8VO	28548132	Bronze			2022-12-18	WOS:000402062500007
J	Bordon, Y				Bordon, Yvonne			Oncostatin M - a new target in IBD?	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X					0	3	3	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2017	17	5					280	280		10.1038/nri.2017.45	http://dx.doi.org/10.1038/nri.2017.45			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ET1SY	28443640	Bronze			2022-12-18	WOS:000400050400006
J	Flemming, A				Flemming, Alexandra			Successful checkpoint blockade requires positive co-stimulation	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	3	3	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2017	17	4					215	215		10.1038/nri.2017.32	http://dx.doi.org/10.1038/nri.2017.32			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EP4YJ	28345633	Bronze			2022-12-18	WOS:000397385600001
J	O'Neill, L				O'Neill, Luke			IMMUNOMETABOLISM AND THE LAND OF MILK AND HONEY	NATURE REVIEWS IMMUNOLOGY			English	News Item									[O'Neill, Luke] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland	Trinity College Dublin	O'Neill, L (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland.	laoneill@tcd.ie		O'Neill, Luke/0000-0002-4333-2748					0	3	3	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2017	17	4					217	217		10.1038/nri.2017.22	http://dx.doi.org/10.1038/nri.2017.22			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EP4YJ	28287105	Bronze			2022-12-18	WOS:000397385600005
J	Minton, K				Minton, Kirsty			Inflammasome-related ageing	NATURE REVIEWS IMMUNOLOGY			English	News Item														Minton, Kirsty/0000-0002-3857-8030					0	3	3	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2017	17	2					77	77		10.1038/nri.2017.3	http://dx.doi.org/10.1038/nri.2017.3			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EK2CD	28111474	Bronze			2022-12-18	WOS:000393734100001
J	Minton, K				Minton, Kirsty			INNATE LYMPHOID CELLS ILC diversity maintained by microbiota	NATURE REVIEWS IMMUNOLOGY			English	News Item														Minton, Kirsty/0000-0002-3857-8030				Gury-BenAri M, CELL	1	3	3	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2016	16	10								10.1038/nri.2016.101	http://dx.doi.org/10.1038/nri.2016.101			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DX7FL	27573484				2022-12-18	WOS:000384551900001
J	Kugelberg, E				Kugelberg, Elisabeth			AUTOIMMUNITY Infection stimulates self-antigen presentation	NATURE REVIEWS IMMUNOLOGY			English	News Item														Kugelberg, Elisabeth/0000-0002-8302-3595					0	3	3	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2016	16	9					534	534		10.1038/nri.2016.91	http://dx.doi.org/10.1038/nri.2016.91			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DU7ZZ	27477128				2022-12-18	WOS:000382434400002
J	Leavy, O				Leavy, Olive			T CELL RESPONSES Defective mitochondria disrupt CD8(+) T cells	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	3	3	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2016	16	9								10.1038/nri.2016.98	http://dx.doi.org/10.1038/nri.2016.98			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DU7ZZ	27558410				2022-12-18	WOS:000382434400003
J	Bishop, GA				Bishop, Gail A.			B CELL-T CELL INTERACTION: ANTIGEN BRIDGE TO ANTIGEN PRESENTATION	NATURE REVIEWS IMMUNOLOGY			English	News Item									[Bishop, Gail A.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Bishop, Gail A.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Bishop, GA (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.; Bishop, GA (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.	gail-bishop@uiowa.edu		Bishop, Gail/0000-0002-1291-5078	NIEHS NIH HHS [P30 ES005605] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bishop GA, 2001, CURR OPIN IMMUNOL, V13, P278, DOI 10.1016/S0952-7915(00)00216-8; SWAIN SL, 1987, IMMUNOL REV, V99, P263, DOI 10.1111/j.1600-065X.1987.tb01180.x	2	3	3	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2016	16	8					467	467		10.1038/nri.2016.82	http://dx.doi.org/10.1038/nri.2016.82			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS8CT	27396445	Bronze			2022-12-18	WOS:000381011200007
J	Bird, L				Bird, Lucy			T CELLS Mitochondrial shape shifters	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bird, Lucy/0000-0002-3914-6045					0	3	3	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUL	2016	16	7								10.1038/nri.2016.79	http://dx.doi.org/10.1038/nri.2016.79			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP9SR	27349280	Bronze			2022-12-18	WOS:000378837900003
J	Minton, K				Minton, Kirsty			Inflammatory pathology of Fanconi anaemia	NATURE REVIEWS IMMUNOLOGY			English	News Item														Minton, Kirsty/0000-0002-3857-8030					0	3	3	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2016	16	6								10.1038/nri.2016.60	http://dx.doi.org/10.1038/nri.2016.60			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DN0GP	27180812	Bronze			2022-12-18	WOS:000376742700003
J	Leavy, O				Leavy, Olive			MACROPHAGES Dissolving cholesterol to unclog arteries	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2016	16	5								10.1038/nri.2016.50	http://dx.doi.org/10.1038/nri.2016.50			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DK5UE	27121648	Bronze			2022-12-18	WOS:000374985400003
J	Takeda, K				Takeda, Kiyoshi			A METABOLIC BRIDGE BETWEEN MICROBIOTA AND HUMANS	NATURE REVIEWS IMMUNOLOGY			English	News Item									[Takeda, Kiyoshi] Osaka Univ, Dept Microbiol & Immunol, Grad Sch Med, WPI Immunol Frontier Res Ctr IFReC, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan	Osaka University	Takeda, K (corresponding author), Osaka Univ, Dept Microbiol & Immunol, Grad Sch Med, WPI Immunol Frontier Res Ctr IFReC, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ktakeda@ongene.med.osaka-u.ac.jp		Takeda, Kiyoshi/0000-0002-1778-6332					0	3	3	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2016	16	4					206	206		10.1038/nri.2016.18	http://dx.doi.org/10.1038/nri.2016.18			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH7MD	26852927				2022-12-18	WOS:000372977200005
J	Kugelberg, E				Kugelberg, Elisabeth			Find me and eat me	NATURE REVIEWS IMMUNOLOGY			English	News Item														Kugelberg, Elisabeth/0000-0002-8302-3595					0	3	3	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAR	2016	16	3					131	131		10.1038/nri.2016.23	http://dx.doi.org/10.1038/nri.2016.23			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DF5LU	26922908	Bronze			2022-12-18	WOS:000371394100004
J	Leavy, O				Leavy, Olive			IMMUNE MEMORY Sequential evolution of B cell memory	NATURE REVIEWS IMMUNOLOGY			English	News Item																		De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; Weisel F. J., 2016, IMMUNITY	2	3	3	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2016	16	2								10.1038/nri.2016.15	http://dx.doi.org/10.1038/nri.2016.15			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DC4IG	26806486				2022-12-18	WOS:000369183800003
J	Kugelberg, E				Kugelberg, Elisabeth			Reducing silence to improve therapy	NATURE REVIEWS IMMUNOLOGY			English	News Item														Kugelberg, Elisabeth/0000-0002-8302-3595					0	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2015	15	12					730	730		10.1038/nri3941	http://dx.doi.org/10.1038/nri3941			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CY1FS	26542634	Bronze			2022-12-18	WOS:000366152700009
J	Bordon, Y				Bordon, Yvonne			The bug eye bandits	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X				Horai R, 2015, IMMUNITY, V43, P343, DOI 10.1016/j.immuni.2015.07.014	1	3	3	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2015	15	10					595	595		10.1038/nri3911	http://dx.doi.org/10.1038/nri3911			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CS2PE	26338264				2022-12-18	WOS:000361912600001
J	Kugelberg, E				Kugelberg, Elisabeth			NLRP3 goes beyond the inflammasome	NATURE REVIEWS IMMUNOLOGY			English	News Item														Kugelberg, Elisabeth/0000-0002-8302-3595				Bruchard M., 2015, NAT IMMUNOL	1	3	3	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2015	15	8					467	467		10.1038/nri3886	http://dx.doi.org/10.1038/nri3886			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CN5DZ	26160614				2022-12-18	WOS:000358451300004
J	Minton, K				Minton, Kirsty			PLANT IMMUNITY Host mimicry of pathogen virulence targets	NATURE REVIEWS IMMUNOLOGY			English	News Item														Minton, Kirsty/0000-0002-3857-8030					0	3	3	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUL	2015	15	7								10.1038/nri3876	http://dx.doi.org/10.1038/nri3876			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CL3RC	26065587				2022-12-18	WOS:000356867100001
J	Bordon, Y				Bordon, Yvonne			IMMUNOMETABOLISM ILC2s skew the fat	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X					0	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2015	15	2					67	67		10.1038/nri3805	http://dx.doi.org/10.1038/nri3805			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CA0ZQ	25547848				2022-12-18	WOS:000348642400001
J	Kugelberg, E				Kugelberg, Elisabeth			MACROPHAGES Capturing HIV-infected T cells	NATURE REVIEWS IMMUNOLOGY			English	News Item														Kugelberg, Elisabeth/0000-0002-8302-3595					0	3	3	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2015	15	1					2	2		10.1038/nri3794	http://dx.doi.org/10.1038/nri3794			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AX3JJ	25503915				2022-12-18	WOS:000346835400002
J	David, R				David, Rachel			DENDRITIC CELLS The true face of migratory DCs	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Anandasabapathy N, 2014, J EXP MED, V211, P1875, DOI 10.1084/jem.20131397	1	3	3	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2014	14	10					649	649		10.1038/nri3741	http://dx.doi.org/10.1038/nri3741			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AQ5PD	25190284				2022-12-18	WOS:000342860200004
J	Bordon, Y				Bordon, Yvonne			INNATE IMMUNITY A COX detox for the immune system?	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X					0	3	3	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2014	14	6					358	359		10.1038/nri3686	http://dx.doi.org/10.1038/nri3686			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AJ7AP	24798368				2022-12-18	WOS:000337849700007
J	Davis, DM				Davis, Daniel M.			Presenting the marvels of immunity COMMENT	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material									Univ Manchester, Manchester Collaborat Ctr Inflammat Res, Manchester M13 9NT, Lancs, England	University of Manchester	Davis, DM (corresponding author), Univ Manchester, Manchester Collaborat Ctr Inflammat Res, 46 Grafton St, Manchester M13 9NT, Lancs, England.	daniel.davis@manchester.ac.uk		Davis, Daniel/0000-0002-9182-291X	Biotechnology and Biological Sciences Research Council [BB/I013407/2] Funding Source: researchfish; BBSRC [BB/I013407/2] Funding Source: UKRI; MRC [G0500563, G1001044] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council Funding Source: Medline; Medical Research Council [G0500563, G1001044] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; Davis DM, 2013, COMPATIBILITY GENE; Dawkins Richard, 2008, OXFORD BOOK MODERN S; Doherty P., 2006, BEGINNERS GUIDE WINN; Goldacre B., 2014, GUARDIAN LOND   0410; Hall S. S., 1997, COMMOTION BLOOD LIFE; Medawar P. B., 1981, ADVICE YOUNG SCI; Mukherjee S., 2010, EMPEROR ALL MALADIES; Sagan C., 1996, DEMON HAUNTED WORLD; Wade Nicholas, 2013, NY TIMES; Watts S, 2014, NATURE, V508, P151, DOI 10.1038/508151a; Weinberg R. A., 1999, ONE RENEGADE CELL; Zmkernagel R. M., 1974, NATURE, V251, P547	13	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2014	14	6					351	353		10.1038/nri3681	http://dx.doi.org/10.1038/nri3681			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AJ7AP	24769836	Bronze			2022-12-18	WOS:000337849700001
J	Kugelberg, E				Kugelberg, Elisabeth			INFECTIOUS DISEASE Opposing effects of IL-10	NATURE REVIEWS IMMUNOLOGY			English	News Item														Kugelberg, Elisabeth/0000-0002-8302-3595					0	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2014	14	6					356	357		10.1038/nri3693	http://dx.doi.org/10.1038/nri3693			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AJ7AP	24854586	Bronze			2022-12-18	WOS:000337849700005
J	Leavy, O				Leavy, Olive			MACROPHAGES Peritoneal population depends on GATA6	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	3	3	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2014	14	6					360	360		10.1038/nri3695	http://dx.doi.org/10.1038/nri3695			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AJ7AP	24854587				2022-12-18	WOS:000337849700010
J	Bordon, Y				Bordon, Yvonne			INFLAMMATION TNF snuffs out steroids	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X				Huang SC, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004786	1	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2014	14	4								10.1038/nri3649	http://dx.doi.org/10.1038/nri3649			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AD6YY	24625845	Bronze			2022-12-18	WOS:000333408800009
J	Kugelberg, E				Kugelberg, Elisabeth			DENDRITIC CELLS TLR agonists trigger rapid metabolic changes	NATURE REVIEWS IMMUNOLOGY			English	News Item														Kugelberg, Elisabeth/0000-0002-8302-3595				Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833	1	3	3	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2014	14	4								10.1038/nri3652	http://dx.doi.org/10.1038/nri3652			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AD6YY	24662378	Bronze			2022-12-18	WOS:000333408800001
J	Bordon, Y				Bordon, Yvonne			TUMOUR IMMUNOLOGY Anticancer drugs need bugs	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X					0	3	3	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2014	14	1					1	1		10.1038/nri3591	http://dx.doi.org/10.1038/nri3591			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	279LT	24336106	Bronze			2022-12-18	WOS:000328962200001
J	Bordon, Y				Bordon, Yvonne			NEONATAL IMMUNITY Hush-a by baby	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X					0	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2014	14	1					4	4		10.1038/nri3584	http://dx.doi.org/10.1038/nri3584			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	279LT	24310086				2022-12-18	WOS:000328962200004
J	Bordon, Y				Bordon, Yvonne			T CELL RESPONSES A dendritic cell designed for two	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X				Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; Murakami R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073270	3	3	3	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2013	13	12					844	844		10.1038/nri3560	http://dx.doi.org/10.1038/nri3560			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	262EU	24136622				2022-12-18	WOS:000327717900003
J	Bordon, Y				Bordon, Yvonne			MUCOSAL IMMUNOLOGY Air miles for T cells	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X					0	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2013	13	10					705	705		10.1038/nri3537	http://dx.doi.org/10.1038/nri3537			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	224GH	24037417				2022-12-18	WOS:000324870400004
J	Bordon, Y				Bordon, Yvonne			NEUROIMMUNOLOGY Pain - blame it on the bug, eh?	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X					0	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2013	13	10					706	706		10.1038/nri3533	http://dx.doi.org/10.1038/nri3533			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	224GH	23995628	Bronze			2022-12-18	WOS:000324870400005
J	Bordon, Y				Bordon, Yvonne			ASTHMA AND ALLERGY TGF beta - too much of a good thing?	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X				Frischmeyer-Guerrerio PA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006448	1	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2013	13	9								10.1038/nri3519	http://dx.doi.org/10.1038/nri3519			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	208BA	23907447	Bronze			2022-12-18	WOS:000323648900006
J	Paludan, SR; Bowie, AG; Horan, KA; Fitzgerald, KA				Paludan, Soren R.; Bowie, Andrew G.; Horan, Kristy A.; Fitzgerald, Katherine A.			Recognition of herpesviruses by the innate immune system (vol 11, pg 143, 2011)	NATURE REVIEWS IMMUNOLOGY			English	Correction													Fitzgerald, Katherine/ABE-6317-2020					Paludan SR, 2011, NAT REV IMMUNOL, V11, P143, DOI 10.1038/nri2937	1	3	3	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2013	13	8								10.1038/nri3497	http://dx.doi.org/10.1038/nri3497			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	188TS		Bronze			2022-12-18	WOS:000322217500015
J	Papatriantafyllou, M				Papatriantafyllou, Maria			T CELLS Maintaining T cell homeostasis	NATURE REVIEWS IMMUNOLOGY			English	News Item													Papatriantafyllou, Maria/ADP-1463-2022						0	3	4	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2013	13	8					546	546		10.1038/nri3504	http://dx.doi.org/10.1038/nri3504			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	188TS	23868219				2022-12-18	WOS:000322217500005
J	Papatriantafyllou, M				Papatriantafyllou, Maria			REGULATORY T CELLS Distilling regulatory T cell inducers	NATURE REVIEWS IMMUNOLOGY			English	News Item													Papatriantafyllou, Maria/ADP-1463-2022						0	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2013	13	8								10.1038/nri3506	http://dx.doi.org/10.1038/nri3506			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	188TS	24046840	Bronze			2022-12-18	WOS:000322217500006
J	Papatriantafyllou, M				Papatriantafyllou, Maria			CYTOKINES IRF7 lost in translation	NATURE REVIEWS IMMUNOLOGY			English	News Item													Papatriantafyllou, Maria/ADP-1463-2022					Lee MS, 2013, NAT IMMUNOL, V14, P346, DOI 10.1038/ni.2535	1	3	3	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2013	13	4					221	221		10.1038/nri3425	http://dx.doi.org/10.1038/nri3425			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	112US	23449338	Bronze			2022-12-18	WOS:000316620100004
J	Leavy, O				Leavy, Olive			ASTHMA AND ALLERGY Apoptotic cell clearance lets you breathe easy	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	3	4	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	MAR	2013	13	3					157	157		10.1038/nri3404	http://dx.doi.org/10.1038/nri3404			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	112TJ	23391994	Bronze			2022-12-18	WOS:000316616100008
J	Minton, K				Minton, Kirsty			HIV From one STI to another ... with love	NATURE REVIEWS IMMUNOLOGY			English	News Item														Minton, Kirsty/0000-0002-3857-8030					0	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	MAR	2013	13	3					154	154		10.1038/nri3402	http://dx.doi.org/10.1038/nri3402			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	112TJ	23391993				2022-12-18	WOS:000316616100004
J	Papatriantafyllou, M				Papatriantafyllou, Maria			INNATE IMMUNITY Caspase 8 prevents inflammasome activation	NATURE REVIEWS IMMUNOLOGY			English	News Item													Papatriantafyllou, Maria/ADP-1463-2022						0	3	4	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2013	13	2					68	68		10.1038/nri3387	http://dx.doi.org/10.1038/nri3387			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	089JK	23334248				2022-12-18	WOS:000314906600003
J	Bordon, Y				Bordon, Yvonne			CELL MIGRATION Pericytes - route planners	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X				STARK K, 2012, NATURE IMMUNOL, DOI DOI 10.1038/NI.2477	1	3	3	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2013	13	1					5	5		10.1038/nri3371	http://dx.doi.org/10.1038/nri3371			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	058QI	23222503	Bronze			2022-12-18	WOS:000312648300007
J	Alderton, GK				Alderton, Gemma K.			TUMOUR IMMUNOLOGY TIM3 suppresses antitumour DCs	NATURE REVIEWS IMMUNOLOGY			English	News Item														Alderton, Gemma/0000-0003-3041-8451					0	3	4	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2012	12	9								10.1038/nri3288	http://dx.doi.org/10.1038/nri3288			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	998NZ	22918461	Bronze			2022-12-18	WOS:000308248200009
J	Hutchinson, E				Hutchinson, Ezzie			VACCINATION Oral vaccine induces genitorectal immunity	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Lycke N, 2012, NAT REV IMMUNOL, V12, P592, DOI 10.1038/nri3251; Zhu Q, 2012, NAT MED, V18, P1291, DOI 10.1038/nm.2866	2	3	3	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2012	12	9					619	619		10.1038/nri3283	http://dx.doi.org/10.1038/nri3283			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	998NZ	22878813	Bronze			2022-12-18	WOS:000308248200007
J	Bordon, Y				Bordon, Yvonne			AUTOIMMUNITY MicroRNA-23b keeps TABs on tissue inflammation	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X					0	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JUL	2012	12	7								10.1038/nri3250	http://dx.doi.org/10.1038/nri3250			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	965YF	22735839	Bronze			2022-12-18	WOS:000305803000003
J	Leavy, O				Leavy, Olive			MUCOSAL IMMUNOLOGY The good the gut bugs do	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2012	12	5					319	319		10.1038/nri3213	http://dx.doi.org/10.1038/nri3213			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	933ET	22498779	Bronze			2022-12-18	WOS:000303343300002
J	Rappuoli, R; Mandl, CW; Black, S; De Gregorio, E				Rappuoli, Rino; Mandl, Christian W.; Black, Steven; De Gregorio, Ennio			Vaccines for the twenty-first century society (vol 11, pg 865, 2011)	NATURE REVIEWS IMMUNOLOGY			English	Correction																		Rappuoli R, 2011, NAT REV IMMUNOL, V11, P865, DOI 10.1038/nri3085	1	3	3	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	MAR	2012	12	3					225	225		10.1038/nri3168	http://dx.doi.org/10.1038/nri3168			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899CJ		Bronze			2022-12-18	WOS:000300790600016
J	Bordon, Y				Bordon, Yvonne			IMMUNE TOLERANCE Suicide is painless	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X				Benseler V, 2011, P NATL ACAD SCI USA, V108, P16735, DOI 10.1073/pnas.1112251108	1	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2011	11	11					719	719		10.1038/nri3092	http://dx.doi.org/10.1038/nri3092			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	842GW	21997791	Bronze			2022-12-18	WOS:000296584700007
J	Papatriantafyllou, M				Papatriantafyllou, Maria			Innate immunity: MAVS build-ups for defence	NATURE REVIEWS IMMUNOLOGY			English	News Item													Papatriantafyllou, Maria/ADP-1463-2022					Skaug B, 2011, CELL	1	3	4	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2011	11	9					570	570		10.1038/nri3050	http://dx.doi.org/10.1038/nri3050			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	811XB	21836618				2022-12-18	WOS:000294250400013
J	Papatriantafyllou, M				Papatriantafyllou, Maria			MACROPHAGES Support from the locals	NATURE REVIEWS IMMUNOLOGY			English	News Item													Papatriantafyllou, Maria/ADP-1463-2022						0	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JUL	2011	11	7								10.1038/nri3016	http://dx.doi.org/10.1038/nri3016			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	782QS	21701520	Bronze			2022-12-18	WOS:000292025300007
J	Papatriantafyllou, M				Papatriantafyllou, Maria			MACROPHAGES Iron macrophages	NATURE REVIEWS IMMUNOLOGY			English	News Item													Papatriantafyllou, Maria/ADP-1463-2022					Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490	1	3	3	2	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	MAR	2011	11	3					158	158		10.1038/nri2947	http://dx.doi.org/10.1038/nri2947			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	726OG	21452590				2022-12-18	WOS:000287732500003
J	Bird, L				Bird, Lucy			IMMUNE REGULATION MicroRNAs keep microglia quiet	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bird, Lucy/0000-0002-3914-6045				Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266	1	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2011	11	2					76	76		10.1038/nri2924	http://dx.doi.org/10.1038/nri2924			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	711KD	21467980				2022-12-18	WOS:000286589300008
J	Bordon, Y				Bordon, Yvonne			LYMPHOCYTE MIGRATION Travel agents for two	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X				LI Z, 2011, NATURE IMMUNOL  0109, DOI DOI 10.1038/NI.1984	1	3	4	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2011	11	2					77	77		10.1038/nri2927	http://dx.doi.org/10.1038/nri2927			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	711KD	21467982	Bronze			2022-12-18	WOS:000286589300010
J	Leavy, O				Leavy, Olive			HAEMATOPOIESIS Baby tolerance	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Mold JE, 2010, SCIENCE, V330, P1695, DOI 10.1126/science.1196509	1	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2011	11	2					78	78		10.1038/nri2923	http://dx.doi.org/10.1038/nri2923			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	711KD	21467984				2022-12-18	WOS:000286589300011
J	Bordon, Y				Bordon, Yvonne			ASTHMA AND ALLERGY A breathtaking chemokine	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X					0	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2010	10	12								10.1038/nri2897	http://dx.doi.org/10.1038/nri2897			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	685CD	21155172	Bronze			2022-12-18	WOS:000284601100006
J	Bird, L				Bird, Lucy			IMMUNE REGULATION Controlling neutrophil plasticity	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bird, Lucy/0000-0002-3914-6045				De Santo C, 2010, NAT IMMUNOL, V11, P1039, DOI 10.1038/ni.1942	1	3	3	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2010	10	11								10.1038/nri2877	http://dx.doi.org/10.1038/nri2877			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	670NM	21080614				2022-12-18	WOS:000283431100010
J	Bird, L				Bird, Lucy			INFECTIOUS DISEASE The tuberculosis signature	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247	1	3	3	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2010	10	10					677	677		10.1038/nri2854	http://dx.doi.org/10.1038/nri2854			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	653YV	20879165	Bronze			2022-12-18	WOS:000282136100003
J	Bird, L				Bird, Lucy			HIV Calculating control	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bird, Lucy/0000-0002-3914-6045				KOSMRLJ A, 2010, NATURE          0505, DOI DOI 10.1038/NATURE08997	1	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2010	10	6					379	379		10.1038/nri2795	http://dx.doi.org/10.1038/nri2795			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	600MI	20514667	Bronze			2022-12-18	WOS:000277990100001
J	Bordon, Y				Bordon, Yvonne			INNATE IMMUNITY Toll tremors	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X				Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127	1	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2010	10	5					291	291		10.1038/nri2767	http://dx.doi.org/10.1038/nri2767			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	586ZD	20425918				2022-12-18	WOS:000276953900007
J	Abreu, MT				Abreu, Maria T.			Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function (vol 10, pg 131, 2010)	NATURE REVIEWS IMMUNOLOGY			English	Correction																		Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707	1	3	3	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	MAR	2010	10	3								10.1038/nri2728	http://dx.doi.org/10.1038/nri2728			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	561KM		Bronze			2022-12-18	WOS:000274975600007
J	Gaffen, SL				Gaffen, Sarah L.			Structure and signalling in the IL-17 receptor family (vol 9, pg 556, 2009)	NATURE REVIEWS IMMUNOLOGY			English	Correction																		Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978	2	3	3	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2009	9	10								10.1038/nri2625	http://dx.doi.org/10.1038/nri2625			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	498IS		Bronze			2022-12-18	WOS:000270133000019
J	David, R				David, Rachel			IMMUNE RESPONSES Rearranging the cytoskeleton	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Park H, 2008, J EXP MED, V205, P2899, DOI 10.1084/jem.20080340	1	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2009	9	1					8	8		10.1038/nri2477	http://dx.doi.org/10.1038/nri2477			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	387JY		Bronze			2022-12-18	WOS:000261949700009
J	Ahmad, S				Ahmad, Sharon			IgA - peacemaker in the gut	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013	1	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2008	8	1					6	6		10.1038/nri2237	http://dx.doi.org/10.1038/nri2237			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	249SS					2022-12-18	WOS:000252250600007
J	Mathis, D; Benoist, C				Mathis, Diane; Benoist, Christophe			Yes, it does	NATURE REVIEWS IMMUNOLOGY			English	Letter									Harvard Univ, Sch Med, Brigham & Womens Hosp, Joslin Diabet Ctr,Sect Immunol & Immunogenet, Boston, MA 02215 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Mathis, D (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Joslin Diabet Ctr,Sect Immunol & Immunogenet, Boston, MA 02215 USA.	cbdm@joslin.harvard.edu; cbdm@joslin.harvard.edu						Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; DeVoss JJ, 2007, CURR OPIN GENET DEV, V17, P193, DOI 10.1016/j.gde.2007.04.001; Jiang WY, 2005, J EXP MED, V202, P805, DOI 10.1084/jem.20050693	3	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2007	7	11								10.1038/nri2136-c2	http://dx.doi.org/10.1038/nri2136-c2			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	224KA		Bronze			2022-12-18	WOS:000250444700019
J	Ahmad, S				Ahmad, Sharon			Innate immunity - Pannexin-1: the missing link?	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997	2	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2007	7	6					418	418		10.1038/nri2110	http://dx.doi.org/10.1038/nri2110			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	172HN					2022-12-18	WOS:000246794900009
J	Leavy, O				Leavy, Olive			Regulatory T cells in autoimmunity	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564	1	3	5	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2007	7	5					322	322		10.1038/nri2078	http://dx.doi.org/10.1038/nri2078			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	160WB					2022-12-18	WOS:000245972000003
J	Bird, L				Bird, Lucy			Research highlights	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Hur EM, 2007, NAT IMMUNOL, V8, P74, DOI 10.1038/ni1415	1	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2007	7	1					7	7		10.1038/nri2004	http://dx.doi.org/10.1038/nri2004			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	119TP					2022-12-18	WOS:000243036700008
J	Li, XD				Li, XD			Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity.	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102	1	3	3	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2006	6	1					8	8						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	000FW					2022-12-18	WOS:000234447300012
J	Bird, L				Bird, L			Asthma and allergy - TSLP: key role in allergic responses confirmed	NATURE REVIEWS IMMUNOLOGY			English	News Item							THYMIC STROMAL LYMPHOPOIETIN; MICE											Al-Shami A, 2005, J EXP MED, V202, P829, DOI 10.1084/jem.20050199; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	3	3	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2005	5	10					747	747		10.1038/nri1727	http://dx.doi.org/10.1038/nri1727			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	969JE		Bronze			2022-12-18	WOS:000232229600008
J	Bell, E				Bell, E			Immune regulation - NKT-cell defects in XLP	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Nichols KE, 2005, IMMUNOL REV, V203, P180, DOI 10.1111/j.0105-2896.2005.00230.x; Nichols KE, 2005, NAT MED, V11, P340, DOI 10.1038/nm1189	2	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2005	5	4					265	265		10.1038/nri1595	http://dx.doi.org/10.1038/nri1595			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	912PX		Bronze			2022-12-18	WOS:000228092800002
J	Bell, E				Bell, E			T-cell activation - T-cell-APC interactions	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Friedl P, 2004, TRENDS CELL BIOL, V14, P557, DOI 10.1016/j.tcb.2004.09.005; Gunzer M, 2004, BLOOD, V104, P2801, DOI 10.1182/blood-2004-03-1193	2	3	3	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2004	4	12					930	930		10.1038/nri1515	http://dx.doi.org/10.1038/nri1515			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	875YM		Bronze			2022-12-18	WOS:000225459100009
J	Bell, E				Bell, E			Innate immunity - TLR signalling	NATURE REVIEWS IMMUNOLOGY			English	News Item																		HOEBE K, 2003, NATURE          0723; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	2	3	3	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2003	3	9					692	692		10.1038/nri1185	http://dx.doi.org/10.1038/nri1185			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	725GM		Bronze			2022-12-18	WOS:000185535500006
J	Bell, E				Bell, E			Antibodies - Eliminating the bad guys	NATURE REVIEWS IMMUNOLOGY			English	News Item																		WARDEMANN H, 2003, SCIENCE         0815	1	3	3	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2003	3	9					692	693		10.1038/nri1193	http://dx.doi.org/10.1038/nri1193			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	725GM					2022-12-18	WOS:000185535500005
J	Bell, J				Bell, J			Complex killing	NATURE REVIEWS IMMUNOLOGY			English	News Item																		MELKER SS, 2002, IMMUNITY, V16, P417	1	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2002	2	5					301	301		10.1038/nri807	http://dx.doi.org/10.1038/nri807			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	636DD		Bronze			2022-12-18	WOS:000180438500001
J	Bell, J				Bell, J			Winning moves	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395	1	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2002	2	1					9	9		10.1038/nri708	http://dx.doi.org/10.1038/nri708			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	635KP					2022-12-18	WOS:000180398300018
J	Buckland, J				Buckland, J			The ageing process	NATURE REVIEWS IMMUNOLOGY			English	News Item																		ANDERSON G, NATURE REV IMMUNOL, V1, P31; Sano S, 2001, IMMUNITY, V15, P261, DOI 10.1016/S1074-7613(01)00180-7	2	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2001	1	1					8	9		10.1038/35095542	http://dx.doi.org/10.1038/35095542			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	635KK		Bronze			2022-12-18	WOS:000180397900016
J	Hotez, PJ				Hotez, Peter J.			Will anti-vaccine activism in the USA reverse global goals? COMMENT	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material								In the time of the COVID-19 pandemic, anti-vaccine activism in the USA accelerated, amplified and formed an alliance with political groups and even extremists. An organized, well-funded and empowered anti-science movement now threatens to spill over and threaten all childhood immunizations in the USA and globally.	[Hotez, Peter J.] Baylor Coll Med, Texas Childrens Hosp Ctr Vaccine Dev, Natl Sch Trop Med, Dept Pediat, Houston, TX 77030 USA; [Hotez, Peter J.] Baylor Coll Med, Texas Childrens Hosp Ctr Vaccine Dev, Natl Sch Trop Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Hotez, PJ (corresponding author), Baylor Coll Med, Texas Childrens Hosp Ctr Vaccine Dev, Natl Sch Trop Med, Dept Pediat, Houston, TX 77030 USA.; Hotez, PJ (corresponding author), Baylor Coll Med, Texas Childrens Hosp Ctr Vaccine Dev, Natl Sch Trop Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.	hotez@bcm.edu						Abul Kalam M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256496; Banco E., 2022, POLITICO; Cooper S, 2021, EXPERT REV VACCINES, V20, P921, DOI 10.1080/14760584.2021.1949291; Hotez PJ, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI149072; Hotez PJ, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3001369; Jaupart P, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001789; Karafillakis E, 2022, LANCET, V399, P699, DOI 10.1016/S0140-6736(22)00150-7; Mutombo PN, 2022, LANCET GLOB HEALTH, V10, pE320, DOI 10.1016/S2214-109X(21)00563-5; Simas C, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-021-00279-w; Wilkinson E, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o360	10	2	2	2	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2022	22	9					525	526		10.1038/s41577-022-00770-9	http://dx.doi.org/10.1038/s41577-022-00770-9		AUG 2022	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	4E2XF	35915141	Green Published, Bronze			2022-12-18	WOS:000834697100001
J	Charlesworth, CT; Hsu, I; Wilkinson, AC; Nakauchi, H				Charlesworth, Carsten T.; Hsu, Ian; Wilkinson, Adam C.; Nakauchi, Hiromitsu			Immunological barriers to haematopoietic stem cell gene therapy	NATURE REVIEWS IMMUNOLOGY			English	Review							MAJOR HISTOCOMPATIBILITY COMPLEX; CYTOTOXIC-T-LYMPHOCYTE; IMMUNE-RESPONSES; IN-VIVO; BONE-MARROW; PREEXISTING IMMUNITY; LENTIVIRAL VECTORS; MICE LACKING; TOLERANCE; TRANSPLANTATION	Cell and gene therapies using haematopoietic stem cells (HSCs) epitomize the transformative potential of regenerative medicine. Recent clinical successes for gene therapies involving autologous HSC transplantation (HSCT) demonstrate the potential of genetic engineering in this stem cell type for curing disease. With recent advances in CRISPR gene-editing technologies, methodologies for the ex vivo expansion of HSCs and non-genotoxic conditioning protocols, the range of clinical indications for HSC-based gene therapies is expected to significantly expand. However, substantial immunological challenges need to be overcome. These include pre-existing immunity to gene-therapy reagents, immune responses to neoantigens introduced into HSCs by genetic engineering, and unique challenges associated with next-generation and off-the-shelf HSC products. By synthesizing these factors in this Review, we hope to encourage more research to address the immunological issues associated with current and next-generation HSC-based gene therapies to help realize the full potential of this field. To realize the full potential of genetic engineering of haematopoietic stem cells for a broad range of clinical indications, substantial immunological challenges must be overcome. These include innate and adaptive immune responses to gene-therapy reagents and adaptive immune responses to neoantigens expressed by genetically engineered cells.	[Charlesworth, Carsten T.; Nakauchi, Hiromitsu] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA; [Charlesworth, Carsten T.; Nakauchi, Hiromitsu] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Hsu, Ian; Wilkinson, Adam C.] Univ Oxford, MRC Weatherall Inst Mol Med, Oxford, England	Stanford University; Stanford University; University of Oxford	Nakauchi, H (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA.; Nakauchi, H (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.; Wilkinson, AC (corresponding author), Univ Oxford, MRC Weatherall Inst Mol Med, Oxford, England.	adam.wilkinson@imm.ox.ac.uk; nakauchi@stanford.edu		Charlesworth, Carsten/0000-0002-8588-6204; Hsu, Ian/0000-0002-1648-5060	National Science Foundation (NSF); Medical Research Council (MRC); Kay Kendall Leukaemia Fund; National Institutes of Health (NIH) [R01DK116944, R01HL147124]; Virginia and D.K. Ludwig Fund for Cancer Research (D.K. Ludwig Fund)	National Science Foundation (NSF)(National Science Foundation (NSF)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Kay Kendall Leukaemia Fund; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia and D.K. Ludwig Fund for Cancer Research (D.K. Ludwig Fund)	C.T.C. is supported by the National Science Foundation (NSF). A.C.W. acknowledges support from the Medical Research Council (MRC) and the Kay Kendall Leukaemia Fund. H.N. is supported by the National Institutes of Health (NIH) (grants R01DK116944; R01HL147124) and the Virginia and D.K. Ludwig Fund for Cancer Research (D.K. Ludwig Fund).	Agarwal R, 2020, BLOOD, V136, DOI 10.1182/blood-2020-137762; Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Aiuti A, 2017, EMBO MOL MED, V9, P737, DOI 10.15252/emmm.201707573; Akbarpour M, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3032; [Anonymous], 2020, NAT BIOTECHNOL, V38, P910, DOI 10.1038/s41587-020-0642-9; Anzalone AV, 2020, NAT BIOTECHNOL, V38, P824, DOI 10.1038/s41587-020-0561-9; Anzalone AV, 2019, NATURE, V576, P149, DOI 10.1038/s41586-019-1711-4; Bai T, 2019, NAT MED, V25, P1566, DOI 10.1038/s41591-019-0601-5; Beagles KE, 2005, HUM GENE THER, V16, P725, DOI 10.1089/hum.2005.16.725; Bernardo ME, 2016, HUM GENE THER, V27, P741, DOI 10.1089/hum.2016.103; Bhatt KH, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0508-3; BLAESE RM, 1995, SCIENCE, V270, P475, DOI 10.1126/science.270.5235.475; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Boutin S, 2010, HUM GENE THER, V21, P704, DOI 10.1089/hum.2009.182; Boztug K, 2010, NEW ENGL J MED, V363, P1918, DOI 10.1056/NEJMoa1003548; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; Bubnic SJ, 2005, HEMATOLOGY, V10, P289, DOI 10.1080/10245330500093468; Burger P, 2012, BLOOD, V119, P5512, DOI 10.1182/blood-2011-10-386805; Burke BP., 2015, MOL THER NUCL ACIDS, V4; Calcedo R, 2017, P NATL ACAD SCI USA, V114, P1655, DOI 10.1073/pnas.1617726114; CALNE RY, 1969, NATURE, V223, P472, DOI 10.1038/223472a0; Cavazzana M, 2019, NAT REV DRUG DISCOV, V18, P447, DOI 10.1038/s41573-019-0020-9; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Chanut FJA, 2021, HUM GENE THER, V32, P66, DOI 10.1089/hum.2020.135; Charlesworth CT, 2019, NAT MED, V25, P249, DOI 10.1038/s41591-018-0326-x; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; Chhabra A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aae0501; Chiu YL, 2002, MOL CELL, V10, P585, DOI 10.1016/S1097-2765(02)00630-5; CIVIN CI, 1984, J IMMUNOL, V133, P157; Coleman MA, 2013, BLOOD, V121, P1049, DOI 10.1182/blood-2012-06-434100; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cunningham EC, 2013, TRANSPLANTATION, V95, P70, DOI 10.1097/TP.0b013e318278d39a; Czechowicz A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08201-x; De La Serna J, 2016, BONE MARROW TRANSPL, V51, P961, DOI 10.1038/bmt.2016.42; De Oliveira SN, 2013, HUM GENE THER, V24, P824, DOI 10.1089/hum.2012.202; Demirci S, 2020, STEM CELL TRANSL MED, V9, P1549, DOI 10.1002/sctm.20-0247; Dendrou CA, 2018, NAT REV IMMUNOL, V18, P325, DOI 10.1038/nri.2017.143; Deuse T, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2022091118; Deuse T, 2019, NAT BIOTECHNOL, V37, P252, DOI 10.1038/s41587-019-0016-3; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; Dowdy SF, 2017, NAT BIOTECHNOL, V35, P222, DOI 10.1038/nbt.3802; Drysdale CM, 2020, MOL THER-METH CLIN D, V16, P42, DOI 10.1016/j.omtm.2019.10.010; Dudek AM, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.660302; Dunleavy, 2021, PRICING SITUATION UN; Eaves CJ, 2015, BLOOD, V125, P2605, DOI 10.1182/blood-2014-12-570200; Fares I, 2014, SCIENCE, V345, P1509, DOI 10.1126/science.1256337; Ferrari G, 2021, NAT REV GENET, V22, P216, DOI 10.1038/s41576-020-00298-5; Frangoul H, 2021, NEW ENGL J MED, V384, P252, DOI 10.1056/NEJMoa2031054; Furlan R, 2021, MOL THER, V29, P896, DOI 10.1016/j.ymthe.2021.02.003; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Gentner B, 2021, NEW ENGL J MED, V385, P1929, DOI 10.1056/NEJMoa2106596; George BM, 2019, CELL STEM CELL, V25, P185, DOI 10.1016/j.stem.2019.05.018; George LA, 2020, MOL THER, V28, P2073, DOI 10.1016/j.ymthe.2020.06.001; Gillmore JD, 2021, NEW ENGL J MED, V385, P493, DOI 10.1056/NEJMoa2107454; Ginn SL, 2017, MOL THER-NUCL ACIDS, V6, P1, DOI 10.1016/j.omtn.2016.11.011; Goldstein JM, 2019, CELL REP, V27, P1254, DOI 10.1016/j.celrep.2019.03.105; Gornalusse GG, 2017, NAT BIOTECHNOL, V35, P765, DOI 10.1038/nbt.3860; Gouw SC, 2012, BLOOD, V119, P2922, DOI 10.1182/blood-2011-09-379453; Gragert L, 2014, NEW ENGL J MED, V371, P339, DOI 10.1056/NEJMsa1311707; Granot N, 2020, HAEMATOLOGICA, V105, P2716, DOI 10.3324/haematol.2019.245688; Greiner V, 2019, ISCIENCE, V12, P369, DOI 10.1016/j.isci.2019.01.032; GRUSBY MJ, 1993, P NATL ACAD SCI USA, V90, P3913, DOI 10.1073/pnas.90.9.3913; Gyurkocza B, 2014, BLOOD, V124, P344, DOI 10.1182/blood-2014-02-514778; Hakim FT, 2005, J CLIN INVEST, V115, P930, DOI 10.1172/JCI22492; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hill GR, 2021, ANNU REV IMMUNOL, V39, P19, DOI 10.1146/annurev-immunol-102119-073227; Hosel M, 2012, HEPATOLOGY, V55, P287, DOI 10.1002/hep.24625; Humbert O, 2018, BLOOD ADV, V2, P987, DOI 10.1182/bloodadvances.2018016451; Irving AT, 2021, NATURE, V589, P363, DOI 10.1038/s41586-020-03128-0; Jacobson SG, 2015, NEW ENGL J MED, V372, P1920, DOI 10.1056/NEJMoa1412965; Kariko K, 2008, MOL THER, V16, P1833, DOI 10.1038/mt.2008.200; Kim MY, 2018, CELL, V173, P1439, DOI 10.1016/j.cell.2018.05.013; Krishnamurthy S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12922-y; Kung SKP, 2003, MOL THER, V8, P981, DOI 10.1016/j.ymthe.2003.08.020; Li A, 2020, MOL THER, V28, P1432, DOI 10.1016/j.ymthe.2020.04.017; Li C, 2021, MOL THER, V29, P822, DOI 10.1016/j.ymthe.2020.09.001; Li CW, 2009, J VIROL, V83, P6817, DOI 10.1128/JVI.00278-09; Liao WN, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.573915; Liu XG, 2011, NAT IMMUNOL, V12, P416, DOI 10.1038/ni.2015; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Long BR, 2019, MOL THER-METH CLIN D, V13, P440, DOI 10.1016/j.omtm.2019.03.006; Lutzko C, 1999, BLOOD, V93, P1895; MacDonald KG, 2016, J CLIN INVEST, V126, P1413, DOI 10.1172/JCI82771; Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338; Manilay JO, 1998, TRANSPLANTATION, V66, P96, DOI 10.1097/00007890-199807150-00015; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Meadows AS, 2019, MOL THER-METH CLIN D, V13, P453, DOI 10.1016/j.omtm.2019.04.004; Mendell JR, 2010, NEW ENGL J MED, V363, P1429, DOI 10.1056/NEJMoa1000228; Mikhael NL, 2019, BLOOD RES, V54, P274, DOI 10.5045/br.2019.54.4.274; Milani M, 2017, EMBO MOL MED, V9, P1558, DOI 10.15252/emmm.201708148; Mingozzi F, 2007, NAT MED, V13, P419, DOI 10.1038/nm1549; Mingozzi F, 2017, ANNU REV VIROL, V4, P511, DOI 10.1146/annurev-virology-101416-041936; Morgan RA, 2017, CELL STEM CELL, V21, P574, DOI 10.1016/j.stem.2017.10.010; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Myburgh R, 2020, LEUKEMIA, V34, P2688, DOI 10.1038/s41375-020-0818-9; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Noyan F, 2017, AM J TRANSPLANT, V17, P917, DOI 10.1111/ajt.14175; Ochi K, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23763-z; Ogonek J, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00507; Pasi KJ, 2020, NEW ENGL J MED, V382, P29, DOI 10.1056/NEJMoa1908490; Petrillo C, 2018, CELL STEM CELL, V23, P820, DOI 10.1016/j.stem.2018.10.008; Pien GC, 2009, J CLIN INVEST, V119, P1688, DOI 10.1172/JCI36891; Piras F, 2021, GENE THER, V28, P16, DOI 10.1038/s41434-020-0175-3; Piras F, 2017, EMBO MOL MED, V9, P1198, DOI 10.15252/emmm.201707922; Ponder KP, 2008, J CLIN INVEST, V118, P2686, DOI 10.1172/JCI36521; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Rasaiyaah J, 2013, NATURE, V503, P402, DOI 10.1038/nature12769; Riddell J, 2014, CELL, V157, P549, DOI 10.1016/j.cell.2014.04.006; Riddell SR, 1996, NAT MED, V2, P216, DOI 10.1038/nm0296-216; Rio P, 2019, NAT MED, V25, P1396, DOI 10.1038/s41591-019-0550-z; Robinson J, 2016, HUM IMMUNOL, V77, P233, DOI 10.1016/j.humimm.2016.01.020; Rosenzweig M, 2001, BLOOD, V97, P1951, DOI 10.1182/blood.V97.7.1951; Rothgangl T, 2021, NAT BIOTECHNOL, V39, P949, DOI 10.1038/s41587-021-00933-4; Rust BJ, 2020, MOL THER-METH CLIN D, V19, P438, DOI 10.1016/j.omtm.2020.10.002; Sack BK, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.13; Sandler VM, 2014, NATURE, V511, P312, DOI 10.1038/nature13547; Schiroli G, 2019, CELL STEM CELL, V24, P551, DOI 10.1016/j.stem.2019.02.019; Schiroli G, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan0820; Shimoto M, 2017, BLOOD, V129, P2124, DOI 10.1182/blood-2016-09-740563; Shirley JL, 2020, MOL THER, V28, P709, DOI 10.1016/j.ymthe.2020.01.001; Sibbald B, 2001, CAN MED ASSOC J, V164, P1612; Squeri G, 2019, MOL THER, V27, P1215, DOI 10.1016/j.ymthe.2019.04.014; Staahl BT, 2017, NAT BIOTECHNOL, V35, P431, DOI 10.1038/nbt.3806; Styczynski J, 2020, BONE MARROW TRANSPL, V55, DOI 10.1038/s41409-019-0624-z; Swart JF, 2017, NAT REV RHEUMATOL, V13, P244, DOI 10.1038/nrrheum.2017.7; Tarantal AF, 2012, MOL THER, V20, P1033, DOI 10.1038/mt.2011.312; Taya Y, 2016, SCIENCE, V354, P1152, DOI 10.1126/science.aag3145; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; THOMAS ED, 1957, NEW ENGL J MED, V257, P491, DOI 10.1056/NEJM195709122571102; Thompson AA, 2018, NEW ENGL J MED, V378, P1479, DOI 10.1056/NEJMoa1705342; Tiercy JM, 2016, HAEMATOLOGICA, V101, P680, DOI 10.3324/haematol.2015.141119; Todo S, 2016, HEPATOLOGY, V64, P632, DOI 10.1002/hep.28459; Uchida N, 2014, GENE THER, V21, P148, DOI 10.1038/gt.2013.67; Uchida N, 2019, MOL THER, V27, P1586, DOI 10.1016/j.ymthe.2019.05.022; Uchida N, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.59; Vaidyanathan S, 2018, MOL THER-NUCL ACIDS, V12, P530, DOI 10.1016/j.omtn.2018.06.010; Vatakis DN, 2011, P NATL ACAD SCI USA, V108, pE1408, DOI 10.1073/pnas.1115050108; Voss JE, 2019, ELIFE, V8, DOI 10.7554/eLife.42995; Wagner DL, 2019, NAT MED, V25, P242, DOI 10.1038/s41591-018-0204-6; Wahlstrom Justin T, 2015, Curr Pediatr Rep, V3, P1; Weischendorff S, 2019, BIOL BLOOD MARROW TR, V25, P1432, DOI 10.1016/j.bbmt.2019.03.018; Wienert B, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005840; Wilkinson AC., 2021, NAT COMMUN, V12; Wilkinson AC, 2020, NAT REV GENET, V21, P541, DOI 10.1038/s41576-020-0241-0; Wilkinson AC, 2019, NATURE, V571, P117, DOI 10.1038/s41586-019-1244-x; Wu XF, 2018, CELL, V172, P423, DOI 10.1016/j.cell.2017.11.018; Xu HG, 2019, CELL STEM CELL, V24, P566, DOI 10.1016/j.stem.2019.02.005; Xu L, 2019, NEW ENGL J MED, V381, P1240, DOI 10.1056/NEJMoa1817426; XUN CQ, 1994, BLOOD, V83, P2360; Yin LJ, 2020, MOL THER-NUCL ACIDS, V21, P147, DOI 10.1016/j.omtn.2020.05.030; Yla-Herttuala S, 2012, MOL THER, V20, P1831, DOI 10.1038/mt.2012.194; Zeng J, 2020, NAT MED, V26, P535, DOI 10.1038/s41591-020-0790-y; Zhu JG, 2009, J CLIN INVEST, V119, P2388, DOI 10.1172/JCI37607	154	2	2	4	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2022	22	12					719	733		10.1038/s41577-022-00698-0	http://dx.doi.org/10.1038/s41577-022-00698-0		MAR 2022	15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6M3AE	35301483	Bronze, Green Published			2022-12-18	WOS:000770218400001
J	Poland, GA; Kennedy, RB				Poland, Gregory A.; Kennedy, Richard B.			Vaccine safety in an era of novel vaccines: a proposed research agenda COMMENT	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material							AUTOIMMUNE-DISEASE; NARCOLEPSY; INFECTION	Vaccines have outstanding efficacy and safety records, and the evolving science of vaccines is enabling us to better understand their mechanisms of action as well as the pathways that drive vaccine-related adverse events. This understanding is particularly crucial as novel vaccine antigens, platforms and adjuvants are increasingly being used.	[Poland, Gregory A.; Kennedy, Richard B.] Mayo Clin, Mayo Vaccine Res Grp, Rochester, MN 55905 USA	Mayo Clinic	Poland, GA (corresponding author), Mayo Clin, Mayo Vaccine Res Grp, Rochester, MN 55905 USA.	poland.gregory@mayo.edu		Kennedy, Rick/0000-0001-6164-4967; Poland, Gregory/0000-0001-5057-4457				Ahmed SS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2354; Bilotta C, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.729251; Cates JE, 2021, PEDIATR INFECT DIS J, V40, P1135, DOI 10.1097/INF.0000000000003286; Katzav A, 2013, J AUTOIMMUN, V45, P24, DOI 10.1016/j.jaut.2013.06.010; Offit PA, 2003, PEDIATRICS, V111, P653, DOI 10.1542/peds.111.3.653; Partinen M, 2014, LANCET NEUROL, V13, P600, DOI 10.1016/S1474-4422(14)70075-4; Vojtek I, 2019, VACCINE, V37, P539, DOI 10.1016/j.vaccine.2018.12.005; Watson PS, 2019, INT J INFECT DIS, V85, P22, DOI 10.1016/j.ijid.2019.05.019; Wheeler CM, 2012, LANCET ONCOL, V13, P100, DOI 10.1016/S1470-2045(11)70287-X; Wraith DC, 2003, LANCET, V362, P1659, DOI 10.1016/S0140-6736(03)14802-7	10	2	2	1	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2022	22	4					203	204		10.1038/s41577-022-00695-3	http://dx.doi.org/10.1038/s41577-022-00695-3		FEB 2022	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0F2ER	35197577	Bronze, Green Published			2022-12-18	WOS:000760016700002
J	Bird, L				Bird, Lucy			Magnesium: essential for T cells	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material								T cells need magnesium to function efficiently. They sense it via the cell surface integrin LFA-1, which triggers outside-in signalling to augment T cell effector functions against infection or cancers.										L?tscher J., 2022, CELL, DOI [10.1016/j.cell.2022.01.014, DOI 10.1016/J.CELL.2022.01.014]	1	2	2	2	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAR	2022	22	3					145	145		10.1038/s41577-022-00688-2	http://dx.doi.org/10.1038/s41577-022-00688-2		FEB 2022	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZM0ED	35140365				2022-12-18	WOS:000753298900003
J	Ruffin, N; Guerreiro-Cacais, AO				Ruffin, Nicolas; Guerreiro-Cacais, Andre Ortlieb			A PAN-CANCER SIGNATURE FOR DYSFUNCTIONAL T CELLS	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material; Early Access									[Ruffin, Nicolas; Guerreiro-Cacais, Andre Ortlieb] Karolinska Inst, Preprint Club, Stockholm, Sweden	Karolinska Institutet	Ruffin, N (corresponding author), Karolinska Inst, Preprint Club, Stockholm, Sweden.	highlights@preprintclub.com		Ruffin, Nicolas/0000-0002-3698-5505				Jerby-Arnon L, 2021, PAN CANC MAPPING SIN, DOI [10.1101/2021.10.31.466532, DOI 10.1101/2021.10.31.466532]; Ruffin N, PREPRINT J CLUB	2	2	2	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.												10.1038/s41577-021-00672-2	http://dx.doi.org/10.1038/s41577-021-00672-2		DEC 2021	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XO9MT	34912107				2022-12-18	WOS:000730501400001
J	Bird, L				Bird, Lucy			APOL1 variants contribute to racial disparity in sepsis	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material																		Wu J, IMMUNITY, DOI [10.1016/j.immuni.2021.10.004(2021, DOI 10.1016/J.IMMUNI.2021.10.004(2021]	1	2	2	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2021	21	12					759	759						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XD3NF	34707254	Bronze, Green Published			2022-12-18	WOS:000722617000003
J	Minton, K				Minton, Kirsty			Vitamin D shuts down T cell-mediated inflammation	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material								This study links the complement-mediated retraction of T helper 1 cell responses to vitamin D receptor signalling, an autoregulatory loop that might be impaired in patients with COVID-19.				k.minton@nature.com						Chauss D, 2022, NAT IMMUNOL, V23, P62, DOI 10.1038/s41590-021-01080-3	1	2	2	0	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2022	22	1					1	1		10.1038/s41577-021-00663-3	http://dx.doi.org/10.1038/s41577-021-00663-3		NOV 2021	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YA8ZK	34799725	Green Published, Bronze			2022-12-18	WOS:000720586900001
J	Bird, L				Bird, Lucy			APOL1 variants contribute to racial disparity in sepsis	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material; Early Access												l.bird@nature.com						Wu JN, 2021, IMMUNITY, V54, P2632, DOI 10.1016/j.immuni.2021.10.004	1	2	2	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.												10.1038/s41577-021-00647-3	http://dx.doi.org/10.1038/s41577-021-00647-3		OCT 2021	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WO5VN	34707254	Bronze, Green Published			2022-12-18	WOS:000712521800002
J	Randolph, GJ				Randolph, Gwendalyn J.			TISSUE MACROPHAGES BREAK DOGMA	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material									[Randolph, Gwendalyn J.] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Randolph, GJ (corresponding author), Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA.	gjrandolph@wustl.edu		Randolph, Gwendalyn/0000-0001-9045-1195				Aziz A, 2009, SCIENCE, V326, P867, DOI 10.1126/science.1176056; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Zhu Y, 2017, IMMUNITY, V47, P323, DOI 10.1016/j.immuni.2017.07.014	5	2	2	1	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2021	21	10					625	625		10.1038/s41577-021-00620-0	http://dx.doi.org/10.1038/s41577-021-00620-0			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UX9XG	34580463				2022-12-18	WOS:000701188100021
J	Lapenna, A; De Palma, M; Lewis, CE				Lapenna, Antonio; De Palma, Michele; Lewis, Claire E.			Perivascular macrophages in health and disease (vol 18, pg 689, 2018)	NATURE REVIEWS IMMUNOLOGY			English	Correction												claire.lewis@sheffield.ac.uk	De Palma, Michele/L-5350-2016	De Palma, Michele/0000-0001-9128-5459				Lapenna A, 2018, NAT REV IMMUNOL, V18, P689, DOI 10.1038/s41577-018-0056-9	1	2	2	1	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2021	21	11					752	752		10.1038/s41577-021-00630-y	http://dx.doi.org/10.1038/s41577-021-00630-y		SEP 2021	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WM9XX	34548650	Bronze			2022-12-18	WOS:000698067000002
J	Lavelle, EC; Ward, RW				Lavelle, Ed C.; Ward, Ross W.			Mucosal vaccines - fortifying the frontiers (Aug, 2021, 10.1038/s41577-021-00583-2)	NATURE REVIEWS IMMUNOLOGY			English	Correction												lavellee@tcd.ie	Lavelle, Ed/A-1716-2008	Lavelle, Ed/0000-0002-3167-1080; Ward, Ross/0000-0001-5242-4022				Lavelle EC, 2022, NAT REV IMMUNOL, V22, P236, DOI 10.1038/s41577-021-00583-2	1	2	2	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2022	22	4					266	266		10.1038/s41577-021-00599-8	http://dx.doi.org/10.1038/s41577-021-00599-8		AUG 2021	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0F2ER	34345023	Green Published, Bronze			2022-12-18	WOS:000680776300001
J	Newman, J; Horowitz, A				Newman, Jenna; Horowitz, Amir			NK CELLS SEIZE PD1 FROM LEUKAEMIA CELLS	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material									[Newman, Jenna; Horowitz, Amir] Icahn Sch Med Mt Sinai, OxMS Preprint Journal Club, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Newman, J; Horowitz, A (corresponding author), Icahn Sch Med Mt Sinai, OxMS Preprint Journal Club, New York, NY 10029 USA.	highlights@preprintclub.com; highlights@preprintclub.com						Hasim MS., 2021, WHEN KILLERS BECOME, DOI [10.1101/2020.06.26.174342, DOI 10.1101/2020.06.26.174342]; Hsu J, 2018, J CLIN INVEST, V128, P4654, DOI 10.1172/JCI99317; Judge SJ, 2020, J CLIN INVEST, V130, P3051, DOI [10.1172/JCI33353, 10.1172/JCI133353]; Newman J, 2021, OXFORD MOUNT SINAL O	4	2	2	0	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2021	21	6					345	345		10.1038/s41577-021-00562-7	http://dx.doi.org/10.1038/s41577-021-00562-7		MAY 2021	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SM0ZK	33981086	Green Accepted			2022-12-18	WOS:000650100500001
J	Gupta, RK				Gupta, Ravindra K.			Will SARS-CoV-2 variants of concern affect the promise of vaccines? (Apr, 10.1038/s41577-021-00556-5, 2021)	NATURE REVIEWS IMMUNOLOGY			English	Correction												rkg20@cam.ac.uk						Gupta RK, 2021, NAT REV IMMUNOL, V21, P340, DOI 10.1038/s41577-021-00556-5	1	2	2	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2021	21	6					405	405		10.1038/s41577-021-00560-9	http://dx.doi.org/10.1038/s41577-021-00560-9		MAY 2021	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SM0ZK	33972765	Green Published, Bronze			2022-12-18	WOS:000648862400001
J	Bordon, Y				Bordon, Yvonne			Variant constraint by mRNA vaccines	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material								The currently licensed mRNA vaccines for SARS-CoV-2 can elicit cross-neutralizing antibodies against B.1.351 variants of the virus, but are less potent against these variants.				y.bordon@nature.com						Stamatatos L, 2021, SCIENCE, V372, P1413, DOI 10.1126/science.abg9175	1	2	2	0	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2021	21	5					274	275		10.1038/s41577-021-00548-5	http://dx.doi.org/10.1038/s41577-021-00548-5		APR 2021	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RX5DH	33837367	Bronze, Green Published			2022-12-18	WOS:000638528000001
J	Male, V				Male, Victoria			Are COVID-19 vaccines safe in pregnancy? (Mar, 10.1038/s41577-021-00525-y, 2021)	NATURE REVIEWS IMMUNOLOGY			English	Correction								A Correction to this paper has been published: https://doi.org/10.1038/s41577-021-00533-y.				v.male@imperial.ac.uk						Male V, 2021, NAT REV IMMUNOL, V21, P200, DOI 10.1038/s41577-021-00525-y	1	2	2	0	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2021	21	4					268	268		10.1038/s41577-021-00533-y	http://dx.doi.org/10.1038/s41577-021-00533-y		MAR 2021	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RH0WY	33712745	Green Published, Bronze			2022-12-18	WOS:000628060900002
J	[Anonymous]				[Anonymous]			SARS-CoV-2 variant evades antibodies whilst maintaining fitness	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material																			0	2	2	0	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAR	2021	21	3					136	136						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QR3TZ	33542501	Green Published, Bronze			2022-12-18	WOS:000625136400007
J	Minton, K				Minton, Kirsty			IL-17a-mediated anxiety	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material												k.minton@nature.com						de Lima KA, 2020, NAT IMMUNOL, V21, P1421, DOI 10.1038/s41590-020-0776-4	1	2	2	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2020	20	11					647	647		10.1038/s41577-020-00453-3	http://dx.doi.org/10.1038/s41577-020-00453-3		SEP 2020	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OI7ET	32934354				2022-12-18	WOS:000569541800001
J	Dersh, D; Holly, J; Yewdell, JW				Dersh, Devin; Holly, Jaroslav; Yewdell, Jonathan W.			A few good peptides: MHC class I-based cancer immunosurveillance and immunoevasion (Aug, 10.1038/s41577-020-0390-6, 2020)	NATURE REVIEWS IMMUNOLOGY			English	Correction												jyewdell@nih.gov						Dersh D, 2021, NAT REV IMMUNOL, V21, P116, DOI 10.1038/s41577-020-0390-6	1	2	2	1	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2020	20	10					644	644		10.1038/s41577-020-00445-3	http://dx.doi.org/10.1038/s41577-020-00445-3		SEP 2020	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NS7PF	32873889	Bronze			2022-12-18	WOS:000565125600002
J	Sette, A; Crotty, S				Sette, Alessandro; Crotty, Shane			Pre-existing immunity to SARS-CoV-2: the knowns and unknowns (vol 52, pg 891, 2020)	NATURE REVIEWS IMMUNOLOGY			English	Correction												alex@lji.org; shane@lji.org	Sette, Alessandro/AFO-8916-2022					Sette A, 2020, NAT REV IMMUNOL, V20, P457, DOI 10.1038/s41577-020-0389-z	1	2	2	0	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2020	20	10					644	644		10.1038/s41577-020-00430-w	http://dx.doi.org/10.1038/s41577-020-00430-w		AUG 2020	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NS7PF	32807863	Green Published, Bronze			2022-12-18	WOS:000560653000001
J	Alrubayyi, A				Alrubayyi, Aljawharah			NK cells in COVID-19: protectors or opponents? (jul, 10.1038/s41577-020-0408-0, 2020)	NATURE REVIEWS IMMUNOLOGY			English	Correction												covid19lit@medsci.ox.ac.uk						Alrubayyi Aljawharah, 2020, Nat Rev Immunol, V20, P520, DOI 10.1038/s41577-020-0408-0	1	2	2	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2020	20	9					579	579		10.1038/s41577-020-00419-5	http://dx.doi.org/10.1038/s41577-020-00419-5		AUG 2020	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NF2RF	32753763	Bronze, Green Published			2022-12-18	WOS:000555774700001
J	Bird, L				Bird, Lucy			Gut bacteria support antiviral immunity	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material								Bile acid from intestinal symbiotic bacteria helps to resist alphavirus infection by supporting type I interferon responses by plasmacytoid dendritic cells, which in turn limit the permissiveness of circulating monocytes to viral infection.				l.bird@nature.com						Winkler ES, 2020, CELL, V182, P901, DOI 10.1016/j.cell.2020.06.029	1	2	2	0	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2020	20	9					520	521		10.1038/s41577-020-00412-y	http://dx.doi.org/10.1038/s41577-020-00412-y		JUL 2020	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NF2RF	32724197				2022-12-18	WOS:000553407800001
J	Minton, K				Minton, Kirsty			Peritoneal sex differences	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material								Differences in peritoneal macrophages between male and female mice depend on both their rate of renewal from the bone marrow and the influence of local tissue factors.				k.minton@nature.com						Bain CC, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc4466	1	2	2	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2020	20	8					460	461		10.1038/s41577-020-0385-3	http://dx.doi.org/10.1038/s41577-020-0385-3		JUL 2020	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MQ1WG	32612209				2022-12-18	WOS:000545664600002
J	Bordon, Y				Bordon, Yvonne			Blocking SIRP alpha could restore macrophage appetite and mitigate pneumonia	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material												y.bordon@nature.com						Roquilly A, 2020, NAT IMMUNOL, V21, P636, DOI 10.1038/s41590-020-0673-x	1	2	2	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2020	20	6					349	349		10.1038/s41577-020-0339-9	http://dx.doi.org/10.1038/s41577-020-0339-9			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LT4QN	32483337	Bronze			2022-12-18	WOS:000537057000008
J	Bird, L				Bird, Lucy			MR1-restricted pan-cancer T cells	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material																			0	2	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAR	2020	20	3					141	141						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KU1CK	32024985	Bronze			2022-12-18	WOS:000519447500012
J	Bordon, Y				Bordon, Yvonne			MAFG activity in astrocytes drives CNS inflammation	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material								A population of astrocytes characterized by decreased NRF2 and increased MAFG activity contributes to central nervous system inflammation.				y.bordon@nature.com						Wheeler MA, 2020, NATURE, V578, P593, DOI 10.1038/s41586-020-1999-0	1	2	2	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2020	20	4					205	205		10.1038/s41577-020-0291-8	http://dx.doi.org/10.1038/s41577-020-0291-8		FEB 2020	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KY8BR	32099084	Bronze			2022-12-18	WOS:000517263200002
J	Bird, L				Bird, Lucy			MR1-restricted pan-cancer T cells	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material; Early Access																		Crowther MD, 2020, NAT IMMUNOL, V21, P178, DOI 10.1038/s41590-019-0578-8	1	2	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.												10.1038/s41577-020-0284-7	http://dx.doi.org/10.1038/s41577-020-0284-7		FEB 2020	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KI3XP	32024985	Bronze			2022-12-18	WOS:000511282000001
J	Bird, L				Bird, Lucy			Myeloid PD1 in the frame	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material																		Strauss L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aay1863	1	2	2	0	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2020	20	2					72	73						2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KI2EH	31937936				2022-12-18	WOS:000511159600016
J	Minton, K				Minton, Kirsty			Overcoming CAR T cell exhaustion	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material																		Lynn RC, 2019, NATURE, V576, P293, DOI 10.1038/s41586-019-1805-z	1	2	2	0	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2020	20	2					72	73						2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KI2EH	31844329				2022-12-18	WOS:000511159600015
J	Bird, L				Bird, Lucy			Myeloid PD1 in the frame	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material; Early Access								T cells expressing programmed cell death 1 (PD1) have been considered the main targets of immune checkpoint blockade therapy. But a new study shows that targeting PD1 on myeloid cells reprogrammes tumour-induced myelopoiesis to favour maturation of effector myeloid cells that promote antitumour immunity.				l.bird@nature.com						Strauss L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aay1863	1	2	2	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.												10.1038/s41577-020-0276-7	http://dx.doi.org/10.1038/s41577-020-0276-7		JAN 2020	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KD9GJ	31937936				2022-12-18	WOS:000508169400001
J	Bordon, Y				Bordon, Yvonne			Kupffer cells: finding their niche	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material																		Bonnardel J, 2019, IMMUNITY, V51, P638, DOI 10.1016/j.immuni.2019.08.017; Sakai M, 2019, IMMUNITY, V51, P655, DOI 10.1016/j.immuni.2019.09.002	2	2	2	0	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2019	19	11					660	661						2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JI6FX					2022-12-18	WOS:000493564300003
J	Hart, PH				Hart, Prue H.			Sun-immune connection	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material									[Hart, Prue H.] Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia	Telethon Kids Institute; University of Western Australia	Hart, PH (corresponding author), Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia.	Prue.Hart@telethonkids.org.au						DEFABO EC, 1983, J EXP MED, V158, P84, DOI 10.1084/jem.158.1.84; Zhu HY, 2018, CELL, V173, P1716, DOI 10.1016/j.cell.2018.04.014	2	2	2	0	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2019	19	11					661	661		10.1038/s41577-019-0216-6	http://dx.doi.org/10.1038/s41577-019-0216-6			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JI6FX	31467404	Bronze			2022-12-18	WOS:000493564300004
J	Minton, K				Minton, Kirsty			Regulation of endosomal TLRs	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material																		Majer O, 2019, NATURE, V575, P366, DOI 10.1038/s41586-019-1612-6; Majer O, 2019, NATURE, V575, P371, DOI 10.1038/s41586-019-1611-7	2	2	2	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2019	19	11					660	661						2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JI6FX					2022-12-18	WOS:000493564300002
J	Bordon, Y				Bordon, Yvonne			Bacterial metabolites shape neonatal immune system	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material																		Hu MJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10703-1; Levan SR, 2019, NAT MICROBIOL, V4, P1851, DOI 10.1038/s41564-019-0498-2; Skelly AN, 2019, NAT REV IMMUNOL, V19, P305, DOI 10.1038/s41577-019-0144-5	3	2	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2019	19	9					537	537		10.1038/s41577-019-0207-7	http://dx.doi.org/10.1038/s41577-019-0207-7			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IU9XS	31371823	Bronze			2022-12-18	WOS:000483934500007
J	Bird, L				Bird, Lucy			Stromal IL-33 balances fat stores	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material														Bird, Lucy/0000-0002-3914-6045					0	2	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUL	2019	19	7					412	413		10.1038/s41577-019-0179-7	http://dx.doi.org/10.1038/s41577-019-0179-7			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IF7MB	31110269				2022-12-18	WOS:000473267100002
J	Maini, MK				Maini, Mala K.			CD8(+) T cells cure without killing	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material									[Maini, Mala K.] UCL, Div Infect & Immun, London, England	University of London; University College London	Maini, MK (corresponding author), UCL, Div Infect & Immun, London, England.	m.maini@ucl.ac.uk		Maini, Mala/0000-0001-6384-1462				Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; BERTOLETTI A, 1994, NATURE, V369, P407, DOI 10.1038/369407a0	2	2	2	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2019	19	4					201	201		10.1038/s41577-019-0150-7	http://dx.doi.org/10.1038/s41577-019-0150-7			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HQ7KW	30846857	Bronze			2022-12-18	WOS:000462600000004
J	Brodin, P				Brodin, Petter			Systems-level patterns emerge	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material							HUMAN IMMUNE-SYSTEM; AGE	2018 was a good year for studies of human immunology. A growing number of analyses are now being carried out directly on human samples, leading to novel findings and an increasing understanding of immune system variation. Systems-level analyses that simultaneously capture information about many immune cell populations and proteins are particularly useful for revealing interesting patterns among highly variable humans. This year, several such systems-level analyses were carried out to address immune variation between different age groups, revealing global patterns of immune system development in the young and immune system decline in the elderly. Here, I highlight some of these key advances.	[Brodin, Petter] Karolinska Inst, Dept Womens & Childrens Hlth, Sci Life Lab, Stockholm, Sweden; [Brodin, Petter] Karolinska Univ Hosp, Dept Newborn Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Brodin, P (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Sci Life Lab, Stockholm, Sweden.; Brodin, P (corresponding author), Karolinska Univ Hosp, Dept Newborn Med, Stockholm, Sweden.	petter.brodin@ki.se	Brodin, Petter/C-3317-2011	Brodin, Petter/0000-0002-8103-0046				Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Brodin P, 2017, NAT REV IMMUNOL, V17, P21, DOI 10.1038/nri.2016.125; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Carr EJ, 2016, NAT IMMUNOL, V17, P461, DOI 10.1038/ni.3371; Cheung P, 2018, CELL, V173, P1385, DOI 10.1016/j.cell.2018.03.079; Kaczorowski KJ, 2017, P NATL ACAD SCI USA, V114, pE6097, DOI 10.1073/pnas.1705065114; Olin A, 2018, CELL, V174, P1277, DOI 10.1016/j.cell.2018.06.045; Piasecka B, 2018, P NATL ACAD SCI USA, V115, pE488, DOI 10.1073/pnas.1714765115; Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031	9	2	2	3	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2019	19	2					87	88		10.1038/s41577-018-0106-3	http://dx.doi.org/10.1038/s41577-018-0106-3			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HJ4PH	30604773				2022-12-18	WOS:000457155400015
J	Bird, L				Bird, Lucy			TRANSPLANTATION Targeting trained immunity	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material														Bird, Lucy/0000-0002-3914-6045					0	2	4	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2019	19	1					2	3		10.1038/s41577-018-0097-0	http://dx.doi.org/10.1038/s41577-018-0097-0			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HG1JL	30487529				2022-12-18	WOS:000454709800002
J	Minton, K				Minton, Kirsty			MICROBIOTA B1 B cells link gut dysbiosis and insulin resistance	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material														Minton, Kirsty/0000-0002-3857-8030					0	2	2	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2019	19	1					1	1		10.1038/s41577-018-0096-1	http://dx.doi.org/10.1038/s41577-018-0096-1			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HG1JL	30482912	Bronze			2022-12-18	WOS:000454709800001
J	Chiossone, L; Dumas, PY; Vienne, M; Vivier, E				Chiossone, Laura; Dumas, Pierre-Yves; Vienne, Margaux; Vivier, Eric			Natural killer cells and other innate lymphoid cells in cancer (vol 18, pg 671, 2018)	NATURE REVIEWS IMMUNOLOGY			English	Correction													Vienne, Margaux/AAI-2109-2021; Vivier, Eric/F-8939-2010	Vivier, Eric/0000-0001-7022-8287; Dumas, Pierre-Yves/0000-0003-0119-3548; Chiossone, Laura/0000-0002-9097-5869				Chiossone L, 2018, NAT REV IMMUNOL, V18, P671, DOI 10.1038/s41577-018-0061-z	1	2	2	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2018	18	11					726	726		10.1038/s41577-018-0077-4	http://dx.doi.org/10.1038/s41577-018-0077-4			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GY2WG	30315207	Bronze			2022-12-18	WOS:000448404500015
J	Lee, CZW; Kozaki, T; Ginhoux, F				Lee, Christopher Z. W.; Kozaki, Tatsuya; Ginhoux, Florent			Studying tissue macrophages in vitro: are iPSC-derived cells the answer? (vol 18, pg 716, 2018)	NATURE REVIEWS IMMUNOLOGY			English	Correction														Ginhoux, Florent/0000-0002-2857-7755				Lee CZW, 2018, NAT REV IMMUNOL, V18, P716, DOI 10.1038/s41577-018-0054-y	1	2	2	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2018	18	11					726	726		10.1038/s41577-018-0060-0	http://dx.doi.org/10.1038/s41577-018-0060-0			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GY2WG	30166617				2022-12-18	WOS:000448404500016
J	Flemming, A				Flemming, Alexandra			Bacteria-primed T cells identified as culprit in glaucoma	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material																			0	2	2	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2018	18	10					603	603		10.1038/s41577-018-0063-x	http://dx.doi.org/10.1038/s41577-018-0063-x			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GV0TG	30185929	Bronze			2022-12-18	WOS:000445775700008
J	Flemming, A				Flemming, Alexandra			T(H)9 cells tackle advanced tumours	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material																			0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2018	18	8					479	479		10.1038/s41577-018-0032-4	http://dx.doi.org/10.1038/s41577-018-0032-4			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GO3CD	29946075	Bronze			2022-12-18	WOS:000439863400001
J	Otto, G				Otto, Grant			Tumour decides immune cell ins and outs	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material														Otto, Grant/0000-0001-8709-3366					0	2	3	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2018	18	8					481	481		10.1038/s41577-018-0038-y	http://dx.doi.org/10.1038/s41577-018-0038-y			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GO3CD	29985485				2022-12-18	WOS:000439863400004
J	Minton, K				Minton, Kirsty			LC3 anchors TLR9 signalling	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material														Minton, Kirsty/0000-0002-3857-8030					0	2	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUL	2018	18	7					418	419		10.1038/s41577-018-0019-1	http://dx.doi.org/10.1038/s41577-018-0019-1			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK8IE	29752467				2022-12-18	WOS:000436463300002
J	Bordon, Y				Bordon, Yvonne			Old drug, new trick	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material														Bordon, Yvonne/0000-0002-9728-012X					0	2	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2018	18	5					295	295		10.1038/nri.2018.29	http://dx.doi.org/10.1038/nri.2018.29			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GE1DD	29658511	Bronze			2022-12-18	WOS:000430956100009
J	Otto, G				Otto, Grant			Itaconate helps KEAP1's cool	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material														Otto, Grant/0000-0001-8709-3366					0	2	4	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2018	18	5					294	294		10.1038/nri.2018.27	http://dx.doi.org/10.1038/nri.2018.27			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GE1DD	29629713				2022-12-18	WOS:000430956100006
J	Starling, S				Starling, Shimona			Stem cell hope for cancer treatment	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material														Starling, Shimona/0000-0001-6059-8006					0	2	2	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2018	18	4					223	223		10.1038/nri.2018.16	http://dx.doi.org/10.1038/nri.2018.16			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GA5UH	29503455	Bronze			2022-12-18	WOS:000428398900004
J	Minton, K				Minton, Kirsty			Pathobiont peacekeepers	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material														Minton, Kirsty/0000-0002-3857-8030					0	2	2	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAR	2018	18	3					152	152		10.1038/nri.2018.11	http://dx.doi.org/10.1038/nri.2018.11			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FX5KU	29449703				2022-12-18	WOS:000426118500007
J	Starling, S				Starling, Shimona			T cells activate the fear	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material														Starling, Shimona/0000-0001-6059-8006					0	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2017	17	12					730	730		10.1038/nri.2017.126	http://dx.doi.org/10.1038/nri.2017.126			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FN6YI	29109541	Bronze			2022-12-18	WOS:000416162500002
J	Sidaway, P				Sidaway, Peter			Neutrophil differentiation is autophagy dependent	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material																			0	2	2	2	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2017	17	11								10.1038/nri.2017.122	http://dx.doi.org/10.1038/nri.2017.122			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FL1LO	29076498	Bronze			2022-12-18	WOS:000413976600003
J	Starling, S				Starling, Shimona			TYPE 2 IMMUNITY Hero turns villain in fatty liver	NATURE REVIEWS IMMUNOLOGY			English	Editorial Material														Starling, Shimona/0000-0001-6059-8006					0	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2017	17	8								10.1038/nri.2017.81	http://dx.doi.org/10.1038/nri.2017.81			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FB8YL	28714482	Bronze			2022-12-18	WOS:000406426200005
J	Flemming, A				Flemming, Alexandra			TUMOUR IMMUNOLOGY LAP targeting reduces tolerogenic cells in cancer	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUL	2017	17	7					402	402		10.1038/nri.2017.65	http://dx.doi.org/10.1038/nri.2017.65			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY6TP	28627519				2022-12-18	WOS:000404116500002
J	Bird, L				Bird, Lucy			NEUROIMMUNOLOGY Macrophages help you burn energy	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bird, Lucy/0000-0002-3914-6045					0	2	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2017	17	6								10.1038/nri.2017.56	http://dx.doi.org/10.1038/nri.2017.56			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EV8VO	28504258				2022-12-18	WOS:000402062500003
J	Flemming, A				Flemming, Alexandra			TUMOUR IMMUNOLOGY Immune atlas sheds light on anticancer responses	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	2	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2017	17	6								10.1038/nri.2017.59	http://dx.doi.org/10.1038/nri.2017.59			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EV8VO	28548134	Bronze			2022-12-18	WOS:000402062500005
J	Flemming, A				Flemming, Alexandra			Mechanism of adaptive immunity found in the fruitfly	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	2	2	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2017	17	5								10.1038/nri.2017.44	http://dx.doi.org/10.1038/nri.2017.44			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ET1SY	28443639	Bronze			2022-12-18	WOS:000400050400003
J	Minton, K				Minton, Kirsty			Circulating precursor for human ILCs	NATURE REVIEWS IMMUNOLOGY			English	News Item														Minton, Kirsty/0000-0002-3857-8030					0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2017	17	4					216	216		10.1038/nri.2017.29	http://dx.doi.org/10.1038/nri.2017.29			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EP4YJ	28317924				2022-12-18	WOS:000397385600002
J	Bordon, Y				Bordon, Yvonne			Pollutants drive atopic dermatitis	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X					0	2	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2017	17	1					1	1		10.1038/nri.2016.141	http://dx.doi.org/10.1038/nri.2016.141			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EH6TX	27941892				2022-12-18	WOS:000391907900001
J	Kugelberg, E				Kugelberg, Elisabeth			Interferons suppress antibody responses	NATURE REVIEWS IMMUNOLOGY			English	News Item														Kugelberg, Elisabeth/0000-0002-8302-3595					0	2	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2016	16	12					720	720		10.1038/nri.2016.128	http://dx.doi.org/10.1038/nri.2016.128			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ED8PX	27885278				2022-12-18	WOS:000389134500005
J	Leavy, O				Leavy, Olive			ASTHMA AND ALLERGY Old McDonald had a farm (but no asthma)!	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	2	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2016	16	9					535	535		10.1038/nri.2016.97	http://dx.doi.org/10.1038/nri.2016.97			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DU7ZZ	27558411	Bronze			2022-12-18	WOS:000382434400004
J	Kingwell, K				Kingwell, Katie			Two-pronged attack on HIV	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2016	16	8					465	465		10.1038/nri.2016.87	http://dx.doi.org/10.1038/nri.2016.87			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS8CT	27461148				2022-12-18	WOS:000381011200004
J	Minton, K				Minton, Kirsty			INFLAMMASOME To die or not to die	NATURE REVIEWS IMMUNOLOGY			English	News Item														Minton, Kirsty/0000-0002-3857-8030					0	2	2	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUL	2016	16	7								10.1038/nri.2016.73	http://dx.doi.org/10.1038/nri.2016.73			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP9SR	27320315	Bronze			2022-12-18	WOS:000378837900006
J	Mehta, A; Baltimore, D				Mehta, Arnav; Baltimore, David			MicroRNAs as regulatory elements in immune system logic (vol 16, pg 279, 2016)	NATURE REVIEWS IMMUNOLOGY			English	Correction																		Mehta A, 2016, NAT REV IMMUNOL, V16, P279, DOI 10.1038/nri.2016.40	1	2	2	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2016	16	6					401	401		10.1038/nri.2016.65	http://dx.doi.org/10.1038/nri.2016.65			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DN0GP		Bronze			2022-12-18	WOS:000376742700013
J	Hancock, REW; Haney, EF; Gill, EE				Hancock, Robert E. W.; Haney, Evan F.; Gill, Erin E.			The immunology of host defence peptides: beyond antimicrobial activity (vol 16, pg 321, 2016)	NATURE REVIEWS IMMUNOLOGY			English	Correction																		Hancock REW, 2016, NAT REV IMMUNOL, V16, P321, DOI 10.1038/nri.2016.29	1	2	2	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2016	16	5												1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DK5UE					2022-12-18	WOS:000374985400012
J	Hussell, T				Hussell, Tracy			HETEROLOGOUS IMMUNITY MEETS TISSUE-SPECIFIC TRAINING	NATURE REVIEWS IMMUNOLOGY			English	News Item									[Hussell, Tracy] Univ Manchester, MCCIR, Oxford Rd, Manchester M13 9PT, Lancs, England	University of Manchester	Hussell, T (corresponding author), Univ Manchester, MCCIR, Oxford Rd, Manchester M13 9PT, Lancs, England.	tracy.hussell@manchester.ac.uk	Hussell, Tracy/O-4630-2014	Hussell, Tracy/0000-0001-7186-6141	MRC [MC_PC_15072, G0802752] Funding Source: UKRI; Medical Research Council [MC_PC_15072, G0802752] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))			0	2	2	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2016	16	5					275	275		10.1038/nri.2016.41	http://dx.doi.org/10.1038/nri.2016.41			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DK5UE	27040642	Bronze			2022-12-18	WOS:000374985400004
J	Bird, L				Bird, Lucy			Ageing muscles lose T Reg-eneration	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bird, Lucy/0000-0002-3914-6045					0	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2016	16	4					204	204		10.1038/nri.2016.30	http://dx.doi.org/10.1038/nri.2016.30			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH7MD	26972726				2022-12-18	WOS:000372977200002
J	Minton, K				Minton, Kirsty			MUCOSAL IMMUNOLOGY Weaning off food allergy	NATURE REVIEWS IMMUNOLOGY			English	News Item														Minton, Kirsty/0000-0002-3857-8030					0	2	2	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAR	2016	16	3					133	133		10.1038/nri.2016.24	http://dx.doi.org/10.1038/nri.2016.24			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DF5LU	26898112				2022-12-18	WOS:000371394100006
J	Bird, L				Bird, Lucy			IMMUNE MEMORY ILC2s drive allergen recall	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bird, Lucy/0000-0002-3914-6045				Halim TYF, 2016, NAT IMMUNOL, V17, P57, DOI 10.1038/ni.3294	1	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2016	16	2					72	72		10.1038/nri.2016.10	http://dx.doi.org/10.1038/nri.2016.10			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DC4IG	26806480				2022-12-18	WOS:000369183800002
J	Kugelberg, E				Kugelberg, Elisabeth			IMMUNOMETABOLISM Unravelling the puzzle to longevity and immunity	NATURE REVIEWS IMMUNOLOGY			English	News Item														Kugelberg, Elisabeth/0000-0002-8302-3595				Youm Y.-H., 2016, P NATL ACAD SCI US	1	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2016	16	2					74	74		10.1038/nri.2016.16	http://dx.doi.org/10.1038/nri.2016.16			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DC4IG	26831525				2022-12-18	WOS:000369183800005
J	Bordon, Y				Bordon, Yvonne			A smoke-induced microRNA fires up DCs	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X					0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2015	15	12					728	729		10.1038/nri3935	http://dx.doi.org/10.1038/nri3935			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CY1FS	26515080				2022-12-18	WOS:000366152700006
J	Bordon, Y				Bordon, Yvonne			NEUTROPHILS Growing old disgracefully?	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X					0	2	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2015	15	11					665	665		10.1038/nri3924	http://dx.doi.org/10.1038/nri3924			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CU7CG	26471779				2022-12-18	WOS:000363692400001
J	Dennis, EA; Norris, PC				Dennis, Edward A.; Norris, Paul C.			Eicosanoid storm in infection and inflammation (vol 15, pg 511, 2015)	NATURE REVIEWS IMMUNOLOGY			English	Correction													Dennis, Edward A./M-5554-2019	Dennis, Edward A./0000-0003-3738-3140				Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859	1	2	3	2	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2015	15	11								10.1038/nri3928	http://dx.doi.org/10.1038/nri3928			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CU7CG		Bronze			2022-12-18	WOS:000363692400012
J	O'Shea, J				O'Shea, John			A FIRST LOOK AT T-H CELL TRANSCRIPTOMES	NATURE REVIEWS IMMUNOLOGY			English	News Item									NIAMSD, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	O'Shea, J (corresponding author), NIAMSD, NIH, Bethesda, MD 20892 USA.	John.Oshea@nih.gov							0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2015	15	11					668	668		10.1038/nri3913	http://dx.doi.org/10.1038/nri3913			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CU7CG	26403100				2022-12-18	WOS:000363692400005
J	Minton, K				Minton, Kirsty			Neutrophils leave a trail for T cells	NATURE REVIEWS IMMUNOLOGY			English	News Item														Minton, Kirsty/0000-0002-3857-8030				Lim K, 2015, SCIENCE, V349, DOI 10.1126/science.aaa4352	1	2	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2015	15	10					597	597		10.1038/nri3917	http://dx.doi.org/10.1038/nri3917			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CS2PE	26388330	Bronze			2022-12-18	WOS:000361912600004
J	Bordon, Y				Bordon, Yvonne			A painful difference between the sexes	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X				Grace PM, 2014, NAT REV IMMUNOL, V14, P217, DOI 10.1038/nri3621; Sorge RE., 2015, NAT NEUROSCI	2	2	2	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2015	15	8					469	469		10.1038/nri3892	http://dx.doi.org/10.1038/nri3892			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CN5DZ	26184714				2022-12-18	WOS:000358451300007
J	Bordon, Y				Bordon, Yvonne			Microbiota-induced T cells block allergic inflammation	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X				Ohnmacht C, 2015, SCIENCE	1	2	4	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2015	15	8								10.1038/nri3894	http://dx.doi.org/10.1038/nri3894			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CN5DZ		Bronze			2022-12-18	WOS:000358451300006
J	Leavy, O				Leavy, Olive			Benefits of exhaustion	NATURE REVIEWS IMMUNOLOGY			English	News Item																		McKinney E.F., 2015, NATURE; Wherry E.J., NAT REV IMM IN PRESS	2	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2015	15	8					468	468		10.1038/nri3890	http://dx.doi.org/10.1038/nri3890			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CN5DZ	26160615				2022-12-18	WOS:000358451300005
J	Leavy, O				Leavy, Olive			MUCOSAL IMMUNOLOGY Message in a bottle	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	2	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUL	2015	15	7								10.1038/nri3872	http://dx.doi.org/10.1038/nri3872			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CL3RC	26052096	Bronze			2022-12-18	WOS:000356867100002
J	Leavy, O				Leavy, Olive			A triple blow for cancer	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	2	2	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2015	15	5					265	265		10.1038/nri3844	http://dx.doi.org/10.1038/nri3844			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG6YV	25814401				2022-12-18	WOS:000353449800001
J	Leavy, O				Leavy, Olive			Brain-fat axis in adaptive immunity	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	2	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2015	15	5					267	267		10.1038/nri3853	http://dx.doi.org/10.1038/nri3853			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG6YV	25907457				2022-12-18	WOS:000353449800004
J	Kugelberg, E				Kugelberg, Elisabeth			INFLAMMASOME Starving inflammation	NATURE REVIEWS IMMUNOLOGY			English	News Item														Kugelberg, Elisabeth/0000-0002-8302-3595					0	2	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2015	15	4					199	199		10.1038/nri3832	http://dx.doi.org/10.1038/nri3832			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CE5CH	25743221	Bronze			2022-12-18	WOS:000351847200001
J	Minton, K				Minton, Kirsty			A second chance for antibodies	NATURE REVIEWS IMMUNOLOGY			English	News Item														Minton, Kirsty/0000-0002-3857-8030					0	2	2	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAR	2015	15	3					131	131		10.1038/nri3829	http://dx.doi.org/10.1038/nri3829			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CC4MR	25698675				2022-12-18	WOS:000350328000003
J	Kugelberg, E				Kugelberg, Elisabeth			Double skin protection	NATURE REVIEWS IMMUNOLOGY			English	News Item														Kugelberg, Elisabeth/0000-0002-8302-3595					0	2	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2015	15	2								10.1038/nri3811	http://dx.doi.org/10.1038/nri3811			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CA0ZQ	25614313				2022-12-18	WOS:000348642400003
J	Bordon, Y				Bordon, Yvonne			MICROBIOTA Gut bacteria cross malaria	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X					0	2	2	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2015	15	1					1	1		10.1038/nri3796	http://dx.doi.org/10.1038/nri3796			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AX3JJ	25534616				2022-12-18	WOS:000346835400001
J	Bordon, Y				Bordon, Yvonne			PARASITE IMMUNITY Chitinase-like proteins smoke out worms	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X					0	2	2	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2014	14	12					775	775		10.1038/nri3770	http://dx.doi.org/10.1038/nri3770			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU4FW	25359441				2022-12-18	WOS:000345566400001
J	Shipman, L				Shipman, Lydia			CYTOKINES ISG15-human deficiency reveals new proficiency	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	2	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2014	14	12								10.1038/nri3767	http://dx.doi.org/10.1038/nri3767			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU4FW	25359440				2022-12-18	WOS:000345566400007
J	Leavy, O				Leavy, Olive			NATURAL KILLER CELLS RAG keeps natural killers fit	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	2	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2014	14	11								10.1038/nri3760	http://dx.doi.org/10.1038/nri3760			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AS8BQ	25301254				2022-12-18	WOS:000344475800006
J	Minton, K				Minton, Kirsty			MICROBIOTA Support your friends to resist your enemies	NATURE REVIEWS IMMUNOLOGY			English	News Item														Minton, Kirsty/0000-0002-3857-8030					0	2	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2014	14	11					715	715		10.1038/nri3765	http://dx.doi.org/10.1038/nri3765			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AS8BQ	25341430				2022-12-18	WOS:000344475800004
J	Minton, K				Minton, Kirsty			A 'natural' vaccine adjuvant	NATURE REVIEWS IMMUNOLOGY			English	News Item														Minton, Kirsty/0000-0002-3857-8030				Oh I. Z., 2014, IMMUNITY	1	2	2	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2014	14	10					650	651		10.1038/nri3745	http://dx.doi.org/10.1038/nri3745			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AQ5PD	25234145				2022-12-18	WOS:000342860200006
J	Nunes-Alves, C				Nunes-Alves, Claudio			INFLAMMASOMES New LPS receptors discovered	NATURE REVIEWS IMMUNOLOGY			English	News Item														Nunes-Alves, Claudio/0000-0001-9639-0477				Shi J, 2014, NATURE	1	2	2	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2014	14	9								10.1038/nri3736	http://dx.doi.org/10.1038/nri3736			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO5KL	25145754				2022-12-18	WOS:000341383600006
J	Bordon, Y				Bordon, Yvonne			INNATE IMMUNITY Peroxisomes pack a distinct punch	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X					0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2014	14	8					516	517		10.1038/nri3718	http://dx.doi.org/10.1038/nri3718			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AM7UR	25013966				2022-12-18	WOS:000340074700003
J	Kugelberg, E				Kugelberg, Elisabeth			T CELL RECOGNITION A hidden heavy metal	NATURE REVIEWS IMMUNOLOGY			English	News Item														Kugelberg, Elisabeth/0000-0002-8302-3595					0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2014	14	8					518	519		10.1038/nri3724	http://dx.doi.org/10.1038/nri3724			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AM7UR	25060578	Bronze			2022-12-18	WOS:000340074700005
J	Legg, K				Legg, Katrin			CYTOKINES Tipping TB off balance	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	2	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2014	14	8					516	517		10.1038/nri3722	http://dx.doi.org/10.1038/nri3722			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AM7UR	25033906	Bronze			2022-12-18	WOS:000340074700002
J	Kugelberg, E				Kugelberg, Elisabeth			NEUTROPHILS Bugging transplantation	NATURE REVIEWS IMMUNOLOGY			English	News Item														Kugelberg, Elisabeth/0000-0002-8302-3595					0	2	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUL	2014	14	7					430	430		10.1038/nri3703	http://dx.doi.org/10.1038/nri3703			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AL0UB	24903912				2022-12-18	WOS:000338841200002
J	Bordon, Y				Bordon, Yvonne			AUTOIMMUNITY A breakthrough to explain sex bias?	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X					0	2	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2014	14	6					355	355		10.1038/nri3696	http://dx.doi.org/10.1038/nri3696			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AJ7AP	24854585	Bronze			2022-12-18	WOS:000337849700003
J	Minton, K				Minton, Kirsty			T CELL SIGNALLING p53 controls the crowd	NATURE REVIEWS IMMUNOLOGY			English	News Item														Minton, Kirsty/0000-0002-3857-8030					0	2	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2014	14	6					358	359		10.1038/nri3687	http://dx.doi.org/10.1038/nri3687			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AJ7AP	24810199				2022-12-18	WOS:000337849700008
J	Guilliams, M; Bruhns, P; Saeys, Y; Hammad, H; Lambrecht, BN				Guilliams, Martin; Bruhns, Pierre; Saeys, Yvan; Hammad, Hamida; Lambrecht, Bart N.			The function of Fc gamma receptors in dendritic cells and macrophages	NATURE REVIEWS IMMUNOLOGY			English	Correction													Saeys, Yvan/C-1311-2009; Bruhns, Pierre/F-5567-2013; Hammad, Hamida/J-9391-2015	Saeys, Yvan/0000-0002-0415-1506; Bruhns, Pierre/0000-0002-4709-8936; Hammad, Hamida/0000-0003-3762-8603				Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582	1	2	2	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2014	14	5								10.1038/nri3666	http://dx.doi.org/10.1038/nri3666			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AF8ZB		Bronze			2022-12-18	WOS:000335003400017
J	Kugelberg, E				Kugelberg, Elisabeth			IMMUNOGENETICS Tracking immune activity across the genome	NATURE REVIEWS IMMUNOLOGY			English	News Item														Kugelberg, Elisabeth/0000-0002-8302-3595				Fairfax BP, 2014, SCIENCE; Lee M. N., 2014, SCIENCE	2	2	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2014	14	4								10.1038/nri3653	http://dx.doi.org/10.1038/nri3653			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AD6YY	24662379	Bronze			2022-12-18	WOS:000333408800006
J	Kugelberg, E				Kugelberg, Elisabeth			NEUTROPHILS Nanoparticles targeting the bad guys	NATURE REVIEWS IMMUNOLOGY			English	News Item														Kugelberg, Elisabeth/0000-0002-8302-3595				Wang ZJ, 2014, NAT NANOTECHNOL, V9, P204, DOI [10.1038/NNANO.2014.17, 10.1038/nnano.2014.17]	1	2	2	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2014	14	4								10.1038/nri3648	http://dx.doi.org/10.1038/nri3648			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AD6YY	24625844				2022-12-18	WOS:000333408800008
J	Bird, L				Bird, Lucy			Innate control of IgA	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bird, Lucy/0000-0002-3914-6045				Kruglov AA, 2013, SCIENCE, V342, P1243, DOI 10.1126/science.1243364	1	2	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2014	14	2					66	67		10.1038/nri3613	http://dx.doi.org/10.1038/nri3613			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA3VI	24457481				2022-12-18	WOS:000331022400008
J	Kugelberg, E				Kugelberg, Elisabeth			A new clue to sleepiness	NATURE REVIEWS IMMUNOLOGY			English	News Item														Kugelberg, Elisabeth/0000-0002-8302-3595				De la Herran-Arita AK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007762	1	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2014	14	2					66	67						2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA3VI	24445664				2022-12-18	WOS:000331022400009
J	Leavy, O				Leavy, Olive			Muscling in on repair	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054	1	2	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2014	14	2					63	63		10.1038/nri3602	http://dx.doi.org/10.1038/nri3602			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA3VI	24378844	Bronze			2022-12-18	WOS:000331022400004
J	Leavy, O				Leavy, Olive			MACROPHAGES Early antifungal defence in kidneys	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	2	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	JAN	2014	14	1								10.1038/nri3589	http://dx.doi.org/10.1038/nri3589			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	279LT	24336105	Bronze			2022-12-18	WOS:000328962200009
J	Papatriantafyllou, M				Papatriantafyllou, Maria			IMMUNOTHERAPY Cancer immunotherapy for the elderly	NATURE REVIEWS IMMUNOLOGY			English	News Item													Papatriantafyllou, Maria/ADP-1463-2022					Bouchlaka MN, 2013, J EXP MED, V210, P2223, DOI 10.1084/jem.20131219	1	2	3	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2013	13	11								10.1038/nri3557	http://dx.doi.org/10.1038/nri3557			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	241HY	24113867	Bronze			2022-12-18	WOS:000326158400006
J	Papatriantafyllou, M				Papatriantafyllou, Maria			HAEMATOPOIESIS Two versions of the Ikaros tale	NATURE REVIEWS IMMUNOLOGY			English	News Item													Papatriantafyllou, Maria/ADP-1463-2022					Schjerven H, 2013, NAT IMMUNOL, V14, P1073, DOI 10.1038/ni.2707	1	2	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2013	13	11								10.1038/nri3550	http://dx.doi.org/10.1038/nri3550			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	241HY	24096335	Bronze			2022-12-18	WOS:000326158400003
J	Bird, L				Bird, Lucy			B CELL DEVELOPMENT A window of opportunity	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bird, Lucy/0000-0002-3914-6045					0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2013	13	10					707	707		10.1038/nri3540	http://dx.doi.org/10.1038/nri3540			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	224GH	24064517				2022-12-18	WOS:000324870400007
J	Papatriantafyllou, M				Papatriantafyllou, Maria			REGULATORY T CELLS Keeping the numbers steady	NATURE REVIEWS IMMUNOLOGY			English	News Item													Papatriantafyllou, Maria/ADP-1463-2022					Pierson W, 2013, NAT IMMUNOL, V14, P959, DOI 10.1038/ni.2649	1	2	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2013	13	9								10.1038/nri3514	http://dx.doi.org/10.1038/nri3514			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	208BA	23887242				2022-12-18	WOS:000323648900005
J	Rickert, RC				Rickert, Robert C.			New insights into pre- BCR and BCR signalling with relevance to B cell malignancies (vol 13, pg 578, 2013)	NATURE REVIEWS IMMUNOLOGY			English	Correction																		Rickert RC, 2013, NAT REV IMMUNOL, V13, P578, DOI 10.1038/nri3487	1	2	2	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2013	13	9								10.1038/nri3526	http://dx.doi.org/10.1038/nri3526			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	208BA		Bronze			2022-12-18	WOS:000323648900016
J	Smith, DM; Simon, JK; Baker, JR				Smith, Douglas M.; Simon, Jakub K.; Baker, James R., Jr.			Applications of nanotechnology for immunology (vol 13, pg 592, 2013)	NATURE REVIEWS IMMUNOLOGY			English	Correction																		Smith DM, 2013, NAT REV IMMUNOL, V13, P592, DOI 10.1038/nri3488	1	2	2	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2013	13	9								10.1038/nri3517	http://dx.doi.org/10.1038/nri3517			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	208BA		Bronze			2022-12-18	WOS:000323648900015
J	Bird, L				Bird, Lucy			B CELL TOLERANCE STALling B cell responses	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bird, Lucy/0000-0002-3914-6045					0	2	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2013	13	8								10.1038/nri3503	http://dx.doi.org/10.1038/nri3503			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	188TS	23868217	Bronze			2022-12-18	WOS:000322217500009
J	Bordon, Y				Bordon, Yvonne			MUCOSAL IMMUNOLOGY ILCs broker peace deals in the gut	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X					0	2	2	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JUL	2013	13	7					473	473		10.1038/nri3480	http://dx.doi.org/10.1038/nri3480			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	170LT	23743477				2022-12-18	WOS:000320853100007
J	Chen, LP; Flies, DB				Chen, Lieping; Flies, Dallas B.			Molecular mechanisms of T cell co-stimulation and co-inhibition (vol 13, pg 27, 2013)	NATURE REVIEWS IMMUNOLOGY			English	Correction																		Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405	1	2	2	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JUL	2013	13	7												1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	170LT					2022-12-18	WOS:000320853100014
J	Leavy, O				Leavy, Olive			HAEMATOPOIESIS Neutrophil clearance keeps the beat	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JUL	2013	13	7								10.1038/nri3483	http://dx.doi.org/10.1038/nri3483			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	170LT	23765058				2022-12-18	WOS:000320853100003
J	Leavy, O				Leavy, Olive			Adaptive control of NK cells	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	2	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2013	13	6					394	394		10.1038/nri3471	http://dx.doi.org/10.1038/nri3471			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	151FE	23681100	Bronze			2022-12-18	WOS:000319445300006
J	Minton, K				Minton, Kirsty			Resistance is futile	NATURE REVIEWS IMMUNOLOGY			English	News Item														Minton, Kirsty/0000-0002-3857-8030					0	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2013	13	6					391	391		10.1038/nri3462	http://dx.doi.org/10.1038/nri3462			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	151FE	23648969	Bronze			2022-12-18	WOS:000319445300001
J	Papatriantafyllou, M				Papatriantafyllou, Maria			The origins of colonic T-Reg cells	NATURE REVIEWS IMMUNOLOGY			English	News Item													Papatriantafyllou, Maria/ADP-1463-2022						0	2	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2013	13	6								10.1038/nri3468	http://dx.doi.org/10.1038/nri3468			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	151FE	23681099	Bronze			2022-12-18	WOS:000319445300005
J	Bordon, Y				Bordon, Yvonne			NEUROINFLAMMATION Inflammatory brain drain	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X					0	2	2	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2013	13	2					69	69		10.1038/nri3392	http://dx.doi.org/10.1038/nri3392			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	089JK	23334247				2022-12-18	WOS:000314906600006
J	Bordon, Y				Bordon, Yvonne			INNATE IMMUNITY Bitter enemies	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X				Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240	1	2	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2012	12	11								10.1038/nri3332	http://dx.doi.org/10.1038/nri3332			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	029UZ	23080389				2022-12-18	WOS:000310523400007
J	Papatriantafyllou, M				Papatriantafyllou, Maria			INNATE IMMUNITY Inflammasome triggered by cell swelling	NATURE REVIEWS IMMUNOLOGY			English	News Item													Papatriantafyllou, Maria/ADP-1463-2022					Compan V, 2012, IMMUNITY, V37, P487, DOI 10.1016/j.immuni.2012.06.013	1	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2012	12	11								10.1038/nri3324	http://dx.doi.org/10.1038/nri3324			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	029UZ	23037555				2022-12-18	WOS:000310523400003
J	Papatriantafyllou, M				Papatriantafyllou, Maria			SIGNALLING PI3K delta keeps TLR4 signalling on track	NATURE REVIEWS IMMUNOLOGY			English	News Item													Papatriantafyllou, Maria/ADP-1463-2022					Aksoy E, 2012, NAT IMMUNOL, V13, P1045, DOI 10.1038/ni.2426	1	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	NOV	2012	12	11								10.1038/nri3330	http://dx.doi.org/10.1038/nri3330			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	029UZ	23059427				2022-12-18	WOS:000310523400005
J	Hutchinson, E				Hutchinson, Ezzie			TUMOUR IMMUNOLOGY Differing roles for MYD88 in carcinogenesis	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2012	12	10					681	681		10.1038/nri3304	http://dx.doi.org/10.1038/nri3304			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	012VD	22955844	Bronze			2022-12-18	WOS:000309263800004
J	Leavy, O				Leavy, Olive			(en)ABLing T cell migration	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	2	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	SEP	2012	12	9					616	616		10.1038/nri3282	http://dx.doi.org/10.1038/nri3282			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	998NZ	22858759				2022-12-18	WOS:000308248200002
J	Hutchinson, E				Hutchinson, Ezzie			TOLERANCE PD1-a multitasking receptor	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Patsoukis N, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002796	1	2	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2012	12	8					553	553		10.1038/nri3266	http://dx.doi.org/10.1038/nri3266			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	978RI	22828908	Bronze			2022-12-18	WOS:000306762500006
J	Bordon, Y				Bordon, Yvonne			AUTOIMMUNITY Inflammasome dependency key for treating EAE	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X					0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JUL	2012	12	7					477	477		10.1038/nri3248	http://dx.doi.org/10.1038/nri3248			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	965YF	22699830	Bronze			2022-12-18	WOS:000305803000007
J	Kahrstrom, CT				Kahrstroem, Christina Tobin			INNATE IMMUNITY Destructive interference of PRRs	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	2	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JUL	2012	12	7					474	474		10.1038/nri3245	http://dx.doi.org/10.1038/nri3245			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	965YF	22653229				2022-12-18	WOS:000305803000002
J	Leavy, O				Leavy, Olive			ANTIGEN PRESENTATION Visualizing DC dynamics in the lung	NATURE REVIEWS IMMUNOLOGY			English	News Item																			0	2	2	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JUL	2012	12	7					473	473		10.1038/nri3246	http://dx.doi.org/10.1038/nri3246			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	965YF	22653228	Bronze			2022-12-18	WOS:000305803000001
J	Bird, L				Bird, Lucy			INNATE IMMUNITY ADAM17-gatekeeper of the skin barrier	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bird, Lucy/0000-0002-3914-6045					0	2	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	MAR	2012	12	3					154	154		10.1038/nri3178	http://dx.doi.org/10.1038/nri3178			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899CJ	22362351				2022-12-18	WOS:000300790600007
J	Leavy, O				Leavy, Olive			NATURAL KILLER CELLS Maturation and function of NK cells	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044	1	2	2	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	MAR	2012	12	3								10.1038/nri3172	http://dx.doi.org/10.1038/nri3172			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899CJ	22322319				2022-12-18	WOS:000300790600003
J	Leavy, O				Leavy, Olive			MUCOSAL IMMUNOLOGY Multifunctional gut IgA(+) plasma cells	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Fritz J. H, 2011, NATURE          1211, DOI [10.1038/nature10698, DOI 10.1038/NATURE10698]	1	2	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	FEB	2012	12	2					75	75		10.1038/nri3157	http://dx.doi.org/10.1038/nri3157			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	892OU	22240626	Bronze			2022-12-18	WOS:000300296300004
J	Bordon, Y				Bordon, Yvonne			IMMUNOTHERAPY Leukadherins get a grip on inflammation	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X				Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Maiguel D, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001811	2	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	OCT	2011	11	10					638	638		10.1038/nri3079	http://dx.doi.org/10.1038/nri3079			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	823WC	21941286	Bronze			2022-12-18	WOS:000295156600003
J	Woodman, I				Woodman, Isabel			T CELLS A metabolic sHIFt to turn 17	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278	1	2	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	AUG	2011	11	8					503	503		10.1038/nri3037	http://dx.doi.org/10.1038/nri3037			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	796RN	21785454				2022-12-18	WOS:000293069600008
J	Bordon, Y				Bordon, Yvonne			ASTHMA AND ALLERGY Influenza virus and an innate form of asthma	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X					0	2	4	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JUL	2011	11	7					443	443		10.1038/nri3013	http://dx.doi.org/10.1038/nri3013			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	782QS	21681195	Bronze			2022-12-18	WOS:000292025300008
J	Bordon, Y				Bordon, Yvonne			PHAGOCYTOSIS A synapse for snaps	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X				Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071	1	2	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2011	11	6								10.1038/nri3000	http://dx.doi.org/10.1038/nri3000			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	768PT	21610736				2022-12-18	WOS:000290948600008
J	Leavy, O				Leavy, Olive			INNATE IMMUNITY GBPs coordinate vesicular trafficking for host defence	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711	1	2	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2011	11	6								10.1038/nri3003	http://dx.doi.org/10.1038/nri3003			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	768PT	21610737	Bronze			2022-12-18	WOS:000290948600010
J	Leavy, O				Leavy, Olive			INNATE IMMUNITY Linking lipids and inflammasomes	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Im SS, 2011, CELL METAB, V13, P540, DOI 10.1016/j.cmet.2011.04.001	1	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2011	11	6								10.1038/nri2997	http://dx.doi.org/10.1038/nri2997			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	768PT	21610734	Bronze			2022-12-18	WOS:000290948600003
J	Woodman, I				Woodman, Isabel			SIGNALLING PI3K beta - linking signals for neutrophil activation	NATURE REVIEWS IMMUNOLOGY			English	News Item																		Kulkarni S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001617	1	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	JUN	2011	11	6								10.1038/nri2994	http://dx.doi.org/10.1038/nri2994			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	768PT	21597475	Bronze			2022-12-18	WOS:000290948600005
J	Bordon, Y				Bordon, Yvonne			T CELL SIGNALLING Heavy metal rocks T cells	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X					0	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2011	11	5					300	300		10.1038/nri2977	http://dx.doi.org/10.1038/nri2977			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	753LH	21494265				2022-12-18	WOS:000289774700004
J	Bordon, Y				Bordon, Yvonne			ALLERGY Shocking behaviour	NATURE REVIEWS IMMUNOLOGY			English	News Item														Bordon, Yvonne/0000-0002-9728-012X					0	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733			NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2011	11	5					302	302		10.1038/nri2980	http://dx.doi.org/10.1038/nri2980			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	753LH	21508976				2022-12-18	WOS:000289774700006
